<!DOCTYPE html>
<html lang="en">
  <head>
    <title>US20190338263A1 - Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
      - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/US20190338263A1/en">
    <meta name="description" content="
     The present invention encompasses engineered nucleases which recognize and cleave a recognition sequence within a Hepatitis B virus (HBV) genome. The engineered meganucleases can exhibit at least one optimized characteristic, such as enhanced specificity and/or efficiency of indel formation, when compared to the first-generation meganuclease HBV 11-12x.26. Further, the invention encompasses pharmaceutical compositions comprising engineered meganuclease proteins, nucleic acids encoding engineered meganucleases, and the use of such compositions for treating HBV infections or hepatocellular carcinoma. 
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
     ">
    <meta name="DC.date" content="2019-04-11" scheme="dateSubmitted">
    <meta name="DC.description" content="
     The present invention encompasses engineered nucleases which recognize and cleave a recognition sequence within a Hepatitis B virus (HBV) genome. The engineered meganucleases can exhibit at least one optimized characteristic, such as enhanced specificity and/or efficiency of indel formation, when compared to the first-generation meganuclease HBV 11-12x.26. Further, the invention encompasses pharmaceutical compositions comprising engineered meganuclease proteins, nucleic acids encoding engineered meganucleases, and the use of such compositions for treating HBV infections or hepatocellular carcinoma. 
   
   ">
    <meta name="citation_patent_application_number" content="US:16/381,668">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/4e/9d/ec/cedc7308e1d97a/US20190338263A1.pdf">
    <meta name="citation_patent_publication_number" content="US:20190338263:A1">
    <meta name="DC.date" content="2019-11-07">
    <meta name="DC.contributor" content="James Jefferson SMITH" scheme="inventor">
    <meta name="DC.contributor" content="Janel Lape" scheme="inventor">
    <meta name="DC.contributor" content="Victor Bartsevich" scheme="inventor">
    <meta name="DC.contributor" content="Hui Li" scheme="inventor">
    <meta name="DC.contributor" content="Precision Biosciences Inc" scheme="assignee">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      
      #gb { top: 15px; left: auto; right: 0; width: auto; min-width: 135px !important; }   
      body { transition: none; }
    </style>
    <script></script>

    <script>
      window.version = 'patent-search.search_20250707_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;
      window.experiments.plogs = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20250707_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20250707_RC00/scs/compiled_dir/search-app-vulcanized.html">
  </head>
  <body unresolved>
    
    
    <script></script>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20250707_RC00/scs/compiled_dir/search-app-vulcanized.js"></script>
    <search-app>
      
      

      <article class="result" itemscope itemtype="http://schema.org/ScholarlyArticle">
  <h1 itemprop="pageTitle">US20190338263A1 - Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
      - Google Patents</h1>
  <span itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
     </span>

  <meta itemprop="type" content="patent">
  <a href="https://patentimages.storage.googleapis.com/4e/9d/ec/cedc7308e1d97a/US20190338263A1.pdf" itemprop="pdfLink">Download PDF</a>
  <h2>Info</h2>

  <dl>
    <dt>Publication number</dt>
    <dd itemprop="publicationNumber">US20190338263A1</dd>
    <meta itemprop="numberWithoutCodes" content="20190338263">
    <meta itemprop="kindCode" content="A1">
    <meta itemprop="publicationDescription" content="Patent application publication">
    <span>US20190338263A1</span>
    <span>US16/381,668</span>
    <span>US201916381668A</span>
    <span>US2019338263A1</span>
    <span>US 20190338263 A1</span>
    <span>US20190338263 A1</span>
    <span>US 20190338263A1</span>
    <span>  </span>
    <span> </span>
    <span> </span>
    <span>US 201916381668 A</span>
    <span>US201916381668 A</span>
    <span>US 201916381668A</span>
    <span>US 2019338263 A1</span>
    <span>US2019338263 A1</span>
    <span>US 2019338263A1</span>

    <dt>Authority</dt>
    <dd itemprop="countryCode">US</dd>
    <dd itemprop="countryName">United States</dd>

    <dt>Prior art keywords</dt>
    <dd itemprop="priorArtKeywords" repeat>hbv</dd>
    <dd itemprop="priorArtKeywords" repeat>seq</dd>
    <dd itemprop="priorArtKeywords" repeat>meganuclease</dd>
    <dd itemprop="priorArtKeywords" repeat>engineered meganuclease</dd>
    <dd itemprop="priorArtKeywords" repeat>engineered</dd>

    <dt>Prior art date</dt>
    <dd><time itemprop="priorArtDate" datetime="2018-04-12">2018-04-12</time></dd>

    <dt>Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)</dt>
    <dd itemprop="legalStatusIfi" itemscope>
      <span itemprop="status">Granted</span>
    </dd>
  </dl>

  <dt>Application number</dt>
  <dd itemprop="applicationNumber">US16/381,668</dd>

  

  <dt>Other versions</dt>
  <dd itemprop="directAssociations" itemscope repeat>
    <a href="/patent/US11142750B2/en">
      <span itemprop="publicationNumber">US11142750B2</span>
      (<span itemprop="primaryLanguage">en</span>
    </a>
  </dd>

  <dt>Inventor</dt>
  <dd itemprop="inventor" repeat>James Jefferson SMITH</dd>
  <dd itemprop="inventor" repeat>Janel Lape</dd>
  <dd itemprop="inventor" repeat>Victor Bartsevich</dd>
  <dd itemprop="inventor" repeat>Hui Li</dd>

  <dt>Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)</dt>
  <dd itemprop="assigneeCurrent" repeat>
    Precision Biosciences Inc
  </dd>

  <dt>Original Assignee</dt>
  <dd itemprop="assigneeOriginal" repeat>Precision Biosciences Inc</dd>

  <dt>Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)</dt>
  <dd><time itemprop="priorityDate" datetime="2018-04-12">2018-04-12</time></dd>

  <dt>Filing date</dt>
  <dd><time itemprop="filingDate" datetime="2019-04-11">2019-04-11</time></dd>

  <dt>Publication date</dt>
  <dd><time itemprop="publicationDate" datetime="2019-11-07">2019-11-07</time></dd>

  
  <dd itemprop="events" itemscope repeat>
    <time itemprop="date" datetime="2019-04-11">2019-04-11</time>
    <span itemprop="title">Application filed by Precision Biosciences Inc</span>
    <span itemprop="type">filed</span>
    <span itemprop="critical" content="true" bool>Critical</span>
    
    
    
    <span itemprop="assigneeSearch">Precision Biosciences Inc</span>
  </dd>
  <dd itemprop="events" itemscope repeat>
    <time itemprop="date" datetime="2019-04-11">2019-04-11</time>
    <span itemprop="title">Priority to US16/381,668</span>
    <span itemprop="type">priority</span>
    <span itemprop="critical" content="true" bool>Critical</span>
    
    
    <span itemprop="documentId">patent/US11142750B2/en</span>
    
  </dd>
  <dd itemprop="events" itemscope repeat>
    <time itemprop="date" datetime="2019-06-13">2019-06-13</time>
    <span itemprop="title">Assigned to PRECISION BIOSCIENCES, INC.</span>
    <span itemprop="type">reassignment</span>
    
    
    
    
    <span itemprop="assigneeSearch">PRECISION BIOSCIENCES, INC.</span>
    <span itemprop="description" repeat>ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).</span>
    <span itemprop="description" repeat>Assignors: BARTSEVICH, VICTOR, LAPE, Janel, LI, HUI, SMITH, JAMES JEFFERSON</span>
  </dd>
  <dd itemprop="events" itemscope repeat>
    <time itemprop="date" datetime="2019-11-07">2019-11-07</time>
    <span itemprop="title">Publication of US20190338263A1</span>
    <span itemprop="type">publication</span>
    <span itemprop="critical" content="true" bool>Critical</span>
    
    
    <span itemprop="documentId">patent/US20190338263A1/en</span>
    
  </dd>
  <dd itemprop="events" itemscope repeat>
    <time itemprop="date" datetime="2021-09-20">2021-09-20</time>
    <span itemprop="title">Priority to US17/479,173</span>
    <span itemprop="type">priority</span>
    
    
    
    <span itemprop="documentId">patent/US11788077B2/en</span>
    
  </dd>
  <dd itemprop="events" itemscope repeat>
    <time itemprop="date" datetime="2021-10-12">2021-10-12</time>
    <span itemprop="title">Application granted</span>
    <span itemprop="type">granted</span>
    <span itemprop="critical" content="true" bool>Critical</span>
    
    
    
    
  </dd>
  <dd itemprop="events" itemscope repeat>
    <time itemprop="date" datetime="2021-10-12">2021-10-12</time>
    <span itemprop="title">Publication of US11142750B2</span>
    <span itemprop="type">publication</span>
    <span itemprop="critical" content="true" bool>Critical</span>
    
    
    <span itemprop="documentId">patent/US11142750B2/en</span>
    
  </dd>
  <dd itemprop="events" itemscope repeat>
    <time itemprop="date" datetime="2023-09-12">2023-09-12</time>
    <span itemprop="title">Priority to US18/465,727</span>
    <span itemprop="type">priority</span>
    
    
    
    <span itemprop="documentId">patent/US20240035011A1/en</span>
    
  </dd>
  <dd itemprop="events" itemscope repeat>
    <time itemprop="date" datetime="2025-01-17">2025-01-17</time>
    <span itemprop="title">Priority to US19/029,554</span>
    <span itemprop="type">priority</span>
    
    
    
    <span itemprop="documentId">patent/US20250171757A1/en</span>
    
  </dd>
  <dd itemprop="events" itemscope repeat>
    <time itemprop="date">Status</time>
    <span itemprop="title">Active</span>
    <span itemprop="type">legal-status</span>
    <span itemprop="critical" content="true" bool>Critical</span>
    <span itemprop="current" content="true" bool>Current</span>
    
    
    
  </dd>
  <dd itemprop="events" itemscope repeat>
    <time itemprop="date" datetime="2039-07-31">2039-07-31</time>
    <span itemprop="title">Adjusted expiration</span>
    <span itemprop="type">legal-status</span>
    <span itemprop="critical" content="true" bool>Critical</span>
    
    
    
    
  </dd>

  <h2>Links</h2>
  <ul>
    <li itemprop="links" itemscope repeat>
          <meta itemprop="id" content="usptoLink">
          <a href="https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/srchnum.html&r=1&f=G&l=50&d=PG01&s1=20190338263.PGNR." itemprop="url" target="_blank"><span itemprop="text">USPTO</span></a>
        </li>
        
        <li itemprop="links" itemscope repeat>
          <meta itemprop="id" content="usptoPatentCenterLink">
          <a href="https://patentcenter.uspto.gov/applications/16381668" itemprop="url" target="_blank"><span itemprop="text">USPTO PatentCenter</span></a>
        </li>
        <li itemprop="links" itemscope repeat>
          <meta itemprop="id" content="usptoAssignmentLink">
          <a href="https://assignment.uspto.gov/patent/index.html#/patent/search/resultFilter?searchInput=20190338263" itemprop="url" target="_blank"><span itemprop="text">USPTO Assignment</span></a>
        </li>

    <li itemprop="links" itemscope repeat>
        <meta itemprop="id" content="espacenetLink">
        <a href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=US&amp;NR=2019338263A1&amp;KC=A1&amp;FT=D" itemprop="url" target="_blank"><span itemprop="text">Espacenet</span></a>
      </li>
      

    

    <li itemprop="links" itemscope repeat>
      <meta itemprop="id" content="globalDossierLink">
      <a href="https://globaldossier.uspto.gov/result/application/US/16381668/1" itemprop="url" target="_blank"><span itemprop="text">Global Dossier</span></a>
    </li>

    

      

      

      <li itemprop="links" itemscope repeat>
        <meta itemprop="id" content="stackexchangeLink">
        <a href="https://patents.stackexchange.com/questions/tagged/US20190338263" itemprop="url"><span itemprop="text">Discuss</span></a>
      </li>
      
  </ul>

  <ul itemprop="concept" itemscope>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000700721</span>
      <span itemprop="name">Hepatitis B virus</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>title</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">493</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000007523</span>
      <span itemprop="name">nucleic acids</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">166</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000039446</span>
      <span itemprop="name">nucleic acids</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">92</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020004707</span>
      <span itemprop="name">nucleic acids</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">92</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000008194</span>
      <span itemprop="name">pharmaceutical composition</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">48</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000203</span>
      <span itemprop="name">mixture</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">42</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000015181</span>
      <span itemprop="name">infectious disease</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">36</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">206010073071</span>
      <span itemprop="name">hepatocellular carcinoma</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">31</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000015572</span>
      <span itemprop="name">biosynthetic process</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">30</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000844</span>
      <span itemprop="name">hepatocellular carcinoma</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">30</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020004999</span>
      <span itemprop="name">messenger RNA</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">125</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000003275</span>
      <span itemprop="name">alpha amino acid group</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">75</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091028043</span>
      <span itemprop="name">Nucleic acid sequence</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">73</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000002632</span>
      <span itemprop="name">lipids</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">66</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000000034</span>
      <span itemprop="name">method</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">58</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000003776</span>
      <span itemprop="name">cleavage reaction</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">53</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000007017</span>
      <span itemprop="name">scission</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">53</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002105</span>
      <span itemprop="name">nanoparticle</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">36</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000040430</span>
      <span itemprop="name">polynucleotide</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">36</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091033319</span>
      <span itemprop="name">polynucleotide</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">36</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002157</span>
      <span itemprop="name">polynucleotide</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">36</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000013603</span>
      <span itemprop="name">viral vector</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">35</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020004511</span>
      <span itemprop="name">Recombinant DNA</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">21</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000035755</span>
      <span itemprop="name">proliferation</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">19</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000009472</span>
      <span itemprop="name">formulation</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">16</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003937</span>
      <span itemprop="name">drug carrier</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">10</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002829</span>
      <span itemprop="name">reductive effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">10</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000001727</span>
      <span itemprop="name">in vivo</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>claims</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">8</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108090000623</span>
      <span itemprop="name">proteins and genes</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">141</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000004169</span>
      <span itemprop="name">proteins and genes</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">64</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710163270</span>
      <span itemprop="name">Nuclease</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>abstract</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">45</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000004027</span>
      <span itemprop="name">cell</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">231</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020004414</span>
      <span itemprop="name">DNA</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">97</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003112</span>
      <span itemprop="name">inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">78</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000018102</span>
      <span itemprop="name">proteins</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">62</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003814</span>
      <span itemprop="name">drug</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">61</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">-1</span>
      <span itemprop="name">cationic lipid</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">45</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010050663</span>
      <span itemprop="name">endodeoxyribonuclease CreI</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">41</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108090000765</span>
      <span itemprop="name">processed proteins &amp; peptides</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">41</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000014509</span>
      <span itemprop="name">gene expression</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">40</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000003556</span>
      <span itemprop="name">assay</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">36</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000004196</span>
      <span itemprop="name">processed proteins &amp; peptides</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">36</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229920001184</span>
      <span itemprop="name">polypeptide</span>
      <span itemprop="domain">Polymers</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">35</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000013598</span>
      <span itemprop="name">vector</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">33</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">KKMFSVNFPUPGCA-UHFFFAOYSA-N</span>
      <span itemprop="name">4-fluoro-3-(4-hydroxypiperidin-1-yl)sulfonyl-n-(3,4,5-trifluorophenyl)benzamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1CC(O)CCN1S(=O)(=O)C1=CC(C(=O)NC=2C=C(F)C(F)=C(F)C=2)=CC=C1F</span>
      <span itemprop="inchi_key">KKMFSVNFPUPGCA-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">31</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000427</span>
      <span itemprop="name">antigen</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">28</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091007433</span>
      <span itemprop="name">antigens</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">28</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000036639</span>
      <span itemprop="name">antigens</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">28</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002245</span>
      <span itemprop="name">particle</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">28</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000001890</span>
      <span itemprop="name">transfection</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">28</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000001875</span>
      <span itemprop="name">compounds</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">27</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000004185</span>
      <span itemprop="name">liver</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">27</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940124597</span>
      <span itemprop="name">therapeutic agent</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">27</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000027455</span>
      <span itemprop="name">binding</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">26</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010042407</span>
      <span itemprop="name">Endonucleases</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">23</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091007491</span>
      <span itemprop="name">NSP3 Papain-like protease domains</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">23</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000005516</span>
      <span itemprop="name">engineering process</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">23</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000002672</span>
      <span itemprop="name">hepatitis B</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">22</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000003494</span>
      <span itemprop="name">hepatocyte</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">22</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000000694</span>
      <span itemprop="name">effects</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">21</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000001519</span>
      <span itemprop="name">tissue</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">21</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003612</span>
      <span itemprop="name">virological effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">21</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940126656</span>
      <span itemprop="name">GS-4224</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">20</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010043121</span>
      <span itemprop="name">Green Fluorescent Proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">20</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000004144</span>
      <span itemprop="name">Green Fluorescent Proteins</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">20</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000005090</span>
      <span itemprop="name">green fluorescent protein</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">20</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000001014</span>
      <span itemprop="name">amino acid</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">19</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000007935</span>
      <span itemprop="name">neutral effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">19</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000006467</span>
      <span itemprop="name">substitution reaction</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">19</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000013607</span>
      <span itemprop="name">AAV vector</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">18</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000004458</span>
      <span itemprop="name">analytical method</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">18</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000562</span>
      <span itemprop="name">conjugate</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">18</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HVYWMOMLDIMFJA-DPAQBDIFSA-N</span>
      <span itemprop="name">cholesterol</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2</span>
      <span itemprop="inchi_key">HVYWMOMLDIMFJA-DPAQBDIFSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">17</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100031780</span>
      <span itemprop="name">Endonuclease</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">16</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000013518</span>
      <span itemprop="name">transcription</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">16</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000035897</span>
      <span itemprop="name">transcription</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">16</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000004978</span>
      <span itemprop="name">chinese hamster ovary cell</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">15</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004048</span>
      <span itemprop="name">modification</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">15</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012986</span>
      <span itemprop="name">modification</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">15</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000004806</span>
      <span itemprop="name">packaging method and process</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">15</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000008685</span>
      <span itemprop="name">targeting</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">15</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000053602</span>
      <span itemprop="name">DNA</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">14</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000700605</span>
      <span itemprop="name">Viruses</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">14</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000005520</span>
      <span itemprop="name">cutting process</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">14</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000005647</span>
      <span itemprop="name">linker group</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">14</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000523</span>
      <span itemprop="name">sample</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">14</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000024891</span>
      <span itemprop="name">symptom</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">14</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012217</span>
      <span itemprop="name">deletion</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">13</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000037430</span>
      <span itemprop="name">deletion</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">13</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000003780</span>
      <span itemprop="name">insertion</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">13</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000037431</span>
      <span itemprop="name">insertion</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">13</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091032973</span>
      <span itemprop="name">(ribonucleotides)n&#43;m</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">12</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710132601</span>
      <span itemprop="name">Capsid protein</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">12</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940079593</span>
      <span itemprop="name">drug</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">12</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000006780</span>
      <span itemprop="name">non-homologous end joining</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">12</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000013612</span>
      <span itemprop="name">plasmid</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">12</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960001355</span>
      <span itemprop="name">tenofovir disoproxil</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">12</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">RTZKZFJDLAIYFH-UHFFFAOYSA-N</span>
      <span itemprop="name">Diethyl ether</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCOCC</span>
      <span itemprop="inchi_key">RTZKZFJDLAIYFH-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">11</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000007847</span>
      <span itemprop="name">digital PCR</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">11</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003446</span>
      <span itemprop="name">ligand</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">11</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000009467</span>
      <span itemprop="name">reduction</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">11</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JFVZFKDSXNQEJW-CQSZACIVSA-N</span>
      <span itemprop="name">tenofovir disoproxil</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N</span>
      <span itemprop="inchi_key">JFVZFKDSXNQEJW-CQSZACIVSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">11</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VCMJCVGFSROFHV-WZGZYPNHSA-N</span>
      <span itemprop="name">tenofovir disoproxil fumarate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N</span>
      <span itemprop="inchi_key">VCMJCVGFSROFHV-WZGZYPNHSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">11</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010078049</span>
      <span itemprop="name">Interferon alpha-2</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">10</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940024606</span>
      <span itemprop="name">amino acid</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">10</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000001413</span>
      <span itemprop="name">amino acids</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">10</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003795</span>
      <span itemprop="name">chemical substances by application</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">10</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000518</span>
      <span itemprop="name">lethal</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">10</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001665</span>
      <span itemprop="name">lethal effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">10</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229920001223</span>
      <span itemprop="name">polyethylene glycol</span>
      <span itemprop="domain">Polymers</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">10</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SVUJNSGGPUCLQZ-FQQAACOVSA-N</span>
      <span itemprop="name">tenofovir alafenamide fumarate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)\C=C\C(O)=O.O([P@@](=O)(CO[C@H](C)CN1C2=NC=NC(N)=C2N=C1)N[C@@H](C)C(=O)OC(C)C)C1=CC=CC=C1.O([P@@](=O)(CO[C@H](C)CN1C2=NC=NC(N)=C2N=C1)N[C@@H](C)C(=O)OC(C)C)C1=CC=CC=C1</span>
      <span itemprop="inchi_key">SVUJNSGGPUCLQZ-FQQAACOVSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">10</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960005486</span>
      <span itemprop="name">vaccine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">10</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">FWMNVWWHGCHHJJ-SKKKGAJSSA-N</span>
      <span itemprop="name">4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1</span>
      <span itemprop="inchi_key">FWMNVWWHGCHHJJ-SKKKGAJSSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108700028369</span>
      <span itemprop="name">Alleles</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091034117</span>
      <span itemprop="name">Oligonucleotide</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000001744</span>
      <span itemprop="name">T-lymphocyte</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000012000</span>
      <span itemprop="name">cholesterol</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002744</span>
      <span itemprop="name">homologous recombination</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000006801</span>
      <span itemprop="name">homologous recombination</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002502</span>
      <span itemprop="name">liposome</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000004519</span>
      <span itemprop="name">manufacturing process</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000178</span>
      <span itemprop="name">monomer</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002773</span>
      <span itemprop="name">nucleotide</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000003729</span>
      <span itemprop="name">nucleotide group</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000047</span>
      <span itemprop="name">product</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000010076</span>
      <span itemprop="name">replication</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001225</span>
      <span itemprop="name">therapeutic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">9</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002202</span>
      <span itemprop="name">Polyethylene glycol</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">8</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000011543</span>
      <span itemprop="name">agarose gel</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">8</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000000539</span>
      <span itemprop="name">amino acid group</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">8</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000000840</span>
      <span itemprop="name">anti-viral effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">8</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000037265</span>
      <span itemprop="name">diseases, disorders, signs and symptoms</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">8</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000000987</span>
      <span itemprop="name">immune system</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">8</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940121354</span>
      <span itemprop="name">immunomodulator</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">8</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004568</span>
      <span itemprop="name">DNA-binding</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000004533</span>
      <span itemprop="name">Endonucleases</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100034349</span>
      <span itemprop="name">Integrase</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000011931</span>
      <span itemprop="name">Nucleoproteins</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010061100</span>
      <span itemprop="name">Nucleoproteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000002689</span>
      <span itemprop="name">Toll-like receptor</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020000411</span>
      <span itemprop="name">Toll-like receptor</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002776</span>
      <span itemprop="name">aggregation</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000004220</span>
      <span itemprop="name">aggregation</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000556</span>
      <span itemprop="name">agonist</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000001514</span>
      <span itemprop="name">detection method</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002955</span>
      <span itemprop="name">immunomodulating agent</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960003507</span>
      <span itemprop="name">interferon alfa-2b</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001105</span>
      <span itemprop="name">regulatory effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MIXCUJKCXRNYFM-UHFFFAOYSA-M</span>
      <span itemprop="name">sodium;diiodomethanesulfonate;n-propyl-n-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Na&#43;].[O-]S(=O)(=O)C(I)I.C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl</span>
      <span itemprop="inchi_key">MIXCUJKCXRNYFM-UHFFFAOYSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960004693</span>
      <span itemprop="name">tenofovir disoproxil fumarate</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">7</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710142246</span>
      <span itemprop="name">External core antigen</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101150066002</span>
      <span itemprop="name">GFP gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000238631</span>
      <span itemprop="name">Hexapoda</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012270</span>
      <span itemprop="name">PD-1 inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012668</span>
      <span itemprop="name">PD-1-inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010092799</span>
      <span itemprop="name">RNA-directed DNA polymerase</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091006611</span>
      <span itemprop="name">SLC10A1</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091081021</span>
      <span itemprop="name">Sense strand</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010078233</span>
      <span itemprop="name">Thymalfasin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012190</span>
      <span itemprop="name">activator</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000004899</span>
      <span itemprop="name">c-terminal region</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000001767</span>
      <span itemprop="name">cationic compounds</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002068</span>
      <span itemprop="name">genetic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000010362</span>
      <span itemprop="name">genome editing</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002440</span>
      <span itemprop="name">hepatic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000003205</span>
      <span itemprop="name">muscle</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940121655</span>
      <span itemprop="name">pd-1 inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000003904</span>
      <span itemprop="name">phospholipids</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000028327</span>
      <span itemprop="name">secretion</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012163</span>
      <span itemprop="name">sequencing technique</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940021747</span>
      <span itemprop="name">therapeutic vaccine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">NZVYCXVTEHPMHE-ZSUJOUNUSA-N</span>
      <span itemprop="name">thymalfasin</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O</span>
      <span itemprop="inchi_key">NZVYCXVTEHPMHE-ZSUJOUNUSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960004231</span>
      <span itemprop="name">thymalfasin</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">6</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000004452</span>
      <span itemprop="name">Arginase</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108700024123</span>
      <span itemprop="name">Arginases</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940123014</span>
      <span itemprop="name">DNA polymerase inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000016928</span>
      <span itemprop="name">DNA-directed DNA polymerase</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000004190</span>
      <span itemprop="name">Enzymes</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108090000790</span>
      <span itemprop="name">Enzymes</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012271</span>
      <span itemprop="name">PD-L1 inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020004459</span>
      <span itemprop="name">Small interfering RNA</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102400000800</span>
      <span itemprop="name">Thymosin alpha-1</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010067390</span>
      <span itemprop="name">Viral Proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940118555</span>
      <span itemprop="name">Viral entry inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">NRLNQCOGCKAESA-KWXKLSQISA-N</span>
      <span itemprop="name">[(6z,9z,28z,31z)-heptatriaconta-6,9,28,31-tetraen-19-yl] 4-(dimethylamino)butanoate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCC(OC(=O)CCCN(C)C)CCCCCCCC\C=C/C\C=C/CCCCC</span>
      <span itemprop="inchi_key">NRLNQCOGCKAESA-KWXKLSQISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003321</span>
      <span itemprop="name">amplification</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000001449</span>
      <span itemprop="name">anionic compounds</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000013459</span>
      <span itemprop="name">approach</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000002091</span>
      <span itemprop="name">cationic group</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002800</span>
      <span itemprop="name">charge carrier</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000134</span>
      <span itemprop="name">cyclophilin inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000011161</span>
      <span itemprop="name">development</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000018109</span>
      <span itemprop="name">developmental process</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000029087</span>
      <span itemprop="name">digestion</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940088598</span>
      <span itemprop="name">enzyme</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002474</span>
      <span itemprop="name">experimental method</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000000684</span>
      <span itemprop="name">flow cytometry</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000006870</span>
      <span itemprop="name">function</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000006639</span>
      <span itemprop="name">indoleamine 2,3-dioxygenase</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020004201</span>
      <span itemprop="name">indoleamine 2,3-dioxygenase</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001939</span>
      <span itemprop="name">inductive effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000003199</span>
      <span itemprop="name">nucleic acid amplification method</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000036961</span>
      <span itemprop="name">partial effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940121656</span>
      <span itemprop="name">pd-l1 inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229920000642</span>
      <span itemprop="name">polymer</span>
      <span itemprop="domain">Polymers</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002864</span>
      <span itemprop="name">sequence alignment</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960004946</span>
      <span itemprop="name">tenofovir alafenamide</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LDEKQSIMHVQZJK-CAQYMETFSA-N</span>
      <span itemprop="name">tenofovir alafenamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O([P@@](=O)(CO[C@H](C)CN1C2=NC=NC(N)=C2N=C1)N[C@@H](C)C(=O)OC(C)C)C1=CC=CC=C1</span>
      <span itemprop="inchi_key">LDEKQSIMHVQZJK-CAQYMETFSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960003560</span>
      <span itemprop="name">tenofovir alafenamide fumarate</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XLYOFNOQVPJJNP-UHFFFAOYSA-N</span>
      <span itemprop="name">water</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O</span>
      <span itemprop="inchi_key">XLYOFNOQVPJJNP-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">5</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">OPCHFPHZPIURNA-MFERNQICSA-N</span>
      <span itemprop="name">(2s)-2,5-bis(3-aminopropylamino)-n-[2-(dioctadecylamino)acetyl]pentanamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCCCCCCCCCCCCN(CC(=O)NC(=O)[C@H](CCCNCCCN)NCCCN)CCCCCCCCCCCCCCCCCC</span>
      <span itemprop="inchi_key">OPCHFPHZPIURNA-MFERNQICSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">NRJAVPSFFCBXDT-HUESYALOSA-N</span>
      <span itemprop="name">1,2-distearoyl-sn-glycero-3-phosphocholine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N&#43;](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC</span>
      <span itemprop="inchi_key">NRJAVPSFFCBXDT-HUESYALOSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010029445</span>
      <span itemprop="name">Agammaglobulinaemia Tyrosine Kinase</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000000844</span>
      <span itemprop="name">Cell Surface Receptors</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010001857</span>
      <span itemprop="name">Cell Surface Receptors</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010019670</span>
      <span itemprop="name">Chimeric Antigen Receptors</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020004638</span>
      <span itemprop="name">Circular DNA</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091026890</span>
      <span itemprop="name">Coding region</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XQSPYNMVSIKCOC-NTSWFWBYSA-N</span>
      <span itemprop="name">Emtricitabine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=C(F)C(N)=NC(=O)N1[C@H]1O[C@@H](CO)SC1</span>
      <span itemprop="inchi_key">XQSPYNMVSIKCOC-NTSWFWBYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DHMQDGOQFOQNFH-UHFFFAOYSA-N</span>
      <span itemprop="name">Glycine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">NCC(O)=O</span>
      <span itemprop="inchi_key">DHMQDGOQFOQNFH-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101001125026</span>
      <span itemprop="name">Homo sapiens Nucleotide-binding oligomerization domain-containing protein 2</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010050904</span>
      <span itemprop="name">Interferons</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100032913</span>
      <span itemprop="name">Leukocyte surface antigen CD47</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000124008</span>
      <span itemprop="name">Mammalia</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100029441</span>
      <span itemprop="name">Nucleotide-binding oligomerization domain-containing protein 2</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091007960</span>
      <span itemprop="name">PI3Ks</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000003993</span>
      <span itemprop="name">Phosphatidylinositol 3-kinases</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108090000430</span>
      <span itemprop="name">Phosphatidylinositol 3-kinases</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020004682</span>
      <span itemprop="name">Single-Stranded DNA</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091023040</span>
      <span itemprop="name">Transcription factor</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000040945</span>
      <span itemprop="name">Transcription factor</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100022153</span>
      <span itemprop="name">Tumor necrosis factor receptor superfamily member 4</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710165473</span>
      <span itemprop="name">Tumor necrosis factor receptor superfamily member 4</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100029823</span>
      <span itemprop="name">Tyrosine-protein kinase BTK</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020005202</span>
      <span itemprop="name">Viral DNA</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000007792</span>
      <span itemprop="name">addition</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002659</span>
      <span itemprop="name">cell therapy</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001413</span>
      <span itemprop="name">cellular effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001419</span>
      <span itemprop="name">dependent effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">201000010099</span>
      <span itemprop="name">disease</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000035475</span>
      <span itemprop="name">disorder</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000839</span>
      <span itemprop="name">emulsion</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000001415</span>
      <span itemprop="name">gene therapy</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000784</span>
      <span itemprop="name">hepatotoxin</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000000338</span>
      <span itemprop="name">in vitro</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000411</span>
      <span itemprop="name">inducer</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000004962</span>
      <span itemprop="name">mammalian cell</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012528</span>
      <span itemprop="name">membrane</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">RTGDFNSFWBGLEC-SYZQJQIISA-N</span>
      <span itemprop="name">mycophenolate mofetil</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">COC1=C(C)C=2COC(=O)C=2C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1</span>
      <span itemprop="inchi_key">RTGDFNSFWBGLEC-SYZQJQIISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960004866</span>
      <span itemprop="name">mycophenolate mofetil</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">RRTPWQXEERTRRK-UHFFFAOYSA-N</span>
      <span itemprop="name">n-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)oxybutyl]octadecanamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=CC=CC2=C3N(OCCCCNC(=O)CCCCCCCCCCCCCCCCC)C(CCCC)=NC3=C(N)N=C21</span>
      <span itemprop="inchi_key">RRTPWQXEERTRRK-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002777</span>
      <span itemprop="name">nucleoside</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000013641</span>
      <span itemprop="name">positive control</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002062</span>
      <span itemprop="name">proliferating effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000003384</span>
      <span itemprop="name">small molecules</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">APSBXTVYXVQYAB-UHFFFAOYSA-M</span>
      <span itemprop="name">sodium docusate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Na&#43;].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC</span>
      <span itemprop="inchi_key">APSBXTVYXVQYAB-UHFFFAOYSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960004556</span>
      <span itemprop="name">tenofovir</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002560</span>
      <span itemprop="name">therapeutic procedure</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000419</span>
      <span itemprop="name">toxicity</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001988</span>
      <span itemprop="name">toxicity</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000013519</span>
      <span itemprop="name">translation</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000011144</span>
      <span itemprop="name">upstream manufacturing</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000029812</span>
      <span itemprop="name">viral genome replication</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000002845</span>
      <span itemprop="name">virion</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012800</span>
      <span itemprop="name">visualization</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">4</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">KILNVBDSWZSGLL-KXQOOQHDSA-N</span>
      <span itemprop="name">1,2-dihexadecanoyl-sn-glycero-3-phosphocholine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N&#43;](C)(C)C)OC(=O)CCCCCCCCCCCCCCC</span>
      <span itemprop="inchi_key">KILNVBDSWZSGLL-KXQOOQHDSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LDGWQMRUWMSZIU-LQDDAWAPSA-M</span>
      <span itemprop="name">2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N&#43;](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC</span>
      <span itemprop="inchi_key">LDGWQMRUWMSZIU-LQDDAWAPSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">KSXTUUUQYQYKCR-LQDDAWAPSA-M</span>
      <span itemprop="name">2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;chloride</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N&#43;](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC</span>
      <span itemprop="inchi_key">KSXTUUUQYQYKCR-LQDDAWAPSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">RGHYDLZMTYDBDT-UHFFFAOYSA-N</span>
      <span itemprop="name">2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)-7-pyrido[2,3-d]pyrimidinone</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1N(CC)C2=NC(N)=NC(C)=C2C=C1C=1C=CNN=1</span>
      <span itemprop="inchi_key">RGHYDLZMTYDBDT-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101150037123</span>
      <span itemprop="name">APOE gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000009081</span>
      <span itemprop="name">Apolipoprotein A-II</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010087614</span>
      <span itemprop="name">Apolipoprotein A-II</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091007065</span>
      <span itemprop="name">BIRCs</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100031151</span>
      <span itemprop="name">C-C chemokine receptor type 2</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710149815</span>
      <span itemprop="name">C-C chemokine receptor type 2</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940045513</span>
      <span itemprop="name">CTLA4 antagonist</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108090000565</span>
      <span itemprop="name">Capsid Proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100023321</span>
      <span itemprop="name">Ceruloplasmin</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100039498</span>
      <span itemprop="name">Cytotoxic T-lymphocyte protein 4</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940127399</span>
      <span itemprop="name">DNA Polymerase Inhibitors</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004544</span>
      <span itemprop="name">DNA amplification</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000033616</span>
      <span itemprop="name">DNA repair</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000007018</span>
      <span itemprop="name">DNA scission</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000007260</span>
      <span itemprop="name">Deoxyribonuclease I</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010008532</span>
      <span itemprop="name">Deoxyribonuclease I</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000196324</span>
      <span itemprop="name">Embryophyta</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LFQSCWFLJHTTHZ-UHFFFAOYSA-N</span>
      <span itemprop="name">Ethanol</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCO</span>
      <span itemprop="inchi_key">LFQSCWFLJHTTHZ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004471</span>
      <span itemprop="name">Glycine</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091027305</span>
      <span itemprop="name">Heteroduplex</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000889276</span>
      <span itemprop="name">Homo sapiens Cytotoxic T-lymphocyte protein 4</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000959820</span>
      <span itemprop="name">Homo sapiens Interferon alpha-1/13</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000837639</span>
      <span itemprop="name">Homo sapiens Thyroxine-binding globulin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000669402</span>
      <span itemprop="name">Homo sapiens Toll-like receptor 7</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000800483</span>
      <span itemprop="name">Homo sapiens Toll-like receptor 8</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000002265</span>
      <span itemprop="name">Human Growth Hormone</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010000521</span>
      <span itemprop="name">Human Growth Hormone</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000854</span>
      <span itemprop="name">Human Growth Hormone</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100040019</span>
      <span itemprop="name">Interferon alpha-1/13</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000014150</span>
      <span itemprop="name">Interferons</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010002350</span>
      <span itemprop="name">Interleukin-2</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000000588</span>
      <span itemprop="name">Interleukin-2</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091092195</span>
      <span itemprop="name">Intron</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000018697</span>
      <span itemprop="name">Membrane Proteins</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010052285</span>
      <span itemprop="name">Membrane Proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108700026244</span>
      <span itemprop="name">Open Reading Frames</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012828</span>
      <span itemprop="name">PI3K inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229920002873</span>
      <span itemprop="name">Polyethylenimine</span>
      <span itemprop="domain">Polymers</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010041388</span>
      <span itemprop="name">Ribonucleotide Reductases</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000000505</span>
      <span itemprop="name">Ribonucleotide Reductases</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091081024</span>
      <span itemprop="name">Start codon</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010046075</span>
      <span itemprop="name">Thymosin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000007501</span>
      <span itemprop="name">Thymosin</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000002248</span>
      <span itemprop="name">Thyroxine-Binding Globulin</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010000259</span>
      <span itemprop="name">Thyroxine-Binding Globulin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000008235</span>
      <span itemprop="name">Toll-Like Receptor 9</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010060818</span>
      <span itemprop="name">Toll-Like Receptor 9</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100039390</span>
      <span itemprop="name">Toll-like receptor 7</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100033110</span>
      <span itemprop="name">Toll-like receptor 8</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">CJCYTUJOSMYXLE-JDLSZIHUSA-N</span>
      <span itemprop="name">[[(2r,3s,5r)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-[(2r,3r,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl]oxyphosphoryl]sulfanylmethyl propan-2-yl carbonate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N1([C@@H]2O[C@H](CO)[C@@H](OP(=O)(OC[C@@H]3[C@H](C[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)SCOC(=O)OC(C)C)[C@H]2OC)C=CC(=O)NC1=O</span>
      <span itemprop="inchi_key">CJCYTUJOSMYXLE-JDLSZIHUSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WOZSCQDILHKSGG-UHFFFAOYSA-N</span>
      <span itemprop="name">adefovir depivoxil</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N1=CN=C2N(CCOCP(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C)C=NC2=C1N</span>
      <span itemprop="inchi_key">WOZSCQDILHKSGG-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000015395</span>
      <span itemprop="name">alpha 1-Antitrypsin</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010050122</span>
      <span itemprop="name">alpha 1-Antitrypsin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940024142</span>
      <span itemprop="name">alpha 1-antitrypsin</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000001408</span>
      <span itemprop="name">amides</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000000129</span>
      <span itemprop="name">anionic group</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000000692</span>
      <span itemprop="name">anti-sense effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000009286</span>
      <span itemprop="name">beneficial effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004071</span>
      <span itemprop="name">biological effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960000074</span>
      <span itemprop="name">biopharmaceutical</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000969</span>
      <span itemprop="name">carrier</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004700</span>
      <span itemprop="name">cellular uptake</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940106189</span>
      <span itemprop="name">ceramide</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001684</span>
      <span itemprop="name">chronic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000019425</span>
      <span itemprop="name">cirrhosis of liver</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003086</span>
      <span itemprop="name">colorant</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002648</span>
      <span itemprop="name">combination therapy</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003247</span>
      <span itemprop="name">decreasing effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002939</span>
      <span itemprop="name">deleterious effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000412</span>
      <span itemprop="name">dendrimer</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229920000736</span>
      <span itemprop="name">dendritic polymer</span>
      <span itemprop="domain">Polymers</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000001982</span>
      <span itemprop="name">diacylglycerols</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000000375</span>
      <span itemprop="name">direct analysis in real time</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000011304</span>
      <span itemprop="name">droplet digital PCR</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012063</span>
      <span itemprop="name">dual-affinity re-targeting</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000005538</span>
      <span itemprop="name">encapsulation</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000011156</span>
      <span itemprop="name">evaluation</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940121360</span>
      <span itemprop="name">farnesoid X receptor (fxr) agonists</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012634</span>
      <span itemprop="name">fragment</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000221</span>
      <span itemprop="name">frame shift mutation induction</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000037433</span>
      <span itemprop="name">frameshift</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000010353</span>
      <span itemprop="name">genetic engineering</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SPSXSWRZQFPVTJ-ZQQKUFEYSA-N</span>
      <span itemprop="name">hepatitis b vaccine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1</span>
      <span itemprop="inchi_key">SPSXSWRZQFPVTJ-ZQQKUFEYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000833</span>
      <span itemprop="name">heterodimer</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000048799</span>
      <span itemprop="name">human SERPINA7</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000017</span>
      <span itemprop="name">hydrogel</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000028993</span>
      <span itemprop="name">immune response</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002347</span>
      <span itemprop="name">injection</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000007924</span>
      <span itemprop="name">injection</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003993</span>
      <span itemprop="name">interaction</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940079322</span>
      <span itemprop="name">interferon</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003834</span>
      <span itemprop="name">intracellular effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JTEGQNOMFQHVDC-NKWVEPMBSA-N</span>
      <span itemprop="name">lamivudine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1</span>
      <span itemprop="inchi_key">JTEGQNOMFQHVDC-NKWVEPMBSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000000670</span>
      <span itemprop="name">limiting effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">201000007270</span>
      <span itemprop="name">liver cancer</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000014018</span>
      <span itemprop="name">liver neoplasm</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000463</span>
      <span itemprop="name">material</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001404</span>
      <span itemprop="name">mediated effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000693</span>
      <span itemprop="name">micelle</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000035772</span>
      <span itemprop="name">mutation</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000013642</span>
      <span itemprop="name">negative control</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229910052757</span>
      <span itemprop="name">nitrogen</span>
      <span itemprop="domain">Inorganic materials</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000004940</span>
      <span itemprop="name">nucleus</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000009438</span>
      <span itemprop="name">off-target cleavage</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000005457</span>
      <span itemprop="name">optimization</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010092851</span>
      <span itemprop="name">peginterferon alfa-2b</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012071</span>
      <span itemprop="name">phase</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WTJKGGKOPKCXLL-RRHRGVEJSA-N</span>
      <span itemprop="name">phosphatidylcholine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N&#43;](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC</span>
      <span itemprop="inchi_key">WTJKGGKOPKCXLL-RRHRGVEJSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000008104</span>
      <span itemprop="name">phosphatidylethanolamines</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940043441</span>
      <span itemprop="name">phosphoinositide 3-kinase inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940021993</span>
      <span itemprop="name">prophylactic vaccine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940121649</span>
      <span itemprop="name">protein inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012268</span>
      <span itemprop="name">protein inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940076155</span>
      <span itemprop="name">protein modulator</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940044601</span>
      <span itemprop="name">receptor agonist</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000018</span>
      <span itemprop="name">receptor agonist</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000008929</span>
      <span itemprop="name">regeneration</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000011069</span>
      <span itemprop="name">regeneration method</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000205</span>
      <span itemprop="name">reproductive and developmental toxicity</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">FECGNJPYVFEKOD-VMPITWQZSA-N</span>
      <span itemprop="name">resminostat</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=CC(CN(C)C)=CC=C1S(=O)(=O)N1C=C(\C=C\C(=O)NO)C=C1</span>
      <span itemprop="inchi_key">FECGNJPYVFEKOD-VMPITWQZSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001177</span>
      <span itemprop="name">retroviral effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940121497</span>
      <span itemprop="name">sintilimab</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000243</span>
      <span itemprop="name">solution</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000126</span>
      <span itemprop="name">substance</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LCJVIYPJPCBWKS-NXPQJCNCSA-N</span>
      <span itemprop="name">thymosin</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O</span>
      <span itemprop="inchi_key">LCJVIYPJPCBWKS-NXPQJCNCSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XUIIKFGFIJCVMT-UHFFFAOYSA-N</span>
      <span itemprop="name">thyroxine-binding globulin</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">IC1=CC(CC([NH3&#43;])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1</span>
      <span itemprop="inchi_key">XUIIKFGFIJCVMT-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000331</span>
      <span itemprop="name">toxic</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002588</span>
      <span itemprop="name">toxic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000010361</span>
      <span itemprop="name">transduction</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000026683</span>
      <span itemprop="name">transduction</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">3</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MTCFGRXMJLQNBG-REOHCLBHSA-N</span>
      <span itemprop="name">(2S)-2-Amino-3-hydroxypropansure</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC[C@H](N)C(O)=O</span>
      <span itemprop="inchi_key">MTCFGRXMJLQNBG-REOHCLBHSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">RLMNJYLIJGOVNP-OYUXLBQNSA-N</span>
      <span itemprop="name">(2e,3e)-1-(4-bromophenyl)-3-hydrazinylidene-2-[(3-methylphenyl)hydrazinylidene]propan-1-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC1=CC=CC(N\N=C(/C=N/N)\C(=O)C=2C=CC(Br)=CC=2)=C1</span>
      <span itemprop="inchi_key">RLMNJYLIJGOVNP-OYUXLBQNSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">YPBKTZBXSBLTDK-PKNBQFBNSA-N</span>
      <span itemprop="name">(3e)-3-[(3-bromo-4-fluoroanilino)-nitrosomethylidene]-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">NS(=O)(=O)NCCNC1=NON\C1=C(N=O)/NC1=CC=C(F)C(Br)=C1</span>
      <span itemprop="inchi_key">YPBKTZBXSBLTDK-PKNBQFBNSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SLKDGVPOSSLUAI-PGUFJCEWSA-N</span>
      <span itemprop="name">1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCC</span>
      <span itemprop="inchi_key">SLKDGVPOSSLUAI-PGUFJCEWSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LVNGJLRDBYCPGB-UHFFFAOYSA-N</span>
      <span itemprop="name">1,2-distearoylphosphatidylethanolamine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[NH3&#43;])OC(=O)CCCCCCCCCCCCCCCCC</span>
      <span itemprop="inchi_key">LVNGJLRDBYCPGB-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LYMICVBGNUEHGE-FUQPUAIBSA-N</span>
      <span itemprop="name">1-[(2r,3r,4r,5r)-4-[[(2r,3s,5r)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N1([C@@H]2O[C@H](CO)[C@@H](OP(O)(=S)OC[C@@H]3[C@H](C[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)[C@H]2OC)C=CC(=O)NC1=O</span>
      <span itemprop="inchi_key">LYMICVBGNUEHGE-FUQPUAIBSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WALUVDCNGPQPOD-UHFFFAOYSA-M</span>
      <span itemprop="name">2,3-di(tetradecoxy)propyl-(2-hydroxyethyl)-dimethylazanium;bromide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Br-].CCCCCCCCCCCCCCOCC(C[N&#43;](C)(C)CCO)OCCCCCCCCCCCCCC</span>
      <span itemprop="inchi_key">WALUVDCNGPQPOD-UHFFFAOYSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">NEZDNQCXEZDCBI-UHFFFAOYSA-N</span>
      <span itemprop="name">2-azaniumylethyl 2,3-di(tetradecanoyloxy)propyl phosphate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCC</span>
      <span itemprop="inchi_key">NEZDNQCXEZDCBI-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HDXDQPRPFRKGKZ-INIZCTEOSA-N</span>
      <span itemprop="name">3-(3-fluorophenyl)-2-[(1s)-1-(7h-purin-6-ylamino)propyl]chromen-4-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C=1([C@@H](NC=2C=3NC=NC=3N=CN=2)CC)OC2=CC=CC=C2C(=O)C=1C1=CC=CC(F)=C1</span>
      <span itemprop="inchi_key">HDXDQPRPFRKGKZ-INIZCTEOSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HNTKPUXXCNQLFR-KWXKLSQISA-N</span>
      <span itemprop="name">3-[2,2-bis[(9z,12z)-octadeca-9,12-dienyl]-1,3-dioxolan-4-yl]-n,n-dimethylpropan-1-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCC1(CCCCCCCC\C=C/C\C=C/CCCCC)OCC(CCCN(C)C)O1</span>
      <span itemprop="inchi_key">HNTKPUXXCNQLFR-KWXKLSQISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WNEODWDFDXWOLU-QHCPKHFHSA-N</span>
      <span itemprop="name">3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1</span>
      <span itemprop="inchi_key">WNEODWDFDXWOLU-QHCPKHFHSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010082126</span>
      <span itemprop="name">Alanine transaminase</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010063104</span>
      <span itemprop="name">Apoptosis Regulatory Proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000010565</span>
      <span itemprop="name">Apoptosis Regulatory Proteins</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004475</span>
      <span itemprop="name">Arginine</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000010356</span>
      <span itemprop="name">CRISPR-Cas9 genome editing</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">CURLTUGMZLYLDI-UHFFFAOYSA-N</span>
      <span itemprop="name">Carbon dioxide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C=O</span>
      <span itemprop="inchi_key">CURLTUGMZLYLDI-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000004039</span>
      <span itemprop="name">Caspase-9</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108090000566</span>
      <span itemprop="name">Caspase-9</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010051109</span>
      <span itemprop="name">Cell-Penetrating Peptides</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000020313</span>
      <span itemprop="name">Cell-Penetrating Peptides</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000019034</span>
      <span itemprop="name">Chemokines</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010012236</span>
      <span itemprop="name">Chemokines</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000195597</span>
      <span itemprop="name">Chlamydomonas reinhardtii</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000004127</span>
      <span itemprop="name">Cytokines</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108090000695</span>
      <span itemprop="name">Cytokines</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000000311</span>
      <span itemprop="name">Cytosine Deaminase</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010080611</span>
      <span itemprop="name">Cytosine Deaminase</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000006820</span>
      <span itemprop="name">DNA synthesis</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010014303</span>
      <span itemprop="name">DNA-directed DNA polymerase</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XULFJDKZVHTRLG-JDVCJPALSA-N</span>
      <span itemprop="name">DOSPA trifluoroacetate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[O-]C(=O)C(F)(F)F.CCCCCCCC\C=C/CCCCCCCCOCC(C[N&#43;](C)(C)CCNC(=O)C(CCCNCCCN)NCCCN)OCCCCCCCC\C=C/CCCCCCCC</span>
      <span itemprop="inchi_key">XULFJDKZVHTRLG-JDVCJPALSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">IAZDPXIOMUYVGZ-UHFFFAOYSA-N</span>
      <span itemprop="name">Dimethylsulphoxide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CS(C)=O</span>
      <span itemprop="inchi_key">IAZDPXIOMUYVGZ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">206010016654</span>
      <span itemprop="name">Fibrosis</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940125771</span>
      <span itemprop="name">GS-9688</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DUAGQYUORDTXOR-GPQRQXLASA-N</span>
      <span itemprop="name">Gentiopicrin</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)C2=CCOC(=O)C2=CO1</span>
      <span itemprop="inchi_key">DUAGQYUORDTXOR-GPQRQXLASA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DUAGQYUORDTXOR-WULZUDSJSA-N</span>
      <span itemprop="name">Gentiopicrin</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1[C@@H](C=C)C=2C(C(=O)OCC=2)=CO1</span>
      <span itemprop="inchi_key">DUAGQYUORDTXOR-WULZUDSJSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WHUUTDBJXJRKMK-UHFFFAOYSA-N</span>
      <span itemprop="name">Glutamic acid</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)C(N)CCC(O)=O</span>
      <span itemprop="inchi_key">WHUUTDBJXJRKMK-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JZNWSCPGTDBMEW-UHFFFAOYSA-N</span>
      <span itemprop="name">Glycerophosphorylethanolamin</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">NCCOP(O)(=O)OCC(O)CO</span>
      <span itemprop="inchi_key">JZNWSCPGTDBMEW-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000285387</span>
      <span itemprop="name">HBV genotype A</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000013271</span>
      <span itemprop="name">Hemopexin</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010026027</span>
      <span itemprop="name">Hemopexin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010088652</span>
      <span itemprop="name">Histocompatibility Antigens Class I</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000008949</span>
      <span itemprop="name">Histocompatibility Antigens Class I</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000823116</span>
      <span itemprop="name">Homo sapiens Alpha-1-antitrypsin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101001040800</span>
      <span itemprop="name">Homo sapiens Integral membrane protein GPR180</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101001050886</span>
      <span itemprop="name">Homo sapiens Lysine-specific histone demethylase 1A</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000831496</span>
      <span itemprop="name">Homo sapiens Toll-like receptor 3</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010003272</span>
      <span itemprop="name">Hyaluronate lyase</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000001974</span>
      <span itemprop="name">Hyaluronidases</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940124915</span>
      <span itemprop="name">Infanrix</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100021244</span>
      <span itemprop="name">Integral membrane protein GPR180</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100040018</span>
      <span itemprop="name">Interferon alpha-2</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000007438</span>
      <span itemprop="name">Interferon alpha-beta Receptor</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010086140</span>
      <span itemprop="name">Interferon alpha-beta Receptor</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010005716</span>
      <span itemprop="name">Interferon beta-1a</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010002586</span>
      <span itemprop="name">Interleukin-7</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101150008942</span>
      <span itemprop="name">J gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ODKSFYDXXFIFQN-BYPYZUCNSA-P</span>
      <span itemprop="name">L-argininium(2&#43;)</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">NC(=[NH2&#43;])NCCC[C@H]([NH3&#43;])C(O)=O</span>
      <span itemprop="inchi_key">ODKSFYDXXFIFQN-BYPYZUCNSA-P</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">CKLJMWTZIZZHCS-REOHCLBHSA-N</span>
      <span itemprop="name">L-aspartic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)[C@@H](N)CC(O)=O</span>
      <span itemprop="inchi_key">CKLJMWTZIZZHCS-REOHCLBHSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WHUUTDBJXJRKMK-VKHMYHEASA-N</span>
      <span itemprop="name">L-glutamic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)[C@@H](N)CCC(O)=O</span>
      <span itemprop="inchi_key">WHUUTDBJXJRKMK-VKHMYHEASA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010054278</span>
      <span itemprop="name">Lac Repressors</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710128836</span>
      <span itemprop="name">Large T antigen</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710084021</span>
      <span itemprop="name">Large envelope protein</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004472</span>
      <span itemprop="name">Lysine</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">KDXKERNSBIXSRK-UHFFFAOYSA-N</span>
      <span itemprop="name">Lysine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">NCCCCC(N)C(O)=O</span>
      <span itemprop="inchi_key">KDXKERNSBIXSRK-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100024985</span>
      <span itemprop="name">Lysine-specific histone demethylase 1A</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000012750</span>
      <span itemprop="name">Membrane Glycoproteins</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010090054</span>
      <span itemprop="name">Membrane Glycoproteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101100481579</span>
      <span itemprop="name">Mus musculus Tlr11 gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101100481580</span>
      <span itemprop="name">Mus musculus Tlr12 gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">KBARHGHBFILILC-NGIJKBHDSA-N</span>
      <span itemprop="name">N-[(7R,8R)-8-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,10,16,20,23,25,28,31-decamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]acetamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CCCCCCNC(C)=O)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)N(C)C1=O)C(C)C</span>
      <span itemprop="inchi_key">KBARHGHBFILILC-NGIJKBHDSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">YGACXVRLDHEXKY-WXRXAMBDSA-N</span>
      <span itemprop="name">O[C@H](C[C@H]1c2c(cccc2F)-c2cncn12)[C@H]1CC[C@H](O)CC1</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O[C@H](C[C@H]1c2c(cccc2F)-c2cncn12)[C@H]1CC[C@H](O)CC1</span>
      <span itemprop="inchi_key">YGACXVRLDHEXKY-WXRXAMBDSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000037581</span>
      <span itemprop="name">Persistent Infection</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ATUOYWHBWRKTHZ-UHFFFAOYSA-N</span>
      <span itemprop="name">Propane</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCC</span>
      <span itemprop="inchi_key">ATUOYWHBWRKTHZ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091005685</span>
      <span itemprop="name">RIG-I-like receptors</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">IWUCXVSUMQZMFG-AFCXAGJDSA-N</span>
      <span itemprop="name">Ribavirin</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1</span>
      <span itemprop="inchi_key">IWUCXVSUMQZMFG-AFCXAGJDSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940044665</span>
      <span itemprop="name">STING agonist</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">240000004808</span>
      <span itemprop="name">Saccharomyces cerevisiae</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MTCFGRXMJLQNBG-UHFFFAOYSA-N</span>
      <span itemprop="name">Serine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OCC(N)C(O)=O</span>
      <span itemprop="inchi_key">MTCFGRXMJLQNBG-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000024932</span>
      <span itemprop="name">T cell mediated immunity</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091008874</span>
      <span itemprop="name">T cell receptors</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000016266</span>
      <span itemprop="name">T-Cell Antigen Receptors</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000006601</span>
      <span itemprop="name">Thymidine Kinase</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020004440</span>
      <span itemprop="name">Thymidine kinase</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100024324</span>
      <span itemprop="name">Toll-like receptor 3</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DRTQHJPVMGBUCF-XVFCMESISA-N</span>
      <span itemprop="name">Uridine</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1</span>
      <span itemprop="inchi_key">DRTQHJPVMGBUCF-XVFCMESISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HIHOWBSBBDRPDW-PTHRTHQKSA-N</span>
      <span itemprop="name">[(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] n-[2-(dimethylamino)ethyl]carbamate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1C=C2C[C@@H](OC(=O)NCCN(C)C)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2</span>
      <span itemprop="inchi_key">HIHOWBSBBDRPDW-PTHRTHQKSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MWRBNPKJOOWZPW-XPWSMXQVSA-N</span>
      <span itemprop="name">[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C\CCCCCCCC</span>
      <span itemprop="inchi_key">MWRBNPKJOOWZPW-XPWSMXQVSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JLCPHMBAVCMARE-UHFFFAOYSA-N</span>
      <span itemprop="name">[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate</span>
      <span itemprop="domain">Polymers</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O</span>
      <span itemprop="inchi_key">JLCPHMBAVCMARE-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002253</span>
      <span itemprop="name">acid</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000007513</span>
      <span itemprop="name">acids</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960001997</span>
      <span itemprop="name">adefovir</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QYIXCDOBOSTCEI-UHFFFAOYSA-N</span>
      <span itemprop="name">alpha-cholestanol</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2</span>
      <span itemprop="inchi_key">QYIXCDOBOSTCEI-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000005557</span>
      <span itemprop="name">antagonist</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000611</span>
      <span itemprop="name">antibody drug conjugate</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940049595</span>
      <span itemprop="name">antibody-drug conjugate</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000074</span>
      <span itemprop="name">antisense oligonucleotide</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012230</span>
      <span itemprop="name">antisense oligonucleotides</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000008346</span>
      <span itemprop="name">aqueous phase</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ODKSFYDXXFIFQN-UHFFFAOYSA-N</span>
      <span itemprop="name">arginine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)C(N)CCCNC(N)=N</span>
      <span itemprop="inchi_key">ODKSFYDXXFIFQN-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000003704</span>
      <span itemprop="name">aspartic acid</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960003852</span>
      <span itemprop="name">atezolizumab</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">OQFSQFPPLPISGP-UHFFFAOYSA-N</span>
      <span itemprop="name">beta-carboxyaspartic acid</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)C(N)C(C(O)=O)C(O)=O</span>
      <span itemprop="inchi_key">OQFSQFPPLPISGP-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000015556</span>
      <span itemprop="name">catabolic process</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229920006317</span>
      <span itemprop="name">cationic polymer</span>
      <span itemprop="domain">Polymers</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000010261</span>
      <span itemprop="name">cell growth</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000033077</span>
      <span itemprop="name">cellular process</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000003841</span>
      <span itemprop="name">chloride salts</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000001841</span>
      <span itemprop="name">cholesterols</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WLNARFZDISHUGS-MIXBDBMTSA-N</span>
      <span itemprop="name">cholesteryl hemisuccinate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1C=C2C[C@@H](OC(=O)CCC(O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2</span>
      <span itemprop="inchi_key">WLNARFZDISHUGS-MIXBDBMTSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000000349</span>
      <span itemprop="name">chromosome</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000010367</span>
      <span itemprop="name">cloning</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000011260</span>
      <span itemprop="name">co-administration</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940000425</span>
      <span itemprop="name">combination drug</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000433</span>
      <span itemprop="name">cytotoxic</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001472</span>
      <span itemprop="name">cytotoxic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000006731</span>
      <span itemprop="name">degradation reaction</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000000502</span>
      <span itemprop="name">dialysis</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">UMGXUWVIJIQANV-UHFFFAOYSA-M</span>
      <span itemprop="name">didecyl(dimethyl)azanium;bromide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Br-].CCCCCCCCCC[N&#43;](C)(C)CCCCCCCCCC</span>
      <span itemprop="inchi_key">UMGXUWVIJIQANV-UHFFFAOYSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000006471</span>
      <span itemprop="name">dimerization reaction</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">PSLWZOIUBRXAQW-UHFFFAOYSA-M</span>
      <span itemprop="name">dimethyl(dioctadecyl)azanium;bromide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Br-].CCCCCCCCCCCCCCCCCC[N&#43;](C)(C)CCCCCCCCCCCCCCCCCC</span>
      <span itemprop="inchi_key">PSLWZOIUBRXAQW-UHFFFAOYSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MWRBNPKJOOWZPW-CLFAGFIQSA-N</span>
      <span itemprop="name">dioleoyl phosphatidylethanolamine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C/CCCCCCCC</span>
      <span itemprop="inchi_key">MWRBNPKJOOWZPW-CLFAGFIQSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950009791</span>
      <span itemprop="name">durvalumab</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010057988</span>
      <span itemprop="name">ecdysone receptor</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000004520</span>
      <span itemprop="name">electroporation</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960000366</span>
      <span itemprop="name">emtricitabine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000002889</span>
      <span itemprop="name">endothelial cell</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QDGZDCVAUDNJFG-FXQIFTODSA-N</span>
      <span itemprop="name">entecavir (anhydrous)</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)C1=C</span>
      <span itemprop="inchi_key">QDGZDCVAUDNJFG-FXQIFTODSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950006370</span>
      <span itemprop="name">epacadostat</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000002148</span>
      <span itemprop="name">esters</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SQGRDKSRFFUBBU-UHFFFAOYSA-N</span>
      <span itemprop="name">ethyl 4-(2-bromo-4-fluorophenyl)-6-(morpholin-4-ylmethyl)-2-(1,3-thiazol-2-yl)-1,4-dihydropyrimidine-5-carboxylate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N1C(C=2SC=CN=2)=NC(C=2C(=CC(F)=CC=2)Br)C(C(=O)OCC)=C1CN1CCOCC1</span>
      <span itemprop="inchi_key">SQGRDKSRFFUBBU-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QUIWHXQETADMGN-UHFFFAOYSA-N</span>
      <span itemprop="name">evobrutinib</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C=1C=C(OC=2C=CC=CC=2)C=CC=1C=1C(N)=NC=NC=1NCC1CCN(C(=O)C=C)CC1</span>
      <span itemprop="inchi_key">QUIWHXQETADMGN-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004927</span>
      <span itemprop="name">fusion</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020001507</span>
      <span itemprop="name">fusion proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000037865</span>
      <span itemprop="name">fusion proteins</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012239</span>
      <span itemprop="name">gene modification</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000005017</span>
      <span itemprop="name">genetic modification</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000013617</span>
      <span itemprop="name">genetically modified food</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000013922</span>
      <span itemprop="name">glutamic acid</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004220</span>
      <span itemprop="name">glutamic acid</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960004443</span>
      <span itemprop="name">hemophilus influenzae b vaccines</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940124736</span>
      <span itemprop="name">hepatitis-B vaccine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000334</span>
      <span itemprop="name">hepatotoxic</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003082</span>
      <span itemprop="name">hepatotoxic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000051631</span>
      <span itemprop="name">human SERPINA1</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000005260</span>
      <span itemprop="name">human cell</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000028996</span>
      <span itemprop="name">humoral immune response</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960002773</span>
      <span itemprop="name">hyaluronidase</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XXSMGPRMXLTPCZ-UHFFFAOYSA-N</span>
      <span itemprop="name">hydroxychloroquine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">ClC1=CC=C2C(NC(C)CCCN(CCO)CC)=CC=NC2=C1</span>
      <span itemprop="inchi_key">XXSMGPRMXLTPCZ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012642</span>
      <span itemprop="name">immune effector</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000001802</span>
      <span itemprop="name">infusion</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004615</span>
      <span itemprop="name">ingredient</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000010354</span>
      <span itemprop="name">integration</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960003521</span>
      <span itemprop="name">interferon alfa-2a</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000007918</span>
      <span itemprop="name">intramuscular administration</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000001990</span>
      <span itemprop="name">intravenous administration</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960001627</span>
      <span itemprop="name">lamivudine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000019423</span>
      <span itemprop="name">liver disease</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002609</span>
      <span itemprop="name">medium</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091070501</span>
      <span itemprop="name">miRNA</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002679</span>
      <span itemprop="name">microRNA</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003607</span>
      <span itemprop="name">modifier</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">NFQBIAXADRDUGK-KWXKLSQISA-N</span>
      <span itemprop="name">n,n-dimethyl-2,3-bis[(9z,12z)-octadeca-9,12-dienoxy]propan-1-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCOCC(CN(C)C)OCCCCCCCC\C=C/C\C=C/CCCCC</span>
      <span itemprop="inchi_key">NFQBIAXADRDUGK-KWXKLSQISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">KWRYMZHCQIOOEB-LBPRGKRZSA-N</span>
      <span itemprop="name">n-[(1s)-1-(7-fluoro-2-pyridin-2-ylquinolin-3-yl)ethyl]-7h-purin-6-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)=CC2=CC=C(F)C=C2N=C1C1=CC=CC=N1</span>
      <span itemprop="inchi_key">KWRYMZHCQIOOEB-LBPRGKRZSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000007908</span>
      <span itemprop="name">nanoemulsion</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000007481</span>
      <span itemprop="name">next generation sequencing</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000003833</span>
      <span itemprop="name">nucleoside derivatives</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000037361</span>
      <span itemprop="name">pathway</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010092853</span>
      <span itemprop="name">peginterferon alfa-2a</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960003931</span>
      <span itemprop="name">peginterferon alfa-2b</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000003359</span>
      <span itemprop="name">percent control normalization</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002085</span>
      <span itemprop="name">persistent effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004962</span>
      <span itemprop="name">physiological condition</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001323</span>
      <span itemprop="name">posttranslational effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000008439</span>
      <span itemprop="name">repair process</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000011160</span>
      <span itemprop="name">research</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">BXNMTOQRYBFHNZ-UHFFFAOYSA-N</span>
      <span itemprop="name">resiquimod</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=CC=CC2=C(N(C(COCC)=N3)CC(C)(C)O)C3=C(N)N=C21</span>
      <span itemprop="inchi_key">BXNMTOQRYBFHNZ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950010550</span>
      <span itemprop="name">resiquimod</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950002821</span>
      <span itemprop="name">resminostat</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004044</span>
      <span itemprop="name">response</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004043</span>
      <span itemprop="name">responsiveness</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000010839</span>
      <span itemprop="name">reverse transcription</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960000329</span>
      <span itemprop="name">ribavirin</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HZCAHMRRMINHDJ-DBRKOABJSA-N</span>
      <span itemprop="name">ribavirin</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1</span>
      <span itemprop="inchi_key">HZCAHMRRMINHDJ-DBRKOABJSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003161</span>
      <span itemprop="name">ribonuclease inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">KNUXHTWUIVMBBY-JRJYXWDASA-N</span>
      <span itemprop="name">rintatolimod</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1.O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1.O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1</span>
      <span itemprop="inchi_key">KNUXHTWUIVMBBY-JRJYXWDASA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950006564</span>
      <span itemprop="name">rintatolimod</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003419</span>
      <span itemprop="name">rna directed dna polymerase inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012216</span>
      <span itemprop="name">screening</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">BLGWHBSBBJNKJO-UHFFFAOYSA-N</span>
      <span itemprop="name">serabelisib</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C=1C=C2OC(N)=NC2=CC=1C(=CN12)C=CC1=NC=C2C(=O)N1CCOCC1</span>
      <span itemprop="inchi_key">BLGWHBSBBJNKJO-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000004400</span>
      <span itemprop="name">serine</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000003607</span>
      <span itemprop="name">serino group</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H]</span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003007</span>
      <span itemprop="name">single stranded DNA break</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002741</span>
      <span itemprop="name">site-directed mutagenesis</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000006228</span>
      <span itemprop="name">supernatant</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000003786</span>
      <span itemprop="name">synthesis reaction</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">IQFYYKKMVGJFEH-CSMHCCOUSA-N</span>
      <span itemprop="name">telbivudine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1NC(=O)C(C)=CN1[C@H]1O[C@@H](CO)[C@H](O)C1</span>
      <span itemprop="inchi_key">IQFYYKKMVGJFEH-CSMHCCOUSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012360</span>
      <span itemprop="name">testing method</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108700020534</span>
      <span itemprop="name">tetracycline resistance-encoding transposon repressor</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">2</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">RVIZTCLKCHZBMR-KWXKLSQISA-N</span>
      <span itemprop="name">(12z,15z)-1-(dimethylamino)-2-[(9z,12z)-octadeca-9,12-dienoxy]henicosa-12,15-dien-4-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCOC(CN(C)C)CC(=O)CCCCCCC\C=C/C\C=C/CCCCC</span>
      <span itemprop="inchi_key">RVIZTCLKCHZBMR-KWXKLSQISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QSIOZNXDXNWPNX-AKEJEFCPSA-N</span>
      <span itemprop="name">(1r,2s,3r,5r)-3-(6-aminopurin-9-yl)-2-fluoro-5-(hydroxymethyl)-4-methylidenecyclopentan-1-ol</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=NC=2C(N)=NC=NC=2N1[C@H]1[C@H](F)[C@H](O)[C@@H](CO)C1=C</span>
      <span itemprop="inchi_key">QSIOZNXDXNWPNX-AKEJEFCPSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JSFCZQSJQXFJDS-QAPCUYQASA-N</span>
      <span itemprop="name">(2-chloro-4-phenoxyphenyl)-[4-[[(3R,6S)-6-(hydroxymethyl)oxan-3-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]methanone</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">ClC1=C(C=CC(=C1)OC1=CC=CC=C1)C(=O)C1=CNC=2N=CN=C(C=21)N[C@H]1CO[C@@H](CC1)CO</span>
      <span itemprop="inchi_key">JSFCZQSJQXFJDS-QAPCUYQASA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">CCIDLBRRXVNEDK-KJTVYDLOSA-N</span>
      <span itemprop="name">(2S)-2-aminobutanedioic acid [[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)[C@@H](N)CC(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N</span>
      <span itemprop="inchi_key">CCIDLBRRXVNEDK-KJTVYDLOSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">STUWGJZDJHPWGZ-LBPRGKRZSA-N</span>
      <span itemprop="name">(2S)-N1-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)-4-pyridinyl]-2-thiazolyl]pyrrolidine-1,2-dicarboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">S1C(C=2C=C(N=CC=2)C(C)(C)C(F)(F)F)=C(C)N=C1NC(=O)N1CCC[C@H]1C(N)=O</span>
      <span itemprop="inchi_key">STUWGJZDJHPWGZ-LBPRGKRZSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZADWXFSZEAPBJS-SNVBAGLBSA-N</span>
      <span itemprop="name">(2r)-2-amino-3-(1-methylindol-3-yl)propanoic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=CC=C2N(C)C=C(C[C@@H](N)C(O)=O)C2=C1</span>
      <span itemprop="inchi_key">ZADWXFSZEAPBJS-SNVBAGLBSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LICFWYDUJZDCLK-DJNXLDHESA-N</span>
      <span itemprop="name">(2s)-1-[3,7-bis(2-methoxyethoxycarbonylamino)heptyl]pyrrolidine-2-carboxylic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">COCCOC(=O)NCCCCC(NC(=O)OCCOC)CCN1CCC[C@H]1C(O)=O</span>
      <span itemprop="inchi_key">LICFWYDUJZDCLK-DJNXLDHESA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZZJLMZYUGLJBSO-LAEOZQHASA-N</span>
      <span itemprop="name">(3R,4S)-3-amino-1-[(2S)-2-aminopropanoyl]-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N[C@]1(CN(C[C@@H]1CCCB(O)O)C([C@H](C)N)=O)C(=O)O</span>
      <span itemprop="inchi_key">ZZJLMZYUGLJBSO-LAEOZQHASA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QLRRJMOBVVGXEJ-XHSDSOJGSA-N</span>
      <span itemprop="name">(3r,4s)-1-(6-amino-5-fluoropyrimidin-4-yl)-3-[(3r)-3-[3-chloro-5-(trifluoromethyl)anilino]-2-oxopiperidin-1-yl]piperidine-4-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N([C@@H]1CCCN(C1=O)[C@H]1CN(CC[C@@H]1C(=O)N)C=1C(=C(N)N=CN=1)F)C1=CC(Cl)=CC(C(F)(F)F)=C1</span>
      <span itemprop="inchi_key">QLRRJMOBVVGXEJ-XHSDSOJGSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">FDSDDLLOMXWXRY-JAQKLANPSA-N</span>
      <span itemprop="name">(3s)-4-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-3-[[2-[[(2s)-5-(diaminomethylideneamino)-2-[[4-oxo-4-[[4-(4-oxo-8-phenylchromen-2-yl)morpholin-4-ium-4-yl]methoxy]butanoyl]amino]pentanoyl]amino]acetyl]amino]-4-oxobutanoic acid;acetate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC([O-])=O.C=1C(=O)C2=CC=CC(C=3C=CC=CC=3)=C2OC=1[N&#43;]1(COC(=O)CCC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O)CCOCC1</span>
      <span itemprop="inchi_key">FDSDDLLOMXWXRY-JAQKLANPSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">AQHMBDAHQGYLIU-XNFHFXFQSA-N</span>
      <span itemprop="name">(3s,6s,9s,12r,15s,18s,21s,24s,27r,30s,33s)-27-[2-(dimethylamino)ethylsulfanyl]-30-ethyl-33-[(e,1r,2r)-1-hydroxy-2-methylhex-4-enyl]-24-(2-hydroxy-2-methylpropyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)(C)O)N(C)C(=O)[C@@H](SCCN(C)C)N(C)C1=O</span>
      <span itemprop="inchi_key">AQHMBDAHQGYLIU-XNFHFXFQSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ONKCBKDTKZIWHZ-MRWFHJSOSA-N</span>
      <span itemprop="name">(4r)-4-[[(2r)-6-amino-2-[[(2r)-2-[[4-(aminocarbamothioylamino)benzoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoyl]amino]-5-[[(2r)-1-amino-6-[bis[2-[[4-[2-(1h-imidazol-5-yl)ethylamino]-4-oxobutanoyl]amino]acetyl]amino]-1-oxohexan-2-yl]amino]-5-oxope</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C([C@H](C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN(C(=O)CNC(=O)CCC(=O)NCCC=1NC=NC=1)C(=O)CNC(=O)CCC(=O)NCCC=1NC=NC=1)C(N)=O)NC(=O)C=1C=CC(NC(=S)NN)=CC=1)C1=CC=C(O)C=C1</span>
      <span itemprop="inchi_key">ONKCBKDTKZIWHZ-MRWFHJSOSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SGKRLCUYIXIAHR-AKNGSSGZSA-N</span>
      <span itemprop="name">(4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O</span>
      <span itemprop="inchi_key">SGKRLCUYIXIAHR-AKNGSSGZSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QYIXCDOBOSTCEI-QCYZZNICSA-N</span>
      <span itemprop="name">(5alpha)-cholestan-3beta-ol</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1</span>
      <span itemprop="inchi_key">QYIXCDOBOSTCEI-QCYZZNICSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">AKLBERUGKZNEJY-RTEPGWBGSA-N</span>
      <span itemprop="name">(5s,8s,10ar)-3-[3-[[(5s,8s,10ar)-8-(benzhydrylcarbamoyl)-5-[[(2s)-2-(methylamino)propanoyl]amino]-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocin-3-yl]sulfonyl]phenyl]sulfonyl-n-benzhydryl-5-[[(2s)-2-(methylamino)propanoyl]amino]-6-oxo-1,2,4</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C([C@@H]1CC[C@@H]2CCN(C[C@@H](C(N21)=O)NC(=O)[C@H](C)NC)S(=O)(=O)C=1C=C(C=CC=1)S(=O)(=O)N1C[C@@H](C(=O)N2[C@@H](CC[C@@H]2CC1)C(=O)NC(C=1C=CC=CC=1)C=1C=CC=CC=1)NC(=O)[C@H](C)NC)NC(C=1C=CC=CC=1)C1=CC=CC=C1</span>
      <span itemprop="inchi_key">AKLBERUGKZNEJY-RTEPGWBGSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VDYVTMXBGOIUMS-KWXKLSQISA-N</span>
      <span itemprop="name">(6z,9z,29z,32z)-19-[(dimethylamino)methyl]octatriaconta-6,9,29,32-tetraene-18,21-dione</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCC(=O)CC(CN(C)C)C(=O)CCCCCCC\C=C/C\C=C/CCCCC</span>
      <span itemprop="inchi_key">VDYVTMXBGOIUMS-KWXKLSQISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">RNOAOAWBMHREKO-QFIPXVFZSA-N</span>
      <span itemprop="name">(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C(C=C)(=O)N1CCC(CC1)[C@@H]1CCNC=2N1N=C(C=2C(=O)N)C1=CC=C(C=C1)OC1=CC=CC=C1</span>
      <span itemprop="inchi_key">RNOAOAWBMHREKO-QFIPXVFZSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZRYMMWAJAFUANM-INIZCTEOSA-N</span>
      <span itemprop="name">(7s)-3-fluoro-4-[3-(8-fluoro-1-methyl-2,4-dioxoquinazolin-3-yl)-2-methylphenyl]-7-(2-hydroxypropan-2-yl)-6,7,8,9-tetrahydro-5h-carbazole-1-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1[C@@H](C(C)(C)O)CCC2=C1NC1=C2C(C2=C(C(=CC=C2)N2C(C3=CC=CC(F)=C3N(C)C2=O)=O)C)=C(F)C=C1C(N)=O</span>
      <span itemprop="inchi_key">ZRYMMWAJAFUANM-INIZCTEOSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LCFFREMLXLZNHE-GBOLQPHISA-N</span>
      <span itemprop="name">(e)-2-[(3r)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C12=C(N)N=CN=C2N([C@@H]2CCCN(C2)C(=O)C(/C#N)=C/C(C)(C)N2CCN(CC2)C2COC2)N=C1C(C(=C1)F)=CC=C1OC1=CC=CC=C1</span>
      <span itemprop="inchi_key">LCFFREMLXLZNHE-GBOLQPHISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">FWOQVRURHRPVKE-ZVDJXTMWSA-M</span>
      <span itemprop="name">1,2-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;chloride</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C([N&#43;](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC</span>
      <span itemprop="inchi_key">FWOQVRURHRPVKE-ZVDJXTMWSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">PORPENFLTBBHSG-MGBGTMOVSA-N</span>
      <span itemprop="name">1,2-dihexadecanoyl-sn-glycerol-3-phosphate</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC</span>
      <span itemprop="inchi_key">PORPENFLTBBHSG-MGBGTMOVSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SJKLCUGQVVYDCX-HRNVLBFRSA-N</span>
      <span itemprop="name">1-(4-tert-butylphenyl)sulfonyl-3-[(3R)-3-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]urea</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCNC(=O)NS(=O)(=O)c4ccc(cc4)C(C)(C)C)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@@H](O)C[C@@H]12</span>
      <span itemprop="inchi_key">SJKLCUGQVVYDCX-HRNVLBFRSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SOJJMSYMCLIQCZ-CYBMUJFWSA-N</span>
      <span itemprop="name">1-[(2r)-4-[2-(2-aminopyrimidin-5-yl)-6-morpholin-4-yl-9-(2,2,2-trifluoroethyl)purin-8-yl]-2-methylpiperazin-1-yl]ethanone</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1CN(C(C)=O)[C@H](C)CN1C1=NC2=C(N3CCOCC3)N=C(C=3C=NC(N)=NC=3)N=C2N1CC(F)(F)F</span>
      <span itemprop="inchi_key">SOJJMSYMCLIQCZ-CYBMUJFWSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QLAVHTXREMEJLM-DYTVHUQLSA-N</span>
      <span itemprop="name">1-[(2r,4s,5r)-5-[[[(2r,3s,5r)-5-(4-amino-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-4-[[(2r,3s,5r)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-sulfanylphosphoryl]oxyoxolan-2-yl]-5-methylpyrimidine-2,4-di</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(S)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(N=C(N)C=C2)=O)CO)[C@@H](OP(S)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)C1</span>
      <span itemprop="inchi_key">QLAVHTXREMEJLM-DYTVHUQLSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XXEDEGOAYSGNPS-ZOWNYOTGSA-N</span>
      <span itemprop="name">1-[(3s)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5h-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one;phosphoric acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OP(O)(O)=O.C1N(C(=O)CC)CC[C@@H]1NC1=NC=NC2=C1CN(C=1C=C(C(OC)=NC=1)C(F)(F)F)CC2</span>
      <span itemprop="inchi_key">XXEDEGOAYSGNPS-ZOWNYOTGSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">KCBAYDCNRMMPRM-KWXKLSQISA-N</span>
      <span itemprop="name">1-[2,2-bis[(9z,12z)-octadeca-9,12-dienyl]-1,3-dioxan-5-yl]-n,n-dimethylmethanamine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCC1(CCCCCCCC\C=C/C\C=C/CCCCC)OCC(CN(C)C)CO1</span>
      <span itemprop="inchi_key">KCBAYDCNRMMPRM-KWXKLSQISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">BUOBCSGIAFXNKP-KWXKLSQISA-N</span>
      <span itemprop="name">1-[2,2-bis[(9z,12z)-octadeca-9,12-dienyl]-1,3-dioxolan-4-yl]-n,n-dimethylmethanamine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCC1(CCCCCCCC\C=C/C\C=C/CCCCC)OCC(CN(C)C)O1</span>
      <span itemprop="inchi_key">BUOBCSGIAFXNKP-KWXKLSQISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">PLKOSISDOAHHCI-QYCRHRGJSA-N</span>
      <span itemprop="name">1-[2,3-bis[(9z,12z)-octadeca-9,12-dienoxy]propyl]-4-methylpiperazine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCOCC(OCCCCCCCC\C=C/C\C=C/CCCCC)CN1CCN(C)CC1</span>
      <span itemprop="inchi_key">PLKOSISDOAHHCI-QYCRHRGJSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">NKHPSESDXTWSQB-WRBBJXAJSA-N</span>
      <span itemprop="name">1-[3,4-bis[(z)-octadec-9-enoxy]phenyl]-n,n-dimethylmethanamine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCC\C=C/CCCCCCCCOC1=CC=C(CN(C)C)C=C1OCCCCCCCC\C=C/CCCCCCCC</span>
      <span itemprop="inchi_key">NKHPSESDXTWSQB-WRBBJXAJSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DWZAEMINVBZMHQ-UHFFFAOYSA-N</span>
      <span itemprop="name">1-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1CC(N(C)C)CCN1C(=O)C(C=C1)=CC=C1NC(=O)NC1=CC=C(C=2N=C(N=C(N=2)N2CCOCC2)N2CCOCC2)C=C1</span>
      <span itemprop="inchi_key">DWZAEMINVBZMHQ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZGRDYKFVDCFJCZ-UHFFFAOYSA-N</span>
      <span itemprop="name">1-[4-[5-[5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-1-ethyl-1,2,4-triazol-3-yl]piperidin-1-yl]-3-hydroxypropan-1-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCN1N=C(C2CCN(CC2)C(=O)CCO)N=C1C(N=1)=CN=C(N)C=1C1=NN=C(C(C)(C)C)O1</span>
      <span itemprop="inchi_key">ZGRDYKFVDCFJCZ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">UVBYMVOUBXYSFV-XUTVFYLZSA-N</span>
      <span itemprop="name">1-methylpseudouridine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1NC(=O)N(C)C=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1</span>
      <span itemprop="inchi_key">UVBYMVOUBXYSFV-XUTVFYLZSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VSNHCAURESNICA-NJFSPNSNSA-N</span>
      <span itemprop="name">1-oxidanylurea</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N[14C](=O)NO</span>
      <span itemprop="inchi_key">VSNHCAURESNICA-NJFSPNSNSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">PAZGBAOHGQRCBP-DDDNOICHSA-N</span>
      <span itemprop="name">1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C/CCCCCCCC</span>
      <span itemprop="inchi_key">PAZGBAOHGQRCBP-DDDNOICHSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZOAIEFWMQLYMTF-UHFFFAOYSA-N</span>
      <span itemprop="name">18-(4-iodophenyl)octadecyl 2-(trimethylazaniumyl)ethyl phosphate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C[N&#43;](C)(C)CCOP([O-])(=O)OCCCCCCCCCCCCCCCCCCC1=CC=C(I)C=C1</span>
      <span itemprop="inchi_key">ZOAIEFWMQLYMTF-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DBXGGXLBTWZXBB-MRXNPFEDSA-N</span>
      <span itemprop="name">2-(6-fluorobenzimidazol-1-yl)-9-[(4r)-8-fluoro-3,4-dihydro-2h-chromen-4-yl]-7h-purin-8-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1COC2=C(F)C=CC=C2[C@@H]1N(C1=N2)C(=O)NC1=CN=C2N1C=NC2=CC=C(F)C=C21</span>
      <span itemprop="inchi_key">DBXGGXLBTWZXBB-MRXNPFEDSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">IUVCFHHAEHNCFT-INIZCTEOSA-N</span>
      <span itemprop="name">2-[(1s)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=C(F)C(OC(C)C)=CC=C1C(C1=C(N)N=CN=C11)=NN1[C@@H](C)C1=C(C=2C=C(F)C=CC=2)C(=O)C2=CC(F)=CC=C2O1</span>
      <span itemprop="inchi_key">IUVCFHHAEHNCFT-INIZCTEOSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XGUSXITVGKLQPW-WQOJUNMYSA-N</span>
      <span itemprop="name">2-[1-[[(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]butoxy]-n,n-dimethyl-3-[(9z,12z)-octadeca-9,12-dienoxy]propan-1-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(CCC)OC(CN(C)C)COCCCCCCCC\C=C/C\C=C/CCCCC)C1</span>
      <span itemprop="inchi_key">XGUSXITVGKLQPW-WQOJUNMYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LRFJOIPOPUJUMI-KWXKLSQISA-N</span>
      <span itemprop="name">2-[2,2-bis[(9z,12z)-octadeca-9,12-dienyl]-1,3-dioxolan-4-yl]-n,n-dimethylethanamine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCC1(CCCCCCCC\C=C/C\C=C/CCCCC)OCC(CCN(C)C)O1</span>
      <span itemprop="inchi_key">LRFJOIPOPUJUMI-KWXKLSQISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">UAXHPOBBKRWJGA-ZDUSSCGKSA-N</span>
      <span itemprop="name">2-[2-[(2s)-2-methyl-2,3-dihydroindol-1-yl]-2-oxoethyl]-6-morpholin-4-yl-1h-pyrimidin-4-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C([C@@H]1C)C2=CC=CC=C2N1C(=O)CC(NC(=O)C=1)=NC=1N1CCOCC1</span>
      <span itemprop="inchi_key">UAXHPOBBKRWJGA-ZDUSSCGKSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">KZSKGLFYQAYZCO-UHFFFAOYSA-N</span>
      <span itemprop="name">2-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]-3-hydroxyazetidin-1-yl]pyridine-4-carboxylic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)C1=CC=NC(N2CC(O)(C2)C=2C(=CC(OCC=3C(=NOC=3C3CC3)C=3C(=CC=CC=3Cl)Cl)=CC=2)Cl)=C1</span>
      <span itemprop="inchi_key">KZSKGLFYQAYZCO-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JKMHFZQWWAIEOD-UHFFFAOYSA-N</span>
      <span itemprop="name">2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OCC[NH&#43;]1CCN(CCS([O-])(=O)=O)CC1</span>
      <span itemprop="inchi_key">JKMHFZQWWAIEOD-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">PGYFLJKHWJVRMC-ZXRZDOCRSA-N</span>
      <span itemprop="name">2-[4-[[(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]butoxy]-n,n-dimethyl-3-[(9z,12z)-octadeca-9,12-dienoxy]propan-1-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OCCCCOC(CN(C)C)COCCCCCCCC\C=C/C\C=C/CCCCC)C1</span>
      <span itemprop="inchi_key">PGYFLJKHWJVRMC-ZXRZDOCRSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MCIDWGZGWVSZMK-UHFFFAOYSA-N</span>
      <span itemprop="name">2-[6-(1h-indol-4-yl)-1h-indazol-4-yl]-5-[(4-propan-2-ylpiperazin-1-yl)methyl]-1,3-oxazole</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1CN(C(C)C)CCN1CC1=CN=C(C=2C=3C=NNC=3C=C(C=2)C=2C=3C=CNC=3C=CC=2)O1</span>
      <span itemprop="inchi_key">MCIDWGZGWVSZMK-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">UEXBBJAYBDAHLG-FJESMAGSSA-N</span>
      <span itemprop="name">2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one (Z)-but-2-enedioic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)\C=C/C(O)=O.C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)C1=C</span>
      <span itemprop="inchi_key">UEXBBJAYBDAHLG-FJESMAGSSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">RTJUXLYUUDBAJN-KVQBGUIXSA-N</span>
      <span itemprop="name">2-amino-9-[(2r,4s,5r)-4-fluoro-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](F)[C@@H](CO)O1</span>
      <span itemprop="inchi_key">RTJUXLYUUDBAJN-KVQBGUIXSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XUMALORDVCFWKV-IBGZPJMESA-N</span>
      <span itemprop="name">2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C[C@H](NC(=O)C1=C2N=CC=CN2N=C1N)C1=CC2=CC=CC(C#CC3=CN(C)N=C3)=C2C(=O)N1C1=CC=CC=C1</span>
      <span itemprop="inchi_key">XUMALORDVCFWKV-IBGZPJMESA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MWYDSXOGIBMAET-UHFFFAOYSA-N</span>
      <span itemprop="name">2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]pyrimidine-5-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">NC1=NC=C(C=N1)C(=O)N=C1N=C2C(=C(C=CC2=C2N1CCN2)OCCCN1CCOCC1)OC</span>
      <span itemprop="inchi_key">MWYDSXOGIBMAET-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QSPOQCXMGPDIHI-UHFFFAOYSA-N</span>
      <span itemprop="name">2-amino-n,n-dipropyl-8-[4-(pyrrolidine-1-carbonyl)phenyl]-3h-1-benzazepine-4-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=C2N=C(N)CC(C(=O)N(CCC)CCC)=CC2=CC=C1C(C=C1)=CC=C1C(=O)N1CCCC1</span>
      <span itemprop="inchi_key">QSPOQCXMGPDIHI-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QINPEPAQOBZPOF-UHFFFAOYSA-N</span>
      <span itemprop="name">2-amino-n-[3-[[3-(2-chloro-5-methoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-2-methylpropanamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">COC1=CC=C(Cl)C(NC=2C(=NC3=CC=CC=C3N=2)NS(=O)(=O)C=2C=C(NC(=O)C(C)(C)N)C=CC=2)=C1</span>
      <span itemprop="inchi_key">QINPEPAQOBZPOF-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JQKOHRZNEOQNJE-ZZEZOPTASA-N</span>
      <span itemprop="name">2-azaniumylethyl [3-octadecanoyloxy-2-[(z)-octadec-9-enoyl]oxypropyl] phosphate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[NH3&#43;])OC(=O)CCCCCCC\C=C/CCCCCCCC</span>
      <span itemprop="inchi_key">JQKOHRZNEOQNJE-ZZEZOPTASA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XTKLTGBKIDQGQL-UHFFFAOYSA-N</span>
      <span itemprop="name">2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylbenzimidazole-4-carboxylic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC1=NC2=C(C(O)=O)C=C(N3CCOCC3)C=C2N1CC1=CC=CC(C(F)(F)F)=C1C</span>
      <span itemprop="inchi_key">XTKLTGBKIDQGQL-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">BEUQXVWXFDOSAQ-UHFFFAOYSA-N</span>
      <span itemprop="name">2-methyl-2-[4-[2-(5-methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]propanamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC(C)N1N=C(C)N=C1C1=CN(CCOC=2C3=CC=C(C=2)C2=CN(N=C2)C(C)(C)C(N)=O)C3=N1</span>
      <span itemprop="inchi_key">BEUQXVWXFDOSAQ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">GJTBSTBJLVYKAU-XVFCMESISA-N</span>
      <span itemprop="name">2-thiouridine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)NC(=O)C=C1</span>
      <span itemprop="inchi_key">GJTBSTBJLVYKAU-XVFCMESISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SDLWKRZBLTZSEL-UHFFFAOYSA-N</span>
      <span itemprop="name">3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC1=CC(OCCOCCC(F)(F)P(O)(O)=O)=CC=C1CCC1=CN=C(C(N)=NC=2C3=CC=C(CCC(O)=O)C=2)C3=C1</span>
      <span itemprop="inchi_key">SDLWKRZBLTZSEL-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">BVZVICBYYOYVEP-MAZCIEHSSA-N</span>
      <span itemprop="name">3-[bis[(9z,12z)-octadeca-9,12-dienyl]amino]propane-1,2-diol</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCN(CC(O)CO)CCCCCCCC\C=C/C\C=C/CCCCC</span>
      <span itemprop="inchi_key">BVZVICBYYOYVEP-MAZCIEHSSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MIJYXULNPSFWEK-GTOFXWBISA-N</span>
      <span itemprop="name">3beta-hydroxyolean-12-en-28-oic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C</span>
      <span itemprop="inchi_key">MIJYXULNPSFWEK-GTOFXWBISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">BZKCILXIFHAPAQ-KWXKLSQISA-N</span>
      <span itemprop="name">4-[2,2-bis[(9z,12z)-octadeca-9,12-dienyl]-1,3-dioxolan-4-yl]-n,n-dimethylbutan-1-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCC1(CCCCCCCC\C=C/C\C=C/CCCCC)OCC(CCCCN(C)C)O1</span>
      <span itemprop="inchi_key">BZKCILXIFHAPAQ-KWXKLSQISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WPFUFWIHMYZXSF-UHFFFAOYSA-N</span>
      <span itemprop="name">4-[2-(difluoromethyl)benzimidazol-1-yl]-n-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1CN(C)CCC1C1=CC=CC=C1CC(C)(C)NC1=NC(N2CCOCC2)=NC(N2C3=CC=CC=C3N=C2C(F)F)=N1</span>
      <span itemprop="inchi_key">WPFUFWIHMYZXSF-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VFOKSTCIRGDTBR-UHFFFAOYSA-N</span>
      <span itemprop="name">4-amino-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C12=NC(OCCCC)=NC(N)=C2NC(=O)CN1CC(C=1)=CC=CC=1CN1CCCC1</span>
      <span itemprop="inchi_key">VFOKSTCIRGDTBR-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HSBKFSPNDWWPSL-VDTYLAMSSA-N</span>
      <span itemprop="name">4-amino-5-fluoro-1-[(2s,5r)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=C(F)C(N)=NC(=O)N1[C@@H]1C=C[C@H](CO)O1</span>
      <span itemprop="inchi_key">HSBKFSPNDWWPSL-VDTYLAMSSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960000549</span>
      <span itemprop="name">4-dimethylaminophenol</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VHYFNPMBLIVWCW-UHFFFAOYSA-N</span>
      <span itemprop="name">4-dimethylaminopyridine</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CN(C)C1=CC=NC=C1</span>
      <span itemprop="inchi_key">VHYFNPMBLIVWCW-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ADGGYDAFIHSYFI-UHFFFAOYSA-N</span>
      <span itemprop="name">5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=NC(N)=CC(C(F)(F)F)=C1C1=NC(N2CCOCC2)=NC(N2CCOCC2)=N1</span>
      <span itemprop="inchi_key">ADGGYDAFIHSYFI-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LGWACEZVCMBSKW-UHFFFAOYSA-N</span>
      <span itemprop="name">5-(6,6-dimethyl-4-morpholin-4-yl-8,9-dihydropurino[8,9-c][1,4]oxazin-2-yl)pyrimidin-2-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC1(C)OCCN(C2=N3)C1=NC2=C(N1CCOCC1)N=C3C1=CN=C(N)N=C1</span>
      <span itemprop="inchi_key">LGWACEZVCMBSKW-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">BBLXLHYPDOMJMO-UHFFFAOYSA-N</span>
      <span itemprop="name">5-(butan-2-ylsulfamoyl)-n-(3,4-difluorophenyl)-2-fluorobenzamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCC(C)NS(=O)(=O)C1=CC=C(F)C(C(=O)NC=2C=C(F)C(F)=CC=2)=C1</span>
      <span itemprop="inchi_key">BBLXLHYPDOMJMO-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZAYHVCMSTBRABG-UHFFFAOYSA-N</span>
      <span itemprop="name">5-Methylcytidine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1N=C(N)C(C)=CN1C1C(O)C(O)C(CO)O1</span>
      <span itemprop="inchi_key">ZAYHVCMSTBRABG-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HIMUHMBGRATXMK-LBPRGKRZSA-N</span>
      <span itemprop="name">5-[1-[(3s)-1-prop-2-enoylpyrrolidin-3-yl]oxyisoquinolin-3-yl]-1,2-dihydro-1,2,4-triazol-3-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1N(C(=O)C=C)CC[C@@H]1OC1=NC(C=2NC(=O)NN=2)=CC2=CC=CC=C12</span>
      <span itemprop="inchi_key">HIMUHMBGRATXMK-LBPRGKRZSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">BBLXLHYPDOMJMO-SNVBAGLBSA-N</span>
      <span itemprop="name">5-[[(2r)-butan-2-yl]sulfamoyl]-n-(3,4-difluorophenyl)-2-fluorobenzamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC[C@@H](C)NS(=O)(=O)C1=CC=C(F)C(C(=O)NC=2C=C(F)C(F)=CC=2)=C1</span>
      <span itemprop="inchi_key">BBLXLHYPDOMJMO-SNVBAGLBSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MNWOBDDXRRBONM-UHFFFAOYSA-N</span>
      <span itemprop="name">5-amino-1-[[3,5-dichloro-4-(4-chlorobenzoyl)phenyl]methyl]triazole-4-carboxamide;2,4-dioxo-1h-pyrimidine-6-carboxylic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)C1=CC(=O)NC(=O)N1.NC1=C(C(=O)N)N=NN1CC(C=C1Cl)=CC(Cl)=C1C(=O)C1=CC=C(Cl)C=C1</span>
      <span itemprop="inchi_key">MNWOBDDXRRBONM-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZAYHVCMSTBRABG-JXOAFFINSA-N</span>
      <span itemprop="name">5-methylcytidine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1</span>
      <span itemprop="inchi_key">ZAYHVCMSTBRABG-JXOAFFINSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">PESKGJQREUXSRR-UXIWKSIVSA-N</span>
      <span itemprop="name">5alpha-cholestan-3-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C([C@@H]1CC2)C(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1</span>
      <span itemprop="inchi_key">PESKGJQREUXSRR-UXIWKSIVSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">PESKGJQREUXSRR-UHFFFAOYSA-N</span>
      <span itemprop="name">5beta-cholestanone</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1CC2CC(=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2</span>
      <span itemprop="inchi_key">PESKGJQREUXSRR-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LBJVBJYMZKEREY-UHFFFAOYSA-N</span>
      <span itemprop="name">6,11,11-trioxo-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-5H-benzo[b][1,4]benzothiazepine-3-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">FC(F)(F)C1=NC=C(CNC(=O)C2=CC3=C(C=C2)S(=O)(=O)C2=CC=CC=C2C(=O)N3)S1</span>
      <span itemprop="inchi_key">LBJVBJYMZKEREY-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">RSIWALKZYXPAGW-NSHDSACASA-N</span>
      <span itemprop="name">6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1</span>
      <span itemprop="inchi_key">RSIWALKZYXPAGW-NSHDSACASA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XWHARLVGMNPKNZ-UHFFFAOYSA-N</span>
      <span itemprop="name">6-N-cyclopropyl-2-N-quinolin-6-yl-7H-purine-2,6-diamine methanesulfonic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CS(O)(=O)=O.CS(O)(=O)=O.C1CC1Nc1nc(Nc2ccc3ncccc3c2)nc2nc[nH]c12</span>
      <span itemprop="inchi_key">XWHARLVGMNPKNZ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">UBLOHCIYTDRGJH-UHFFFAOYSA-N</span>
      <span itemprop="name">6-[2-[[4-amino-3-(3-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-3-[(2-chlorophenyl)methyl]-4-oxoquinazolin-5-yl]-n,n-bis(2-methoxyethyl)hex-5-ynamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C=1C=CC=C(Cl)C=1CN1C(=O)C=2C(C#CCCCC(=O)N(CCOC)CCOC)=CC=CC=2N=C1CN(C1=NC=NC(N)=C11)N=C1C1=CC=CC(O)=C1</span>
      <span itemprop="inchi_key">UBLOHCIYTDRGJH-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SSZHESNDOMBSRV-UHFFFAOYSA-N</span>
      <span itemprop="name">6-amino-2-(butylamino)-9-[[6-[2-(dimethylamino)ethoxy]pyridin-3-yl]methyl]-7h-purin-8-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C12=NC(NCCCC)=NC(N)=C2NC(=O)N1CC1=CC=C(OCCN(C)C)N=C1</span>
      <span itemprop="inchi_key">SSZHESNDOMBSRV-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LFMPVTVPXHNXOT-HNNXBMFYSA-N</span>
      <span itemprop="name">6-amino-2-[(2s)-pentan-2-yl]oxy-9-(5-piperidin-1-ylpentyl)-7h-purin-8-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C12=NC(O[C@@H](C)CCC)=NC(N)=C2NC(=O)N1CCCCCN1CCCCC1</span>
      <span itemprop="inchi_key">LFMPVTVPXHNXOT-HNNXBMFYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SEJLPXCPMNSRAM-GOSISDBHSA-N</span>
      <span itemprop="name">6-amino-9-[(3r)-1-but-2-ynoylpyrrolidin-3-yl]-7-(4-phenoxyphenyl)purin-8-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1N(C(=O)C#CC)CC[C@H]1N1C(=O)N(C=2C=CC(OC=3C=CC=CC=3)=CC=2)C2=C(N)N=CN=C21</span>
      <span itemprop="inchi_key">SEJLPXCPMNSRAM-GOSISDBHSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">BRBZPYDLUUWBCD-UHFFFAOYSA-N</span>
      <span itemprop="name">7-(2-chloro-6-fluorophenyl)-5-(4-chlorophenyl)-1,5,6,7-tetrahydrotetrazolo[1,5-a]pyrimidine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">FC1=CC=CC(Cl)=C1C1N2NN=NC2=NC(C=2C=CC(Cl)=CC=2)C1</span>
      <span itemprop="inchi_key">BRBZPYDLUUWBCD-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">OGHAROSJZRTIOK-KQYNXXCUSA-O</span>
      <span itemprop="name">7-methylguanosine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=2N=C(N)NC(=O)C=2[N&#43;](C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O</span>
      <span itemprop="inchi_key">OGHAROSJZRTIOK-KQYNXXCUSA-O</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LMJFJIDLEAWOQJ-CQSZACIVSA-N</span>
      <span itemprop="name">8-[(1r)-1-(3,5-difluoroanilino)ethyl]-n,n-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N([C@H](C)C=1C2=C(C(C=C(O2)N2CCOCC2)=O)C=C(C=1)C(=O)N(C)C)C1=CC(F)=CC(F)=C1</span>
      <span itemprop="inchi_key">LMJFJIDLEAWOQJ-CQSZACIVSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ACCFLVVUVBJNGT-AWEZNQCLSA-N</span>
      <span itemprop="name">8-[5-(2-hydroxypropan-2-yl)pyridin-3-yl]-1-[(2s)-2-methoxypropyl]-3-methylimidazo[4,5-c]quinolin-2-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CN1C(=O)N(C[C@H](C)OC)C(C2=C3)=C1C=NC2=CC=C3C1=CN=CC(C(C)(C)O)=C1</span>
      <span itemprop="inchi_key">ACCFLVVUVBJNGT-AWEZNQCLSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SJVQHLPISAIATJ-ZDUSSCGKSA-N</span>
      <span itemprop="name">8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]-1-isoquinolinone</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)=CC2=CC=CC(Cl)=C2C(=O)N1C1=CC=CC=C1</span>
      <span itemprop="inchi_key">SJVQHLPISAIATJ-ZDUSSCGKSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JXQUAHHUSMJUFV-HZPZRMRQSA-N</span>
      <span itemprop="name">9-[2-[[(2r,4s)-4-(3-chlorophenyl)-2-oxo-1,3,2$l^{5}-dioxaphosphinan-2-yl]methoxy]ethyl]purin-6-amine;methanesulfonic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CS(O)(=O)=O.C1([C@@H]2CCO[P@](O2)(=O)COCCN2C=3N=CN=C(C=3N=C2)N)=CC=CC(Cl)=C1</span>
      <span itemprop="inchi_key">JXQUAHHUSMJUFV-HZPZRMRQSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960005531</span>
      <span itemprop="name">AMG 319</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101150072844</span>
      <span itemprop="name">APOM gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">206010067484</span>
      <span itemprop="name">Adverse reaction</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100036475</span>
      <span itemprop="name">Alanine aminotransferase 1</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010088751</span>
      <span itemprop="name">Albumins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000009027</span>
      <span itemprop="name">Albumins</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010019182</span>
      <span itemprop="name">Alloferon</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100021619</span>
      <span itemprop="name">Ankyrin repeat and SOCS box protein 5</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000005666</span>
      <span itemprop="name">Apolipoprotein A-I</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010059886</span>
      <span itemprop="name">Apolipoprotein A-I</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100029470</span>
      <span itemprop="name">Apolipoprotein E</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710095339</span>
      <span itemprop="name">Apolipoprotein E</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100037324</span>
      <span itemprop="name">Apolipoprotein M</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000712891</span>
      <span itemprop="name">Arenavirus</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DCXYFEDJOCDNAF-UHFFFAOYSA-N</span>
      <span itemprop="name">Asparagine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)C(N)CC(N)=O</span>
      <span itemprop="inchi_key">DCXYFEDJOCDNAF-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100029822</span>
      <span itemprop="name">B- and T-lymphocyte attenuator</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710144268</span>
      <span itemprop="name">B- and T-lymphocyte attenuator</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010074708</span>
      <span itemprop="name">B7-H1 Antigen</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">CWHUFRVAEUJCEF-UHFFFAOYSA-N</span>
      <span itemprop="name">BKM120</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=NC(N)=CC(C(F)(F)F)=C1C1=CC(N2CCOCC2)=NC(N2CCOCC2)=N1</span>
      <span itemprop="inchi_key">CWHUFRVAEUJCEF-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940124291</span>
      <span itemprop="name">BTK inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010016529</span>
      <span itemprop="name">Bacillus amyloliquefaciens ribonuclease</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010077805</span>
      <span itemprop="name">Bacterial Proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DWRXFEITVBNRMK-UHFFFAOYSA-N</span>
      <span itemprop="name">Beta-D-1-Arabinofuranosylthymine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1</span>
      <span itemprop="inchi_key">DWRXFEITVBNRMK-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">PKWRMUKBEYJEIX-DXXQBUJASA-N</span>
      <span itemprop="name">Birinapant</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CN[C@@H](C)C(=O)N[C@@H](CC)C(=O)N1C[C@@H](O)C[C@H]1CC1=C(C2=C(C3=CC=C(F)C=C3N2)C[C@H]2N(C[C@@H](O)C2)C(=O)[C@H](CC)NC(=O)[C@H](C)NC)NC2=CC(F)=CC=C12</span>
      <span itemprop="inchi_key">PKWRMUKBEYJEIX-DXXQBUJASA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091003079</span>
      <span itemprop="name">Bovine Serum Albumin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">CPELXLSAUQHCOX-UHFFFAOYSA-M</span>
      <span itemprop="name">Bromide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Br-]</span>
      <span itemprop="inchi_key">CPELXLSAUQHCOX-UHFFFAOYSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000011357</span>
      <span itemprop="name">CAR T-cell therapy</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100027207</span>
      <span itemprop="name">CD27 antigen</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940122973</span>
      <span itemprop="name">CD4 agonist</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100025221</span>
      <span itemprop="name">CD70 antigen</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091001711</span>
      <span itemprop="name">CRV-431</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004215</span>
      <span itemprop="name">Carbon black (E152)</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000010667</span>
      <span itemprop="name">Carcinoma of liver and intrahepatic biliary tract</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100026548</span>
      <span itemprop="name">Caspase-8</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108090000538</span>
      <span itemprop="name">Caspase-8</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LZZYPRNAOMGNLH-UHFFFAOYSA-M</span>
      <span itemprop="name">Cetrimonium bromide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Br-].CCCCCCCCCCCCCCCC[N&#43;](C)(C)C</span>
      <span itemprop="inchi_key">LZZYPRNAOMGNLH-UHFFFAOYSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229920001661</span>
      <span itemprop="name">Chitosan</span>
      <span itemprop="domain">Polymers</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VEXZGXHMUGYJMC-UHFFFAOYSA-M</span>
      <span itemprop="name">Chloride anion</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Cl-]</span>
      <span itemprop="inchi_key">VEXZGXHMUGYJMC-UHFFFAOYSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000017667</span>
      <span itemprop="name">Chronic Disease</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020004705</span>
      <span itemprop="name">Codon</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000035473</span>
      <span itemprop="name">Communicable disease</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940124901</span>
      <span itemprop="name">Comvax</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000004420</span>
      <span itemprop="name">Creatine Kinase</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010042126</span>
      <span itemprop="name">Creatine kinase</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000195493</span>
      <span itemprop="name">Cryptophyta</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229930105110</span>
      <span itemprop="name">Cyclosporin A</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">PMATZTZNYRCHOR-CGLBZJNRSA-N</span>
      <span itemprop="name">Cyclosporin A</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O</span>
      <span itemprop="inchi_key">PMATZTZNYRCHOR-CGLBZJNRSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010036949</span>
      <span itemprop="name">Cyclosporine</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000701022</span>
      <span itemprop="name">Cytomegalovirus</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100001074</span>
      <span itemprop="name">DNA strand break</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940124721</span>
      <span itemprop="name">DTP-Hib-HBV vaccine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZBNZXTGUTAYRHI-UHFFFAOYSA-N</span>
      <span itemprop="name">Dasatinib</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1Cl</span>
      <span itemprop="inchi_key">ZBNZXTGUTAYRHI-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000702421</span>
      <span itemprop="name">Dependoparvovirus</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101800000585</span>
      <span itemprop="name">Diphtheria toxin fragment A</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000006144</span>
      <span itemprop="name">Dulbeccos modied Eagle&#39;s medium</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000001301</span>
      <span itemprop="name">EGF receptor</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108060006698</span>
      <span itemprop="name">EGF receptor</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">UPEZCKBFRMILAV-JNEQICEOSA-N</span>
      <span itemprop="name">Ecdysone</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2</span>
      <span itemprop="inchi_key">UPEZCKBFRMILAV-JNEQICEOSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JKLISIRFYWXLQG-UHFFFAOYSA-N</span>
      <span itemprop="name">Epioleonolsaeure</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C</span>
      <span itemprop="inchi_key">JKLISIRFYWXLQG-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108700038635</span>
      <span itemprop="name">Euvax-B</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">GHASVSINZRGABV-UHFFFAOYSA-N</span>
      <span itemprop="name">Fluorouracil</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">FC1=CNC(=O)NC1=O</span>
      <span itemprop="inchi_key">GHASVSINZRGABV-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VZCYOOQTPOCHFL-OWOJBTEDSA-N</span>
      <span itemprop="name">Fumaric acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)\C=C\C(O)=O</span>
      <span itemprop="inchi_key">VZCYOOQTPOCHFL-OWOJBTEDSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000233866</span>
      <span itemprop="name">Fungi</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091092584</span>
      <span itemprop="name">GDNA</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LRULVYSBRWUVGR-FCHUYYIVSA-N</span>
      <span itemprop="name">GSK2879552</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=CC(C(=O)O)=CC=C1CN1CCC(CN[C@H]2[C@@H](C2)C=2C=CC=CC=2)CC1</span>
      <span itemprop="inchi_key">LRULVYSBRWUVGR-FCHUYYIVSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100028652</span>
      <span itemprop="name">Gamma-enolase</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710191797</span>
      <span itemprop="name">Gamma-enolase</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000011201</span>
      <span itemprop="name">Ginkgo</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">244000194101</span>
      <span itemprop="name">Ginkgo biloba</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000008100</span>
      <span itemprop="name">Ginkgo biloba</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010024636</span>
      <span itemprop="name">Glutathione</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000285452</span>
      <span itemprop="name">HBV genotype B</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000285424</span>
      <span itemprop="name">HBV genotype C</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000285366</span>
      <span itemprop="name">HBV genotype D</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000285370</span>
      <span itemprop="name">HBV genotype E</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000285563</span>
      <span itemprop="name">HBV genotype F</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000285576</span>
      <span itemprop="name">HBV genotype G</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000007995</span>
      <span itemprop="name">HEPES buffer</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000588031</span>
      <span itemprop="name">Heliothis armigera entomopoxvirus Spindolin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000700739</span>
      <span itemprop="name">Hepadnaviridae</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">206010073069</span>
      <span itemprop="name">Hepatic cancer</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100034458</span>
      <span itemprop="name">Hepatitis A virus cellular receptor 2</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MAJYPBAJPNUFPV-BQBZGAKWSA-N</span>
      <span itemprop="name">His-Cys</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">SC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1</span>
      <span itemprop="inchi_key">MAJYPBAJPNUFPV-BQBZGAKWSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010074870</span>
      <span itemprop="name">Histone Demethylases</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000008157</span>
      <span itemprop="name">Histone Demethylases</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000754309</span>
      <span itemprop="name">Homo sapiens Ankyrin repeat and SOCS box protein 5</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000914511</span>
      <span itemprop="name">Homo sapiens CD27 antigen</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000934356</span>
      <span itemprop="name">Homo sapiens CD70 antigen</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000941029</span>
      <span itemprop="name">Homo sapiens Endoplasmic reticulum junction formation protein lunapark</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101001068133</span>
      <span itemprop="name">Homo sapiens Hepatitis A virus cellular receptor 2</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000731738</span>
      <span itemprop="name">Homo sapiens Inactive ADP-ribosyltransferase ARH2</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101001002657</span>
      <span itemprop="name">Homo sapiens Interleukin-2</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000868279</span>
      <span itemprop="name">Homo sapiens Leukocyte surface antigen CD47</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101001137987</span>
      <span itemprop="name">Homo sapiens Lymphocyte activation gene 3 protein</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000615488</span>
      <span itemprop="name">Homo sapiens Methyl-CpG-binding domain protein 2</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101001109501</span>
      <span itemprop="name">Homo sapiens NKG2-D type II integral membrane protein</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101001125032</span>
      <span itemprop="name">Homo sapiens Nucleotide-binding oligomerization domain-containing protein 1</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000693234</span>
      <span itemprop="name">Homo sapiens PDZ domain-containing protein 4</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101001000069</span>
      <span itemprop="name">Homo sapiens Protein phosphatase 1 regulatory subunit 12B</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000831007</span>
      <span itemprop="name">Homo sapiens T-cell immunoreceptor with Ig and ITIM domains</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000914514</span>
      <span itemprop="name">Homo sapiens T-cell-specific surface glycoprotein CD28</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000763579</span>
      <span itemprop="name">Homo sapiens Toll-like receptor 1</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000763537</span>
      <span itemprop="name">Homo sapiens Toll-like receptor 10</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000831567</span>
      <span itemprop="name">Homo sapiens Toll-like receptor 2</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000669447</span>
      <span itemprop="name">Homo sapiens Toll-like receptor 4</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000669460</span>
      <span itemprop="name">Homo sapiens Toll-like receptor 5</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000669406</span>
      <span itemprop="name">Homo sapiens Toll-like receptor 6</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000801234</span>
      <span itemprop="name">Homo sapiens Tumor necrosis factor receptor superfamily member 18</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000987003</span>
      <span itemprop="name">Homo sapiens Tumor protein 63</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101000863873</span>
      <span itemprop="name">Homo sapiens Tyrosine-protein phosphatase non-receptor type substrate 1</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091006905</span>
      <span itemprop="name">Human Serum Albumin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000008100</span>
      <span itemprop="name">Human Serum Albumin</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000700588</span>
      <span itemprop="name">Human alphaherpesvirus 1</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000701085</span>
      <span itemprop="name">Human alphaherpesvirus 3</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000725303</span>
      <span itemprop="name">Human immunodeficiency virus</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101900297506</span>
      <span itemprop="name">Human immunodeficiency virus type 1 group M subtype B Reverse transcriptase/ribonuclease H</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940122393</span>
      <span itemprop="name">Hyaluronidase inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VEXZGXHMUGYJMC-UHFFFAOYSA-N</span>
      <span itemprop="name">Hydrochloric acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">Cl</span>
      <span itemprop="inchi_key">VEXZGXHMUGYJMC-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940124753</span>
      <span itemprop="name">IL-2 agonist</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100032448</span>
      <span itemprop="name">Inactive ADP-ribosyltransferase ARH2</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">206010061218</span>
      <span itemprop="name">Inflammation</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710203526</span>
      <span itemprop="name">Integrase</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010047761</span>
      <span itemprop="name">Interferon-alpha</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000006992</span>
      <span itemprop="name">Interferon-alpha</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010079944</span>
      <span itemprop="name">Interferon-alpha2b</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010074328</span>
      <span itemprop="name">Interferon-gamma</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000008070</span>
      <span itemprop="name">Interferon-gamma</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000713321</span>
      <span itemprop="name">Intracisternal A-particles</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940118465</span>
      <span itemprop="name">Isomerase inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101150069255</span>
      <span itemprop="name">KLRC1 gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100021457</span>
      <span itemprop="name">Killer cell lectin-like receptor subfamily G member 1</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710150988</span>
      <span itemprop="name">Killer cell lectin-like receptor subfamily G member 1</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XUJNEKJLAYXESH-REOHCLBHSA-N</span>
      <span itemprop="name">L-Cysteine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">SC[C@H](N)C(O)=O</span>
      <span itemprop="inchi_key">XUJNEKJLAYXESH-REOHCLBHSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">AHLPHDHHMVZTML-BYPYZUCNSA-N</span>
      <span itemprop="name">L-Ornithine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">NCCC[C@H](N)C(O)=O</span>
      <span itemprop="inchi_key">AHLPHDHHMVZTML-BYPYZUCNSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QNAYBMKLOCPYGJ-REOHCLBHSA-N</span>
      <span itemprop="name">L-alanine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C[C@H](N)C(O)=O</span>
      <span itemprop="inchi_key">QNAYBMKLOCPYGJ-REOHCLBHSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DCXYFEDJOCDNAF-REOHCLBHSA-N</span>
      <span itemprop="name">L-asparagine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)[C@@H](N)CC(N)=O</span>
      <span itemprop="inchi_key">DCXYFEDJOCDNAF-REOHCLBHSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZDXPYRJPNDTMRX-VKHMYHEASA-N</span>
      <span itemprop="name">L-glutamine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)[C@@H](N)CCC(N)=O</span>
      <span itemprop="inchi_key">ZDXPYRJPNDTMRX-VKHMYHEASA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">KDXKERNSBIXSRK-YFKPBYRVSA-N</span>
      <span itemprop="name">L-lysine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">NCCCC[C@H](N)C(O)=O</span>
      <span itemprop="inchi_key">KDXKERNSBIXSRK-YFKPBYRVSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">AYFVYJQAPQTCCC-GBXIJSLDSA-N</span>
      <span itemprop="name">L-threonine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C[C@@H](O)[C@H](N)C(O)=O</span>
      <span itemprop="inchi_key">AYFVYJQAPQTCCC-GBXIJSLDSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">OUYCCCASQSFEME-QMMMGPOBSA-N</span>
      <span itemprop="name">L-tyrosine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)[C@@H](N)CC1=CC=C(O)C=C1</span>
      <span itemprop="inchi_key">OUYCCCASQSFEME-QMMMGPOBSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002067</span>
      <span itemprop="name">L01XE06 - Dasatinib</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002177</span>
      <span itemprop="name">L01XE27 - Ibrutinib</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000713666</span>
      <span itemprop="name">Lentivirus</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HLFSDGLLUJUHTE-SNVBAGLBSA-N</span>
      <span itemprop="name">Levamisole</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1([C@H]2CN3CCSC3=N2)=CC=CC=C1</span>
      <span itemprop="inchi_key">HLFSDGLLUJUHTE-SNVBAGLBSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012097</span>
      <span itemprop="name">Lipofectamine 2000</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">206010067125</span>
      <span itemprop="name">Liver injury</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100020862</span>
      <span itemprop="name">Lymphocyte activation gene 3 protein</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010091221</span>
      <span itemprop="name">Lymphotoxin beta Receptor</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101100404845</span>
      <span itemprop="name">Macaca mulatta NKG2A gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">AFVFQIVMOAPDHO-UHFFFAOYSA-M</span>
      <span itemprop="name">Methanesulfonate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CS([O-])(=O)=O</span>
      <span itemprop="inchi_key">AFVFQIVMOAPDHO-UHFFFAOYSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000006890</span>
      <span itemprop="name">Methyl-CpG-Binding Protein 2</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010072388</span>
      <span itemprop="name">Methyl-CpG-Binding Protein 2</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100021299</span>
      <span itemprop="name">Methyl-CpG-binding domain protein 2</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101100481581</span>
      <span itemprop="name">Mus musculus Tlr13 gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VQAYFKKCNSOZKM-IOSLPCCCSA-N</span>
      <span itemprop="name">N(6)-methyladenosine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=NC=2C(NC)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O</span>
      <span itemprop="inchi_key">VQAYFKKCNSOZKM-IOSLPCCCSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SBVBIDUKSBJYEF-VIFPVBQESA-N</span>
      <span itemprop="name">N-(3-cyano-4-fluorophenyl)-1-methyl-4-[[(2S)-1,1,1-trifluoropropan-2-yl]sulfamoyl]pyrrole-2-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1)S(N[C@H](C(F)(F)F)C)(=O)=O)C</span>
      <span itemprop="inchi_key">SBVBIDUKSBJYEF-VIFPVBQESA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">RRMJMHOQSALEJJ-UHFFFAOYSA-N</span>
      <span itemprop="name">N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CN(C)CC=1C(=NN(C=1)C1=NC(=NC=C1)NC=1C(=CC(=C(C=1)NC(C=C)=O)N1CCOCC1)OC)C1=CC=CC=C1</span>
      <span itemprop="inchi_key">RRMJMHOQSALEJJ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QJTLLKKDFGPDPF-QGZVFWFLSA-N</span>
      <span itemprop="name">N-[8-[(2R)-2-hydroxy-3-morpholin-4-ylpropoxy]-7-methoxy-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]-2-methylpyridine-3-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC1=C(C=CC=N1)C(=O)N=C2N=C3C(=C4N2CCN4)C=CC(=C3OC)OC[C@@H](CN5CCOCC5)O</span>
      <span itemprop="inchi_key">QJTLLKKDFGPDPF-QGZVFWFLSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">UNHZLHSLZZWMNP-LLVKDONJSA-N</span>
      <span itemprop="name">NC(=O)c1ccc([C@@H]2CCCN(C2)C(=O)C=C)c2cc[nH]c12</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">NC(=O)c1ccc([C@@H]2CCCN(C2)C(=O)C=C)c2cc[nH]c12</span>
      <span itemprop="inchi_key">UNHZLHSLZZWMNP-LLVKDONJSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WKDBRCUUDXLTIM-NSHDSACASA-N</span>
      <span itemprop="name">NC1=NC=NC(=C1C#N)N[C@@H](C)C1=CC=2N(N=C1C1=CC=CC=C1)C(=CN=2)Cl</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">NC1=NC=NC(=C1C#N)N[C@@H](C)C1=CC=2N(N=C1C1=CC=CC=C1)C(=CN=2)Cl</span>
      <span itemprop="inchi_key">WKDBRCUUDXLTIM-NSHDSACASA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100022682</span>
      <span itemprop="name">NKG2-A/NKG2-B type II integral membrane protein</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100022680</span>
      <span itemprop="name">NKG2-D type II integral membrane protein</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VQAYFKKCNSOZKM-UHFFFAOYSA-N</span>
      <span itemprop="name">NSC 29409</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=NC=2C(NC)=NC=NC=2N1C1OC(CO)C(O)C1O</span>
      <span itemprop="inchi_key">VQAYFKKCNSOZKM-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100038082</span>
      <span itemprop="name">Natural killer cell receptor 2B4</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710141230</span>
      <span itemprop="name">Natural killer cell receptor 2B4</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">206010028980</span>
      <span itemprop="name">Neoplasm</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101150083031</span>
      <span itemprop="name">Nod2 gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020005497</span>
      <span itemprop="name">Nuclear hormone receptor</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000007399</span>
      <span itemprop="name">Nuclear hormone receptor</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108090001074</span>
      <span itemprop="name">Nucleocapsid Proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100030991</span>
      <span itemprop="name">Nucleolar and spindle-associated protein 1</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100029424</span>
      <span itemprop="name">Nucleotide-binding oligomerization domain-containing protein 1</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VYLOOGHLKSNNEK-PIIMJCKOSA-N</span>
      <span itemprop="name">OC(=O)c1cc(F)c2nc(sc2c1)N1[C@H]2CC[C@@H]1C[C@@H](C2)OCc1c(onc1-c1ccccc1OC(F)(F)F)C1CC1</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)c1cc(F)c2nc(sc2c1)N1[C@H]2CC[C@@H]1C[C@@H](C2)OCc1c(onc1-c1ccccc1OC(F)(F)F)C1CC1</span>
      <span itemprop="inchi_key">VYLOOGHLKSNNEK-PIIMJCKOSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">YBRJHZPWOMJYKQ-UHFFFAOYSA-N</span>
      <span itemprop="name">Oleanolic acid</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O</span>
      <span itemprop="inchi_key">YBRJHZPWOMJYKQ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MIJYXULNPSFWEK-UHFFFAOYSA-N</span>
      <span itemprop="name">Oleanolinsaeure</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C</span>
      <span itemprop="inchi_key">MIJYXULNPSFWEK-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">AHLPHDHHMVZTML-UHFFFAOYSA-N</span>
      <span itemprop="name">Orn-delta-NH2</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">NCCCC(N)C(O)=O</span>
      <span itemprop="inchi_key">AHLPHDHHMVZTML-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">UTJLXEIPEHZYQJ-UHFFFAOYSA-N</span>
      <span itemprop="name">Ornithine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)C(C)CCCN</span>
      <span itemprop="inchi_key">UTJLXEIPEHZYQJ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000004316</span>
      <span itemprop="name">Oxidoreductases</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108090000854</span>
      <span itemprop="name">Oxidoreductases</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101150084044</span>
      <span itemprop="name">P gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100034574</span>
      <span itemprop="name">P protein</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710181008</span>
      <span itemprop="name">P protein</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012408</span>
      <span itemprop="name">PCR amplification</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100025653</span>
      <span itemprop="name">PDZ domain-containing protein 4</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012648</span>
      <span itemprop="name">POLY-ICLC</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QIUASFSNWYMDFS-NILGECQDSA-N</span>
      <span itemprop="name">PX-866</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC(=O)O[C@@H]1C[C@]2(C)C(=O)CC[C@H]2C2=C1[C@@]1(C)[C@@H](COC)OC(=O)\C(=C\N(CC=C)CC=C)C1=C(O)C2=O</span>
      <span itemprop="inchi_key">QIUASFSNWYMDFS-NILGECQDSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010088535</span>
      <span itemprop="name">Pep-1 peptide</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000009658</span>
      <span itemprop="name">Peptidylprolyl Isomerase</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010020062</span>
      <span itemprop="name">Peptidylprolyl Isomerase</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710177166</span>
      <span itemprop="name">Phosphoprotein</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004952</span>
      <span itemprop="name">Polyamide</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004698</span>
      <span itemprop="name">Polyethylene</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004793</span>
      <span itemprop="name">Polystyrene</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100024216</span>
      <span itemprop="name">Programmed cell death 1 ligand 1</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100036545</span>
      <span itemprop="name">Protein phosphatase 1 regulatory subunit 12B</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229930185560</span>
      <span itemprop="name">Pseudouridine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">PTJWIQPHWPFNBW-UHFFFAOYSA-N</span>
      <span itemprop="name">Pseudouridine C</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC1C(O)C(CO)OC1C1=CNC(=O)NC1=O</span>
      <span itemprop="inchi_key">PTJWIQPHWPFNBW-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000009572</span>
      <span itemprop="name">RNA Polymerase II</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010009460</span>
      <span itemprop="name">RNA Polymerase II</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012228</span>
      <span itemprop="name">RNA interference-mediated gene silencing</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000033787</span>
      <span itemprop="name">Rare developmental defect during embryogenesis</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010008281</span>
      <span itemprop="name">Recombinant Fusion Proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000007056</span>
      <span itemprop="name">Recombinant Fusion Proteins</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108700033496</span>
      <span itemprop="name">Recombivax HB</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940124942</span>
      <span itemprop="name">Recombivax HB</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940123934</span>
      <span itemprop="name">Reductase inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091081062</span>
      <span itemprop="name">Repeated sequence (DNA)</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710141795</span>
      <span itemprop="name">Ribonuclease inhibitor</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940122208</span>
      <span itemprop="name">Ribonuclease inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100037968</span>
      <span itemprop="name">Ribonuclease inhibitor</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101150010882</span>
      <span itemprop="name">S gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010090287</span>
      <span itemprop="name">SCY-635</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091006279</span>
      <span itemprop="name">SLC5A12</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010088573</span>
      <span itemprop="name">STG-175</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091061939</span>
      <span itemprop="name">Selfish DNA</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000700584</span>
      <span itemprop="name">Simplexvirus</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100037203</span>
      <span itemprop="name">Sodium-coupled monocarboxylate transporter 2</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010090804</span>
      <span itemprop="name">Streptavidin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101710172711</span>
      <span itemprop="name">Structural protein</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000001435</span>
      <span itemprop="name">Synapsin</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108050009621</span>
      <span itemprop="name">Synapsin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100024834</span>
      <span itemprop="name">T-cell immunoreceptor with Ig and ITIM domains</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100027213</span>
      <span itemprop="name">T-cell-specific surface glycoprotein CD28</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940126123</span>
      <span itemprop="name">TAK-020</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940124615</span>
      <span itemprop="name">TLR 7 agonist</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101150038509</span>
      <span itemprop="name">TLR9 gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004098</span>
      <span itemprop="name">Tetracycline</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">AYFVYJQAPQTCCC-UHFFFAOYSA-N</span>
      <span itemprop="name">Threonine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC(O)C(N)C(O)=O</span>
      <span itemprop="inchi_key">AYFVYJQAPQTCCC-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004473</span>
      <span itemprop="name">Threonine</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100027010</span>
      <span itemprop="name">Toll-like receptor 1</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100027009</span>
      <span itemprop="name">Toll-like receptor 10</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100024333</span>
      <span itemprop="name">Toll-like receptor 2</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100039360</span>
      <span itemprop="name">Toll-like receptor 4</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100039357</span>
      <span itemprop="name">Toll-like receptor 5</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100039387</span>
      <span itemprop="name">Toll-like receptor 6</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000004887</span>
      <span itemprop="name">Transforming Growth Factor beta</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108090001012</span>
      <span itemprop="name">Transforming Growth Factor beta</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MSLJYSGFUMYUDX-UHFFFAOYSA-N</span>
      <span itemprop="name">Trimidox</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">ON=C(N)C1=CC(O)=C(O)C(O)=C1</span>
      <span itemprop="inchi_key">MSLJYSGFUMYUDX-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100033728</span>
      <span itemprop="name">Tumor necrosis factor receptor superfamily member 18</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100022156</span>
      <span itemprop="name">Tumor necrosis factor receptor superfamily member 3</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100027881</span>
      <span itemprop="name">Tumor protein 63</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940124922</span>
      <span itemprop="name">Twinrix</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100021869</span>
      <span itemprop="name">Tyrosine aminotransferase</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102100029948</span>
      <span itemprop="name">Tyrosine-protein phosphatase non-receptor type substrate 1</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">206010046865</span>
      <span itemprop="name">Vaccinia virus infection</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010003533</span>
      <span itemprop="name">Viral Envelope Proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010087302</span>
      <span itemprop="name">Viral Structural Proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010066342</span>
      <span itemprop="name">Virus Receptors</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000018265</span>
      <span itemprop="name">Virus Receptors</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HIMJIPRMECETLJ-UHFFFAOYSA-N</span>
      <span itemprop="name">Wogonin</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3</span>
      <span itemprop="inchi_key">HIMJIPRMECETLJ-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241001492404</span>
      <span itemprop="name">Woodchuck hepatitis virus</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">101150003160</span>
      <span itemprop="name">X gene</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HGVNLRPZOWWDKD-UHFFFAOYSA-N</span>
      <span itemprop="name">ZSTK-474</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">FC(F)C1=NC2=CC=CC=C2N1C(N=1)=NC(N2CCOCC2)=NC=1N1CCOCC1</span>
      <span itemprop="inchi_key">HGVNLRPZOWWDKD-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241001441550</span>
      <span itemprop="name">Zeiformes</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SCTJKHUUZLXJIP-RUZDIDTESA-N</span>
      <span itemprop="name">[(2r)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(3-hexadecoxypropoxy)phosphinic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N1=CN=C2N(C[C@@H](C)OCP(O)(=O)OCCCOCCCCCCCCCCCCCCCC)C=NC2=C1N</span>
      <span itemprop="inchi_key">SCTJKHUUZLXJIP-RUZDIDTESA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">RLAHNGKRJJEIJL-RFZPGFLSSA-N</span>
      <span itemprop="name">[(2r,4r)-4-(2,6-diaminopurin-9-yl)-1,3-dioxolan-2-yl]methanol</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C12=NC(N)=NC(N)=C2N=CN1[C@H]1CO[C@@H](CO)O1</span>
      <span itemprop="inchi_key">RLAHNGKRJJEIJL-RFZPGFLSSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">FJAOCNGVPLTSLD-NKWVEPMBSA-N</span>
      <span itemprop="name">[(2s,5r)-5-(2-amino-6-methoxypurin-9-yl)oxolan-2-yl]methanol</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=NC=2C(OC)=NC(N)=NC=2N1[C@H]1CC[C@@H](CO)O1</span>
      <span itemprop="inchi_key">FJAOCNGVPLTSLD-NKWVEPMBSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">TTWXVHUYMARJHI-KWXKLSQISA-N</span>
      <span itemprop="name">[(6Z,9Z,29Z,32Z)-20-[(dimethylamino)methyl]octatriaconta-6,9,29,32-tetraen-19-yl] carbamate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCC(CN(C)C)C(OC(N)=O)CCCCCCCC\C=C/C\C=C/CCCCC</span>
      <span itemprop="inchi_key">TTWXVHUYMARJHI-KWXKLSQISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">KDNSSKPZBDNJDF-UHFFFAOYSA-N</span>
      <span itemprop="name">[1-[(2-aminopurin-9-yl)methyl]cyclopropyl]oxymethylphosphonic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C12=NC(N)=NC=C2N=CN1CC1(OCP(O)(O)=O)CC1</span>
      <span itemprop="inchi_key">KDNSSKPZBDNJDF-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HCAJCMUKLZSPFT-KWXKLSQISA-N</span>
      <span itemprop="name">[3-(dimethylamino)-2-[(9z,12z)-octadeca-9,12-dienoyl]oxypropyl] (9z,12z)-octadeca-9,12-dienoate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC(CN(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC</span>
      <span itemprop="inchi_key">HCAJCMUKLZSPFT-KWXKLSQISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HMNZFMSWFCAGGW-XPWSMXQVSA-N</span>
      <span itemprop="name">[3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC</span>
      <span itemprop="inchi_key">HMNZFMSWFCAGGW-XPWSMXQVSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VJLRLTSXTLICIR-UHFFFAOYSA-N</span>
      <span itemprop="name">[8-[6-amino-5-(trifluoromethyl)pyridin-3-yl]-1-[6-(2-cyanopropan-2-yl)pyridin-3-yl]-3-methylimidazo[4,5-c]quinolin-2-ylidene]cyanamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N#CN=C1N(C)C2=CN=C3C=CC(C=4C=C(C(N)=NC=4)C(F)(F)F)=CC3=C2N1C1=CC=C(C(C)(C)C#N)N=C1</span>
      <span itemprop="inchi_key">VJLRLTSXTLICIR-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZPQSANIZYBRYBQ-PFEQFJNWSA-N</span>
      <span itemprop="name">[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate 2,4-dioxo-1H-pyrimidine-6-carboxylic acid</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)C1=CC(=O)NC(=O)N1.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N</span>
      <span itemprop="inchi_key">ZPQSANIZYBRYBQ-PFEQFJNWSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">CJCYTUJOSMYXLE-NHMFLIHISA-N</span>
      <span itemprop="name">[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl]oxyphosphoryl]sulfanylmethyl propan-2-yl carbonate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CO[C@@H]1[C@H](O[P@@](=O)(OC[C@H]2O[C@H](C[C@@H]2O)n2cnc3c(N)ncnc23)SCOC(=O)OC(C)C)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O</span>
      <span itemprop="inchi_key">CJCYTUJOSMYXLE-NHMFLIHISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001594</span>
      <span itemprop="name">aberrant effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002159</span>
      <span itemprop="name">abnormal effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WDENQIQQYWYTPO-IBGZPJMESA-N</span>
      <span itemprop="name">acalabrutinib</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC#CC(=O)N1CCC[C@H]1C1=NC(C=2C=CC(=CC=2)C(=O)NC=2N=CC=CC=2)=C2N1C=CN=C2N</span>
      <span itemprop="inchi_key">WDENQIQQYWYTPO-IBGZPJMESA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000009825</span>
      <span itemprop="name">accumulation</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">YQNQNVDNTFHQSW-UHFFFAOYSA-N</span>
      <span itemprop="name">acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C([N&#43;]([O-])=O)S1</span>
      <span itemprop="inchi_key">YQNQNVDNTFHQSW-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004480</span>
      <span itemprop="name">active ingredient</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000006838</span>
      <span itemprop="name">adverse reaction</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000001042</span>
      <span itemprop="name">affinity chromatography</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950001741</span>
      <span itemprop="name">agatolimod</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000004279</span>
      <span itemprop="name">alanine</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108700025316</span>
      <span itemprop="name">aldesleukin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000000735</span>
      <span itemprop="name">allogeneic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003281</span>
      <span itemprop="name">allosteric effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950010482</span>
      <span itemprop="name">alpelisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">UPEZCKBFRMILAV-UHFFFAOYSA-N</span>
      <span itemprop="name">alpha-Ecdysone</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21</span>
      <span itemprop="inchi_key">UPEZCKBFRMILAV-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004075</span>
      <span itemprop="name">alteration</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950005846</span>
      <span itemprop="name">amdoxovir</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004599</span>
      <span itemprop="name">antimicrobial</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002246</span>
      <span itemprop="name">antineoplastic agent</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LJTSIMVOOOLKOL-FNRDIUJOSA-N</span>
      <span itemprop="name">antroquinonol</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">COC1=C(OC)C(=O)[C@H](C)[C@@H](C\C=C(/C)CC\C=C(/C)CCC=C(C)C)[C@H]1O</span>
      <span itemprop="inchi_key">LJTSIMVOOOLKOL-FNRDIUJOSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LJTSIMVOOOLKOL-KCZVDYSFSA-N</span>
      <span itemprop="name">antroquinonol</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">COC1=C(OC)C(=O)[C@H](C)[C@@H](CC=C(/C)CCC=C(/C)CCC=C(C)C)[C@H]1O</span>
      <span itemprop="inchi_key">LJTSIMVOOOLKOL-KCZVDYSFSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000003782</span>
      <span itemprop="name">apoptosis assay</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000009582</span>
      <span itemprop="name">asparagine</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960001230</span>
      <span itemprop="name">asparagine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950003870</span>
      <span itemprop="name">astodrimer</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002238</span>
      <span itemprop="name">attenuated effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950002916</span>
      <span itemprop="name">avelumab</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940003504</span>
      <span itemprop="name">avonex</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001580</span>
      <span itemprop="name">bacterial effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940002637</span>
      <span itemprop="name">baraclude</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004888</span>
      <span itemprop="name">barrier function</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HDRGJRSISASRAJ-WKPMUQCKSA-N</span>
      <span itemprop="name">bazlitoran</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CO[C@@H]1[C@H](O)[C@@H](COP(=O)(S)O[C@@H]2[C@@H](COP(=O)(S)O[C@H]3C[C@@H](O[C@@H]3COP(=O)(S)O[C@H]4C[C@@H](O[C@@H]4COP(=O)(S)O[C@H]5C[C@@H](O[C@@H]5COP(=O)(S)O[C@H]6C[C@@H](O[C@@H]6COP(=O)(S)O[C@H]7C[C@@H](O[C@@H]7COP(=O)(S)O[C@H]8C[C@@H](O[C@@H]8COP(=O)(S)O[C@H]9C[C@@H](O[C@@H]9COP(=O)(S)O[C@H]%10C[C@@H](O[C@@H]%10COP(=O)(S)O[C@@H]%11[C@@H](COP(=O)(S)O[C@@H]%12[C@@H](COP(=O)(S)O[C@H]%13C[C@@H](O[C@@H]%13COP(=O)(S)O[C@H]%14C[C@@H](O[C@@H]%14COP(=O)(S)O[C@H]%15C[C@@H](O[C@@H]%15COP(=O)(S)O[C@H]%16C[C@@H](O[C@@H]%16COP(=O)(S)O[C@H]%17C[C@@H](O[C@@H]%17COP(=O)(S)O[C@H]%18C[C@@H](O[C@@H]%18CO)N%19C=CC(=NC%19=O)N)N%20C=C(C)C(=O)NC%20=O)n%21cnc%22c(N)ncnc%21%22)N%23C=C(C)C(=O)NC%23=O)N%24C=CC(=NC%24=O)N)N%25C=C(C)C(=O)NC%25=O)O[C@H]([C@@H]%12OC)n%26cnc%27C(=O)NC(=Nc%26%27)N)O[C@H]([C@@H]%11OC)N%28C=CC(=O)NC%28=O)N%29C=C(C)C(=NC%29=O)N)n%30ccc%31C(=O)NC(=Nc%30%31)N)N%32C=C(C)C(=O)NC%32=O)N%33C=C(C)C(=O)NC%33=O)N%34C=CC(=NC%34=O)N)N%35C=C(C)C(=O)NC%35=O)N%36C=CC(=NC%36=O)N)N%37C=C(C)C(=O)NC%37=O)O[C@H]([C@@H]2OC)n%38cnc%39C(=O)NC(=Nc%38%39)N)O[C@H]1N%40C=CC(=O)NC%40=O</span>
      <span itemprop="inchi_key">HDRGJRSISASRAJ-WKPMUQCKSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960005347</span>
      <span itemprop="name">belatacept</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000008901</span>
      <span itemprop="name">benefit</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ABSXPNGWJFAPRT-UHFFFAOYSA-N</span>
      <span itemprop="name">benzenesulfonic acid;n-[3-[[5-fluoro-2-[4-(2-methoxyethoxy)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OS(=O)(=O)C1=CC=CC=C1.C1=CC(OCCOC)=CC=C1NC1=NC=C(F)C(NC=2C=C(NC(=O)C=C)C=CC=2)=N1</span>
      <span itemprop="inchi_key">ABSXPNGWJFAPRT-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950002782</span>
      <span itemprop="name">besifovir</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">IQFYYKKMVGJFEH-UHFFFAOYSA-N</span>
      <span itemprop="name">beta-L-thymidine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1</span>
      <span itemprop="inchi_key">IQFYYKKMVGJFEH-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DRTQHJPVMGBUCF-PSQAKQOGSA-N</span>
      <span itemprop="name">beta-L-uridine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1</span>
      <span itemprop="inchi_key">DRTQHJPVMGBUCF-PSQAKQOGSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WGDUUQDYDIIBKT-UHFFFAOYSA-N</span>
      <span itemprop="name">beta-Pseudouridine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC1OC(CN2C=CC(=O)NC2=O)C(O)C1O</span>
      <span itemprop="inchi_key">WGDUUQDYDIIBKT-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001588</span>
      <span itemprop="name">bifunctional effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012620</span>
      <span itemprop="name">biological material</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000033228</span>
      <span itemprop="name">biological regulation</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940126587</span>
      <span itemprop="name">biotherapeutics</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950004237</span>
      <span itemprop="name">birinapant</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010063132</span>
      <span itemprop="name">birinapant</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000004369</span>
      <span itemprop="name">blood</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000008280</span>
      <span itemprop="name">blood</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000010836</span>
      <span itemprop="name">blood and blood product</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940125691</span>
      <span itemprop="name">blood product</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950003628</span>
      <span itemprop="name">buparlisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">AIYUHDOJVYHVIT-UHFFFAOYSA-M</span>
      <span itemprop="name">caesium chloride</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Cl-].[Cs&#43;]</span>
      <span itemprop="inchi_key">AIYUHDOJVYHVIT-UHFFFAOYSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950007712</span>
      <span itemprop="name">camrelizumab</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">201000011510</span>
      <span itemprop="name">cancer</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000001818</span>
      <span itemprop="name">capillary gel electrophoresis</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000000234</span>
      <span itemprop="name">capsid</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940124765</span>
      <span itemprop="name">capsid inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000003917</span>
      <span itemprop="name">carbamoyl group</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[H]N([H])C(*)=O</span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000004432</span>
      <span itemprop="name">carbon atom</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C*</span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229910002092</span>
      <span itemprop="name">carbon dioxide</span>
      <span itemprop="domain">Inorganic materials</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000001569</span>
      <span itemprop="name">carbon dioxide</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">BVKZGUZCCUSVTD-UHFFFAOYSA-N</span>
      <span itemprop="name">carbonic acid</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(O)=O</span>
      <span itemprop="inchi_key">BVKZGUZCCUSVTD-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003197</span>
      <span itemprop="name">catalytic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000030833</span>
      <span itemprop="name">cell death</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003833</span>
      <span itemprop="name">cell viability</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950001357</span>
      <span itemprop="name">celmoleukin</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940121420</span>
      <span itemprop="name">cemiplimab</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000003169</span>
      <span itemprop="name">central nervous system</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000001783</span>
      <span itemprop="name">ceramides</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000001638</span>
      <span itemprop="name">cerebellum</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940098124</span>
      <span itemprop="name">cesium chloride</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">YMKDRGPMQRFJGP-UHFFFAOYSA-M</span>
      <span itemprop="name">cetylpyridinium chloride</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Cl-].CCCCCCCCCCCCCCCC[N&#43;]1=CC=CC=C1</span>
      <span itemprop="inchi_key">YMKDRGPMQRFJGP-UHFFFAOYSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960001927</span>
      <span itemprop="name">cetylpyridinium chloride</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000008859</span>
      <span itemprop="name">change</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012512</span>
      <span itemprop="name">characterization method</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">OKYYOKGIPDRZJA-CPSXWDTOSA-N</span>
      <span itemprop="name">chembl2103792</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(N=C(N)C=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(N=C(N)C=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(N=C(N)C=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(N=C(N)C=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)CO)[C@@H](O)C1</span>
      <span itemprop="inchi_key">OKYYOKGIPDRZJA-CPSXWDTOSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000006243</span>
      <span itemprop="name">chemical reaction</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002559</span>
      <span itemprop="name">chemokine receptor antagonist</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000003763</span>
      <span itemprop="name">chloroplast</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">GGCLNOIGPMGLDB-GYKMGIIDSA-N</span>
      <span itemprop="name">cholest-5-en-3-one</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1C=C2CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2</span>
      <span itemprop="inchi_key">GGCLNOIGPMGLDB-GYKMGIIDSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">NYOXRYYXRWJDKP-UHFFFAOYSA-N</span>
      <span itemprop="name">cholestenone</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2</span>
      <span itemprop="inchi_key">NYOXRYYXRWJDKP-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960001231</span>
      <span itemprop="name">choline</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000013611</span>
      <span itemprop="name">chromosomal DNA</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002759</span>
      <span itemprop="name">chromosomal effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960001265</span>
      <span itemprop="name">ciclosporin</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000007882</span>
      <span itemprop="name">cirrhosis</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000007979</span>
      <span itemprop="name">citrate buffer</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960005338</span>
      <span itemprop="name">clevudine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">GBBJCSTXCAQSSJ-XQXXSGGOSA-N</span>
      <span itemprop="name">clevudine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1NC(=O)C(C)=CN1[C@@H]1[C@H](F)[C@@H](O)[C@H](CO)O1</span>
      <span itemprop="inchi_key">GBBJCSTXCAQSSJ-XQXXSGGOSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000000052</span>
      <span itemprop="name">comparative effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000000295</span>
      <span itemprop="name">complement effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000004590</span>
      <span itemprop="name">computer program</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000013256</span>
      <span itemprop="name">coordination polymer</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950002550</span>
      <span itemprop="name">copanlisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">QYIXCDOBOSTCEI-NWKZBHTNSA-N</span>
      <span itemprop="name">coprostanol</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C([C@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1</span>
      <span itemprop="inchi_key">QYIXCDOBOSTCEI-NWKZBHTNSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000011258</span>
      <span itemprop="name">core-shell material</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012045</span>
      <span itemprop="name">crude solution</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000018417</span>
      <span itemprop="name">cysteine</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XUJNEKJLAYXESH-UHFFFAOYSA-N</span>
      <span itemprop="name">cysteine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">SCC(N)C(O)=O</span>
      <span itemprop="inchi_key">XUJNEKJLAYXESH-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000000805</span>
      <span itemprop="name">cytoplasm</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940127089</span>
      <span itemprop="name">cytotoxic agent</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000006378</span>
      <span itemprop="name">damage</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960002448</span>
      <span itemprop="name">dasatinib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000000432</span>
      <span itemprop="name">density-gradient centrifugation</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003599</span>
      <span itemprop="name">detergent</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000022734</span>
      <span itemprop="name">developmental defect during embryogenesis</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000005265</span>
      <span itemprop="name">dialkylamine group</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000001985</span>
      <span itemprop="name">dialkylglycerols</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000009792</span>
      <span itemprop="name">diffusion process</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000000539</span>
      <span itemprop="name">dimer</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">UAKOZKUVZRMOFN-JDVCJPALSA-M</span>
      <span itemprop="name">dimethyl-bis[(z)-octadec-9-enyl]azanium;chloride</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Cl-].CCCCCCCC\C=C/CCCCCCCC[N&#43;](C)(C)CCCCCCCC\C=C/CCCCCCCC</span>
      <span itemprop="inchi_key">UAKOZKUVZRMOFN-JDVCJPALSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000008034</span>
      <span itemprop="name">disappearance</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000006185</span>
      <span itemprop="name">dispersion</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000010494</span>
      <span itemprop="name">dissociation reaction</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000005593</span>
      <span itemprop="name">dissociations</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000009826</span>
      <span itemprop="name">distribution</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002552</span>
      <span itemprop="name">dosage form</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960003722</span>
      <span itemprop="name">doxycycline</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950004949</span>
      <span itemprop="name">duvelisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">UPEZCKBFRMILAV-JMZLNJERSA-N</span>
      <span itemprop="name">ecdysone</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21</span>
      <span itemprop="inchi_key">UPEZCKBFRMILAV-JMZLNJERSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940056913</span>
      <span itemprop="name">eftilagimod alfa</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950006528</span>
      <span itemprop="name">elvucitabine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940001018</span>
      <span itemprop="name">emtriva</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960000980</span>
      <span itemprop="name">entecavir</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000007613</span>
      <span itemprop="name">environmental effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000001976</span>
      <span itemprop="name">enzyme digestion</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001973</span>
      <span itemprop="name">epigenetic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000002919</span>
      <span itemprop="name">epithelial cell</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000003560</span>
      <span itemprop="name">epithelium corneal</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940074057</span>
      <span itemprop="name">epivir hbv</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000008029</span>
      <span itemprop="name">eradication</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003628</span>
      <span itemprop="name">erosive effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003797</span>
      <span itemprop="name">essential amino acid</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000002169</span>
      <span itemprop="name">ethanolamines</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">OLNTVTPDXPETLC-XPWALMASSA-N</span>
      <span itemprop="name">ezetimibe</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1</span>
      <span itemprop="inchi_key">OLNTVTPDXPETLC-XPWALMASSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960000815</span>
      <span itemprop="name">ezetimibe</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960004396</span>
      <span itemprop="name">famciclovir</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">GGXKWVWZWMLJEH-UHFFFAOYSA-N</span>
      <span itemprop="name">famcyclovir</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1</span>
      <span itemprop="inchi_key">GGXKWVWZWMLJEH-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">206010016256</span>
      <span itemprop="name">fatigue</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012091</span>
      <span itemprop="name">fetal bovine serum</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004761</span>
      <span itemprop="name">fibrosis</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003176</span>
      <span itemprop="name">fibrotic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XRECTZIEBJDKEO-UHFFFAOYSA-N</span>
      <span itemprop="name">flucytosine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">NC1=NC(=O)NC=C1F</span>
      <span itemprop="inchi_key">XRECTZIEBJDKEO-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960004413</span>
      <span itemprop="name">flucytosine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960002949</span>
      <span itemprop="name">fluorouracil</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950008209</span>
      <span itemprop="name">gedatolisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000009368</span>
      <span itemprop="name">gene silencing by RNA</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000034356</span>
      <span itemprop="name">gene-regulatory proteins</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091006104</span>
      <span itemprop="name">gene-regulatory proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000118</span>
      <span itemprop="name">genetic alteration</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004077</span>
      <span itemprop="name">genetic alteration</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012248</span>
      <span itemprop="name">genetic selection</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000003205</span>
      <span itemprop="name">genotyping method</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZDXPYRJPNDTMRX-UHFFFAOYSA-N</span>
      <span itemprop="name">glutamine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)C(N)CCC(N)=O</span>
      <span itemprop="inchi_key">ZDXPYRJPNDTMRX-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000004554</span>
      <span itemprop="name">glutamine</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">RWSXRVCMGQZWBV-WDSKDSINSA-N</span>
      <span itemprop="name">glutathione</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O</span>
      <span itemprop="inchi_key">RWSXRVCMGQZWBV-WDSKDSINSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000012010</span>
      <span itemprop="name">growth</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003394</span>
      <span itemprop="name">haemopoietic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000005802</span>
      <span itemprop="name">health problem</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000010438</span>
      <span itemprop="name">heat treatment</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010085930</span>
      <span itemprop="name">heberbiovac-HB</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940065376</span>
      <span itemprop="name">hepagam b</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000234</span>
      <span itemprop="name">hepatic damage</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000006454</span>
      <span itemprop="name">hepatitis</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000283</span>
      <span itemprop="name">hepatitis</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010050151</span>
      <span itemprop="name">hepatitis B hyperimmune globulin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940036107</span>
      <span itemprop="name">hepatitis b immunoglobulin</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960002348</span>
      <span itemprop="name">hepatitis b surface antigen vaccine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000006359</span>
      <span itemprop="name">hepatoblastoma</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940097709</span>
      <span itemprop="name">hepsera</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000005556</span>
      <span itemprop="name">hormone</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940088597</span>
      <span itemprop="name">hormone</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010086162</span>
      <span itemprop="name">human BT088 immunoglobulin</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000007442</span>
      <span itemprop="name">human BT088 immunoglobulin</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000055277</span>
      <span itemprop="name">human IL2</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229930195733</span>
      <span itemprop="name">hydrocarbon</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000002430</span>
      <span itemprop="name">hydrocarbons</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000007062</span>
      <span itemprop="name">hydrolysis</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000006460</span>
      <span itemprop="name">hydrolysis reaction</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229920001477</span>
      <span itemprop="name">hydrophilic polymer</span>
      <span itemprop="domain">Polymers</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002209</span>
      <span itemprop="name">hydrophobic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960004171</span>
      <span itemprop="name">hydroxychloroquine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000000521</span>
      <span itemprop="name">hyperimmunizing effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960001507</span>
      <span itemprop="name">ibrutinib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XYFPWWZEPKGCCK-GOSISDBHSA-N</span>
      <span itemprop="name">ibrutinib</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=2C(N)=NC=NC=2N([C@H]2CN(CCC2)C(=O)C=C)N=C1C(C=C1)=CC=C1OC1=CC=CC=C1</span>
      <span itemprop="inchi_key">XYFPWWZEPKGCCK-GOSISDBHSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960003445</span>
      <span itemprop="name">idelalisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">YKLIKGKUANLGSB-HNNXBMFYSA-N</span>
      <span itemprop="name">idelalisib</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1([C@@H](NC=2[C]3N=CN=C3N=CN=2)CC)=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1</span>
      <span itemprop="inchi_key">YKLIKGKUANLGSB-HNNXBMFYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010034964</span>
      <span itemprop="name">igantibe</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XZZXIYZZBJDEEP-UHFFFAOYSA-N</span>
      <span itemprop="name">imipramine hydrochloride</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Cl-].C1CC2=CC=CC=C2N(CCC[NH&#43;](C)C)C2=CC=CC=C21</span>
      <span itemprop="inchi_key">XZZXIYZZBJDEEP-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960002751</span>
      <span itemprop="name">imiquimod</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DOUYETYNHWVLEO-UHFFFAOYSA-N</span>
      <span itemprop="name">imiquimod</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21</span>
      <span itemprop="inchi_key">DOUYETYNHWVLEO-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000002865</span>
      <span itemprop="name">immune cell</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000003018</span>
      <span itemprop="name">immunoassay</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002584</span>
      <span itemprop="name">immunomodulator</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002513</span>
      <span itemprop="name">implantation</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000006872</span>
      <span itemprop="name">improvement</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000011065</span>
      <span itemprop="name">in-situ storage</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940069667</span>
      <span itemprop="name">inarigivir soproxil</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950009034</span>
      <span itemprop="name">indoximod</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000004054</span>
      <span itemprop="name">inflammatory process</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000000977</span>
      <span itemprop="name">initiatory effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108700043043</span>
      <span itemprop="name">inosine glycyl-cysteinyl-glutamate disodium</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000017730</span>
      <span itemprop="name">intein-mediated protein splicing</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960004061</span>
      <span itemprop="name">interferon alfa-n1</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010006088</span>
      <span itemprop="name">interferon alfa-n1</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960004461</span>
      <span itemprop="name">interferon beta-1a</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960003130</span>
      <span itemprop="name">interferon gamma</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002955</span>
      <span itemprop="name">isolation</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003394</span>
      <span itemprop="name">isomerase inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000005304</span>
      <span itemprop="name">joining</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000009384</span>
      <span itemprop="name">kangtai</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000003734</span>
      <span itemprop="name">kidney</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002372</span>
      <span itemprop="name">labelling</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940121291</span>
      <span itemprop="name">lenvervimab</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960001614</span>
      <span itemprop="name">levamisole</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002479</span>
      <span itemprop="name">lipoplex</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000007788</span>
      <span itemprop="name">liquid</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">CJZRVARTODENJN-UHFFFAOYSA-N</span>
      <span itemprop="name">litenimod</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1NC(=O)C(C)=CN1C(O1)CC(O)C1COP(O)(=S)OC1CC(N2C3=NC=NC(N)=C3N=C2)OC1COP(O)(=S)OC1CC(N2C(N=C(N)C=C2)=O)OC1COP(O)(=S)OC1CC(N2C(NC(=O)C(C)=C2)=O)OC1COP(O)(=S)OC1CC(N2C3=C(C(NC(N)=N3)=O)N=C2)OC1COP(O)(=S)OC1CC(N2C(N=C(N)C=C2)=O)OC1COP(O)(=S)OC1CC(N2C3=NC=NC(N)=C3N=C2)OC1COP(O)(=S)OC1CC(N2C3=C(C(NC(N)=N3)=O)N=C2)OC1COP(O)(=S)OC1CC(N2C(NC(=O)C(C)=C2)=O)OC1COP(O)(=S)OC1CC(N2C3=NC=NC(N)=C3N=C2)OC1COP(O)(=S)OC1CC(N2C(NC(=O)C(C)=C2)=O)OC1COP(O)(=S)OC1CC(N2C(NC(=O)C(C)=C2)=O)OC1COP(O)(=S)OC1CC(N2C3=C(C(NC(N)=N3)=O)N=C2)OC1COP(O)(=S)OC1CC(N2C(N=C(N)C=C2)=O)OC1COP(O)(=S)OC1CC(N2C3=NC=NC(N)=C3N=C2)OC1COP(O)(=S)OC1CC(N2C3=NC=NC(N)=C3N=C2)OC1COP(O)(=S)OC1CC(N2C(NC(=O)C(C)=C2)=O)OC1COP(O)(=S)OC1CC(N2C3=NC=NC(N)=C3N=C2)OC1COP(O)(=S)OC1CC(N2C(NC(=O)C(C)=C2)=O)OC1COP(O)(=S)OC1CC(N2C(NC(=O)C(C)=C2)=O)OC1COP(O)(=S)OC1CC(N2C3=C(C(NC(N)=N3)=O)N=C2)OC1COP(O)(=S)OC(C(O1)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=S)OC2C(OC(C2)N2C(NC(=O)C(C)=C2)=O)CO)CC1N1C=CC(N)=NC1=O</span>
      <span itemprop="inchi_key">CJZRVARTODENJN-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950011554</span>
      <span itemprop="name">litenimod</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012317</span>
      <span itemprop="name">liver biopsy</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">201000002250</span>
      <span itemprop="name">liver carcinoma</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000008818</span>
      <span itemprop="name">liver damage</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003908</span>
      <span itemprop="name">liver function</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000005228</span>
      <span itemprop="name">liver tissue</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000007774</span>
      <span itemprop="name">longterm</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229920002521</span>
      <span itemprop="name">macromolecule</span>
      <span itemprop="domain">Polymers</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000014759</span>
      <span itemprop="name">maintenance of location</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000035853</span>
      <span itemprop="name">malformation syndrome</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000011159</span>
      <span itemprop="name">matrix material</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000035800</span>
      <span itemprop="name">maturation</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000005259</span>
      <span itemprop="name">measurement</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000007246</span>
      <span itemprop="name">mechanism</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002844</span>
      <span itemprop="name">melting</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000008018</span>
      <span itemprop="name">melting</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950002475</span>
      <span itemprop="name">mesilate</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229910052751</span>
      <span itemprop="name">metal</span>
      <span itemprop="domain">Inorganic materials</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002184</span>
      <span itemprop="name">metal</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MYWUZJCMWCOHBA-VIFPVBQESA-N</span>
      <span itemprop="name">methamphetamine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CN[C@@H](C)CC1=CC=CC=C1</span>
      <span itemprop="inchi_key">MYWUZJCMWCOHBA-VIFPVBQESA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">FVNJBPMQWSIGJK-HNNXBMFYSA-N</span>
      <span itemprop="name">methyl (4r)-4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoropyridin-2-yl)-6-methyl-1,4-dihydropyrimidine-5-carboxylate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1([C@@H]2N=C(NC(C)=C2C(=O)OC)C=2C(=CC(F)=CN=2)F)=CC=C(F)C=C1Cl</span>
      <span itemprop="inchi_key">FVNJBPMQWSIGJK-HNNXBMFYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">FEFIBEHSXLKJGI-UHFFFAOYSA-N</span>
      <span itemprop="name">methyl 2-[3-[[3-(6-amino-2-butoxy-8-oxo-7h-purin-9-yl)propyl-(3-morpholin-4-ylpropyl)amino]methyl]phenyl]acetate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C12=NC(OCCCC)=NC(N)=C2NC(=O)N1CCCN(CC=1C=C(CC(=O)OC)C=CC=1)CCCN1CCOCC1</span>
      <span itemprop="inchi_key">FEFIBEHSXLKJGI-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HPNSFSBZBAHARI-UHFFFAOYSA-N</span>
      <span itemprop="name">micophenolic acid</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2</span>
      <span itemprop="inchi_key">HPNSFSBZBAHARI-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000000813</span>
      <span itemprop="name">microbial effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZAHQPTJLOCWVPG-UHFFFAOYSA-N</span>
      <span itemprop="name">mitoxantrone dihydrochloride</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO</span>
      <span itemprop="inchi_key">ZAHQPTJLOCWVPG-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WOUUWUGULFOVHG-UHFFFAOYSA-N</span>
      <span itemprop="name">mivotilate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">S1CSC1=C(C(=O)OC(C)C)C(=O)NC1=NC(C)=CS1</span>
      <span itemprop="inchi_key">WOUUWUGULFOVHG-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950008403</span>
      <span itemprop="name">mivotilate</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002156</span>
      <span itemprop="name">mixing</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002625</span>
      <span itemprop="name">monoclonal antibody therapy</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950007627</span>
      <span itemprop="name">motolimod</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000002703</span>
      <span itemprop="name">mutagenesis</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000350</span>
      <span itemprop="name">mutagenesis</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">WXRNKMCXPUWCHR-UHFFFAOYSA-N</span>
      <span itemprop="name">n,5-dimethylhexan-3-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCC(NC)CC(C)C</span>
      <span itemprop="inchi_key">WXRNKMCXPUWCHR-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XVUQPECVOGMPRU-ZPPAUJSGSA-N</span>
      <span itemprop="name">n,n-dimethyl-1,2-bis[(9z,12z)-octadeca-9,12-dienoxy]propan-1-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCOC(C)C(N(C)C)OCCCCCCCC\C=C/C\C=C/CCCCC</span>
      <span itemprop="inchi_key">XVUQPECVOGMPRU-ZPPAUJSGSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">OZBZDYGIYDRTBV-RSLAUBRISA-N</span>
      <span itemprop="name">n,n-dimethyl-1,2-bis[(9z,12z,15z)-octadeca-9,12,15-trienoxy]propan-1-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC\C=C/C\C=C/C\C=C/CCCCCCCCOC(C)C(N(C)C)OCCCCCCCC\C=C/C\C=C/C\C=C/CC</span>
      <span itemprop="inchi_key">OZBZDYGIYDRTBV-RSLAUBRISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">MAFHEURJBRFHIT-YEUCEMRASA-N</span>
      <span itemprop="name">n,n-dimethyl-1,2-bis[(z)-octadec-9-enoxy]propan-1-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCC\C=C/CCCCCCCCOC(C)C(N(C)C)OCCCCCCCC\C=C/CCCCCCCC</span>
      <span itemprop="inchi_key">MAFHEURJBRFHIT-YEUCEMRASA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HNPWJTONLANQJY-UHFFFAOYSA-N</span>
      <span itemprop="name">n,n-dimethyl-1,2-dioctadecoxypropan-1-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCCCCCCCCCCCCOC(C)C(N(C)C)OCCCCCCCCCCCCCCCCCC</span>
      <span itemprop="inchi_key">HNPWJTONLANQJY-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">GLGLUQVVDHRLQK-WRBBJXAJSA-N</span>
      <span itemprop="name">n,n-dimethyl-2,3-bis[(z)-octadec-9-enoxy]propan-1-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCC\C=C/CCCCCCCCOCC(CN(C)C)OCCCCCCCC\C=C/CCCCCCCC</span>
      <span itemprop="inchi_key">GLGLUQVVDHRLQK-WRBBJXAJSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">UKXOXMLXFQEEQJ-KWXKLSQISA-N</span>
      <span itemprop="name">n,n-dimethyl-2,3-bis[[(9z,12z)-octadeca-9,12-dienyl]sulfanyl]propan-1-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCC\C=C/C\C=C/CCCCCCCCSCC(CN(C)C)SCCCCCCCC\C=C/C\C=C/CCCCC</span>
      <span itemprop="inchi_key">UKXOXMLXFQEEQJ-KWXKLSQISA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LNLJHGXOFYUARS-OAQYLSRUSA-N</span>
      <span itemprop="name">n-[(1r)-1-[8-chloro-2-(1-oxidopyridin-1-ium-3-yl)quinolin-3-yl]-2,2,2-trifluoroethyl]pyrido[3,2-d]pyrimidin-4-amine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[O-][N&#43;]1=CC=CC(C=2C(=CC3=CC=CC(Cl)=C3N=2)[C@@H](NC=2C3=NC=CC=C3N=CN=2)C(F)(F)F)=C1</span>
      <span itemprop="inchi_key">LNLJHGXOFYUARS-OAQYLSRUSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DAZSWUUAFHBCGE-KRWDZBQOSA-N</span>
      <span itemprop="name">n-[(2s)-3-methyl-1-oxo-1-pyrrolidin-1-ylbutan-2-yl]-3-phenylpropanamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">N([C@@H](C(C)C)C(=O)N1CCCC1)C(=O)CCC1=CC=CC=C1</span>
      <span itemprop="inchi_key">DAZSWUUAFHBCGE-KRWDZBQOSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DPHPCLGZSLZAGL-UHFFFAOYSA-N</span>
      <span itemprop="name">n-[(4-fluorophenyl)methyl]-5-(2-methylpropyl)-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CC(C)CC=1SC(C=2SC=CN=2)=NC=1C(=O)NCC1=CC=C(F)C=C1</span>
      <span itemprop="inchi_key">DPHPCLGZSLZAGL-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">OQIUTYABZMBBME-FMQUCBEESA-N</span>
      <span itemprop="name">n-[(e)-1-bromo-1-(2-methoxyphenyl)-3-oxo-3-piperidin-1-ylprop-1-en-2-yl]-4-nitrobenzamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">COC1=CC=CC=C1\C(Br)=C(C(=O)N1CCCCC1)/NC(=O)C1=CC=C([N&#43;]([O-])=O)C=C1</span>
      <span itemprop="inchi_key">OQIUTYABZMBBME-FMQUCBEESA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JOWXJLIFIIOYMS-UHFFFAOYSA-N</span>
      <span itemprop="name">n-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=NC(OC)=CC=C1C1=NC(N2CCOCC2)=C(SC(CN(C)C=2N=CC(=CN=2)C(=O)NO)=C2)C2=N1</span>
      <span itemprop="inchi_key">JOWXJLIFIIOYMS-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940060932</span>
      <span itemprop="name">nabi-hb</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000000822</span>
      <span itemprop="name">natural killer cell</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229910052754</span>
      <span itemprop="name">neon</span>
      <span itemprop="domain">Inorganic materials</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">GKAOGPIIYCISHV-UHFFFAOYSA-N</span>
      <span itemprop="name">neon atom</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Ne]</span>
      <span itemprop="inchi_key">GKAOGPIIYCISHV-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950008835</span>
      <span itemprop="name">neratinib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JWNPDZNEKVCWMY-VQHVLOKHSA-N</span>
      <span itemprop="name">neratinib</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C=12C=C(NC(=O)\C=C\CN(C)C)C(OCC)=CC2=NC=C(C#N)C=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1</span>
      <span itemprop="inchi_key">JWNPDZNEKVCWMY-VQHVLOKHSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000002569</span>
      <span itemprop="name">neuron</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940121308</span>
      <span itemprop="name">nidufexor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JYTIXGYXBIBOMN-UHFFFAOYSA-N</span>
      <span itemprop="name">nidufexor</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">Cn1nc(C(=O)N(Cc2ccccc2)Cc2ccc(cc2)C(O)=O)c2COc3ccc(Cl)cc3-c12</span>
      <span itemprop="inchi_key">JYTIXGYXBIBOMN-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960002480</span>
      <span itemprop="name">nitazoxanide</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960003301</span>
      <span itemprop="name">nivolumab</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091027963</span>
      <span itemprop="name">non-coding RNA</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000042567</span>
      <span itemprop="name">non-coding RNA</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002726</span>
      <span itemprop="name">nonnucleoside reverse transcriptase inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000252</span>
      <span itemprop="name">nontoxic</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000003000</span>
      <span itemprop="name">nontoxic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940127073</span>
      <span itemprop="name">nucleoside analogue</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000003835</span>
      <span itemprop="name">nucleoside group</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940100243</span>
      <span itemprop="name">oleanolic acid</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">CGBJSGAELGCMKE-UHFFFAOYSA-N</span>
      <span itemprop="name">omipalisib</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">COC1=NC=C(C=2C=C3C(C=4C=NN=CC=4)=CC=NC3=CC=2)C=C1NS(=O)(=O)C1=CC=C(F)C=C1F</span>
      <span itemprop="inchi_key">CGBJSGAELGCMKE-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003960</span>
      <span itemprop="name">organic solvent</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000008520</span>
      <span itemprop="name">organization</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960003104</span>
      <span itemprop="name">ornithine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000003254</span>
      <span itemprop="name">palate</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950004852</span>
      <span itemprop="name">panulisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000007170</span>
      <span itemprop="name">pathology</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940002988</span>
      <span itemprop="name">pegasys</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960003930</span>
      <span itemprop="name">peginterferon alfa-2a</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940106366</span>
      <span itemprop="name">pegintron</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960002621</span>
      <span itemprop="name">pembrolizumab</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940023041</span>
      <span itemprop="name">peptide vaccine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">SZFPYBIJACMNJV-UHFFFAOYSA-N</span>
      <span itemprop="name">perifosine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N&#43;](C)(C)CC1</span>
      <span itemprop="inchi_key">SZFPYBIJACMNJV-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950010632</span>
      <span itemprop="name">perifosine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002688</span>
      <span itemprop="name">persistence</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010083127</span>
      <span itemprop="name">phage repressor proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000008105</span>
      <span itemprop="name">phosphatidylcholines</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940067605</span>
      <span itemprop="name">phosphatidylethanolamines</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229910052698</span>
      <span itemprop="name">phosphorus</span>
      <span itemprop="domain">Inorganic materials</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229930195126</span>
      <span itemprop="name">picroside</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">KEUKDVIGAVVGLF-RUYHYXBRSA-N</span>
      <span itemprop="name">picroside I</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC[C@]12O[C@H]1[C@@H]3O[C@@H](O[C@@H]4O[C@H](COC(=O)C=Cc5ccccc5)[C@@H](O)[C@H](O)[C@H]4O)C=C[C@@H]3[C@H]2O</span>
      <span itemprop="inchi_key">KEUKDVIGAVVGLF-RUYHYXBRSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">AKNILCMFRRDTEY-UHFFFAOYSA-N</span>
      <span itemprop="name">picroside II</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1=C(O)C(OC)=CC(C(=O)OC2C3C(C(OC=C3)OC3C(C(O)C(O)C(CO)O3)O)C3(CO)OC32)=C1</span>
      <span itemprop="inchi_key">AKNILCMFRRDTEY-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950004941</span>
      <span itemprop="name">pictilisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">LHNIIDJUOCFXAP-UHFFFAOYSA-N</span>
      <span itemprop="name">pictrelisib</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C1CN(S(=O)(=O)C)CCN1CC1=CC2=NC(C=3C=4C=NNC=4C=CC=3)=NC(N3CCOCC3)=C2S1</span>
      <span itemprop="inchi_key">LHNIIDJUOCFXAP-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950010773</span>
      <span itemprop="name">pidilizumab</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950005769</span>
      <span itemprop="name">pilaralisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940072689</span>
      <span itemprop="name">plaquenil</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000013600</span>
      <span itemprop="name">plasmid vector</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108700002563</span>
      <span itemprop="name">poly ICLC</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940115270</span>
      <span itemprop="name">poly iclc</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229920001606</span>
      <span itemprop="name">poly(lactic acid-co-glycolic acid)</span>
      <span itemprop="domain">Polymers</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229920002647</span>
      <span itemprop="name">polyamide</span>
      <span itemprop="domain">Polymers</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010011110</span>
      <span itemprop="name">polyarginine</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950001452</span>
      <span itemprop="name">pradefovir</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000002924</span>
      <span itemprop="name">primary amino group</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[H]N([H])*</span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000008569</span>
      <span itemprop="name">process</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012545</span>
      <span itemprop="name">processing</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000005522</span>
      <span itemprop="name">programmed cell death</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940087463</span>
      <span itemprop="name">proleukin</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001915</span>
      <span itemprop="name">proofreading effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XEABSBMNTNXEJM-UHFFFAOYSA-N</span>
      <span itemprop="name">propagermanium</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)CC[Ge](=O)O[Ge](=O)CCC(O)=O</span>
      <span itemprop="inchi_key">XEABSBMNTNXEJM-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950002828</span>
      <span itemprop="name">propagermanium</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000001294</span>
      <span itemprop="name">propane</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000000069</span>
      <span itemprop="name">prophylactic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">HZLWUYJLOIAQFC-UHFFFAOYSA-N</span>
      <span itemprop="name">prosapogenin PS-A</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O</span>
      <span itemprop="inchi_key">HZLWUYJLOIAQFC-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002797</span>
      <span itemprop="name">proteolythic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">PTJWIQPHWPFNBW-GBNDHIKLSA-N</span>
      <span itemprop="name">pseudouridine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O</span>
      <span itemprop="inchi_key">PTJWIQPHWPFNBW-GBNDHIKLSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000003254</span>
      <span itemprop="name">radicals</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000007420</span>
      <span itemprop="name">reactivation</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940044551</span>
      <span itemprop="name">receptor antagonist</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002464</span>
      <span itemprop="name">receptor antagonist</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000005962</span>
      <span itemprop="name">receptors</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108020003175</span>
      <span itemprop="name">receptors</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108700018720</span>
      <span itemprop="name">recombinant interferon alpha 2b-like</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000004064</span>
      <span itemprop="name">recycling</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091008146</span>
      <span itemprop="name">restriction endonucleases</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DWRXFEITVBNRMK-JXOAFFINSA-N</span>
      <span itemprop="name">ribothymidine</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1</span>
      <span itemprop="inchi_key">DWRXFEITVBNRMK-JXOAFFINSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950006764</span>
      <span itemprop="name">rigosertib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">OWBFCJROIKNMGD-BQYQJAHWSA-N</span>
      <span itemprop="name">rigosertib</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">COC1=CC(OC)=CC(OC)=C1\C=C\S(=O)(=O)CC1=CC=C(OC)C(NCC(O)=O)=C1</span>
      <span itemprop="inchi_key">OWBFCJROIKNMGD-BQYQJAHWSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VLQLUZFVFXYXQE-USRGLUTNSA-M</span>
      <span itemprop="name">rigosertib sodium</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Na&#43;].COC1=CC(OC)=CC(OC)=C1\C=C\S(=O)(=O)CC1=CC=C(OC)C(NCC([O-])=O)=C1</span>
      <span itemprop="inchi_key">VLQLUZFVFXYXQE-USRGLUTNSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950000089</span>
      <span itemprop="name">ropeginterferon alfa-2b</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102220232161</span>
      <span itemprop="name">rs1085307160</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102220232162</span>
      <span itemprop="name">rs1085307161</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000009962</span>
      <span itemprop="name">secretion pathway</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000035945</span>
      <span itemprop="name">sensitivity</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000011452</span>
      <span itemprop="name">sequencing regimen</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940075439</span>
      <span itemprop="name">smac mimetic</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000002460</span>
      <span itemprop="name">smooth muscle</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">JAJWGJBVLPIOOH-IZYKLYLVSA-M</span>
      <span itemprop="name">sodium taurocholate</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">[Na&#43;].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1</span>
      <span itemprop="inchi_key">JAJWGJBVLPIOOH-IZYKLYLVSA-M</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000007787</span>
      <span itemprop="name">solid</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000000527</span>
      <span itemprop="name">sonication</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950007865</span>
      <span itemprop="name">sonolisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">125000006850</span>
      <span itemprop="name">spacer group</span>
      <span itemprop="domain">Chemical group</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950002089</span>
      <span itemprop="name">spebrutinib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000894007</span>
      <span itemprop="name">species</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000000952</span>
      <span itemprop="name">spleen</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000009076</span>
      <span itemprop="name">src-Family Kinases</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108010087686</span>
      <span itemprop="name">src-Family Kinases</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000007858</span>
      <span itemprop="name">starting material</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000000130</span>
      <span itemprop="name">stem cell</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001629</span>
      <span itemprop="name">suppression</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000004094</span>
      <span itemprop="name">surface-active agent</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000002459</span>
      <span itemprop="name">sustained effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">206010042863</span>
      <span itemprop="name">synovial sarcoma</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000007910</span>
      <span itemprop="name">systemic administration</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950001269</span>
      <span itemprop="name">taselisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960005311</span>
      <span itemprop="name">telbivudine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940121336</span>
      <span itemprop="name">telratolimod</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950008214</span>
      <span itemprop="name">tenalisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960002180</span>
      <span itemprop="name">tetracycline</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229930101283</span>
      <span itemprop="name">tetracycline</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000019364</span>
      <span itemprop="name">tetracycline</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000003522</span>
      <span itemprop="name">tetracyclines</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">ZRKFYGHZFMAOKI-QMGMOQQFSA-N</span>
      <span itemprop="name">tgfbeta</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1</span>
      <span itemprop="inchi_key">ZRKFYGHZFMAOKI-QMGMOQQFSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000008521</span>
      <span itemprop="name">threonine</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000036962</span>
      <span itemprop="name">time dependent</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950007123</span>
      <span itemprop="name">tislelizumab</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">231100000167</span>
      <span itemprop="name">toxic agent</span>
      <span itemprop="domain">Toxicity</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000003440</span>
      <span itemprop="name">toxic substance</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108700012359</span>
      <span itemprop="name">toxins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">VZCYOOQTPOCHFL-UHFFFAOYSA-N</span>
      <span itemprop="name">trans-butenedioic acid</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)C=CC(O)=O</span>
      <span itemprop="inchi_key">VZCYOOQTPOCHFL-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000012096</span>
      <span itemprop="name">transfection reagent</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012546</span>
      <span itemprop="name">transfer</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000009466</span>
      <span itemprop="name">transformation</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000009261</span>
      <span itemprop="name">transgenic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001052</span>
      <span itemprop="name">transient effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000005945</span>
      <span itemprop="name">translocation</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">102000035160</span>
      <span itemprop="name">transmembrane proteins</span>
      <span itemprop="domain">Human genes</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">108091005703</span>
      <span itemprop="name">transmembrane proteins</span>
      <span itemprop="domain">Proteins</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950007217</span>
      <span itemprop="name">tremelimumab</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940070126</span>
      <span itemprop="name">tropifexor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940008349</span>
      <span itemprop="name">truvada</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000002753</span>
      <span itemprop="name">trypsin inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">OUYCCCASQSFEME-UHFFFAOYSA-N</span>
      <span itemprop="name">tyrosine</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC(=O)C(N)CC1=CC=C(O)C=C1</span>
      <span itemprop="inchi_key">OUYCCCASQSFEME-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">235000002374</span>
      <span itemprop="name">tyrosine</span>
      <span itemprop="domain">Nutrition</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940121358</span>
      <span itemprop="name">tyrosine kinase inhibitor</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">239000005483</span>
      <span itemprop="name">tyrosine kinase inhibitor</span>
      <span itemprop="domain">Substances</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">150000004917</span>
      <span itemprop="name">tyrosine kinase inhibitor derivatives</span>
      <span itemprop="domain">Chemical class</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940063032</span>
      <span itemprop="name">tyzeka</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000701161</span>
      <span itemprop="name">unidentified adenovirus</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241000701447</span>
      <span itemprop="name">unidentified baculovirus</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">241001430294</span>
      <span itemprop="name">unidentified retrovirus</span>
      <span itemprop="domain">Species</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940091440</span>
      <span itemprop="name">uniferon</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">DRTQHJPVMGBUCF-UHFFFAOYSA-N</span>
      <span itemprop="name">uracil arabinoside</span>
      <span itemprop="domain">Natural products</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1</span>
      <span itemprop="inchi_key">DRTQHJPVMGBUCF-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229940045145</span>
      <span itemprop="name">uridine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">208000007089</span>
      <span itemprop="name">vaccinia</span>
      <span itemprop="domain">Diseases</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">210000005166</span>
      <span itemprop="name">vasculature</span>
      <span itemprop="domain">Anatomy</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950003036</span>
      <span itemprop="name">vesatolimod</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000008957</span>
      <span itemprop="name">viral persistence</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229960004854</span>
      <span itemprop="name">viral vaccine</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">230000001790</span>
      <span itemprop="name">virustatic effect</span>
      <span itemprop="domain">Effects</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XLGQSYUNOIJBNR-UHFFFAOYSA-N</span>
      <span itemprop="name">vonafexor</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1S(=O)(=O)C1=C(Cl)C=CC=C1Cl</span>
      <span itemprop="inchi_key">XLGQSYUNOIJBNR-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">229950001576</span>
      <span itemprop="name">voxtalisib</span>
      <span itemprop="domain">Drugs</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000007482</span>
      <span itemprop="name">whole exome sequencing</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">238000012070</span>
      <span itemprop="name">whole genome sequencing analysis</span>
      <span itemprop="domain">Methods</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles"></span>
      <span itemprop="inchi_key"></span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
    <li itemprop="match" itemscope repeat>
      <span itemprop="id">XLTFNNCXVBYBSX-UHFFFAOYSA-N</span>
      <span itemprop="name">wogonin</span>
      <span itemprop="domain">Chemical compound</span>
      <span itemprop="svg_large"></span>
      <span itemprop="svg_small"></span>
      <span itemprop="smiles">COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1</span>
      <span itemprop="inchi_key">XLTFNNCXVBYBSX-UHFFFAOYSA-N</span>
      <span itemprop="similarity">0.000</span>
      <span itemprop="sections" repeat>description</span>
      <span itemprop="count">1</span>
    </li>
  </ul>

  <section>
    <h2>Images</h2>
    <ul>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/90/81/75/f07c96565c7467/US20190338263A1-20191107-D00000.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/e9/8b/90/687d186521be25/US20190338263A1-20191107-D00000.png">
        <ul>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/ad/0a/60/ee98a2d7a38210/US20190338263A1-20191107-D00001.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/bb/b9/67/ac53803fa44dbc/US20190338263A1-20191107-D00001.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="1">
            <meta itemprop="id" content="2">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="1012">
              <meta itemprop="top" content="396">
              <meta itemprop="right" content="1045">
              <meta itemprop="bottom" content="440">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/2e/13/93/93037a95984430/US20190338263A1-20191107-D00002.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/f8/03/7e/7f85fb83bca276/US20190338263A1-20191107-D00002.png">
        <ul>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/02/a2/fb/cf07110ea54dc9/US20190338263A1-20191107-D00003.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/0d/21/aa/0f08e0bb146060/US20190338263A1-20191107-D00003.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="3">
            <meta itemprop="id" content="3">
            <meta itemprop="label" content="base pair">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="1076">
              <meta itemprop="top" content="38">
              <meta itemprop="right" content="1097">
              <meta itemprop="bottom" content="71">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/bb/78/2b/23f0fbba616ec0/US20190338263A1-20191107-D00004.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/71/2c/52/08802986b89a0a/US20190338263A1-20191107-D00004.png">
        <ul>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/91/77/32/e67a5abfba109b/US20190338263A1-20191107-D00005.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/ac/ee/64/812b2234a5a359/US20190338263A1-20191107-D00005.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="5">
            <meta itemprop="id" content="23">
            <meta itemprop="label" content="CHO">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="880">
              <meta itemprop="top" content="227">
              <meta itemprop="right" content="909">
              <meta itemprop="bottom" content="258">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="5">
            <meta itemprop="id" content="24">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="928">
              <meta itemprop="top" content="227">
              <meta itemprop="right" content="964">
              <meta itemprop="bottom" content="258">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/67/9a/47/71dac121f8474d/US20190338263A1-20191107-D00006.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/12/70/1f/2bb08f379462ba/US20190338263A1-20191107-D00006.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="6">
            <meta itemprop="id" content="0">
            <meta itemprop="label" content="values">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="175">
              <meta itemprop="top" content="1368">
              <meta itemprop="right" content="208">
              <meta itemprop="bottom" content="1408">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="6">
            <meta itemprop="id" content="30">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="143">
              <meta itemprop="top" content="53">
              <meta itemprop="right" content="207">
              <meta itemprop="bottom" content="96">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="6">
            <meta itemprop="id" content="5">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="176">
              <meta itemprop="top" content="1150">
              <meta itemprop="right" content="208">
              <meta itemprop="bottom" content="1191">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/76/54/cf/5bea8d26da262c/US20190338263A1-20191107-D00007.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/c5/5c/07/f881d44b66150c/US20190338263A1-20191107-D00007.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="0">
            <meta itemprop="label" content="values">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="254">
              <meta itemprop="top" content="2522">
              <meta itemprop="right" content="283">
              <meta itemprop="bottom" content="2557">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="0">
            <meta itemprop="label" content="values">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="334">
              <meta itemprop="top" content="1177">
              <meta itemprop="right" content="363">
              <meta itemprop="bottom" content="1213">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="1">
            <meta itemprop="label" content="inducible gene">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="337">
              <meta itemprop="top" content="1084">
              <meta itemprop="right" content="366">
              <meta itemprop="bottom" content="1117">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="2">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="253">
              <meta itemprop="top" content="2404">
              <meta itemprop="right" content="281">
              <meta itemprop="bottom" content="2438">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="2">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="334">
              <meta itemprop="top" content="988">
              <meta itemprop="right" content="363">
              <meta itemprop="bottom" content="1020">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="3">
            <meta itemprop="label" content="base pair">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="333">
              <meta itemprop="top" content="893">
              <meta itemprop="right" content="363">
              <meta itemprop="bottom" content="925">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="4">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="333">
              <meta itemprop="top" content="797">
              <meta itemprop="right" content="365">
              <meta itemprop="bottom" content="827">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="4">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="252">
              <meta itemprop="top" content="2284">
              <meta itemprop="right" content="284">
              <meta itemprop="bottom" content="2316">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="5">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="337">
              <meta itemprop="top" content="700">
              <meta itemprop="right" content="363">
              <meta itemprop="bottom" content="733">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="6">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="336">
              <meta itemprop="top" content="604">
              <meta itemprop="right" content="361">
              <meta itemprop="bottom" content="637">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="6">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="255">
              <meta itemprop="top" content="2164">
              <meta itemprop="right" content="283">
              <meta itemprop="bottom" content="2197">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="7">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="334">
              <meta itemprop="top" content="509">
              <meta itemprop="right" content="364">
              <meta itemprop="bottom" content="542">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="8">
            <meta itemprop="label" content="AAV serotypes">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="335">
              <meta itemprop="top" content="414">
              <meta itemprop="right" content="363">
              <meta itemprop="bottom" content="447">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="7">
            <meta itemprop="id" content="8">
            <meta itemprop="label" content="AAV serotypes">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="253">
              <meta itemprop="top" content="2044">
              <meta itemprop="right" content="281">
              <meta itemprop="bottom" content="2079">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/cf/42/9c/0c6c46d46b02a6/US20190338263A1-20191107-D00008.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/a6/e1/54/308a176824e6a3/US20190338263A1-20191107-D00008.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="0">
            <meta itemprop="label" content="values">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="311">
              <meta itemprop="top" content="1178">
              <meta itemprop="right" content="341">
              <meta itemprop="bottom" content="1211">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="0">
            <meta itemprop="label" content="values">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="254">
              <meta itemprop="top" content="2501">
              <meta itemprop="right" content="282">
              <meta itemprop="bottom" content="2536">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="1">
            <meta itemprop="label" content="inducible gene">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="311">
              <meta itemprop="top" content="1074">
              <meta itemprop="right" content="340">
              <meta itemprop="bottom" content="1107">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="2">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="310">
              <meta itemprop="top" content="968">
              <meta itemprop="right" content="337">
              <meta itemprop="bottom" content="999">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="2">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="253">
              <meta itemprop="top" content="2382">
              <meta itemprop="right" content="281">
              <meta itemprop="bottom" content="2415">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="3">
            <meta itemprop="label" content="base pair">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="307">
              <meta itemprop="top" content="861">
              <meta itemprop="right" content="339">
              <meta itemprop="bottom" content="896">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="4">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="309">
              <meta itemprop="top" content="755">
              <meta itemprop="right" content="341">
              <meta itemprop="bottom" content="787">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="4">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="253">
              <meta itemprop="top" content="2263">
              <meta itemprop="right" content="284">
              <meta itemprop="bottom" content="2296">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="5">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="312">
              <meta itemprop="top" content="647">
              <meta itemprop="right" content="336">
              <meta itemprop="bottom" content="680">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="6">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="310">
              <meta itemprop="top" content="540">
              <meta itemprop="right" content="336">
              <meta itemprop="bottom" content="573">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="6">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="255">
              <meta itemprop="top" content="2142">
              <meta itemprop="right" content="280">
              <meta itemprop="bottom" content="2177">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="7">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="309">
              <meta itemprop="top" content="435">
              <meta itemprop="right" content="339">
              <meta itemprop="bottom" content="468">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="8">
            <meta itemprop="label" content="AAV serotypes">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="310">
              <meta itemprop="top" content="328">
              <meta itemprop="right" content="340">
              <meta itemprop="bottom" content="360">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="8">
            <meta itemprop="id" content="8">
            <meta itemprop="label" content="AAV serotypes">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="254">
              <meta itemprop="top" content="2023">
              <meta itemprop="right" content="282">
              <meta itemprop="bottom" content="2055">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/03/fd/42/d6eff29c476d43/US20190338263A1-20191107-D00009.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/da/af/a6/ae4f0973b81a13/US20190338263A1-20191107-D00009.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="9">
            <meta itemprop="id" content="0">
            <meta itemprop="label" content="values">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="176">
              <meta itemprop="top" content="1260">
              <meta itemprop="right" content="209">
              <meta itemprop="bottom" content="1298">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="9">
            <meta itemprop="id" content="2">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="1992">
              <meta itemprop="top" content="599">
              <meta itemprop="right" content="2021">
              <meta itemprop="bottom" content="647">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="9">
            <meta itemprop="id" content="30">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="145">
              <meta itemprop="top" content="742">
              <meta itemprop="right" content="207">
              <meta itemprop="bottom" content="784">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="9">
            <meta itemprop="id" content="40">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="146">
              <meta itemprop="top" content="572">
              <meta itemprop="right" content="206">
              <meta itemprop="bottom" content="613">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="9">
            <meta itemprop="id" content="70">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="147">
              <meta itemprop="top" content="54">
              <meta itemprop="right" content="205">
              <meta itemprop="bottom" content="95">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/f5/5c/e2/8262d24a92811e/US20190338263A1-20191107-D00010.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/27/6d/0a/be1c48dc90fa4f/US20190338263A1-20191107-D00010.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="10">
            <meta itemprop="id" content="0">
            <meta itemprop="label" content="values">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="324">
              <meta itemprop="top" content="1187">
              <meta itemprop="right" content="352">
              <meta itemprop="bottom" content="1220">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="10">
            <meta itemprop="id" content="0">
            <meta itemprop="label" content="values">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="321">
              <meta itemprop="top" content="2510">
              <meta itemprop="right" content="351">
              <meta itemprop="bottom" content="2543">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="10">
            <meta itemprop="id" content="30">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="297">
              <meta itemprop="top" content="1682">
              <meta itemprop="right" content="347">
              <meta itemprop="bottom" content="1714">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="10">
            <meta itemprop="id" content="30">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="300">
              <meta itemprop="top" content="463">
              <meta itemprop="right" content="349">
              <meta itemprop="bottom" content="495">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="10">
            <meta itemprop="id" content="40">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="301">
              <meta itemprop="top" content="223">
              <meta itemprop="right" content="350">
              <meta itemprop="bottom" content="255">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="10">
            <meta itemprop="id" content="5">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="322">
              <meta itemprop="top" content="2375">
              <meta itemprop="right" content="345">
              <meta itemprop="bottom" content="2404">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="10">
            <meta itemprop="id" content="5">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="324">
              <meta itemprop="top" content="1068">
              <meta itemprop="right" content="349">
              <meta itemprop="bottom" content="1097">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/da/15/fd/d656e7a1cbb5ef/US20190338263A1-20191107-D00011.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/45/ef/a5/a342b6f0d22907/US20190338263A1-20191107-D00011.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="11">
            <meta itemprop="id" content="3">
            <meta itemprop="label" content="base pair">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="980">
              <meta itemprop="top" content="93">
              <meta itemprop="right" content="1002">
              <meta itemprop="bottom" content="112">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="11">
            <meta itemprop="id" content="75">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="1459">
              <meta itemprop="top" content="1948">
              <meta itemprop="right" content="1481">
              <meta itemprop="bottom" content="1984">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="11">
            <meta itemprop="id" content="8">
            <meta itemprop="label" content="AAV serotypes">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="1204">
              <meta itemprop="top" content="90">
              <meta itemprop="right" content="1225">
              <meta itemprop="bottom" content="111">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/a6/21/51/b2e81e1acdef9d/US20190338263A1-20191107-D00012.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/4d/72/60/27dd399726f2b3/US20190338263A1-20191107-D00012.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="12">
            <meta itemprop="id" content="0">
            <meta itemprop="label" content="values">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="838">
              <meta itemprop="top" content="54">
              <meta itemprop="right" content="856">
              <meta itemprop="bottom" content="70">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="12">
            <meta itemprop="id" content="1">
            <meta itemprop="label" content="inducible gene">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="125">
              <meta itemprop="top" content="2698">
              <meta itemprop="right" content="147">
              <meta itemprop="bottom" content="2715">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="12">
            <meta itemprop="id" content="2">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="975">
              <meta itemprop="top" content="2698">
              <meta itemprop="right" content="995">
              <meta itemprop="bottom" content="2715">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="12">
            <meta itemprop="id" content="3">
            <meta itemprop="label" content="base pair">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="550">
              <meta itemprop="top" content="2697">
              <meta itemprop="right" content="570">
              <meta itemprop="bottom" content="2714">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="12">
            <meta itemprop="id" content="3">
            <meta itemprop="label" content="base pair">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="1186">
              <meta itemprop="top" content="2698">
              <meta itemprop="right" content="1205">
              <meta itemprop="bottom" content="2714">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="12">
            <meta itemprop="id" content="4">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="910">
              <meta itemprop="top" content="53">
              <meta itemprop="right" content="927">
              <meta itemprop="bottom" content="71">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/58/3d/dd/677f4ea49e4fdc/US20190338263A1-20191107-D00013.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/7f/fd/ea/13a9c3620cba92/US20190338263A1-20191107-D00013.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="13">
            <meta itemprop="id" content="1">
            <meta itemprop="label" content="inducible gene">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="325">
              <meta itemprop="top" content="46">
              <meta itemprop="right" content="362">
              <meta itemprop="bottom" content="95">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="13">
            <meta itemprop="id" content="1">
            <meta itemprop="label" content="inducible gene">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="52">
              <meta itemprop="top" content="860">
              <meta itemprop="right" content="105">
              <meta itemprop="bottom" content="912">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="13">
            <meta itemprop="id" content="2">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="515">
              <meta itemprop="top" content="46">
              <meta itemprop="right" content="550">
              <meta itemprop="bottom" content="95">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="13">
            <meta itemprop="id" content="2">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="51">
              <meta itemprop="top" content="953">
              <meta itemprop="right" content="107">
              <meta itemprop="bottom" content="1002">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="13">
            <meta itemprop="id" content="3">
            <meta itemprop="label" content="base pair">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="706">
              <meta itemprop="top" content="45">
              <meta itemprop="right" content="740">
              <meta itemprop="bottom" content="92">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="13">
            <meta itemprop="id" content="3">
            <meta itemprop="label" content="base pair">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="51">
              <meta itemprop="top" content="1042">
              <meta itemprop="right" content="107">
              <meta itemprop="bottom" content="1090">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="13">
            <meta itemprop="id" content="4">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="900">
              <meta itemprop="top" content="46">
              <meta itemprop="right" content="941">
              <meta itemprop="bottom" content="96">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="13">
            <meta itemprop="id" content="5">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="1094">
              <meta itemprop="top" content="46">
              <meta itemprop="right" content="1127">
              <meta itemprop="bottom" content="96">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/c5/5a/77/eb00bbcfee28c8/US20190338263A1-20191107-D00014.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/d5/4a/ed/db890edd179055/US20190338263A1-20191107-D00014.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="14">
            <meta itemprop="id" content="0">
            <meta itemprop="label" content="values">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="188">
              <meta itemprop="top" content="1134">
              <meta itemprop="right" content="223">
              <meta itemprop="bottom" content="1176">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="14">
            <meta itemprop="id" content="30">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="159">
              <meta itemprop="top" content="53">
              <meta itemprop="right" content="221">
              <meta itemprop="bottom" content="98">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/d6/5c/e8/d4c970ab5519b2/US20190338263A1-20191107-D00015.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/d2/15/f4/7a2c5214ab333f/US20190338263A1-20191107-D00015.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="15">
            <meta itemprop="id" content="0">
            <meta itemprop="label" content="values">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="43">
              <meta itemprop="top" content="866">
              <meta itemprop="right" content="74">
              <meta itemprop="bottom" content="901">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="15">
            <meta itemprop="id" content="30">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="16">
              <meta itemprop="top" content="367">
              <meta itemprop="right" content="71">
              <meta itemprop="bottom" content="405">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="15">
            <meta itemprop="id" content="40">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="16">
              <meta itemprop="top" content="204">
              <meta itemprop="right" content="71">
              <meta itemprop="bottom" content="238">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="15">
            <meta itemprop="id" content="5">
            <meta itemprop="label" content="dependent manner">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="44">
              <meta itemprop="top" content="784">
              <meta itemprop="right" content="71">
              <meta itemprop="bottom" content="817">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="15">
            <meta itemprop="id" content="6">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="1096">
              <meta itemprop="top" content="1087">
              <meta itemprop="right" content="1122">
              <meta itemprop="bottom" content="1127">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/77/82/9a/e421705b1ab671/US20190338263A1-20191107-D00016.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/b6/43/ec/84b1842ab33c4b/US20190338263A1-20191107-D00016.png">
        <ul>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="16">
            <meta itemprop="id" content="0">
            <meta itemprop="label" content="values">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="154">
              <meta itemprop="top" content="948">
              <meta itemprop="right" content="180">
              <meta itemprop="bottom" content="980">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="16">
            <meta itemprop="id" content="4">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="625">
              <meta itemprop="top" content="14">
              <meta itemprop="right" content="658">
              <meta itemprop="bottom" content="63">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="16">
            <meta itemprop="id" content="40">
            <meta itemprop="label" content="positions">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="123">
              <meta itemprop="top" content="632">
              <meta itemprop="right" content="183">
              <meta itemprop="bottom" content="666">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="16">
            <meta itemprop="id" content="6">
            <meta itemprop="label" content="day">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="1337">
              <meta itemprop="top" content="12">
              <meta itemprop="right" content="1368">
              <meta itemprop="bottom" content="64">
            </span>
          </li>
          <li itemprop="callouts" itemscope repeat>
            <meta itemprop="figurePage" content="16">
            <meta itemprop="id" content="80">
            <meta itemprop="label" content="residue">
            <span itemprop="bounds" itemscope>
              <meta itemprop="left" content="123">
              <meta itemprop="top" content="313">
              <meta itemprop="right" content="182">
              <meta itemprop="bottom" content="347">
            </span>
          </li>
        </ul>
      </li>
      <li itemprop="images" itemscope repeat>
        <img itemprop="thumbnail" src="https://patentimages.storage.googleapis.com/07/4e/7d/eb1d75f5756d97/US20190338263A1-20191107-D00017.png">
        <meta itemprop="full" content="https://patentimages.storage.googleapis.com/84/26/b5/804f2e45fadce8/US20190338263A1-20191107-D00017.png">
        <ul>
        </ul>
      </li>
    </ul>
  </section>

  <section>
    <h2>Classifications</h2>
    <ul>
      <li>
        <ul itemprop="classifications" itemscope repeat>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C</span>&mdash;<span itemprop="Description">CHEMISTRY; METALLURGY</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12</span>&mdash;<span itemprop="Description">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N</span>&mdash;<span itemprop="Description">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N9/00</span>&mdash;<span itemprop="Description">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N9/14</span>&mdash;<span itemprop="Description">Hydrolases (3)</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N9/16</span>&mdash;<span itemprop="Description">Hydrolases (3) acting on ester bonds (3.1)</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N9/22</span>&mdash;<span itemprop="Description">Ribonucleases [RNase]; Deoxyribonucleases [DNase]</span>
            <meta itemprop="Leaf" content="true"><meta itemprop="FirstCode" content="true"><meta itemprop="IsCPC" content="true">
          </li>
        </ul>
      </li>
      <li>
        <ul itemprop="classifications" itemscope repeat>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A</span>&mdash;<span itemprop="Description">HUMAN NECESSITIES</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61</span>&mdash;<span itemprop="Description">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K</span>&mdash;<span itemprop="Description">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K47/00</span>&mdash;<span itemprop="Description">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K47/50</span>&mdash;<span itemprop="Description">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K47/69</span>&mdash;<span itemprop="Description">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K47/6921</span>&mdash;<span itemprop="Description">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K47/6927</span>&mdash;<span itemprop="Description">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K47/6929</span>&mdash;<span itemprop="Description">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle</span>
            <meta itemprop="Leaf" content="true"><meta itemprop="IsCPC" content="true">
          </li>
        </ul>
      </li>
      <li>
        <ul itemprop="classifications" itemscope repeat>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A</span>&mdash;<span itemprop="Description">HUMAN NECESSITIES</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61</span>&mdash;<span itemprop="Description">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K</span>&mdash;<span itemprop="Description">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K9/00</span>&mdash;<span itemprop="Description">Medicinal preparations characterised by special physical form</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K9/14</span>&mdash;<span itemprop="Description">Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K9/16</span>&mdash;<span itemprop="Description">Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K9/1605</span>&mdash;<span itemprop="Description">Excipients; Inactive ingredients</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">A61K9/1617</span>&mdash;<span itemprop="Description">Organic compounds, e.g. phospholipids, fats</span>
            <meta itemprop="Leaf" content="true"><meta itemprop="IsCPC" content="true">
          </li>
        </ul>
      </li>
      <li>
        <ul itemprop="classifications" itemscope repeat>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C</span>&mdash;<span itemprop="Description">CHEMISTRY; METALLURGY</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12</span>&mdash;<span itemprop="Description">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N</span>&mdash;<span itemprop="Description">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N15/00</span>&mdash;<span itemprop="Description">Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N15/09</span>&mdash;<span itemprop="Description">Recombinant DNA-technology</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N15/63</span>&mdash;<span itemprop="Description">Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N15/79</span>&mdash;<span itemprop="Description">Vectors or expression systems specially adapted for eukaryotic hosts</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N15/85</span>&mdash;<span itemprop="Description">Vectors or expression systems specially adapted for eukaryotic hosts for animal cells</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N15/86</span>&mdash;<span itemprop="Description">Viral vectors</span>
            <meta itemprop="Leaf" content="true"><meta itemprop="IsCPC" content="true">
          </li>
        </ul>
      </li>
      <li>
        <ul itemprop="classifications" itemscope repeat>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C</span>&mdash;<span itemprop="Description">CHEMISTRY; METALLURGY</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12</span>&mdash;<span itemprop="Description">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12Y</span>&mdash;<span itemprop="Description">ENZYMES</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12Y301/00</span>&mdash;<span itemprop="Description">Hydrolases acting on ester bonds (3.1)</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12Y301/21</span>&mdash;<span itemprop="Description">Endodeoxyribonucleases producing 5&#39;-phosphomonoesters (3.1.21)</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12Y301/21001</span>&mdash;<span itemprop="Description">Deoxyribonuclease I (3.1.21.1)</span>
            <meta itemprop="Leaf" content="true"><meta itemprop="IsCPC" content="true">
          </li>
        </ul>
      </li>
      <li>
        <ul itemprop="classifications" itemscope repeat>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C</span>&mdash;<span itemprop="Description">CHEMISTRY; METALLURGY</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12</span>&mdash;<span itemprop="Description">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N</span>&mdash;<span itemprop="Description">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N15/00</span>&mdash;<span itemprop="Description">Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N15/09</span>&mdash;<span itemprop="Description">Recombinant DNA-technology</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N15/63</span>&mdash;<span itemprop="Description">Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N15/79</span>&mdash;<span itemprop="Description">Vectors or expression systems specially adapted for eukaryotic hosts</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N15/85</span>&mdash;<span itemprop="Description">Vectors or expression systems specially adapted for eukaryotic hosts for animal cells</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N15/8509</span>&mdash;<span itemprop="Description">Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N2015/8518</span>&mdash;<span itemprop="Description">Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles</span>
            <meta itemprop="Leaf" content="true"><meta itemprop="Additional" content="true"><meta itemprop="IsCPC" content="true">
          </li>
        </ul>
      </li>
      <li>
        <ul itemprop="classifications" itemscope repeat>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C</span>&mdash;<span itemprop="Description">CHEMISTRY; METALLURGY</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12</span>&mdash;<span itemprop="Description">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N</span>&mdash;<span itemprop="Description">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N2310/00</span>&mdash;<span itemprop="Description">Structure or type of the nucleic acid</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N2310/10</span>&mdash;<span itemprop="Description">Type of nucleic acid</span>
            <meta itemprop="IsCPC" content="true">
          </li>
          <li itemprop="classifications" itemscope repeat>
            <span itemprop="Code">C12N2310/20</span>&mdash;<span itemprop="Description">Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]</span>
            <meta itemprop="Leaf" content="true"><meta itemprop="Additional" content="true"><meta itemprop="IsCPC" content="true">
          </li>
        </ul>
      </li>
    </ul>
  </section>

  

  

  <section>
    <h2>Definitions</h2>
    <ul>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">relates to the field of oncology, molecular biology and recombinant nucleic acid technology.</span>
        <meta itemprop="num_attr" content="0001">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">relates to optimized engineered meganucleases having specificity for a recognition sequence within the genome of genotypes A-G of the Hepatitis B virus.</span>
        <meta itemprop="num_attr" content="0001">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">engineered meganucleases</span>
        <span itemprop="definition">are useful in methods for treating Hepatitis B virus infections and hepatocellular carcinoma caused by Hepatitis B virus.</span>
        <meta itemprop="num_attr" content="0001">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV infection</span>
        <span itemprop="definition">is a serious and common infectious disease of the liver.</span>
        <meta itemprop="num_attr" content="0003">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Chronic infection</span>
        <span itemprop="definition">is associated with an increased risk to develop severe liver diseases, including liver cirrhosis and hepatocellular carcinoma (HCC), one of the most common forms of human cancer.</span>
        <meta itemprop="num_attr" content="0003">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HCC</span>
        <span itemprop="definition">liver cirrhosis and hepatocellular carcinoma</span>
        <meta itemprop="num_attr" content="0003">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the estimated risk of HCC in chronic HBV carriers</span>
        <span itemprop="definition">is approximately 100 times greater than in uninfected individuals.</span>
        <meta itemprop="num_attr" content="0003">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">About a third of the world population</span>
        <span itemprop="definition">has been infected at one point in their lives, including 240 million to 350 million who have chronic infections.</span>
        <meta itemprop="num_attr" content="0003">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Currently available anti-HBV drugs</span>
        <span itemprop="definition">have limitations. For example, interferon alpha administration is associated with severe adverse reactions. Nucleoside analogues are virostatic and require long-term administration.</span>
        <meta itemprop="num_attr" content="0003">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV genome</span>
        <span itemprop="definition">exhibits genetic variability with an estimated rate of 1.4-3.2  10   5 nucleotide substitutions per site per year. A large number of virus variants arise during replication as a result of nucleotide misincorporations in the absence of any proof reading capacity by the viral polymerase. This variability has resulted in well-recognized subtypes of the virus. HBV has been classified into well-defined genotypes on the basis of an inter-group divergence of 8% or more in the complete genomic sequence, each having a distinct geographical distribution.</span>
        <meta itemprop="num_attr" content="0004">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Genotype A</span>
        <span itemprop="definition">is widespread in sub-Saharan Africa, Northern Europe, and Western Africa; genotypes B and C are common in Asia; genotype C is primarily observed in Southeast Asia; genotype D is dominant in Africa, Europe, Mediterranean countries, and India; genotype G is reported in France, Germany, and the United States; and genotype H is commonly encountered in Central and South America. Genotype I has recently been reported in Vietnam and Laos. The newest HBV genotype, genotype J, has been identified in the Ryukyu Islands in Japan.</span>
        <meta itemprop="num_attr" content="0004">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV</span>
        <span itemprop="definition">is an enveloped DNA virus that belongs to the Hepadnaviridae family. It contains a small, partially double-stranded (DS), relaxed-circular DNA (rcDNA) genome that replicates by reverse transcription of an RNA intermediate, the pregenomic RNA (pgRNA).</span>
        <meta itemprop="num_attr" content="0005">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">DS</span>
        <span itemprop="definition">small, partially double-stranded</span>
        <meta itemprop="num_attr" content="0005">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">rcDNA</span>
        <span itemprop="definition">relaxed-circular DNA</span>
        <meta itemprop="num_attr" content="0005">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">pgRNA</span>
        <span itemprop="definition">pregenomic RNA</span>
        <meta itemprop="num_attr" content="0005">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the circular DNA genome of HBV</span>
        <span itemprop="definition">is unusual because the DNA is not fully double-stranded.</span>
        <meta itemprop="num_attr" content="0005">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">One end of the full length strand</span>
        <span itemprop="definition">is linked to the viral DNA polymerase.</span>
        <meta itemprop="num_attr" content="0005">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the genome</span>
        <span itemprop="definition">is approximately 3020-3320 nucleotides long (for the full-length strand) and 1700-2800 nucleotides long (for the short length-strand).</span>
        <meta itemprop="num_attr" content="0005">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the negative-sense (non-coding)</span>
        <span itemprop="definition">is complementary to the viral mRNA.</span>
        <meta itemprop="num_attr" content="0005">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">C</span>
        <span itemprop="definition">genes encoded by the genome</span>
        <meta itemprop="num_attr" content="0006">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">X</span>
        <span itemprop="definition">genes encoded by the genome</span>
        <meta itemprop="num_attr" content="0006">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">P</span>
        <span itemprop="definition">genes encoded by the genome</span>
        <meta itemprop="num_attr" content="0006">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the core protein</span>
        <span itemprop="definition">is coded for by gene C (HBcAg), and its start codon is preceded by an upstream in-frame AUG start codon from which the pre-core protein is produced.</span>
        <meta itemprop="num_attr" content="0006">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBeAg</span>
        <span itemprop="definition">is produced by proteolytic processing of the pre-core protein.</span>
        <meta itemprop="num_attr" content="0006">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the DNA polymerase</span>
        <span itemprop="definition">is encoded by gene P.</span>
        <meta itemprop="num_attr" content="0006">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Gene S</span>
        <span itemprop="definition">codes for the surface antigen (HBsAg).</span>
        <meta itemprop="num_attr" content="0006">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBsAg gene</span>
        <span itemprop="definition">is one long open reading frame but contains three in frame start (ATG) codons that divide the gene into three sections: pre-S1, pre-S2, and S.</span>
        <meta itemprop="num_attr" content="0006">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral DNA</span>
        <span itemprop="definition">is found in the nucleus soon after infection of the cell.</span>
        <meta itemprop="num_attr" content="0007">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the partially double-stranded DNA</span>
        <span itemprop="definition">is rendered fully double-stranded by completion of the (&#43;) sense strand and removal of a protein molecule from the (  ) sense strand and a short sequence of RNA from the (&#43;) sense strand.</span>
        <meta itemprop="num_attr" content="0007">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Non-coding bases</span>
        <span itemprop="definition">are removed from the ends of the (  ) sense strand and the ends are rejoined.</span>
        <meta itemprop="num_attr" content="0007">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV life cycle</span>
        <span itemprop="definition">begins when the virus attaches to the host cell and is internalized.</span>
        <meta itemprop="num_attr" content="0008">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">NTCP</span>
        <span itemprop="definition">sodium-taurocholate co-transporting polypeptide</span>
        <meta itemprop="num_attr" content="0008">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">rcDNA</span>
        <span itemprop="definition">virion relaxed circular DNA</span>
        <meta itemprop="num_attr" content="0008">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">cccDNA</span>
        <span itemprop="definition">covalently closed-circular DNA</span>
        <meta itemprop="num_attr" content="0008">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the episomal cccDNA</span>
        <span itemprop="definition">serves as the template for the transcription of the pregenomic RNA (pgRNA) and the other viral mRNAs by the host RNA polymerase II.</span>
        <meta itemprop="num_attr" content="0008">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the transcripts</span>
        <span itemprop="definition">are then exported to the cytoplasm, where translation of the viral proteins occurs.</span>
        <meta itemprop="num_attr" content="0008">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Reverse transcriptase</span>
        <span itemprop="definition">binds to pgRNA and triggers assembly of the core proteins into immature, RNA-containing nucleocapsids.</span>
        <meta itemprop="num_attr" content="0008">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the immature nucleocapsids</span>
        <span itemprop="definition">then undergo a process of maturation whereby pgRNA is reversed transcribed by RT to make the mature rcDNA.</span>
        <meta itemprop="num_attr" content="0008">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a unique feature of hepadnavirus reverse transcription</span>
        <span itemprop="definition">is the RT primed initiation of minus-strand DNA synthesis, which leads to the covalent linkage of RT to the 5 end of the minus-strand DNA.</span>
        <meta itemprop="num_attr" content="0008">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">rcDNA-containing nucleocapsids</span>
        <span itemprop="definition">are then enveloped by the viral surface proteins and secreted as virions (secretion pathway) or, alternatively, are recycled back to the nucleus to further amplify the pool of cccDNA (recycling pathway).</span>
        <meta itemprop="num_attr" content="0009">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Persistence of cccDNA in hepatocytes</span>
        <span itemprop="definition">plays a key role in viral persistence, reactivation of viral replication after cessation of antiviral therapy, and resistance to therapy.</span>
        <meta itemprop="num_attr" content="0009">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Homing endonucleases</span>
        <span itemprop="definition">are a group of naturally-occurring nucleases which recognize 15-40 base-pair cleavage sites commonly found in the genomes of plants and fungi. They are frequently associated with parasitic DNA elements, such as group 1 self-splicing introns and inteins. They naturally promote homologous recombination or gene insertion at specific locations in the host genome by producing a double-stranded break in the chromosome, which recruits the cellular DNA-repair machinery (Stoddard (2006), Q. Rev. Biophys. 38: 49-95).</span>
        <meta itemprop="num_attr" content="0010">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">LAGLIDADG</span>
        <span itemprop="definition">Homing endonucleases are commonly grouped into four families: the LAGLIDADG (SEQ ID NO: 2) family, the GIY-YIG family, the His-Cys box family and the HNH family. These families are characterized by structural motifs, which affect catalytic activity and recognition sequence. For instance, members of the LAGLIDADG (SEQ ID NO: 2) family are characterized by having either one or two copies of the conserved LAGLIDADG (SEQ ID NO: 2) motif (see Chevalier et al. (2001), Nucleic Acids Res. 29(18): 3757-3774).</span>
        <meta itemprop="num_attr" content="0010">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">LAGLIDADG</span>
        <span itemprop="definition">SEQ ID NO: 2</span>
        <meta itemprop="num_attr" content="0010">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">homing endonucleases with a single copy of the LAGLIDADG (SEQ ID NO: 2) motif</span>
        <span itemprop="definition">form homodimers, whereas members with two copies of the LAGLIDADG (SEQ ID NO: 2) motif are found as monomers.</span>
        <meta itemprop="num_attr" content="0010">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Methods for producing homing endonucleases</span>
        <span itemprop="definition">are known in the art.</span>
        <meta itemprop="num_attr" content="0010">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">I-CreI</span>
        <span itemprop="definition">(SEQ ID NO: 1) is a member of the LAGLIDADG (SEQ ID NO: 2) family of homing endonucleases which recognizes and cuts a 22 basepair recognition sequence in the chloroplast chromosome of the algae Chlamydomonas reinhardtii . Genetic selection techniques have been used to modify the wild-type I-CreI cleavage site preference (Sussman et al. (2004), J. Mol. Biol. 342: 31-41; Chames et al. (2005), Nucleic Acids Res. 33: e178; Seligman et al. (2002), Nucleic Acids Res. 30: 3870-9, Arnould et al. (2006), J. Mol.</span>
        <meta itemprop="num_attr" content="0011">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">I-CreI and its engineered derivatives</span>
        <span itemprop="definition">are normally dimeric but can be fused into a single polypeptide using a short peptide linker that joins the C-terminus of a first subunit to the N-terminus of a second subunit (see also Li et al. (2009), Nucleic Acids Res. 37:1650-62; Grizot et al. (2009), Nucleic Acids Res. 37:5405-19).</span>
        <meta itemprop="num_attr" content="0012">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a functional single-chain meganuclease</span>
        <span itemprop="definition">can be expressed from a single transcript.</span>
        <meta itemprop="num_attr" content="0012">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">engineered meganucleases</span>
        <span itemprop="definition">for treatment of HBV infections has been suggested.</span>
        <meta itemprop="num_attr" content="0013">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">WO 2010/136841</span>
        <span itemprop="definition">suggests the use of engineered meganucleases for cleaving the genome of non-genomically integrating viruses.</span>
        <meta itemprop="num_attr" content="0013">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Such meganucleases</span>
        <span itemprop="definition">include variants of I-CreI targeting 22 base pair meganuclease recognition sequences which differ from those disclosed herein, and which are only present in a few HBV genotypes.</span>
        <meta itemprop="num_attr" content="0013">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the present invention</span>
        <span itemprop="definition">improves upon the engineered meganucleases previously described in the art in a number of aspects.</span>
        <meta itemprop="num_attr" content="0015">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">it</span>
        <span itemprop="definition">is critical that on-target specificity is enhanced (i.e., increased) while reducing or eliminating off-target cutting within the target cell genome.</span>
        <meta itemprop="num_attr" content="0015">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Applicants</span>
        <span itemprop="definition">have developed second-generation engineered meganucleases which target the HBV 11-12 recognition sequence.</span>
        <meta itemprop="num_attr" content="0015">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the meganucleases of the present invention</span>
        <span itemprop="definition">have novel and unique sequences which were generated through extensive experimentation.</span>
        <meta itemprop="num_attr" content="0015">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">these second-generation meganucleases</span>
        <span itemprop="definition">have a number of improved and unexpected properties when compared to the previously disclosed first-generation nucleases, including a significant reduction in off-target cutting in the host cell genome and enhanced (i.e., increased) formation of indels (i.e., insertions or deletions within the HBV genome at the cleavage site, indicative of on-target cutting) in cell lines comprising an integrated copy of the HBV genome.</span>
        <meta itemprop="num_attr" content="0015">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">indels</span>
        <span itemprop="definition">i.e., insertions or deletions within the HBV genome at the cleavage site, indicative of on-target cutting</span>
        <meta itemprop="num_attr" content="0015">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the meganucleases of the invention</span>
        <span itemprop="definition">advance the art in a number of ways that are necessary for development of a clinical product targeting HBV infection and HBV-related hepatocellular carcinoma.</span>
        <meta itemprop="num_attr" content="0015">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the present invention</span>
        <span itemprop="definition">provides second-generation engineered meganucleases that recognize and cleave a recognition sequence conserved across multiple genotypes of Hepatitis B viruses. Cleavage at the recognition sequence by an engineered meganuclease disclosed herein can disrupt expression of one or more viral proteins due to non-homologous end joining (NHEJ) at the cleavage site. NHEJ can result in insertions, deletions, or result in a frameshift mutation that can interfere with gene expression.</span>
        <meta itemprop="num_attr" content="0016">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a suicide gene</span>
        <span itemprop="definition">can be introduced into a Hepatitis B virus (HBV) genome via homologous recombination.</span>
        <meta itemprop="num_attr" content="0016">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV genome or cccDNA</span>
        <span itemprop="definition">may be degraded following cleavage at the HBV 11-12 recognition sequence. Accordingly, by interrupting normal gene expression, the infection and proliferation of HBV can be reduced or eliminated according to the methods disclosed herein. Such meganucleases are, therefore, useful for treating or reducing the proliferation of HBV in infected individuals worldwide.</span>
        <meta itemprop="num_attr" content="0016">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the present invention</span>
        <span itemprop="definition">also provides pharmaceutical compositions and methods for treatment of a subject having HBV or HCC which utilize an engineered meganuclease having specificity for a recognition sequence comprising SEQ ID NO: 10 within a Hepatitis B virus genome.</span>
        <meta itemprop="num_attr" content="0017">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the present invention</span>
        <span itemprop="definition">further provides methods of delivering the engineered meganucleases disclosed herein, or a nucleic acid encoding the same, to a subject infected with HBV in order to reduce the level of HBV virus or HBV cccDNA and/or reduce the symptoms associated with an HBV infection.</span>
        <meta itemprop="num_attr" content="0017">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the presently disclosed engineered meganucleases</span>
        <span itemprop="definition">exhibit at least one optimized characteristic in comparison to the first-generation meganuclease HBV 11-12x.26.</span>
        <meta itemprop="num_attr" content="0018">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">optimized characteristics</span>
        <span itemprop="definition">include improved (i.e., increased) specificity resulting in reduced off-target cutting, and enhanced (i.e., increased) efficiency of cleavage and indel formation at the HBV 11-12 recognition sequence, for example in cells comprising an integrated copy of the HBV genome.</span>
        <meta itemprop="num_attr" content="0018">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides an engineered meganuclease that recognizes and cleaves the HBV 11-12 recognition sequence (SEQ ID NO: 10) within a Hepatitis B virus genome.</span>
        <meta itemprop="num_attr" content="0019">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the engineered meganuclease</span>
        <span itemprop="definition">comprises a first subunit and a second subunit, wherein the first subunit binds to a first recognition half-site of the recognition sequence and comprises a first hypervariable (HVR1) region, wherein the second subunit binds to a second recognition half site of the recognition sequence and comprises a second hypervariable (HVR2) region, and wherein said HVR1 has at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 215-270 of the presently disclosed HBV 11-12L.363 meganu</span>
        <meta itemprop="num_attr" content="0019">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR1 region</span>
        <span itemprop="definition">comprises an amino acid sequence corresponding to residues 215-270 of SEQ ID NOs: 12 or 13 with up to 1, 2, 3, 4, 5, 6, or 7 amino acid substitutions.</span>
        <meta itemprop="num_attr" content="0020">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR1 region</span>
        <span itemprop="definition">comprises residues corresponding to residues 223, 233, 239, 241, 259, 263, 264, and 268 of SEQ ID NO: 12. In some embodiments, the HVR1 region comprises residues corresponding to residues 223, 233, 241, 259, 262, 263, 264, and 268 of SEQ ID NO: 13.</span>
        <meta itemprop="num_attr" content="0021">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR1 region</span>
        <span itemprop="definition">comprises residues corresponding to residues 215, 217, 219, 221, 223, 224, 229, 231, 233, 235, 237, 259, 261, 266, and 268 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0022">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR1 region</span>
        <span itemprop="definition">comprises residues corresponding to residues 239, 241, 263, and 264 of SEQ ID NO: 12.</span>
        <meta itemprop="num_attr" content="0023">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR1 region</span>
        <span itemprop="definition">comprises residues corresponding to residues 241, 262, 263, and 264 of SEQ ID NO: 13.</span>
        <meta itemprop="num_attr" content="0024">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR1 region</span>
        <span itemprop="definition">comprises residues corresponding to residues 215, 217, 219, 221, 223, 224, 229, 231, 233, 235, 237, 239, 241, 259, 261, 262, 263, 264, 266, and 268 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0025">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR1 region</span>
        <span itemprop="definition">comprises Y, R, K, or D at a residue corresponding to residue 257 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0026">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR1 region</span>
        <span itemprop="definition">comprises residues 215-270 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0027">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first subunit</span>
        <span itemprop="definition">comprises an amino acid sequence having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 198-344 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0028">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first subunit</span>
        <span itemprop="definition">comprises an amino acid sequence having at least 94% sequence identity to residues 198-344 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0028">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first subunit</span>
        <span itemprop="definition">comprises an amino acid sequence corresponding to residues 198-344 of SEQ ID NOs: 12 or 13 with up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 amino acid substitutions.</span>
        <meta itemprop="num_attr" content="0028">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first subunit</span>
        <span itemprop="definition">comprises G, S, or A at a residue corresponding to residue 210 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0029">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first subunit</span>
        <span itemprop="definition">comprises E, Q, or K at a residue corresponding to residue 271 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0030">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first subunit</span>
        <span itemprop="definition">comprises a residue corresponding to residue 271 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0031">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first subunit</span>
        <span itemprop="definition">comprises residues 198-344 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0032">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR2 region</span>
        <span itemprop="definition">comprises an amino acid sequence having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 24-79 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0033">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR2 region</span>
        <span itemprop="definition">comprises an amino acid sequence corresponding to residues 24-79 of SEQ ID NOs: 12 or 13 with up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11 amino acid substitutions.</span>
        <meta itemprop="num_attr" content="0033">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR2 region</span>
        <span itemprop="definition">comprises residues corresponding to residues 26 and 77 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0034">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR2 region</span>
        <span itemprop="definition">comprises residues corresponding to residues 24, 26, 28, 30, 32, 33, 38, 40, 42, 44, 46, 68, 70, 75, and 77 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0035">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR2 region</span>
        <span itemprop="definition">comprises Y, R, K, or D at a residue corresponding to residue 66 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0036">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR2 region</span>
        <span itemprop="definition">comprises residues 24-79 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0037">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second subunit</span>
        <span itemprop="definition">comprises an amino acid sequence having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 7-153 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0038">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second subunit</span>
        <span itemprop="definition">comprises an amino acid sequence having at least 99% sequence identity to an amino acid sequence corresponding to residues 7-153 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0038">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second subunit</span>
        <span itemprop="definition">comprises an amino acid sequence corresponding to residues 7-153 of SEQ ID NOs: 12 or 13 with up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 amino acid substitutions.</span>
        <meta itemprop="num_attr" content="0038">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second subunit</span>
        <span itemprop="definition">comprises G, S, or A at a residue corresponding to residue 19 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0039">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second subunit</span>
        <span itemprop="definition">comprises E, Q, or K at a residue corresponding to residue 80 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0040">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second subunit</span>
        <span itemprop="definition">comprises a residue corresponding to residue 80 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0041">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second subunit</span>
        <span itemprop="definition">comprises residues 7-153 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0042">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first subunit of the engineered meganuclease</span>
        <span itemprop="definition">has at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 198-344 of SEQ ID NO: 12 or 13, and the second subunit comprises an amino acid sequence having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 7-153 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0043">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first subunit of the engineered meganuclease</span>
        <span itemprop="definition">has at least 94% sequence identity to an amino acid sequence corresponding to residues 198-344 of SEQ ID NO: 12 or 13 and the second subunit comprises an amino acid sequence having at least 99% sequence identity to an amino acid sequence corresponding to residues 7-153 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0043">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first subunit and/or the second subunit</span>
        <span itemprop="definition">can comprise up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 amino acid substitutions relative to residues 198-344 and residues 7-153, respectively, of SEQ ID NOs: 12 and 13.</span>
        <meta itemprop="num_attr" content="0043">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the engineered meganuclease</span>
        <span itemprop="definition">comprises a linker, wherein the linker covalently joins the first subunit and the second subunit.</span>
        <meta itemprop="num_attr" content="0044">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the engineered meganuclease</span>
        <span itemprop="definition">comprises an amino acid sequence having at least about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99% sequence identity to the amino acid sequence of SEQ ID NO: 12 or 13. In certain embodiments, the engineered meganuclease comprises an amino acid sequence having at least 97% sequence identity to the amino acid sequence of SEQ ID NO: 12.</span>
        <meta itemprop="num_attr" content="0045">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the engineered meganuclease</span>
        <span itemprop="definition">comprises the amino acid sequence of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0046">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides a polynucleotide comprising a nucleic acid sequence encoding an engineered meganuclease described herein.</span>
        <meta itemprop="num_attr" content="0047">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the polynucleotide</span>
        <span itemprop="definition">is an mRNA.</span>
        <meta itemprop="num_attr" content="0048">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the mRNA</span>
        <span itemprop="definition">is a polycistronic mRNA encoding one or more engineered meganucleases described herein.</span>
        <meta itemprop="num_attr" content="0049">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the polycistronic mRNA</span>
        <span itemprop="definition">encodes at least one of the presently disclosed engineered meganucleases which recognizes and cleaves a recognition sequence comprising SEQ ID NO: 10, and a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0049">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second recognition sequence</span>
        <span itemprop="definition">comprises the HBV 5-6 recognition sequence (which is set forth as SEQ ID NO: 21).</span>
        <meta itemprop="num_attr" content="0049">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a polycistronic mRNA of the invention</span>
        <span itemprop="definition">can encode one or more engineered meganucleases described herein and one or more additional proteins that induce a therapeutically beneficial effect in an HBV-infected cell and/or HBV-infected subject.</span>
        <meta itemprop="num_attr" content="0050">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides a recombinant DNA construct comprising a polynucleotide described herein.</span>
        <meta itemprop="num_attr" content="0051">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the recombinant DNA construct</span>
        <span itemprop="definition">comprises a cassette comprising a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein.</span>
        <meta itemprop="num_attr" content="0051">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the recombinant DNA construct</span>
        <span itemprop="definition">comprises at least a first cassette and a second cassette, wherein the first cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein, and wherein the second cassette comprises a promoter and a nucleic acid sequence encoding a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0051">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second recognition sequence</span>
        <span itemprop="definition">comprises SEQ ID NO: 21.</span>
        <meta itemprop="num_attr" content="0051">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the recombinant DNA construct</span>
        <span itemprop="definition">comprises a cassette comprising a promoter and a polycistronic nucleic acid sequence, wherein the promoter drives expression of the polycistronic nucleic acid sequence to generate a polycistronic mRNA described herein in a target cell.</span>
        <meta itemprop="num_attr" content="0052">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the recombinant DNA construct</span>
        <span itemprop="definition">encodes a viral vector comprising a nucleic acid sequence encoding an engineered meganuclease disclosed herein.</span>
        <meta itemprop="num_attr" content="0053">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">is a recombinant AAV vector.</span>
        <meta itemprop="num_attr" content="0053">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides a viral vector comprising a nucleic acid sequence encoding an engineered meganuclease described herein.</span>
        <meta itemprop="num_attr" content="0054">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">is a recombinant AAV vector.</span>
        <meta itemprop="num_attr" content="0054">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">comprises a cassette comprising a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein.</span>
        <meta itemprop="num_attr" content="0055">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">comprises at least a first cassette and a second cassette, wherein the first cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein, and wherein the second cassette comprises a promoter and a nucleic acid sequence encoding a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0055">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second recognition sequence</span>
        <span itemprop="definition">comprises SEQ ID NO: 21.</span>
        <meta itemprop="num_attr" content="0055">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">comprises one cassette comprising a promoter and a polycistronic nucleic acid sequence, wherein the promoter drives expression of the polycistronic nucleic acid sequence to generate a polycistronic mRNA described herein in a target cell.</span>
        <meta itemprop="num_attr" content="0056">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides a pharmaceutical composition for treatment of a subject having Hepatitis B virus or hepatocellular carcinoma caused by Hepatitis B virus, the pharmaceutical composition comprising a pharmaceutically acceptable carrier and: (a) a nucleic acid encoding an engineered meganuclease described herein; or (b) an engineered meganuclease described herein.</span>
        <meta itemprop="num_attr" content="0057">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the nucleic acid sequence of the pharmaceutical composition encoding an engineered meganuclease disclosed herein</span>
        <span itemprop="definition">is an mRNA described herein.</span>
        <meta itemprop="num_attr" content="0058">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the mRNA</span>
        <span itemprop="definition">can be a polycistronic mRNA described herein, such that an engineered meganuclease described herein is expressed in the target cell in vivo, along with a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0058">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second recognition sequence</span>
        <span itemprop="definition">comprises SEQ ID NO: 21.</span>
        <meta itemprop="num_attr" content="0058">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the pharmaceutical composition</span>
        <span itemprop="definition">comprises a recombinant DNA construct described herein comprising the nucleic acid sequence encoding an engineered meganuclease disclosed herein.</span>
        <meta itemprop="num_attr" content="0059">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the recombinant DNA construct</span>
        <span itemprop="definition">comprises a cassette comprising a promoter and a nucleic acid sequence encoding an engineered meganuclease of the invention.</span>
        <meta itemprop="num_attr" content="0059">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the recombinant DNA construct of the pharmaceutical composition</span>
        <span itemprop="definition">comprises at least a first cassette and a second cassette, wherein the first cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein, and wherein the second cassette comprises a promoter and a nucleic acid sequence encoding a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0059">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second recognition sequence</span>
        <span itemprop="definition">comprises SEQ ID NO: 21.</span>
        <meta itemprop="num_attr" content="0059">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the recombinant DNA construct of the pharmaceutical composition</span>
        <span itemprop="definition">comprises a cassette comprising a promoter and a polycistronic nucleic acid sequence, wherein the promoter drives expression of the polycistronic nucleic acid sequence to generate a polycistronic mRNA described herein in the target cell in vivo.</span>
        <meta itemprop="num_attr" content="0060">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the pharmaceutical composition</span>
        <span itemprop="definition">comprises a viral vector comprising the nucleic acid sequence encoding an engineered meganuclease disclosed herein.</span>
        <meta itemprop="num_attr" content="0061">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">can be a retrovirus, a lentivirus, an adenovirus, or an AAV.</span>
        <meta itemprop="num_attr" content="0061">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">can be a recombinant AAV vector.</span>
        <meta itemprop="num_attr" content="0061">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">comprises a cassette comprising a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein.</span>
        <meta itemprop="num_attr" content="0062">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">comprises at least a first cassette and a second cassette, wherein the first cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein, and wherein the second cassette comprises a promoter and a nucleic acid sequence encoding a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0062">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second recognition sequence</span>
        <span itemprop="definition">comprises SEQ ID NO: 21.</span>
        <meta itemprop="num_attr" content="0062">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">comprises one cassette comprising a promoter and a polycistronic nucleic acid sequence, wherein the promoter drives expression of the polycistronic nucleic acid sequence to generate a polycistronic mRNA described herein in the target cell in vivo.</span>
        <meta itemprop="num_attr" content="0063">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the pharmaceutical composition</span>
        <span itemprop="definition">comprises an engineered meganuclease described herein.</span>
        <meta itemprop="num_attr" content="0064">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the pharmaceutical composition</span>
        <span itemprop="definition">comprises an engineered meganuclease described herein and a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0064">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second recognition sequence</span>
        <span itemprop="definition">comprises SEQ ID NO: 21.</span>
        <meta itemprop="num_attr" content="0064">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the pharmaceutical composition</span>
        <span itemprop="definition">comprises a nucleic acid encoding an engineered meganuclease described herein and a nucleic acid encoding a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0065">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second recognition sequence</span>
        <span itemprop="definition">comprises SEQ ID NO: 21.</span>
        <meta itemprop="num_attr" content="0065">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the two nucleic acids</span>
        <span itemprop="definition">may be comprised by mRNAs described herein, recombinant DNA constructs described herein, and/or viral vectors described herein.</span>
        <meta itemprop="num_attr" content="0065">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the pharmaceutical composition</span>
        <span itemprop="definition">can comprise one or more mRNAs described herein encapsulated within lipid nanoparticles.</span>
        <meta itemprop="num_attr" content="0066">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the lipid nanoparticles of the pharmaceutical composition</span>
        <span itemprop="definition">can comprise at least a first mRNA and at least a second mRNA, wherein the first mRNA encodes an engineered meganuclease described herein, and the second mRNA encodes a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0066">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second recognition sequence</span>
        <span itemprop="definition">comprises SEQ ID NO: 21.</span>
        <meta itemprop="num_attr" content="0066">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the lipid nanoparticles of the pharmaceutical composition</span>
        <span itemprop="definition">can comprise one or more polycistronic mRNAs described herein, wherein the polycistronic mRNA encodes an engineered meganuclease described herein and a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0066">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second recognition sequence</span>
        <span itemprop="definition">comprises SEQ ID NO: 21.</span>
        <meta itemprop="num_attr" content="0066">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the lipid nanoparticles</span>
        <span itemprop="definition">have a composition which enhances delivery and uptake in the liver, and specifically within hepatocytes.</span>
        <meta itemprop="num_attr" content="0066">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides a lipid nanoparticle, or a lipid nanoparticle formulation, comprising mRNA encoding at least one engineered meganuclease described herein.</span>
        <meta itemprop="num_attr" content="0067">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the lipid nanoparticles</span>
        <span itemprop="definition">can comprise at least a first mRNA and at least a second mRNA, wherein the first mRNA encodes an engineered meganuclease described herein, and the second mRNA encodes a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0068">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second recognition sequence</span>
        <span itemprop="definition">comprises SEQ ID NO: 21.</span>
        <meta itemprop="num_attr" content="0068">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the lipid nanoparticles of the pharmaceutical composition</span>
        <span itemprop="definition">can comprise one or more polycistronic mRNAs described herein, wherein the polycistronic mRNA encodes an engineered meganuclease described herein and a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0069">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second recognition sequence</span>
        <span itemprop="definition">comprises SEQ ID NO: 21.</span>
        <meta itemprop="num_attr" content="0069">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the lipid nanoparticles</span>
        <span itemprop="definition">have a composition which enhances delivery and uptake in the liver, and specifically within hepatocytes.</span>
        <meta itemprop="num_attr" content="0070">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides a method for treating a subject having HBV or hepatocellular carcinoma caused by HBV</span>
        <meta itemprop="num_attr" content="0071">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a method for reducing the level and/or proliferation of HBV, or reducing the symptoms associated with HBV</span>
        <span itemprop="definition">comprise delivering to a target cell in the subject: (a) a therapeutically effective amount of a nucleic acid encoding an engineered meganuclease described herein, wherein the engineered meganuclease is expressed in the target cell in vivo; or (b) a therapeutically effective amount of an engineered meganuclease protein described herein; wherein the engineered meganuclease recognizes and cleaves a recognition sequence comprising SEQ ID NO: 10 within the HBV genome in the target cell.</span>
        <meta itemprop="num_attr" content="0071">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the method</span>
        <span itemprop="definition">can reduce or eliminate the infection and/or proliferation of HBV in the subject.</span>
        <meta itemprop="num_attr" content="0071">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the methods</span>
        <span itemprop="definition">reduce circulating HBsAg levels, circulating HBeAg levels, circulating HBV DNA levels, and/or hepatic cccDNA levels.</span>
        <meta itemprop="num_attr" content="0072">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides a method for treating a subject having HCC caused by HBV.</span>
        <meta itemprop="num_attr" content="0073">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the methods</span>
        <span itemprop="definition">comprise delivering to a target cell in the subject: (1) (a) a nucleic acid encoding an engineered meganuclease described herein, wherein the engineered meganuclease is expressed in the target cell in vivo; or (b) an engineered meganuclease protein; and (2) a nucleic acid comprising a polynucleotide sequence encoding a suicide gene and sequences homologous to sequences flanking the meganuclease cleavage site; wherein the engineered meganuclease recognizes and cleaves a recognition sequence comprising SEQ ID NO: 10 within the Hepatitis B virus genome, thus cleaving the HBV genome in the target cell; wherein the suicide gene is inserted into the cleaved HBV genome by homologous recombination; and wherein expression of the suicide gene kills the target cell.</span>
        <meta itemprop="num_attr" content="0073">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the suicide gene</span>
        <span itemprop="definition">is directly lethal to the target cell.</span>
        <meta itemprop="num_attr" content="0074">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the directly lethal suicide gene</span>
        <span itemprop="definition">encodes a toxic polypeptide or a pro-apoptotic protein.</span>
        <meta itemprop="num_attr" content="0074">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the suicide gene</span>
        <span itemprop="definition">is indirectly lethal to the target cell, and directs the subject&#39;s own immune system to kill the target cell.</span>
        <meta itemprop="num_attr" content="0074">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the indirectly lethal suicide gene</span>
        <span itemprop="definition">encodes a cell surface protein which is recognized as foreign by the subject&#39;s immune system and is targeted by a humoral or cellular immune response.</span>
        <meta itemprop="num_attr" content="0074">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the indirectly lethal suicide gene</span>
        <span itemprop="definition">encodes a polypeptide which is presented by an MHC Class I molecule, is recognized as foreign by the subject&#39;s immune system, and is targeted by a cytotoxic immune response.</span>
        <meta itemprop="num_attr" content="0074">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the methods of treatment for HBV infection or HCC</span>
        <span itemprop="definition">comprise administering to the subject any pharmaceutical composition of the invention described herein which comprises, at least, a pharmaceutically acceptable carrier and (a) a nucleic acid encoding an engineered meganuclease described herein, wherein the engineered meganuclease is expressed in a target cell in vivo; or (b) an engineered meganuclease protein described herein.</span>
        <meta itemprop="num_attr" content="0075">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the engineered meganuclease, or the nucleic acid encoding the engineered meganuclease</span>
        <span itemprop="definition">can be delivered to a target hepatocyte cell.</span>
        <meta itemprop="num_attr" content="0076">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an effective amount of the engineered meganuclease, or the nucleic acid encoding the engineered meganuclease</span>
        <span itemprop="definition">can be delivered to a target hepatocyte cell.</span>
        <meta itemprop="num_attr" content="0076">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the methods</span>
        <span itemprop="definition">reduce circulating HBsAg levels, circulating HBeAg levels, circulating HBV DNA levels, and/or hepatic cccDNA levels.</span>
        <meta itemprop="num_attr" content="0077">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">delivery to a hepatocyte cell</span>
        <span itemprop="definition">occurs ex vivo, wherein an effective amount of the hepatocyte cells having been delivered the engineered meganuclease, or the nucleic acid encoding the engineered meganuclease, are administered to a subject.</span>
        <meta itemprop="num_attr" content="0078">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a hepatotoxic protein</span>
        <span itemprop="definition">or a nucleic acid or AAV encoding a hepatotoxic protein, is administered with the pharmaceutical compositions disclosed herein.</span>
        <meta itemprop="num_attr" content="0079">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the engineered meganuclease</span>
        <span itemprop="definition">comprises the amino acid sequence of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0080">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the subject</span>
        <span itemprop="definition">can be a mammal, such as a human.</span>
        <meta itemprop="num_attr" content="0081">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides an engineered meganuclease described herein for use as a medicament.</span>
        <meta itemprop="num_attr" content="0082">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">further provides the use of an engineered meganuclease, described herein in the manufacture of a medicament for treating HBV, for reducing the level or proliferation of HBV, reducing the symptoms associated with HBV, or treating HCC.</span>
        <meta itemprop="num_attr" content="0082">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides an isolated polynucleotide for use as a medicament, wherein the isolated polynucleotide comprises a nucleic acid sequence encoding an engineered meganuclease disclosed herein.</span>
        <meta itemprop="num_attr" content="0083">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">further provides the use of an isolated polynucleotide in the manufacture of a medicament for treating HBV, for reducing the level or proliferation of HBV, reducing the symptoms associated with HBV, or treating HCC.</span>
        <meta itemprop="num_attr" content="0083">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides a recombinant AAV vector for use as a medicament, wherein the recombinant AAV vector comprises a polynucleotide, and wherein the polynucleotide comprises a nucleic acid sequence encoding an engineered meganuclease disclosed herein.</span>
        <meta itemprop="num_attr" content="0084">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">further provides the use of a recombinant AAV vector in the manufacture of a medicament for treating HBV, for reducing the level or proliferation of HBV, reducing the symptoms associated with HBV, or treating HCC, wherein the recombinant AAV vector comprises a polynucleotide, and wherein the polynucleotide comprises a nucleic acid sequence encoding an engineered meganuclease disclosed herein.</span>
        <meta itemprop="num_attr" content="0084">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 1</span>
        <span itemprop="definition">shows a genomic map of the HBV genome and identifies all ORFs.</span>
        <meta itemprop="num_attr" content="0085">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Virus particles</span>
        <span itemprop="definition">have a partially double-stranded genome (indicated by a dashed line) with a cohesive overlap that spans the 5 regions of each strand and that is flanked by direct repeat sequences (DR1 and DR2).</span>
        <meta itemprop="num_attr" content="0085">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the gene S</span>
        <span itemprop="definition">encodes the major hepatitis B surface antigen (HBsAg) protein and its glycosylated partner, which are transmembrane proteins in the virus envelope.</span>
        <meta itemprop="num_attr" content="0085">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">In-frame sequences upstream from the S gene</span>
        <span itemprop="definition">encode the pre-S domains, which are translated with the S sequences to make the pre-S and S polypeptides (middle and large proteins) that contain the virus receptor for infection of hepatocytes.</span>
        <meta itemprop="num_attr" content="0085">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Gene C</span>
        <span itemprop="definition">encodes the hepatitis B core antigen (HBcAg) which forms the nucleocapsid of the virus.</span>
        <meta itemprop="num_attr" content="0085">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the P region</span>
        <span itemprop="definition">encodes the virus reverse transcriptase that also has DNA-dependent DNA polymerase activity and RNase H activity required for virus replication.</span>
        <meta itemprop="num_attr" content="0085">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV</span>
        <span itemprop="definition">is a DNA virus, it replicates through a pre-genomic RNA intermediate.</span>
        <meta itemprop="num_attr" content="0085">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the X gene</span>
        <span itemprop="definition">encodes the small regulatory protein of the virus, the hepatitis B x (HBx) antigen.</span>
        <meta itemprop="num_attr" content="0085">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBx</span>
        <span itemprop="definition">is a transactivating protein that stimulates virus gene expression and replication, protects virus-infected cells against immune-mediated destruction and contributes to the development of hepatocellular carcinoma.</span>
        <meta itemprop="num_attr" content="0085">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 2</span>
        <span itemprop="definition">HBV 11-12 recognition sequence in the HBV genome.</span>
        <meta itemprop="num_attr" content="0086">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV 11-12 recognition sequence</span>
        <span itemprop="definition">targeted by engineered meganucleases of the invention, comprises two recognition half-sites. Each recognition half-site comprises 9 base pairs, separated by a 4 base pair central sequence.</span>
        <meta itemprop="num_attr" content="0086">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV 11-12 recognition sequence</span>
        <span itemprop="definition">(SEQ ID NO: 10) comprises two recognition half-sites referred to as HBV11 and HBV12.</span>
        <meta itemprop="num_attr" content="0086">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 3</span>
        <span itemprop="definition">Alignment of HBV recognition sequences in HBV genotypes A-G.</span>
        <meta itemprop="num_attr" content="0087">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV 11-12 recognition sequence targeted by engineered meganucleases of the invention</span>
        <span itemprop="definition">is conserved across multiple HBV genotypes.</span>
        <meta itemprop="num_attr" content="0087">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV 11-12 recognition sequence</span>
        <span itemprop="definition">spans residues 1259-1280 of HBV genotype A set forth in SEQ ID NO: 3, and this recognition sequence is fully conserved in genotypes B, C, D, E, F, and G (SEQ ID NOs: 4-9).</span>
        <meta itemprop="num_attr" content="0087">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the engineered meganucleases of the invention</span>
        <span itemprop="definition">comprise two subunits, wherein the first subunit comprising the HVR1 region binds to a first recognition half-site (e.g., HBV11) and the second subunit comprising the HVR2 region binds to a second recognition half-site (e.g., HBV12).</span>
        <meta itemprop="num_attr" content="0088">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first subunit comprising the HVR1 region</span>
        <span itemprop="definition">can be positioned as either the N-terminal or C-terminal subunit.</span>
        <meta itemprop="num_attr" content="0088">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second subunit comprising the HVR2 region</span>
        <span itemprop="definition">can be positioned as either the N-terminal or C-terminal subunit.</span>
        <meta itemprop="num_attr" content="0088">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 5</span>
        <span itemprop="definition">Schematic of reporter assay in CHO cells for evaluating engineered meganucleases of the invention.</span>
        <meta itemprop="num_attr" content="0089">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a CHO cell line</span>
        <span itemprop="definition">was produced in which a reporter cassette was integrated stably into the genome of the cell.</span>
        <meta itemprop="num_attr" content="0089">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the reporter cassette</span>
        <span itemprop="definition">comprised, in 5 to 3 order: an SV40 Early Promoter; the 5 2/3 of the GFP gene; the recognition sequence for an engineered meganuclease of the invention (e.g., the HBV 11-12 recognition sequence); the recognition sequence for the CHO 23/24 meganuclease (WO 2012/167192); and the 3 2/3 of the GFP gene.</span>
        <meta itemprop="num_attr" content="0089">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Cells stably transfected with this cassette</span>
        <span itemprop="definition">did not express GFP in the absence of a DNA break-inducing agent.</span>
        <meta itemprop="num_attr" content="0089">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Meganucleases</span>
        <span itemprop="definition">were introduced by transduction of plasmid DNA or mRNA encoding each meganuclease. When a DNA break was induced at either of the meganuclease recognition sequences, the duplicated regions of the GFP gene recombined with one another to produce a functional GFP gene. The percentage of GFP-expressing cells could then be determined by flow cytometry as an indirect measure of the frequency of genome cleavage by the meganucleases.</span>
        <meta itemprop="num_attr" content="0089">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 6</span>
        <span itemprop="definition">Efficiency of engineered meganucleases for recognizing and cleaving the HBV 11-12 recognition sequence in a CHO cell reporter assay.</span>
        <meta itemprop="num_attr" content="0090">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the results shown</span>
        <span itemprop="definition">provide the percentage of GFP-expressing cells observed, which indicates the efficacy of each meganuclease for cleaving the target recognition sequence or the CHO 23/24 recognition sequence.</span>
        <meta itemprop="num_attr" content="0090">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a negative control (bs)</span>
        <span itemprop="definition">was further included in the assay.</span>
        <meta itemprop="num_attr" content="0090">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 7</span>
        <span itemprop="definition">Efficiency of engineered meganucleases for recognizing and cleaving the HBV11 off-target (HBV11 Off) recognition sequence in a CHO cell reporter assay. Plasmids encoding the HBV 11-12 meganucleases of the invention were transfected into HBV11 Off cells which contain the counter selected HBV11 Off recognition sequence (SEQ ID NO: 23) between the GFP direct repeats, as well as a CHO 23-24 recognition sequence. A) Cleavage of the HBV11 Off recognition sequence by the first-generation HBV 11-12x.26 meganuclease. B) Cleavage of the HBV11 Off recognition sequence by the second-generation HBV11-12L.363 and HBV 11-12L.367 meganucleases.</span>
        <meta itemprop="num_attr" content="0091">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 23</span>
        <span itemprop="definition">the counter selected HBV11 Off recognition sequence</span>
        <meta itemprop="num_attr" content="0091">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 8</span>
        <span itemprop="definition">Efficiency of engineered meganucleases for recognizing and cleaving the HBV12 off-target (HBV12 Off) recognition sequence in a CHO cell reporter assay. Plasmids encoding The HBV 11-12 meganucleases of the invention were transfected into HBV12 Off cells which contain the counter selected HBV12 Off recognition sequence (SEQ ID NO: 24) between the GFP direct repeats, as well as a CHO 23-24 recognition sequence. A) Cleavage of the HBV12 Off recognition sequence by the first-generation HBV 11-12x.26 meganuclease. B) Cleavage of the HBV12 Off recognition sequence by the second-generation HBV11-12L.363 and HBV 11-12L.367 meganucleases.</span>
        <meta itemprop="num_attr" content="0092">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 24</span>
        <span itemprop="definition">the counter selected HBV12 Off recognition sequence</span>
        <meta itemprop="num_attr" content="0092">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 9</span>
        <span itemprop="definition">Efficiency of engineered meganucleases for recognizing and cleaving the HBV 11-12 recognition sequence in a CHO cell reporter assay.</span>
        <meta itemprop="num_attr" content="0093">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the results shown</span>
        <span itemprop="definition">provide the percentage of GFP-expressing cells observed over the 7 day period of analysis, which indicates the efficacy of each meganuclease for cleaving a target recognition sequence or the CHO 23/24 recognition sequence as a function of time.</span>
        <meta itemprop="num_attr" content="0093">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 10</span>
        <span itemprop="definition">Efficiency of engineered meganucleases for recognizing and cleaving the HBV11 Off and HBV12 Off recognition sequences in a CHO cell reporter assay.</span>
        <meta itemprop="num_attr" content="0094">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">mRNA encoding the HBV 11-12 meganucleases of the invention</span>
        <span itemprop="definition">were transfected into HBV11 Off cells or HBV12 Off cells and were screened for efficacy in the CHO cell reporter assay at 2, 5, and 7 days after nucleofection in order to determine toxicity. The results shown provide the percentage of GFP-expressing cells observed over the 7 day period of analysis.</span>
        <meta itemprop="num_attr" content="0094">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 11</span>
        <span itemprop="definition">Oligo capture assay in a HepG2 cell line lacking the HBV 11-12 recognition sequence. Oligo capture data is shown for HBV 11-12x.26, HBV 11-12L.188, HBV 11-12L.363, and HBV 11-12L.367. Data is graphically visualized wherein off target sites are plotted according to their number of aligned reads on the X axis, and the number of mismatched base pairs compared to the intended site are indicated by color, with darker colors indicating closer overall matches between off-targets and the intended binding site.</span>
        <meta itemprop="num_attr" content="0095">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 12</span>
        <span itemprop="definition">Oligo capture assay in a HepG2 HepB cell line, which comprises a partial HBV genome including the HBV 11-12 recognition sequence.</span>
        <meta itemprop="num_attr" content="0096">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Oligo capture data of HBV 11-12x.26 and HBV 11-12L.363</span>
        <span itemprop="definition">are graphically visualized wherein off target sites are plotted according to their number of aligned reads on the X axis, and the number of mismatched base pairs compared to the intended site are indicated by color, with darker colors indicating closer overall matches between off-targets and the intended binding site. Intended target sites are indicated by circles.</span>
        <meta itemprop="num_attr" content="0096">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 13</span>
        <span itemprop="definition">Efficiency of indel formation detected by T7E assay.</span>
        <meta itemprop="num_attr" content="0097">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a HepG2 cell line</span>
        <span itemprop="definition">(HepG2 HepB) was generated that stably expressed one copy of a   1500 bp region of the Hepatitis B genome including the HBV 11-12 meganuclease target site.</span>
        <meta itemprop="num_attr" content="0097">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HepG2 HepB cells</span>
        <span itemprop="definition">were transfected with mRNA encoding HBV 11-12L.26, HBV 11-12L.188, HBV 11-12L.363, HBV 11-12L.367, or HBV 11-12x.26, respectively.</span>
        <meta itemprop="num_attr" content="0097">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">genomic DNA</span>
        <span itemprop="definition">was isolated from cells for analysis of indel formation by T7E assay.</span>
        <meta itemprop="num_attr" content="0097">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Genomic DNA from mock transfected HepG2 HepB cells</span>
        <span itemprop="definition">was used as a control. Amplification was confirmed by visualization of a   1650 bp band on an agarose gel. PCR-amplified DNA was denatured and slowly rehybridized to allow formation of heteroduplex DNA sequences and then digested with T7 endonuclease I. Digestion products were visualized on an agarose gel.</span>
        <meta itemprop="num_attr" content="0097">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 14</span>
        <span itemprop="definition">Efficiency of indel formation detected by digital PCR.</span>
        <meta itemprop="num_attr" content="0098">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HepG2 HepB cells</span>
        <span itemprop="definition">were transfected with mRNA encoding HBV 11-12L.26, HBV 11-12L.188, HBV 11-12L.363, HBV 11-12L.367, or HBV 11-12x.26, respectively.</span>
        <meta itemprop="num_attr" content="0098">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">genomic DNA</span>
        <span itemprop="definition">was isolated from cells for analysis of indel formation by digital PCR.</span>
        <meta itemprop="num_attr" content="0098">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Genomic DNA from mock transfected HepG2 HepB cells</span>
        <span itemprop="definition">was used as a control.</span>
        <meta itemprop="num_attr" content="0098">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Digital PCR</span>
        <span itemprop="definition">was performed using the QX200 droplet digital PCR system.</span>
        <meta itemprop="num_attr" content="0098">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a FAM-tagged TaqMan probe</span>
        <span itemprop="definition">was designed to recognize the HBV 11-12 meganuclease target site, as well as a HEX-tagged TaqMan probe that binds genomic sequence   100 bp downstream of the target site.</span>
        <meta itemprop="num_attr" content="0098">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the probes</span>
        <span itemprop="definition">were multiplexed for genomic DNA amplification.</span>
        <meta itemprop="num_attr" content="0098">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Droplets</span>
        <span itemprop="definition">were gated by fluorescence amplitude to indicate double-positive, double-negative, and single-positive populations. Indels were calculated as the number of HEX-positive droplets divided by the number of double-positive (FAM&#43;/HEX&#43;) droplets.</span>
        <meta itemprop="num_attr" content="0098">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 15</span>
        <span itemprop="definition">Indel frequency in HepG2 HepB cells after electroporation with HBV 11-12 mRNA.</span>
        <meta itemprop="num_attr" content="0099">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HepG2 HepB cells</span>
        <span itemprop="definition">were transfected with two different lots of mRNA (3129 and 3606) encoding HBV 11-12L.363 and one lot of mRNA encoding HBV 11-12x.26.</span>
        <meta itemprop="num_attr" content="0099">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">genomic DNA</span>
        <span itemprop="definition">was isolated from cells for analysis of indel formation by digital PCR.</span>
        <meta itemprop="num_attr" content="0099">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Genomic DNA from mock transfected HepG2 HepB cells</span>
        <span itemprop="definition">was used as a control.</span>
        <meta itemprop="num_attr" content="0099">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Digital PCR</span>
        <span itemprop="definition">was performed using the QX200 droplet digital PCR system.</span>
        <meta itemprop="num_attr" content="0099">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a FAM-tagged TaqMan probe</span>
        <span itemprop="definition">was designed to recognize the HBV 11-12 meganuclease target site, as well as a HEX-tagged TaqMan probe that binds genomic sequence   100 bp downstream of the target site.</span>
        <meta itemprop="num_attr" content="0099">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the probes</span>
        <span itemprop="definition">were multiplexed for genomic DNA amplification.</span>
        <meta itemprop="num_attr" content="0099">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Droplets</span>
        <span itemprop="definition">were gated by fluorescence amplitude to indicate double-positive, double-negative, and single-positive populations. Indels were calculated as the number of HEX-positive droplets divided by the number of double-positive (FAM&#43;/HEX&#43;) droplets.</span>
        <meta itemprop="num_attr" content="0099">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 16</span>
        <span itemprop="definition">In vitro antiviral evaluation of HBV 11-12L.363 in HBV-integrated HepAD38 cells.</span>
        <meta itemprop="num_attr" content="0100">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a HepAD38 cell line which expresses wild-type HBV (subtype ayw)</span>
        <span itemprop="definition">was transfected with mRNA (3 ug) encoding HBV 11-12L.363, HBV 11-12x.26, and mCherry (TriLink) respectively, by using the Lipofectamine MessengerMAX (Thermo Fisher), TranslT-mRNA (Mirus), jetMESSENGER (Polyplus), or lipid nanoparticles (Precision BioSciences), each according to the manufacturer&#39;s instructions.</span>
        <meta itemprop="num_attr" content="0100">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">FIG. 17</span>
        <span itemprop="definition">Detection of indels in HBV 11-12L.363 mRNA-transfected HepAD38 cells.</span>
        <meta itemprop="num_attr" content="0101">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">genomic DNA</span>
        <span itemprop="definition">was isolated from HepAD38 cells for analysis of indel formation by GeneART Genomic Cleavage Detection (GCD) Kit (Thermo Fisher).</span>
        <meta itemprop="num_attr" content="0101">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">GCD</span>
        <span itemprop="definition">GeneART Genomic Cleavage Detection</span>
        <meta itemprop="num_attr" content="0101">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Genomic DNA from mCherry transfected HepAD38 cells</span>
        <span itemprop="definition">were used as a control. Amplification was confirmed by the visualization of a   467 bp band on an agarose gel.</span>
        <meta itemprop="num_attr" content="0101">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">PCR-amplified DNA</span>
        <span itemprop="definition">was analyzed in the cleavage assay and digestion products were visualized on an agarose gel.</span>
        <meta itemprop="num_attr" content="0101">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 1</span>
        <span itemprop="definition">sets forth the amino acid sequence of the wild-type I-CreI meganuclease from Chlamydomonas reinhardtii.</span>
        <meta itemprop="num_attr" content="0102">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 2</span>
        <span itemprop="definition">sets forth the amino acid sequence of the LAGLIDADG motif.</span>
        <meta itemprop="num_attr" content="0103">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 3</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of HBV genotype A.</span>
        <meta itemprop="num_attr" content="0104">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 4</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of HBV genotype B.</span>
        <meta itemprop="num_attr" content="0105">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 5</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of HBV genotype C.</span>
        <meta itemprop="num_attr" content="0106">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 6</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of HBV genotype D.</span>
        <meta itemprop="num_attr" content="0107">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 7</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of HBV genotype E.</span>
        <meta itemprop="num_attr" content="0108">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 8</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of HBV genotype F.</span>
        <meta itemprop="num_attr" content="0109">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 9</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of HBV genotype G.</span>
        <meta itemprop="num_attr" content="0110">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 10</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the sense strand of the HBV 11-12 recognition sequence.</span>
        <meta itemprop="num_attr" content="0111">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 11</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the antisense strand of the HBV 11-12 recognition sequence.</span>
        <meta itemprop="num_attr" content="0112">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 12</span>
        <span itemprop="definition">sets forth the amino acid sequence of the HBV 11-12L.363 meganuclease.</span>
        <meta itemprop="num_attr" content="0113">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 13</span>
        <span itemprop="definition">sets forth the amino acid sequence of the HBV 11-12L.367 meganuclease.</span>
        <meta itemprop="num_attr" content="0114">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 14</span>
        <span itemprop="definition">sets forth the amino acid sequence of the HBV 11-12x.26 meganuclease.</span>
        <meta itemprop="num_attr" content="0115">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 15</span>
        <span itemprop="definition">sets forth the amino acid sequence of the HBV 11-12L.363 meganuclease HBV11-binding subunit.</span>
        <meta itemprop="num_attr" content="0116">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 16</span>
        <span itemprop="definition">sets forth the amino acid sequence of the HBV 11-12L.367 meganuclease HBV11-binding subunit.</span>
        <meta itemprop="num_attr" content="0117">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 17</span>
        <span itemprop="definition">sets forth the amino acid sequence of the HBV 11-12x.26 meganuclease HBV11-binding subunit.</span>
        <meta itemprop="num_attr" content="0118">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 18</span>
        <span itemprop="definition">sets forth the amino acid sequence of the HBV 11-12L.363 meganuclease HBV12-binding subunit.</span>
        <meta itemprop="num_attr" content="0119">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 19</span>
        <span itemprop="definition">sets forth the amino acid sequence of the HBV 11-12L.367 meganuclease HBV12-binding subunit.</span>
        <meta itemprop="num_attr" content="0120">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 20</span>
        <span itemprop="definition">sets forth the amino acid sequence of the HBV 11-12x.26 meganuclease HBV12-binding subunit.</span>
        <meta itemprop="num_attr" content="0121">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 21</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the HBV 5-6 recognition sequence (sense).</span>
        <meta itemprop="num_attr" content="0122">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 22</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the HBV 5-6 recognition sequence (antisense).</span>
        <meta itemprop="num_attr" content="0123">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 23</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the HBV11 Off recognition sequence.</span>
        <meta itemprop="num_attr" content="0124">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 24</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the HBV12 Off recognition sequence.</span>
        <meta itemprop="num_attr" content="0125">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 25</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the P1 PCR primer.</span>
        <meta itemprop="num_attr" content="0126">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 26</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the P2 PCR primer.</span>
        <meta itemprop="num_attr" content="0127">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 27</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the P3 PCR primer.</span>
        <meta itemprop="num_attr" content="0128">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 28</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the P4 PCR primer.</span>
        <meta itemprop="num_attr" content="0129">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 29</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the T1 PCR primer.</span>
        <meta itemprop="num_attr" content="0130">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 30</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the T2 PCR primer.</span>
        <meta itemprop="num_attr" content="0131">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 31</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the AD38-F1012 primer.</span>
        <meta itemprop="num_attr" content="0132">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 32</span>
        <span itemprop="definition">sets forth the nucleic acid sequence of the AD38-R1479 primer.</span>
        <meta itemprop="num_attr" content="0133">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 33</span>
        <span itemprop="definition">sets froth the amino acid sequence of a polypeptide linker.</span>
        <meta itemprop="num_attr" content="0134">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a</span>
        <span itemprop="definition">can mean one or more than one.</span>
        <meta itemprop="num_attr" content="0139">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a cell</span>
        <span itemprop="definition">can mean a single cell or a multiplicity of cells.</span>
        <meta itemprop="num_attr" content="0139">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">nuclease</span>
        <span itemprop="definition">and endonuclease refers to enzymes which cleave a phosphodiester bond within a polynucleotide chain.</span>
        <meta itemprop="num_attr" content="0141">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">cleave</span>
        <span itemprop="definition">or cleavage refer to the endonuclease-mediated hydrolysis of phosphodiester bonds within the backbone of a recognition sequence within a target sequence that results in a double-stranded break within the target sequence, referred to herein as a cleavage site. Depending upon the endonuclease, cleavage can result in double-stranded fragments with blunt ends or fragments with 5 or 3 base overhangs.</span>
        <meta itemprop="num_attr" content="0142">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the term meganuclease</span>
        <span itemprop="definition">refers to an endonuclease that binds double-stranded DNA at a recognition sequence that is greater than 12 base pairs. In some embodiments, the recognition sequence for a meganuclease of the present disclosure is 22 base pairs.</span>
        <meta itemprop="num_attr" content="0143">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a meganuclease</span>
        <span itemprop="definition">can be an endonuclease that is derived from I-CreI, and can refer to an engineered variant of I-CreI that has been modified relative to natural I-CreI with respect to, for example, DNA-binding specificity, DNA cleavage activity, DNA-binding affinity, or dimerization properties. Methods for producing such modified variants of I-CreI are known in the art (e.g.</span>
        <meta itemprop="num_attr" content="0143">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a meganuclease as used herein</span>
        <span itemprop="definition">binds to double-stranded DNA as a heterodimer.</span>
        <meta itemprop="num_attr" content="0143">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a meganuclease</span>
        <span itemprop="definition">may also be a single-chain meganuclease in which a pair of DNA-binding domains is joined into a single polypeptide using a peptide linker.</span>
        <meta itemprop="num_attr" content="0143">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the term homing endonuclease</span>
        <span itemprop="definition">is synonymous with the term meganuclease.</span>
        <meta itemprop="num_attr" content="0143">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Meganucleases of the present disclosure</span>
        <span itemprop="definition">are substantially non-toxic when expressed in the targeted cells as described herein such that cells can be transfected and maintained at 37 C. without observing substantial deleterious effects on overall cell viability or significant reductions in meganuclease cleavage activity when measured using the methods described herein.</span>
        <meta itemprop="num_attr" content="0143">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">single-chain meganuclease</span>
        <span itemprop="definition">refers to a polypeptide comprising a pair of nuclease subunits joined by a linker such that the subunits interact functionally like a heterodimer to cleave a double-stranded recognition site.</span>
        <meta itemprop="num_attr" content="0144">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a single-chain meganuclease</span>
        <span itemprop="definition">has the organization: N-terminal subunit-Linker-C-terminal subunit.</span>
        <meta itemprop="num_attr" content="0144">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the two meganuclease subunits</span>
        <span itemprop="definition">will generally be non-identical in amino acid sequence and will recognize non-identical DNA half-sites within a recognition sequence.</span>
        <meta itemprop="num_attr" content="0144">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">single-chain meganucleases</span>
        <span itemprop="definition">typically cleave pseudo-palindromic or non-palindromic recognition sequences.</span>
        <meta itemprop="num_attr" content="0144">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a single-chain meganuclease</span>
        <span itemprop="definition">may be referred to as a single-chain heterodimer or single-chain heterodimeric meganuclease although it is not, in fact, dimeric.</span>
        <meta itemprop="num_attr" content="0144">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the term meganuclease</span>
        <span itemprop="definition">can refer to a dimeric or single-chain meganuclease.</span>
        <meta itemprop="num_attr" content="0144">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">linker</span>
        <span itemprop="definition">refers to an exogenous peptide sequence used to join two meganuclease subunits into a single polypeptide.</span>
        <meta itemprop="num_attr" content="0145">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a linker</span>
        <span itemprop="definition">may have a sequence that is found in natural proteins, or may be an artificial sequence that is not found in any natural protein.</span>
        <meta itemprop="num_attr" content="0145">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a linker</span>
        <span itemprop="definition">may be flexible and lacking in secondary structure or may have a propensity to form a specific three-dimensional structure under physiological conditions.</span>
        <meta itemprop="num_attr" content="0145">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a linker</span>
        <span itemprop="definition">can include, without limitation, any of those encompassed by U.S. Pat. Nos. 8,445,251, 9,340,777, 9,434,931, and 10,041,053, each of which is incorporated by reference in its entirety.</span>
        <meta itemprop="num_attr" content="0145">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a linker</span>
        <span itemprop="definition">may have at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to SEQ ID NO: 33, which sets forth residues 154-195 of any one of SEQ ID NOs: 12-14.</span>
        <meta itemprop="num_attr" content="0145">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a linker</span>
        <span itemprop="definition">may have an amino acid sequence comprising SEQ ID NO:33, which sets forth residues 154-195 of any one of SEQ ID NOs: 12-14.</span>
        <meta itemprop="num_attr" content="0145">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the term recombinant or engineered</span>
        <span itemprop="definition">means having an altered amino acid sequence as a result of the application of genetic engineering techniques to nucleic acids which encode the protein, and cells or organisms which express the protein.</span>
        <meta itemprop="num_attr" content="0146">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a nucleic acid</span>
        <span itemprop="definition">the term recombinant or engineered means having an altered nucleic acid sequence as a result of the application of genetic engineering techniques. Genetic engineering techniques include, but are not limited to, PCR and DNA cloning technologies; transfection, transformation and other gene transfer technologies; homologous recombination; site-directed mutagenesis; and gene fusion.</span>
        <meta itemprop="num_attr" content="0146">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Genetic engineering techniques</span>
        <span itemprop="definition">include, but are not limited to, PCR and DNA cloning technologies; transfection, transformation and other gene transfer technologies; homologous recombination; site-directed mutagenesis; and gene fusion.</span>
        <meta itemprop="num_attr" content="0146">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a protein having an amino acid sequence identical to a naturally-occurring protein, but produced by cloning and expression in a heterologous host</span>
        <span itemprop="definition">is not considered recombinant.</span>
        <meta itemprop="num_attr" content="0146">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">wild-type</span>
        <span itemprop="definition">refers to the most common naturally occurring allele (i.e., polynucleotide sequence) in the allele population of the same type of gene, wherein a polypeptide encoded by the wild-type allele has its original functions.</span>
        <meta itemprop="num_attr" content="0147">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">wild-type</span>
        <span itemprop="definition">also refers to a polypeptide encoded by a wild-type allele. Wild-type alleles (i.e., polynucleotides) and polypeptides are distinguishable from mutant or variant alleles and polypeptides, which comprise one or more mutations and/or substitutions relative to the wild-type sequence(s).</span>
        <meta itemprop="num_attr" content="0147">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Wild-type nucleases</span>
        <span itemprop="definition">are distinguishable from recombinant or non-naturally-occurring nucleases.</span>
        <meta itemprop="num_attr" content="0147">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">wild-type</span>
        <span itemprop="definition">can also refer to a cell, an organism, and/or a subject which possesses a wild-type allele of a particular gene, or a cell, an organism, and/or a subject used for comparative purposes.</span>
        <meta itemprop="num_attr" content="0147">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the term genetically-modified</span>
        <span itemprop="definition">refers to a cell or organism in which, or in an ancestor of which, a genomic DNA sequence has been deliberately modified by recombinant technology. As used herein, the term genetically-modified encompasses the term transgenic.</span>
        <meta itemprop="num_attr" content="0148">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">modification</span>
        <span itemprop="definition">means any insertion, deletion, or substitution of an amino acid residue in the recombinant sequence relative to a reference sequence (e.g., a wild-type or a native sequence).</span>
        <meta itemprop="num_attr" content="0149">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the terms recognition sequence or recognition site</span>
        <span itemprop="definition">refer to a DNA sequence that is bound and cleaved by an endonuclease.</span>
        <meta itemprop="num_attr" content="0150">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a recognition sequence</span>
        <span itemprop="definition">comprises a pair of inverted, 9 basepair half sites which are separated by four basepairs.</span>
        <meta itemprop="num_attr" content="0150">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the N-terminal domain of the protein</span>
        <span itemprop="definition">contacts a first half-site and the C-terminal domain of the protein contacts a second half-site. Cleavage by a meganuclease produces four basepair 3 overhangs.</span>
        <meta itemprop="num_attr" content="0150">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Overhangs, or sticky ends</span>
        <span itemprop="definition">are short, single-stranded DNA segments that can be produced by endonuclease cleavage of a double-stranded DNA sequence.</span>
        <meta itemprop="num_attr" content="0150">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the overhang</span>
        <span itemprop="definition">comprises bases 10-13 of the 22 basepair recognition sequence.</span>
        <meta itemprop="num_attr" content="0150">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">target site</span>
        <span itemprop="definition">or target sequence refers to a region of the chromosomal DNA of a cell comprising a recognition sequence for a nuclease.</span>
        <meta itemprop="num_attr" content="0151">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">DNA-binding affinity</span>
        <span itemprop="definition">means the tendency of a meganuclease to non-covalently associate with a reference DNA molecule (e.g., a recognition sequence or an arbitrary sequence). Binding affinity is measured by a dissociation constant, Kd.</span>
        <meta itemprop="num_attr" content="0152">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Kd</span>
        <span itemprop="definition">dissociation constant</span>
        <meta itemprop="num_attr" content="0152">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a nuclease</span>
        <span itemprop="definition">has altered binding affinity if the Kd of the nuclease for a reference recognition sequence is increased or decreased by a statistically significant percent change, or biologically significant amount (e.g., at least 2  , or 2   to 10  ), relative to a reference nuclease.</span>
        <meta itemprop="num_attr" content="0152">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the term specificity</span>
        <span itemprop="definition">means the ability of a nuclease to recognize and cleave double-stranded DNA molecules only at a particular sequence of base pairs referred to as the recognition sequence, or only at a particular set of recognition sequences.</span>
        <meta itemprop="num_attr" content="0153">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the set of recognition sequences</span>
        <span itemprop="definition">will share certain conserved positions or sequence motifs, but may be degenerate at one or more positions.</span>
        <meta itemprop="num_attr" content="0153">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a highly-specific nuclease</span>
        <span itemprop="definition">is capable of cleaving only one or a very few recognition sequences. Specificity can be determined by any method known in the art.</span>
        <meta itemprop="num_attr" content="0153">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a meganuclease</span>
        <span itemprop="definition">has altered specificity if it binds to and cleaves a recognition sequence which is not bound to and cleaved by a reference meganuclease (e.g., a wild-type) under physiological conditions, or if the rate of cleavage of a recognition sequence is increased or decreased by a biologically significant amount (e.g., at least 2  , or 2  -10  ) relative to a reference meganuclease.</span>
        <meta itemprop="num_attr" content="0154">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a reference meganuclease</span>
        <span itemprop="definition">e.g., a wild-type</span>
        <meta itemprop="num_attr" content="0154">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the presently disclosed engineered meganucleases</span>
        <span itemprop="definition">have improved (i.e., increased) specificity for the target recognition sequence that comprises SEQ ID NO: 10 (i.e., HBV 11-12) as compared to the HBV 11-12x.26 meganuclease (the amino acid sequence of which is set forth as SEQ ID NO: 14).</span>
        <meta itemprop="num_attr" content="0155">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the presently disclosed engineered meganucleases</span>
        <span itemprop="definition">exhibit reduced off-target cleavage as compared to the HBV 11-12x.26 meganuclease.</span>
        <meta itemprop="num_attr" content="0155">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Off-target cleavage by a meganuclease</span>
        <span itemprop="definition">can be measured using any method known in the art, including for example, oligo capture analysis as described here, a T7 endonuclease (T7E) assay as described herein, digital PCR as described herein, targeted sequencing of particular off-target sites, exome sequencing, whole genome sequencing, direct in situ breaks labeling enrichment on streptavidin and next-generation sequencing (BLESS), genome-wide, unbiased identification of DSBs enabled by sequencing (GUIDE-seq), and linear amplification-mediated high-throughput genome-wide translocation sequencing (LAM-HTGTS) (see, e.g., Zischew ski et al. (2017), Biotechnology Advances 35(1):95-104, which is incorporated by reference in its entirety).</span>
        <meta itemprop="num_attr" content="0155">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">T7E</span>
        <span itemprop="definition">T7 endonuclease</span>
        <meta itemprop="num_attr" content="0155">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">digital PCR</span>
        <span itemprop="definition">digital PCR as described herein</span>
        <meta itemprop="num_attr" content="0155">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">targeted sequencing of particular off-target sites</span>
        <span itemprop="definition">exome sequencing</span>
        <meta itemprop="num_attr" content="0155">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">exome sequencing</span>
        <span itemprop="definition">whole genome sequencing</span>
        <meta itemprop="num_attr" content="0155">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">BLESS</span>
        <span itemprop="definition">next</span>
        <meta itemprop="num_attr" content="0155">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">homologous recombination</span>
        <span itemprop="definition">refers to the natural, cellular process in which a double-stranded DNA-break is repaired using a homologous DNA sequence as the repair template (see, e.g. Cahill et al. (2006), Front. Biosci. 11:1958-1976).</span>
        <meta itemprop="num_attr" content="0156">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the homologous DNA sequence</span>
        <span itemprop="definition">may be an endogenous chromosomal sequence or an exogenous nucleic acid that was delivered to the cell.</span>
        <meta itemprop="num_attr" content="0156">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">non-homologous end-joining</span>
        <span itemprop="definition">refers to the natural, cellular process in which a double-stranded DNA-break is repaired by the direct joining of two non-homologous DNA segments (see, e.g. Cahill et al. (2006), Front. Biosci. 11:1958-1976). DNA repair by non-homologous end-joining is error-prone and frequently results in the untemplated addition or deletion of DNA sequences at the site of repair. In some instances, cleavage at a target recognition sequence results in NHEJ at a target recognition site.</span>
        <meta itemprop="num_attr" content="0157">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Nuclease-induced cleavage of a target site in the coding sequence of a gene followed by DNA repair by NHEJ</span>
        <span itemprop="definition">can introduce mutations into the coding sequence, such as frameshift mutations, that disrupt gene function.</span>
        <meta itemprop="num_attr" content="0157">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">engineered meganucleases</span>
        <span itemprop="definition">can be used to effectively knock-out a gene in a population of cells.</span>
        <meta itemprop="num_attr" content="0157">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">homology arms</span>
        <span itemprop="definition">or sequences homologous to sequences flanking a meganuclease cleavage site refer to sequences flanking the 5 and 3 ends of a nucleic acid molecule which promote insertion of the nucleic acid molecule into a cleavage site generated by a meganuclease.</span>
        <meta itemprop="num_attr" content="0158">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">homology arms</span>
        <span itemprop="definition">can have a length of at least 50 base pairs, preferably at least 100 base pairs, and up to 2000 base pairs or more, and can have at least 90%, preferably at least 95%, or more, sequence homology to their corresponding sequences in the genome.</span>
        <meta itemprop="num_attr" content="0158">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">sequence similarity</span>
        <span itemprop="definition">As used herein with respect to both amino acid sequences and nucleic acid sequences, the terms percent identity, sequence identity, percentage similarity, sequence similarity and the like refer to a measure of the degree of similarity of two sequences based upon an alignment of the sequences which maximizes similarity between aligned amino acid residues or nucleotides, and which is a function of the number of identical or similar residues or nucleotides, the number of total residues or nucleotides, and the presence and length of gaps in the sequence alignment. A variety of algorithms and computer programs are available for determining sequence similarity using standard parameters.</span>
        <meta itemprop="num_attr" content="0159">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">sequence similarity</span>
        <span itemprop="definition">is measured using the BLASTp program for amino acid sequences and the BLASTn program for nucleic acid sequences, both of which are available through the National Center for Biotechnology Information (www.ncbi.nlm.nih.gov/), and are described in, for example, Altschul et al. (1990), J. Mol. Biol. 215:403-410; Gish and States (1993), Nature Genet. 3:266-272; Madden et al. (1996), Meth. Enzymol. 266:131-141; Altschul et al. (1997), Nucleic Acids Res. 25:33 89-3402); Zhang et al. (2000), J. Comput. Biol.</span>
        <meta itemprop="num_attr" content="0159">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the term corresponding to</span>
        <span itemprop="definition">is used to indicate that a specified modification in the first protein is a substitution of the same amino acid residue as in the modification in the second protein, and that the amino acid position of the modification in the first protein corresponds to or aligns with the amino acid position of the modification in the second protein when the two proteins are subjected to standard sequence alignments (e.g., using the BLASTp program).</span>
        <meta itemprop="num_attr" content="0160">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the modification of residue X to amino acid A in the first protein</span>
        <span itemprop="definition">will correspond to the modification of residue Y to amino acid A in the second protein if residues X and Y correspond to each other in a sequence alignment, and despite the fact that X and Y may be different numbers.</span>
        <meta itemprop="num_attr" content="0160">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the term recognition half-site, recognition sequence half-site, or simply half-site</span>
        <span itemprop="definition">means a nucleic acid sequence in a double-stranded DNA molecule which is recognized by a monomer of a homodimeric or heterodimeric meganuclease, or by one subunit of a single-chain meganuclease.</span>
        <meta itemprop="num_attr" content="0161">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">hypervariable region</span>
        <span itemprop="definition">refers to a localized sequence within a meganuclease monomer or subunit that comprises amino acids with relatively high variability.</span>
        <meta itemprop="num_attr" content="0162">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a hypervariable region</span>
        <span itemprop="definition">can comprise about 50-60 contiguous residues, about 53-57 contiguous residues, or preferably about 56 residues.</span>
        <meta itemprop="num_attr" content="0162">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the residues of a hypervariable region</span>
        <span itemprop="definition">may correspond to positions 24-79 or positions 215-270 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0162">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a hypervariable region</span>
        <span itemprop="definition">can comprise one or more residues that contact DNA bases in a recognition sequence and can be modified to alter base preference of the monomer or subunit.</span>
        <meta itemprop="num_attr" content="0162">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a hypervariable region</span>
        <span itemprop="definition">can also comprise one or more residues that bind to the DNA backbone when the meganuclease associates with a double-stranded DNA recognition sequence. Such residues can be modified to alter the binding affinity of the meganuclease for the DNA backbone and the target recognition sequence.</span>
        <meta itemprop="num_attr" content="0162">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a hypervariable region</span>
        <span itemprop="definition">may comprise between 1-20 residues that exhibit variability and can be modified to influence base preference and/or DNA-binding affinity. In particular embodiments, a hypervariable region comprises between about 15-20 residues that exhibit variability and can be modified to influence base preference and/or DNA-binding affinity.</span>
        <meta itemprop="num_attr" content="0162">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">variable residues within a hypervariable region</span>
        <span itemprop="definition">correspond to one or more of positions 24, 26, 28, 30, 32, 33, 38, 40, 42, 44, 46, 68, 70, 75, and 77 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0163">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">variable residues within a hypervariable region</span>
        <span itemprop="definition">correspond to one or more of positions 215, 217, 219, 221, 223, 224, 229, 231, 233, 235, 237, 261, 266, and 268 of SEQ ID NO: 12 or 13. In some embodiments, variable residues within a hypervariable region further correspond to one or more of positions 239, 241, 263, and 264 of SEQ ID NO: 12, or one or more of positions 241, 262, 263, and 264 of SEQ ID NO: 13.</span>
        <meta itemprop="num_attr" content="0164">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">variable residues within a hypervariable region</span>
        <span itemprop="definition">correspond to one or more of positions In other embodiments, variable residues within a hypervariable region correspond to one or more of positions 215, 217, 219, 221, 223, 224, 229, 231, 233, 235, 237, 239, 241, 259, 261, 262, 263, 264, 266, and 268 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0164">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a recombinant construct</span>
        <span itemprop="definition">comprises an artificial combination of nucleic acid fragments, including, without limitation, regulatory and coding sequences that are not found together in nature.</span>
        <meta itemprop="num_attr" content="0165">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a recombinant DNA construct</span>
        <span itemprop="definition">may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source and arranged in a manner different than that found in nature.</span>
        <meta itemprop="num_attr" content="0165">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Such a construct</span>
        <span itemprop="definition">may be used by itself or may be used in conjunction with a vector.</span>
        <meta itemprop="num_attr" content="0165">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a vector or recombinant DNA vector</span>
        <span itemprop="definition">may be a construct that includes a replication system and sequences that are capable of transcription and translation of a polypeptide-encoding sequence in a given host cell. If a vector is used then the choice of vector is dependent upon the method that will be used to transform host cells as is well known to those skilled in the art.</span>
        <meta itemprop="num_attr" content="0166">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Vectors</span>
        <span itemprop="definition">can include, without limitation, plasmid vectors and recombinant viral vectors (e.g., AAV vectors), or any other vector known in that art suitable for delivering a gene encoding a meganuclease of the invention to a target cell.</span>
        <meta itemprop="num_attr" content="0166">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">AAV vectors</span>
        <span itemprop="definition">recombinant viral vectors</span>
        <meta itemprop="num_attr" content="0166">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the skilled artisan</span>
        <span itemprop="definition">is well aware of the genetic elements that must be present on the vector in order to successfully transform, select and propagate host cells comprising any of the isolated nucleotides or nucleic acid sequences of the invention.</span>
        <meta itemprop="num_attr" content="0166">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a vector</span>
        <span itemprop="definition">can also refer to a viral vector.</span>
        <meta itemprop="num_attr" content="0167">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Viral vectors</span>
        <span itemprop="definition">can include, without limitation, retroviral vectors, lentiviral vectors, adenoviral vectors, and adeno-associated viral vectors (AAV).</span>
        <meta itemprop="num_attr" content="0167">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a polycistronic mRNA</span>
        <span itemprop="definition">refers to a single messenger RNA that comprises two or more coding sequences (i.e., cistrons) and encodes more than one protein.</span>
        <meta itemprop="num_attr" content="0168">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a polycistronic mRNA</span>
        <span itemprop="definition">can comprise any element known in the art to allow for the translation of two or more genes from the same mRNA molecule including, but not limited to, an IRES element, a T2A element, a P2A element, an E2A element, and an F2A element.</span>
        <meta itemprop="num_attr" content="0168">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">control</span>
        <span itemprop="definition">refers to a cell that provides a reference point for measuring changes in genotype or phenotype of a genetically-modified cell.</span>
        <meta itemprop="num_attr" content="0169">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a control cell</span>
        <span itemprop="definition">may comprise, for example: (a) a wild-type cell, i.e., of the same genotype as the starting material for the genetic alteration which resulted in the genetically-modified cell; (b) a cell of the same genotype as the genetically-modified cell but which has been transformed with a null construct (i.e., with a construct which has no known effect on the trait of interest); or, (c) a cell genetically identical to the genetically-modified cell but which is not exposed to conditions or stimuli or further genetic modifications that would induce expression of altered genotype or phenotype.</span>
        <meta itemprop="num_attr" content="0169">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">treatment</span>
        <span itemprop="definition">refers to the administration of an engineered meganuclease of the invention, or a nucleic acid encoding an engineered meganuclease of the invention to a subject infected with HBV for the purpose of slowing or stopping the rate of HBV proliferation of the virus by cleaving the genome of at least one HBV particle.</span>
        <meta itemprop="num_attr" content="0170">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Such treatment</span>
        <span itemprop="definition">reduces or prevents transfection and replication of HBV in the subject, and provides either partial or complete relief of one or more symptoms of HBV in the subject.</span>
        <meta itemprop="num_attr" content="0170">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Means to assess alleviation of symptoms of HBV infection</span>
        <span itemprop="definition">may include measurement of liver functions by determining levels of the enzyme alanine aminotransferase (ALT) or by measuring sero conversion, namely disappearance and/or reduction of the circulating HBeAg and/or HBsAg levels. Further, alleviation or reduction of symptoms of HBV can be determined by examining liver biopsies and measuring the level of tissue fibrosis by methods well known in the art. The number of circulating viral particles can be determined for example by measuring HBV DNA levels using PCR or by detecting HBsAg levels in the blood.</span>
        <meta itemprop="num_attr" content="0170">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">ALT</span>
        <span itemprop="definition">enzyme alanine aminotransferase</span>
        <meta itemprop="num_attr" content="0170">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">treatment</span>
        <span itemprop="definition">can further refer to the administration of a cell (e.g., hepatocyte cell) comprising a nucleic acid encoding an engineered meganuclease, wherein the cell is delivered to a target tissue (e.g., liver) and produces the engineered meganuclease in an amount sufficient to treat an HBV infection in the subject, thereby resulting in either partial or complete relief of one or more symptoms of HBV.</span>
        <meta itemprop="num_attr" content="0170">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a cell</span>
        <span itemprop="definition">e.g., hepatocyte cell</span>
        <meta itemprop="num_attr" content="0170">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a target tissue</span>
        <span itemprop="definition">e.g., liver</span>
        <meta itemprop="num_attr" content="0170">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease of the invention, a nucleic acid encoding the same, or a genetically-modified cell or population of genetically-modified cells described herein</span>
        <span itemprop="definition">is administered during treatment in the form of a pharmaceutical composition of the invention.</span>
        <meta itemprop="num_attr" content="0170">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Hepatitis B Virus infection</span>
        <span itemprop="definition">refers to any condition related to or resulting from infection with a Hepatitis B virus, such as chronic liver diseases/disorders, inflammations, fibrotic conditions and proliferative disorders, such as liver cancers.</span>
        <meta itemprop="num_attr" content="0171">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Chronic persistent HBV infection</span>
        <span itemprop="definition">can cause fatigue, liver damage, cirrhosis of the liver, and hepatocellular carcinoma, a primary liver cancer.</span>
        <meta itemprop="num_attr" content="0171">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">proliferating and proliferation</span>
        <span itemprop="definition">refer to HBV viruses or HBV cccDNA actively dividing and/or infecting human cells.</span>
        <meta itemprop="num_attr" content="0172">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">reduction in proliferation</span>
        <span itemprop="definition">refers to any decrease in the proliferation of HBV including reduction of at least 1%, 2%, 3%, 4%, 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% when compared to an appropriate control not having been administered the engineered meganuclease, or nucleic acid encoding the engineered meganuclease, disclosed herein.</span>
        <meta itemprop="num_attr" content="0172">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">proliferative disorder</span>
        <span itemprop="definition">refers to any disease/disorder marked by unwanted or aberrant proliferation of cells or tissue.</span>
        <meta itemprop="num_attr" content="0172">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">proliferative disorder</span>
        <span itemprop="definition">also refers to conditions in which the unregulated and/or abnormal growth of cells can lead to the development of an unwanted condition or disease, which can be cancerous or non-cancerous.</span>
        <meta itemprop="num_attr" content="0172">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an effective amount of the engineered meganuclease or pharmaceutical compositions disclosed herein</span>
        <span itemprop="definition">reduces the level or proliferation of HBV or reduces at least one symptom of HBV in a subject with an HBV infection.</span>
        <meta itemprop="num_attr" content="0173">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">gc/kg</span>
        <span itemprop="definition">or gene copies/kilogram refers to the number of copies of a nucleic acid encoding an engineered meganuclease described herein per weight in kilograms of a subject that is administered the nucleic acid encoding the engineered meganuclease.</span>
        <meta itemprop="num_attr" content="0174">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">lipid nanoparticle</span>
        <span itemprop="definition">refers to a lipid composition having a typically spherical structure with an average diameter between 10 and 1000 nanometers.</span>
        <meta itemprop="num_attr" content="0175">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">lipid nanoparticles</span>
        <span itemprop="definition">can comprise at least one cationic lipid, at least one non-cationic lipid, and at least one conjugated lipid.</span>
        <meta itemprop="num_attr" content="0175">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Lipid nanoparticles known in the art that are suitable for encapsulating nucleic acids, such as mRNA,</span>
        <span itemprop="definition">are contemplated for use in the invention.</span>
        <meta itemprop="num_attr" content="0175">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">variable</span>
        <span itemprop="definition">As used herein, the recitation of a numerical range for a variable is intended to convey that the invention may be practiced with the variable equal to any of the values within that range. Thus, for a variable which is inherently discrete, the variable can be equal to any integer value within the numerical range, including the end-points of the range. Similarly, for a variable which is inherently continuous, the variable can be equal to any real value within the numerical range, including the end-points of the range.</span>
        <meta itemprop="num_attr" content="0176">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a variable which is described as having values between 0 and 2</span>
        <span itemprop="definition">can take the values 0, 1 or 2 if the variable is inherently discrete, and can take the values 0.0, 0.1, 0.01, 0.001, or any other real values   0 and   2 if the variable is inherently continuous.</span>
        <meta itemprop="num_attr" content="0176">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the present invention</span>
        <span itemprop="definition">is based, in part, on the discovery of second-generation HBV 11-12 meganucleases which have improved properties when compared to first-generation HBV 11-12 meganucleases, such as improved (i.e., increased) specificity resulting in reduced off-target cutting, and enhanced (i.e., increased) efficiency of cleavage and indel formation at the HBV 11-12 recognition sequence, particularly in cells comprising an integrated copy of the HBV genome.</span>
        <meta itemprop="num_attr" content="0177">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the optimized, second-generation meganucleases of the invention</span>
        <span itemprop="definition">recognize the HBV 11-12 recognition sequence (SEQ ID NO: 10) in the P gene of the Hepatitis B virus that encodes the viral DNA polymerase.</span>
        <meta itemprop="num_attr" content="0178">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV 11-12 recognition sequence</span>
        <span itemprop="definition">is conserved across at least HBV genotypes A-G (SEQ ID NOs: 3-9), which advantageously allows for the presently disclosed engineered meganucleases to target HBV infections around the globe.</span>
        <meta itemprop="num_attr" content="0178">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Cleavage at the HBV 11-12 recognition sequence</span>
        <span itemprop="definition">can allow for non-homologous end joining (NHEJ) at the cleavage site and can disrupt expression of one or more viral proteins (e.g., viral DNA polymerase) due to NHEJ at the cleavage site that results in insertions, deletions, or frameshift mutations.</span>
        <meta itemprop="num_attr" content="0179">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">NHEJ</span>
        <span itemprop="definition">non-homologous end joining</span>
        <meta itemprop="num_attr" content="0179">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">cleavage of the HBV genome at the HBV 11-12 recognition sequence</span>
        <span itemprop="definition">may promote degradation of the HBV genome and/or HBV cccDNA. Disruption of the expression of the viral protein(s) can reduce or eliminate the infection and/or proliferation of HBV.</span>
        <meta itemprop="num_attr" content="0179">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">cleavage at the HBV 11-12 recognition sequence</span>
        <span itemprop="definition">can further allow for homologous recombination of exogenous nucleic acid sequences directly into the HBV genome to disrupt the expression of one or more viral proteins.</span>
        <meta itemprop="num_attr" content="0180">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a suicide gene</span>
        <span itemprop="definition">can be introduced into a HBV genome via homologous recombination.</span>
        <meta itemprop="num_attr" content="0180">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the present invention</span>
        <span itemprop="definition">encompasses engineered meganucleases which recognize and cleave the HBV 11-12 recognition sequence within a HBV genome.</span>
        <meta itemprop="num_attr" content="0181">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the present invention</span>
        <span itemprop="definition">also encompasses methods of using such engineered meganucleases in a pharmaceutical composition and in methods for treating HBV infection.</span>
        <meta itemprop="num_attr" content="0181">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">encompasses pharmaceutical compositions comprising engineered meganuclease proteins, or nucleic acids encoding engineered meganucleases, and the use of such compositions for the treatment of HBV infection and hepatocellular carcinoma (HCC).</span>
        <meta itemprop="num_attr" content="0181">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HCC</span>
        <span itemprop="definition">hepatocellular carcinoma</span>
        <meta itemprop="num_attr" content="0181">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">can be practiced using engineered meganucleases.</span>
        <meta itemprop="num_attr" content="0182">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the nucleases used to practice the invention</span>
        <span itemprop="definition">are single-chain meganucleases.</span>
        <meta itemprop="num_attr" content="0183">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a single-chain meganuclease</span>
        <span itemprop="definition">comprises an N-terminal subunit and a C-terminal subunit joined by a linker peptide.</span>
        <meta itemprop="num_attr" content="0183">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Each of the two domains</span>
        <span itemprop="definition">recognizes half of the recognition sequence (i.e., a recognition half-site) and the site of DNA cleavage is at the middle of the recognition sequence near the interface of the two subunits.</span>
        <meta itemprop="num_attr" content="0183">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">DNA strand breaks</span>
        <span itemprop="definition">are offset by four base pairs such that DNA cleavage by a meganuclease generates a pair of four base pair, 3 single-strand overhangs.</span>
        <meta itemprop="num_attr" content="0183">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the engineered meganucleases of the invention</span>
        <span itemprop="definition">have been engineered to recognize and cleave the HBV 11-12 recognition sequence (SEQ ID NO: 10).</span>
        <meta itemprop="num_attr" content="0184">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV 11-12 recognition sequence</span>
        <span itemprop="definition">is positioned within the P protein ORF of multiple HBV genotypes.</span>
        <meta itemprop="num_attr" content="0184">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV 11-12 recognition sequence</span>
        <span itemprop="definition">can at least be found in the genome of multiple HBV genotypes, including genotypes A, B, C, D, E, F, and G (e.g., SEQ ID NOs: 3-9, respectively).</span>
        <meta itemprop="num_attr" content="0184">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Engineered meganucleases of the invention</span>
        <span itemprop="definition">comprise a first subunit, comprising a first hypervariable (HVR1) region, and a second subunit, comprising a second hypervariable (HVR2) region. Further, the first subunit binds to a first recognition half-site in the recognition sequence (i.e., the HBV11 half-site), and the second subunit binds to a second recognition half-site in the recognition sequence (i.e., the HBV12 half-site).</span>
        <meta itemprop="num_attr" content="0185">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first and second subunits</span>
        <span itemprop="definition">can be oriented such that the first subunit, which comprises the HVR1 region and binds the first half-site, is positioned as the N-terminal subunit, and the second subunit, which comprises the HVR2 region and binds the second half-site, is positioned as the C-terminal subunit.</span>
        <meta itemprop="num_attr" content="0185">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first and second subunits</span>
        <span itemprop="definition">can be oriented such that the first subunit, which comprises the HVR1 region and binds the first half-site, is positioned as the C-terminal subunit, and the second subunit, which comprises the HVR2 region and binds the second half-site, is positioned as the N-terminal subunit.</span>
        <meta itemprop="num_attr" content="0185">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Exemplary engineered meganucleases that recognize and cleave the HBV 11-12 recognition sequence</span>
        <span itemprop="definition">are provided in Table 1.</span>
        <meta itemprop="num_attr" content="0185">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the presently disclosed engineered meganucleases</span>
        <span itemprop="definition">exhibit at least one optimized characteristic in comparison to the first-generation meganuclease HBV 11-12x.26.</span>
        <meta itemprop="num_attr" content="0186">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">optimized characteristics</span>
        <span itemprop="definition">include improved (i.e. increased) specificity resulting in reduced off-target cutting, and enhanced (i.e., increased) efficiency of cleavage and indel (i.e., insertion or deletion) formation at the HBV 11-12 recognition sequence, particularly in cells comprising an integrated copy of the HBV genome.</span>
        <meta itemprop="num_attr" content="0186">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the presently disclosed engineered meganucleases</span>
        <span itemprop="definition">when delivered to a population of HBV-infected target cells, is able to generate a greater percentage of virions or cells with a cleavage and/or indel in the HBV genome (either incorporated or unincorporated).</span>
        <meta itemprop="num_attr" content="0186">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the population of HBV or target cells</span>
        <span itemprop="definition">comprises at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more of HBV or target cells comprising a cleavage and/or indel in the HBV genome (either incorporated or unincorporated).</span>
        <meta itemprop="num_attr" content="0186">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Cleavage and/or indel formation by a meganuclease</span>
        <span itemprop="definition">can be measured using any method known in the art, including T7E assay, digital PCR, mismatch detection assays, mismatch cleavage assay, high-resolution melting analysis (HRMA), heteroduplex mobility assay, sequencing, and fluorescent PCR capillary gel electrophoresis (see, e.g., Zischewski et al. (2017) Biotechnology Advances 35(1):95-104, which is incorporated by reference in its entirety).</span>
        <meta itemprop="num_attr" content="0186">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein</span>
        <span itemprop="definition">can be delivered to and/or expressed from DNA/RNA in target cells that can provide the engineered meganuclease to the HBV genome.</span>
        <meta itemprop="num_attr" content="0187">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Engineered meganucleases disclosed herein</span>
        <span itemprop="definition">can be delivered into a cell in the form of protein or, preferably, as a nucleic acid encoding the engineered meganuclease.</span>
        <meta itemprop="num_attr" content="0188">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">nucleic acid</span>
        <span itemprop="definition">can be DNA (e.g., circular or linearized plasmid DNA or PCR products) or RNA (e.g., mRNA).</span>
        <meta itemprop="num_attr" content="0188">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">RNA</span>
        <span itemprop="definition">e.g., mRNA</span>
        <meta itemprop="num_attr" content="0188">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the engineered meganuclease coding sequence</span>
        <span itemprop="definition">is delivered in DNA form, it should be operably linked to a promoter to facilitate transcription of the nuclease gene.</span>
        <meta itemprop="num_attr" content="0188">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Mammalian promoters suitable for the invention</span>
        <span itemprop="definition">include constitutive promoters such as the cytomegalovirus early (CMV) promoter (Thomsen et al.</span>
        <meta itemprop="num_attr" content="0188">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">CMV</span>
        <span itemprop="definition">cytomegalovirus early</span>
        <meta itemprop="num_attr" content="0188">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">An engineered meganuclease of the invention</span>
        <span itemprop="definition">can also be operably linked to a synthetic promoter.</span>
        <meta itemprop="num_attr" content="0188">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Synthetic promoters</span>
        <span itemprop="definition">can include, without limitation, the JeT promoter (WO 2002/012514).</span>
        <meta itemprop="num_attr" content="0188">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a nucleic acid sequence encoding an engineered meganuclease as disclosed herein</span>
        <span itemprop="definition">can be operably linked to a liver-specific promoter.</span>
        <meta itemprop="num_attr" content="0188">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">liver-specific promoters</span>
        <span itemprop="definition">include, without limitation, human alpha-1 antitrypsin promoter, hybrid liver-specific promoter (hepatic locus control region from ApoE gene (ApoE-HCR) and a liver-specific alpha1-antitrypsin promoter), human thyroxine binding globulin (TBG) promoter, and apolipoprotein A-II promoter.</span>
        <meta itemprop="num_attr" content="0188">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a nucleic acid sequence encoding at least one engineered meganuclease</span>
        <span itemprop="definition">is delivered on a recombinant DNA construct or expression cassette.</span>
        <meta itemprop="num_attr" content="0189">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the recombinant DNA construct</span>
        <span itemprop="definition">can comprise an expression cassette (i.e., cassette) comprising a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein.</span>
        <meta itemprop="num_attr" content="0189">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the recombinant DNA construct</span>
        <span itemprop="definition">comprises at least a first cassette and a second cassette, wherein the first cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein, and wherein the second cassette comprises a promoter and a nucleic acid sequence encoding a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0189">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Non-limiting examples of other recognition sequences within the genome of a Hepatitis B virus</span>
        <span itemprop="definition">include the HBV 5-6 recognition sequence (set forth as SEQ ID NO: 21).</span>
        <meta itemprop="num_attr" content="0189">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the recombinant DNA construct</span>
        <span itemprop="definition">comprises a cassette comprising a promoter and a polycistronic nucleic acid sequence, wherein the promoter drives expression of the polycistronic nucleic acid sequence to generate a polycistronic mRNA described herein in a target cell.</span>
        <meta itemprop="num_attr" content="0190">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">mRNA encoding an engineered meganuclease</span>
        <span itemprop="definition">is delivered to a cell because this reduces the likelihood that the gene encoding the engineered meganuclease will integrate into the genome of the cell.</span>
        <meta itemprop="num_attr" content="0191">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Such mRNA encoding an engineered meganuclease</span>
        <span itemprop="definition">can be produced using methods known in the art such as in vitro transcription.</span>
        <meta itemprop="num_attr" content="0191">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the mRNA</span>
        <span itemprop="definition">is 5 capped using 7-methyl-guanosine, anti-reverse cap analogs (ARCA) (U.S. Pat. No. 7,074,596), CleanCap analogs such as Cap 1 analogs (Trilink, San Diego, Calif.), or enzymatically capped using vaccinia capping enzyme or similar.</span>
        <meta itemprop="num_attr" content="0191">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the mRNA</span>
        <span itemprop="definition">may be polyadenylated.</span>
        <meta itemprop="num_attr" content="0191">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the mRNA</span>
        <span itemprop="definition">may contain various 5 and 3 untranslated sequence elements to enhance expression the encoded engineered meganuclease and/or stability of the mRNA itself.</span>
        <meta itemprop="num_attr" content="0191">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Such elements</span>
        <span itemprop="definition">can include, for example, posttranslational regulatory elements such as a woodchuck hepatitis virus posttranslational regulatory element.</span>
        <meta itemprop="num_attr" content="0191">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the mRNA</span>
        <span itemprop="definition">may contain nucleoside analogs or naturally-occurring nucleosides, such as pseudouridine, 5-methylcytidine, N6-methyladenosine, 5-methyluridine, or 2-thiouridine. Additional nucleoside analogs include, for example, those described in U.S. Pat. No. 8,278,036.</span>
        <meta itemprop="num_attr" content="0191">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an mRNA encoding an engineered nuclease of the invention</span>
        <span itemprop="definition">can be a polycistronic mRNA encoding two or more of the presently disclosed meganucleases which are simultaneously expressed in a cell.</span>
        <meta itemprop="num_attr" content="0192">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a polycistronic mRNA</span>
        <span itemprop="definition">can encode at least a first and a second engineered meganuclease, wherein the first engineered meganuclease is an engineered meganuclease described herein, and wherein the second engineered meganuclease recognizes and cleaves a second recognition sequence in the HBV genome that differs from SEQ ID NO: 10 (e.g., the HBV 5-6 recognition sequence), such that the HBV genome is cleaved at multiple sites.</span>
        <meta itemprop="num_attr" content="0192">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">SEQ ID NO: 10</span>
        <span itemprop="definition">e.g., the HBV 5-6 recognition sequence</span>
        <meta itemprop="num_attr" content="0192">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a polycistronic mRNA</span>
        <span itemprop="definition">can encode an engineered meganuclease described herein and at least one additional protein which induces a therapeutically beneficial effect in the cell.</span>
        <meta itemprop="num_attr" content="0192">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a polycistronic mRNA of the invention</span>
        <span itemprop="definition">can comprise any element known in the art to allow for the translation of two or more genes from the same mRNA molecule including, but not limited to, an IRES element, a T2A element, a P2A element, an E2A element, and an F2A element.</span>
        <meta itemprop="num_attr" content="0192">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a nucleic acid encoding an endonuclease of the invention</span>
        <span itemprop="definition">can be introduced into the cell using a single-stranded DNA template.</span>
        <meta itemprop="num_attr" content="0193">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the single-stranded DNA</span>
        <span itemprop="definition">can further comprise a 5 and/or a 3 AAV inverted terminal repeat (ITR) upstream and/or downstream of the sequence encoding the engineered meganuclease.</span>
        <meta itemprop="num_attr" content="0193">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">ITR</span>
        <span itemprop="definition">inverted terminal repeat</span>
        <meta itemprop="num_attr" content="0193">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the single-stranded DNA</span>
        <span itemprop="definition">can further comprise a 5 and/or a 3 homology arm upstream and/or downstream of the sequence encoding the engineered meganuclease.</span>
        <meta itemprop="num_attr" content="0193">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">genes encoding an endonuclease of the invention</span>
        <span itemprop="definition">can be introduced into a cell using a linearized DNA template.</span>
        <meta itemprop="num_attr" content="0194">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a plasmid DNA encoding an endonuclease</span>
        <span itemprop="definition">can be digested by one or more restriction enzymes such that the circular plasmid DNA is linearized prior to being introduced into a cell.</span>
        <meta itemprop="num_attr" content="0194">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the methods</span>
        <span itemprop="definition">comprise delivering an engineered meganuclease described herein (or a nucleic acid encoding the same) and a nucleic acid comprising a polynucleotide sequence encoding a suicide gene and sequences homologous to sequences flanking the meganuclease cleavage site, wherein the engineered meganuclease recognizes and cleaves a recognition sequence comprising SEQ ID NO: 10 within the Hepatitis B virus genome, thus cleaving the HBV genome, wherein the suicide gene is inserted into the cleaved HBV genome by homologous recombination.</span>
        <meta itemprop="num_attr" content="0195">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a suicide gene</span>
        <span itemprop="definition">is a nucleic acid that encodes a product that causes cell death by itself or in the presence of other compounds.</span>
        <meta itemprop="num_attr" content="0196">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a representative example of such a suicide gene</span>
        <span itemprop="definition">is one that encodes thymidine kinase of herpes simplex virus. Additional examples are genes that encode thymidine kinase of varicella zoster virus and the bacterial gene cytosine deaminase that can convert 5-fluorocytosine to the highly toxic compound 5-fluorouracil.</span>
        <meta itemprop="num_attr" content="0196">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Suicide genes</span>
        <span itemprop="definition">also include as non-limiting examples genes that encode caspase-9, caspase-8, or cytosine deaminase. In some examples, caspase-9 can be activated using a specific chemical inducer of dimerization (CID).</span>
        <meta itemprop="num_attr" content="0196">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the suicide gene</span>
        <span itemprop="definition">is directly lethal to the HBV or a target cell (e.g., HCC cell).</span>
        <meta itemprop="num_attr" content="0196">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the directly lethal suicide gene</span>
        <span itemprop="definition">encodes a toxic polypeptide or a pro-apoptotic protein.</span>
        <meta itemprop="num_attr" content="0196">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the suicide gene</span>
        <span itemprop="definition">is indirectly lethal to the target cell, and directs the subject&#39;s own immune system to kill the target cell.</span>
        <meta itemprop="num_attr" content="0196">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the indirectly lethal suicide gene</span>
        <span itemprop="definition">encodes a cell surface protein which is recognized as foreign by the subject&#39;s immune system and is targeted by a humoral or cellular immune response.</span>
        <meta itemprop="num_attr" content="0196">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the indirectly lethal suicide gene</span>
        <span itemprop="definition">encodes a polypeptide which is presented by an MHC Class I molecule, is recognized as foreign by the subject&#39;s immune system, and is targeted by a cytotoxic immune response.</span>
        <meta itemprop="num_attr" content="0196">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Purified meganuclease proteins</span>
        <span itemprop="definition">can be delivered into cells to cleave genomic DNA by a variety of different mechanisms known in the art, including those further detailed herein below.</span>
        <meta itemprop="num_attr" content="0197">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the target tissue(s) for delivery of engineered meganucleases of the invention</span>
        <span itemprop="definition">include, without limitation, cells of the liver, such as a hepatocyte cell or preferably a primary hepatocyte, more preferably a human hepatocyte or a human primary hepatocyte, a HepG2.2.15 or a HepG2-hNTCP cell.</span>
        <meta itemprop="num_attr" content="0198">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganucleases of the invention</span>
        <span itemprop="definition">can be delivered as purified protein or as RNA or DNA encoding the meganuclease.</span>
        <meta itemprop="num_attr" content="0198">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease proteins, or mRNA, or DNA vectors encoding meganucleases</span>
        <span itemprop="definition">are supplied to target cells (e.g., cells in the liver) via injection directly to the target tissue.</span>
        <meta itemprop="num_attr" content="0198">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease protein, mRNA, DNA, or cells expressing meganucleases</span>
        <span itemprop="definition">can be delivered systemically via the circulatory system.</span>
        <meta itemprop="num_attr" content="0198">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease proteins, DNA/mRNA encoding meganucleases, or cells expressing meganuclease proteins</span>
        <span itemprop="definition">are formulated for systemic administration, or administration to target tissues, in a pharmaceutically acceptable carrier in accordance with known techniques. See, e.g., Remington, The Science And Practice of Pharmacy (21st ed., Philadelphia, Lippincott, Williams &amp; Wilkins, 2005).</span>
        <meta itemprop="num_attr" content="0199">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">proteins/RNA/mRNA/cells</span>
        <span itemprop="definition">are typically admixed with a pharmaceutically acceptable carrier.</span>
        <meta itemprop="num_attr" content="0199">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the carrier</span>
        <span itemprop="definition">must, of course, be acceptable in the sense of being compatible with any other ingredients in the formulation and must not be deleterious to the patient.</span>
        <meta itemprop="num_attr" content="0199">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the carrier</span>
        <span itemprop="definition">can be a solid or a liquid, or both, and can be formulated with the compound as a unit-dose formulation.</span>
        <meta itemprop="num_attr" content="0199">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">about 1  10 10 gc/kg to about 1  10 14 gc/kg</span>
        <span itemprop="definition">e.g., 1  10 10 gc/kg, 1  10 11 gc/kg, 1  10 12 gc/kg, 1  10 13 gc/kg, or 1  10 14 gc/kg</span>
        <meta itemprop="num_attr" content="0200">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a nucleic acid encoding the engineered meganuclease</span>
        <span itemprop="definition">is administered to the subject.</span>
        <meta itemprop="num_attr" content="0200">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">At least about 1  10 10 gc/kg, at least about 1  10 11 gc/kg, at least about 1  10 12 gc/kg, at least about 1  10 13 gc/kg, or at least about 1  10 14 gc/kg of a nucleic acid encoding the engineered meganuclease</span>
        <span itemprop="definition">is administered to the subject.</span>
        <meta itemprop="num_attr" content="0200">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">about 1  10 10 gc/kg to about 1  10 11 gc/kg, about 1  10 11 gc/kg to about 1  10 12 gc/kg, about 1  10 12 gc/kg to about 1  10 13 gc/kg, or about 1  10 13 gc/kg to about 1  10 14 gc/kg of a nucleic acid encoding the engineered meganuclease</span>
        <span itemprop="definition">is administered to the subject.</span>
        <meta itemprop="num_attr" content="0200">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the subject</span>
        <span itemprop="definition">is administered a lipid nanoparticle formulation with about 0.1 mg/kg to about 3 mg/kg of mRNA encoding an engineered meganuclease. In some embodiments, the subject is administered a lipid nanoparticle formulation with at least about 0.1 mg/kg, at least about 0.25 mg/kg, at least about 0.5 mg/kg, at least about 0.75 mg/kg, at least about 1.0 mg/kg, at least about 1.5 mg/kg, at least about 2.0 mg/kg, at least about 2.5 mg/kg, or at least about 3.0 mg/kg of mRNA encoding an engineered meganuclease.</span>
        <meta itemprop="num_attr" content="0201">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the subject</span>
        <span itemprop="definition">is administered a lipid nanoparticle formulation within about 0.1 mg/kg to about 0.25 mg/kg, about 0.25 mg/kg to about 0.5 mg/kg, about 0.5 mg/kg to about 0.75 mg/kg, about 0.75 mg/kg to about 1.0 mg/kg, about 1.0 mg/kg to about 1.5 mg/kg, about 1.5 mg/kg to about 2.0 mg/kg, about 2.0 mg/kg to about 2.5 mg/kg, or about 2.5 mg/kg to about 3.0 mg/kg of mRNA encoding and engineered meganuclease.</span>
        <meta itemprop="num_attr" content="0201">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease proteins</span>
        <span itemprop="definition">are coupled to a cell penetrating peptide or targeting ligand to facilitate cellular uptake.</span>
        <meta itemprop="num_attr" content="0202">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">cell penetrating peptides</span>
        <span itemprop="definition">known in the art include poly-arginine (Jearawiriyapaisarn, et al. (2008) Mol Ther. 16:1624-9), TAT peptide from the HIV virus (Hudecz et al. (2005), Med. Res. Rev. 25: 679-736), MPG (Simeoni, et al. (2003) Nucleic Acids Res. 31:2717-2724), Pep-1 (Deshayes et al.</span>
        <meta itemprop="num_attr" content="0202">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease proteins</span>
        <span itemprop="definition">are coupled covalently or non-covalently to an antibody that recognizes a specific cell-surface receptor expressed on target cells such that the meganuclease protein/DNA/mRNA binds to and is internalized by the target cells.</span>
        <meta itemprop="num_attr" content="0202">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease protein/DNA/mRNA</span>
        <span itemprop="definition">can be coupled covalently or non-covalently to the natural ligand (or a portion of the natural ligand) for such a cell-surface receptor.</span>
        <meta itemprop="num_attr" content="0202">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease proteins</span>
        <span itemprop="definition">are encapsulated within biodegradable hydrogels for injection or implantation within the desired region of the liver (e.g., in proximity to hepatic sinusoidal endothelial cells or hematopoietic endothelial cells, or progenitor cells which differentiate into the same).</span>
        <meta itemprop="num_attr" content="0203">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Hydrogels</span>
        <span itemprop="definition">can provide sustained and tunable release of the therapeutic payload to the desired region of the target tissue without the need for frequent injections, and stimuli-responsive materials (e.g., temperature- and pH-responsive hydrogels) can be designed to release the payload in response to environmental or externally applied cues (Kang Derwent et al. (2008) Trans Am Ophthalmol Soc. 106:206-214).</span>
        <meta itemprop="num_attr" content="0203">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease proteins, or DNA/mRNA encoding meganucleases</span>
        <span itemprop="definition">are coupled covalently or, preferably, non-covalently to a nanoparticle or encapsulated within such a nanoparticle using methods known in the art (Sharma, et al. (2014) Biomed Res Int. 2014).</span>
        <meta itemprop="num_attr" content="0204">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a nanoparticle</span>
        <span itemprop="definition">is a nanoscale delivery system whose length scale is   1   m, preferably   100 nm.</span>
        <meta itemprop="num_attr" content="0204">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Such nanoparticles</span>
        <span itemprop="definition">may be designed using a core composed of metal, lipid, polymer, or biological macromolecule, and multiple copies of the meganuclease proteins, mRNA, or DNA can be attached to or encapsulated with the nanoparticle core.</span>
        <meta itemprop="num_attr" content="0204">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Nanoparticles</span>
        <span itemprop="definition">may be further modified with polymers or lipids (e.g., chitosan, cationic polymers, or cationic lipids) to form a core-shell nanoparticle whose surface confers additional functionalities to enhance cellular delivery and uptake of the payload (Jian et al. (2012) Biomaterials. 33(30): 7621-30).</span>
        <meta itemprop="num_attr" content="0204">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Nanoparticles</span>
        <span itemprop="definition">may additionally be advantageously coupled to targeting molecules to direct the nanoparticle to the appropriate cell type and/or increase the likelihood of cellular uptake. Examples of such targeting molecules include antibodies specific for cell-surface receptors and the natural ligands (or portions of the natural ligands) for cell surface receptors.</span>
        <meta itemprop="num_attr" content="0204">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the meganuclease proteins or DNA/mRNA encoding the meganucleases</span>
        <span itemprop="definition">are encapsulated within liposomes or complexed using cationic lipids (see, e.g., LIPOFECTAMINE transfection reagent, Life Technologies Corp., Carlsbad, Calif.; Zuris et al. (2015) Nat Biotechnol. 33: 73-80; Mishra et al. (2011) J Drug Deliv. 2011:863734).</span>
        <meta itemprop="num_attr" content="0205">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the liposome and lipoplex formulations</span>
        <span itemprop="definition">can protect the payload from degradation, enhance accumulation and retention at the target site, and facilitate cellular uptake and delivery efficiency through fusion with and/or disruption of the cellular membranes of the target cells.</span>
        <meta itemprop="num_attr" content="0205">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease proteins</span>
        <span itemprop="definition">are encapsulated within polymeric scaffolds (e.g., PLGA) or complexed using cationic polymers (e.g., PEI, PLL) (Tamboli et al. (2011) Ther Deliv. 2(4): 523-536).</span>
        <meta itemprop="num_attr" content="0206">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Polymeric carriers</span>
        <span itemprop="definition">can be designed to provide tunable drug release rates through control of polymer erosion and drug diffusion, and high drug encapsulation efficiencies can offer protection of the therapeutic payload until intracellular delivery to the desired target cell population.</span>
        <meta itemprop="num_attr" content="0206">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease proteins</span>
        <span itemprop="definition">are combined with amphiphilic molecules that self-assemble into micelles (Tong et al. (2007) J Gene Med. 9(11): 956-66).</span>
        <meta itemprop="num_attr" content="0207">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Polymeric micelles</span>
        <span itemprop="definition">may include a micellar shell formed with a hydrophilic polymer (e.g., polyethyleneglycol) that can prevent aggregation, mask charge interactions, and reduce nonspecific interactions.</span>
        <meta itemprop="num_attr" content="0207">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a hydrophilic polymer</span>
        <span itemprop="definition">e.g., polyethyleneglycol</span>
        <meta itemprop="num_attr" content="0207">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease proteins</span>
        <span itemprop="definition">or DNA/mRNA encoding meganucleases, are formulated into an emulsion or a nanoemulsion (i.e., having an average particle diameter of   1 nm) for administration and/or delivery to the target cell.</span>
        <meta itemprop="num_attr" content="0208">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">emulsion</span>
        <span itemprop="definition">refers to, without limitation, any oil-in-water, water-in-oil, water-in-oil-in-water, or oil-in-water-in-oil dispersions or droplets, including lipid structures that can form as a result of hydrophobic forces that drive apolar residues (e.g., long hydrocarbon chains) away from water and polar head groups toward water, when a water immiscible phase is mixed with an aqueous phase.</span>
        <meta itemprop="num_attr" content="0208">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">lipid structures</span>
        <span itemprop="definition">include, but are not limited to, unilamellar, paucilamellar, and multilamellar lipid vesicles, micelles, and lamellar phases.</span>
        <meta itemprop="num_attr" content="0208">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Emulsions</span>
        <span itemprop="definition">are composed of an aqueous phase and a lipophilic phase (typically containing an oil and an organic solvent). Emulsions also frequently contain one or more surfactants. Nanoemulsion formulations are well known, e.g., as described in U.S. Pat. Nos. 6,015,832, 6,506,803, 6,635,676, 6,559,189, and 7,767,216, each of which is incorporated herein by reference in its entirety.</span>
        <meta itemprop="num_attr" content="0208">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease proteins</span>
        <span itemprop="definition">are covalently attached to, or non-covalently associated with, multifunctional polymer conjugates, DNA dendrimers, and polymeric dendrimers (Mastorakos et al. (2015) Nanoscale. 7(9): 3845-56; Cheng et al. (2008) J Pharm Sci. 97(1): 123-43).</span>
        <meta itemprop="num_attr" content="0209">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the dendrimer generation</span>
        <span itemprop="definition">can control the payload capacity and size, and can provide a high drug payload capacity.</span>
        <meta itemprop="num_attr" content="0209">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">display of multiple surface groups</span>
        <span itemprop="definition">can be leveraged to improve stability, reduce nonspecific interactions, and enhance cell-specific targeting and drug release.</span>
        <meta itemprop="num_attr" content="0209">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">genes encoding a meganuclease</span>
        <span itemprop="definition">are delivered using a viral vector.</span>
        <meta itemprop="num_attr" content="0210">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">viral vectors</span>
        <span itemprop="definition">are known in the art and include retroviral vectors, lentiviral vectors, adenoviral vectors, and adeno-associated virus (AAV) vectors (reviewed in Vannucci, et al. (2013 New Microbiol. 36:1-22).</span>
        <meta itemprop="num_attr" content="0210">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vectors</span>
        <span itemprop="definition">are injected directly into target tissues (e.g., liver tissue).</span>
        <meta itemprop="num_attr" content="0210">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vectors</span>
        <span itemprop="definition">are delivered systemically via the circulatory system. It is known in the art that different AAV vectors tend to localize to different tissues.</span>
        <meta itemprop="num_attr" content="0210">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">AAV vectors</span>
        <span itemprop="definition">can also be self-complementary such that they do not require second-strand DNA synthesis in the host cell (McCarty, et al. (2001) Gene Ther. 8:1248-54).</span>
        <meta itemprop="num_attr" content="0210">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the meganuclease genes</span>
        <span itemprop="definition">are delivered in DNA form (e.g. plasmid) and/or via a viral vector (e.g. AAV) they must be operably linked to a promoter.</span>
        <meta itemprop="num_attr" content="0211">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a viral promoter</span>
        <span itemprop="definition">such as endogenous promoters from the viral vector (e.g. the LTR of a lentiviral vector) or the well-known cytomegalovirus- or SV40 virus-early promoters.</span>
        <meta itemprop="num_attr" content="0211">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease genes</span>
        <span itemprop="definition">are operably linked to a promoter that drives gene expression preferentially in the target cells.</span>
        <meta itemprop="num_attr" content="0211">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">liver-specific promoters</span>
        <span itemprop="definition">include, without limitation, human alpha-1 antitrypsin promoter, hybrid liver-specific promoter (hepatic locus control region from ApoE gene (ApoE-HCR) and a liver-specific alpha1-antitrypsin promoter), human thyroxine binding globulin (TBG) promoter, and apolipoprotein A-II promoter.</span>
        <meta itemprop="num_attr" content="0211">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">comprises a cassette comprising a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein.</span>
        <meta itemprop="num_attr" content="0212">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">could also comprise two or more cassettes, wherein at least a first cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein, and wherein at least a second cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease that has specificity for a different HBV recognition sequence other than the HBV 11-12 recognition sequence.</span>
        <meta itemprop="num_attr" content="0212">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vector</span>
        <span itemprop="definition">comprises one cassette comprising a promoter and a polycistronic nucleic acid sequence, wherein the promoter drives expression of the polycistronic nucleic acid sequence to generate a polycistronic mRNA, such as polycistronic mRNA encoding an engineered meganuclease, described herein in a target cell.</span>
        <meta itemprop="num_attr" content="0212">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">native hepatocytes which have been removed from the mammal</span>
        <span itemprop="definition">can be transduced with a vector which encodes the engineered meganuclease.</span>
        <meta itemprop="num_attr" content="0213">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">native hepatocytes of the HBV-infected subject</span>
        <span itemprop="definition">can be transduced ex vivo with an adenoviral vector (i.e., an AAV vector) which encodes the engineered meganuclease and/or a molecule that stimulates liver regeneration, such as a hepatotoxin.</span>
        <meta itemprop="num_attr" content="0213">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an adenoviral vector</span>
        <span itemprop="definition">i.e., an AAV vector</span>
        <meta itemprop="num_attr" content="0213">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the hepatotoxin</span>
        <span itemprop="definition">is uPA, and has been modified to inhibit its secretion from the hepatocyte once expressed by the viral vector.</span>
        <meta itemprop="num_attr" content="0213">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the vector</span>
        <span itemprop="definition">encodes tPA, which can stimulate hepatocyte regeneration de novo.</span>
        <meta itemprop="num_attr" content="0213">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the transduced hepatocytes which have been removed from the mammal</span>
        <span itemprop="definition">can then be returned to the mammal, where conditions are provided which are conducive to expression of the engineered meganuclease.</span>
        <meta itemprop="num_attr" content="0213">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the transduced hepatocytes</span>
        <span itemprop="definition">can be returned to the patient by infusion through the spleen or portal vasculature, and administration may be single or multiple over a period of 1 to 5 or more days.</span>
        <meta itemprop="num_attr" content="0213">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a retroviral, pseudotype or adenoviral associated vector</span>
        <span itemprop="definition">i.e., an AAV vector</span>
        <meta itemprop="num_attr" content="0214">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">AAV vector</span>
        <span itemprop="definition">a retroviral, pseudotype or adenoviral associated vector</span>
        <meta itemprop="num_attr" content="0214">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Administration of a vector encoding the engineered meganuclease</span>
        <span itemprop="definition">can occur with administration of an adenoviral vector that encodes a secretion-impaired hepatotoxin, or encodes tPA, which stimulates hepatocyte regeneration without acting as a hepatotoxin.</span>
        <meta itemprop="num_attr" content="0214">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Appropriate doses</span>
        <span itemprop="definition">will depend, among other factors, on the specifics of any AAV vector chosen (e.g., serotype, etc.), on the route of administration, on the subject being treated (i.e., age, weight, sex, and general condition of the subject), and the mode of administration.</span>
        <meta itemprop="num_attr" content="0215">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the appropriate dosage</span>
        <span itemprop="definition">may vary from patient to patient.</span>
        <meta itemprop="num_attr" content="0215">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">An appropriate effective amount</span>
        <span itemprop="definition">can be readily determined by one of skill in the art.</span>
        <meta itemprop="num_attr" content="0215">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Dosage treatment</span>
        <span itemprop="definition">may be a single dose schedule or a multiple dose schedule.</span>
        <meta itemprop="num_attr" content="0215">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the subject</span>
        <span itemprop="definition">may be administered as many doses as appropriate.</span>
        <meta itemprop="num_attr" content="0215">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">One of skill in the art</span>
        <span itemprop="definition">can readily determine an appropriate number of doses.</span>
        <meta itemprop="num_attr" content="0215">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the dosage</span>
        <span itemprop="definition">may need to be adjusted to take into consideration an alternative route of administration, or balance the therapeutic benefit against any side effects.</span>
        <meta itemprop="num_attr" content="0215">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an engineered meganuclease of the invention, or a pharmaceutically acceptable carrier and a polynucleotide comprising a nucleic acid encoding an engineered meganuclease of the invention.</span>
        <meta itemprop="num_attr" content="0216">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a cell of the invention which can be delivered to a target tissue where the cell expresses the engineered meganuclease as disclosed herein.</span>
        <meta itemprop="num_attr" content="0216">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Pharmaceutical compositions of the invention</span>
        <span itemprop="definition">can be useful for treating a subject having HBV, reducing the level or proliferation of HBV, reducing at least one symptom of HBV, or treating HCC.</span>
        <meta itemprop="num_attr" content="0216">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">compositions</span>
        <span itemprop="definition">can be designed or selected according to the genotype of the target HBV strain.</span>
        <meta itemprop="num_attr" content="0217">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the meganucleases of the invention</span>
        <span itemprop="definition">have been engineered to recognize and cleave a recognition sequence in specific genotypes of HBV.</span>
        <meta itemprop="num_attr" content="0217">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12 meganucleases</span>
        <span itemprop="definition">e.g., SEQ ID NOs: 12 and 13</span>
        <meta itemprop="num_attr" content="0217">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">recognize and cleave the HBV 11-12 recognition sequence that is at least found in the genome of HBV genotypes A, B, C, D, E, F, and G</span>
        <span itemprop="definition">e.g., SEQ ID NOs: 3-9, respectively.</span>
        <meta itemprop="num_attr" content="0217">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">recognition sequences of the engineered meganucleases disclosed herein</span>
        <span itemprop="definition">can be found in isolates of HBV genotypes A, B, C, D, E, F, and G that do not share 100% sequence identity to the respective genotype examples provided in SEQ ID NOs: 3-9.</span>
        <meta itemprop="num_attr" content="0217">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV isolates</span>
        <span itemprop="definition">can share at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more sequence identity with the corresponding genotype example provided in any of SEQ ID NOs: 3-9.</span>
        <meta itemprop="num_attr" content="0217">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the pharmaceutical compositions disclosed herein</span>
        <span itemprop="definition">can be administered to a subject having any genotype of HBV comprising a recognition sequence set forth in SEQ ID NO: 10.</span>
        <meta itemprop="num_attr" content="0217">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">compositions</span>
        <span itemprop="definition">can be prepared in accordance with known techniques. See, e.g., Remington, The Science And Practice of Pharmacy (21st ed., Philadelphia, Lippincott, Williams &amp; Wilkins, 2005).</span>
        <meta itemprop="num_attr" content="0218">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">meganuclease polypeptides</span>
        <span itemprop="definition">or DNA/RNA encoding the same or cells expressing the same</span>
        <meta itemprop="num_attr" content="0218">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a pharmaceutically acceptable carrier</span>
        <span itemprop="definition">In the manufacture of a pharmaceutical formulation according to the invention, meganuclease polypeptides (or DNA/RNA encoding the same or cells expressing the same) are typically admixed with a pharmaceutically acceptable carrier and the resulting composition is administered to a subject.</span>
        <meta itemprop="num_attr" content="0218">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the carrier</span>
        <span itemprop="definition">must, of course, be acceptable in the sense of being compatible with any other ingredients in the formulation and must not be deleterious to the subject.</span>
        <meta itemprop="num_attr" content="0218">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">pharmaceutical compositions of the invention</span>
        <span itemprop="definition">can further comprise one or more additional agents or biological molecules useful in the treatment of a disease in the subject. Likewise, the additional agent(s) and/or biological molecule(s) can be co-administered as a separate composition.</span>
        <meta itemprop="num_attr" content="0218">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the presently disclosed engineered meganucleases</span>
        <span itemprop="definition">can have improved (i.e., increased) specificity resulting in reduced off-target cutting, and enhanced (i.e., increased) efficiency of cleavage and indel formation, particularly in cells comprising an integrated copy of the HBV genome, as compared to the HBV11-12x.26 meganuclease</span>
        <meta itemprop="num_attr" content="0219">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the presently disclosed pharmaceutical compositions comprising optimized engineered meganucleases, nucleic acid sequences encoding the same, or cells expressing the same</span>
        <span itemprop="definition">also have improved (i.e., increased) efficacy in treating HBV, reducing the level or proliferation of HBV, reducing at least one symptom of HBV, or treating HCC in a subject, when compared to the administration of pharmaceutical compositions comprising the HBV11-12x.26 meganuclease.</span>
        <meta itemprop="num_attr" content="0219">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">compositions of the invention</span>
        <span itemprop="definition">can include combinations of the engineered meganucleases described herein (or nucleic acids encoding engineered meganucleases or cells expressing engineered meganucleases).</span>
        <meta itemprop="num_attr" content="0220">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">pharmaceutical compositions of the invention</span>
        <span itemprop="definition">can include at least two engineered meganucleases (or nucleic acids encoding engineered meganucleases or cells expressing engineered meganucleases), wherein at least a first engineered meganuclease is one described herein that recognizes and cleaves the HBV 11-12 recognition sequence, and wherein at least a second engineered meganuclease recognizes and cleaves a second recognition sequence in the HBV genome other than the HBV 11-12 recognition sequence, such that a single pharmaceutical composition is broadly useful for the treatment of a wide array of HBV genotypes and/or genotype isolates in a subject.</span>
        <meta itemprop="num_attr" content="0220">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">compositions of the invention</span>
        <span itemprop="definition">can include polycistronic mRNAs (or recombinant DNA constructs or viral vectors having cassettes which, when expressed, produce polycistronic mRNAs) that encode multiple engineered meganucleases described herein.</span>
        <meta itemprop="num_attr" content="0220">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">compositions of the invention</span>
        <span itemprop="definition">can include polycistronic mRNAs (or recombinant DNA constructs or viral vectors having cassettes which, when expressed, produce polycistronic mRNAs) that encode at least two engineered meganucleases, wherein at least a first engineered meganuclease is one described herein that recognizes and cleaves the HBV 11-12 recognition sequence, and wherein at least a second engineered meganuclease recognizes and cleaves a second recognition sequence in the HBV genome other than the HBV 11-12 recognition sequence.</span>
        <meta itemprop="num_attr" content="0220">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Such pharmaceutical compositions</span>
        <span itemprop="definition">are also broadly useful for the treatment of a wide array of HBV genotypes and/or genotype isolates in a subject. In either case, such pharmaceutical compositions can be useful as a single treatment when the specific HBV genotype or isolate is known or unknown in the subject.</span>
        <meta itemprop="num_attr" content="0220">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">compositions</span>
        <span itemprop="definition">comprising multiple different engineered meganucleases (including at least one of the engineered meganucleases disclosed herein) or comprising nucleic molecules encoding multiple different engineered meganucleases (including at least one of the engineered meganucleases disclosed herein) that target recognition sequences within the HBV genome, can be administered to a patient infected with multiple genotypes of HBV, or infected with unknown genotypes of HBV. Accordingly, providing pharmaceutical compositions with multiple different engineered meganucleases or comprising nucleic molecules encoding multiple different engineered meganucleases affords a flexible option for treatment and control of HBV infection where resources do not allow for accurate genotyping HBV and where fast and broad treatment solutions are desired.</span>
        <meta itemprop="num_attr" content="0221">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the pharmaceutical composition</span>
        <span itemprop="definition">can comprise one or more mRNAs described herein encapsulated within lipid nanoparticles, which are described elsewhere herein.</span>
        <meta itemprop="num_attr" content="0222">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">lipid nanoparticles</span>
        <span itemprop="definition">can comprise two or more mRNAs described herein.</span>
        <meta itemprop="num_attr" content="0222">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">lipid nanoparticles</span>
        <span itemprop="definition">can comprise at least two mRNAs, wherein at least a first mRNA is an mRNA described herein that encodes an engineered meganuclease described herein that recognizes and cleaves the HBV 11-12 recognition sequence, and wherein at least a second mRNA encodes a second engineered meganuclease that recognizes and cleaves a recognition sequence within an HBV genome other than the HBV 11-12 recognition sequence.</span>
        <meta itemprop="num_attr" content="0222">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">lipid nanoparticles</span>
        <span itemprop="definition">can comprise one or more polycistronic mRNAs described herein, wherein each polycistronic mRNA encodes two or more engineered meganucleases, wherein at least one engineered meganuclease is an engineered meganuclease described herein that recognizes and cleaves the HBV 11-12 recognition sequence, and wherein at least a second engineered meganuclease recognizes and cleaves a recognition sequence within a HBV genome other than the HBV 11-12 recognition sequence.</span>
        <meta itemprop="num_attr" content="0222">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">lipid nanoparticles contemplated for use in the invention</span>
        <span itemprop="definition">comprise at least one cationic lipid, at least one non-cationic lipid, and at least one conjugated lipid.</span>
        <meta itemprop="num_attr" content="0223">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">lipid nanoparticles</span>
        <span itemprop="definition">can comprise from about 50 mol % to about 85 mol % of a cationic lipid, from about 13 mol % to about 49.5 mol % of a non-cationic lipid, and from about 0.5 mol % to about 10 mol % of a lipid conjugate, and are produced in such a manner as to have a non-lamellar (i.e., non-bilayer) morphology.</span>
        <meta itemprop="num_attr" content="0223">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">lipid nanoparticles</span>
        <span itemprop="definition">can comprise from about 40 mol % to about 85 mol % of a cationic lipid, from about 13 mol % to about 49.5 mol % of a non-cationic lipid, and from about 0.5 mol % to about 10 mol % of a lipid conjugate, and are produced in such a manner as to have a non-lamellar (i.e., non-bilayer) morphology.</span>
        <meta itemprop="num_attr" content="0223">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Cationic lipids</span>
        <span itemprop="definition">can include, for example, one or more of the following: palmitoyi-oleoyl-nor-arginine (PONA), MPDACA, GUADACA, ((6Z,9Z,28Z,31Z)-heptatriaconta-6,9,28,31-tetraen-19-yl4-(dimethylamino)butanoate) (MC3), LenMC3, CP-LenMC3,   -LenMC3, CP-  -LenMC3, MC3MC, MC2MC, MC3 Ether, MC4 Ether, MC3 Amide, Pan-MC3, Pan-MC4 and Pan MC5, 1,2-dilinoleyloxy-N,N-dimethylaminopropane (DLinDMA), 1,2-dilinolenyloxy-N,N-dimethylaminopropane (DLenDMA), 2,2-dilinoleyl-4-(2-dimethylamino</span>
        <meta itemprop="num_attr" content="0224">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the cationic lipid</span>
        <span itemprop="definition">can also be DLinDMA, DLin-K-C2-DMA (XTC2), MC3, LenMC3, CP-LenMC3,   -LenMC3, CP-  -LenMC3, MC3MC, MC2MC, MC3 Ether, MC4 Ether, MC3 Amide, Pan-MC3, Pan-MC4, Pan MC5, or mixtures thereof.</span>
        <meta itemprop="num_attr" content="0224">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">XTC2</span>
        <span itemprop="definition">DLin-K-C2-DMA</span>
        <meta itemprop="num_attr" content="0224">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the cationic lipid</span>
        <span itemprop="definition">may comprise from about 50 mol % to about 90 mol %, from about 50 mol % to about 85 mol %, from about 50 mol % to about 80 mol %, from about 50 mol % to about 75 mol %, from about 50 mol % to about 70 mol %, from about 50 mol % to about 65 mol %, or from about 50 mol % to about 60 mol % of the total lipid present in the particle.</span>
        <meta itemprop="num_attr" content="0225">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the cationic lipid</span>
        <span itemprop="definition">may comprise from about 40 mol % to about 90 mol %, from about 40 mol % to about 85 mol %, from about 40 mol % to about 80 mol %, from about 40 mol % to about 75 mol %, from about 40 mol % to about 70 mol %, from about 40 mol % to about 65 mol %, or from about 40 mol % to about 60 mol % of the total lipid present in the particle.</span>
        <meta itemprop="num_attr" content="0226">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the non-cationic lipid</span>
        <span itemprop="definition">may comprise, e.g., one or more anionic lipids and/or neutral lipids.</span>
        <meta itemprop="num_attr" content="0227">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the non-cationic lipid</span>
        <span itemprop="definition">comprises one of the following neutral lipid components: (1) cholesterol or a derivative thereof; (2) a phospholipid; or (3) a mixture of a phospholipid and cholesterol or a derivative thereof.</span>
        <meta itemprop="num_attr" content="0227">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Examples of cholesterol derivatives</span>
        <span itemprop="definition">include, but are not limited to, cholestanol, cholestanone, cholestenone, coprostanol, cholesteryl-2-hydroxyethyl ether, cholesteryl-4-hydroxybutyl ether, and mixtures thereof.</span>
        <meta itemprop="num_attr" content="0227">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the phospholipid</span>
        <span itemprop="definition">may be a neutral lipid including, but not limited to, dipalmitoylphosphatidylcholine (DPPC), distearoylphosphatidylcholine (DSPC), dioleoylphosphatidylethanolamine (DOPE), palmitoyloleoyl-phosphatidylcholine (POPC), palmitoyloleoyl-phosphatidylethanolamine (POPE), palmitoyloleyol-phosphatidylglycerol (POPG), dipalmitoyl-phosphatidylethanolamine (DPPE), dimyristoyl-phosphatidylethanolamine (DMPE), distearoyl-phosphatidylethanolamine (DSPE), monomethyl-phosphatidylethanolamine, dimethyl-phosphatidylethanolamine, dielaidoyl-phosphatidylethanolamine (DEPE), stearoyloleoyl-phosphatidylethanolamine (S OPE), egg phosphati</span>
        <meta itemprop="num_attr" content="0227">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the non-cationic lipid</span>
        <span itemprop="definition">may comprise from about 10 mol % to about 60 mol %, from about 15 mol % to about 60 mol %, from about 20 mol % to about 60 mol %, from about 25 mol % to about 60 mol %, from about 30 mol % to about 60 mol %, from about 10 mol % to about 55 mol %, from about 15 mol % to about 55 mol %, from about 20 mol % to about 55 mol %, from about 25 mol % to about 55 mol %, from about 30 mol % to about 55 mol %, from about 13 mol % to about 50 mol %, from about 15 mol % to about 50 mol % or from about 20 mol % to about 50 mol % of the total lipid present in the particle.</span>
        <meta itemprop="num_attr" content="0228">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the non-cationic lipid</span>
        <span itemprop="definition">is a mixture of a phospholipid and</span>
        <meta itemprop="num_attr" content="0228">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the conjugated lipid that inhibits aggregation of particles</span>
        <span itemprop="definition">may comprise, e.g., one or more of the following: a polyethyleneglycol (PEG)-lipid conjugate, a polyamide (ATTA)-lipid conjugate, a cationic-polymer-lipid conjugates (CPLs), or mixtures thereof.</span>
        <meta itemprop="num_attr" content="0229">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the nucleic acid-lipid particles</span>
        <span itemprop="definition">comprise either a PEG-lipid conjugate or an ATTA-lipid conjugate.</span>
        <meta itemprop="num_attr" content="0229">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the PEG-lipid conjugate or ATTA-lipid conjugate</span>
        <span itemprop="definition">is used together with a CPL.</span>
        <meta itemprop="num_attr" content="0229">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the conjugated lipid that inhibits aggregation of particles</span>
        <span itemprop="definition">may comprise a PEG-lipid including, e.g., a PEG-diacylglycerol (DAG), a PEG dialkyloxypropyl (DAA), a PEG-phospholipid, a PEG-ceramide (Cer), or mixtures thereof.</span>
        <meta itemprop="num_attr" content="0229">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the PEG-DAA conjugate</span>
        <span itemprop="definition">may be PEG-di lauryloxypropyl (C12), a PEG-dimyristyloxypropyl (C14), a PEG-dipalmityloxypropyl (C16), a PEG-distearyloxypropyl (C18), or mixtures thereof.</span>
        <meta itemprop="num_attr" content="0229">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Additional PEG-lipid conjugates suitable for use in the invention</span>
        <span itemprop="definition">include, but are not limited to, mPEG2000-1,2-di-O-alkyl-sn3-carbomoylglyceride (PEG-C-DOMG).</span>
        <meta itemprop="num_attr" content="0230">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">PEG-C-DOMG</span>
        <span itemprop="definition">mPEG2000-1,2-di-O-alkyl-sn3-carbomoylglyceride</span>
        <meta itemprop="num_attr" content="0230">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Additional PEG-lipid conjugates suitable for use in the invention</span>
        <span itemprop="definition">include, without limitation, 1-[8-(1,2-dimyristoyl-3-propanoxy)-carboxamido-3,6-dioxaoctanyl]carbamoyl-  -methyl-poly(ethylene glycol) (2KPEG-DMG).</span>
        <meta itemprop="num_attr" content="0230">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">2KPEG-DMG</span>
        <span itemprop="definition">The synthesis of 2KPEG-DMG is described in U.S. Pat. No. 7,404,969.</span>
        <meta itemprop="num_attr" content="0230">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the conjugated lipid that inhibits aggregation of particles</span>
        <span itemprop="definition">may comprise from about 0.1 mol % to about 2 mol %, from about 0.5 mol % to about 2 mol %, from about 1 mol % to about 2 mol %, from about 0.6 mol % to about 1.9 mol %, from about 0.7 mol % to about 1.8 mol %, from about 0.8 mol % to about 1.7 mol %, from about 1 mol % to about 1.8 mol %, from about 1.2 mol % to about 1.8 mol %, from about 1.2 mol % to about 1.8 mol %, from about 1.2 mol % to about 1.7 mol %, from about 1.3 mol % to about 1.6 mol %, from about 1.4 mol % to about 1.5 mol %, or about 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2 mol % (or any fraction thereof</span>
        <meta itemprop="num_attr" content="0231">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the PEG moiety</span>
        <span itemprop="definition">has an average molecular weight of about 2,000 Daltons.</span>
        <meta itemprop="num_attr" content="0231">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the conjugated lipid that inhibits aggregation of particles</span>
        <span itemprop="definition">may comprise from about 5.0 mol % to about 10 mol %, from about 5 mol % to about 9 mol %, from about 5 mol % to about 8 mol %, from about 6 mol % to about 9 mol %, from about 6 mol % to about 8 mol %, or about 5 mol %, 6 mol %, 7 mol %, 8 mol %, 9 mol %, or 10 mol % (or any fraction thereof or range therein) of the total lipid present in the particle.</span>
        <meta itemprop="num_attr" content="0231">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the PEG moiety</span>
        <span itemprop="definition">has an average molecular weight of about 750 Daltons.</span>
        <meta itemprop="num_attr" content="0231">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the composition</span>
        <span itemprop="definition">may comprise amphoteric liposomes, which contain at least one positive and at least one negative charge carrier, which differs from the positive one, the isoelectric point of the liposomes being between 4 and 8. This objective is accomplished owing to the fact that liposomes are prepared with a pH-dependent, changing charge.</span>
        <meta itemprop="num_attr" content="0232">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Liposomal structures with the desired properties</span>
        <span itemprop="definition">are formed, for example, when the amount of membrane-forming or membrane-based cationic charge carriers exceeds that of the anionic charge carriers at a low pH and the ratio is reversed at a higher pH. This is always the case when the ionizable components have a pKa value between 4 and 9. As the pH of the medium drops, all cationic charge carriers are charged more and all anionic charge carriers lose their charge.</span>
        <meta itemprop="num_attr" content="0233">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Cationic compounds useful for amphoteric liposomes</span>
        <span itemprop="definition">include those cationic compounds previously described herein above.</span>
        <meta itemprop="num_attr" content="0234">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">strongy cationic compounds</span>
        <span itemprop="definition">can include, for example: DC-Choi 3-  -[N(N,N-dimethylmethane) carbamoyl] cholesterol, TC-Choi 3-  -[N(N,N,N-trimethylaminoethane) carbamoyl cholesterol, BGSC bisguanidinium-spermidine-cholesterol, BGTC bis-guadinium-tren-cholesterol, DOTAP (1,2-dioleoyloxypropyl)-N,N,N-trimethylammonium chloride, DOSPER (1,3-dioleoyloxy-2-(6-carboxy-spermyl)-propylarnide, DOTMA (1,2-dioleoyloxypropyl)-N,N,N-trimethylamronium chloride) (Lipofectin</span>
        <meta itemprop="num_attr" content="0234">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">weakly cationic compounds</span>
        <span itemprop="definition">include, without limitation: His-Chol (histaminyl-cholesterol hemisuccinate), Mo-Chol (morpholine-N-ethylamino-cholesterol hemisuccinate), or histidinyl-PE.</span>
        <meta itemprop="num_attr" content="0235">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">neutral compounds</span>
        <span itemprop="definition">include, without limitation: cholesterol, ceramides, phosphatidyl cholines, phosphatidyl ethanolamines, tetraether lipids, or diacyl glycerols.</span>
        <meta itemprop="num_attr" content="0236">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Anionic compounds useful for amphoteric liposomes</span>
        <span itemprop="definition">include those non-cationic compounds previously described herein.</span>
        <meta itemprop="num_attr" content="0237">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">examples of weakly anionic compounds</span>
        <span itemprop="definition">can include: CHEMS (cholesterol hemisuccinate), alkyl carboxylic acids with 8 to 25 carbon atoms, or diacyl glycerol hemisuccinate.</span>
        <meta itemprop="num_attr" content="0237">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Additional weakly anionic compounds</span>
        <span itemprop="definition">can include the amides of aspartic acid, or glutamic acid and PE as well as PS and its amides with glycine, alanine, glutamine, asparagine, serine, cysteine, threonine, tyrosine, glutamic acid, aspartic acid or other amino acids or aminodicarboxylic acids.</span>
        <meta itemprop="num_attr" content="0237">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the esters of hydroxycarboxylic acids or hydroxydicarboxylic acids and PS</span>
        <span itemprop="definition">are also weakly anionic compounds.</span>
        <meta itemprop="num_attr" content="0237">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">amphoteric liposomes</span>
        <span itemprop="definition">may contain a conjugated lipid, such as those described herein above.</span>
        <meta itemprop="num_attr" content="0238">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">conjugated lipids</span>
        <span itemprop="definition">include, without limitation, PEG-modified phosphatidylethanolamine and phosphatidic acid, PEG-ceramide conjugates (e.g., PEG-CerC14 or PEG-CerC20), PEG-modified dialkylamines and PEG-modified 1,2-diacyloxypropan-3-amines.</span>
        <meta itemprop="num_attr" content="0238">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">PEG-modified diacylglycerols and dialkylglycerols</span>
        <span itemprop="definition">are particularly preferred.</span>
        <meta itemprop="num_attr" content="0238">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the neutral lipids</span>
        <span itemprop="definition">may comprise from about 10 mol % to about 60 mol %, from about 15 mol % to about 60 mol %, from about 20 mol % to about 60 mol %, from about 25 mol % to about 60 mol %, from about 30 mol % to about 60 mol %, from about 10 mol % to about 55 mol %, from about 15 mol % to about 55 mol %, from about 20 mol % to about 55 mol %, from about 25 mol % to about 55 mol %, from about 30 mol % to about 55 mol %, from about 13 mol % to about 50 mol %, from about 15 mol % to about 50 mol % or from about 20 mol % to about 50 mol % of the total lipid present in the particle.</span>
        <meta itemprop="num_attr" content="0239">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the conjugated lipid that inhibits aggregation of particles</span>
        <span itemprop="definition">may comprise from about 0.1 mol % to about 2 mol %, from about 0.5 mol % to about 2 mol %, from about 1 mol % to about 2 mol %, from about 0.6 mol % to about 1.9 mol %, from about 0.7 mol % to about 1.8 mol %, from about 0.8 mol % to about 1.7 mol %, from about 1 mol % to about 1.8 mol %, from about 1.2 mol % to about 1.8 mol %, from about 1.2 mol % to about 1.8 mol %, from about 1.2 mol % to about 1.7 mol %, from about 1.3 mol % to about 1.6 mol %, from about 1.4 mol % to about 1.5 mol %, or about 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2 mol % (or any fraction thereof</span>
        <meta itemprop="num_attr" content="0240">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the PEG moiety</span>
        <span itemprop="definition">has an average molecular weight of about 2,000 Daltons.</span>
        <meta itemprop="num_attr" content="0240">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the conjugated lipid that inhibits aggregation of particles</span>
        <span itemprop="definition">may comprise from about 5.0 mol % to about 10 mol %, from about 5 mol % to about 9 mol %, from about 5 mol % to about 8 mol %, from about 6 mol % to about 9 mol %, from about 6 mol % to about 8 mol %, or about 5 mol %, 6 mol %, 7 mol %, 8 mol %, 9 mol %, or 10 mol % (or any fraction thereof or range therein) of the total lipid present in the particle.</span>
        <meta itemprop="num_attr" content="0240">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the PEG moiety</span>
        <span itemprop="definition">has an average molecular weight of about 750 Daltons.</span>
        <meta itemprop="num_attr" content="0240">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the remaining balance of the amphoteric liposome</span>
        <span itemprop="definition">can comprise a mixture of cationic compounds and anionic compounds formulated at various ratios.</span>
        <meta itemprop="num_attr" content="0241">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the ratio of cationic to anionic lipid</span>
        <span itemprop="definition">may selected in order to achieve the desired properties of nucleic acid encapsulation, zeta potential, pKa, or other physicochemical property that is at least in part dependent on the presence of charged lipid components.</span>
        <meta itemprop="num_attr" content="0241">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the lipid nanoparticles</span>
        <span itemprop="definition">have a composition which specifically enhances delivery and uptake in the liver, and specifically within hepatocytes.</span>
        <meta itemprop="num_attr" content="0242">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">compositions of the invention</span>
        <span itemprop="definition">can further comprise one or more additional agents useful in the treatment of HBV infection or HCC in the subject.</span>
        <meta itemprop="num_attr" content="0243">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the present disclosure</span>
        <span itemprop="definition">also provides engineered meganucleases described herein (or nucleic acids encoding the same or cells expressing the engineered meganucleases) for use as a medicament.</span>
        <meta itemprop="num_attr" content="0244">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the present disclosure</span>
        <span itemprop="definition">further provides the use of an engineered meganuclease described herein (or a nucleic acid encoding the same or cells expressing an engineered meganuclease) in the manufacture of a medicament for treating HBV, for reducing the level or proliferation of HBV, reducing the symptoms associated with HBV, or treating HCC.</span>
        <meta itemprop="num_attr" content="0244">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the invention</span>
        <span itemprop="definition">provides viral vectors (e.g., recombinant AAV vectors) for use in the methods of the invention.</span>
        <meta itemprop="num_attr" content="0245">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Recombinant AAV vectors</span>
        <span itemprop="definition">are typically produced in mammalian cell lines such as HEK-293. Because the viral cap and rep genes are removed from the vector to prevent its self-replication to make room for the therapeutic gene(s) to be delivered (e.g. the meganuclease gene), it is necessary to provide these in trans in the packaging cell line. In addition, it is necessary to provide the helper (e.g. adenoviral) components necessary to support replication (Cots et al. (2013), Curr. Gene Ther. 13(5): 370-81).</span>
        <meta itemprop="num_attr" content="0245">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">helper</span>
        <span itemprop="definition">e.g. adenoviral</span>
        <meta itemprop="num_attr" content="0245">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">recombinant AAV vectors</span>
        <span itemprop="definition">are produced using a triple-transfection in which a cell line is transfected with a first plasmid encoding the helper components, a second plasmid comprising the cap and rep genes, and a third plasmid comprising the viral ITRs containing the intervening DNA sequence to be packaged into the virus.</span>
        <meta itemprop="num_attr" content="0245">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Viral particles comprising a genome (ITRs and intervening gene(s) of interest) encased in a capsid</span>
        <span itemprop="definition">are then isolated from cells by freeze-thaw cycles, sonication, detergent, or other means known in the art. Particles are then purified using cesium-chloride density gradient centrifugation or affinity chromatography and subsequently delivered to the gene(s) of interest to cells, tissues, or an organism such as a human patient.</span>
        <meta itemprop="num_attr" content="0245">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">any meganuclease expressed in the packaging cell line</span>
        <span itemprop="definition">may be capable of cleaving the viral genome before it can be packaged into viral particles. This will result in reduced packaging efficiency and/or the packaging of fragmented genomes.</span>
        <meta itemprop="num_attr" content="0246">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Several approaches</span>
        <span itemprop="definition">can be used to prevent meganuclease expression in the packaging cells, including:</span>
        <meta itemprop="num_attr" content="0246">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the meganuclease</span>
        <span itemprop="definition">can be placed under the control of a tissue-specific promoter that is not active in the packaging cells.</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a tissue-specific promoter</span>
        <span itemprop="definition">that is not active in the packaging cells.</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a muscle-specific promoter</span>
        <span itemprop="definition">can be used.</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">muscle-specific promoters</span>
        <span itemprop="definition">include C5-12 (Liu, et al. (2004) Hum Gene Ther. 15:783-92), the muscle-specific creatine kinase (MCK) promoter (Yuasa, et al. (2002) Gene Ther. 9:1576-88), or the smooth muscle 22 (SM22) promoter (Haase, et al. (2013) BMC Biotechnol. 13:49-54).</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">CNS-specific promoters</span>
        <span itemprop="definition">examples include the NSE, Synapsin, and MeCP2 promoters (Lentz, et al. (2012) Neurobiol Dis. 48:179-88).</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">liver-specific promoters</span>
        <span itemprop="definition">include albumin promoters (such as Palb), human al-antitrypsin (such as PalAT), and hemopexin (such as Phpx) (Kramer et al., (2003) Mol.</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">hybrid liver-specific promoter</span>
        <span itemprop="definition">hepatic locus control region from ApoE gene (ApoE-HCR) and a liver-specific alpha1-antitrypsin promoter</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">human thyroxine binding globulin (TBG) promoter</span>
        <span itemprop="definition">human thyroxine binding globulin</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">apolipoprotein A-II promoter</span>
        <span itemprop="definition">examples include eye-specific promoters include opsin, and corneal epithelium-specific K12 promoters (Martin et al. (2002) Methods (28): 267-75) (Tong et al., (2007) J Gene Med, 9:956-66).</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">tissue-specific promoters</span>
        <span itemprop="definition">are not highly-active in HEK-293 cells and, thus, will not be expected to yield significant levels of meganuclease gene expression in packaging cells when incorporated into viral vectors of the present invention.</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the viral vectors of the present invention</span>
        <span itemprop="definition">contemplate the use of other cell lines with the use of incompatible tissue specific promoters (i.e., the well-known HeLa cell line (human epithelial cell) and using the liver-specific hemopexin promoter).</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">tissue specific promoters</span>
        <span itemprop="definition">include: synovial sarcomas PDZD4 (cerebellum), C6 (liver), ASB5 (muscle), PPP1R12B (heart), SLC5A12 (kidney), cholesterol regulation APOM (liver), ADPRHL1 (heart), and monogenic malformation syndromes TP73L (muscle).</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">synovial sarcomas PDZD4</span>
        <span itemprop="definition">cerebellum</span>
        <meta itemprop="num_attr" content="0247">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the vector</span>
        <span itemprop="definition">can be packaged in cells from a different species in which the meganuclease is not likely to be expressed.</span>
        <meta itemprop="num_attr" content="0248">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">viral particles</span>
        <span itemprop="definition">can be produced in microbial, insect, or plant cells using mammalian promoters, such as the well-known cytomegalovirus- or SV40 virus-early promoters, which are not active in the non-mammalian packaging cells.</span>
        <meta itemprop="num_attr" content="0248">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">mammalian promoters</span>
        <span itemprop="definition">such as the well-known cytomegalovirus- or SV40 virus-early promoters, which are not active in the non-mammalian packaging cells.</span>
        <meta itemprop="num_attr" content="0248">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">viral particles</span>
        <span itemprop="definition">are produced in insect cells using the baculovirus system as described by Gao, et al. (Gao et al. (2007), J. Biotechnol. 131(2):138-43).</span>
        <meta itemprop="num_attr" content="0248">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a meganuclease under the control of a mammalian promoter</span>
        <span itemprop="definition">is unlikely to be expressed in these cells (Airenne et al. (2013), Mol. Ther. 21(4):739-49).</span>
        <meta itemprop="num_attr" content="0248">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">insect cells</span>
        <span itemprop="definition">utilize different mRNA splicing motifs than mammalian cells.</span>
        <meta itemprop="num_attr" content="0248">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a mammalian intron</span>
        <span itemprop="definition">such as the human growth hormone (HGH) intron or the SV40 large T antigen intron, into the coding sequence of a meganuclease. Because these introns are not spliced efficiently from pre-mRNA transcripts in insect cells, insect cells will not express a functional meganuclease and will package the full-length genome.</span>
        <meta itemprop="num_attr" content="0248">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HGH</span>
        <span itemprop="definition">human growth hormone</span>
        <meta itemprop="num_attr" content="0248">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">mammalian cells to which the resulting recombinant AAV particles are delivered</span>
        <span itemprop="definition">will properly splice the pre-mRNA and will express functional meganuclease protein.</span>
        <meta itemprop="num_attr" content="0248">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Haifeng Chen</span>
        <span itemprop="definition">has reported the use of the HGH and SV40 large T antigen introns to attenuate expression of the toxic proteins barnase and diphtheria toxin fragment A in insect packaging cells, enabling the production of recombinant AAV vectors carrying these toxin genes (Chen, H (2012) Mol Ther Nucleic Acids. 1(11): e57).</span>
        <meta itemprop="num_attr" content="0248">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the meganuclease gene</span>
        <span itemprop="definition">can be operably linked to an inducible promoter such that a small-molecule inducer is required for meganuclease expression.</span>
        <meta itemprop="num_attr" content="0249">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">inducible promoters</span>
        <span itemprop="definition">include the Tet-On system (Clontech; Chen et al. (2015), BMC Biotechnol. 15(1):4)) and the RheoSwitch system (Intrexon; Sowa et al. (2011), Spine, 36(10): E623-8).</span>
        <meta itemprop="num_attr" content="0249">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Practicing the current invention using such ligand-inducible transcription activators</span>
        <span itemprop="definition">includes: 1) placing the meganuclease gene under the control of a promoter that responds to the corresponding transcription factor, the meganuclease gene having (a) binding site(s) for the transcription factor; and 2) including the gene encoding the transcription factor in the packaged viral genome</span>
        <meta itemprop="num_attr" content="0249">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the latter step</span>
        <span itemprop="definition">is necessary because the meganuclease will not be expressed in the target cells or tissues following recombinant AAV delivery if the transcription activator is not also provided to the same cells.</span>
        <meta itemprop="num_attr" content="0249">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the transcription activator</span>
        <span itemprop="definition">then induces meganuclease gene expression only in cells or tissues that are treated with the cognate small-molecule activator.</span>
        <meta itemprop="num_attr" content="0249">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">This approach</span>
        <span itemprop="definition">is advantageous because it enables meganuclease gene expression to be regulated in a spatio-temporal manner by selecting when and to which tissues the small-molecule inducer is delivered.</span>
        <meta itemprop="num_attr" content="0249">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the requirement to include the inducer in the viral genome</span>
        <span itemprop="definition">which has significantly limited carrying capacity, creates a drawback to this approach.</span>
        <meta itemprop="num_attr" content="0249">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">recombinant AAV particles</span>
        <span itemprop="definition">are produced in a mammalian cell line that expresses a transcription repressor that prevents expression of the meganuclease.</span>
        <meta itemprop="num_attr" content="0250">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Transcription repressors</span>
        <span itemprop="definition">are known in the art and include the Tet-Repressor, the Lac-Repressor, the Cro repressor, and the Lambda-repressor.</span>
        <meta itemprop="num_attr" content="0250">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Many nuclear hormone receptors</span>
        <span itemprop="definition">such as the ecdysone receptor also act as transcription repressors in the absence of their cognate hormone ligand.</span>
        <meta itemprop="num_attr" content="0250">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">packaging cells</span>
        <span itemprop="definition">are transfected/transduced with a vector encoding a transcription repressor and the meganuclease gene in the viral genome (packaging vector) is operably linked to a promoter that is modified to comprise binding sites for the repressor such that the repressor silences the promoter.</span>
        <meta itemprop="num_attr" content="0250">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the gene encoding the transcription repressor</span>
        <span itemprop="definition">can be placed in a variety of positions. It can be encoded on a separate vector; it can be incorporated into the packaging vector outside of the ITR sequences; it can be incorporated into the cap/rep vector or the adenoviral helper vector; or it can be stably integrated into the genome of the packaging cell such that it is expressed constitutively.</span>
        <meta itemprop="num_attr" content="0250">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Chang and Roninson</span>
        <span itemprop="definition">modified the strong, constitutive CMV and RSV promoters to comprise operators for the Lac repressor and showed that gene expression from the modified promoters was greatly attenuated in cells expressing the repressor (Chang and Roninson (1996), Gene 183:137-42).</span>
        <meta itemprop="num_attr" content="0250">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the use of a non-human transcription repressor</span>
        <span itemprop="definition">ensures that transcription of the meganuclease gene will be repressed only in the packaging cells expressing the repressor and not in target cells or tissues transduced with the resulting recombinant AAV vector.</span>
        <meta itemprop="num_attr" content="0250">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Embodiments of the invention</span>
        <span itemprop="definition">encompass the engineered meganucleases described herein, and variants thereof. Further embodiments of the invention encompass polynucleotides comprising a nucleic acid sequence encoding the meganucleases described herein, and variants of such polynucleotides.</span>
        <meta itemprop="num_attr" content="0251">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">variants</span>
        <span itemprop="definition">is intended to mean substantially similar sequences.</span>
        <meta itemprop="num_attr" content="0252">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a variant polypeptide</span>
        <span itemprop="definition">is intended to mean a polypeptide derived from the native polypeptide by deletion or addition of one or more amino acids at one or more internal sites in the native protein and/or substitution of one or more amino acids at one or more sites in the native polypeptide.</span>
        <meta itemprop="num_attr" content="0252">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a native polynucleotide or polypeptide</span>
        <span itemprop="definition">comprises a parental sequence from which variants are derived.</span>
        <meta itemprop="num_attr" content="0252">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Variant polypeptides encompassed by the embodiments</span>
        <span itemprop="definition">are biologically active.</span>
        <meta itemprop="num_attr" content="0252">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12 recognition sequence</span>
        <span itemprop="definition">SEQ ID NO: 10</span>
        <meta itemprop="num_attr" content="0252">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">they</span>
        <span itemprop="definition">continue to possess the desired biological activity of the native protein; i.e., the ability to recognize and cleave the HBV 11-12 recognition sequence (SEQ ID NO: 10) within the genome of a Hepatitis B virus, and in some embodiments, exhibit at least one improved property over the first-generation HBV 11-12x.26 meganuclease, such as improved (i.e., increased) specificity and enhanced (i.e., increased) efficiency of cleavage and indel formation.</span>
        <meta itemprop="num_attr" content="0252">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Such variants</span>
        <span itemprop="definition">may result, for example, from human manipulation.</span>
        <meta itemprop="num_attr" content="0252">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Biologically active variants of a native polypeptide of the embodiments</span>
        <span itemprop="definition">will have at least about 40%, about 45%, about 50%, about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99%, sequence identity to the amino acid sequence of the native polypeptide or native subunit, as determined by sequence alignment programs and parameters described elsewhere herein.</span>
        <meta itemprop="num_attr" content="0252">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a biologically active variant of a polypeptide or subunit of the embodiments</span>
        <span itemprop="definition">may differ from that polypeptide or subunit by as few as about 1-40 amino acid residues, as few as about 1-20, as few as about 1-10, as few as about 5, as few as 4, 3, 2, or even 1 amino acid residue.</span>
        <meta itemprop="num_attr" content="0252">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">polypeptides of the embodiments</span>
        <span itemprop="definition">may be altered in various ways including amino acid substitutions, deletions, truncations, and insertions. Methods for such manipulations are generally known in the art. For example, amino acid sequence variants can be prepared by mutations in the DNA. Methods for mutagenesis and polynucleotide alterations are well known in the art. See, for example, Kunkel (1985) Proc. Natl. Acad. Sci. USA 82:488-492; Kunkel et al. (1987) Methods in Enzymol. 154:367-382; U.S. Pat. No. 4,873,192; Walker and Gaastra, eds.</span>
        <meta itemprop="num_attr" content="0253">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">engineered meganucleases of the invention</span>
        <span itemprop="definition">can comprise variants of the HVR1 and HVR2 regions disclosed herein.</span>
        <meta itemprop="num_attr" content="0254">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Parental HVR regions</span>
        <span itemprop="definition">can comprise, for example, residues 24-79 or residues 215-270 of the exemplified engineered meganucleases.</span>
        <meta itemprop="num_attr" content="0254">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">variant HVRs</span>
        <span itemprop="definition">can comprise an amino acid sequence having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 24-79 or residues 215-270 of the engineered meganucleases exemplified herein, such that the variant HVR regions maintain the biological activity of the engineered meganuclease (i.e., binding to and cleaving the recognition sequence).</span>
        <meta itemprop="num_attr" content="0254">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a variant HVR1 region or variant HVR2 region</span>
        <span itemprop="definition">can comprise residues corresponding to the amino acid residues found at specific positions within the parental HVR.</span>
        <meta itemprop="num_attr" content="0254">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">corresponding to</span>
        <span itemprop="definition">means that an amino acid residue in the variant HVR is the same amino acid residue (i.e., a separate identical residue) present in the parental HVR sequence in the same relative position (i.e., in relation to the remaining amino acids in the parent sequence).</span>
        <meta itemprop="num_attr" content="0254">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a parental HVR sequence</span>
        <span itemprop="definition">comprises a serine residue at position 26</span>
        <meta itemprop="num_attr" content="0254">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a variant HVR that comprises a residue corresponding to residue 26</span>
        <span itemprop="definition">will also comprise a serine at a position that is relative (i.e., corresponding) to parental position 26.</span>
        <meta itemprop="num_attr" content="0254">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">engineered meganucleases of the invention</span>
        <span itemprop="definition">comprise an HVR1 region that has at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more sequence identity to an amino acid sequence corresponding to residues 215-270 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0255">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">engineered meganucleases of the invention</span>
        <span itemprop="definition">comprise an HVR2 region that has at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more sequence identity to an amino acid sequence corresponding to residues 24-79 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0256">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">engineered meganucleases of the invention</span>
        <span itemprop="definition">comprise an HVR1 region that has at least 86% sequence identity to an amino acid sequence corresponding to residues 215-270 of SEQ ID NO: 12 or 13 and an HVR2 region that has at least 97% sequence identity to an amino acid sequence corresponding to residues 24-79 of SEQ ID NO: 12 or 13.</span>
        <meta itemprop="num_attr" content="0257">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the data of Table 2</span>
        <span itemprop="definition">provides possible substitutions in the disclosed HVR regions of SEQ ID NO: 12 and 13 which can be relatively conservative in their effects on specificity.</span>
        <meta itemprop="num_attr" content="0259">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the R residue corresponding to I-CreI position 46</span>
        <span itemprop="definition">which contacts an A at position   1 of the recognition half-site of SEQ ID NO: 11, could be replaced with C46 or A46 (which have a preference for contacting A), or G46 (which is relatively neutral in preference);</span>
        <meta itemprop="num_attr" content="0259">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the W residue corresponding to I-CreI position 70</span>
        <span itemprop="definition">which contacts an A at position   1 of the recognition half-site of SEQ ID NO: 11, could be replaced with G70, A70 or S70 (which are relatively neutral in preference);</span>
        <meta itemprop="num_attr" content="0259">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the N residue corresponding to I-CreI position 44</span>
        <span itemprop="definition">which contacts a C at position   2 of the recognition half-site of SEQ ID NO: 11, could be replaced with K44 or R44 (which have a preference for contacting C);</span>
        <meta itemprop="num_attr" content="0259">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the I residue corresponding to I-CreI position 46</span>
        <span itemprop="definition">which contacts an A at position   1 of the recognition half-site of SEQ ID NO</span>
        <meta itemprop="num_attr" content="0259">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the G residue corresponding to I-CreI position 46</span>
        <span itemprop="definition">which contacts a C at position   1 of the recognition half-site of SEQ ID NO: 10, could be replaced with H46, K46 or R46 (which have a preference for contacting C), or T46 (which has a preference for contacting contacts C or T);</span>
        <meta itemprop="num_attr" content="0260">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the N residue corresponding to I-CreI position 70</span>
        <span itemprop="definition">which contacts a C at position   1 of the recognition half-site of SEQ ID NO: 10, could be replaced with R70, which has a preference for contacting C), or G70, A70 or S70 (which are relatively neutral in preference);</span>
        <meta itemprop="num_attr" content="0260">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the E residue corresponding to I-CreI position 44</span>
        <span itemprop="definition">which contacts a C at position   2 of the recognition half-site of SEQ ID NO: 10, could be replaced with the similarly negative residue D44 (which has a preference for contacting G) or K44 or R44 (which are positive residues that have a preference for contacting C);</span>
        <meta itemprop="num_attr" content="0260">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">variants</span>
        <span itemprop="definition">can be tested alone and/or in combination to select variants with desired specificity and/or activity using methods described herein and known in the art. Such variants are within the scope of the invention, although the preferred embodiments are disclosed in SEQ ID NO: 12 and 13.</span>
        <meta itemprop="num_attr" content="0261">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease monomer or subunit described herein</span>
        <span itemprop="definition">can comprise a G, S, or A at a residue corresponding to position 19 of I-CreI or SEQ ID NO: 12 or 13 (WO 2009/001159), a Y, R, K, or D at a residue corresponding to position 66 of I-CreI or SEQ ID NO: 12 or 13, and/or an E, Q, or K at a residue corresponding to position 80 of I-CreI or SEQ ID NO: 12 or 13 (U.S. Pat. No. 8,021,867).</span>
        <meta itemprop="num_attr" content="0262">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a variant</span>
        <span itemprop="definition">comprises a deletion and/or addition of one or more nucleotides at one or more sites within the native polynucleotide.</span>
        <meta itemprop="num_attr" content="0263">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">variants of the nucleic acids of the embodiments</span>
        <span itemprop="definition">will be constructed such that the open reading frame is maintained.</span>
        <meta itemprop="num_attr" content="0263">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">conservative variants</span>
        <span itemprop="definition">include those sequences that, because of the degeneracy of the genetic code, encode the amino acid sequence of one of the polypeptides of the embodiments.</span>
        <meta itemprop="num_attr" content="0263">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Variant polynucleotides</span>
        <span itemprop="definition">include synthetically derived polynucleotides, such as those generated, for example, by using site-directed mutagenesis but which still encode a recombinant nuclease of the embodiments.</span>
        <meta itemprop="num_attr" content="0263">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">variants of a particular polynucleotide of the embodiments</span>
        <span itemprop="definition">will have at least about 40%, about 45%, about 50%, about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99% or more sequence identity to that particular polynucleotide as determined by sequence alignment programs and parameters described elsewhere herein.</span>
        <meta itemprop="num_attr" content="0263">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Variants of a particular polynucleotide of the embodiments</span>
        <span itemprop="definition">can also be evaluated by comparison of the percent sequence identity between the polypeptide encoded by a variant polynucleotide and the polypeptide encoded by the reference polynucleotide.</span>
        <meta itemprop="num_attr" content="0263">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">deletions, insertions, and substitutions of the variant protein sequences encompassed herein</span>
        <span itemprop="definition">are not expected to produce radical changes in the characteristics of the polypeptide. However, when it is difficult to predict the exact effect of the substitution, deletion, or insertion in advance of doing so, one skilled in the art will appreciate that the effect will be evaluated by screening the polypeptide for its ability to preferentially recognize and cleave the HBV 11-12 recognition sequence within the genome of a Hepatitis B virus.</span>
        <meta itemprop="num_attr" content="0264">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a method for treating or preventing an HBV infection in a human having or at risk of having the infection</span>
        <span itemprop="definition">comprising administering to the human a therapeutically effective amount of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, in combination with a therapeutically effective amount of one or more (e.g., one, two, three, four, one or two, one to three, or one to four) additional therapeutic agents.</span>
        <meta itemprop="num_attr" content="0265">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a method for treating or preventing an HBV infection in a human having or at risk of having the infection</span>
        <span itemprop="definition">comprising administering to the human a therapeutically effective amount of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, in combination with a therapeutically effective amount of one or more (e.g., one, two, three, four, one or two, one to three, or one to four) additional therapeutic agents.</span>
        <meta itemprop="num_attr" content="0265">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a method for treating an HBV infection in a human having or at risk of having the infection</span>
        <span itemprop="definition">comprising administering to the human a therapeutically effective amount of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, in combination with a therapeutically effective amount of one or more (e.g., one, two, three, four, one or two, one to three, or one to four) additional therapeutic agents.</span>
        <meta itemprop="num_attr" content="0265">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a therapeutically effective amount of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">in combination with a therapeutically effective amount of one or more (e.g., one, two, three, four, one or two, one to three, or one to four) additional therapeutic agents.</span>
        <meta itemprop="num_attr" content="0265">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the present disclosure</span>
        <span itemprop="definition">provides a method for treating an HBV infection, comprising administering to a patient in need thereof a therapeutically effective amount of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, in combination with a therapeutically effective amount of one or more (e.g., one, two, three, four, one or two, one to three, or one to four) additional therapeutic agents which are suitable for treating an HBV infection.</span>
        <meta itemprop="num_attr" content="0266">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">one or more</span>
        <span itemprop="definition">e.g., one, two, three, four, one or two, one to three, or one to four</span>
        <meta itemprop="num_attr" content="0266">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with one, two, three, four, or more additional therapeutic agents. In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with two additional therapeutic agents. In other embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with three additional therapeutic agents. In further embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with four additional therapeutic agents. The one, two, three, four, or more additional therapeutic agents can be different therapeutic agents selected from the same class of therapeutic agents, and/or they can be selected from different classes of therapeutic agents.</span>
        <meta itemprop="num_attr" content="0267">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with one or more additional therapeutic agents as described above, the components of the composition are administered as a simultaneous or sequential regimen. When administered sequentially, the combination may be administered in two or more administrations.</span>
        <meta itemprop="num_attr" content="0268">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Co-administration of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, with one or more additional therapeutic agents</span>
        <span itemprop="definition">generally refers to simultaneous or sequential administration of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, and one or more additional therapeutic agents, such that therapeutically effective amounts of each agent are present in the body of the patient.</span>
        <meta itemprop="num_attr" content="0269">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Co-administration</span>
        <span itemprop="definition">includes administration of unit dosages of the compounds disclosed herein before or after administration of unit dosages of one or more additional therapeutic agents.</span>
        <meta itemprop="num_attr" content="0270">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">may be administered within seconds, minutes, or hours of the administration of one or more additional therapeutic agents.</span>
        <meta itemprop="num_attr" content="0270">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a unit dose of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is administered first, followed within seconds or minutes by administration of a unit dose of one or more additional therapeutic agents.</span>
        <meta itemprop="num_attr" content="0270">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a unit dose of one or more additional therapeutic agents</span>
        <span itemprop="definition">is administered first, followed by administration of a unit dose of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, within seconds or minutes.</span>
        <meta itemprop="num_attr" content="0270">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a unit dose of a an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is administered first, followed, after a period of hours (e.g., 1-12 hours), by administration of a unit dose of one or more additional therapeutic agents.</span>
        <meta itemprop="num_attr" content="0270">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a unit dose of one or more additional therapeutic agents</span>
        <span itemprop="definition">is administered first, followed, after a period of hours (e.g., 1-12 hours), by administration of a unit dose of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same.</span>
        <meta itemprop="num_attr" content="0270">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with one or more additional therapeutic agents in a unitary dosage form for simultaneous administration to a patient.</span>
        <meta itemprop="num_attr" content="0271">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the engineered meganucleases disclosed herein, or nucleic acids encoding the same</span>
        <span itemprop="definition">may be used or combined with one or more of a chemotherapeutic agent, an immunomodulator, an immunotherapeutic agent, a therapeutic antibody, a therapeutic vaccine, a bispecific antibody and antibody-like therapeutic protein (such as DARTs, Duobodies, Bites, XmAbs, TandAbs, Fab derivatives), an antibody-drug conjugate (ADC), gene modifiers, cell therapies such as CAR-T (chimeric antigen receptor T-cell), and TCR-T (an engineered T cell receptor) agent or any combination thereof.</span>
        <meta itemprop="num_attr" content="0272">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a chemotherapeutic agent</span>
        <span itemprop="definition">such as DARTs, Duobodies, Bites, XmAbs, TandAbs, Fab derivatives</span>
        <meta itemprop="num_attr" content="0272">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">ADC</span>
        <span itemprop="definition">antibody-drug conjugate</span>
        <meta itemprop="num_attr" content="0272">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">cell therapies</span>
        <span itemprop="definition">such as CAR-T (chimeric antigen receptor T-cell), and TCR-T (an engineered T cell receptor) agent or</span>
        <meta itemprop="num_attr" content="0272">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a formulation comprising an engineered meganuclease described herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">may optionally contain one or more other compounds useful for treating HBV.</span>
        <meta itemprop="num_attr" content="0273">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the formulation</span>
        <span itemprop="definition">can contain another active ingredient for treating HBV, such as 3-dioxygenase (IDO) inhibitors, Apolipoprotein A1 modulator, arginase inhibitors, B- and T-lymphocyte attenuator inhibitors, Bruton&#39;s tyrosine kinase (BTK) inhibitors, CCR2 chemokine antagonist, CD137 inhibitors, CD160 inhibitors, CD305 inhibitors, CD4 agonist and modulator, compounds targeting HBcAg, compounds targeting hepatitis B core antigen (HBcAg), core protein allosteric modulators, covalently closed circular DNA (cccDNA) inhibitors, cyclophilin inhibitors, cytotoxic T-lymphocyte-associated protein 4 (ipi4) inhibitors, DNA polymerase inhibitor,</span>
        <meta itemprop="num_attr" content="0273">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">IDO</span>
        <span itemprop="definition">3-dioxy</span>
        <meta itemprop="num_attr" content="0273">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">combination drugs for the treatment of HBV</span>
        <span itemprop="definition">include TRUVADA (tenofovir disoproxil fumarate and emtricitabine); ABX-203, lamivudine, and PEG-IFNalpha; ABX-203 adefovir, and PEG-IFNalpha; and INO-1800 (INO-9112 and RG7944).</span>
        <meta itemprop="num_attr" content="0274">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Examples of other drugs for the treatment of HBV</span>
        <span itemprop="definition">include alpha-hydroxytropolones, amdoxovir, antroquinonol, beta-hydroxycytosine nucleosides, AL-034, CCC-0975, elvucitabine, ezetimibe, cyclosporin A, gentiopicrin (gentiopicroside), JNJ-56136379, nitazoxanide, birinapant, NJK14047, NOV-205 (molixan, BAM-205), oligotide, mivotilate, feron, GST-HG-131, levamisole, Ka Shu Ning, alloferon, WS-007, Y-101 (Ti Fen Tai), rSIFN-co, PEG-IIFNm, KW-3, BP-Inter-014, oleanolic acid, HepB-nRNA, cTP-5 (rTP-5), HSK-II-2, HEISCO-106-1, HE</span>
        <meta itemprop="num_attr" content="0275">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV vaccines</span>
        <span itemprop="definition">include both prophylactic and therapeutic vaccines.</span>
        <meta itemprop="num_attr" content="0276">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV prophylactic vaccines</span>
        <span itemprop="definition">include Vaxelis, Hexaxim, Heplisav, Mosquirix, DTwP-HBV vaccine, Bio-Hep-B, D/T/P/HBV/M (LBVP-0101; LBVW-0101), DTwP-Hepb-Hib-IPV vaccine, Heberpenta L, DTwP-HepB-Hib, V-419, CVI-HBV-001, Tetrabhay, hepatitis B prophylactic vaccine (Advax Super D), Hepatrol-07, GSK-223192A, ENGERIX B, recombinant hepatitis B vaccine (intramuscular, Kangtai Biological Products), recombinant hepatitis B vaccine (Hansenual polymorpha yeast, intramuscular, Hualan Biological Engineering), recombinant hepatitis B surface antigen vaccine, Bimmugen, Eu</span>
        <meta itemprop="num_attr" content="0276">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV therapeutic vaccines</span>
        <span itemprop="definition">include HBsAG-HBIG complex, ARB-1598, Bio-Hep-B, NASVAC, abi-HB (intravenous), ABX-203, Tetrabhay, GX-110E, GS-4774, peptide vaccine (epsilonPA-44), Hepatrol-07, NASVAC (NASTERAP), IMP-321, BEVAC, Revac B mcf, Revac B&#43;, MGN-1333, KW-2, CVI-HBV-002, AltraHepB, VGX-6200, FP-02, FP-02.2 (HepTcell), TG-1050, NU-500, HBVax, im/TriGrid/antigen vaccine, Mega-CD40L-adjuvanted vaccine, HepB-v, RG7944 (INO-1800), recombinant VLP-based therapeutic vaccine (HBV infection, VLP Biotech), AdTG-17909, AdTG-17910 AdTG-18202, ChronVac-</span>
        <meta itemprop="num_attr" content="0277">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">viral vaccines against HBV antigens</span>
        <span itemprop="definition">include, for example, arena virus vaccines (WO 2017076988).</span>
        <meta itemprop="num_attr" content="0278">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV DNA polymerase inhibitors</span>
        <span itemprop="definition">examples include adefovir (HEPSERA), emtricitabine (EMTRIVA), tenofovir disoproxil fumarate (VIREAD), tenofovir alafenamide, tenofovir, tenofovir disoproxil, tenofovir alafenamide fumarate, tenofovir alafenamide hemifumarate, tenofovir dipivoxil, tenofovir dipivoxil fumarate, tenofovir octadecyloxyethyl ester, CMX-157, besifovir, entecavir (BARACLUDE), entecavir maleate, telbivudine (TYZEKA), filocilovir, pradefovir, clevudine, ribavirin, lamivudine (EPIVIR-HBV), phosphazide, fam</span>
        <meta itemprop="num_attr" content="0279">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">immunomodulators</span>
        <span itemprop="definition">examples include rintatolimod, imidol hydrochloride, ingaron, dermaVir, plaquenil (hydroxychloroquine), proleukin, hydroxyurea, mycophenolate mofetil (MPA) and its ester derivative mycophenolate mofetil (MMF), JNJ-440, WF-10, AB-452, ribavirin, IL-12, INO-9112, polymer polyethyleneimine (PEI), Gepon, VGV-1, MOR-22, CRV-431, JNJ-0535, TG-1050, ABI-H2158, BMS-936559, GS-9688, RO-7011785, RG-7854, AB-506, RO-6871765, AIC-649, and IR-103.</span>
        <meta itemprop="num_attr" content="0280">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">TLR</span>
        <span itemprop="definition">Toll-Like Receptor</span>
        <meta itemprop="num_attr" content="">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">TLR modulators</span>
        <span itemprop="definition">include modulators of TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9, TLR10, TLR11, TLR12, and TLR13.</span>
        <meta itemprop="num_attr" content="0281">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">TLR3 modulators</span>
        <span itemprop="definition">include rintatolimod, poly-ICLC, RIBOXXON, Apoxxim, RIBOXXIM, IPH-33, MCT-465, MCT-475, and ND-1.1.</span>
        <meta itemprop="num_attr" content="0281">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">TLR7 modulators</span>
        <span itemprop="definition">include GS-9620, GSK-2245035, imiquimod, resiquimod, DSR-6434, DSP-3025, IMO-4200, MCT-465, MEDI-9197, 3M-051, SB-9922, 3M-052, Limtop, D, telratolimod, SP-0509, TMX-30X, TMX-202, RG-7863, RG-7795, LHC-165, RG-7854, and the compounds disclosed in US20100143301 (Gilead Sciences), US20110098248 (Gilead Sciences), and US20090047249 (Gilead Sciences).</span>
        <meta itemprop="num_attr" content="0282">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">TLR8 modulators</span>
        <span itemprop="definition">include motolimod, resiquimod, 3M-051, 3M-052, MCT-465, IMO-4200, VTX-763, VTX-1463, GS-9688 and the compounds disclosed in US20140045849 (Janssen), US20140073642 (Janssen), WO2014/056953 (Janssen), WO2014/076221 (Janssen), WO2014/128189 (Janssen), US20140350031 (Janssen), WO2014/023813 (Janssen), US20080234251 (Array Biopharma), US20080306050 (Array Biopharma), US20100029585 (Ventirx Pharma), US20110092485 (Ventirx Pharma), US20110118235 (Ventirx Pharma), US20120082658 (Ventirx Pharma), US20120219615 (Ventirx Pharma), US20140066432 (Ventirx Pharma), US20140088085 (Ventirx</span>
        <meta itemprop="num_attr" content="0283">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">TLR9 modulators</span>
        <span itemprop="definition">examples include BB-001, BB-006, CYT-003, IMO-2055, IMO-2125, IMO-3100, IMO-8400, IR-103, IMO-9200, agatolimod, DIMS-9054, DV-1079, DV-1179, AZD-1419, leftolimod (MGN-1703), litenimod, and CYT-003-QbG10.</span>
        <meta itemprop="num_attr" content="0284">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">TLR7, TLR8 and TLR9 modulators</span>
        <span itemprop="definition">include the compounds disclosed in WO2017047769 (Teika Seiyaku), WO2015014815 (Janssen), WO2018045150 (Gilead Sciences Inc), WO2018045144 (Gilead Sciences Inc), WO2015162075 (Roche), WO2017034986 (University of Kansas), WO2018095426 (Jiangsu Hengrui Medicine Co Ltd), WO2016091698 (Roche), WO2016075661 (GlaxoSmithKline Biologicals), WO2016180743 (Roche), WO2018089695 (Dynavax Technologies), WO2016055553 (Roche), WO2015168279 (Novartis), WO2016107536 (Medshine Discovery), WO2018086593 (Livo (Shanghai) Pharmaceutical), WO2017106607 (Merck), WO2017061532 (Sumitomo Dainippon Pharma), WO20160235</span>
        <meta itemprop="num_attr" content="0285">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">interferon alpha receptor ligands</span>
        <span itemprop="definition">examples include interferon alpha-2b (INTRON A), pegylated interferon alpha-2a (PEGASYS), PEGylated interferon alpha-1b, interferon alpha 1b (HAPGEN), Veldona, Infradure, Roferon-A, YPEG-interferon alfa-2a (YPEG-rhlFNalpha-2a), P-1101, Algeron, Alfarona, Ingaron (interferon gamma), rSIFN-co (recombinant super compound interferon), Ypeginterferon alfa-2b (YPEG-rhlFNalpha-2b), MOR-22, peginterferon alfa-2b (PEG-INTRON), Bioferon, Novaferon, Inmutag (Inferon), MULTIFERON, interferon alfa-n1 (HUMOFERON), interferon beta-1a (AVONEX),</span>
        <meta itemprop="num_attr" content="0286">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">hyaluronidase inhibitors</span>
        <span itemprop="definition">examples include astodrimer.</span>
        <meta itemprop="num_attr" content="0287">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HsAg</span>
        <span itemprop="definition">Hepatitis B Surface Antigen</span>
        <meta itemprop="num_attr" content="">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBsAg inhibitors</span>
        <span itemprop="definition">examples include AK-074, HBF-0259, PBHBV-001, PBHBV-2-15, PBHBV-2-1, REP-9AC, REP-9C, REP-9, REP-2139, REP-2139-Ca, REP-2165, REP-2055, REP-2163, REP-2165, REP-2053, REP-2031 and REP-006, and REP-9AC.</span>
        <meta itemprop="num_attr" content="0288">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBsAg secretion inhibitors</span>
        <span itemprop="definition">examples include BM601.</span>
        <meta itemprop="num_attr" content="0289">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Cytotoxic T-lymphocyte-associated protein 4 (ipi4) inhibitors</span>
        <span itemprop="definition">include AGEN-2041, AGEN-1884, ipilumimab, belatacept, PSI-001, PRS-010, Probody mAbs, tremelimumab, and JHL-1155.</span>
        <meta itemprop="num_attr" content="0290">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">cyclophilin inhibitors</span>
        <span itemprop="definition">include CPI-431-32, EDP-494, OCB-030, SCY-635, NVP-015, NVP-018, NVP-019, STG-175, and the compounds disclosed in U.S. Pat. No. 8,513,184 (Gilead Sciences), US20140030221 (Gilead Sciences), US20130344030 (Gilead Sciences), and US20130344029 (Gilead Sciences).</span>
        <meta itemprop="num_attr" content="0291">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV viral entry inhibitors</span>
        <span itemprop="definition">examples include Myrcludex B.</span>
        <meta itemprop="num_attr" content="0292">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">antisense oligonucleotide targeting viral mRNA</span>
        <span itemprop="definition">examples include ISIS-HBVRx, IONIS-HBVRx, IONIS-GSK6-LRx, IONIS-HBV-LRx, GSK-3389404, RG-6004.</span>
        <meta itemprop="num_attr" content="0293">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Short Interfering RNAs</span>
        <span itemprop="definition">siRNA</span>
        <meta itemprop="num_attr" content="0000">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">ddRNAi</span>
        <span itemprop="definition">short Interfering RNAs</span>
        <meta itemprop="num_attr" content="0000">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">siRNA</span>
        <span itemprop="definition">examples include TKM-HBV (TKM-HepB), ALN-HBV, SR-008, HepB-nRNA, and ARC-520, ARC-521, ARB-1740, ARB-1467, DCR-HBVS, RG-6217, ALN-HBV-02, and ARO-HBV.</span>
        <meta itemprop="num_attr" content="0294">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">ddRNAi</span>
        <span itemprop="definition">DNA-directed RNA interference</span>
        <meta itemprop="num_attr" content="0295">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">endonuclease modulators</span>
        <span itemprop="definition">examples include PGN-514.</span>
        <meta itemprop="num_attr" content="0296">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">inhibitors of ribonucleotide reductase</span>
        <span itemprop="definition">include Trimidox.</span>
        <meta itemprop="num_attr" content="0297">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV E antigen inhibitors</span>
        <span itemprop="definition">examples include wogonin.</span>
        <meta itemprop="num_attr" content="0298">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">cccDNA inhibitors</span>
        <span itemprop="definition">examples include BSBI-25, and CHR-101.</span>
        <meta itemprop="num_attr" content="0299">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Example of farnesoid x receptor agonist</span>
        <span itemprop="definition">such as EYP-001, GS-9674, EDP-305, MET-409, Tropifexor, AKN-083, RDX-023, BWD-100, LMB-763, INV-3, NTX-023-1, EP-024297 and GS-8670.</span>
        <meta itemprop="num_attr" content="0300">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV antibodies targeting the surface antigens of the hepatitis B virus</span>
        <span itemprop="definition">include lenvervimab (GC-1102), XTL-17, XTL-19, KN-003, IV Hepabulin SN, and fully human monoclonal antibody therapy (hepatitis B virus infection, Humabs BioMed).</span>
        <meta itemprop="num_attr" content="0301">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV antibodies</span>
        <span itemprop="definition">including monoclonal antibodies and polyclonal antibodies</span>
        <meta itemprop="num_attr" content="0302">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">examples of HBV antibodies</span>
        <span itemprop="definition">include Zutectra, Shang Sheng Gan Di, Uman Big (Hepatitis B Hyperimmune), Omri-Hep-B, Nabi-HB, Hepatect CP, HepaGam B, igantibe, Niuliva, CT-P24, hepatitis B immunoglobulin (intravenous, pH4, HBV infection, Shanghai RAAS Blood Products), and Fovepta (BT-088).</span>
        <meta itemprop="num_attr" content="0302">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Examples of fully human monoclonal antibodies</span>
        <span itemprop="definition">include HBC-34.</span>
        <meta itemprop="num_attr" content="0303">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">pMHC-HBV antigens and TCR-like antibodies against pMHC-HBV antigens</span>
        <span itemprop="definition">include those disclosed in Zhu et al. (2017), Mol. Med. Rep. 16(6): 8605-8612; Shen et al. (2017) Sci. Rep. 7(1): 16400; Sastry et al. (2011), J. Virol. 85(5): 1935-1942; Low et al. (2012) PLoS One 7(12): e51397; Cheng et al. (2019) Sci. Immunol. 4(32); and Zhao (2016) Nat. Commun. 9(1): 2716.</span>
        <meta itemprop="num_attr" content="0304">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">CCR2 chemokine antagonists</span>
        <span itemprop="definition">examples include propagermanium.</span>
        <meta itemprop="num_attr" content="0305">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">thymosin agonists</span>
        <span itemprop="definition">examples include Thymalfasin, recombinant thymosin alpha 1 (GeneScience).</span>
        <meta itemprop="num_attr" content="0306">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">cytokines</span>
        <span itemprop="definition">examples include recombinant IL-7, CYT-107, interleukin-2 (IL-2, Immunex), recombinant human interleukin-2 (Shenzhen Neptunus), IL-15, IL-21, IL-24, and celmoleukin.</span>
        <meta itemprop="num_attr" content="0307">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Nucleoprotein modulators</span>
        <span itemprop="definition">may be either HBV core or capsid protein inhibitors.</span>
        <meta itemprop="num_attr" content="0308">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Examples of nucleoprotein modulators</span>
        <span itemprop="definition">include GS-4882, AB-423, AT-130, GLS4, NVR-1221, NVR-3778, AL-3778, BAY 41-4109, morphothiadine mesilate, ARB-168786, ARB-880, JNJ-379, RG-7907, HEC-72702, AB-506, ABI-H0731, JNJ-440, ABI-H2158 and DVR-23.</span>
        <meta itemprop="num_attr" content="0308">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">capsid inhibitors</span>
        <span itemprop="definition">include the compounds disclosed in US20140275167 (Novira Therapeutics), US20130251673 (Novira Therapeutics), US20140343032 (Roche), WO2014037480 (Roche), US20130267517 (Roche), WO2014131847 (Janssen), WO2014033176 (Janssen), WO2014033170 (Janssen), WO2014033167 (Janssen), WO2015/059212 (Janssen), WO2015118057 (Janssen), WO2015011281 (Janssen), WO2014184365 (Janssen), WO2014184350 (Janssen), WO2014161888 (Janssen), WO2013096744 (Novira), US20150225355 (Novira), US20140178337 (Novira), US20150315159 (Novira), US20150197533 (Novira), US20150274652 (Novira), US20150259324, (Novira), US20150132</span>
        <meta itemprop="num_attr" content="0309">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">transcript inhibitors</span>
        <span itemprop="definition">include the compounds disclosed in WO2017013046 (Roche), WO2017016960 (Roche), WO2017017042 (Roche), WO2017017043 (Roche), WO2017061466 (Toyoma chemicals), WO2016177655 (Roche), WO2016161268 (Enanta).</span>
        <meta itemprop="num_attr" content="0310">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">WO2017001853</span>
        <span itemprop="definition">Redex Pharma</span>
        <meta itemprop="num_attr" content="0310">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">WO2017211791</span>
        <span itemprop="definition">(Roche)</span>
        <meta itemprop="num_attr" content="0310">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">WO2017216685</span>
        <span itemprop="definition">Novartis</span>
        <meta itemprop="num_attr" content="0310">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">WO2017216686</span>
        <span itemprop="definition">Novartis</span>
        <meta itemprop="num_attr" content="0310">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">WO2018019297</span>
        <span itemprop="definition">Ginkgo Pharma</span>
        <meta itemprop="num_attr" content="0310">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">WO2018022282</span>
        <span itemprop="definition">Newave Pharma</span>
        <meta itemprop="num_attr" content="0310">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">US20180030053</span>
        <span itemprop="definition">Novartis</span>
        <meta itemprop="num_attr" content="0310">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">WO2018045911</span>
        <span itemprop="definition">Zhejiang Pharma</span>
        <meta itemprop="num_attr" content="0310">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Examples of stimulators of retinoic acid-inducible gene 1</span>
        <span itemprop="definition">include SB-9200, SB-40, SB-44, ORI-7246, ORI-9350, ORI-7537, ORI-9020, ORI-9198, and ORI-7170, RGT-100.</span>
        <meta itemprop="num_attr" content="0311">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Examples of stimulators of NOD2</span>
        <span itemprop="definition">include inarigivir soproxil (SB-9200).</span>
        <meta itemprop="num_attr" content="0312">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">PI3K inhibitors</span>
        <span itemprop="definition">include idelalisib, ACP-319, AZD-8186, AZD-8835, buparlisib, CDZ-173, CLR-457, pictilisib, neratinib, rigosertib, rigosertib sodium, EN-3342, TGR-1202, alpelisib, duvelisib, IPI-549, UCB-5857, taselisib, XL-765, gedatolisib, ME-401, VS-5584, copanlisib, CAI orotate, perifosine, RG-7666, GSK-2636771, DS-7423, panulisib, GSK-2269557, GSK-2126458, CUDC-907, PQR-309, INCB-40093, pilaralisib, BAY-1082439, puquitinib mesylate, SAR-2454</span>
        <meta itemprop="num_attr" content="0313">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">IDO inhibitors</span>
        <span itemprop="definition">examples include epacadostat (INCB24360), resminostat (4SC-201), indoximod, F-001287, SN-35837, NLG-919, GDC-0919, GBV-1028, GBV-1012, NKTR-218, and the compounds disclosed in US20100015178 (Incyte), US2016137652 (Flexus Biosciences, Inc.), WO2014073738 (Flexus Biosciences, Inc.), and WO2015188085 (Flexus Biosciences, Inc.).</span>
        <meta itemprop="num_attr" content="0314">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">PD-1 inhibitors</span>
        <span itemprop="definition">include cemiplimab, nivolumab, pembrolizumab, pidilizumab, BGB-108, STI-A1014, SHR-1210, PDR-001, PF-06801591, IBI-308, GB-226, STI-1110, JNJ-63723283, CA-170, durvalumab, atezolizumab and mDX-400, JS-001, Camrelizumab, Sintilimab, Sintilimab, tislelizumab, BCD-100, BGB-A333 JNJ-63723283, GLS-010 (WBP-3055), CX-072, AGEN-2034, GNS-1480 (Epidermal growth factor receptor antagonist; Programmed cell death ligand 1 inhibitor), CS-1001 M-7824 (PD-L1/TGF-   bifunctional fusion protein), Genolimzumab, BMS-936559.</span>
        <meta itemprop="num_attr" content="0315">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Examples of PD-L1 inhibitors</span>
        <span itemprop="definition">include atezolizumab, avelumab, AMP-224, MEDI-0680, RG-7446, GX-P2, durvalumab, KY-1003, KD-033, KN-035, MSB-0010718C, TSR-042, ALN-PDL, STI-A1014, GS-4224, CX-072, and BMS-936559.</span>
        <meta itemprop="num_attr" content="0316">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Examples of PD-1 inhibitors</span>
        <span itemprop="definition">include the compounds disclosed in WO2017112730 (Incyte Corp), WO2017087777 (Incyte Corp), WO2017017624, WO2014151634 (BristolMyers Squibb Co), WO201317322 (BristolMyers Squibb Co), WO2018119286 (Incyte Corp), WO2018119266 (Incyte Corp), WO2018119263 (Incyte Corp), WO2018119236 (Incyte Corp), WO2018119221 (Incyte Corp), WO2018118848 (BristolMyers Squibb Co), WO20161266460 (BristolMyers Squibb Co), WO2017087678 (BristolMyers Squibb Co), WO2016149351 (BristolMyers Squibb Co), WO2015033299 (Aurigene Discovery Technologies Ltd), WO2015179615 (Eisai Co Ltd; Eisai Research Institute),</span>
        <meta itemprop="num_attr" content="0317">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">OX-40 receptor agonists</span>
        <span itemprop="definition">examples include IBI-101</span>
        <meta itemprop="num_attr" content="0318">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">IAP inhibitors</span>
        <span itemprop="definition">examples include APG-1387</span>
        <meta itemprop="num_attr" content="0319">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">recombinant thymosin alpha-1</span>
        <span itemprop="definition">examples include NL-004 and PEGylated thymosin alpha-1.</span>
        <meta itemprop="num_attr" content="0320">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">BTK inhibitors</span>
        <span itemprop="definition">examples include ABBV-105, acalabrutinib (ACP-196), ARQ-531, BMS-986142, dasatinib, ibrutinib, GDC-0853, PRN-1008, SNS-062, ONO-4059, BGB-3111, ML-319, MSC-2364447, RDX-022, X-022, AC-058, RG-7845, spebrutinib, TAS-5315, TP-0158, TP-4207, HM-71224, KBP-7536, M-2951, TAK-020, AC-0025, and the compounds disclosed in US20140330015 (Ono Pharmaceutical), US20130079327 (Ono Pharmaceutical), and US20130217880 (Ono Pharmaceutical).</span>
        <meta itemprop="num_attr" content="0321">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">KDM5 inhibitors</span>
        <span itemprop="definition">include the compounds disclosed in WO2016057924 (Genentech/Constellation Pharmaceuticals), US20140275092 (Genentech/Constellation Pharmaceuticals), US20140371195 (Epitherapeutics) and US20140371214 (Epitherapeutics), US20160102096 (Epitherapeutics), US20140194469 (Quanticel), US20140171432, US20140213591 (Quanticel), US20160039808 (Quanticel), US20140275084 (Quanticel), WO2014164708 (Quanticel).</span>
        <meta itemprop="num_attr" content="0322">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">KDM1 inhibitors</span>
        <span itemprop="definition">include the compounds disclosed in U.S. Pat. No. 9,186,337B2 (Oryzon Genomics), GSK-2879552, and RG-6016.</span>
        <meta itemprop="num_attr" content="0323">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">STING agonists</span>
        <span itemprop="definition">include SB-11285, AdVCA0848, STINGVAX, and compounds disclosed in WO 2018065360 (Biolog Life Science Institute Klaslabor and Biochemica-Vertrieb GmbH, Germany), WO 2018009466 (Aduro Biotech), WO 2017186711 (InvivoGen), WO 2017161349 (Immune Sensor), WO 2017106740 (Aduro Biotech), US 20170158724 (Glaxo Smithkiline), WO 2017075477 (Aduro Biotech), US 20170044206 (Merck), WO 2014179760 (University of California), WO2018098203 (Janssn), WO2018118665 (Merck), WO2018118664 (Merck), WO2018100558 (Takeda), WO2018067423 (Merck), WO2018060323 (Boehringer).</span>
        <meta itemprop="num_attr" content="0324">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">NNRTI</span>
        <span itemprop="definition">examples include the compounds disclosed in WO2018118826 (Merck), WO2018080903 (Merck), WO2018119013 (Merck), WO2017100108 (Idenix), WO2017027434 (Merck), WO2017007701 (Merck), WO2008005555 (Gilead).</span>
        <meta itemprop="num_attr" content="0325">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">hepatitis B virus replication inhibitors</span>
        <span itemprop="definition">examples include isothiafludine, IQP-HBV, RM-5038, and Xingantie.</span>
        <meta itemprop="num_attr" content="0326">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Arginase inhibitors</span>
        <span itemprop="definition">include CB-1158, C-201, and resminostat.</span>
        <meta itemprop="num_attr" content="0327">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Gene therapy and cell therapy</span>
        <span itemprop="definition">include the genetic modification to silence a gene, genetic approaches to directly kill the infected cells, the infusion of immune cells designed to replace most of the patient&#39;s own immune system to enhance the immune response to infected cells, or activate the patient&#39;s own immune system to kill infected cells, or find and kill the infected cells, and/or genetic approaches to modify cellular activity to further alter endogenous immune responsiveness against the infection.</span>
        <meta itemprop="num_attr" content="0328">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a population of immune effector cells engineered to express a chimeric antigen receptor (CAR)</span>
        <span itemprop="definition">can be administered, wherein the CAR comprises an HBV antigen-binding domain.</span>
        <meta itemprop="num_attr" content="0329">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the immune effector cell</span>
        <span itemprop="definition">is a T cell or an NK cell.</span>
        <meta itemprop="num_attr" content="0329">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the T cell</span>
        <span itemprop="definition">is a CD4&#43; T cell, a CD8&#43; T cell, or a combination thereof.</span>
        <meta itemprop="num_attr" content="0329">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Cells</span>
        <span itemprop="definition">can be autologous or allogeneic.</span>
        <meta itemprop="num_attr" content="0329">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">T cells expressing HBV-specific T cell receptors</span>
        <span itemprop="definition">can be administered.</span>
        <meta itemprop="num_attr" content="0330">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">TCR-T cells</span>
        <span itemprop="definition">are engineered to target HBV derived peptides presented on the surface of virus-infected cells.</span>
        <meta itemprop="num_attr" content="0330">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">T-Cells expressing HBV surface antigen (HBsAg)-specific TCR</span>
        <span itemprop="definition">can be administered.</span>
        <meta itemprop="num_attr" content="0331">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV surface antigen (HBsAg)-specific TCR</span>
        <span itemprop="definition">can be administered.</span>
        <meta itemprop="num_attr" content="0331">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">TCR-T therapy directed to treatment of HBV</span>
        <span itemprop="definition">can be administered.</span>
        <meta itemprop="num_attr" content="0332">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with an HBV DNA polymerase inhibitor, one or two additional therapeutic agents selected from the group consisting of immunomodulators, TLR modulators, HBsAg inhibitors, HBsAg secretion or assembly inhibitors, HBV therapeutic vaccines, HBV antibodies including HBV antibodies targeting the surface antigens of the hepatitis B virus and bispecific antibodies and antibody-like therapeutic proteins (such as DARTs, DUOBODIES, BITES, XmAbs, TandAbs, Fab derivatives, or TCR-like antibodies), cyclophilin inhibitors, stimulators of retinoic acid-inducible gene 1, stimulators of RIG-I like receptors, PD-1 inhibitors, PD-L1 inhibitors, Arginase inhibitors, PI3K inhibitors, MO inhibitors, and stimulators of NOD2, and one or two additional therapeutic agents selected from the group</span>
        <meta itemprop="num_attr" content="0333">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with an HBV DNA polymerase inhibitor and at least a second additional therapeutic agent selected from the group consisting of: immunomodulators, TLR modulators, HBsAg inhibitors, HBV therapeutic vaccines, HBV antibodies including HBV antibodies targeting the surface antigens of the hepatitis B virus and bispecific antibodies and antibody-like therapeutic proteins (such as DARTs, DUOBODIES, BITES, XmAbs, TandAbs, Fab derivatives, or TCR-like antibodies), cyclophilin inhibitors, stimulators of retinoic acid-inducible gene 1, stimulators of RIG-I like receptors, PD-1 inhibitors, PD-L1 inhibitors, Arginase inhibitors, PI3K inhibitors, IDO inhibitors, and stimulators of NOD2.</span>
        <meta itemprop="num_attr" content="0334">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a second additional therapeutic agent</span>
        <span itemprop="definition">selected from the group consisting of: immunomodulators, TLR modulators,</span>
        <meta itemprop="num_attr" content="0334">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with an HBV DNA polymerase inhibitor and at least a second additional therapeutic agent selected from the group consisting of: HBV viral entry inhibitors, NTCP inhibitors, HBx inhibitors, cccDNA inhibitors, HBV antibodies targeting the surface antigens of the hepatitis B virus, siRNA, miRNA gene therapy agents, sshRNAs, KDM5 inhibitors, and nucleoprotein modulators (HBV core or capsid protein inhibitors).</span>
        <meta itemprop="num_attr" content="0335">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a second additional therapeutic agent</span>
        <span itemprop="definition">selected from the group consisting of: HBV viral entry inhibitors, NTCP inhibitors, HBx inhibitors, cccDNA inhibitors, HBV antibodies targeting the surface antigens of the hepatitis B virus, siRNA, miRNA gene therapy agents, sshRNAs, KDM5 inhibitors, and nucleoprotein modulators (HBV core or capsid protein inhibitors).</span>
        <meta itemprop="num_attr" content="0335">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with compounds such as those disclosed in U.S. Publication No. 2010/0143301 (Gilead Sciences), U.S. Publication No. 2011/0098248 (Gilead Sciences), U.S. Publication No. 2009/0047249 (Gilead Sciences), U.S. Pat. No. 8,722,054 (Gilead Sciences), U.S. Publication No. 2014/0045849 (Janssen), U.S. Publication No.</span>
        <meta itemprop="num_attr" content="0336">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">2012/0082658</span>
        <span itemprop="definition">(Ventirx Pharma), U.S. Publication No. 2012/0219615 (Ventirx Pharma), U.S. Publication No. 2014/0066432 (Ventirx Pharma), U.S. Publication No. 2014/0088085 (Ventirx Pharma), U.S. Publication No. 2014/0275167 (Novira Therapeutics), U.S. Publication No. 2013/0251673 (Novira Therapeutics), U.S. Pat. No. 8,513,184 (Gilead Sciences), U.S. Publication No. 2014/0030221 (Gilead Sciences), U.S. Publication No. 2013/0344030 (Gilead Sciences), U.S. Publication No.</span>
        <meta itemprop="num_attr" content="0336">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">may be combined with one or more (e.g., one, two, three, four, one or two, one to three, or one to four) additional therapeutic agents in any dosage amount of the engineered meganuclease or nucleic acid.</span>
        <meta itemprop="num_attr" content="0337">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with 5-30 mg tenofovir alafenamide fumarate, tenofovir alafenamide hemifumarate, or tenofovir alafenamide. In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with 5-10; 5-15; 5-20; 5-25; 25-30; 20-30; 15-30; or 10-30 mg tenofovir alafenamide fumarate, tenofovir alafenamide hemifumarate, or tenofovir alafenamide.</span>
        <meta itemprop="num_attr" content="0338">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with 10 mg tenofovir alafenamide fumarate, tenofovir alafenamide hemifumarate, or tenofovir alafenamide. In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with 25 mg tenofovir alafenamide fumarate, tenofovir alafenamide hemifumarate, or tenofovir alafenamide.</span>
        <meta itemprop="num_attr" content="0338">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">An engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">may be combined with the agents provided herein in any dosage amount of the compound (e.g., from 50 mg to 500 mg of compound) the same as if each combination of dosages were specifically and individually listed.</span>
        <meta itemprop="num_attr" content="0338">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with 100-400 mg tenofovir disoproxil fumarate, tenofovir disoproxil hemifumarate, or tenofovir disoproxil.</span>
        <meta itemprop="num_attr" content="0339">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with 100-150; 100-200, 100-250; 100-300; 100-350; 150-200; 150-250; 150-300; 150-350; 150-400; 200-250; 200-300; 200-350; 200-400; 250-350; 250-400; 350-400 or 300-400 mg tenofovir disoproxil fumarate, tenofovir disoproxil hemifumarate, or tenofovir disoproxil.</span>
        <meta itemprop="num_attr" content="0339">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with 300 mg tenofovir disoproxil fumarate, tenofovir disoproxil hemifumarate, or tenofovir disoproxil. In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with 250 mg tenofovir disoproxil fumarate, tenofovir disoproxil hemifumarate, or tenofovir disoproxil.</span>
        <meta itemprop="num_attr" content="0339">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">is combined with 150 mg tenofovir disoproxil fumarate, tenofovir disoproxil hemifumarate, or tenofovir disoproxil.</span>
        <meta itemprop="num_attr" content="0339">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">An engineered meganuclease disclosed herein, or a nucleic acid encoding the same</span>
        <span itemprop="definition">may be combined with the agents provided herein in any dosage amount of the compound (e.g., from 50 mg to 500 mg of compound) the same as if each combination of dosages were specifically and individually listed.</span>
        <meta itemprop="num_attr" content="0339">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">kits</span>
        <span itemprop="definition">comprising an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, in combination with one or more (e.g., one, two, three, four, one or two, or one to three, or one to four) additional therapeutic agents are provided.</span>
        <meta itemprop="num_attr" content="0340">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the second-generation HBV 11-12 meganucleases</span>
        <span itemprop="definition">referred to as HBV 11-12L.363 (SEQ ID NO: 12) and HBV 11-12L.367 (SEQ ID NO: 13), were engineered to recognize and cleave the HBV 11-12 recognition sequence (SEQ ID NO: 10), which is present in multiple Hepatitis B virus genotypes, including genotypes A-G (SEQ ID NOs: 3-9, respectively).</span>
        <meta itemprop="num_attr" content="0343">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Each of these second-generation meganucleases</span>
        <span itemprop="definition">comprises an N-terminal nuclease-localization signal derived from SV40, a first meganuclease subunit, a linker sequence, and a second meganuclease subunit.</span>
        <meta itemprop="num_attr" content="0343">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV11-binding subunits and HBV12-binding subunits</span>
        <span itemprop="definition">each comprise a 56 base pair hypervariable region, referred to as HVR1 and HVR2, respectively.</span>
        <meta itemprop="num_attr" content="0343">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR1 region of each HBV11-binding subunit</span>
        <span itemprop="definition">consists of residues 215-270 of SEQ ID NOs: 12 and 13.</span>
        <meta itemprop="num_attr" content="0344">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV11-binding subunits of HBV 11-12L.363 and HBV 11-12L.367</span>
        <span itemprop="definition">are identical to one another outside of the HVR1 region.</span>
        <meta itemprop="num_attr" content="0344">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR1 region of each HBV 11-12 meganuclease</span>
        <span itemprop="definition">comprises modifications relative to the wild-type I-CreI sequence (SEQ ID NO: 1) at positions 215, 217, 219, 221, 223, 224, 229, 231, 233, 235, 237, 239, 241, 259, 261, 263, 264, 266, and 268.</span>
        <meta itemprop="num_attr" content="0344">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the glycine at residue 262</span>
        <span itemprop="definition">is unmodified in HBV 11-12L.363 and modified to an arginine in HBV 11-12L.367. Although not modified relative to wild-type I-CreI in HBV 11-12L.363, this residue is believed to contribute, in combination with the modified HVR1 residues, to specificity of the nuclease.</span>
        <meta itemprop="num_attr" content="0344">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR1 regions of HBV 11-12L.363 and HBV 11-12L.367</span>
        <span itemprop="definition">each share 85.71% sequence identity to the HVR1 region of the first-generation HBV 11-12x.26 meganuclease.</span>
        <meta itemprop="num_attr" content="0344">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR2 region of each HBV12-binding subunit</span>
        <span itemprop="definition">consists of residues 24-79 of SEQ ID NOs: 12 and 13.</span>
        <meta itemprop="num_attr" content="0345">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV12-binding subunits of HBV 11-12L.363 and HBV 11-12L.367</span>
        <span itemprop="definition">are identical to one another outside of the HVR2 region.</span>
        <meta itemprop="num_attr" content="0345">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR2 region of each HBV 11-12 meganuclease</span>
        <span itemprop="definition">comprises modifications relative to the wild-type I-CreI sequence (SEQ ID NO: 1) at positions 24, 26, 28, 30, 33, 38, 40, 42, 44, 46, 68, 70, 75, and 77.</span>
        <meta itemprop="num_attr" content="0345">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the serine residue at position 32 of SEQ ID NOs: 12 and 13</span>
        <span itemprop="definition">is believed to contribute, in combination with the modified HVR2 residues, to specificity of the nuclease.</span>
        <meta itemprop="num_attr" content="0345">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HVR2 region of HBV 11-12L.363 and HBV 11-12L.367</span>
        <span itemprop="definition">each share 96.43% sequence identity to the HVR2 region of the first-generation HBV 11-12x.26 meganuclease.</span>
        <meta itemprop="num_attr" content="0345">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the first-generation HBV 11-12x.26 meganuclease</span>
        <span itemprop="definition">was evaluated for sequence specificity using a method very similar to GUIDE-seq (Tsai et al. (2015), Nat Biotechnology 33:187-197) but adjusted to find potential off-target sites for meganucleases.</span>
        <meta itemprop="num_attr" content="0346">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">potential off-target sites</span>
        <span itemprop="definition">were identified by capturing a probe oligonucleotide in the double strand DNA break.</span>
        <meta itemprop="num_attr" content="0346">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV nucleases</span>
        <span itemprop="definition">generate a four base pair 3 overhang so the probe oligo also contains randomized four base pair overhangs to improve ligation efficiency at sites more likely created by the nuclease cleavage.</span>
        <meta itemprop="num_attr" content="0346">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12x.26 in HEK 293 cells</span>
        <span itemprop="definition">highlighted a number of positions within the protein-DNA interface that were not discriminating the correct sequence adequately. A library to address all of the problem interfaces would be too large to build and screen in our selection system so, instead, half sites were optimized sequentially.</span>
        <meta itemprop="num_attr" content="0346">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV 11-12 single-chain meganuclease</span>
        <span itemprop="definition">has the monomers fused in an orientation where the HBV12-binding subunit is in the N-terminus and the HBV11-binding subunit is in the C-terminus. Optimization of HBV11 began with re-randomizing amino acids in positions that dictate recognition site specificity.</span>
        <meta itemprop="num_attr" content="0346">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV11 Off</span>
        <span itemprop="definition">5-TtCCtccCCATACTGCGGAACT-3 (SEQ ID NO: 23).</span>
        <meta itemprop="num_attr" content="0346">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Nucleases</span>
        <span itemprop="definition">were evaluated using an integrated iGFFP assay (as described below) to determine on versus off target cleavage.</span>
        <meta itemprop="num_attr" content="0346">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">L.188 and L.190</span>
        <span itemprop="definition">were chosen for subsequent library development. Positions in both the HBV11 and HBV12-binding subunits that contribute to recognition site specificity were randomized in this round of optimization.</span>
        <meta itemprop="num_attr" content="0346">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the libraries</span>
        <span itemprop="definition">were simultaneously positively and negatively selected against the intended target site and either HBV11 Off or HBV12 Off: 5-TGCCGATCCATACTGatGAAaa-3 (SEQ ID NO: 24).</span>
        <meta itemprop="num_attr" content="0346">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the off-targets</span>
        <span itemprop="definition">were alternated between successive rounds of selection.</span>
        <meta itemprop="num_attr" content="0346">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a 96-well plate of individual answers</span>
        <span itemprop="definition">i.e., nucleases</span>
        <meta itemprop="num_attr" content="0346">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Two nucleases, HBV 11-12L.363 and L.367,</span>
        <span itemprop="definition">were identified for further testing and were confirmed by full iGFFP testing (described below) that looks at toxicity of the nuclease over a 7 day period.</span>
        <meta itemprop="num_attr" content="0346">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">each HBV 11-12 meganuclease</span>
        <span itemprop="definition">was evaluated using the CHO cell reporter assay previously described (see WO 2012/167192, FIG. 5).</span>
        <meta itemprop="num_attr" content="0347">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a pair of CHO cell reporter lines</span>
        <span itemprop="definition">were produced which carried a non-functional Green Fluorescent Protein (GFP) gene expression cassette integrated into the genome of the cell.</span>
        <meta itemprop="num_attr" content="0347">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the GFP gene in each cell line</span>
        <span itemprop="definition">was interrupted by a pair of recognition sequences such that intracellular cleavage of either recognition sequence by a meganuclease would stimulate a homologous recombination event resulting in a functional GFP gene.</span>
        <meta itemprop="num_attr" content="0347">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12 cells</span>
        <span itemprop="definition">In both cell lines, one of the recognition sequences was derived from the HBV 11-12 target and the second recognition sequence was specifically recognized by a control meganuclease called CHO 23/24.</span>
        <meta itemprop="num_attr" content="0347">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">CHO reporter cells</span>
        <span itemprop="definition">comprising the HBV 11-12 recognition sequence (SEQ ID NO: 10) and the CHO 23/24 recognition sequence are referred to herein as HBV 11-12 cells.</span>
        <meta itemprop="num_attr" content="0347">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12 cells</span>
        <span itemprop="definition">were transfected with plasmid DNA encoding HBV 11-12L.363 or HBV 11-12L.367, or encoding the CHO 23/24 meganuclease. 4  10 5 CHO cells were transfected with 50 ng of plasmid DNA in a 96-well plate using Lipofectamine 2000 (ThermoFisher) according to the manufacturer&#39;s instructions. At 48 hours post-transfection, cells were evaluated by flow cytometry to determine the percentage of GFP-positive cells compared to an untransfected negative control (1-2 bs).</span>
        <meta itemprop="num_attr" content="0348">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Both HBV 11-12 meganucleases</span>
        <span itemprop="definition">were found to produce GFP-positive cells in cell lines comprising the HBV 11-12 recognition sequence at frequencies significantly exceeding the negative control and exceeding the CHO 23/24 positive control, indicating that each HBV 11-12 meganuclease was able to efficiently recognize and cleave the intended HBV 11-12 recognition sequence in a cell (see, FIG. 6 ).</span>
        <meta itemprop="num_attr" content="0348">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV 11-12 meganucleases</span>
        <span itemprop="definition">were also transfected into HBV11 Off or HBV12 Off cells which contain one of the counter selected off-target sequences between the GFP direct repeats.</span>
        <meta itemprop="num_attr" content="0349">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a desirable nuclease in HBV11 Off or HBV12 Off CHO cells</span>
        <span itemprop="definition">has only background level GFP positive cells because it is able to discriminate against cutting the off-target sequence.</span>
        <meta itemprop="num_attr" content="0349">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the CHO 23-24 target site</span>
        <span itemprop="definition">acts as a positive control in these experiments, demonstrating that the GFP can still be produced if the target site is cut by the CHO 23-24 nuclease.</span>
        <meta itemprop="num_attr" content="0349">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the new nucleases</span>
        <span itemprop="definition">demonstrated a significantly improved (i.e., increased) discrimination against the HBV11 Off ( FIG. 7 ) and HBV12 Off ( FIG. 8 ) recognition sequences compared to the first-generation HBV 11-12x.26 meganuclease.</span>
        <meta itemprop="num_attr" content="0349">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12L.363 and L.367 meganucleases</span>
        <span itemprop="definition">were also determined in a time-dependent manner 2, 5, and 7 days after introduction of the meganucleases into HBV 11-12 cells.</span>
        <meta itemprop="num_attr" content="0350">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12 cells</span>
        <span itemprop="definition">(1.0  10 6 ) were electroporated with 1  10 6 copies of meganuclease mRNA per cell using a BioRad Gene Pulser Xcell according to the manufacturer&#39;s instructions.</span>
        <meta itemprop="num_attr" content="0350">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">cells</span>
        <span itemprop="definition">were evaluated by flow cytometry to determine the percentage of GFP-positive cells.</span>
        <meta itemprop="num_attr" content="0350">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a CHO 23/24 meganuclease</span>
        <span itemprop="definition">was also included at each time point as a positive control.</span>
        <meta itemprop="num_attr" content="0350">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Each of the meganucleases</span>
        <span itemprop="definition">showed a superior GFP-positive percentage relative to CHO 23-24 and the percent GFP continued to increase over the course of the experiment, indicating no gross toxicity to the cells ( FIG. 9 ).</span>
        <meta itemprop="num_attr" content="0350">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the extended iGFFP assay</span>
        <span itemprop="definition">was also used to evaluate the same group of meganucleases for discrimination against the two off targets, HBV11 Off and HBV12 Off, over a 7 day period.</span>
        <meta itemprop="num_attr" content="0351">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">cells containing either HBV11 Off or HBV12 Off, and CHO 23-24</span>
        <span itemprop="definition">were electroporated with 1  10 6 copies of meganuclease mRNA per cell using a BioRad Gene Pulser Xcell according to the manufacturer&#39;s instructions.</span>
        <meta itemprop="num_attr" content="0351">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">cells</span>
        <span itemprop="definition">were evaluated by flow cytometry to determine the percentage of GFP-positive cells.</span>
        <meta itemprop="num_attr" content="0351">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a CHO 23/24 meganuclease</span>
        <span itemprop="definition">was also included at each time point as a positive control.</span>
        <meta itemprop="num_attr" content="0351">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Each of the nucleases</span>
        <span itemprop="definition">showed excellent discrimination against both off-targets over the period observed ( FIGS. 10A and 10B ).</span>
        <meta itemprop="num_attr" content="0351">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an oligo capture assay</span>
        <span itemprop="definition">was used to identify off target cutting induced by the first-generation HBV 11-12x.26 meganuclease and the optimized meganucleases HBV 11-12L.188, HBV 11-12L.363, and HBV 11-12L.367.</span>
        <meta itemprop="num_attr" content="0352">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Off target cutting</span>
        <span itemprop="definition">was first assessed in HepG2 cells which lack the HBV 11-12 recognition sequence in their genome.</span>
        <meta itemprop="num_attr" content="0352">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Off target cutting</span>
        <span itemprop="definition">was then assessed in a lentivirus-modified HepG2 cell line that comprises in its genome a partial HBV genome comprising the HBV 11-12 recognition sequence.</span>
        <meta itemprop="num_attr" content="0352">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the oligo capture assay</span>
        <span itemprop="definition">identifies potential off-target sites produced by the HBV 11-12 meganucleases by capturing an oligonucleotide at break sites within the cell&#39;s genomic DNA.</span>
        <meta itemprop="num_attr" content="0353">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">GUIDE-seq</span>
        <span itemprop="definition">was developed for CRISPR-Cas9 generated DNA breaks and there are a few key modifications to the chemistry and analysis in order to apply this technique to the present nucleases.</span>
        <meta itemprop="num_attr" content="0353">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the engineered meganucleases of the invention</span>
        <span itemprop="definition">generate a four base pair 3 overhang.</span>
        <meta itemprop="num_attr" content="0353">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the oligonucleotides used in oligo capture</span>
        <span itemprop="definition">have randomized four base pair overhangs that could be compatible with the overhangs generated with the HBV 11-12 meganuclease. A higher frequency of insertion is observed due to the greater efficiency of ligating sticky ends rather than blunt ends.</span>
        <meta itemprop="num_attr" content="0353">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Cells</span>
        <span itemprop="definition">were transfected with mRNA encoding the nuclease and the double stranded DNA oligonucleotides. After two days, the genomic DNA from these cells was isolated and sonicated to shear the DNA to smaller sizes.</span>
        <meta itemprop="num_attr" content="0353">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">oligonucleotide adapter</span>
        <span itemprop="definition">was ligated to the sheared DNA and PCR was used to amplify any DNA pieces that contain an adapter at one end and the captured oligonucleotide at the other end.</span>
        <meta itemprop="num_attr" content="0353">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the amplified DNA</span>
        <span itemprop="definition">was purified and sequencing libraries were prepared using standard commercial kits.</span>
        <meta itemprop="num_attr" content="0353">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Sequencing libraries</span>
        <span itemprop="definition">were run on an Illumina MiSeq using V2 2x150 kits. The data was filtered and analyzed for valid sites that captured an oligonucleotide and a potential off-target site is predicted.</span>
        <meta itemprop="num_attr" content="0354">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the protocol</span>
        <span itemprop="definition">needed to be adjusted from the PAM search used for CRISPR-cas9 to the HBV 11-12 meganuclease search.</span>
        <meta itemprop="num_attr" content="0354">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the software</span>
        <span itemprop="definition">developed checks each sequence to make sure there is adapter and captured oligo flanking the sequence to verify that it is a valid read.</span>
        <meta itemprop="num_attr" content="0354">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the software</span>
        <span itemprop="definition">also checks for PCR duplicates and removes reads that are identical to help reduce PCR bias.</span>
        <meta itemprop="num_attr" content="0354">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the sequence reads</span>
        <span itemprop="definition">are aligned to a reference genome and grouped sequences within thousand base pair windows are scanned for a potential HBV 11-12 meganuclease site.</span>
        <meta itemprop="num_attr" content="0354">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Each HBV 11-12 meganuclease</span>
        <span itemprop="definition">is a linked dimer. Each monomer recognizes a nine base pair half site with a four base pair spacer in the center between the two half sites. The software looks for the closest sequence match for each half site with no allowed gaps. The middle four base pairs are not considered in the off-target selection because the HBV 11-12 meganucleases can generally tolerate a higher amount of degeneracy at these positions in the target site. The software outputs a list of potential off-target sites with the number of base mismatches in the combined half sites but not counting the middle four base pair mismatches.</span>
        <meta itemprop="num_attr" content="0355">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the software</span>
        <span itemprop="definition">does not eliminate any off-targets based on an arbitrary mismatch filter, unlike CRISPR-Cas9 which eliminates any off-target identified with more than six base pairs mismatched. Instead, background noise generated from random capture of the oligo at fragile spots or hot spots within the genome can be reduced in two ways.</span>
        <meta itemprop="num_attr" content="0355">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">an untreated mock sample</span>
        <span itemprop="definition">is also run though oligo capture and windows of integration sites without the nuclease present can be subtracted from the nuclease containing samples.</span>
        <meta itemprop="num_attr" content="0355">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">running the assay in triplicate and eliminating any sites that do not repeat in at least two of the three repeats</span>
        <span itemprop="definition">is a good way to empirically remove random integration noise.</span>
        <meta itemprop="num_attr" content="0355">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">read count</span>
        <span itemprop="definition">does not directly correlate with cutting frequency at a particular site, it can generally highlight off-targets that are potentially more concerning or more valid because they occur more often.</span>
        <meta itemprop="num_attr" content="0356">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">One way to graphically visualize the oligo capture data as a measure of number of potentially valid off-target sites</span>
        <span itemprop="definition">is shown in FIG. 11 .</span>
        <meta itemprop="num_attr" content="0356">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Each off-target generated by a particular nuclease</span>
        <span itemprop="definition">is plotted based on the number of unique sequence reads aligned at that site. The number of base pair mismatches between the putative off-target site and the intended site are indicated by color scale with darker colors indicating sites that are more similar to the intended target site. For a nuclease with high-specificity, the intended site should have the highest read count. Better nucleases remove both the higher count sites (to the right of the graph) and the sites with high similarity (darker colored points).</span>
        <meta itemprop="num_attr" content="0356">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">each of the optimized meganucleases</span>
        <span itemprop="definition">lacked the higher read count off-targets and reduced the number of high similarity off-targets observed for the first-generation HBV 11-12x.26 meganuclease.</span>
        <meta itemprop="num_attr" content="0357">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the HBV 11-12L.363 and HBV 11-12L.367 meganucleases</span>
        <span itemprop="definition">exhibited further improvements over the earlier generation HBV 11-12L.118 meganuclease.</span>
        <meta itemprop="num_attr" content="0357">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">oligo capture</span>
        <span itemprop="definition">provides a relative activity of a nuclease to target sites within a sample, it is difficult to determine the extent to which these off-targets are cut without an on-target intended site for comparison.</span>
        <meta itemprop="num_attr" content="0357">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12x.26 and HBV 11-12L.363</span>
        <span itemprop="definition">were compared in the HepG2 HepB cell line, which comprises a partial HBV genome including the HBV 11-12 recognition sequence. While the number of reads aligned at the intended site cannot be compared between samples as a measure of total activity at the intended site, the distance between the points indicating the intended site (circled) and the points indicating off-target sites can be compared. The far larger distance between the intended site and the off-target sites for HBV 11-12L.363 than that of HBV 11-12x.26 indicates a large increase in the specificity of the enzyme and a large decrease in cleavage of off-target sites both in number of sites and percentage cleaved.</span>
        <meta itemprop="num_attr" content="0358">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the optimized meganucleases</span>
        <span itemprop="definition">and particularly HBV 11-12L.363 and HBV 11-12L.367, showed clear superiority in specificity over the parental HBV 11-12x.26 as determined by oligo capture. All three optimized enzymes showed a significant reduction in both highly similar, less frequently cleaved sites, and less similar, more frequently cut sites. Further analysis of HBV 11-12L.363 demonstrated a large increase in the ratio of cleavage activity at the intended site to cleavage activity at off-target sites compared to HBV 11-12x.26.</span>
        <meta itemprop="num_attr" content="0359">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Indels</span>
        <span itemprop="definition">HBV 11-12 meganucleases for causing insertions and/or deletions (indels) at their intended recognition sequence (i.e., the HBV 11-12 recognition sequence). Indel formation was detected in these experiments by either a T7 endonuclease I (T7E) digest or digital PCR analysis.</span>
        <meta itemprop="num_attr" content="0360">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">T7E</span>
        <span itemprop="definition">T7 endonuclease I</span>
        <meta itemprop="num_attr" content="0360">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HepG2 HepB</span>
        <span itemprop="definition">was generated by Precision BioSciences to stably express one copy (as determined by digital PCR) of a   1500 bp region of the Hepatitis B genome including the HBV 11-12 meganuclease target site.</span>
        <meta itemprop="num_attr" content="0361">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HepG2 HepB</span>
        <span itemprop="definition">(5  10 5 ) cells were transfected with mRNA (1   g) encoding HBV 11-12L.26, HBV 11-12L.188, HBV 11-12L.363, HBV 11-12L.367, and HBV 11-12x.26, respectively, using the ThermoFisher Neon Transfection System according to the manufacturer&#39;s protocol.</span>
        <meta itemprop="num_attr" content="0361">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">genomic DNA</span>
        <span itemprop="definition">was isolated from cells for analysis of indel formation by T7E and digital PCR. Genomic DNA from mock transfected HepG2 HepB cells was used as a control.</span>
        <meta itemprop="num_attr" content="0361">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">genomic DNA</span>
        <span itemprop="definition">was PCR amplified using P1 and P2 primers:</span>
        <meta itemprop="num_attr" content="0362">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">P1</span>
        <span itemprop="definition">(SEQ ID NO: 25) [5-gccatttttcataagtgttaacttccgctcctc-3]</span>
        <meta itemprop="num_attr" content="0000">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">P2</span>
        <span itemprop="definition">(SEQ ID NO: 26) [5-cgtgcagtcactatggatcaactacttagatg-3]</span>
        <meta itemprop="num_attr" content="0000">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Amplification</span>
        <span itemprop="definition">was confirmed by visualization of a   1650 bp band on an agarose gel.</span>
        <meta itemprop="num_attr" content="0363">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">PCR-amplified DNA</span>
        <span itemprop="definition">was denatured and slowly rehybridized to allow formation of heteroduplex DNA sequences and then digested with T7 endonuclease I. Digestion products were visualized on an agarose gel.</span>
        <meta itemprop="num_attr" content="0363">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">a FAM-tagged TaqMan probe</span>
        <span itemprop="definition">(T1) was designed to recognize the HBV 11-12 meganuclease target site, as well as a HEX-tagged TaqMan probe (T2) that binds genomic sequence   100 bp downstream of the target site, intended to serve as a reference probe.</span>
        <meta itemprop="num_attr" content="0365">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the probes</span>
        <span itemprop="definition">were multiplexed for genomic DNA amplification using primers P3 and P4.</span>
        <meta itemprop="num_attr" content="0365">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Droplets</span>
        <span itemprop="definition">were gated by fluorescence amplitude to indicate double-positive, double-negative, and single-positive populations. Indels were calculated as the number of HEX-positive droplets divided by the number of double-positive (FAM&#43;/HEX&#43;) droplets.</span>
        <meta itemprop="num_attr" content="0365">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">P3</span>
        <span itemprop="definition">(SEQ ID NO: 27) [5-ggtctgtgccaagtgtttg-3]</span>
        <meta itemprop="num_attr" content="0000">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">P4</span>
        <span itemprop="definition">(SEQ ID NO: 28) [5-gtagacaaaggacgttccg-3]</span>
        <meta itemprop="num_attr" content="0000">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">T1</span>
        <span itemprop="definition">(SEQ ID NO: 29) [5-tgccgatccatactgcggaact-3]</span>
        <meta itemprop="num_attr" content="0000">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">T2</span>
        <span itemprop="definition">(SEQ ID NO: 30) [5-cacagcctagcagccatggaaac-3]</span>
        <meta itemprop="num_attr" content="0000">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Genomic DNA from cells treated with HBV 11-12 meganucleases</span>
        <span itemprop="definition">showed 11-27% gene editing at the recognition site ( FIG. 14 ).</span>
        <meta itemprop="num_attr" content="0366">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">genomic DNA from HBV 11-12L.363-treated cells</span>
        <span itemprop="definition">advantageously yielded the highest efficiency of indel formation at 27%, while the first-generation HBV 11-12x.26 produced 13% indel formation, suggesting enhanced (i.e., increased) activity of the optimized HBV 11-12L.363 meganuclease.</span>
        <meta itemprop="num_attr" content="0366">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12 meganucleases</span>
        <span itemprop="definition">have an ability to achieve 11-27% indel formation at their recognition site.</span>
        <meta itemprop="num_attr" content="0367">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12L.363</span>
        <span itemprop="definition">shows enhanced (i.e., increased) activity for indel formation compared to the first-generation HBV 11-12x.26 meganuclease.</span>
        <meta itemprop="num_attr" content="0367">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HepG2 HepB cells described in Example 2</span>
        <span itemprop="definition">were electroporated with meganuclease-encoding mRNA according to the same protocols as above. In this experiment, two different mRNA batches encoding the HBV 11-12L.363 meganucleases were evaluated.</span>
        <meta itemprop="num_attr" content="0368">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12x.26</span>
        <span itemprop="definition">3605</span>
        <meta itemprop="num_attr" content="0368">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">mRNA encoding HBV 11-12L.363</span>
        <span itemprop="definition">3129</span>
        <meta itemprop="num_attr" content="0368">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">mRNA encoding HBV 11-12L.363</span>
        <span itemprop="definition">3606</span>
        <meta itemprop="num_attr" content="0368">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">An mRNA encoding GFP</span>
        <span itemprop="definition">was also electroporated into cells to serve as a transfection control. GFP-transfected cells were analyzed by flow cytometry, and transfection efficiency exceeded 90%. Cells were collected at 2 days and 6 days post-transfection, and subjected to gDNA isolation and ddPCR analysis as previously described in Example 2. Indel frequency was determined from ddPCR analysis.</span>
        <meta itemprop="num_attr" content="0368">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12L.363</span>
        <span itemprop="definition">which was optimized from HBV 11-12x.26, shows   20% indels 2 days post-transfection, and   33% indels at 6 days post-transfection ( FIG. 15 ).</span>
        <meta itemprop="num_attr" content="0369">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Two batches of mRNA encoding HBV 11-12L.363</span>
        <span itemprop="definition">(3129 and 3606) were tested and showed consistent levels of indel formation. Each of these were superior to the level of indel formation observed using HBV 11-12x.26, which showed   10% and 15% indels at 2 days and 6 days post-transfection, respectively.</span>
        <meta itemprop="num_attr" content="0369">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12L.363 nuclease</span>
        <span itemprop="definition">is significantly more active in producing indels at the HBV 11-12 recognition sequence than the previous generation nuclease, HBV 11-12x.26. Furthermore, consistent levels of indels were observed between mRNA batches of HBV 11-12L.363.</span>
        <meta itemprop="num_attr" content="0370">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12 meganuclease and efficacy for insertions and/or deletions (indels) at their intended recognition sequence in HBV-integrated HepAD38 cells</span>
        <span itemprop="definition">were conducted to evaluate the antiviral activities of HBV 11-12 meganuclease and efficacy for insertions and/or deletions (indels) at their intended recognition sequence in HBV-integrated HepAD38 cells.</span>
        <meta itemprop="num_attr" content="0371">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Antiviral activity, secreted HBs antigen</span>
        <span itemprop="definition">was measured by Hepatitis B Surface Antigen Chemiluminescence Immunoassay (CLIA) kit. Indel formation was detected by GeneART Genomic Cleavage Detection kit.</span>
        <meta itemprop="num_attr" content="0371">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">CLIA</span>
        <span itemprop="definition">Hepatitis B Surface Antigen Chemiluminescence Immunoassay</span>
        <meta itemprop="num_attr" content="0371">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV</span>
        <span itemprop="definition">human hepatitis B virus</span>
        <meta itemprop="num_attr" content="0372">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">DMEM/F12</span>
        <span itemprop="definition">Dulbecco&#39;s modified Eagle&#39;s/F12 medium</span>
        <meta itemprop="num_attr" content="0372">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Thermo Fisher</span>
        <span itemprop="definition">Dulbecco&#39;s modified Eagle&#39;s/F12 medium</span>
        <meta itemprop="num_attr" content="0372">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">fetal bovine serum</span>
        <span itemprop="definition">500   g/ml of Penicillin-Streptomycin-Glutamine, 0.3   g/ml tetracycline, 10 mM HEPES, 1  MEM Non-Essential Amino Acids and 1% Dimethyl sulfoxide at 37 C. and 5% carbon dioxide.</span>
        <meta itemprop="num_attr" content="0372">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HepAD38</span>
        <span itemprop="definition">1.5  10  circumflex over ( )  6 cells were transfected with mRNA (3 ug) encoding HBV 11-12L.363, HBV 11-12x.26 and mCherry (TriLink), respectively, by using the Lipofectamine MessengerMAX (Thermo Fisher), TranslT-mRNA (Mirus), and jetMESSENGER (Polyplus) according to the manufacturer&#39;s instructions.</span>
        <meta itemprop="num_attr" content="0372">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HepAD38 (1.5  10  circumflex over ( )  6) cells</span>
        <span itemprop="definition">were also transfected with mRNA (3 ug) formulated in lipid nanoparticles (LNPs).</span>
        <meta itemprop="num_attr" content="0373">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">LNPs</span>
        <span itemprop="definition">lipid nanoparticles</span>
        <meta itemprop="num_attr" content="0373">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the mix of lipids</span>
        <span itemprop="definition">was stored at   80C and thawed by heating to 50 C. in heat block. Lipid mix was taken off heat and vortexed immediately before use in formulation.</span>
        <meta itemprop="num_attr" content="0373">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">mRNA</span>
        <span itemprop="definition">was stored at   80 C.</span>
        <meta itemprop="num_attr" content="0373">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">LNP transfection</span>
        <span itemprop="definition">was performed with or without apolipoprotein E (1   g/mL).</span>
        <meta itemprop="num_attr" content="0373">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">the mRNA materials encoding the HBV 11-12L.363, HBV 11-12x.26 nucleases</span>
        <span itemprop="definition">comprised a clean cap structure (Trilink) with a uridine substitution to N1-methyl-pseudouridine.</span>
        <meta itemprop="num_attr" content="0374">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">both HBV 11-12L.363 and HBV 11-12x.26</span>
        <span itemprop="definition">showed similar antiviral activity, reducing   50% secreted HBs antigen.</span>
        <meta itemprop="num_attr" content="0376">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">genomic DNA</span>
        <span itemprop="definition">was isolated from cells for analysis of indel formation by GeneART Genomic Cleavage Detection Kit (Thermo Fisher). Genomic DNA from mCherry transfected in HepAD38 cells was used as a control.</span>
        <meta itemprop="num_attr" content="0377">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">genomic DNA</span>
        <span itemprop="definition">was PCR amplified using AD38-F1012 and AD38-R1479 primers:</span>
        <meta itemprop="num_attr" content="0378">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">AD38-F1012</span>
        <span itemprop="definition">(SEQ ID NO: 31) [5-GGTTTTGCTGCCCCATTTACA-3]</span>
        <meta itemprop="num_attr" content="0000">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">AD38-R1479</span>
        <span itemprop="definition">(SEQ ID NO: 32) [5-TCCCAAGCGACCCCGAGAAG-3]</span>
        <meta itemprop="num_attr" content="0000">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">Amplification</span>
        <span itemprop="definition">was confirmed by the visualization of a   467 bp band on an agarose gel.</span>
        <meta itemprop="num_attr" content="0379">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">PCR-amplified DNA</span>
        <span itemprop="definition">was analyzed in the cleavage assay according to the manufacture&#39;s protocol. Digestion products were visualized on an agarose gel.</span>
        <meta itemprop="num_attr" content="0379">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12L.363 and HBV 11-12x.26</span>
        <span itemprop="definition">While mCherry-transfected cells yielded a single band at   467 bp, transfected with HBV 11-12L.363 and HBV 11-12x.26, respectively, yielded two lower molecular weight bands at   267 bp and   200 bp after Detection Enzyme digestion, indicating successful gene editing ( FIG. 17 ). Comparing HBV 11-12L.363 with the first-generation HBV 11-12x.26, the increased intensity of lower bands indicates the higher efficiency of gene editing at the target site was achieved.</span>
        <meta itemprop="num_attr" content="0380">
      </li>
      <li itemprop="definitions" itemscope repeat>
        <span itemprop="subject">HBV 11-12L.363</span>
        <span itemprop="definition">showed similar antiviral activities as HBV 11-12x.26 in HBV-integrated HepAD38 cells by mRNA expression. Both HBV 11-12 meganuclease were capable of reducing   50% HBs antigen secretion and achieving significant indels. Although the antiviral activity observed in these studies is lower than reductions observed in previous lentiviral studies with HBV 11-12x.26, these differences could be attributed to lower delivery efficiency of mRNA transfection vs   100% lentiviral transduction, transient mRNA expression having shorter kinetics than persistent lentiviral expression, in addition to suboptimal timing and assay sensitivity for gene editing efficiency assessment.</span>
        <meta itemprop="num_attr" content="0381">
      </li>
    </ul>
  </section>

  <section>
    <h2>Landscapes</h2>
    <ul>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Health &amp; Medical Sciences</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Life Sciences &amp; Earth Sciences</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Chemical &amp; Material Sciences</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Engineering &amp; Computer Science</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Bioinformatics &amp; Cheminformatics</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Genetics &amp; Genomics</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Organic Chemistry</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Zoology</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Wood Science &amp; Technology</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">General Health &amp; Medical Sciences</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Molecular Biology</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">General Engineering &amp; Computer Science</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Medicinal Chemistry</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Biotechnology</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Biomedical Technology</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Biochemistry</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Microbiology</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Biophysics</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Public Health</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Animal Behavior &amp; Ethology</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Epidemiology</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Pharmacology &amp; Pharmacy</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Veterinary Medicine</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Nanotechnology</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Virology</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Physics &amp; Mathematics</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Immunology</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Plant Pathology</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Medicines That Contain Protein Lipid Enzymes And Other Medicines</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Enzymes And Modification Thereof</span>
        (<span itemprop="type">AREA</span>)
      </li>
      <li itemprop="landscapes" itemscope repeat>
        <span itemprop="name">Micro-Organisms Or Cultivation Processes Thereof</span>
        (<span itemprop="type">AREA</span>)
      </li>
    </ul>
  </section>


  <section itemprop="abstract" itemscope>
    <h2>Abstract</h2>
    
    <div itemprop="content" html><abstract mxw-id="PA338320055" lang="EN" load-source="patent-office">
    <div id="p-0001" num="0000" class="abstract">The present invention encompasses engineered nucleases which recognize and cleave a recognition sequence within a Hepatitis B virus (HBV) genome. The engineered meganucleases can exhibit at least one optimized characteristic, such as enhanced specificity and/or efficiency of indel formation, when compared to the first-generation meganuclease HBV 11-12x.26. Further, the invention encompasses pharmaceutical compositions comprising engineered meganuclease proteins, nucleic acids encoding engineered meganucleases, and the use of such compositions for treating HBV infections or hepatocellular carcinoma.</div>
  </abstract>
  </div>
  </section>

  <section itemprop="description" itemscope>
    <h2>Description</h2>
    
    <div itemprop="content" html><ul mxw-id="PDES220807713" lang="EN" load-source="patent-office" class="description">
    
    <heading id="h-0001">FIELD OF THE INVENTION</heading>
    <li> <para-num num="[0001]"> </para-num> <div id="p-0002" num="0001" class="description-line">The invention relates to the field of oncology, molecular biology and recombinant nucleic acid technology. In particular, the invention relates to optimized engineered meganucleases having specificity for a recognition sequence within the genome of genotypes A-G of the Hepatitis B virus. Such engineered meganucleases are useful in methods for treating Hepatitis B virus infections and hepatocellular carcinoma caused by Hepatitis B virus.</div>
    </li> <heading id="h-0002">REFERENCE TO A SEQUENCE LISTING SUBMITTED AS A TEXT FILE VIA EFS-WEB</heading>
    <li> <para-num num="[0002]"> </para-num> <div id="p-0003" num="0002" class="description-line">The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Apr. 11, 2019, is named P1090.70029US01-SEQ-MJT, and is 52 kilobytes in size.</div>
    </li> <heading id="h-0003">BACKGROUND OF THE INVENTION</heading>
    <li> <para-num num="[0003]"> </para-num> <div id="p-0004" num="0003" class="description-line">The Hepatitis B virus (HBV) is a major health problem worldwide and more than 350 million people are chronic carriers. HBV infection is a serious and common infectious disease of the liver. Chronic infection is associated with an increased risk to develop severe liver diseases, including liver cirrhosis and hepatocellular carcinoma (HCC), one of the most common forms of human cancer. The estimated risk of HCC in chronic HBV carriers is approximately 100 times greater than in uninfected individuals. About a third of the world population has been infected at one point in their lives, including 240 million to 350 million who have chronic infections. Over 750,000 people die of hepatitis B each year. About 300,000 of these are due to liver cancer. Currently available anti-HBV drugs have limitations. For example, interferon alpha administration is associated with severe adverse reactions. Nucleoside analogues are virostatic and require long-term administration.</div>
    </li> <li> <para-num num="[0004]"> </para-num> <div id="p-0005" num="0004" class="description-line">The HBV genome exhibits genetic variability with an estimated rate of 1.4-3.210<sup>5 </sup>nucleotide substitutions per site per year. A large number of virus variants arise during replication as a result of nucleotide misincorporations in the absence of any proof reading capacity by the viral polymerase. This variability has resulted in well-recognized subtypes of the virus. HBV has been classified into well-defined genotypes on the basis of an inter-group divergence of 8% or more in the complete genomic sequence, each having a distinct geographical distribution. For example, Genotype A is widespread in sub-Saharan Africa, Northern Europe, and Western Africa; genotypes B and C are common in Asia; genotype C is primarily observed in Southeast Asia; genotype D is dominant in Africa, Europe, Mediterranean countries, and India; genotype G is reported in France, Germany, and the United States; and genotype H is commonly encountered in Central and South America. Genotype I has recently been reported in Vietnam and Laos. The newest HBV genotype, genotype J, has been identified in the Ryukyu Islands in Japan.</div>
    </li> <li> <para-num num="[0005]"> </para-num> <div id="p-0006" num="0005" class="description-line">HBV is an enveloped DNA virus that belongs to the Hepadnaviridae family. It contains a small, partially double-stranded (DS), relaxed-circular DNA (rcDNA) genome that replicates by reverse transcription of an RNA intermediate, the pregenomic RNA (pgRNA). The circular DNA genome of HBV is unusual because the DNA is not fully double-stranded. One end of the full length strand is linked to the viral DNA polymerase. The genome is approximately 3020-3320 nucleotides long (for the full-length strand) and 1700-2800 nucleotides long (for the short length-strand). The negative-sense (non-coding) is complementary to the viral mRNA.</div>
    </li> <li> <para-num num="[0006]"> </para-num> <div id="p-0007" num="0006" class="description-line">There are four known genes encoded by the genome, referred to as C, X, P, and S. The core protein is coded for by gene C (HBcAg), and its start codon is preceded by an upstream in-frame AUG start codon from which the pre-core protein is produced. The HBeAg is produced by proteolytic processing of the pre-core protein. The DNA polymerase is encoded by gene P. Gene S codes for the surface antigen (HBsAg). The HBsAg gene is one long open reading frame but contains three in frame start (ATG) codons that divide the gene into three sections: pre-S1, pre-S2, and S. Because of the multiple start codons, polypeptides of three different sizes called Large (the order from surface to the inside: pre-S 1/pre-S2/S), Middle (pre-S2/S), and Small (S) are produced. The function of the protein coded for by gene X is not fully understood but it is associated with the development of liver cancer. It stimulates genes that promote cell growth and inactivates growth regulating molecules.</div>
    </li> <li> <para-num num="[0007]"> </para-num> <div id="p-0008" num="0007" class="description-line">The viral DNA is found in the nucleus soon after infection of the cell. The partially double-stranded DNA is rendered fully double-stranded by completion of the (+) sense strand and removal of a protein molecule from the () sense strand and a short sequence of RNA from the (+) sense strand. Non-coding bases are removed from the ends of the () sense strand and the ends are rejoined.</div>
    </li> <li> <para-num num="[0008]"> </para-num> <div id="p-0009" num="0008" class="description-line">The HBV life cycle begins when the virus attaches to the host cell and is internalized. Recent studies have demonstrated that sodium-taurocholate co-transporting polypeptide (NTCP) is a functional receptor in HBV infection. The virion relaxed circular DNA (rcDNA) is delivered to the nucleus, where it is repaired to form a covalently closed-circular DNA (cccDNA). The episomal cccDNA serves as the template for the transcription of the pregenomic RNA (pgRNA) and the other viral mRNAs by the host RNA polymerase II. The transcripts are then exported to the cytoplasm, where translation of the viral proteins occurs. Reverse transcriptase (RT) binds to pgRNA and triggers assembly of the core proteins into immature, RNA-containing nucleocapsids. The immature nucleocapsids then undergo a process of maturation whereby pgRNA is reversed transcribed by RT to make the mature rcDNA. A unique feature of hepadnavirus reverse transcription is the RT primed initiation of minus-strand DNA synthesis, which leads to the covalent linkage of RT to the 5 end of the minus-strand DNA.</div>
    </li> <li> <para-num num="[0009]"> </para-num> <div id="p-0010" num="0009" class="description-line">The mature, rcDNA-containing nucleocapsids are then enveloped by the viral surface proteins and secreted as virions (secretion pathway) or, alternatively, are recycled back to the nucleus to further amplify the pool of cccDNA (recycling pathway). Persistence of cccDNA in hepatocytes plays a key role in viral persistence, reactivation of viral replication after cessation of antiviral therapy, and resistance to therapy.</div>
    </li> <li> <para-num num="[0010]"> </para-num> <div id="p-0011" num="0010" class="description-line">Homing endonucleases are a group of naturally-occurring nucleases which recognize 15-40 base-pair cleavage sites commonly found in the genomes of plants and fungi. They are frequently associated with parasitic DNA elements, such as <figure-callout id="1" label="group" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">group</figure-callout> 1 self-splicing introns and inteins. They naturally promote homologous recombination or gene insertion at specific locations in the host genome by producing a double-stranded break in the chromosome, which recruits the cellular DNA-repair machinery (Stoddard (2006), Q. Rev. Biophys. 38: 49-95). Homing endonucleases are commonly grouped into four families: the LAGLIDADG (SEQ ID NO: 2) family, the GIY-YIG family, the His-Cys box family and the HNH family. These families are characterized by structural motifs, which affect catalytic activity and recognition sequence. For instance, members of the LAGLIDADG (SEQ ID NO: 2) family are characterized by having either one or two copies of the conserved LAGLIDADG (SEQ ID NO: 2) motif (see Chevalier et al. (2001), Nucleic Acids Res. 29(18): 3757-3774). The LAGLIDADG (SEQ ID NO: 2) homing endonucleases with a single copy of the LAGLIDADG (SEQ ID NO: 2) motif form homodimers, whereas members with two copies of the LAGLIDADG (SEQ ID NO: 2) motif are found as monomers. Methods for producing homing endonucleases are known in the art.</div>
    </li> <li> <para-num num="[0011]"> </para-num> <div id="p-0012" num="0011" class="description-line">I-CreI (SEQ ID NO: 1) is a member of the LAGLIDADG (SEQ ID NO: 2) family of homing endonucleases which recognizes and cuts a 22 basepair recognition sequence in the chloroplast chromosome of the algae <i>Chlamydomonas reinhardtii</i>. Genetic selection techniques have been used to modify the wild-type I-CreI cleavage site preference (Sussman et al. (2004), J. Mol. Biol. 342: 31-41; Chames et al. (2005), Nucleic Acids Res. 33: e178; Seligman et al. (2002), Nucleic Acids Res. 30: 3870-9, Arnould et al. (2006), J. Mol. Biol. 355: 443-58). Methods for rationally-designing mono-LAGLIDADG (SEQ ID NO: 2) homing endonucleases were described which are capable of comprehensively redesigning I-CreI and other homing endonucleases to target widely-divergent DNA sites, including sites in mammalian, yeast, plant, bacterial, and viral genomes (see, e.g., WO 2007/047859).</div>
    </li> <li> <para-num num="[0012]"> </para-num> <div id="p-0013" num="0012" class="description-line">As first described in WO 2009/059195, I-CreI and its engineered derivatives are normally dimeric but can be fused into a single polypeptide using a short peptide linker that joins the C-terminus of a first subunit to the N-terminus of a second subunit (see also Li et al. (2009), Nucleic Acids Res. 37:1650-62; Grizot et al. (2009), Nucleic Acids Res. 37:5405-19). Thus, a functional single-chain meganuclease can be expressed from a single transcript.</div>
    </li> <li> <para-num num="[0013]"> </para-num> <div id="p-0014" num="0013" class="description-line">The use of engineered meganucleases for treatment of HBV infections has been suggested. For example, WO 2010/136841 suggests the use of engineered meganucleases for cleaving the genome of non-genomically integrating viruses. Such meganucleases include variants of I-CreI targeting 22 base pair meganuclease recognition sequences which differ from those disclosed herein, and which are only present in a few HBV genotypes.</div>
    </li> <li> <para-num num="[0014]"> </para-num> <div id="p-0015" num="0014" class="description-line">Applicants previously disclosed in PCT/US2017/56638 a number of first-generation engineered meganucleases having specificity for recognition sequences present in the HBV genome, including the HBV 11-12 recognition sequence (SEQ ID NO: 10) which is advantageously present in the genome of at least HBV genotypes A-G (SEQ ID NOs: 3-9).</div>
    </li> <li> <para-num num="[0015]"> </para-num> <div id="p-0016" num="0015" class="description-line">The present invention improves upon the engineered meganucleases previously described in the art in a number of aspects. When generating an endonuclease for therapeutic administration to a patient, it is critical that on-target specificity is enhanced (i.e., increased) while reducing or eliminating off-target cutting within the target cell genome. Here, Applicants have developed second-generation engineered meganucleases which target the HBV 11-12 recognition sequence. The meganucleases of the present invention have novel and unique sequences which were generated through extensive experimentation. Additionally, these second-generation meganucleases have a number of improved and unexpected properties when compared to the previously disclosed first-generation nucleases, including a significant reduction in off-target cutting in the host cell genome and enhanced (i.e., increased) formation of indels (i.e., insertions or deletions within the HBV genome at the cleavage site, indicative of on-target cutting) in cell lines comprising an integrated copy of the HBV genome. Thus, the meganucleases of the invention advance the art in a number of ways that are necessary for development of a clinical product targeting HBV infection and HBV-related hepatocellular carcinoma.</div>
    </li> <heading id="h-0004">SUMMARY OF THE INVENTION</heading>
    <li> <para-num num="[0016]"> </para-num> <div id="p-0017" num="0016" class="description-line">The present invention provides second-generation engineered meganucleases that recognize and cleave a recognition sequence conserved across multiple genotypes of Hepatitis B viruses. Cleavage at the recognition sequence by an engineered meganuclease disclosed herein can disrupt expression of one or more viral proteins due to non-homologous end joining (NHEJ) at the cleavage site. NHEJ can result in insertions, deletions, or result in a frameshift mutation that can interfere with gene expression. Alternatively, a suicide gene can be introduced into a Hepatitis B virus (HBV) genome via homologous recombination. In another embodiment, the HBV genome or cccDNA may be degraded following cleavage at the HBV 11-12 recognition sequence. Accordingly, by interrupting normal gene expression, the infection and proliferation of HBV can be reduced or eliminated according to the methods disclosed herein. Such meganucleases are, therefore, useful for treating or reducing the proliferation of HBV in infected individuals worldwide.</div>
    </li> <li> <para-num num="[0017]"> </para-num> <div id="p-0018" num="0017" class="description-line">Suppression or eradication of the replication of HBV in the liver leads to improved liver pathology and decreased progression to liver cirrhosis and hepatocellular carcinoma (HCC). Thus, the present invention also provides pharmaceutical compositions and methods for treatment of a subject having HBV or HCC which utilize an engineered meganuclease having specificity for a recognition sequence comprising SEQ ID NO: 10 within a Hepatitis B virus genome. The present invention further provides methods of delivering the engineered meganucleases disclosed herein, or a nucleic acid encoding the same, to a subject infected with HBV in order to reduce the level of HBV virus or HBV cccDNA and/or reduce the symptoms associated with an HBV infection.</div>
    </li> <li> <para-num num="[0018]"> </para-num> <div id="p-0019" num="0018" class="description-line">In some embodiments, the presently disclosed engineered meganucleases exhibit at least one optimized characteristic in comparison to the first-generation meganuclease HBV 11-12x.26. Such optimized characteristics include improved (i.e., increased) specificity resulting in reduced off-target cutting, and enhanced (i.e., increased) efficiency of cleavage and indel formation at the HBV 11-12 recognition sequence, for example in cells comprising an integrated copy of the HBV genome.</div>
    </li> <li> <para-num num="[0019]"> </para-num> <div id="p-0020" num="0019" class="description-line">Thus, in one aspect, the invention provides an engineered meganuclease that recognizes and cleaves the HBV 11-12 recognition sequence (SEQ ID NO: 10) within a Hepatitis B virus genome. The engineered meganuclease comprises a first subunit and a second subunit, wherein the first subunit binds to a first recognition half-site of the recognition sequence and comprises a first hypervariable (HVR1) region, wherein the second subunit binds to a second recognition half site of the recognition sequence and comprises a second hypervariable (HVR2) region, and wherein said HVR1 has at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 215-270 of the presently disclosed HBV 11-12L.363 meganuclease (the amino acid sequence of which is set forth as SEQ ID NO: 12) or the presently disclosed HBV 11-12L.367 meganuclease (the amino acid sequence of which is set forth as SEQ ID NO: 13).</div>
    </li> <li> <para-num num="[0020]"> </para-num> <div id="p-0021" num="0020" class="description-line">In certain embodiments, the HVR1 region comprises an amino acid sequence corresponding to residues 215-270 of SEQ ID NOs: 12 or 13 with up to 1, 2, 3, 4, 5, 6, or 7 amino acid substitutions.</div>
    </li> <li> <para-num num="[0021]"> </para-num> <div id="p-0022" num="0021" class="description-line">In some embodiments, the HVR1 region comprises residues corresponding to residues 223, 233, 239, 241, 259, 263, 264, and 268 of SEQ ID NO: 12. In some embodiments, the HVR1 region comprises residues corresponding to residues 223, 233, 241, 259, 262, 263, 264, and 268 of SEQ ID NO: 13.</div>
    </li> <li> <para-num num="[0022]"> </para-num> <div id="p-0023" num="0022" class="description-line">In some embodiments, the HVR1 region comprises residues corresponding to residues 215, 217, 219, 221, 223, 224, 229, 231, 233, 235, 237, 259, 261, 266, and 268 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0023]"> </para-num> <div id="p-0024" num="0023" class="description-line">In some embodiments, the HVR1 region comprises residues corresponding to residues 239, 241, 263, and 264 of SEQ ID NO: 12.</div>
    </li> <li> <para-num num="[0024]"> </para-num> <div id="p-0025" num="0024" class="description-line">In some embodiments, the HVR1 region comprises residues corresponding to residues 241, 262, 263, and 264 of SEQ ID NO: 13.</div>
    </li> <li> <para-num num="[0025]"> </para-num> <div id="p-0026" num="0025" class="description-line">In some embodiments, the HVR1 region comprises residues corresponding to residues 215, 217, 219, 221, 223, 224, 229, 231, 233, 235, 237, 239, 241, 259, 261, 262, 263, 264, 266, and 268 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0026]"> </para-num> <div id="p-0027" num="0026" class="description-line">In certain embodiments, the HVR1 region comprises Y, R, K, or D at a residue corresponding to residue 257 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0027]"> </para-num> <div id="p-0028" num="0027" class="description-line">In certain embodiments, the HVR1 region comprises residues 215-270 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0028]"> </para-num> <div id="p-0029" num="0028" class="description-line">In particular embodiments, the first subunit comprises an amino acid sequence having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 198-344 of SEQ ID NO: 12 or 13. In certain embodiments, the first subunit comprises an amino acid sequence having at least 94% sequence identity to residues 198-344 of SEQ ID NO: 12 or 13. In some embodiments, the first subunit comprises an amino acid sequence corresponding to residues 198-344 of SEQ ID NOs: 12 or 13 with up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 amino acid substitutions.</div>
    </li> <li> <para-num num="[0029]"> </para-num> <div id="p-0030" num="0029" class="description-line">In certain embodiments, the first subunit comprises G, S, or A at a residue corresponding to residue 210 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0030]"> </para-num> <div id="p-0031" num="0030" class="description-line">In certain embodiments, the first subunit comprises E, Q, or K at a residue corresponding to residue 271 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0031]"> </para-num> <div id="p-0032" num="0031" class="description-line">In certain embodiments, the first subunit comprises a residue corresponding to residue 271 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0032]"> </para-num> <div id="p-0033" num="0032" class="description-line">In particular embodiments, the first subunit comprises residues 198-344 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0033]"> </para-num> <div id="p-0034" num="0033" class="description-line">In some such embodiments, the HVR2 region comprises an amino acid sequence having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 24-79 of SEQ ID NO: 12 or 13. In certain embodiments, the HVR2 region comprises an amino acid sequence corresponding to residues 24-79 of SEQ ID NOs: 12 or 13 with up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11 amino acid substitutions.</div>
    </li> <li> <para-num num="[0034]"> </para-num> <div id="p-0035" num="0034" class="description-line">In certain embodiments, the HVR2 region comprises residues corresponding to residues 26 and 77 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0035]"> </para-num> <div id="p-0036" num="0035" class="description-line">In certain embodiments, the HVR2 region comprises residues corresponding to <figure-callout id="24" label="residues" filenames="US20190338263A1-20191107-D00005.png" state="{{state}}"> <figure-callout id="30" label="residues" filenames="US20190338263A1-20191107-D00006.png,US20190338263A1-20191107-D00009.png" state="{{state}}"> <figure-callout id="40" label="residues" filenames="US20190338263A1-20191107-D00009.png,US20190338263A1-20191107-D00010.png" state="{{state}}"> <figure-callout id="70" label="residues" filenames="US20190338263A1-20191107-D00009.png" state="{{state}}"> <figure-callout id="75" label="residues" filenames="US20190338263A1-20191107-D00011.png" state="{{state}}">residues</figure-callout> </figure-callout> </figure-callout> </figure-callout> </figure-callout> 24, 26, 28, 30, 32, 33, 38, 40, 42, 44, 46, 68, 70, 75, and 77 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0036]"> </para-num> <div id="p-0037" num="0036" class="description-line">In certain embodiments, the HVR2 region comprises Y, R, K, or D at a residue corresponding to residue 66 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0037]"> </para-num> <div id="p-0038" num="0037" class="description-line">In particular embodiments, the HVR2 region comprises residues 24-79 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0038]"> </para-num> <div id="p-0039" num="0038" class="description-line">In some embodiments, the second subunit comprises an amino acid sequence having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 7-153 of SEQ ID NO: 12 or 13. In certain embodiments, the second subunit comprises an amino acid sequence having at least 99% sequence identity to an amino acid sequence corresponding to residues 7-153 of SEQ ID NO: 12 or 13. In particular embodiments, the second subunit comprises an amino acid sequence corresponding to residues 7-153 of SEQ ID NOs: 12 or 13 with up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 amino acid substitutions.</div>
    </li> <li> <para-num num="[0039]"> </para-num> <div id="p-0040" num="0039" class="description-line">In certain embodiments, the second subunit comprises G, S, or A at a residue corresponding to residue 19 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0040]"> </para-num> <div id="p-0041" num="0040" class="description-line">In certain embodiments, the second subunit comprises E, Q, or K at a residue corresponding to <figure-callout id="80" label="residue" filenames="US20190338263A1-20191107-D00016.png" state="{{state}}">residue</figure-callout> 80 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0041]"> </para-num> <div id="p-0042" num="0041" class="description-line">In certain embodiments, the second subunit comprises a residue corresponding to <figure-callout id="80" label="residue" filenames="US20190338263A1-20191107-D00016.png" state="{{state}}">residue</figure-callout> 80 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0042]"> </para-num> <div id="p-0043" num="0042" class="description-line">In particular embodiments, the second subunit comprises residues 7-153 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0043]"> </para-num> <div id="p-0044" num="0043" class="description-line">In some embodiments, the first subunit of the engineered meganuclease has at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 198-344 of SEQ ID NO: 12 or 13, and the second subunit comprises an amino acid sequence having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 7-153 of SEQ ID NO: 12 or 13. In particular embodiments, the first subunit of the engineered meganuclease has at least 94% sequence identity to an amino acid sequence corresponding to residues 198-344 of SEQ ID NO: 12 or 13, and the second subunit comprises an amino acid sequence having at least 99% sequence identity to an amino acid sequence corresponding to residues 7-153 of SEQ ID NO: 12 or 13. In certain embodiments, the first subunit and/or the second subunit can comprise up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 amino acid substitutions relative to residues 198-344 and residues 7-153, respectively, of SEQ ID NOs: 12 and 13.</div>
    </li> <li> <para-num num="[0044]"> </para-num> <div id="p-0045" num="0044" class="description-line">In certain embodiments, the engineered meganuclease comprises a linker, wherein the linker covalently joins the first subunit and the second subunit.</div>
    </li> <li> <para-num num="[0045]"> </para-num> <div id="p-0046" num="0045" class="description-line">In some embodiments, the engineered meganuclease comprises an amino acid sequence having at least about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99% sequence identity to the amino acid sequence of SEQ ID NO: 12 or 13. In certain embodiments, the engineered meganuclease comprises an amino acid sequence having at least 97% sequence identity to the amino acid sequence of SEQ ID NO: 12.</div>
    </li> <li> <para-num num="[0046]"> </para-num> <div id="p-0047" num="0046" class="description-line">In particular embodiments, the engineered meganuclease comprises the amino acid sequence of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0047]"> </para-num> <div id="p-0048" num="0047" class="description-line">In another aspect, the invention provides a polynucleotide comprising a nucleic acid sequence encoding an engineered meganuclease described herein.</div>
    </li> <li> <para-num num="[0048]"> </para-num> <div id="p-0049" num="0048" class="description-line">In certain embodiments, the polynucleotide is an mRNA.</div>
    </li> <li> <para-num num="[0049]"> </para-num> <div id="p-0050" num="0049" class="description-line">In further embodiments, the mRNA is a polycistronic mRNA encoding one or more engineered meganucleases described herein. In certain embodiments, the polycistronic mRNA encodes at least one of the presently disclosed engineered meganucleases which recognizes and cleaves a recognition sequence comprising SEQ ID NO: 10, and a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. In some of these embodiments, the second recognition sequence comprises the HBV 5-6 recognition sequence (which is set forth as SEQ ID NO: 21).</div>
    </li> <li> <para-num num="[0050]"> </para-num> <div id="p-0051" num="0050" class="description-line">In further embodiments, a polycistronic mRNA of the invention can encode one or more engineered meganucleases described herein and one or more additional proteins that induce a therapeutically beneficial effect in an HBV-infected cell and/or HBV-infected subject.</div>
    </li> <li> <para-num num="[0051]"> </para-num> <div id="p-0052" num="0051" class="description-line">In another aspect, the invention provides a recombinant DNA construct comprising a polynucleotide described herein. In some embodiments, the recombinant DNA construct comprises a cassette comprising a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein. In other embodiments, the recombinant DNA construct comprises at least a first cassette and a second cassette, wherein the first cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein, and wherein the second cassette comprises a promoter and a nucleic acid sequence encoding a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. In some of these embodiments, the second recognition sequence comprises SEQ ID NO: 21.</div>
    </li> <li> <para-num num="[0052]"> </para-num> <div id="p-0053" num="0052" class="description-line">In other embodiments, the recombinant DNA construct comprises a cassette comprising a promoter and a polycistronic nucleic acid sequence, wherein the promoter drives expression of the polycistronic nucleic acid sequence to generate a polycistronic mRNA described herein in a target cell.</div>
    </li> <li> <para-num num="[0053]"> </para-num> <div id="p-0054" num="0053" class="description-line">In certain embodiments, the recombinant DNA construct encodes a viral vector comprising a nucleic acid sequence encoding an engineered meganuclease disclosed herein. In particular embodiments, the viral vector is a recombinant AAV vector.</div>
    </li> <li> <para-num num="[0054]"> </para-num> <div id="p-0055" num="0054" class="description-line">In another aspect, the invention provides a viral vector comprising a nucleic acid sequence encoding an engineered meganuclease described herein. In particular embodiments, the viral vector is a recombinant AAV vector.</div>
    </li> <li> <para-num num="[0055]"> </para-num> <div id="p-0056" num="0055" class="description-line">In some embodiments, the viral vector comprises a cassette comprising a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein. In other embodiments, the viral vector comprises at least a first cassette and a second cassette, wherein the first cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein, and wherein the second cassette comprises a promoter and a nucleic acid sequence encoding a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. In some of these embodiments, the second recognition sequence comprises SEQ ID NO: 21.</div>
    </li> <li> <para-num num="[0056]"> </para-num> <div id="p-0057" num="0056" class="description-line">In other embodiments, the viral vector comprises one cassette comprising a promoter and a polycistronic nucleic acid sequence, wherein the promoter drives expression of the polycistronic nucleic acid sequence to generate a polycistronic mRNA described herein in a target cell.</div>
    </li> <li> <para-num num="[0057]"> </para-num> <div id="p-0058" num="0057" class="description-line">In another aspect, the invention provides a pharmaceutical composition for treatment of a subject having Hepatitis B virus or hepatocellular carcinoma caused by Hepatitis B virus, the pharmaceutical composition comprising a pharmaceutically acceptable carrier and: (a) a nucleic acid encoding an engineered meganuclease described herein; or (b) an engineered meganuclease described herein.</div>
    </li> <li> <para-num num="[0058]"> </para-num> <div id="p-0059" num="0058" class="description-line">In one embodiment, the nucleic acid sequence of the pharmaceutical composition encoding an engineered meganuclease disclosed herein is an mRNA described herein. In some such embodiments, the mRNA can be a polycistronic mRNA described herein, such that an engineered meganuclease described herein is expressed in the target cell in vivo, along with a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. In some of these embodiments, the second recognition sequence comprises SEQ ID NO: 21.</div>
    </li> <li> <para-num num="[0059]"> </para-num> <div id="p-0060" num="0059" class="description-line">In another embodiment, the pharmaceutical composition comprises a recombinant DNA construct described herein comprising the nucleic acid sequence encoding an engineered meganuclease disclosed herein. In some such embodiments, the recombinant DNA construct comprises a cassette comprising a promoter and a nucleic acid sequence encoding an engineered meganuclease of the invention. In other embodiments, the recombinant DNA construct of the pharmaceutical composition comprises at least a first cassette and a second cassette, wherein the first cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein, and wherein the second cassette comprises a promoter and a nucleic acid sequence encoding a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. In some of these embodiments, the second recognition sequence comprises SEQ ID NO: 21.</div>
    </li> <li> <para-num num="[0060]"> </para-num> <div id="p-0061" num="0060" class="description-line">In other embodiments, the recombinant DNA construct of the pharmaceutical composition comprises a cassette comprising a promoter and a polycistronic nucleic acid sequence, wherein the promoter drives expression of the polycistronic nucleic acid sequence to generate a polycistronic mRNA described herein in the target cell in vivo.</div>
    </li> <li> <para-num num="[0061]"> </para-num> <div id="p-0062" num="0061" class="description-line">In another embodiment, the pharmaceutical composition comprises a viral vector comprising the nucleic acid sequence encoding an engineered meganuclease disclosed herein. In one such embodiment, the viral vector can be a retrovirus, a lentivirus, an adenovirus, or an AAV. In a particular embodiment, the viral vector can be a recombinant AAV vector.</div>
    </li> <li> <para-num num="[0062]"> </para-num> <div id="p-0063" num="0062" class="description-line">In some such embodiments, the viral vector comprises a cassette comprising a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein. In other embodiments, the viral vector comprises at least a first cassette and a second cassette, wherein the first cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein, and wherein the second cassette comprises a promoter and a nucleic acid sequence encoding a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. In some of these embodiments, the second recognition sequence comprises SEQ ID NO: 21.</div>
    </li> <li> <para-num num="[0063]"> </para-num> <div id="p-0064" num="0063" class="description-line">In other such embodiments, the viral vector comprises one cassette comprising a promoter and a polycistronic nucleic acid sequence, wherein the promoter drives expression of the polycistronic nucleic acid sequence to generate a polycistronic mRNA described herein in the target cell in vivo.</div>
    </li> <li> <para-num num="[0064]"> </para-num> <div id="p-0065" num="0064" class="description-line">In other embodiments, the pharmaceutical composition comprises an engineered meganuclease described herein. In various embodiments, the pharmaceutical composition comprises an engineered meganuclease described herein and a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. In some of these embodiments, the second recognition sequence comprises SEQ ID NO: 21.</div>
    </li> <li> <para-num num="[0065]"> </para-num> <div id="p-0066" num="0065" class="description-line">In still other embodiments, the pharmaceutical composition comprises a nucleic acid encoding an engineered meganuclease described herein and a nucleic acid encoding a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. In some of these embodiments, the second recognition sequence comprises SEQ ID NO: 21. In such embodiments, the two nucleic acids may be comprised by mRNAs described herein, recombinant DNA constructs described herein, and/or viral vectors described herein.</div>
    </li> <li> <para-num num="[0066]"> </para-num> <div id="p-0067" num="0066" class="description-line">In some embodiments, the pharmaceutical composition can comprise one or more mRNAs described herein encapsulated within lipid nanoparticles. In particular embodiments, the lipid nanoparticles of the pharmaceutical composition can comprise at least a first mRNA and at least a second mRNA, wherein the first mRNA encodes an engineered meganuclease described herein, and the second mRNA encodes a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. In some of these embodiments, the second recognition sequence comprises SEQ ID NO: 21. In other embodiments, the lipid nanoparticles of the pharmaceutical composition can comprise one or more polycistronic mRNAs described herein, wherein the polycistronic mRNA encodes an engineered meganuclease described herein and a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. In some of these embodiments, the second recognition sequence comprises SEQ ID NO: 21. In some embodiments, the lipid nanoparticles have a composition which enhances delivery and uptake in the liver, and specifically within hepatocytes.</div>
    </li> <li> <para-num num="[0067]"> </para-num> <div id="p-0068" num="0067" class="description-line">In another aspect, the invention provides a lipid nanoparticle, or a lipid nanoparticle formulation, comprising mRNA encoding at least one engineered meganuclease described herein.</div>
    </li> <li> <para-num num="[0068]"> </para-num> <div id="p-0069" num="0068" class="description-line">In particular embodiments, the lipid nanoparticles can comprise at least a first mRNA and at least a second mRNA, wherein the first mRNA encodes an engineered meganuclease described herein, and the second mRNA encodes a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. In some of these embodiments, the second recognition sequence comprises SEQ ID NO: 21.</div>
    </li> <li> <para-num num="[0069]"> </para-num> <div id="p-0070" num="0069" class="description-line">In other embodiments, the lipid nanoparticles of the pharmaceutical composition can comprise one or more polycistronic mRNAs described herein, wherein the polycistronic mRNA encodes an engineered meganuclease described herein and a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. In some of these embodiments, the second recognition sequence comprises SEQ ID NO: 21.</div>
    </li> <li> <para-num num="[0070]"> </para-num> <div id="p-0071" num="0070" class="description-line">In some embodiments, the lipid nanoparticles have a composition which enhances delivery and uptake in the liver, and specifically within hepatocytes.</div>
    </li> <li> <para-num num="[0071]"> </para-num> <div id="p-0072" num="0071" class="description-line">In another aspect, the invention provides a method for treating a subject having HBV or hepatocellular carcinoma caused by HBV Likewise, provided herein is a method for reducing the level and/or proliferation of HBV, or reducing the symptoms associated with HBV. The methods comprise delivering to a target cell in the subject: (a) a therapeutically effective amount of a nucleic acid encoding an engineered meganuclease described herein, wherein the engineered meganuclease is expressed in the target cell in vivo; or (b) a therapeutically effective amount of an engineered meganuclease protein described herein; wherein the engineered meganuclease recognizes and cleaves a recognition sequence comprising SEQ ID NO: 10 within the HBV genome in the target cell. The method can reduce or eliminate the infection and/or proliferation of HBV in the subject.</div>
    </li> <li> <para-num num="[0072]"> </para-num> <div id="p-0073" num="0072" class="description-line">In certain embodiments, the methods reduce circulating HBsAg levels, circulating HBeAg levels, circulating HBV DNA levels, and/or hepatic cccDNA levels.</div>
    </li> <li> <para-num num="[0073]"> </para-num> <div id="p-0074" num="0073" class="description-line">In another aspect, the invention provides a method for treating a subject having HCC caused by HBV. The methods comprise delivering to a target cell in the subject: (1) (a) a nucleic acid encoding an engineered meganuclease described herein, wherein the engineered meganuclease is expressed in the target cell in vivo; or (b) an engineered meganuclease protein; and (2) a nucleic acid comprising a polynucleotide sequence encoding a suicide gene and sequences homologous to sequences flanking the meganuclease cleavage site; wherein the engineered meganuclease recognizes and cleaves a recognition sequence comprising SEQ ID NO: 10 within the Hepatitis B virus genome, thus cleaving the HBV genome in the target cell; wherein the suicide gene is inserted into the cleaved HBV genome by homologous recombination; and wherein expression of the suicide gene kills the target cell.</div>
    </li> <li> <para-num num="[0074]"> </para-num> <div id="p-0075" num="0074" class="description-line">In some embodiments, the suicide gene is directly lethal to the target cell. In some such embodiments, the directly lethal suicide gene encodes a toxic polypeptide or a pro-apoptotic protein. In some embodiments, the suicide gene is indirectly lethal to the target cell, and directs the subject&#39;s own immune system to kill the target cell. In some such embodiments, the indirectly lethal suicide gene encodes a cell surface protein which is recognized as foreign by the subject&#39;s immune system and is targeted by a humoral or cellular immune response. In other such embodiments, the indirectly lethal suicide gene encodes a polypeptide which is presented by an MHC Class I molecule, is recognized as foreign by the subject&#39;s immune system, and is targeted by a cytotoxic immune response.</div>
    </li> <li> <para-num num="[0075]"> </para-num> <div id="p-0076" num="0075" class="description-line">In further embodiments, the methods of treatment for HBV infection or HCC comprise administering to the subject any pharmaceutical composition of the invention described herein which comprises, at least, a pharmaceutically acceptable carrier and (a) a nucleic acid encoding an engineered meganuclease described herein, wherein the engineered meganuclease is expressed in a target cell in vivo; or (b) an engineered meganuclease protein described herein.</div>
    </li> <li> <para-num num="[0076]"> </para-num> <div id="p-0077" num="0076" class="description-line">In some embodiments of the methods of treatment for HBV infection or HCC, the engineered meganuclease, or the nucleic acid encoding the engineered meganuclease, can be delivered to a target hepatocyte cell. In particular embodiments, an effective amount of the engineered meganuclease, or the nucleic acid encoding the engineered meganuclease, can be delivered to a target hepatocyte cell.</div>
    </li> <li> <para-num num="[0077]"> </para-num> <div id="p-0078" num="0077" class="description-line">In certain embodiments, the methods reduce circulating HBsAg levels, circulating HBeAg levels, circulating HBV DNA levels, and/or hepatic cccDNA levels.</div>
    </li> <li> <para-num num="[0078]"> </para-num> <div id="p-0079" num="0078" class="description-line">In particular embodiments, delivery to a hepatocyte cell occurs ex vivo, wherein an effective amount of the hepatocyte cells having been delivered the engineered meganuclease, or the nucleic acid encoding the engineered meganuclease, are administered to a subject.</div>
    </li> <li> <para-num num="[0079]"> </para-num> <div id="p-0080" num="0079" class="description-line">In some embodiments, a hepatotoxic protein, or a nucleic acid or AAV encoding a hepatotoxic protein, is administered with the pharmaceutical compositions disclosed herein.</div>
    </li> <li> <para-num num="[0080]"> </para-num> <div id="p-0081" num="0080" class="description-line">In particular embodiments of the methods, the engineered meganuclease comprises the amino acid sequence of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0081]"> </para-num> <div id="p-0082" num="0081" class="description-line">In particular embodiments of the methods, the subject can be a mammal, such as a human.</div>
    </li> <li> <para-num num="[0082]"> </para-num> <div id="p-0083" num="0082" class="description-line">In another aspect, the invention provides an engineered meganuclease described herein for use as a medicament. The invention further provides the use of an engineered meganuclease, described herein in the manufacture of a medicament for treating HBV, for reducing the level or proliferation of HBV, reducing the symptoms associated with HBV, or treating HCC.</div>
    </li> <li> <para-num num="[0083]"> </para-num> <div id="p-0084" num="0083" class="description-line">In another aspect, the invention provides an isolated polynucleotide for use as a medicament, wherein the isolated polynucleotide comprises a nucleic acid sequence encoding an engineered meganuclease disclosed herein. The invention further provides the use of an isolated polynucleotide in the manufacture of a medicament for treating HBV, for reducing the level or proliferation of HBV, reducing the symptoms associated with HBV, or treating HCC.</div>
    </li> <li> <para-num num="[0084]"> </para-num> <div id="p-0085" num="0084" class="description-line">In another aspect, the invention provides a recombinant AAV vector for use as a medicament, wherein the recombinant AAV vector comprises a polynucleotide, and wherein the polynucleotide comprises a nucleic acid sequence encoding an engineered meganuclease disclosed herein. The invention further provides the use of a recombinant AAV vector in the manufacture of a medicament for treating HBV, for reducing the level or proliferation of HBV, reducing the symptoms associated with HBV, or treating HCC, wherein the recombinant AAV vector comprises a polynucleotide, and wherein the polynucleotide comprises a nucleic acid sequence encoding an engineered meganuclease disclosed herein.</div>
    
    
    </li> <description-of-drawings>
      <heading id="h-0005">BRIEF DESCRIPTION OF THE FIGURES</heading>
      <li> <para-num num="[0085]"> </para-num> <div id="p-0086" num="0085" class="description-line"> <figref idrefs="DRAWINGS">FIG. 1</figref> shows a genomic map of the HBV genome and identifies all ORFs. Virus particles have a partially double-stranded genome (indicated by a dashed line) with a cohesive overlap that spans the 5 regions of each strand and that is flanked by direct repeat sequences (DR1 and DR2). The gene S encodes the major hepatitis B surface antigen (HBsAg) protein and its glycosylated partner, which are transmembrane proteins in the virus envelope. In-frame sequences upstream from the S gene encode the pre-S domains, which are translated with the S sequences to make the pre-S and S polypeptides (middle and large proteins) that contain the virus receptor for infection of hepatocytes. Gene C encodes the hepatitis B core antigen (HBcAg) which forms the nucleocapsid of the virus. The P region encodes the virus reverse transcriptase that also has DNA-dependent DNA polymerase activity and RNase H activity required for virus replication. Although HBV is a DNA virus, it replicates through a pre-genomic RNA intermediate. Finally, the X gene encodes the small regulatory protein of the virus, the hepatitis B x (HBx) antigen. HBx is a transactivating protein that stimulates virus gene expression and replication, protects virus-infected cells against immune-mediated destruction and contributes to the development of hepatocellular carcinoma.</div>
      </li> <li> <para-num num="[0086]"> </para-num> <div id="p-0087" num="0086" class="description-line"> <figref idrefs="DRAWINGS">FIG. 2</figref>. HBV 11-12 recognition sequence in the HBV genome. The HBV 11-12 recognition sequence, targeted by engineered meganucleases of the invention, comprises two recognition half-sites. Each recognition half-site comprises 9 base pairs, separated by a 4 base pair central sequence. The HBV 11-12 recognition sequence (SEQ ID NO: 10) comprises two recognition half-sites referred to as HBV11 and HBV12.</div>
      </li> <li> <para-num num="[0087]"> </para-num> <div id="p-0088" num="0087" class="description-line"> <figref idrefs="DRAWINGS">FIG. 3</figref>. Alignment of HBV recognition sequences in HBV genotypes A-G. The HBV 11-12 recognition sequence targeted by engineered meganucleases of the invention is conserved across multiple HBV genotypes. The HBV 11-12 recognition sequence spans residues 1259-1280 of HBV genotype A set forth in SEQ ID NO: 3, and this recognition sequence is fully conserved in genotypes B, C, D, E, F, and G (SEQ ID NOs: 4-9).</div>
      </li> <li> <para-num num="[0088]"> </para-num> <div id="p-0089" num="0088" class="description-line"> <figref idrefs="DRAWINGS">FIG. 4</figref>. The engineered meganucleases of the invention comprise two subunits, wherein the first subunit comprising the HVR1 region binds to a first recognition half-site (e.g., HBV11) and the second subunit comprising the HVR2 region binds to a second recognition half-site (e.g., HBV12). In embodiments where the engineered meganuclease is a single-chain meganuclease, the first subunit comprising the HVR1 region can be positioned as either the N-terminal or C-terminal subunit. Likewise, the second subunit comprising the HVR2 region can be positioned as either the N-terminal or C-terminal subunit.</div>
      </li> <li> <para-num num="[0089]"> </para-num> <div id="p-0090" num="0089" class="description-line"> <figref idrefs="DRAWINGS">FIG. 5</figref>. Schematic of reporter assay in CHO cells for evaluating engineered meganucleases of the invention. A CHO cell line was produced in which a reporter cassette was integrated stably into the genome of the cell. The reporter cassette comprised, in 5 to 3 order: an SV40 Early Promoter; the 5 2/3 of the GFP gene; the recognition sequence for an engineered meganuclease of the invention (e.g., the HBV 11-12 recognition sequence); the recognition sequence for the <figure-callout id="23" label="CHO" filenames="US20190338263A1-20191107-D00005.png" state="{{state}}">CHO</figure-callout> 23/24 meganuclease (WO 2012/167192); and the 3 2/3 of the GFP gene. Cells stably transfected with this cassette did not express GFP in the absence of a DNA break-inducing agent. Meganucleases were introduced by transduction of plasmid DNA or mRNA encoding each meganuclease. When a DNA break was induced at either of the meganuclease recognition sequences, the duplicated regions of the GFP gene recombined with one another to produce a functional GFP gene. The percentage of GFP-expressing cells could then be determined by flow cytometry as an indirect measure of the frequency of genome cleavage by the meganucleases.</div>
      </li> <li> <para-num num="[0090]"> </para-num> <div id="p-0091" num="0090" class="description-line"> <figref idrefs="DRAWINGS">FIG. 6</figref>. Efficiency of engineered meganucleases for recognizing and cleaving the HBV 11-12 recognition sequence in a CHO cell reporter assay. The HBV 11-12L.363 and HBV 11-12L.367 meganucleases, set forth in SEQ ID NOs: 12 and 13, respectively, were engineered to target the HBV 11-12 recognition sequence (SEQ ID NO: 10), and were screened for efficacy in the CHO cell reporter assay. The results shown provide the percentage of GFP-expressing cells observed, which indicates the efficacy of each meganuclease for cleaving the target recognition sequence or the <figure-callout id="23" label="CHO" filenames="US20190338263A1-20191107-D00005.png" state="{{state}}">CHO</figure-callout> 23/24 recognition sequence. A negative control (bs) was further included in the assay.</div>
      </li> <li> <para-num num="[0091]"> </para-num> <div id="p-0092" num="0091" class="description-line"> <figref idrefs="DRAWINGS">FIG. 7</figref>. Efficiency of engineered meganucleases for recognizing and cleaving the HBV11 off-target (HBV11 Off) recognition sequence in a CHO cell reporter assay. Plasmids encoding the HBV 11-12 meganucleases of the invention were transfected into HBV11 Off cells which contain the counter selected HBV11 Off recognition sequence (SEQ ID NO: 23) between the GFP direct repeats, as well as a CHO 23-24 recognition sequence. A) Cleavage of the HBV11 Off recognition sequence by the first-generation HBV 11-12x.26 meganuclease. B) Cleavage of the HBV11 Off recognition sequence by the second-generation HBV11-12L.363 and HBV 11-12L.367 meganucleases.</div>
      </li> <li> <para-num num="[0092]"> </para-num> <div id="p-0093" num="0092" class="description-line"> <figref idrefs="DRAWINGS">FIG. 8</figref>. Efficiency of engineered meganucleases for recognizing and cleaving the HBV12 off-target (HBV12 Off) recognition sequence in a CHO cell reporter assay. Plasmids encoding The HBV 11-12 meganucleases of the invention were transfected into HBV12 Off cells which contain the counter selected HBV12 Off recognition sequence (SEQ ID NO: 24) between the GFP direct repeats, as well as a CHO 23-24 recognition sequence. A) Cleavage of the HBV12 Off recognition sequence by the first-generation HBV 11-12x.26 meganuclease. B) Cleavage of the HBV12 Off recognition sequence by the second-generation HBV11-12L.363 and HBV 11-12L.367 meganucleases.</div>
      </li> <li> <para-num num="[0093]"> </para-num> <div id="p-0094" num="0093" class="description-line"> <figref idrefs="DRAWINGS">FIG. 9</figref>. Efficiency of engineered meganucleases for recognizing and cleaving the HBV 11-12 recognition sequence in a CHO cell reporter assay. The HBV 11-12L.363 and HBV 11-12L.367 meganucleases, set forth in SEQ ID NOs: 12 and 13, respectively, were screened for efficacy in the CHO cell reporter assay at 2, 5, and 7 days after nucleofection in order to determine toxicity associated with expression of the meganuclease. The results shown provide the percentage of GFP-expressing cells observed over the 7 day period of analysis, which indicates the efficacy of each meganuclease for cleaving a target recognition sequence or the <figure-callout id="23" label="CHO" filenames="US20190338263A1-20191107-D00005.png" state="{{state}}">CHO</figure-callout> 23/24 recognition sequence as a function of time.</div>
      </li> <li> <para-num num="[0094]"> </para-num> <div id="p-0095" num="0094" class="description-line"> <figref idrefs="DRAWINGS">FIG. 10</figref>. Efficiency of engineered meganucleases for recognizing and cleaving the HBV11 Off and HBV12 Off recognition sequences in a CHO cell reporter assay. mRNA encoding the HBV 11-12 meganucleases of the invention were transfected into HBV11 Off cells or HBV12 Off cells and were screened for efficacy in the CHO cell reporter assay at 2, 5, and 7 days after nucleofection in order to determine toxicity. The results shown provide the percentage of GFP-expressing cells observed over the 7 day period of analysis. A) Cleavage of the HBV11 Off recognition sequence by the HBV 11-12L.363 and HBV 11-12L.367 meganucleases. B) Cleavage of the HBV12 Off recognition sequence by the HBV11-12L.363 and HBV 11-12L.367 meganucleases.</div>
      </li> <li> <para-num num="[0095]"> </para-num> <div id="p-0096" num="0095" class="description-line"> <figref idrefs="DRAWINGS">FIG. 11</figref>. Oligo capture assay in a HepG2 cell line lacking the HBV 11-12 recognition sequence. Oligo capture data is shown for HBV 11-12x.26, HBV 11-12L.188, HBV 11-12L.363, and HBV 11-12L.367. Data is graphically visualized wherein off target sites are plotted according to their number of aligned reads on the X axis, and the number of mismatched base pairs compared to the intended site are indicated by color, with darker colors indicating closer overall matches between off-targets and the intended binding site.</div>
      </li> <li> <para-num num="[0096]"> </para-num> <div id="p-0097" num="0096" class="description-line"> <figref idrefs="DRAWINGS">FIG. 12</figref>. Oligo capture assay in a HepG2 HepB cell line, which comprises a partial HBV genome including the HBV 11-12 recognition sequence. Oligo capture data of HBV 11-12x.26 and HBV 11-12L.363 are graphically visualized wherein off target sites are plotted according to their number of aligned reads on the X axis, and the number of mismatched base pairs compared to the intended site are indicated by color, with darker colors indicating closer overall matches between off-targets and the intended binding site. Intended target sites are indicated by circles.</div>
      </li> <li> <para-num num="[0097]"> </para-num> <div id="p-0098" num="0097" class="description-line"> <figref idrefs="DRAWINGS">FIG. 13</figref>. Efficiency of indel formation detected by T7E assay. A HepG2 cell line (HepG2 HepB) was generated that stably expressed one copy of a 1500 bp region of the Hepatitis B genome including the HBV 11-12 meganuclease target site. HepG2 HepB cells were transfected with mRNA encoding HBV 11-12L.26, HBV 11-12L.188, HBV 11-12L.363, HBV 11-12L.367, or HBV 11-12x.26, respectively. At two days post-transfection, genomic DNA was isolated from cells for analysis of indel formation by T7E assay. Genomic DNA from mock transfected HepG2 HepB cells was used as a control. Amplification was confirmed by visualization of a 1650 bp band on an agarose gel. PCR-amplified DNA was denatured and slowly rehybridized to allow formation of heteroduplex DNA sequences and then digested with T7 endonuclease I. Digestion products were visualized on an agarose gel.</div>
      </li> <li> <para-num num="[0098]"> </para-num> <div id="p-0099" num="0098" class="description-line"> <figref idrefs="DRAWINGS">FIG. 14</figref>. Efficiency of indel formation detected by digital PCR. HepG2 HepB cells were transfected with mRNA encoding HBV 11-12L.26, HBV 11-12L.188, HBV 11-12L.363, HBV 11-12L.367, or HBV 11-12x.26, respectively. At two days post-transfection, genomic DNA was isolated from cells for analysis of indel formation by digital PCR. Genomic DNA from mock transfected HepG2 HepB cells was used as a control. Digital PCR was performed using the QX200 droplet digital PCR system. A FAM-tagged TaqMan probe was designed to recognize the HBV 11-12 meganuclease target site, as well as a HEX-tagged TaqMan probe that binds genomic sequence 100 bp downstream of the target site. The probes were multiplexed for genomic DNA amplification. Droplets were gated by fluorescence amplitude to indicate double-positive, double-negative, and single-positive populations. Indels were calculated as the number of HEX-positive droplets divided by the number of double-positive (FAM+/HEX+) droplets.</div>
      </li> <li> <para-num num="[0099]"> </para-num> <div id="p-0100" num="0099" class="description-line"> <figref idrefs="DRAWINGS">FIG. 15</figref>. Indel frequency in HepG2 HepB cells after electroporation with HBV 11-12 mRNA. HepG2 HepB cells were transfected with two different lots of mRNA (3129 and 3606) encoding HBV 11-12L.363 and one lot of mRNA encoding HBV 11-12x.26. At two days and six days post-transfection, genomic DNA was isolated from cells for analysis of indel formation by digital PCR. Genomic DNA from mock transfected HepG2 HepB cells was used as a control. Digital PCR was performed using the QX200 droplet digital PCR system. A FAM-tagged TaqMan probe was designed to recognize the HBV 11-12 meganuclease target site, as well as a HEX-tagged TaqMan probe that binds genomic sequence 100 bp downstream of the target site. The probes were multiplexed for genomic DNA amplification. Droplets were gated by fluorescence amplitude to indicate double-positive, double-negative, and single-positive populations. Indels were calculated as the number of HEX-positive droplets divided by the number of double-positive (FAM+/HEX+) droplets.</div>
      </li> <li> <para-num num="[0100]"> </para-num> <div id="p-0101" num="0100" class="description-line"> <figref idrefs="DRAWINGS">FIG. 16</figref>. In vitro antiviral evaluation of HBV 11-12L.363 in HBV-integrated HepAD38 cells. A HepAD38 cell line which expresses wild-type HBV (subtype ayw) was transfected with mRNA (3 ug) encoding HBV 11-12L.363, HBV 11-12x.26, and mCherry (TriLink) respectively, by using the Lipofectamine MessengerMAX (Thermo Fisher), TranslT-mRNA (Mirus), jetMESSENGER (Polyplus), or lipid nanoparticles (Precision BioSciences), each according to the manufacturer&#39;s instructions. At <figure-callout id="4" label="day" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">day</figure-callout> 4 and <figure-callout id="6" label="day" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">day</figure-callout> 6 post-transfection, supernatant was collected for measuring secreted HBs antigen by CLIA assay (AutoBio). To determine the percentage of HBs antigen reduction, mCherry transfected HepAD38 cells were used as 100% control.</div>
      </li> <li> <para-num num="[0101]"> </para-num> <div id="p-0102" num="0101" class="description-line"> <figref idrefs="DRAWINGS">FIG. 17</figref>. Detection of indels in HBV 11-12L.363 mRNA-transfected HepAD38 cells. At day six post-transfection of HBV 11-12L.363 mRNA, genomic DNA was isolated from HepAD38 cells for analysis of indel formation by GeneART Genomic Cleavage Detection (GCD) Kit (Thermo Fisher). Genomic DNA from mCherry transfected HepAD38 cells were used as a control. Amplification was confirmed by the visualization of a 467 bp band on an agarose gel. PCR-amplified DNA was analyzed in the cleavage assay and digestion products were visualized on an agarose gel.</div>
    </li> </description-of-drawings>
    
    
    <heading id="h-0006">BRIEF DESCRIPTION OF THE SEQUENCES</heading>
    <li> <para-num num="[0102]"> </para-num> <div id="p-0103" num="0102" class="description-line">SEQ ID NO: 1 sets forth the amino acid sequence of the wild-type I-CreI meganuclease from <i>Chlamydomonas reinhardtii. </i> </div>
    </li> <li> <para-num num="[0103]"> </para-num> <div id="p-0104" num="0103" class="description-line">SEQ ID NO: 2 sets forth the amino acid sequence of the LAGLIDADG motif.</div>
    </li> <li> <para-num num="[0104]"> </para-num> <div id="p-0105" num="0104" class="description-line">SEQ ID NO: 3 sets forth the nucleic acid sequence of HBV genotype A.</div>
    </li> <li> <para-num num="[0105]"> </para-num> <div id="p-0106" num="0105" class="description-line">SEQ ID NO: 4 sets forth the nucleic acid sequence of HBV genotype B.</div>
    </li> <li> <para-num num="[0106]"> </para-num> <div id="p-0107" num="0106" class="description-line">SEQ ID NO: 5 sets forth the nucleic acid sequence of HBV genotype C.</div>
    </li> <li> <para-num num="[0107]"> </para-num> <div id="p-0108" num="0107" class="description-line">SEQ ID NO: 6 sets forth the nucleic acid sequence of HBV genotype D.</div>
    </li> <li> <para-num num="[0108]"> </para-num> <div id="p-0109" num="0108" class="description-line">SEQ ID NO: 7 sets forth the nucleic acid sequence of HBV genotype E.</div>
    </li> <li> <para-num num="[0109]"> </para-num> <div id="p-0110" num="0109" class="description-line">SEQ ID NO: 8 sets forth the nucleic acid sequence of HBV genotype F.</div>
    </li> <li> <para-num num="[0110]"> </para-num> <div id="p-0111" num="0110" class="description-line">SEQ ID NO: 9 sets forth the nucleic acid sequence of HBV genotype G.</div>
    </li> <li> <para-num num="[0111]"> </para-num> <div id="p-0112" num="0111" class="description-line">SEQ ID NO: 10 sets forth the nucleic acid sequence of the sense strand of the HBV 11-12 recognition sequence.</div>
    </li> <li> <para-num num="[0112]"> </para-num> <div id="p-0113" num="0112" class="description-line">SEQ ID NO: 11 sets forth the nucleic acid sequence of the antisense strand of the HBV 11-12 recognition sequence.</div>
    </li> <li> <para-num num="[0113]"> </para-num> <div id="p-0114" num="0113" class="description-line">SEQ ID NO: 12 sets forth the amino acid sequence of the HBV 11-12L.363 meganuclease.</div>
    </li> <li> <para-num num="[0114]"> </para-num> <div id="p-0115" num="0114" class="description-line">SEQ ID NO: 13 sets forth the amino acid sequence of the HBV 11-12L.367 meganuclease.</div>
    </li> <li> <para-num num="[0115]"> </para-num> <div id="p-0116" num="0115" class="description-line">SEQ ID NO: 14 sets forth the amino acid sequence of the HBV 11-12x.26 meganuclease.</div>
    </li> <li> <para-num num="[0116]"> </para-num> <div id="p-0117" num="0116" class="description-line">SEQ ID NO: 15 sets forth the amino acid sequence of the HBV 11-12L.363 meganuclease HBV11-binding subunit.</div>
    </li> <li> <para-num num="[0117]"> </para-num> <div id="p-0118" num="0117" class="description-line">SEQ ID NO: 16 sets forth the amino acid sequence of the HBV 11-12L.367 meganuclease HBV11-binding subunit.</div>
    </li> <li> <para-num num="[0118]"> </para-num> <div id="p-0119" num="0118" class="description-line">SEQ ID NO: 17 sets forth the amino acid sequence of the HBV 11-12x.26 meganuclease HBV11-binding subunit.</div>
    </li> <li> <para-num num="[0119]"> </para-num> <div id="p-0120" num="0119" class="description-line">SEQ ID NO: 18 sets forth the amino acid sequence of the HBV 11-12L.363 meganuclease HBV12-binding subunit.</div>
    </li> <li> <para-num num="[0120]"> </para-num> <div id="p-0121" num="0120" class="description-line">SEQ ID NO: 19 sets forth the amino acid sequence of the HBV 11-12L.367 meganuclease HBV12-binding subunit.</div>
    </li> <li> <para-num num="[0121]"> </para-num> <div id="p-0122" num="0121" class="description-line">SEQ ID NO: 20 sets forth the amino acid sequence of the HBV 11-12x.26 meganuclease HBV12-binding subunit.</div>
    </li> <li> <para-num num="[0122]"> </para-num> <div id="p-0123" num="0122" class="description-line">SEQ ID NO: 21 sets forth the nucleic acid sequence of the HBV 5-6 recognition sequence (sense).</div>
    </li> <li> <para-num num="[0123]"> </para-num> <div id="p-0124" num="0123" class="description-line">SEQ ID NO: 22 sets forth the nucleic acid sequence of the HBV 5-6 recognition sequence (antisense).</div>
    </li> <li> <para-num num="[0124]"> </para-num> <div id="p-0125" num="0124" class="description-line">SEQ ID NO: 23 sets forth the nucleic acid sequence of the HBV11 Off recognition sequence.</div>
    </li> <li> <para-num num="[0125]"> </para-num> <div id="p-0126" num="0125" class="description-line">SEQ ID NO: 24 sets forth the nucleic acid sequence of the HBV12 Off recognition sequence.</div>
    </li> <li> <para-num num="[0126]"> </para-num> <div id="p-0127" num="0126" class="description-line">SEQ ID NO: 25 sets forth the nucleic acid sequence of the P1 PCR primer.</div>
    </li> <li> <para-num num="[0127]"> </para-num> <div id="p-0128" num="0127" class="description-line">SEQ ID NO: 26 sets forth the nucleic acid sequence of the P2 PCR primer.</div>
    </li> <li> <para-num num="[0128]"> </para-num> <div id="p-0129" num="0128" class="description-line">SEQ ID NO: 27 sets forth the nucleic acid sequence of the P3 PCR primer.</div>
    </li> <li> <para-num num="[0129]"> </para-num> <div id="p-0130" num="0129" class="description-line">SEQ ID NO: 28 sets forth the nucleic acid sequence of the P4 PCR primer.</div>
    </li> <li> <para-num num="[0130]"> </para-num> <div id="p-0131" num="0130" class="description-line">SEQ ID NO: 29 sets forth the nucleic acid sequence of the T1 PCR primer.</div>
    </li> <li> <para-num num="[0131]"> </para-num> <div id="p-0132" num="0131" class="description-line">SEQ ID NO: 30 sets forth the nucleic acid sequence of the T2 PCR primer.</div>
    </li> <li> <para-num num="[0132]"> </para-num> <div id="p-0133" num="0132" class="description-line">SEQ ID NO: 31 sets forth the nucleic acid sequence of the AD38-F1012 primer.</div>
    </li> <li> <para-num num="[0133]"> </para-num> <div id="p-0134" num="0133" class="description-line">SEQ ID NO: 32 sets forth the nucleic acid sequence of the AD38-R1479 primer.</div>
    </li> <li> <para-num num="[0134]"> </para-num> <div id="p-0135" num="0134" class="description-line">SEQ ID NO: 33 sets froth the amino acid sequence of a polypeptide linker.</div>
    </li> <heading id="h-0007">DETAILED DESCRIPTION OF THE INVENTION</heading>
    <heading id="h-0008">1.1 References and Definitions</heading>
    <li> <para-num num="[0135]"> </para-num> <div id="p-0136" num="0135" class="description-line">The patent and scientific literature referred to herein establishes knowledge that is available to those of skill in the art. The issued US and non-US patents, allowed applications, published US, non-US, and PCT application, co-owned and co-pending unpublished US patent applications, published foreign applications, and scientific, technical, and medical references, including GenBank database sequences, public genetic and protein database accession numbers or codes (and the nucleic acid and/or amino acid sequences associated therewith), which are cited herein are hereby incorporated by reference to the same extent as if each was specifically and individually indicated to be incorporated by reference.</div>
    </li> <li> <para-num num="[0136]"> </para-num> <div id="p-0137" num="0136" class="description-line">The present invention can be embodied in different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. For example, features illustrated with respect to one embodiment can be incorporated into other embodiments, and features illustrated with respect to a particular embodiment can be deleted from that embodiment. In addition, numerous variations and additions to the embodiments suggested herein will be apparent to those skilled in the art in light of the instant disclosure, which do not depart from the instant invention.</div>
    </li> <li> <para-num num="[0137]"> </para-num> <div id="p-0138" num="0137" class="description-line">Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood as of the priority date by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention.</div>
    </li> <li> <para-num num="[0138]"> </para-num> <div id="p-0139" num="0138" class="description-line">All publications, patent applications, patents, and other references mentioned herein are incorporated by reference herein in their entirety.</div>
    </li> <li> <para-num num="[0139]"> </para-num> <div id="p-0140" num="0139" class="description-line">As used herein, a, an, or the can mean one or more than one. For example, a cell can mean a single cell or a multiplicity of cells.</div>
    </li> <li> <para-num num="[0140]"> </para-num> <div id="p-0141" num="0140" class="description-line">As used herein, unless specifically indicated otherwise, the word or is used in the inclusive sense of and/or and not the exclusive sense of either/or.</div>
    </li> <li> <para-num num="[0141]"> </para-num> <div id="p-0142" num="0141" class="description-line">As used herein, the terms nuclease and endonuclease refers to enzymes which cleave a phosphodiester bond within a polynucleotide chain.</div>
    </li> <li> <para-num num="[0142]"> </para-num> <div id="p-0143" num="0142" class="description-line">As used herein with respect to double-stranded DNA, the terms cleave or cleavage refer to the endonuclease-mediated hydrolysis of phosphodiester bonds within the backbone of a recognition sequence within a target sequence that results in a double-stranded break within the target sequence, referred to herein as a cleavage site. Depending upon the endonuclease, cleavage can result in double-stranded fragments with blunt ends or fragments with 5 or 3 base overhangs.</div>
    </li> <li> <para-num num="[0143]"> </para-num> <div id="p-0144" num="0143" class="description-line">As used herein, the term meganuclease refers to an endonuclease that binds double-stranded DNA at a recognition sequence that is greater than 12 base pairs. In some embodiments, the recognition sequence for a meganuclease of the present disclosure is 22 base pairs. A meganuclease can be an endonuclease that is derived from I-CreI, and can refer to an engineered variant of I-CreI that has been modified relative to natural I-CreI with respect to, for example, DNA-binding specificity, DNA cleavage activity, DNA-binding affinity, or dimerization properties. Methods for producing such modified variants of I-CreI are known in the art (e.g. WO 2007/047859, incorporated by reference in its entirety). A meganuclease as used herein binds to double-stranded DNA as a heterodimer. A meganuclease may also be a single-chain meganuclease in which a pair of DNA-binding domains is joined into a single polypeptide using a peptide linker. The term homing endonuclease is synonymous with the term meganuclease. Meganucleases of the present disclosure are substantially non-toxic when expressed in the targeted cells as described herein such that cells can be transfected and maintained at 37 C. without observing substantial deleterious effects on overall cell viability or significant reductions in meganuclease cleavage activity when measured using the methods described herein.</div>
    </li> <li> <para-num num="[0144]"> </para-num> <div id="p-0145" num="0144" class="description-line">As used herein, the term single-chain meganuclease refers to a polypeptide comprising a pair of nuclease subunits joined by a linker such that the subunits interact functionally like a heterodimer to cleave a double-stranded recognition site. A single-chain meganuclease has the organization: N-terminal subunit-Linker-C-terminal subunit. The two meganuclease subunits will generally be non-identical in amino acid sequence and will recognize non-identical DNA half-sites within a recognition sequence. Thus, single-chain meganucleases typically cleave pseudo-palindromic or non-palindromic recognition sequences. A single-chain meganuclease may be referred to as a single-chain heterodimer or single-chain heterodimeric meganuclease although it is not, in fact, dimeric. For clarity, unless otherwise specified, the term meganuclease can refer to a dimeric or single-chain meganuclease.</div>
    </li> <li> <para-num num="[0145]"> </para-num> <div id="p-0146" num="0145" class="description-line">As used herein, the term linker refers to an exogenous peptide sequence used to join two meganuclease subunits into a single polypeptide. A linker may have a sequence that is found in natural proteins, or may be an artificial sequence that is not found in any natural protein. A linker may be flexible and lacking in secondary structure or may have a propensity to form a specific three-dimensional structure under physiological conditions. A linker can include, without limitation, any of those encompassed by U.S. Pat. Nos. 8,445,251, 9,340,777, 9,434,931, and 10,041,053, each of which is incorporated by reference in its entirety. In some embodiments, a linker may have at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to SEQ ID NO: 33, which sets forth residues 154-195 of any one of SEQ ID NOs: 12-14. In some embodiments, a linker may have an amino acid sequence comprising SEQ ID NO:33, which sets forth residues 154-195 of any one of SEQ ID NOs: 12-14.</div>
    </li> <li> <para-num num="[0146]"> </para-num> <div id="p-0147" num="0146" class="description-line">As used herein, with respect to a protein, the term recombinant or engineered means having an altered amino acid sequence as a result of the application of genetic engineering techniques to nucleic acids which encode the protein, and cells or organisms which express the protein. With respect to a nucleic acid, the term recombinant or engineered means having an altered nucleic acid sequence as a result of the application of genetic engineering techniques. Genetic engineering techniques include, but are not limited to, PCR and DNA cloning technologies; transfection, transformation and other gene transfer technologies; homologous recombination; site-directed mutagenesis; and gene fusion. In accordance with this definition, a protein having an amino acid sequence identical to a naturally-occurring protein, but produced by cloning and expression in a heterologous host, is not considered recombinant.</div>
    </li> <li> <para-num num="[0147]"> </para-num> <div id="p-0148" num="0147" class="description-line">As used herein, the term wild-type refers to the most common naturally occurring allele (i.e., polynucleotide sequence) in the allele population of the same type of gene, wherein a polypeptide encoded by the wild-type allele has its original functions. The term wild-type also refers to a polypeptide encoded by a wild-type allele. Wild-type alleles (i.e., polynucleotides) and polypeptides are distinguishable from mutant or variant alleles and polypeptides, which comprise one or more mutations and/or substitutions relative to the wild-type sequence(s). Whereas a wild-type allele or polypeptide can confer a normal phenotype in an organism, a mutant or variant allele or polypeptide can, in some instances, confer an altered phenotype. Wild-type nucleases are distinguishable from recombinant or non-naturally-occurring nucleases. The term wild-type can also refer to a cell, an organism, and/or a subject which possesses a wild-type allele of a particular gene, or a cell, an organism, and/or a subject used for comparative purposes.</div>
    </li> <li> <para-num num="[0148]"> </para-num> <div id="p-0149" num="0148" class="description-line">As used herein, the term genetically-modified refers to a cell or organism in which, or in an ancestor of which, a genomic DNA sequence has been deliberately modified by recombinant technology. As used herein, the term genetically-modified encompasses the term transgenic.</div>
    </li> <li> <para-num num="[0149]"> </para-num> <div id="p-0150" num="0149" class="description-line">As used herein with respect to recombinant proteins, the term modification means any insertion, deletion, or substitution of an amino acid residue in the recombinant sequence relative to a reference sequence (e.g., a wild-type or a native sequence).</div>
    </li> <li> <para-num num="[0150]"> </para-num> <div id="p-0151" num="0150" class="description-line">As used herein, the terms recognition sequence or recognition site refer to a DNA sequence that is bound and cleaved by an endonuclease. In the case of a meganuclease, a recognition sequence comprises a pair of inverted, 9 basepair half sites which are separated by four basepairs. In the case of a single-chain meganuclease, the N-terminal domain of the protein contacts a first half-site and the C-terminal domain of the protein contacts a second half-site. Cleavage by a meganuclease produces four <figure-callout id="3" label="basepair" filenames="US20190338263A1-20191107-D00003.png,US20190338263A1-20191107-D00007.png" state="{{state}}">basepair</figure-callout> 3 overhangs. Overhangs, or sticky ends are short, single-stranded DNA segments that can be produced by endonuclease cleavage of a double-stranded DNA sequence. In the case of meganucleases and single-chain meganucleases derived from I-CreI, the overhang comprises bases 10-13 of the 22 basepair recognition sequence.</div>
    </li> <li> <para-num num="[0151]"> </para-num> <div id="p-0152" num="0151" class="description-line">As used herein, the term target site or target sequence refers to a region of the chromosomal DNA of a cell comprising a recognition sequence for a nuclease.</div>
    </li> <li> <para-num num="[0152]"> </para-num> <div id="p-0153" num="0152" class="description-line">As used herein, the term DNA-binding affinity or binding affinity means the tendency of a meganuclease to non-covalently associate with a reference DNA molecule (e.g., a recognition sequence or an arbitrary sequence). Binding affinity is measured by a dissociation constant, Kd. As used herein, a nuclease has altered binding affinity if the Kd of the nuclease for a reference recognition sequence is increased or decreased by a statistically significant percent change, or biologically significant amount (e.g., at least 2, or 2 to 10), relative to a reference nuclease.</div>
    </li> <li> <para-num num="[0153]"> </para-num> <div id="p-0154" num="0153" class="description-line">As used herein, the term specificity means the ability of a nuclease to recognize and cleave double-stranded DNA molecules only at a particular sequence of base pairs referred to as the recognition sequence, or only at a particular set of recognition sequences. The set of recognition sequences will share certain conserved positions or sequence motifs, but may be degenerate at one or more positions. A highly-specific nuclease is capable of cleaving only one or a very few recognition sequences. Specificity can be determined by any method known in the art.</div>
    </li> <li> <para-num num="[0154]"> </para-num> <div id="p-0155" num="0154" class="description-line">As used herein, a meganuclease has altered specificity if it binds to and cleaves a recognition sequence which is not bound to and cleaved by a reference meganuclease (e.g., a wild-type) under physiological conditions, or if the rate of cleavage of a recognition sequence is increased or decreased by a biologically significant amount (e.g., at least 2, or 2-10) relative to a reference meganuclease.</div>
    </li> <li> <para-num num="[0155]"> </para-num> <div id="p-0156" num="0155" class="description-line">In some embodiments, the presently disclosed engineered meganucleases have improved (i.e., increased) specificity for the target recognition sequence that comprises SEQ ID NO: 10 (i.e., HBV 11-12) as compared to the HBV 11-12x.26 meganuclease (the amino acid sequence of which is set forth as SEQ ID NO: 14). Thus, in certain embodiments, the presently disclosed engineered meganucleases exhibit reduced off-target cleavage as compared to the HBV 11-12x.26 meganuclease. Off-target cleavage by a meganuclease can be measured using any method known in the art, including for example, oligo capture analysis as described here, a T7 endonuclease (T7E) assay as described herein, digital PCR as described herein, targeted sequencing of particular off-target sites, exome sequencing, whole genome sequencing, direct in situ breaks labeling enrichment on streptavidin and next-generation sequencing (BLESS), genome-wide, unbiased identification of DSBs enabled by sequencing (GUIDE-seq), and linear amplification-mediated high-throughput genome-wide translocation sequencing (LAM-HTGTS) (see, e.g., Zischew ski et al. (2017), Biotechnology Advances 35(1):95-104, which is incorporated by reference in its entirety).</div>
    </li> <li> <para-num num="[0156]"> </para-num> <div id="p-0157" num="0156" class="description-line">As used herein, the term homologous recombination or HR refers to the natural, cellular process in which a double-stranded DNA-break is repaired using a homologous DNA sequence as the repair template (see, e.g. Cahill et al. (2006), Front. Biosci. 11:1958-1976). The homologous DNA sequence may be an endogenous chromosomal sequence or an exogenous nucleic acid that was delivered to the cell.</div>
    </li> <li> <para-num num="[0157]"> </para-num> <div id="p-0158" num="0157" class="description-line">As used herein, the term non-homologous end-joining or NHEJ refers to the natural, cellular process in which a double-stranded DNA-break is repaired by the direct joining of two non-homologous DNA segments (see, e.g. Cahill et al. (2006), Front. Biosci. 11:1958-1976). DNA repair by non-homologous end-joining is error-prone and frequently results in the untemplated addition or deletion of DNA sequences at the site of repair. In some instances, cleavage at a target recognition sequence results in NHEJ at a target recognition site. Nuclease-induced cleavage of a target site in the coding sequence of a gene followed by DNA repair by NHEJ can introduce mutations into the coding sequence, such as frameshift mutations, that disrupt gene function. Thus, engineered meganucleases can be used to effectively knock-out a gene in a population of cells.</div>
    </li> <li> <para-num num="[0158]"> </para-num> <div id="p-0159" num="0158" class="description-line">As used herein, homology arms or sequences homologous to sequences flanking a meganuclease cleavage site refer to sequences flanking the 5 and 3 ends of a nucleic acid molecule which promote insertion of the nucleic acid molecule into a cleavage site generated by a meganuclease. In general, homology arms can have a length of at least 50 base pairs, preferably at least 100 base pairs, and up to 2000 base pairs or more, and can have at least 90%, preferably at least 95%, or more, sequence homology to their corresponding sequences in the genome.</div>
    </li> <li> <para-num num="[0159]"> </para-num> <div id="p-0160" num="0159" class="description-line">As used herein with respect to both amino acid sequences and nucleic acid sequences, the terms percent identity, sequence identity, percentage similarity, sequence similarity and the like refer to a measure of the degree of similarity of two sequences based upon an alignment of the sequences which maximizes similarity between aligned amino acid residues or nucleotides, and which is a function of the number of identical or similar residues or nucleotides, the number of total residues or nucleotides, and the presence and length of gaps in the sequence alignment. A variety of algorithms and computer programs are available for determining sequence similarity using standard parameters. As used herein, sequence similarity is measured using the BLASTp program for amino acid sequences and the BLASTn program for nucleic acid sequences, both of which are available through the National Center for Biotechnology Information (www.ncbi.nlm.nih.gov/), and are described in, for example, Altschul et al. (1990), J. Mol. Biol. 215:403-410; Gish and States (1993), Nature Genet. 3:266-272; Madden et al. (1996), Meth. Enzymol. 266:131-141; Altschul et al. (1997), Nucleic Acids Res. 25:33 89-3402); Zhang et al. (2000), J. Comput. Biol. 7(1-2):203-14. As used herein, percent similarity of two amino acid sequences is the score based upon the following parameters for the BLASTp algorithm: word size=3; gap opening penalty=11; gap extension penalty=1; and scoring matrix=BLOSUM62. As used herein, percent similarity of two nucleic acid sequences is the score based upon the following parameters for the BLASTn algorithm: word size=11; gap opening penalty=5; gap extension penalty=2; match reward=1; and mismatch penalty=3.</div>
    </li> <li> <para-num num="[0160]"> </para-num> <div id="p-0161" num="0160" class="description-line">As used herein with respect to modifications of two proteins or amino acid sequences, the term corresponding to is used to indicate that a specified modification in the first protein is a substitution of the same amino acid residue as in the modification in the second protein, and that the amino acid position of the modification in the first protein corresponds to or aligns with the amino acid position of the modification in the second protein when the two proteins are subjected to standard sequence alignments (e.g., using the BLASTp program). Thus, the modification of residue X to amino acid A in the first protein will correspond to the modification of residue Y to amino acid A in the second protein if residues X and Y correspond to each other in a sequence alignment, and despite the fact that X and Y may be different numbers.</div>
    </li> <li> <para-num num="[0161]"> </para-num> <div id="p-0162" num="0161" class="description-line">As used herein, the term recognition half-site, recognition sequence half-site, or simply half-site means a nucleic acid sequence in a double-stranded DNA molecule which is recognized by a monomer of a homodimeric or heterodimeric meganuclease, or by one subunit of a single-chain meganuclease.</div>
    </li> <li> <para-num num="[0162]"> </para-num> <div id="p-0163" num="0162" class="description-line">As used herein, the term hypervariable region refers to a localized sequence within a meganuclease monomer or subunit that comprises amino acids with relatively high variability. A hypervariable region can comprise about 50-60 contiguous residues, about 53-57 contiguous residues, or preferably about 56 residues. In some embodiments, the residues of a hypervariable region may correspond to positions 24-79 or positions 215-270 of SEQ ID NO: 12 or 13. A hypervariable region can comprise one or more residues that contact DNA bases in a recognition sequence and can be modified to alter base preference of the monomer or subunit. A hypervariable region can also comprise one or more residues that bind to the DNA backbone when the meganuclease associates with a double-stranded DNA recognition sequence. Such residues can be modified to alter the binding affinity of the meganuclease for the DNA backbone and the target recognition sequence. In different embodiments of the invention, a hypervariable region may comprise between 1-20 residues that exhibit variability and can be modified to influence base preference and/or DNA-binding affinity. In particular embodiments, a hypervariable region comprises between about 15-20 residues that exhibit variability and can be modified to influence base preference and/or DNA-binding affinity.</div>
    </li> <li> <para-num num="[0163]"> </para-num> <div id="p-0164" num="0163" class="description-line">In some embodiments, variable residues within a hypervariable region correspond to one or more of <figure-callout id="24" label="positions" filenames="US20190338263A1-20191107-D00005.png" state="{{state}}"> <figure-callout id="30" label="positions" filenames="US20190338263A1-20191107-D00006.png,US20190338263A1-20191107-D00009.png" state="{{state}}"> <figure-callout id="40" label="positions" filenames="US20190338263A1-20191107-D00009.png,US20190338263A1-20191107-D00010.png" state="{{state}}"> <figure-callout id="70" label="positions" filenames="US20190338263A1-20191107-D00009.png" state="{{state}}"> <figure-callout id="75" label="positions" filenames="US20190338263A1-20191107-D00011.png" state="{{state}}">positions</figure-callout> </figure-callout> </figure-callout> </figure-callout> </figure-callout> 24, 26, 28, 30, 32, 33, 38, 40, 42, 44, 46, 68, 70, 75, and 77 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0164]"> </para-num> <div id="p-0165" num="0164" class="description-line">In some embodiments, variable residues within a hypervariable region correspond to one or more of positions 215, 217, 219, 221, 223, 224, 229, 231, 233, 235, 237, 261, 266, and 268 of SEQ ID NO: 12 or 13. In some embodiments, variable residues within a hypervariable region further correspond to one or more of positions 239, 241, 263, and 264 of SEQ ID NO: 12, or one or more of positions 241, 262, 263, and 264 of SEQ ID NO: 13. In other embodiments, variable residues within a hypervariable region correspond to one or more of positions In other embodiments, variable residues within a hypervariable region correspond to one or more of positions 215, 217, 219, 221, 223, 224, 229, 231, 233, 235, 237, 239, 241, 259, 261, 262, 263, 264, 266, and 268 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0165]"> </para-num> <div id="p-0166" num="0165" class="description-line">The terms recombinant DNA construct, recombinant construct, expression cassette, expression construct, chimeric construct, construct, and recombinant DNA fragment are used interchangeably herein and are single or double-stranded polynucleotides. A recombinant construct comprises an artificial combination of nucleic acid fragments, including, without limitation, regulatory and coding sequences that are not found together in nature. For example, a recombinant DNA construct may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source and arranged in a manner different than that found in nature. Such a construct may be used by itself or may be used in conjunction with a vector.</div>
    </li> <li> <para-num num="[0166]"> </para-num> <div id="p-0167" num="0166" class="description-line">As used herein, a vector or recombinant DNA vector may be a construct that includes a replication system and sequences that are capable of transcription and translation of a polypeptide-encoding sequence in a given host cell. If a vector is used then the choice of vector is dependent upon the method that will be used to transform host cells as is well known to those skilled in the art. Vectors can include, without limitation, plasmid vectors and recombinant viral vectors (e.g., AAV vectors), or any other vector known in that art suitable for delivering a gene encoding a meganuclease of the invention to a target cell. The skilled artisan is well aware of the genetic elements that must be present on the vector in order to successfully transform, select and propagate host cells comprising any of the isolated nucleotides or nucleic acid sequences of the invention.</div>
    </li> <li> <para-num num="[0167]"> </para-num> <div id="p-0168" num="0167" class="description-line">As used herein, a vector can also refer to a viral vector. Viral vectors can include, without limitation, retroviral vectors, lentiviral vectors, adenoviral vectors, and adeno-associated viral vectors (AAV).</div>
    </li> <li> <para-num num="[0168]"> </para-num> <div id="p-0169" num="0168" class="description-line">As used herein, a polycistronic mRNA refers to a single messenger RNA that comprises two or more coding sequences (i.e., cistrons) and encodes more than one protein. A polycistronic mRNA can comprise any element known in the art to allow for the translation of two or more genes from the same mRNA molecule including, but not limited to, an IRES element, a T2A element, a P2A element, an E2A element, and an F2A element.</div>
    </li> <li> <para-num num="[0169]"> </para-num> <div id="p-0170" num="0169" class="description-line">As used herein, a control or control cell refers to a cell that provides a reference point for measuring changes in genotype or phenotype of a genetically-modified cell. A control cell may comprise, for example: (a) a wild-type cell, i.e., of the same genotype as the starting material for the genetic alteration which resulted in the genetically-modified cell; (b) a cell of the same genotype as the genetically-modified cell but which has been transformed with a null construct (i.e., with a construct which has no known effect on the trait of interest); or, (c) a cell genetically identical to the genetically-modified cell but which is not exposed to conditions or stimuli or further genetic modifications that would induce expression of altered genotype or phenotype.</div>
    </li> <li> <para-num num="[0170]"> </para-num> <div id="p-0171" num="0170" class="description-line">As used herein, the terms treatment or treating a subject refers to the administration of an engineered meganuclease of the invention, or a nucleic acid encoding an engineered meganuclease of the invention to a subject infected with HBV for the purpose of slowing or stopping the rate of HBV proliferation of the virus by cleaving the genome of at least one HBV particle. Such treatment reduces or prevents transfection and replication of HBV in the subject, and provides either partial or complete relief of one or more symptoms of HBV in the subject. Means to assess alleviation of symptoms of HBV infection may include measurement of liver functions by determining levels of the enzyme alanine aminotransferase (ALT) or by measuring sero conversion, namely disappearance and/or reduction of the circulating HBeAg and/or HBsAg levels. Further, alleviation or reduction of symptoms of HBV can be determined by examining liver biopsies and measuring the level of tissue fibrosis by methods well known in the art. The number of circulating viral particles can be determined for example by measuring HBV DNA levels using PCR or by detecting HBsAg levels in the blood. The terms treatment or treating a subject can further refer to the administration of a cell (e.g., hepatocyte cell) comprising a nucleic acid encoding an engineered meganuclease, wherein the cell is delivered to a target tissue (e.g., liver) and produces the engineered meganuclease in an amount sufficient to treat an HBV infection in the subject, thereby resulting in either partial or complete relief of one or more symptoms of HBV. In some aspects, an engineered meganuclease of the invention, a nucleic acid encoding the same, or a genetically-modified cell or population of genetically-modified cells described herein is administered during treatment in the form of a pharmaceutical composition of the invention.</div>
    </li> <li> <para-num num="[0171]"> </para-num> <div id="p-0172" num="0171" class="description-line">The term Hepatitis B Virus infection refers to any condition related to or resulting from infection with a Hepatitis B virus, such as chronic liver diseases/disorders, inflammations, fibrotic conditions and proliferative disorders, such as liver cancers. Chronic persistent HBV infection can cause fatigue, liver damage, cirrhosis of the liver, and hepatocellular carcinoma, a primary liver cancer.</div>
    </li> <li> <para-num num="[0172]"> </para-num> <div id="p-0173" num="0172" class="description-line">The terms proliferating and proliferation as used herein refer to HBV viruses or HBV cccDNA actively dividing and/or infecting human cells. Thus, reduction in proliferation refers to any decrease in the proliferation of HBV including reduction of at least 1%, 2%, 3%, 4%, 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% when compared to an appropriate control not having been administered the engineered meganuclease, or nucleic acid encoding the engineered meganuclease, disclosed herein. Throughout this application, the term proliferative disorder refers to any disease/disorder marked by unwanted or aberrant proliferation of cells or tissue. As used herein, the term proliferative disorder also refers to conditions in which the unregulated and/or abnormal growth of cells can lead to the development of an unwanted condition or disease, which can be cancerous or non-cancerous.</div>
    </li> <li> <para-num num="[0173]"> </para-num> <div id="p-0174" num="0173" class="description-line">The term effective amount or therapeutically effective amount refers to an amount sufficient to effect beneficial or desirable biological and/or clinical results. The therapeutically effective amount will vary depending on the formulation or composition used, the disease and its severity and the age, weight, physical condition and responsiveness of the subject to be treated. In specific embodiments, an effective amount of the engineered meganuclease or pharmaceutical compositions disclosed herein reduces the level or proliferation of HBV or reduces at least one symptom of HBV in a subject with an HBV infection.</div>
    </li> <li> <para-num num="[0174]"> </para-num> <div id="p-0175" num="0174" class="description-line">The term gc/kg or gene copies/kilogram refers to the number of copies of a nucleic acid encoding an engineered meganuclease described herein per weight in kilograms of a subject that is administered the nucleic acid encoding the engineered meganuclease.</div>
    </li> <li> <para-num num="[0175]"> </para-num> <div id="p-0176" num="0175" class="description-line">The term lipid nanoparticle refers to a lipid composition having a typically spherical structure with an average diameter between 10 and 1000 nanometers. In some formulations, lipid nanoparticles can comprise at least one cationic lipid, at least one non-cationic lipid, and at least one conjugated lipid. Lipid nanoparticles known in the art that are suitable for encapsulating nucleic acids, such as mRNA, are contemplated for use in the invention.</div>
    </li> <li> <para-num num="[0176]"> </para-num> <div id="p-0177" num="0176" class="description-line">As used herein, the recitation of a numerical range for a variable is intended to convey that the invention may be practiced with the variable equal to any of the values within that range. Thus, for a variable which is inherently discrete, the variable can be equal to any integer value within the numerical range, including the end-points of the range. Similarly, for a variable which is inherently continuous, the variable can be equal to any real value within the numerical range, including the end-points of the range. As an example, and without limitation, a variable which is described as having values between 0 and 2 can take the <figure-callout id="0" label="values" filenames="US20190338263A1-20191107-D00006.png,US20190338263A1-20191107-D00007.png" state="{{state}}"> <figure-callout id="1" label="values" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}"> <figure-callout id="2" label="values" filenames="US20190338263A1-20191107-D00001.png,US20190338263A1-20191107-D00007.png" state="{{state}}">values</figure-callout> </figure-callout> </figure-callout> 0, 1 or 2 if the variable is inherently discrete, and can take the values 0.0, 0.1, 0.01, 0.001, or any other real values 0 and 2 if the variable is inherently continuous.</div>
    </li> <heading id="h-0009">2.1 Principle of the Invention</heading>
    <li> <para-num num="[0177]"> </para-num> <div id="p-0178" num="0177" class="description-line">The present invention is based, in part, on the discovery of second-generation HBV 11-12 meganucleases which have improved properties when compared to first-generation HBV 11-12 meganucleases, such as improved (i.e., increased) specificity resulting in reduced off-target cutting, and enhanced (i.e., increased) efficiency of cleavage and indel formation at the HBV 11-12 recognition sequence, particularly in cells comprising an integrated copy of the HBV genome.</div>
    </li> <li> <para-num num="[0178]"> </para-num> <div id="p-0179" num="0178" class="description-line">Like the first-generation HBV11-12x.26 meganuclease, the optimized, second-generation meganucleases of the invention recognize the HBV 11-12 recognition sequence (SEQ ID NO: 10) in the P gene of the Hepatitis B virus that encodes the viral DNA polymerase. The HBV 11-12 recognition sequence is conserved across at least HBV genotypes A-G (SEQ ID NOs: 3-9), which advantageously allows for the presently disclosed engineered meganucleases to target HBV infections around the globe.</div>
    </li> <li> <para-num num="[0179]"> </para-num> <div id="p-0180" num="0179" class="description-line">Cleavage at the HBV 11-12 recognition sequence can allow for non-homologous end joining (NHEJ) at the cleavage site and can disrupt expression of one or more viral proteins (e.g., viral DNA polymerase) due to NHEJ at the cleavage site that results in insertions, deletions, or frameshift mutations. Alternatively, cleavage of the HBV genome at the HBV 11-12 recognition sequence may promote degradation of the HBV genome and/or HBV cccDNA. Disruption of the expression of the viral protein(s) can reduce or eliminate the infection and/or proliferation of HBV.</div>
    </li> <li> <para-num num="[0180]"> </para-num> <div id="p-0181" num="0180" class="description-line">Additionally, cleavage at the HBV 11-12 recognition sequence can further allow for homologous recombination of exogenous nucleic acid sequences directly into the HBV genome to disrupt the expression of one or more viral proteins. For example, a suicide gene can be introduced into a HBV genome via homologous recombination.</div>
    </li> <li> <para-num num="[0181]"> </para-num> <div id="p-0182" num="0181" class="description-line">Thus, the present invention encompasses engineered meganucleases which recognize and cleave the HBV 11-12 recognition sequence within a HBV genome. The present invention also encompasses methods of using such engineered meganucleases in a pharmaceutical composition and in methods for treating HBV infection. Further, the invention encompasses pharmaceutical compositions comprising engineered meganuclease proteins, or nucleic acids encoding engineered meganucleases, and the use of such compositions for the treatment of HBV infection and hepatocellular carcinoma (HCC).</div>
    </li> <heading id="h-0010">2.2 Optimized Meganucleases that Recognize and Cleave the HBV 11-12 Recognition Sequence within the Genome of HBV</heading>
    <li> <para-num num="[0182]"> </para-num> <div id="p-0183" num="0182" class="description-line">It is known in the art that it is possible to use a site-specific nuclease to make a DNA break in the genome of a virus, and that such a DNA break can result in permanent modification of the genome via NHEJ such that the HBV virion can no longer divide/replicate or infect human cells. Thus, in some embodiments, the invention can be practiced using engineered meganucleases.</div>
    </li> <li> <para-num num="[0183]"> </para-num> <div id="p-0184" num="0183" class="description-line">In particular embodiments, the nucleases used to practice the invention are single-chain meganucleases. A single-chain meganuclease comprises an N-terminal subunit and a C-terminal subunit joined by a linker peptide. Each of the two domains recognizes half of the recognition sequence (i.e., a recognition half-site) and the site of DNA cleavage is at the middle of the recognition sequence near the interface of the two subunits. DNA strand breaks are offset by four base pairs such that DNA cleavage by a meganuclease generates a pair of four base pair, 3 single-strand overhangs.</div>
    </li> <li> <para-num num="[0184]"> </para-num> <div id="p-0185" num="0184" class="description-line">The engineered meganucleases of the invention have been engineered to recognize and cleave the HBV 11-12 recognition sequence (SEQ ID NO: 10). The HBV 11-12 recognition sequence is positioned within the P protein ORF of multiple HBV genotypes. The HBV 11-12 recognition sequence can at least be found in the genome of multiple HBV genotypes, including genotypes A, B, C, D, E, F, and G (e.g., SEQ ID NOs: 3-9, respectively).</div>
    </li> <li> <para-num num="[0185]"> </para-num> <div id="p-0186" num="0185" class="description-line">Engineered meganucleases of the invention comprise a first subunit, comprising a first hypervariable (HVR1) region, and a second subunit, comprising a second hypervariable (HVR2) region. Further, the first subunit binds to a first recognition half-site in the recognition sequence (i.e., the HBV11 half-site), and the second subunit binds to a second recognition half-site in the recognition sequence (i.e., the HBV12 half-site). In embodiments where the engineered meganuclease is a single-chain meganuclease, the first and second subunits can be oriented such that the first subunit, which comprises the HVR1 region and binds the first half-site, is positioned as the N-terminal subunit, and the second subunit, which comprises the HVR2 region and binds the second half-site, is positioned as the C-terminal subunit. In alternative embodiments, the first and second subunits can be oriented such that the first subunit, which comprises the HVR1 region and binds the first half-site, is positioned as the C-terminal subunit, and the second subunit, which comprises the HVR2 region and binds the second half-site, is positioned as the N-terminal subunit. Exemplary engineered meganucleases that recognize and cleave the HBV 11-12 recognition sequence are provided in Table 1.</div>
    </li> <li> <div id="p-0187" num="0000" class="description-line">
      <tables id="TABLE-US-00001" num="00001">
        <patent-tables frame="none" colsep="0" rowsep="0" pgwide="1">
          <table align="left" colsep="0" rowsep="0" cols="1" class="description-table" width="100%">
            <thead>
              <tr class="description-tr">
                <td namest="1" nameend="1" rowsep="1" class="description-td" colspan="1">TABLE 1</td>
              </tr>
            </thead>
            
              <tbody><tr class="description-tr">
                <td namest="1" nameend="1" align="center" rowsep="1" class="description-td" colspan="1"> </td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">Exemplary engineered meganucleases which recognize and cleave</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">the HBV 11-12 recognition sequence (SEQ ID NO: 10).</td>
              </tr>
            
          </tbody></table>
          <table align="left" colsep="0" rowsep="0" cols="10" class="description-table" width="100%">
            <tbody><tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">AA</td>
                <td class="description-td">HBV11</td>
                <td class="description-td">HBV11</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">HBV12</td>
                <td class="description-td">HBV12</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">SEQ</td>
                <td class="description-td">Subunit</td>
                <td class="description-td">Subunit</td>
                <td class="description-td">HVR1</td>
                <td class="description-td">*HVR1</td>
                <td class="description-td">Subunit</td>
                <td class="description-td">Subunit</td>
                <td class="description-td">HVR2</td>
                <td class="description-td">*HVR2</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">Meganuclease</td>
                <td class="description-td">ID</td>
                <td class="description-td">Residues</td>
                <td class="description-td">SEQ ID</td>
                <td class="description-td">Residues</td>
                <td class="description-td">%</td>
                <td class="description-td">Residues</td>
                <td class="description-td">SEQ ID</td>
                <td class="description-td">Residues</td>
                <td class="description-td">%</td>
              </tr>
              <tr class="description-tr">
                <td namest="1" nameend="10" align="center" rowsep="1" class="description-td" colspan="10"> </td>
              </tr>
            
          </tbody></table>
          <table align="left" colsep="0" rowsep="0" cols="10" class="description-table" width="100%">
            <tbody><tr class="description-tr">
                <td class="description-td">HBV 11-12L.363</td>
                <td class="description-td">12</td>
                <td class="description-td">198-344</td>
                <td class="description-td">15</td>
                <td class="description-td">215-270</td>
                <td class="description-td">85.71</td>
                <td class="description-td">7-153</td>
                <td class="description-td">18</td>
                <td class="description-td">24-79</td>
                <td class="description-td">96.43</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">HBV 11-12L.367</td>
                <td class="description-td">13</td>
                <td class="description-td">198-344</td>
                <td class="description-td">16</td>
                <td class="description-td">215-270</td>
                <td class="description-td">85.71</td>
                <td class="description-td">7-153</td>
                <td class="description-td">19</td>
                <td class="description-td">24-79</td>
                <td class="description-td">96.43</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">HBV 11-12x.26</td>
                <td class="description-td">14</td>
                <td class="description-td">198-344</td>
                <td class="description-td">17</td>
                <td class="description-td">215-270</td>
                <td class="description-td">100</td>
                <td class="description-td">7-153</td>
                <td class="description-td">20</td>
                <td class="description-td">24-79</td>
                <td class="description-td">100</td>
              </tr>
              <tr class="description-tr">
                <td namest="1" nameend="10" align="center" rowsep="1" class="description-td" colspan="10"> </td>
              </tr>
              <tr class="description-tr">
                <td namest="1" nameend="10" align="left" id="FOO-00001" class="description-td" colspan="10">*HVR1 % and HVR2 % represent the amino acid sequence identity between the HVR1 and HVR2 regions, respectively, of each meganuclease and the HVR1 and HVR2 regions, respectively, of the HBV 11-12x.26 meganuclease.</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    </li> <li> <para-num num="[0186]"> </para-num> <div id="p-0188" num="0186" class="description-line">In some embodiments, the presently disclosed engineered meganucleases exhibit at least one optimized characteristic in comparison to the first-generation meganuclease HBV 11-12x.26. Such optimized characteristics include improved (i.e. increased) specificity resulting in reduced off-target cutting, and enhanced (i.e., increased) efficiency of cleavage and indel (i.e., insertion or deletion) formation at the HBV 11-12 recognition sequence, particularly in cells comprising an integrated copy of the HBV genome. Thus, in particular embodiments, the presently disclosed engineered meganucleases, when delivered to a population of HBV-infected target cells, is able to generate a greater percentage of virions or cells with a cleavage and/or indel in the HBV genome (either incorporated or unincorporated). In some of these embodiments, the population of HBV or target cells comprises at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more of HBV or target cells comprising a cleavage and/or indel in the HBV genome (either incorporated or unincorporated). Cleavage and/or indel formation by a meganuclease can be measured using any method known in the art, including T7E assay, digital PCR, mismatch detection assays, mismatch cleavage assay, high-resolution melting analysis (HRMA), heteroduplex mobility assay, sequencing, and fluorescent PCR capillary gel electrophoresis (see, e.g., Zischewski et al. (2017) Biotechnology Advances 35(1):95-104, which is incorporated by reference in its entirety).</div>
    </li> <heading id="h-0011">2.3 Methods for Delivering and Expressing Optimized Meganucleases</heading>
    <li> <para-num num="[0187]"> </para-num> <div id="p-0189" num="0187" class="description-line">Disclosed herein are methods for treating an HBV infection or HCC in a subject. Likewise, methods are provided for reducing the symptoms of an HBV infection and reducing the amount of HBV, reducing the rate of proliferation of HBV or treating HCC in a subject comprising administering a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an engineered meganuclease disclosed herein (or a nucleic acid encoding the engineered meganuclease or a cell expressing the engineered meganuclease). In the methods of the invention, an engineered meganuclease disclosed herein can be delivered to and/or expressed from DNA/RNA in target cells that can provide the engineered meganuclease to the HBV genome.</div>
    </li> <li> <para-num num="[0188]"> </para-num> <div id="p-0190" num="0188" class="description-line">Engineered meganucleases disclosed herein can be delivered into a cell in the form of protein or, preferably, as a nucleic acid encoding the engineered meganuclease. Such nucleic acid can be DNA (e.g., circular or linearized plasmid DNA or PCR products) or RNA (e.g., mRNA). For embodiments in which the engineered meganuclease coding sequence is delivered in DNA form, it should be operably linked to a promoter to facilitate transcription of the nuclease gene. Mammalian promoters suitable for the invention include constitutive promoters such as the cytomegalovirus early (CMV) promoter (Thomsen et al. (1984), Proc Natl Acad Sci USA. 81(3):659-63) or the SV40 early promoter (Benoist and Chambon (1981), Nature. 290(5804):304-10) as well as inducible promoters such as the tetracycline-inducible promoter (Dingermann et al. (1992), Mol Cell Biol. 12(9):4038-45). An engineered meganuclease of the invention can also be operably linked to a synthetic promoter. Synthetic promoters can include, without limitation, the JeT promoter (WO 2002/012514). In specific embodiments, a nucleic acid sequence encoding an engineered meganuclease as disclosed herein can be operably linked to a liver-specific promoter. Examples of liver-specific promoters include, without limitation, human alpha-1 antitrypsin promoter, hybrid liver-specific promoter (hepatic locus control region from ApoE gene (ApoE-HCR) and a liver-specific alpha1-antitrypsin promoter), human thyroxine binding globulin (TBG) promoter, and apolipoprotein A-II promoter.</div>
    </li> <li> <para-num num="[0189]"> </para-num> <div id="p-0191" num="0189" class="description-line">In specific embodiments, a nucleic acid sequence encoding at least one engineered meganuclease is delivered on a recombinant DNA construct or expression cassette. For example, the recombinant DNA construct can comprise an expression cassette (i.e., cassette) comprising a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein. In other embodiments, the recombinant DNA construct comprises at least a first cassette and a second cassette, wherein the first cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein, and wherein the second cassette comprises a promoter and a nucleic acid sequence encoding a second engineered meganuclease which recognizes and cleaves a second recognition sequence which is present in a Hepatitis B virus genome but differs from SEQ ID NO: 10. Non-limiting examples of other recognition sequences within the genome of a Hepatitis B virus include the HBV 5-6 recognition sequence (set forth as SEQ ID NO: 21).</div>
    </li> <li> <para-num num="[0190]"> </para-num> <div id="p-0192" num="0190" class="description-line">In other embodiments, the recombinant DNA construct comprises a cassette comprising a promoter and a polycistronic nucleic acid sequence, wherein the promoter drives expression of the polycistronic nucleic acid sequence to generate a polycistronic mRNA described herein in a target cell.</div>
    </li> <li> <para-num num="[0191]"> </para-num> <div id="p-0193" num="0191" class="description-line">In some embodiments, mRNA encoding an engineered meganuclease is delivered to a cell because this reduces the likelihood that the gene encoding the engineered meganuclease will integrate into the genome of the cell. Such mRNA encoding an engineered meganuclease can be produced using methods known in the art such as in vitro transcription. In some embodiments, the mRNA is 5 capped using 7-methyl-guanosine, anti-reverse cap analogs (ARCA) (U.S. Pat. No. 7,074,596), CleanCap analogs such as <figure-callout id="1" label="Cap" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">Cap</figure-callout> 1 analogs (Trilink, San Diego, Calif.), or enzymatically capped using vaccinia capping enzyme or similar. In some embodiments, the mRNA may be polyadenylated. The mRNA may contain various 5 and 3 untranslated sequence elements to enhance expression the encoded engineered meganuclease and/or stability of the mRNA itself. Such elements can include, for example, posttranslational regulatory elements such as a woodchuck hepatitis virus posttranslational regulatory element. The mRNA may contain nucleoside analogs or naturally-occurring nucleosides, such as pseudouridine, 5-methylcytidine, N6-methyladenosine, 5-methyluridine, or 2-thiouridine. Additional nucleoside analogs include, for example, those described in U.S. Pat. No. 8,278,036.</div>
    </li> <li> <para-num num="[0192]"> </para-num> <div id="p-0194" num="0192" class="description-line">In particular embodiments, an mRNA encoding an engineered nuclease of the invention can be a polycistronic mRNA encoding two or more of the presently disclosed meganucleases which are simultaneously expressed in a cell. In some embodiments, a polycistronic mRNA can encode at least a first and a second engineered meganuclease, wherein the first engineered meganuclease is an engineered meganuclease described herein, and wherein the second engineered meganuclease recognizes and cleaves a second recognition sequence in the HBV genome that differs from SEQ ID NO: 10 (e.g., the HBV 5-6 recognition sequence), such that the HBV genome is cleaved at multiple sites. In some embodiments, a polycistronic mRNA can encode an engineered meganuclease described herein and at least one additional protein which induces a therapeutically beneficial effect in the cell. A polycistronic mRNA of the invention can comprise any element known in the art to allow for the translation of two or more genes from the same mRNA molecule including, but not limited to, an IRES element, a T2A element, a P2A element, an E2A element, and an F2A element.</div>
    </li> <li> <para-num num="[0193]"> </para-num> <div id="p-0195" num="0193" class="description-line">In another particular embodiment, a nucleic acid encoding an endonuclease of the invention can be introduced into the cell using a single-stranded DNA template. The single-stranded DNA can further comprise a 5 and/or a 3 AAV inverted terminal repeat (ITR) upstream and/or downstream of the sequence encoding the engineered meganuclease. In other embodiments, the single-stranded DNA can further comprise a 5 and/or a 3 homology arm upstream and/or downstream of the sequence encoding the engineered meganuclease.</div>
    </li> <li> <para-num num="[0194]"> </para-num> <div id="p-0196" num="0194" class="description-line">In another particular embodiment, genes encoding an endonuclease of the invention can be introduced into a cell using a linearized DNA template. In some examples, a plasmid DNA encoding an endonuclease can be digested by one or more restriction enzymes such that the circular plasmid DNA is linearized prior to being introduced into a cell.</div>
    </li> <li> <para-num num="[0195]"> </para-num> <div id="p-0197" num="0195" class="description-line">In some embodiments, the methods comprise delivering an engineered meganuclease described herein (or a nucleic acid encoding the same) and a nucleic acid comprising a polynucleotide sequence encoding a suicide gene and sequences homologous to sequences flanking the meganuclease cleavage site, wherein the engineered meganuclease recognizes and cleaves a recognition sequence comprising SEQ ID NO: 10 within the Hepatitis B virus genome, thus cleaving the HBV genome, wherein the suicide gene is inserted into the cleaved HBV genome by homologous recombination.</div>
    </li> <li> <para-num num="[0196]"> </para-num> <div id="p-0198" num="0196" class="description-line">A suicide gene is a nucleic acid that encodes a product that causes cell death by itself or in the presence of other compounds. A representative example of such a suicide gene is one that encodes thymidine kinase of herpes simplex virus. Additional examples are genes that encode thymidine kinase of varicella zoster virus and the bacterial gene cytosine deaminase that can convert 5-fluorocytosine to the highly toxic compound 5-fluorouracil. Suicide genes also include as non-limiting examples genes that encode caspase-9, caspase-8, or cytosine deaminase. In some examples, caspase-9 can be activated using a specific chemical inducer of dimerization (CID). In some embodiments, the suicide gene is directly lethal to the HBV or a target cell (e.g., HCC cell). In some such embodiments, the directly lethal suicide gene encodes a toxic polypeptide or a pro-apoptotic protein. In some embodiments, the suicide gene is indirectly lethal to the target cell, and directs the subject&#39;s own immune system to kill the target cell. In some such embodiments, the indirectly lethal suicide gene encodes a cell surface protein which is recognized as foreign by the subject&#39;s immune system and is targeted by a humoral or cellular immune response. In other such embodiments, the indirectly lethal suicide gene encodes a polypeptide which is presented by an MHC Class I molecule, is recognized as foreign by the subject&#39;s immune system, and is targeted by a cytotoxic immune response.</div>
    </li> <li> <para-num num="[0197]"> </para-num> <div id="p-0199" num="0197" class="description-line">Purified meganuclease proteins can be delivered into cells to cleave genomic DNA by a variety of different mechanisms known in the art, including those further detailed herein below.</div>
    </li> <li> <para-num num="[0198]"> </para-num> <div id="p-0200" num="0198" class="description-line">The target tissue(s) for delivery of engineered meganucleases of the invention include, without limitation, cells of the liver, such as a hepatocyte cell or preferably a primary hepatocyte, more preferably a human hepatocyte or a human primary hepatocyte, a HepG2.2.15 or a HepG2-hNTCP cell. As discussed, meganucleases of the invention can be delivered as purified protein or as RNA or DNA encoding the meganuclease. In one embodiment, meganuclease proteins, or mRNA, or DNA vectors encoding meganucleases, are supplied to target cells (e.g., cells in the liver) via injection directly to the target tissue. Alternatively, meganuclease protein, mRNA, DNA, or cells expressing meganucleases can be delivered systemically via the circulatory system.</div>
    </li> <li> <para-num num="[0199]"> </para-num> <div id="p-0201" num="0199" class="description-line">In some embodiments, meganuclease proteins, DNA/mRNA encoding meganucleases, or cells expressing meganuclease proteins are formulated for systemic administration, or administration to target tissues, in a pharmaceutically acceptable carrier in accordance with known techniques. See, e.g., Remington, The Science And Practice of Pharmacy (21st ed., Philadelphia, Lippincott, Williams &amp; Wilkins, 2005). In the manufacture of a pharmaceutical formulation according to the invention, proteins/RNA/mRNA/cells are typically admixed with a pharmaceutically acceptable carrier. The carrier must, of course, be acceptable in the sense of being compatible with any other ingredients in the formulation and must not be deleterious to the patient. The carrier can be a solid or a liquid, or both, and can be formulated with the compound as a unit-dose formulation.</div>
    </li> <li> <para-num num="[0200]"> </para-num> <div id="p-0202" num="0200" class="description-line">In some embodiments, about 110<sup>10 </sup>gc/kg to about 110<sup>14 </sup>gc/kg (e.g., 110<sup>10 </sup>gc/kg, 110<sup>11 </sup>gc/kg, 110<sup>12 </sup>gc/kg, 110<sup>13 </sup>gc/kg, or 110<sup>14 </sup>gc/kg) of a nucleic acid encoding the engineered meganuclease is administered to the subject. In some embodiments, at least about 110<sup>10 </sup>gc/kg, at least about 110<sup>11 </sup>gc/kg, at least about 110<sup>12 </sup>gc/kg, at least about 110<sup>13 </sup>gc/kg, or at least about 110<sup>14 </sup>gc/kg of a nucleic acid encoding the engineered meganuclease is administered to the subject. In some embodiments, about 110<sup>10 </sup>gc/kg to about 110<sup>11 </sup>gc/kg, about 110<sup>11 </sup>gc/kg to about 110<sup>12 </sup>gc/kg, about 110<sup>12 </sup>gc/kg to about 110<sup>13 </sup>gc/kg, or about 110<sup>13 </sup>gc/kg to about 110<sup>14 </sup>gc/kg of a nucleic acid encoding the engineered meganuclease is administered to the subject.</div>
    </li> <li> <para-num num="[0201]"> </para-num> <div id="p-0203" num="0201" class="description-line">In some embodiments, the subject is administered a lipid nanoparticle formulation with about 0.1 mg/kg to about 3 mg/kg of mRNA encoding an engineered meganuclease. In some embodiments, the subject is administered a lipid nanoparticle formulation with at least about 0.1 mg/kg, at least about 0.25 mg/kg, at least about 0.5 mg/kg, at least about 0.75 mg/kg, at least about 1.0 mg/kg, at least about 1.5 mg/kg, at least about 2.0 mg/kg, at least about 2.5 mg/kg, or at least about 3.0 mg/kg of mRNA encoding an engineered meganuclease. In some embodiments, the subject is administered a lipid nanoparticle formulation within about 0.1 mg/kg to about 0.25 mg/kg, about 0.25 mg/kg to about 0.5 mg/kg, about 0.5 mg/kg to about 0.75 mg/kg, about 0.75 mg/kg to about 1.0 mg/kg, about 1.0 mg/kg to about 1.5 mg/kg, about 1.5 mg/kg to about 2.0 mg/kg, about 2.0 mg/kg to about 2.5 mg/kg, or about 2.5 mg/kg to about 3.0 mg/kg of mRNA encoding and engineered meganuclease.</div>
    </li> <li> <para-num num="[0202]"> </para-num> <div id="p-0204" num="0202" class="description-line">In some embodiments, meganuclease proteins, or DNA/mRNA encoding the meganuclease, are coupled to a cell penetrating peptide or targeting ligand to facilitate cellular uptake. Examples of cell penetrating peptides known in the art include poly-arginine (Jearawiriyapaisarn, et al. (2008) Mol Ther. 16:1624-9), TAT peptide from the HIV virus (Hudecz et al. (2005), Med. Res. Rev. 25: 679-736), MPG (Simeoni, et al. (2003) Nucleic Acids Res. 31:2717-2724), Pep-1 (Deshayes et al. (2004) Biochemistry 43: 7698-7706, and HSV-1 VP-22 (Deshayes et al. (2005) Cell Mol Life Sci. 62:1839-49. In an alternative embodiment, meganuclease proteins, or DNA/mRNA encoding meganucleases, are coupled covalently or non-covalently to an antibody that recognizes a specific cell-surface receptor expressed on target cells such that the meganuclease protein/DNA/mRNA binds to and is internalized by the target cells. Alternatively, meganuclease protein/DNA/mRNA can be coupled covalently or non-covalently to the natural ligand (or a portion of the natural ligand) for such a cell-surface receptor. (McCall, et al. (2014) Tissue Barriers. 2(4):e944449; Dinda, et al. (2013) Curr Pharm Biotechnol. 14:1264-74; Kang, et al. (2014) Curr Pharm Biotechnol. 15(3):220-30; Qian et al. (2014) Expert Opin Drug Metab Toxicol. 10(11):1491-508).</div>
    </li> <li> <para-num num="[0203]"> </para-num> <div id="p-0205" num="0203" class="description-line">In some embodiments, meganuclease proteins, or DNA/mRNA encoding meganucleases, are encapsulated within biodegradable hydrogels for injection or implantation within the desired region of the liver (e.g., in proximity to hepatic sinusoidal endothelial cells or hematopoietic endothelial cells, or progenitor cells which differentiate into the same). Hydrogels can provide sustained and tunable release of the therapeutic payload to the desired region of the target tissue without the need for frequent injections, and stimuli-responsive materials (e.g., temperature- and pH-responsive hydrogels) can be designed to release the payload in response to environmental or externally applied cues (Kang Derwent et al. (2008) Trans Am Ophthalmol Soc. 106:206-214).</div>
    </li> <li> <para-num num="[0204]"> </para-num> <div id="p-0206" num="0204" class="description-line">In some embodiments, meganuclease proteins, or DNA/mRNA encoding meganucleases, are coupled covalently or, preferably, non-covalently to a nanoparticle or encapsulated within such a nanoparticle using methods known in the art (Sharma, et al. (2014) Biomed Res Int. 2014). A nanoparticle is a nanoscale delivery system whose length scale is &lt;1 m, preferably &lt;100 nm. Such nanoparticles may be designed using a core composed of metal, lipid, polymer, or biological macromolecule, and multiple copies of the meganuclease proteins, mRNA, or DNA can be attached to or encapsulated with the nanoparticle core. This increases the copy number of the protein/mRNA/DNA that is delivered to each cell and, so, increases the intracellular expression of each meganuclease to maximize the likelihood that the target recognition sequences will be cut. The surface of such nanoparticles may be further modified with polymers or lipids (e.g., chitosan, cationic polymers, or cationic lipids) to form a core-shell nanoparticle whose surface confers additional functionalities to enhance cellular delivery and uptake of the payload (Jian et al. (2012) Biomaterials. 33(30): 7621-30). Nanoparticles may additionally be advantageously coupled to targeting molecules to direct the nanoparticle to the appropriate cell type and/or increase the likelihood of cellular uptake. Examples of such targeting molecules include antibodies specific for cell-surface receptors and the natural ligands (or portions of the natural ligands) for cell surface receptors.</div>
    </li> <li> <para-num num="[0205]"> </para-num> <div id="p-0207" num="0205" class="description-line">In some embodiments, the meganuclease proteins or DNA/mRNA encoding the meganucleases are encapsulated within liposomes or complexed using cationic lipids (see, e.g., LIPOFECTAMINE transfection reagent, Life Technologies Corp., Carlsbad, Calif.; Zuris et al. (2015) Nat Biotechnol. 33: 73-80; Mishra et al. (2011) J Drug Deliv. 2011:863734). The liposome and lipoplex formulations can protect the payload from degradation, enhance accumulation and retention at the target site, and facilitate cellular uptake and delivery efficiency through fusion with and/or disruption of the cellular membranes of the target cells.</div>
    </li> <li> <para-num num="[0206]"> </para-num> <div id="p-0208" num="0206" class="description-line">In some embodiments, meganuclease proteins, or DNA/mRNA encoding meganucleases, are encapsulated within polymeric scaffolds (e.g., PLGA) or complexed using cationic polymers (e.g., PEI, PLL) (Tamboli et al. (2011) Ther Deliv. 2(4): 523-536). Polymeric carriers can be designed to provide tunable drug release rates through control of polymer erosion and drug diffusion, and high drug encapsulation efficiencies can offer protection of the therapeutic payload until intracellular delivery to the desired target cell population.</div>
    </li> <li> <para-num num="[0207]"> </para-num> <div id="p-0209" num="0207" class="description-line">In some embodiments, meganuclease proteins, or DNA/mRNA encoding engineered meganucleases, are combined with amphiphilic molecules that self-assemble into micelles (Tong et al. (2007) J Gene Med. 9(11): 956-66). Polymeric micelles may include a micellar shell formed with a hydrophilic polymer (e.g., polyethyleneglycol) that can prevent aggregation, mask charge interactions, and reduce nonspecific interactions.</div>
    </li> <li> <para-num num="[0208]"> </para-num> <div id="p-0210" num="0208" class="description-line">In some embodiments, meganuclease proteins, or DNA/mRNA encoding meganucleases, are formulated into an emulsion or a nanoemulsion (i.e., having an average particle diameter of &lt;1 nm) for administration and/or delivery to the target cell. The term emulsion refers to, without limitation, any oil-in-water, water-in-oil, water-in-oil-in-water, or oil-in-water-in-oil dispersions or droplets, including lipid structures that can form as a result of hydrophobic forces that drive apolar residues (e.g., long hydrocarbon chains) away from water and polar head groups toward water, when a water immiscible phase is mixed with an aqueous phase. These other lipid structures include, but are not limited to, unilamellar, paucilamellar, and multilamellar lipid vesicles, micelles, and lamellar phases. Emulsions are composed of an aqueous phase and a lipophilic phase (typically containing an oil and an organic solvent). Emulsions also frequently contain one or more surfactants. Nanoemulsion formulations are well known, e.g., as described in U.S. Pat. Nos. 6,015,832, 6,506,803, 6,635,676, 6,559,189, and 7,767,216, each of which is incorporated herein by reference in its entirety.</div>
    </li> <li> <para-num num="[0209]"> </para-num> <div id="p-0211" num="0209" class="description-line">In some embodiments, meganuclease proteins, or DNA/mRNA encoding meganucleases, are covalently attached to, or non-covalently associated with, multifunctional polymer conjugates, DNA dendrimers, and polymeric dendrimers (Mastorakos et al. (2015) Nanoscale. 7(9): 3845-56; Cheng et al. (2008) J Pharm Sci. 97(1): 123-43). The dendrimer generation can control the payload capacity and size, and can provide a high drug payload capacity. Moreover, display of multiple surface groups can be leveraged to improve stability, reduce nonspecific interactions, and enhance cell-specific targeting and drug release.</div>
    </li> <li> <para-num num="[0210]"> </para-num> <div id="p-0212" num="0210" class="description-line">In some embodiments, genes encoding a meganuclease are delivered using a viral vector. Such vectors are known in the art and include retroviral vectors, lentiviral vectors, adenoviral vectors, and adeno-associated virus (AAV) vectors (reviewed in Vannucci, et al. (2013 New Microbiol. 36:1-22). In some embodiments, the viral vectors are injected directly into target tissues (e.g., liver tissue). In alternative embodiments, the viral vectors are delivered systemically via the circulatory system. It is known in the art that different AAV vectors tend to localize to different tissues. In liver target tissues, effective transduction of hepatocytes has been shown, for example, with <figure-callout id="2" label="AAV serotypes" filenames="US20190338263A1-20191107-D00001.png,US20190338263A1-20191107-D00007.png" state="{{state}}"> <figure-callout id="8" label="AAV serotypes" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">AAV serotypes</figure-callout> </figure-callout> 2, 8, and 9 (Sands (2011) Methods Mol. Biol. 807:141-157). AAV vectors can also be self-complementary such that they do not require second-strand DNA synthesis in the host cell (McCarty, et al. (2001) Gene Ther. 8:1248-54).</div>
    </li> <li> <para-num num="[0211]"> </para-num> <div id="p-0213" num="0211" class="description-line">If the meganuclease genes are delivered in DNA form (e.g. plasmid) and/or via a viral vector (e.g. AAV) they must be operably linked to a promoter. In some embodiments, this can be a viral promoter such as endogenous promoters from the viral vector (e.g. the LTR of a lentiviral vector) or the well-known cytomegalovirus- or SV40 virus-early promoters. In a preferred embodiment, meganuclease genes are operably linked to a promoter that drives gene expression preferentially in the target cells. Examples of liver-specific promoters include, without limitation, human alpha-1 antitrypsin promoter, hybrid liver-specific promoter (hepatic locus control region from ApoE gene (ApoE-HCR) and a liver-specific alpha1-antitrypsin promoter), human thyroxine binding globulin (TBG) promoter, and apolipoprotein A-II promoter.</div>
    </li> <li> <para-num num="[0212]"> </para-num> <div id="p-0214" num="0212" class="description-line">In particular embodiments, the viral vector comprises a cassette comprising a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein. The viral vector could also comprise two or more cassettes, wherein at least a first cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease described herein, and wherein at least a second cassette comprises a promoter and a nucleic acid sequence encoding an engineered meganuclease that has specificity for a different HBV recognition sequence other than the HBV 11-12 recognition sequence. In some embodiments, the viral vector comprises one cassette comprising a promoter and a polycistronic nucleic acid sequence, wherein the promoter drives expression of the polycistronic nucleic acid sequence to generate a polycistronic mRNA, such as polycistronic mRNA encoding an engineered meganuclease, described herein in a target cell.</div>
    </li> <li> <para-num num="[0213]"> </para-num> <div id="p-0215" num="0213" class="description-line">Methods and compositions are provided for delivering a meganuclease disclosed herein to the liver of a subject infected with HBV. In one embodiment, native hepatocytes which have been removed from the mammal can be transduced with a vector which encodes the engineered meganuclease. Alternatively, native hepatocytes of the HBV-infected subject can be transduced ex vivo with an adenoviral vector (i.e., an AAV vector) which encodes the engineered meganuclease and/or a molecule that stimulates liver regeneration, such as a hepatotoxin. Preferably the hepatotoxin is uPA, and has been modified to inhibit its secretion from the hepatocyte once expressed by the viral vector. In another embodiment, the vector encodes tPA, which can stimulate hepatocyte regeneration de novo. The transduced hepatocytes which have been removed from the mammal can then be returned to the mammal, where conditions are provided which are conducive to expression of the engineered meganuclease. Typically the transduced hepatocytes can be returned to the patient by infusion through the spleen or portal vasculature, and administration may be single or multiple over a period of 1 to 5 or more days.</div>
    </li> <li> <para-num num="[0214]"> </para-num> <div id="p-0216" num="0214" class="description-line">In an in vivo aspect of the methods of the invention, a retroviral, pseudotype or adenoviral associated vector (i.e., an AAV vector) is constructed which encodes the engineered meganuclease and is administered to the subject. Administration of a vector encoding the engineered meganuclease can occur with administration of an adenoviral vector that encodes a secretion-impaired hepatotoxin, or encodes tPA, which stimulates hepatocyte regeneration without acting as a hepatotoxin.</div>
    </li> <li> <para-num num="[0215]"> </para-num> <div id="p-0217" num="0215" class="description-line">Appropriate doses will depend, among other factors, on the specifics of any AAV vector chosen (e.g., serotype, etc.), on the route of administration, on the subject being treated (i.e., age, weight, sex, and general condition of the subject), and the mode of administration. Thus, the appropriate dosage may vary from patient to patient. An appropriate effective amount can be readily determined by one of skill in the art. Dosage treatment may be a single dose schedule or a multiple dose schedule. Moreover, the subject may be administered as many doses as appropriate. One of skill in the art can readily determine an appropriate number of doses. The dosage may need to be adjusted to take into consideration an alternative route of administration, or balance the therapeutic benefit against any side effects.</div>
    </li> <heading id="h-0012">2.4 Pharmaceutical Compositions</heading>
    <li> <para-num num="[0216]"> </para-num> <div id="p-0218" num="0216" class="description-line">In some embodiments, the invention provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an engineered meganuclease of the invention, or a pharmaceutically acceptable carrier and a polynucleotide comprising a nucleic acid encoding an engineered meganuclease of the invention. In other embodiments, the invention provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a cell of the invention which can be delivered to a target tissue where the cell expresses the engineered meganuclease as disclosed herein. Pharmaceutical compositions of the invention can be useful for treating a subject having HBV, reducing the level or proliferation of HBV, reducing at least one symptom of HBV, or treating HCC.</div>
    </li> <li> <para-num num="[0217]"> </para-num> <div id="p-0219" num="0217" class="description-line">Pharmaceutical compositions can be designed or selected according to the genotype of the target HBV strain. As described in detail herein, the meganucleases of the invention have been engineered to recognize and cleave a recognition sequence in specific genotypes of HBV. HBV 11-12 meganucleases (e.g., SEQ ID NOs: 12 and 13), recognize and cleave the HBV 11-12 recognition sequence that is at least found in the genome of HBV genotypes A, B, C, D, E, F, and G (e.g., SEQ ID NOs: 3-9, respectively). Further, recognition sequences of the engineered meganucleases disclosed herein can be found in isolates of HBV genotypes A, B, C, D, E, F, and G that do not share 100% sequence identity to the respective genotype examples provided in SEQ ID NOs: 3-9. As used herein, HBV isolates can share at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more sequence identity with the corresponding genotype example provided in any of SEQ ID NOs: 3-9. In some embodiments, the pharmaceutical compositions disclosed herein can be administered to a subject having any genotype of HBV comprising a recognition sequence set forth in SEQ ID NO: 10.</div>
    </li> <li> <para-num num="[0218]"> </para-num> <div id="p-0220" num="0218" class="description-line">Such pharmaceutical compositions can be prepared in accordance with known techniques. See, e.g., Remington, The Science And Practice of Pharmacy (21st ed., Philadelphia, Lippincott, Williams &amp; Wilkins, 2005). In the manufacture of a pharmaceutical formulation according to the invention, meganuclease polypeptides (or DNA/RNA encoding the same or cells expressing the same) are typically admixed with a pharmaceutically acceptable carrier and the resulting composition is administered to a subject. The carrier must, of course, be acceptable in the sense of being compatible with any other ingredients in the formulation and must not be deleterious to the subject. In some embodiments, pharmaceutical compositions of the invention can further comprise one or more additional agents or biological molecules useful in the treatment of a disease in the subject. Likewise, the additional agent(s) and/or biological molecule(s) can be co-administered as a separate composition.</div>
    </li> <li> <para-num num="[0219]"> </para-num> <div id="p-0221" num="0219" class="description-line">Given that the presently disclosed engineered meganucleases can have improved (i.e., increased) specificity resulting in reduced off-target cutting, and enhanced (i.e., increased) efficiency of cleavage and indel formation, particularly in cells comprising an integrated copy of the HBV genome, as compared to the HBV11-12x.26 meganuclease, in some embodiments, the presently disclosed pharmaceutical compositions comprising optimized engineered meganucleases, nucleic acid sequences encoding the same, or cells expressing the same, also have improved (i.e., increased) efficacy in treating HBV, reducing the level or proliferation of HBV, reducing at least one symptom of HBV, or treating HCC in a subject, when compared to the administration of pharmaceutical compositions comprising the HBV11-12x.26 meganuclease.</div>
    </li> <li> <para-num num="[0220]"> </para-num> <div id="p-0222" num="0220" class="description-line">In particular embodiments, pharmaceutical compositions of the invention can include combinations of the engineered meganucleases described herein (or nucleic acids encoding engineered meganucleases or cells expressing engineered meganucleases). In other embodiments, pharmaceutical compositions of the invention can include at least two engineered meganucleases (or nucleic acids encoding engineered meganucleases or cells expressing engineered meganucleases), wherein at least a first engineered meganuclease is one described herein that recognizes and cleaves the HBV 11-12 recognition sequence, and wherein at least a second engineered meganuclease recognizes and cleaves a second recognition sequence in the HBV genome other than the HBV 11-12 recognition sequence, such that a single pharmaceutical composition is broadly useful for the treatment of a wide array of HBV genotypes and/or genotype isolates in a subject. Likewise, in other embodiments, pharmaceutical compositions of the invention can include polycistronic mRNAs (or recombinant DNA constructs or viral vectors having cassettes which, when expressed, produce polycistronic mRNAs) that encode multiple engineered meganucleases described herein. In other embodiments, pharmaceutical compositions of the invention can include polycistronic mRNAs (or recombinant DNA constructs or viral vectors having cassettes which, when expressed, produce polycistronic mRNAs) that encode at least two engineered meganucleases, wherein at least a first engineered meganuclease is one described herein that recognizes and cleaves the HBV 11-12 recognition sequence, and wherein at least a second engineered meganuclease recognizes and cleaves a second recognition sequence in the HBV genome other than the HBV 11-12 recognition sequence. Such pharmaceutical compositions are also broadly useful for the treatment of a wide array of HBV genotypes and/or genotype isolates in a subject. In either case, such pharmaceutical compositions can be useful as a single treatment when the specific HBV genotype or isolate is known or unknown in the subject.</div>
    </li> <li> <para-num num="[0221]"> </para-num> <div id="p-0223" num="0221" class="description-line">For example, pharmaceutical compositions comprising multiple different engineered meganucleases (including at least one of the engineered meganucleases disclosed herein) or comprising nucleic molecules encoding multiple different engineered meganucleases (including at least one of the engineered meganucleases disclosed herein) that target recognition sequences within the HBV genome, can be administered to a patient infected with multiple genotypes of HBV, or infected with unknown genotypes of HBV. Accordingly, providing pharmaceutical compositions with multiple different engineered meganucleases or comprising nucleic molecules encoding multiple different engineered meganucleases affords a flexible option for treatment and control of HBV infection where resources do not allow for accurate genotyping HBV and where fast and broad treatment solutions are desired.</div>
    </li> <li> <para-num num="[0222]"> </para-num> <div id="p-0224" num="0222" class="description-line">In particular embodiments of the invention, the pharmaceutical composition can comprise one or more mRNAs described herein encapsulated within lipid nanoparticles, which are described elsewhere herein. In particular embodiments, lipid nanoparticles can comprise two or more mRNAs described herein. In other embodiments, lipid nanoparticles can comprise at least two mRNAs, wherein at least a first mRNA is an mRNA described herein that encodes an engineered meganuclease described herein that recognizes and cleaves the HBV 11-12 recognition sequence, and wherein at least a second mRNA encodes a second engineered meganuclease that recognizes and cleaves a recognition sequence within an HBV genome other than the HBV 11-12 recognition sequence. In other embodiments, lipid nanoparticles can comprise one or more polycistronic mRNAs described herein, wherein each polycistronic mRNA encodes two or more engineered meganucleases, wherein at least one engineered meganuclease is an engineered meganuclease described herein that recognizes and cleaves the HBV 11-12 recognition sequence, and wherein at least a second engineered meganuclease recognizes and cleaves a recognition sequence within a HBV genome other than the HBV 11-12 recognition sequence.</div>
    </li> <li> <para-num num="[0223]"> </para-num> <div id="p-0225" num="0223" class="description-line">Some lipid nanoparticles contemplated for use in the invention comprise at least one cationic lipid, at least one non-cationic lipid, and at least one conjugated lipid. In more particular examples, lipid nanoparticles can comprise from about 50 mol % to about 85 mol % of a cationic lipid, from about 13 mol % to about 49.5 mol % of a non-cationic lipid, and from about 0.5 mol % to about 10 mol % of a lipid conjugate, and are produced in such a manner as to have a non-lamellar (i.e., non-bilayer) morphology. In other particular examples, lipid nanoparticles can comprise from about 40 mol % to about 85 mol % of a cationic lipid, from about 13 mol % to about 49.5 mol % of a non-cationic lipid, and from about 0.5 mol % to about 10 mol % of a lipid conjugate, and are produced in such a manner as to have a non-lamellar (i.e., non-bilayer) morphology.</div>
    </li> <li> <para-num num="[0224]"> </para-num> <div id="p-0226" num="0224" class="description-line">Cationic lipids can include, for example, one or more of the following: palmitoyi-oleoyl-nor-arginine (PONA), MPDACA, GUADACA, ((6Z,9Z,28Z,31Z)-heptatriaconta-6,9,28,31-tetraen-19-yl4-(dimethylamino)butanoate) (MC3), LenMC3, CP-LenMC3, -LenMC3, CP--LenMC3, MC3MC, MC2MC, MC3 Ether, MC4 Ether, MC3 Amide, Pan-MC3, Pan-MC4 and Pan MC5, 1,2-dilinoleyloxy-N,N-dimethylaminopropane (DLinDMA), 1,2-dilinolenyloxy-N,N-dimethylaminopropane (DLenDMA), 2,2-dilinoleyl-4-(2-dimethylaminoethyl)-[1,3]-dioxolane (DLin-K-C2-DMA; XTC2), 2,2-dilinoleyl-4-(3-dimethylaminopropyl)-[1,3]-dioxolane (DLin-K-C3-DMA), 2,2-dilinoleyl-4-(4-dimethylaminobutyl)-[1,3]-dioxolane (DLin-K-C4-DMA), 2,2-dilinoleyl-5-dimethylaminomethyl-[1,3]-dioxane (DLin-K6-DMA), 2,2-dilinoleyl-4-N-methylpepiazino-[1,3]-dioxolane (DLin-K-MPZ), 2,2-dilinoleyl-4-dimethylaminomethyl-[1,3]-dioxolane (DLin-K-DMA), 1,2-dilinoleylcarbamoyloxy-3-dimethylaminopropane (DLin-C-DAP), 1,2-dilinoleyoxy-3-(dimethylamino)acetoxypropane (DLin-DAC), 1,2-dilinoleyoxy-3-morpholinopropane (DLin-MA), 1,2-dilinoleoyl-3-dimethylaminopropane (DLinDAP), 1,2-dilinoleylthio-3-dimethylaminopropane (DLin-S-DMA), 1-linoleoyl-2-linoleyloxy-3-dimethylaminopropane (DLin-2-DMAP), 1,2-dilinoleyloxy-3-trimethylaminopropane chloride salt (DLin-TMA.C1), 1,2-dilinoleoyl-3-trimethylaminopropane chloride salt (DLin-TAP.C1), 1,2-dilinoleyloxy-3-(N-methylpiperazino)propane (DLin-MPZ), 3-(N,N-dilinoleylamino)-1,2-propanediol (DLinAP), 3-(N,N-dioleylamino)-1,2-propanedio (DOAP), 1,2-dilinoleyloxo-3-(2-N,N-dimethylamino)ethoxypropane (DLin-EG-DMA), N,N-dioleyl-N,N-dimethylammonium chloride (DODAC), 1,2-dioleyloxy-N,N-dimethylaminopropane (DODMA), 1,2-distearyloxy-N,N-dimethylaminopropane (DSDMA), N-(1-(2,3-dioleyloxy)propyl)-N,N,N-trimethylammonium chloride (DOTMA), N,N-distearyl-N,N-dimethylammonium bromide (DDAB), N-(1-(2,3-dioleoyloxy)propyl)-N,N,N-trimethylammonium chloride (DOTAP), 3-(N(N,N-dimethylaminoethane)-carbamoyl)cholesterol (DC-Chol), N-(1,2-dimyristyloxyprop-3-yl)-N,N-dimethyl-N-hydroxyethyl ammonium bromide (DMRIE), 2,3-dioleyloxy-N-[2(spermine-carboxamido)ethyl]-N,N-dimethyl-1-propanaminiumtrifluoroacetate (DOSPA), dioctadecylamidoglycyl spermine (DOGS), 3-dimethylamino-2-(cholest-5-en-3-beta-oxybutan-4-oxy)-1-(cis,cis-9,12-octadecadienoxy)propane (CLinDMA), 2-[5-(cholest-5-en-3-beta-oxy)-3-oxapentoxy)-3-dimethy-1-(cis,cis-9,1-2-octadecadienoxy)propane (CpLinDMA), N,N-dimethyl-3,4-dioleyloxybenzylamine (DMOBA), 1,2-N,N-dioleylcarbamyl-3-dimethylaminopropane (DOcarbDAP), 1,2-N,N-dilinoleylcarbamyl-3-dimethylaminopropane (DLincarbDAP), or mixtures thereof. The cationic lipid can also be DLinDMA, DLin-K-C2-DMA (XTC2), MC3, LenMC3, CP-LenMC3, -LenMC3, CP--LenMC3, MC3MC, MC2MC, MC3 Ether, MC4 Ether, MC3 Amide, Pan-MC3, Pan-MC4, Pan MC5, or mixtures thereof.</div>
    </li> <li> <para-num num="[0225]"> </para-num> <div id="p-0227" num="0225" class="description-line">In various embodiments, the cationic lipid may comprise from about 50 mol % to about 90 mol %, from about 50 mol % to about 85 mol %, from about 50 mol % to about 80 mol %, from about 50 mol % to about 75 mol %, from about 50 mol % to about 70 mol %, from about 50 mol % to about 65 mol %, or from about 50 mol % to about 60 mol % of the total lipid present in the particle.</div>
    </li> <li> <para-num num="[0226]"> </para-num> <div id="p-0228" num="0226" class="description-line">In other embodiments, the cationic lipid may comprise from about 40 mol % to about 90 mol %, from about 40 mol % to about 85 mol %, from about 40 mol % to about 80 mol %, from about 40 mol % to about 75 mol %, from about 40 mol % to about 70 mol %, from about 40 mol % to about 65 mol %, or from about 40 mol % to about 60 mol % of the total lipid present in the particle.</div>
    </li> <li> <para-num num="[0227]"> </para-num> <div id="p-0229" num="0227" class="description-line">The non-cationic lipid may comprise, e.g., one or more anionic lipids and/or neutral lipids. In particular embodiments, the non-cationic lipid comprises one of the following neutral lipid components: (1) cholesterol or a derivative thereof; (2) a phospholipid; or (3) a mixture of a phospholipid and cholesterol or a derivative thereof. Examples of cholesterol derivatives include, but are not limited to, cholestanol, cholestanone, cholestenone, coprostanol, cholesteryl-2-hydroxyethyl ether, cholesteryl-4-hydroxybutyl ether, and mixtures thereof. The phospholipid may be a neutral lipid including, but not limited to, dipalmitoylphosphatidylcholine (DPPC), distearoylphosphatidylcholine (DSPC), dioleoylphosphatidylethanolamine (DOPE), palmitoyloleoyl-phosphatidylcholine (POPC), palmitoyloleoyl-phosphatidylethanolamine (POPE), palmitoyloleyol-phosphatidylglycerol (POPG), dipalmitoyl-phosphatidylethanolamine (DPPE), dimyristoyl-phosphatidylethanolamine (DMPE), distearoyl-phosphatidylethanolamine (DSPE), monomethyl-phosphatidylethanolamine, dimethyl-phosphatidylethanolamine, dielaidoyl-phosphatidylethanolamine (DEPE), stearoyloleoyl-phosphatidylethanolamine (S OPE), egg phosphatidylcholine (EPC), and mixtures thereof. In certain embodiments, the phospholipid is DPPC, DSPC, or mixtures thereof.</div>
    </li> <li> <para-num num="[0228]"> </para-num> <div id="p-0230" num="0228" class="description-line">In some embodiments, the non-cationic lipid (e.g., one or more phospholipids and/or cholesterol) may comprise from about 10 mol % to about 60 mol %, from about 15 mol % to about 60 mol %, from about 20 mol % to about 60 mol %, from about 25 mol % to about 60 mol %, from about 30 mol % to about 60 mol %, from about 10 mol % to about 55 mol %, from about 15 mol % to about 55 mol %, from about 20 mol % to about 55 mol %, from about 25 mol % to about 55 mol %, from about 30 mol % to about 55 mol %, from about 13 mol % to about 50 mol %, from about 15 mol % to about 50 mol % or from about 20 mol % to about 50 mol % of the total lipid present in the particle. When the non-cationic lipid is a mixture of a phospholipid and cholesterol or a cholesterol derivative, the mixture may comprise up to about 40, 50, or 60 mol % of the total lipid present in the particle.</div>
    </li> <li> <para-num num="[0229]"> </para-num> <div id="p-0231" num="0229" class="description-line">The conjugated lipid that inhibits aggregation of particles may comprise, e.g., one or more of the following: a polyethyleneglycol (PEG)-lipid conjugate, a polyamide (ATTA)-lipid conjugate, a cationic-polymer-lipid conjugates (CPLs), or mixtures thereof. In one preferred embodiment, the nucleic acid-lipid particles comprise either a PEG-lipid conjugate or an ATTA-lipid conjugate. In certain embodiments, the PEG-lipid conjugate or ATTA-lipid conjugate is used together with a CPL. The conjugated lipid that inhibits aggregation of particles may comprise a PEG-lipid including, e.g., a PEG-diacylglycerol (DAG), a PEG dialkyloxypropyl (DAA), a PEG-phospholipid, a PEG-ceramide (Cer), or mixtures thereof. The PEG-DAA conjugate may be PEG-di lauryloxypropyl (C12), a PEG-dimyristyloxypropyl (C14), a PEG-dipalmityloxypropyl (C16), a PEG-distearyloxypropyl (C18), or mixtures thereof.</div>
    </li> <li> <para-num num="[0230]"> </para-num> <div id="p-0232" num="0230" class="description-line">Additional PEG-lipid conjugates suitable for use in the invention include, but are not limited to, mPEG2000-1,2-di-O-alkyl-sn3-carbomoylglyceride (PEG-C-DOMG). The synthesis of PEG-C-DOMG is described in PCT Application No. PCT/US08/88676. Yet additional PEG-lipid conjugates suitable for use in the invention include, without limitation, 1-[8-(1,2-dimyristoyl-3-propanoxy)-carboxamido-3,6-dioxaoctanyl]carbamoyl--methyl-poly(ethylene glycol) (2KPEG-DMG). The synthesis of 2KPEG-DMG is described in U.S. Pat. No. 7,404,969.</div>
    </li> <li> <para-num num="[0231]"> </para-num> <div id="p-0233" num="0231" class="description-line">In some cases, the conjugated lipid that inhibits aggregation of particles (e.g., PEG-lipid conjugate) may comprise from about 0.1 mol % to about 2 mol %, from about 0.5 mol % to about 2 mol %, from about 1 mol % to about 2 mol %, from about 0.6 mol % to about 1.9 mol %, from about 0.7 mol % to about 1.8 mol %, from about 0.8 mol % to about 1.7 mol %, from about 1 mol % to about 1.8 mol %, from about 1.2 mol % to about 1.8 mol %, from about 1.2 mol % to about 1.7 mol %, from about 1.3 mol % to about 1.6 mol %, from about 1.4 mol % to about 1.5 mol %, or about 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2 mol % (or any fraction thereof or range therein) of the total lipid present in the particle. Typically, in such instances, the PEG moiety has an average molecular weight of about 2,000 Daltons. In other cases, the conjugated lipid that inhibits aggregation of particles (e.g., PEG-lipid conjugate) may comprise from about 5.0 mol % to about 10 mol %, from about 5 mol % to about 9 mol %, from about 5 mol % to about 8 mol %, from about 6 mol % to about 9 mol %, from about 6 mol % to about 8 mol %, or about 5 mol %, 6 mol %, 7 mol %, 8 mol %, 9 mol %, or 10 mol % (or any fraction thereof or range therein) of the total lipid present in the particle. Typically, in such instances, the PEG moiety has an average molecular weight of about 750 Daltons.</div>
    </li> <li> <para-num num="[0232]"> </para-num> <div id="p-0234" num="0232" class="description-line">In other embodiments, the composition may comprise amphoteric liposomes, which contain at least one positive and at least one negative charge carrier, which differs from the positive one, the isoelectric point of the liposomes being between 4 and 8. This objective is accomplished owing to the fact that liposomes are prepared with a pH-dependent, changing charge.</div>
    </li> <li> <para-num num="[0233]"> </para-num> <div id="p-0235" num="0233" class="description-line">Liposomal structures with the desired properties are formed, for example, when the amount of membrane-forming or membrane-based cationic charge carriers exceeds that of the anionic charge carriers at a low pH and the ratio is reversed at a higher pH. This is always the case when the ionizable components have a pKa value between 4 and 9. As the pH of the medium drops, all cationic charge carriers are charged more and all anionic charge carriers lose their charge.</div>
    </li> <li> <para-num num="[0234]"> </para-num> <div id="p-0236" num="0234" class="description-line">Cationic compounds useful for amphoteric liposomes include those cationic compounds previously described herein above. Without limitation, strongy cationic compounds can include, for example: DC-Choi 3--[N(N,N-dimethylmethane) carbamoyl] cholesterol, TC-Choi 3--[N(N,N,N-trimethylaminoethane) carbamoyl cholesterol, BGSC bisguanidinium-spermidine-cholesterol, BGTC bis-guadinium-tren-cholesterol, DOTAP (1,2-dioleoyloxypropyl)-N,N,N-trimethylammonium chloride, DOSPER (1,3-dioleoyloxy-2-(6-carboxy-spermyl)-propylarnide, DOTMA (1,2-dioleoyloxypropyl)-N,N,N-trimethylamronium chloride) (Lipofectin), DORIE 1,2-dioleoyloxypropyl)-3-dimethylhydroxyethylammonium bromide, DOSC (1,2-dioleoyl-3-succinyl-sn-glyceryl choline ester), DOGSDSO (1,2-dioleoyl-sn-glycero-3-succinyl-2-hydroxyethyl disulfide omithine), DDAB dimethyldioctadecylammonium bromide, DOGS ((C18)2GlySper3+) N,N-dioctadecylamido-glycol-spermin (Transfectam) (C18)2Gly+N,N-dioctadecylamido-glycine, CTAB cetyltrimethylarnmonium bromide, CpyC cetylpyridinium chloride, DOEPC 1,2-dioleoly-sn-glycero-3-ethylphosphocholine or other O-alkyl-phosphatidylcholine or ethanolamines, amides from lysine, arginine or ornithine and phosphatidyl ethanolamine.</div>
    </li> <li> <para-num num="[0235]"> </para-num> <div id="p-0237" num="0235" class="description-line">Examples of weakly cationic compounds include, without limitation: His-Chol (histaminyl-cholesterol hemisuccinate), Mo-Chol (morpholine-N-ethylamino-cholesterol hemisuccinate), or histidinyl-PE.</div>
    </li> <li> <para-num num="[0236]"> </para-num> <div id="p-0238" num="0236" class="description-line">Examples of neutral compounds include, without limitation: cholesterol, ceramides, phosphatidyl cholines, phosphatidyl ethanolamines, tetraether lipids, or diacyl glycerols.</div>
    </li> <li> <para-num num="[0237]"> </para-num> <div id="p-0239" num="0237" class="description-line">Anionic compounds useful for amphoteric liposomes include those non-cationic compounds previously described herein. Without limitation, examples of weakly anionic compounds can include: CHEMS (cholesterol hemisuccinate), alkyl carboxylic acids with 8 to 25 carbon atoms, or diacyl glycerol hemisuccinate. Additional weakly anionic compounds can include the amides of aspartic acid, or glutamic acid and PE as well as PS and its amides with glycine, alanine, glutamine, asparagine, serine, cysteine, threonine, tyrosine, glutamic acid, aspartic acid or other amino acids or aminodicarboxylic acids. According to the same principle, the esters of hydroxycarboxylic acids or hydroxydicarboxylic acids and PS are also weakly anionic compounds.</div>
    </li> <li> <para-num num="[0238]"> </para-num> <div id="p-0240" num="0238" class="description-line">In some embodiments, amphoteric liposomes may contain a conjugated lipid, such as those described herein above. Particular examples of useful conjugated lipids include, without limitation, PEG-modified phosphatidylethanolamine and phosphatidic acid, PEG-ceramide conjugates (e.g., PEG-CerC14 or PEG-CerC20), PEG-modified dialkylamines and PEG-modified 1,2-diacyloxypropan-3-amines. Particularly preferred are PEG-modified diacylglycerols and dialkylglycerols.</div>
    </li> <li> <para-num num="[0239]"> </para-num> <div id="p-0241" num="0239" class="description-line">In some embodiments, the neutral lipids may comprise from about 10 mol % to about 60 mol %, from about 15 mol % to about 60 mol %, from about 20 mol % to about 60 mol %, from about 25 mol % to about 60 mol %, from about 30 mol % to about 60 mol %, from about 10 mol % to about 55 mol %, from about 15 mol % to about 55 mol %, from about 20 mol % to about 55 mol %, from about 25 mol % to about 55 mol %, from about 30 mol % to about 55 mol %, from about 13 mol % to about 50 mol %, from about 15 mol % to about 50 mol % or from about 20 mol % to about 50 mol % of the total lipid present in the particle.</div>
    </li> <li> <para-num num="[0240]"> </para-num> <div id="p-0242" num="0240" class="description-line">In some cases, the conjugated lipid that inhibits aggregation of particles (e.g., PEG-lipid conjugate) may comprise from about 0.1 mol % to about 2 mol %, from about 0.5 mol % to about 2 mol %, from about 1 mol % to about 2 mol %, from about 0.6 mol % to about 1.9 mol %, from about 0.7 mol % to about 1.8 mol %, from about 0.8 mol % to about 1.7 mol %, from about 1 mol % to about 1.8 mol %, from about 1.2 mol % to about 1.8 mol %, from about 1.2 mol % to about 1.7 mol %, from about 1.3 mol % to about 1.6 mol %, from about 1.4 mol % to about 1.5 mol %, or about 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2 mol % (or any fraction thereof or range therein) of the total lipid present in the particle. Typically, in such instances, the PEG moiety has an average molecular weight of about 2,000 Daltons. In other cases, the conjugated lipid that inhibits aggregation of particles (e.g., PEG-lipid conjugate) may comprise from about 5.0 mol % to about 10 mol %, from about 5 mol % to about 9 mol %, from about 5 mol % to about 8 mol %, from about 6 mol % to about 9 mol %, from about 6 mol % to about 8 mol %, or about 5 mol %, 6 mol %, 7 mol %, 8 mol %, 9 mol %, or 10 mol % (or any fraction thereof or range therein) of the total lipid present in the particle. Typically, in such instances, the PEG moiety has an average molecular weight of about 750 Daltons.</div>
    </li> <li> <para-num num="[0241]"> </para-num> <div id="p-0243" num="0241" class="description-line">Considering the total amount of neutral and conjugated lipids, the remaining balance of the amphoteric liposome can comprise a mixture of cationic compounds and anionic compounds formulated at various ratios. The ratio of cationic to anionic lipid may selected in order to achieve the desired properties of nucleic acid encapsulation, zeta potential, pKa, or other physicochemical property that is at least in part dependent on the presence of charged lipid components.</div>
    </li> <li> <para-num num="[0242]"> </para-num> <div id="p-0244" num="0242" class="description-line">In some embodiments, the lipid nanoparticles have a composition which specifically enhances delivery and uptake in the liver, and specifically within hepatocytes.</div>
    </li> <li> <para-num num="[0243]"> </para-num> <div id="p-0245" num="0243" class="description-line">In some embodiments, pharmaceutical compositions of the invention can further comprise one or more additional agents useful in the treatment of HBV infection or HCC in the subject.</div>
    </li> <li> <para-num num="[0244]"> </para-num> <div id="p-0246" num="0244" class="description-line">The present disclosure also provides engineered meganucleases described herein (or nucleic acids encoding the same or cells expressing the engineered meganucleases) for use as a medicament. The present disclosure further provides the use of an engineered meganuclease described herein (or a nucleic acid encoding the same or cells expressing an engineered meganuclease) in the manufacture of a medicament for treating HBV, for reducing the level or proliferation of HBV, reducing the symptoms associated with HBV, or treating HCC.</div>
    </li> <heading id="h-0013">2.5 Methods for Producing Recombinant Viral Vectors</heading>
    <li> <para-num num="[0245]"> </para-num> <div id="p-0247" num="0245" class="description-line">In some embodiments, the invention provides viral vectors (e.g., recombinant AAV vectors) for use in the methods of the invention. Recombinant AAV vectors are typically produced in mammalian cell lines such as HEK-293. Because the viral cap and rep genes are removed from the vector to prevent its self-replication to make room for the therapeutic gene(s) to be delivered (e.g. the meganuclease gene), it is necessary to provide these in trans in the packaging cell line. In addition, it is necessary to provide the helper (e.g. adenoviral) components necessary to support replication (Cots et al. (2013), Curr. Gene Ther. 13(5): 370-81). Frequently, recombinant AAV vectors are produced using a triple-transfection in which a cell line is transfected with a first plasmid encoding the helper components, a second plasmid comprising the cap and rep genes, and a third plasmid comprising the viral ITRs containing the intervening DNA sequence to be packaged into the virus. Viral particles comprising a genome (ITRs and intervening gene(s) of interest) encased in a capsid are then isolated from cells by freeze-thaw cycles, sonication, detergent, or other means known in the art. Particles are then purified using cesium-chloride density gradient centrifugation or affinity chromatography and subsequently delivered to the gene(s) of interest to cells, tissues, or an organism such as a human patient.</div>
    </li> <li> <para-num num="[0246]"> </para-num> <div id="p-0248" num="0246" class="description-line">Because recombinant AAV particles are typically produced (manufactured) in cells, precautions must be taken in practicing the current invention to ensure that the engineered meganuclease is not expressed in the packaging cells. Because the viral genomes of the invention may comprise a recognition sequence for the meganuclease, any meganuclease expressed in the packaging cell line may be capable of cleaving the viral genome before it can be packaged into viral particles. This will result in reduced packaging efficiency and/or the packaging of fragmented genomes. Several approaches can be used to prevent meganuclease expression in the packaging cells, including:</div>
    </li> <li> <para-num num="[0247]"> </para-num> <div id="p-0249" num="0247" class="description-line">The meganuclease can be placed under the control of a tissue-specific promoter that is not active in the packaging cells. For example, if a viral vector is developed for delivery of (a) meganuclease gene(s) to muscle tissue, a muscle-specific promoter can be used. Examples of muscle-specific promoters include C5-12 (Liu, et al. (2004) Hum Gene Ther. 15:783-92), the muscle-specific creatine kinase (MCK) promoter (Yuasa, et al. (2002) Gene Ther. 9:1576-88), or the smooth muscle 22 (SM22) promoter (Haase, et al. (2013) BMC Biotechnol. 13:49-54). Examples of CNS (neuron)-specific promoters include the NSE, Synapsin, and MeCP2 promoters (Lentz, et al. (2012) Neurobiol Dis. 48:179-88). Examples of liver-specific promoters include albumin promoters (such as Palb), human al-antitrypsin (such as PalAT), and hemopexin (such as Phpx) (Kramer et al., (2003) Mol. Therapy 7:375-85), hybrid liver-specific promoter (hepatic locus control region from ApoE gene (ApoE-HCR) and a liver-specific alpha1-antitrypsin promoter), human thyroxine binding globulin (TBG) promoter, and apolipoprotein A-II promoter. Examples of eye-specific promoters include opsin, and corneal epithelium-specific K12 promoters (Martin et al. (2002) Methods (28): 267-75) (Tong et al., (2007) J Gene Med, 9:956-66). These promoters, or other tissue-specific promoters known in the art, are not highly-active in HEK-293 cells and, thus, will not be expected to yield significant levels of meganuclease gene expression in packaging cells when incorporated into viral vectors of the present invention. Similarly, the viral vectors of the present invention contemplate the use of other cell lines with the use of incompatible tissue specific promoters (i.e., the well-known HeLa cell line (human epithelial cell) and using the liver-specific hemopexin promoter). Other examples of tissue specific promoters include: synovial sarcomas PDZD4 (cerebellum), C6 (liver), ASB5 (muscle), PPP1R12B (heart), SLC5A12 (kidney), cholesterol regulation APOM (liver), ADPRHL1 (heart), and monogenic malformation syndromes TP73L (muscle). (Jacox et al., (2010), PLoS One v.5(8):e12274).</div>
    </li> <li> <para-num num="[0248]"> </para-num> <div id="p-0250" num="0248" class="description-line">Alternatively, the vector can be packaged in cells from a different species in which the meganuclease is not likely to be expressed. For example, viral particles can be produced in microbial, insect, or plant cells using mammalian promoters, such as the well-known cytomegalovirus- or SV40 virus-early promoters, which are not active in the non-mammalian packaging cells. In a preferred embodiment, viral particles are produced in insect cells using the baculovirus system as described by Gao, et al. (Gao et al. (2007), J. Biotechnol. 131(2):138-43). A meganuclease under the control of a mammalian promoter is unlikely to be expressed in these cells (Airenne et al. (2013), Mol. Ther. 21(4):739-49). Moreover, insect cells utilize different mRNA splicing motifs than mammalian cells. Thus, it is possible to incorporate a mammalian intron, such as the human growth hormone (HGH) intron or the SV40 large T antigen intron, into the coding sequence of a meganuclease. Because these introns are not spliced efficiently from pre-mRNA transcripts in insect cells, insect cells will not express a functional meganuclease and will package the full-length genome. In contrast, mammalian cells to which the resulting recombinant AAV particles are delivered will properly splice the pre-mRNA and will express functional meganuclease protein. Haifeng Chen has reported the use of the HGH and SV40 large T antigen introns to attenuate expression of the toxic proteins barnase and diphtheria toxin fragment A in insect packaging cells, enabling the production of recombinant AAV vectors carrying these toxin genes (Chen, H (2012) Mol Ther Nucleic Acids. 1(11): e57).</div>
    </li> <li> <para-num num="[0249]"> </para-num> <div id="p-0251" num="0249" class="description-line">The meganuclease gene can be operably linked to an inducible promoter such that a small-molecule inducer is required for meganuclease expression. Examples of inducible promoters include the Tet-On system (Clontech; Chen et al. (2015), BMC Biotechnol. 15(1):4)) and the RheoSwitch system (Intrexon; Sowa et al. (2011), Spine, 36(10): E623-8). Both systems, as well as similar systems known in the art, rely on ligand-inducible transcription factors (variants of the Tet Repressor and Ecdysone receptor, respectively) that activate transcription in response to a small-molecule activator (Doxycycline or Ecdysone, respectively). Practicing the current invention using such ligand-inducible transcription activators includes: 1) placing the meganuclease gene under the control of a promoter that responds to the corresponding transcription factor, the meganuclease gene having (a) binding site(s) for the transcription factor; and 2) including the gene encoding the transcription factor in the packaged viral genome The latter step is necessary because the meganuclease will not be expressed in the target cells or tissues following recombinant AAV delivery if the transcription activator is not also provided to the same cells. The transcription activator then induces meganuclease gene expression only in cells or tissues that are treated with the cognate small-molecule activator. This approach is advantageous because it enables meganuclease gene expression to be regulated in a spatio-temporal manner by selecting when and to which tissues the small-molecule inducer is delivered. However, the requirement to include the inducer in the viral genome, which has significantly limited carrying capacity, creates a drawback to this approach.</div>
    </li> <li> <para-num num="[0250]"> </para-num> <div id="p-0252" num="0250" class="description-line">In another preferred embodiment, recombinant AAV particles are produced in a mammalian cell line that expresses a transcription repressor that prevents expression of the meganuclease. Transcription repressors are known in the art and include the Tet-Repressor, the Lac-Repressor, the Cro repressor, and the Lambda-repressor. Many nuclear hormone receptors such as the ecdysone receptor also act as transcription repressors in the absence of their cognate hormone ligand. To practice the current invention, packaging cells are transfected/transduced with a vector encoding a transcription repressor and the meganuclease gene in the viral genome (packaging vector) is operably linked to a promoter that is modified to comprise binding sites for the repressor such that the repressor silences the promoter. The gene encoding the transcription repressor can be placed in a variety of positions. It can be encoded on a separate vector; it can be incorporated into the packaging vector outside of the ITR sequences; it can be incorporated into the cap/rep vector or the adenoviral helper vector; or it can be stably integrated into the genome of the packaging cell such that it is expressed constitutively. Methods to modify common mammalian promoters to incorporate transcription repressor sites are known in the art. For example, Chang and Roninson modified the strong, constitutive CMV and RSV promoters to comprise operators for the Lac repressor and showed that gene expression from the modified promoters was greatly attenuated in cells expressing the repressor (Chang and Roninson (1996), Gene 183:137-42). The use of a non-human transcription repressor ensures that transcription of the meganuclease gene will be repressed only in the packaging cells expressing the repressor and not in target cells or tissues transduced with the resulting recombinant AAV vector.</div>
    </li> <heading id="h-0014">2.6 Engineered Meganuclease Variants</heading>
    <li> <para-num num="[0251]"> </para-num> <div id="p-0253" num="0251" class="description-line">Embodiments of the invention encompass the engineered meganucleases described herein, and variants thereof. Further embodiments of the invention encompass polynucleotides comprising a nucleic acid sequence encoding the meganucleases described herein, and variants of such polynucleotides.</div>
    </li> <li> <para-num num="[0252]"> </para-num> <div id="p-0254" num="0252" class="description-line">As used herein, variants is intended to mean substantially similar sequences. A variant polypeptide is intended to mean a polypeptide derived from the native polypeptide by deletion or addition of one or more amino acids at one or more internal sites in the native protein and/or substitution of one or more amino acids at one or more sites in the native polypeptide. As used herein, a native polynucleotide or polypeptide comprises a parental sequence from which variants are derived. Variant polypeptides encompassed by the embodiments are biologically active. That is, they continue to possess the desired biological activity of the native protein; i.e., the ability to recognize and cleave the HBV 11-12 recognition sequence (SEQ ID NO: 10) within the genome of a Hepatitis B virus, and in some embodiments, exhibit at least one improved property over the first-generation HBV 11-12x.26 meganuclease, such as improved (i.e., increased) specificity and enhanced (i.e., increased) efficiency of cleavage and indel formation. Such variants may result, for example, from human manipulation. Biologically active variants of a native polypeptide of the embodiments (e.g., SEQ ID NOs: 12 and 13), or biologically active variants of the recognition half-site binding subunits described herein, will have at least about 40%, about 45%, about 50%, about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99%, sequence identity to the amino acid sequence of the native polypeptide or native subunit, as determined by sequence alignment programs and parameters described elsewhere herein. A biologically active variant of a polypeptide or subunit of the embodiments may differ from that polypeptide or subunit by as few as about 1-40 amino acid residues, as few as about 1-20, as few as about 1-10, as few as about 5, as few as 4, 3, 2, or even 1 amino acid residue.</div>
    </li> <li> <para-num num="[0253]"> </para-num> <div id="p-0255" num="0253" class="description-line">The polypeptides of the embodiments may be altered in various ways including amino acid substitutions, deletions, truncations, and insertions. Methods for such manipulations are generally known in the art. For example, amino acid sequence variants can be prepared by mutations in the DNA. Methods for mutagenesis and polynucleotide alterations are well known in the art. See, for example, Kunkel (1985) Proc. Natl. Acad. Sci. USA 82:488-492; Kunkel et al. (1987) Methods in Enzymol. 154:367-382; U.S. Pat. No. 4,873,192; Walker and Gaastra, eds. (1983) Techniques in Molecular Biology (MacMillan Publishing Company, New York) and the references cited therein. Guidance as to appropriate amino acid substitutions that do not affect biological activity of the protein of interest may be found in the model of Dayhoff et al. (1978) Atlas of Protein Sequence and Structure (Natl. Biomed. Res. Found., Washington, D.C.), herein incorporated by reference. Conservative substitutions, such as exchanging one amino acid with another having similar properties, may be optimal.</div>
    </li> <li> <para-num num="[0254]"> </para-num> <div id="p-0256" num="0254" class="description-line">In some embodiments, engineered meganucleases of the invention can comprise variants of the HVR1 and HVR2 regions disclosed herein. Parental HVR regions can comprise, for example, residues 24-79 or residues 215-270 of the exemplified engineered meganucleases. Thus, variant HVRs can comprise an amino acid sequence having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence identity to an amino acid sequence corresponding to residues 24-79 or residues 215-270 of the engineered meganucleases exemplified herein, such that the variant HVR regions maintain the biological activity of the engineered meganuclease (i.e., binding to and cleaving the recognition sequence). Further, in some embodiments of the invention, a variant HVR1 region or variant HVR2 region can comprise residues corresponding to the amino acid residues found at specific positions within the parental HVR. In this context, corresponding to means that an amino acid residue in the variant HVR is the same amino acid residue (i.e., a separate identical residue) present in the parental HVR sequence in the same relative position (i.e., in relation to the remaining amino acids in the parent sequence). By way of example, if a parental HVR sequence comprises a serine residue at position 26, a variant HVR that comprises a residue corresponding to residue 26 will also comprise a serine at a position that is relative (i.e., corresponding) to parental position 26.</div>
    </li> <li> <para-num num="[0255]"> </para-num> <div id="p-0257" num="0255" class="description-line">In particular embodiments, engineered meganucleases of the invention comprise an HVR1 region that has at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more sequence identity to an amino acid sequence corresponding to residues 215-270 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0256]"> </para-num> <div id="p-0258" num="0256" class="description-line">In certain embodiments, engineered meganucleases of the invention comprise an HVR2 region that has at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more sequence identity to an amino acid sequence corresponding to residues 24-79 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0257]"> </para-num> <div id="p-0259" num="0257" class="description-line">In other particular embodiments, engineered meganucleases of the invention comprise an HVR1 region that has at least 86% sequence identity to an amino acid sequence corresponding to residues 215-270 of SEQ ID NO: 12 or 13 and an HVR2 region that has at least 97% sequence identity to an amino acid sequence corresponding to residues 24-79 of SEQ ID NO: 12 or 13.</div>
    </li> <li> <para-num num="[0258]"> </para-num> <div id="p-0260" num="0258" class="description-line">A substantial number of amino acid modifications to the DNA recognition domain of the wild-type I-CreI meganuclease have previously been identified (e.g., U.S. Pat. No. 8,021,867) which, singly or in combination, result in engineered meganucleases with specificities altered at individual bases within the DNA recognition sequence half-site, such that the resulting rationally-designed meganucleases have half-site specificities different from the wild-type enzyme. Table 2 provides potential substitutions that can be made in an engineered meganuclease monomer or subunit to enhance specificity based on the base present at each half-site position (1 through 9) of a recognition half-site.</div>
    </li> <li> <div id="p-0261" num="0000" class="description-line">
      <tables id="TABLE-US-00002" num="00002">
        <patent-tables frame="none" colsep="0" rowsep="0" pgwide="1">
          <table align="left" colsep="0" rowsep="0" cols="2" class="description-table" width="100%">
            <thead>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td namest="offset" nameend="1" rowsep="1" class="description-td" colspan="2">TABLE 2</td>
              </tr>
            </thead>
            
              <tbody><tr class="description-tr">
                <td class="description-td"> </td>
                <td namest="offset" nameend="1" align="center" rowsep="1" class="description-td" colspan="2"> </td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">Favored Sense-Strand Base</td>
              </tr>
            
          </tbody></table>
          <table align="left" colsep="0" rowsep="0" cols="12" class="description-table" width="100%">
            <tbody><tr class="description-tr">
                <td class="description-td">Posn.</td>
                <td class="description-td">A</td>
                <td class="description-td">C</td>
                <td class="description-td">G</td>
                <td class="description-td">T</td>
                <td class="description-td">A/T</td>
                <td class="description-td">A/C</td>
                <td class="description-td">A/G</td>
                <td class="description-td">C/T</td>
                <td class="description-td">G/T</td>
                <td class="description-td">A/G/T</td>
                <td class="description-td">A/C/G/T</td>
              </tr>
              <tr class="description-tr">
                <td namest="1" nameend="12" align="center" rowsep="1" class="description-td" colspan="12"> </td>
              </tr>
            
          </tbody></table>
          <table align="left" colsep="0" rowsep="0" cols="11" class="description-table" width="100%">
            <tbody><tr class="description-tr">
                <td class="description-td">1</td>
                <td class="description-td">Y75</td>
                <td class="description-td">
                  <b>R70*</b>
                </td>
                <td class="description-td">K70</td>
                <td class="description-td">Q70*</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">
                  <b>T46*</b>
                </td>
                <td class="description-td"> </td>
                <td class="description-td">G70</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">L75*</td>
                <td class="description-td">H75*</td>
                <td class="description-td">E70*</td>
                <td class="description-td">C70</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">A70</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">C75*</td>
                <td class="description-td">R75*</td>
                <td class="description-td">E75*</td>
                <td class="description-td">L70</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">S70</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">Y139*</td>
                <td class="description-td">H46*</td>
                <td class="description-td">E46*</td>
                <td class="description-td">Y75*</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">G46*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">C46*</td>
                <td class="description-td">K46*</td>
                <td class="description-td">D46*</td>
                <td class="description-td">Q75*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">A46*</td>
                <td class="description-td">R46*</td>
                <td class="description-td"> </td>
                <td class="description-td">H75*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">H139</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">Q46*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">H46*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">2</td>
                <td class="description-td">Q70</td>
                <td class="description-td">E70</td>
                <td class="description-td">H70</td>
                <td class="description-td">
                  <b>Q44*</b>
                </td>
                <td class="description-td">C44*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">T44*</td>
                <td class="description-td">D70</td>
                <td class="description-td">D44*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">A44*</td>
                <td class="description-td">K44*</td>
                <td class="description-td">E44*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">V44*</td>
                <td class="description-td">R44*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">I44*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">L44*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">N44*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">3</td>
                <td class="description-td">Q68</td>
                <td class="description-td">E68</td>
                <td class="description-td">
                  <b>R68</b>
                </td>
                <td class="description-td">M68</td>
                <td class="description-td"> </td>
                <td class="description-td">H68</td>
                <td class="description-td"> </td>
                <td class="description-td">Y68</td>
                <td class="description-td">K68</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">C24*</td>
                <td class="description-td">F68</td>
                <td class="description-td"> </td>
                <td class="description-td">C68</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">
                  <b>I24*</b>
                </td>
                <td class="description-td">K24*</td>
                <td class="description-td"> </td>
                <td class="description-td">L68</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">R24*</td>
                <td class="description-td"> </td>
                <td class="description-td">F68</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">4</td>
                <td class="description-td">A26*</td>
                <td class="description-td">E77</td>
                <td class="description-td">R77</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">S77</td>
                <td class="description-td"> </td>
                <td class="description-td">S26*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">Q77</td>
                <td class="description-td">K26*</td>
                <td class="description-td">E26*</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">
                  <b>Q26*</b>
                </td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">5</td>
                <td class="description-td"> </td>
                <td class="description-td">E42</td>
                <td class="description-td">R42</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">
                  <b>K28*</b>
                </td>
                <td class="description-td">C28*</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">M66</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">Q42</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">K66</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">6</td>
                <td class="description-td">Q40</td>
                <td class="description-td">E40</td>
                <td class="description-td">R40</td>
                <td class="description-td">C40</td>
                <td class="description-td">A40</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">
                  <b>S40</b>
                </td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">C28*</td>
                <td class="description-td">R28*</td>
                <td class="description-td"> </td>
                <td class="description-td">I40</td>
                <td class="description-td">A79</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">S28*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">V40</td>
                <td class="description-td">A28*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">C79</td>
                <td class="description-td">H28*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">I79</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">V79</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">Q28*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">7</td>
                <td class="description-td">
                  <b>N30*</b>
                </td>
                <td class="description-td">E38</td>
                <td class="description-td">K38</td>
                <td class="description-td">I38</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">C38</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">H38</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">
                  <b>Q38</b>
                </td>
                <td class="description-td">K30*</td>
                <td class="description-td">R38</td>
                <td class="description-td">L38</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">N38</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">R30*</td>
                <td class="description-td">E30*</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">Q30*</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">8</td>
                <td class="description-td">F33</td>
                <td class="description-td">E33</td>
                <td class="description-td">F33</td>
                <td class="description-td">L33</td>
                <td class="description-td"> </td>
                <td class="description-td">R32*</td>
                <td class="description-td">R33</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">
                  <b>Y33</b>
                </td>
                <td class="description-td">D33</td>
                <td class="description-td">H33</td>
                <td class="description-td">V33</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">I33</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">F33</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">C33</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td">9</td>
                <td class="description-td"> </td>
                <td class="description-td">E32</td>
                <td class="description-td">R32</td>
                <td class="description-td">L32</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">D32</td>
                <td class="description-td"> </td>
                <td class="description-td">
                  <b>S32</b>
                </td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">K32</td>
                <td class="description-td">V32</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">I32</td>
                <td class="description-td"> </td>
                <td class="description-td">N32</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">A32</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">H32</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">C32</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">Q32</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">T32</td>
              </tr>
              <tr class="description-tr">
                <td namest="1" nameend="11" align="center" rowsep="1" class="description-td" colspan="11"> </td>
              </tr>
              <tr class="description-tr">
                <td namest="1" nameend="11" align="left" id="FOO-00002" class="description-td" colspan="11">Bold entries are wild-type contact residues and do not constitute modifications as used herein.</td>
              </tr>
              <tr class="description-tr">
                <td namest="1" nameend="11" align="left" id="FOO-00003" class="description-td" colspan="11">An asterisk indicates that the residue contacts the base on the antisense strand.</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    </li> <li> <para-num num="[0259]"> </para-num> <div id="p-0262" num="0259" class="description-line">Although the effects of multiple amino substitutions in the HVR regions are not independent, the data of Table 2 provides possible substitutions in the disclosed HVR regions of SEQ ID NO: 12 and 13 which can be relatively conservative in their effects on specificity. For example, in the HVR1 regions of both SEQ ID NO: 12 and 13, the R residue corresponding to I-CreI position 46, which contacts an A at position 1 of the recognition half-site of SEQ ID NO: 11, could be replaced with C46 or A46 (which have a preference for contacting A), or G46 (which is relatively neutral in preference); the W residue corresponding to I-CreI position 70, which contacts an A at position 1 of the recognition half-site of SEQ ID NO: 11, could be replaced with G70, A70 or S70 (which are relatively neutral in preference); the N residue corresponding to I-CreI position 44, which contacts a C at position 2 of the recognition half-site of SEQ ID NO: 11, could be replaced with K44 or R44 (which have a preference for contacting C); the I residue corresponding to I-CreI position 68, which contacts a G at position 3 of the recognition half-site of SEQ ID NO: 11, could be replaced with R68 (which has a preference for contacting G), or K68 (which has a preference for contacting G or T); the S residue corresponding to I-CreI position 26, which contacts a C at position 4 of the recognition half-site of SEQ ID NO: 11, could be replaced with K26 (which has a preference for contacting A), Q26 (which has a preference for C or T), or S26 (which is relatively neutral in preference); the I residue corresponding to I-CreI position 42, which contacts a C at position 5 of the recognition half-site of SEQ ID NO: 11, could be replaced with E42 (which has a preference for contacting C); the R residue corresponding to I-CreI position 28, which contacts a T at position 6 of the recognition half-site of SEQ ID NO: 11, could be replaced with Q28 (which has a preference for contacting T), or S28 (which is relatively neutral in preference); the E residue corresponding to I-CreI position 40, which contacts a T at position 6 of the recognition half-site of SEQ ID NO: 11, could be replaced with C40, 140 or V40 (which have a preference for T), or A40 (which has a preference for A or T) or S40 (which is relatively neutral in preference); the R residue corresponding to I-CreI position 30, which contacts a T at position 7 of the recognition half-site of SEQ ID NO: 11, could be replaced with Q30 (which is relatively neutral in preference); the A residue corresponding to I-CreI position 33, which contacts a G at position 8 of the recognition half-site of SEQ ID NO: 11, could be replaced with H33 (which has a preference for contacting G), F33 (which has a preference for contacting A, G or T), or R33 (which has a preference for contacting A or G); and the H residue corresponding to I-CreI position 32, which contacts an A at position 9 of the recognition half-site of SEQ ID NO: 11, could be replaced with S32, N32, Q32 or T32 (which are relatively neutral in preference).</div>
    </li> <li> <para-num num="[0260]"> </para-num> <div id="p-0263" num="0260" class="description-line">Similarly, in the HVR2 regions of both SEQ ID NO: 12 and 13, the G residue corresponding to I-CreI position 46, which contacts a C at position 1 of the recognition half-site of SEQ ID NO: 10, could be replaced with H46, K46 or R46 (which have a preference for contacting C), or T46 (which has a preference for contacting contacts C or T); the N residue corresponding to I-CreI position 70, which contacts a C at position 1 of the recognition half-site of SEQ ID NO: 10, could be replaced with R70, which has a preference for contacting C), or G70, A70 or S70 (which are relatively neutral in preference); the E residue corresponding to I-CreI position 44, which contacts a C at position 2 of the recognition half-site of SEQ ID NO: 10, could be replaced with the similarly negative residue D44 (which has a preference for contacting G) or K44 or R44 (which are positive residues that have a preference for contacting C); the Y residue corresponding to I-CreI position 68, which contacts a T at position 3 of the recognition half-site of SEQ ID NO: 10, could be replaced with M68, C68, L68 or F68 (which have a preference for contacting T), or K68 (which has a preference for contacting G or T); the Q residue corresponding to I-CreI position 26, which contacts an A at position 4 of the recognition half-site of SEQ ID NO: 10, could be replaced with A26 (which has a preference for contacting A) or S26 (which is relatively neutral in preference); the R residue corresponding to I-CreI position 42, which contacts a G at position 5 of the recognition half-site of SEQ ID NO: 10, could be replaced with Q42 (which has a preference for contacting A or G); the A residue corresponding to I-CreI position 28, which contacts a C at position 6 of the recognition half-site of SEQ ID NO: 10, could be replaced with R28 (which has a preference for C), or S28 (which is relatively neutral in preference); the K residue corresponding to I-CreI position 40, which contacts a C at position 6 of the recognition half-site of SEQ ID NO: 10, could be replaced with S40 (which is relatively neutral in preference); the R residue corresponding to I-CreI position 30, which contacts a C at position 7 of the recognition half-site of SEQ ID NO: 10, could be replaced with K30 (which has a preference for contacting C) or Q30 (which is relatively neutral in preference); the F residue corresponding to I-CreI position 33, which contacts a G at position 8 of the recognition half-site of SEQ ID NO: 10, could be replaced with H33 (which has a preference for contacting G) or R33 (which has a preference for contacting A or G); and the S residue corresponding to I-CreI position 32, which contacts a T at position 9 of the recognition half-site of SEQ ID NO: 10, could be replaced with L32, V32, A32, C32 (which have a preference for contacting T), D32 or 132 (which have a preference for contacting C or T) or N32, H32, Q32 or T32 (which are relatively neutral in preference).</div>
    </li> <li> <para-num num="[0261]"> </para-num> <div id="p-0264" num="0261" class="description-line">These variants can be tested alone and/or in combination to select variants with desired specificity and/or activity using methods described herein and known in the art. Such variants are within the scope of the invention, although the preferred embodiments are disclosed in SEQ ID NO: 12 and 13.</div>
    </li> <li> <para-num num="[0262]"> </para-num> <div id="p-0265" num="0262" class="description-line">In addition, modifications can be made in an engineered meganuclease monomer or subunit to modulate DNA-binding affinity and/or activity. For example, an engineered meganuclease monomer or subunit described herein can comprise a G, S, or A at a residue corresponding to position 19 of I-CreI or SEQ ID NO: 12 or 13 (WO 2009/001159), a Y, R, K, or D at a residue corresponding to position 66 of I-CreI or SEQ ID NO: 12 or 13, and/or an E, Q, or K at a residue corresponding to position 80 of I-CreI or SEQ ID NO: 12 or 13 (U.S. Pat. No. 8,021,867).</div>
    </li> <li> <para-num num="[0263]"> </para-num> <div id="p-0266" num="0263" class="description-line">For polynucleotides, a variant comprises a deletion and/or addition of one or more nucleotides at one or more sites within the native polynucleotide. One of skill in the art will recognize that variants of the nucleic acids of the embodiments will be constructed such that the open reading frame is maintained. For polynucleotides, conservative variants include those sequences that, because of the degeneracy of the genetic code, encode the amino acid sequence of one of the polypeptides of the embodiments. Variant polynucleotides include synthetically derived polynucleotides, such as those generated, for example, by using site-directed mutagenesis but which still encode a recombinant nuclease of the embodiments. Generally, variants of a particular polynucleotide of the embodiments will have at least about 40%, about 45%, about 50%, about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99% or more sequence identity to that particular polynucleotide as determined by sequence alignment programs and parameters described elsewhere herein. Variants of a particular polynucleotide of the embodiments (i.e., the reference polynucleotide) can also be evaluated by comparison of the percent sequence identity between the polypeptide encoded by a variant polynucleotide and the polypeptide encoded by the reference polynucleotide.</div>
    </li> <li> <para-num num="[0264]"> </para-num> <div id="p-0267" num="0264" class="description-line">The deletions, insertions, and substitutions of the variant protein sequences encompassed herein are not expected to produce radical changes in the characteristics of the polypeptide. However, when it is difficult to predict the exact effect of the substitution, deletion, or insertion in advance of doing so, one skilled in the art will appreciate that the effect will be evaluated by screening the polypeptide for its ability to preferentially recognize and cleave the HBV 11-12 recognition sequence within the genome of a Hepatitis B virus.</div>
    </li> <heading id="h-0015">2.7 Combination Therapy for HBV</heading>
    <li> <para-num num="[0265]"> </para-num> <div id="p-0268" num="0265" class="description-line">In certain embodiments, a method for treating or preventing an HBV infection in a human having or at risk of having the infection is provided, comprising administering to the human a therapeutically effective amount of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, in combination with a therapeutically effective amount of one or more (e.g., one, two, three, four, one or two, one to three, or one to four) additional therapeutic agents. In one embodiment, a method for treating an HBV infection in a human having or at risk of having the infection is provided, comprising administering to the human a therapeutically effective amount of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, in combination with a therapeutically effective amount of one or more (e.g., one, two, three, four, one or two, one to three, or one to four) additional therapeutic agents.</div>
    </li> <li> <para-num num="[0266]"> </para-num> <div id="p-0269" num="0266" class="description-line">In certain embodiments, the present disclosure provides a method for treating an HBV infection, comprising administering to a patient in need thereof a therapeutically effective amount of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, in combination with a therapeutically effective amount of one or more (e.g., one, two, three, four, one or two, one to three, or one to four) additional therapeutic agents which are suitable for treating an HBV infection.</div>
    </li> <li> <para-num num="[0267]"> </para-num> <div id="p-0270" num="0267" class="description-line">In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with one, two, three, four, or more additional therapeutic agents. In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with two additional therapeutic agents. In other embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with three additional therapeutic agents. In further embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with four additional therapeutic agents. The one, two, three, four, or more additional therapeutic agents can be different therapeutic agents selected from the same class of therapeutic agents, and/or they can be selected from different classes of therapeutic agents.</div>
    </li> <heading id="h-0016">Administration of HBV Combination Therapy</heading>
    <li> <para-num num="[0268]"> </para-num> <div id="p-0271" num="0268" class="description-line">In certain embodiments, when an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with one or more additional therapeutic agents as described above, the components of the composition are administered as a simultaneous or sequential regimen. When administered sequentially, the combination may be administered in two or more administrations.</div>
    </li> <li> <para-num num="[0269]"> </para-num> <div id="p-0272" num="0269" class="description-line">Co-administration of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, with one or more additional therapeutic agents generally refers to simultaneous or sequential administration of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, and one or more additional therapeutic agents, such that therapeutically effective amounts of each agent are present in the body of the patient.</div>
    </li> <li> <para-num num="[0270]"> </para-num> <div id="p-0273" num="0270" class="description-line">Co-administration includes administration of unit dosages of the compounds disclosed herein before or after administration of unit dosages of one or more additional therapeutic agents. The engineered meganuclease disclosed herein, or a nucleic acid encoding the same, may be administered within seconds, minutes, or hours of the administration of one or more additional therapeutic agents. For example, in some embodiments, a unit dose of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is administered first, followed within seconds or minutes by administration of a unit dose of one or more additional therapeutic agents. Alternatively, in other embodiments, a unit dose of one or more additional therapeutic agents is administered first, followed by administration of a unit dose of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, within seconds or minutes. In some embodiments, a unit dose of a an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is administered first, followed, after a period of hours (e.g., 1-12 hours), by administration of a unit dose of one or more additional therapeutic agents. In other embodiments, a unit dose of one or more additional therapeutic agents is administered first, followed, after a period of hours (e.g., 1-12 hours), by administration of a unit dose of an engineered meganuclease disclosed herein, or a nucleic acid encoding the same.</div>
    </li> <li> <para-num num="[0271]"> </para-num> <div id="p-0274" num="0271" class="description-line">In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with one or more additional therapeutic agents in a unitary dosage form for simultaneous administration to a patient.</div>
    </li> <heading id="h-0017">HBV Combination Therapy</heading>
    <li> <para-num num="[0272]"> </para-num> <div id="p-0275" num="0272" class="description-line">The engineered meganucleases disclosed herein, or nucleic acids encoding the same, may be used or combined with one or more of a chemotherapeutic agent, an immunomodulator, an immunotherapeutic agent, a therapeutic antibody, a therapeutic vaccine, a bispecific antibody and antibody-like therapeutic protein (such as DARTs, Duobodies, Bites, XmAbs, TandAbs, Fab derivatives), an antibody-drug conjugate (ADC), gene modifiers, cell therapies such as CAR-T (chimeric antigen receptor T-cell), and TCR-T (an engineered T cell receptor) agent or any combination thereof.</div>
    </li> <li> <para-num num="[0273]"> </para-num> <div id="p-0276" num="0273" class="description-line">In certain embodiments, a formulation comprising an engineered meganuclease described herein, or a nucleic acid encoding the same, may optionally contain one or more other compounds useful for treating HBV. In certain embodiments, the formulation can contain another active ingredient for treating HBV, such as 3-dioxygenase (IDO) inhibitors, Apolipoprotein A1 modulator, arginase inhibitors, B- and T-lymphocyte attenuator inhibitors, Bruton&#39;s tyrosine kinase (BTK) inhibitors, CCR2 chemokine antagonist, CD137 inhibitors, CD160 inhibitors, CD305 inhibitors, CD4 agonist and modulator, compounds targeting HBcAg, compounds targeting hepatitis B core antigen (HBcAg), core protein allosteric modulators, covalently closed circular DNA (cccDNA) inhibitors, cyclophilin inhibitors, cytotoxic T-lymphocyte-associated protein 4 (ipi4) inhibitors, DNA polymerase inhibitor, Endonuclease modulator, epigenetic modifiers, Farnesoid X receptor agonist, HBsAg inhibitors, HBsAg secretion or assembly inhibitors, HBV DNA polymerase inhibitors, HBV replication inhibitors, HBV RNAse inhibitors, HBV viral entry inhibitors, HBx inhibitors, Hepatitis B large envelope protein modulator, Hepatitis B large envelope protein stimulator, Hepatitis B structural protein modulator, hepatitis B surface antigen (HBsAg) inhibitors, hepatitis B surface antigen (HBsAg) secretion or assembly inhibitors, hepatitis B virus E antigen inhibitors, hepatitis B virus replication inhibitors, Hepatitis virus structural protein inhibitor, HIV-1 reverse transcriptase inhibitor, Hyaluronidase inhibitor, IAPs inhibitors, IL-2 agonist, IL-7 agonist, immunomodulators, indoleamine-2 inhibitors, inhibitors of ribonucleotide reductase, Interleukin-2 ligand, ipi4 inhibitors, lysine demethylase inhibitors, histone demethylase inhibitors, KDM1 inhibitors, KDM5 inhibitors, killer cell lectin-like receptor subfamily G member 1 inhibitors, lymphocyte-activation gene 3 inhibitors, lymphotoxin beta receptor activators, modulators of Ax1, modulators of B7-H3, modulators of B7-H4, modulators of CD160, modulators of CD161, modulators of CD27, modulators of CD47, modulators of CD70, modulators of GITR, modulators of HEVEM, modulators of ICOS, modulators of Mer, modulators of NKG2A, modulators of NKG2D, modulators of OX40, modulators of SIRPalpha, modulators of TIGIT, modulators of Tim-4, modulators of Tyro, Na+-taurocholate cotransporting polypeptide (NTCP) inhibitors, natural killer cell receptor 2B4 inhibitors, NOD2 gene stimulator, Nucleoprotein inhibitor, nucleoprotein modulators, OX-40 receptor agonist, PD-1 inhibitors, PD-L1 inhibitors, Peptidylprolyl isomerase inhibitor, phosphatidylinositol-3 kinase (PI3K) inhibitors, Retinoic acid-inducible gene 1 stimulator, Reverse transcriptase inhibitor, Ribonuclease inhibitor, RNA DNA polymerase inhibitor, SLC10A1 gene inhibitor, SMAC mimetics, Src tyrosine kinase inhibitor, stimulator of interferon gene (STING) agonists, stimulators of NOD1, T cell surface glycoprotein CD28 inhibitor, T-cell surface glycoprotein CD8 modulator, Thymosin agonist, Thymosin alpha 1 ligand, Tim-3 inhibitors, TLR-3 agonist, TLR-7 agonist, TLR-9 agonist, TLR9 gene stimulator, toll-like receptor (TLR) modulators, Viral ribonucleotide reductase inhibitor, and combinations thereof.</div>
    </li> <heading id="h-0018">HBV Combination Drugs</heading>
    <li> <para-num num="[0274]"> </para-num> <div id="p-0277" num="0274" class="description-line">Examples of combination drugs for the treatment of HBV include TRUVADA (tenofovir disoproxil fumarate and emtricitabine); ABX-203, lamivudine, and PEG-IFNalpha; ABX-203 adefovir, and PEG-IFNalpha; and INO-1800 (INO-9112 and RG7944).</div>
    </li> <heading id="h-0019">Other HBV Drugs</heading>
    <li> <para-num num="[0275]"> </para-num> <div id="p-0278" num="0275" class="description-line">Examples of other drugs for the treatment of HBV include alpha-hydroxytropolones, amdoxovir, antroquinonol, beta-hydroxycytosine nucleosides, AL-034, CCC-0975, elvucitabine, ezetimibe, cyclosporin A, gentiopicrin (gentiopicroside), JNJ-56136379, nitazoxanide, birinapant, NJK14047, NOV-205 (molixan, BAM-205), oligotide, mivotilate, feron, GST-HG-131, levamisole, Ka Shu Ning, alloferon, WS-007, Y-101 (Ti Fen Tai), rSIFN-co, PEG-IIFNm, KW-3, BP-Inter-014, oleanolic acid, HepB-nRNA, cTP-5 (rTP-5), HSK-II-2, HEISCO-106-1, HEISCO-106, Hepbarna, IBPB-0061A, Hepuyinfen, DasKloster 0014-01, ISA-204, Jiangantai (Ganxikang), MIV-210, OB-AI-004, PF-06, picroside, DasKloster-0039, hepulantai, IMB-2613, TCM-800B, reduced glutathione, RO-6864018, RG-7834, UB-551, and ZH-2N, and the compounds disclosed in US20150210682, (Roche), US 2016/0122344 (Roche), WO2015173164, WO2016023877, US2015252057A (Roche), WO16128335A1 (Roche), WO16120186A1 (Roche), US2016237090A (Roche), WO16107833A1 (Roche), WO16107832A1 (Roche), US2016176899A (Roche), WO16102438A1 (Roche), WO16012470A1 (Roche), US2016220586A (Roche), and US2015031687A (Roche).</div>
    </li> <heading id="h-0020">HBV Vaccines</heading>
    <li> <para-num num="[0276]"> </para-num> <div id="p-0279" num="0276" class="description-line">HBV vaccines include both prophylactic and therapeutic vaccines. Examples of HBV prophylactic vaccines include Vaxelis, Hexaxim, Heplisav, Mosquirix, DTwP-HBV vaccine, Bio-Hep-B, D/T/P/HBV/M (LBVP-0101; LBVW-0101), DTwP-Hepb-Hib-IPV vaccine, Heberpenta L, DTwP-HepB-Hib, V-419, CVI-HBV-001, Tetrabhay, hepatitis B prophylactic vaccine (Advax Super D), Hepatrol-07, GSK-223192A, ENGERIX B, recombinant hepatitis B vaccine (intramuscular, Kangtai Biological Products), recombinant hepatitis B vaccine (Hansenual polymorpha yeast, intramuscular, Hualan Biological Engineering), recombinant hepatitis B surface antigen vaccine, Bimmugen, Euforavac, Eutravac, anrix-DTaP-IPV-Hep B, HBAI-20, Infanrix-DTaP-IPV-Hep B-Hib, Pentabio Vaksin DTP-HB-Hib, Comvac 4, Twinrix, Euvax-B, Tritanrix HB, Infanrix Hep B, Comvax, DTP-Hib-HBV vaccine, DTP-HBV vaccine, Yi Tai, Heberbiovac HB, Trivac HB, GerVax, DTwP-Hep B-Hib vaccine, Bilive, Hepavax-Gene, SUPERVAX, Comvac5, Shanvac-B, Hebsulin, Recombivax HB, Revac B mcf, Revac B+, Fendrix, DTwP-HepB-Hib, DNA-001, Shan5, Shan6, rhHBsAG vaccine, HBI pentavalent vaccine, LBVD, Infanrix HeXa, and DTaP-rHB-Hib vaccine.</div>
    </li> <li> <para-num num="[0277]"> </para-num> <div id="p-0280" num="0277" class="description-line">Examples of HBV therapeutic vaccines include HBsAG-HBIG complex, ARB-1598, Bio-Hep-B, NASVAC, abi-HB (intravenous), ABX-203, Tetrabhay, GX-110E, GS-4774, peptide vaccine (epsilonPA-44), Hepatrol-07, NASVAC (NASTERAP), IMP-321, BEVAC, Revac B mcf, Revac B+, MGN-1333, KW-2, CVI-HBV-002, AltraHepB, VGX-6200, FP-02, FP-02.2 (HepTcell), TG-1050, NU-500, HBVax, im/TriGrid/antigen vaccine, Mega-CD40L-adjuvanted vaccine, HepB-v, RG7944 (INO-1800), recombinant VLP-based therapeutic vaccine (HBV infection, VLP Biotech), AdTG-17909, AdTG-17910 AdTG-18202, ChronVac-B, TG-1050, VVX-001, and Lm HBV.</div>
    </li> <li> <para-num num="[0278]"> </para-num> <div id="p-0281" num="0278" class="description-line">Examples of viral vaccines against HBV antigens include, for example, arena virus vaccines (WO 2017076988).</div>
    </li> <heading id="h-0021">HBV DNA Polymerase Inhibitors</heading>
    <li> <para-num num="[0279]"> </para-num> <div id="p-0282" num="0279" class="description-line">Examples of HBV DNA polymerase inhibitors include adefovir (HEPSERA), emtricitabine (EMTRIVA), tenofovir disoproxil fumarate (VIREAD), tenofovir alafenamide, tenofovir, tenofovir disoproxil, tenofovir alafenamide fumarate, tenofovir alafenamide hemifumarate, tenofovir dipivoxil, tenofovir dipivoxil fumarate, tenofovir octadecyloxyethyl ester, CMX-157, besifovir, entecavir (BARACLUDE), entecavir maleate, telbivudine (TYZEKA), filocilovir, pradefovir, clevudine, ribavirin, lamivudine (EPIVIR-HBV), phosphazide, famciclovir, fusolin, metacavir, SNC-019754, FMCA, AGX-1009, AR-II-04-26, HIP-1302, tenofovir disoproxil aspartate, tenofovir disoproxil orotate, and HS-10234.</div>
    </li> <heading id="h-0022">Immunomodulators</heading>
    <li> <para-num num="[0280]"> </para-num> <div id="p-0283" num="0280" class="description-line">Examples of immunomodulators include rintatolimod, imidol hydrochloride, ingaron, dermaVir, plaquenil (hydroxychloroquine), proleukin, hydroxyurea, mycophenolate mofetil (MPA) and its ester derivative mycophenolate mofetil (MMF), JNJ-440, WF-10, AB-452, ribavirin, IL-12, INO-9112, polymer polyethyleneimine (PEI), Gepon, VGV-1, MOR-22, CRV-431, JNJ-0535, TG-1050, ABI-H2158, BMS-936559, GS-9688, RO-7011785, RG-7854, AB-506, RO-6871765, AIC-649, and IR-103.</div>
    </li> <heading id="h-0023">Toll-Like Receptor (TLR) Modulators</heading>
    <li> <para-num num="[0281]"> </para-num> <div id="p-0284" num="0281" class="description-line">TLR modulators include modulators of TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9, TLR10, TLR11, TLR12, and TLR13. Examples of TLR3 modulators include rintatolimod, poly-ICLC, RIBOXXON, Apoxxim, RIBOXXIM, IPH-33, MCT-465, MCT-475, and ND-1.1.</div>
    </li> <li> <para-num num="[0282]"> </para-num> <div id="p-0285" num="0282" class="description-line">Examples of TLR7 modulators include GS-9620, GSK-2245035, imiquimod, resiquimod, DSR-6434, DSP-3025, IMO-4200, MCT-465, MEDI-9197, 3M-051, SB-9922, 3M-052, Limtop, D, telratolimod, SP-0509, TMX-30X, TMX-202, RG-7863, RG-7795, LHC-165, RG-7854, and the compounds disclosed in US20100143301 (Gilead Sciences), US20110098248 (Gilead Sciences), and US20090047249 (Gilead Sciences).</div>
    </li> <li> <para-num num="[0283]"> </para-num> <div id="p-0286" num="0283" class="description-line">Examples of TLR8 modulators include motolimod, resiquimod, 3M-051, 3M-052, MCT-465, IMO-4200, VTX-763, VTX-1463, GS-9688 and the compounds disclosed in US20140045849 (Janssen), US20140073642 (Janssen), WO2014/056953 (Janssen), WO2014/076221 (Janssen), WO2014/128189 (Janssen), US20140350031 (Janssen), WO2014/023813 (Janssen), US20080234251 (Array Biopharma), US20080306050 (Array Biopharma), US20100029585 (Ventirx Pharma), US20110092485 (Ventirx Pharma), US20110118235 (Ventirx Pharma), US20120082658 (Ventirx Pharma), US20120219615 (Ventirx Pharma), US20140066432 (Ventirx Pharma), US20140088085 (Ventirx Pharma), US20140275167 (Novira Therapeutics), US20130251673 (Novira Therapeutics), U.S. Pat. No. 9,670,205, US20160289229, U.S. patent application Ser. No. 15/692,161, and U.S. patent application Ser. No. 15/692,093.</div>
    </li> <li> <para-num num="[0284]"> </para-num> <div id="p-0287" num="0284" class="description-line">Examples of TLR9 modulators include BB-001, BB-006, CYT-003, IMO-2055, IMO-2125, IMO-3100, IMO-8400, IR-103, IMO-9200, agatolimod, DIMS-9054, DV-1079, DV-1179, AZD-1419, leftolimod (MGN-1703), litenimod, and CYT-003-QbG10.</div>
    </li> <li> <para-num num="[0285]"> </para-num> <div id="p-0288" num="0285" class="description-line">Examples of TLR7, TLR8 and TLR9 modulators include the compounds disclosed in WO2017047769 (Teika Seiyaku), WO2015014815 (Janssen), WO2018045150 (Gilead Sciences Inc), WO2018045144 (Gilead Sciences Inc), WO2015162075 (Roche), WO2017034986 (University of Kansas), WO2018095426 (Jiangsu Hengrui Medicine Co Ltd), WO2016091698 (Roche), WO2016075661 (GlaxoSmithKline Biologicals), WO2016180743 (Roche), WO2018089695 (Dynavax Technologies), WO2016055553 (Roche), WO2015168279 (Novartis), WO2016107536 (Medshine Discovery), WO2018086593 (Livo (Shanghai) Pharmaceutical), WO2017106607 (Merck), WO2017061532 (Sumitomo Dainippon Pharma), WO2016023511 (Chia Tai Tianqing Pharmaceutical), WO2017076346 (Chia Tai Tianqing Pharmaceutical), WO2017046112 (Roche), WO2018078149 (Roche), WO2017040233 (3M Co), WO2016141092 (Gilead Sciences), WO2018049089 (BristolMyers Squibb), WO2015057655 (Eisai Co Ltd), WO2017001307 (Roche), WO2018005586 (BristolMyers Squibb), WO201704023 (3M Co), WO2017163264 (Council of Scientific and Industrial Research (India)), WO2018046460 (GlaxoSmithKline Biologicals), WO2018047081 (Novartis), WO2016142250 (Roche), WO2015168269 (Novartis), WO201804163 (Roche), WO2018038877 (3M Co), WO2015057659 (Eisai Co Ltd), WO2017202704 (Roche), WO2018026620 (BristolMyers Squibb), WO2016029077 (Janus Biotherapeutics), WO201803143 (Merck), WO2016096778 (Roche), WO2017190669 (Shanghai De Novo Pharmatech), U.S. Ser. No. 09/884,866 (University of Minnesota), WO2017219931 (Sichuan KelunBiotech Biopharmaceutical), WO2018002319 (Janssen Sciences), WO2017216054 (Roche), WO2017202703 (Roche), WO2017184735 (IFM Therapeutics), WO2017184746 (IFM Therapeutics), WO2015088045 (Takeda Pharmaceutical), WO2017038909 (Takeda Pharmaceutical), WO2015095780 (University of Kansas), WO2015023958 (University of Kansas).</div>
    </li> <heading id="h-0024">Interferon Alpha Receptor Ligands</heading>
    <li> <para-num num="[0286]"> </para-num> <div id="p-0289" num="0286" class="description-line">Examples of interferon alpha receptor ligands include interferon alpha-2b (INTRON A), pegylated interferon alpha-2a (PEGASYS), PEGylated interferon alpha-1b, interferon alpha 1b (HAPGEN), Veldona, Infradure, Roferon-A, YPEG-interferon alfa-2a (YPEG-rhlFNalpha-2a), P-1101, Algeron, Alfarona, Ingaron (interferon gamma), rSIFN-co (recombinant super compound interferon), Ypeginterferon alfa-2b (YPEG-rhlFNalpha-2b), MOR-22, peginterferon alfa-2b (PEG-INTRON), Bioferon, Novaferon, Inmutag (Inferon), MULTIFERON, interferon alfa-n1 (HUMOFERON), interferon beta-1a (AVONEX), Shaferon, interferon alfa-2b (Axxo), Alfaferone, interferon alfa-2b (BioGeneric Pharma), interferon-alpha 2 (CJ), Laferonum, VIPEG, BLAUFERON-A, BLAUFERON-B, Intermax Alpha, Realdiron, Lanstion, Pegaferon, PDferon-B PDferon-B, interferon alfa-2b (IFN, Laboratorios Bioprofarma), alfainterferona 2b, Kalferon, Pegnano, Feronsure, PegiHep, interferon alfa 2b (Zydus-Cadila), interferon alfa 2a, Optipeg A, Realfa 2B, Reliferon, interferon alfa-2b (Amega), interferon alfa-2b (Virchow), ropeginterferon alfa-2b, rHSA-IFN alpha-2a (recombinant human serum albumin intereferon alpha 2a fusion protein), rHSA-IFN alpha 2b, recombinant human interferon alpha-(1b, 2a, 2b), peginterferon alfa-2b (Amega), peginterferon alfa-2a, Reaferon-EC, Proquiferon, Uniferon, Urifron, interferon alfa-2b (Changchun Institute of Biological Products), Anterferon, Shanferon, Layfferon, Shang Sheng Lei Tai, INTEFEN, SINOGEN, Fukangtai, Pegstat, rHSA-IFN alpha-2b, SFR-9216, and Interapo (Interapa).</div>
    </li> <heading id="h-0025">Hyaluronidase Inhibitors</heading>
    <li> <para-num num="[0287]"> </para-num> <div id="p-0290" num="0287" class="description-line">Examples of hyaluronidase inhibitors include astodrimer.</div>
    </li> <heading id="h-0026">Hepatitis B Surface Antigen (HBsAg) Inhibitors</heading>
    <li> <para-num num="[0288]"> </para-num> <div id="p-0291" num="0288" class="description-line">Examples of HBsAg inhibitors include AK-074, HBF-0259, PBHBV-001, PBHBV-2-15, PBHBV-2-1, REP-9AC, REP-9C, REP-9, REP-2139, REP-2139-Ca, REP-2165, REP-2055, REP-2163, REP-2165, REP-2053, REP-2031 and REP-006, and REP-9AC.</div>
    </li> <li> <para-num num="[0289]"> </para-num> <div id="p-0292" num="0289" class="description-line">Examples of HBsAg secretion inhibitors include BM601.</div>
    </li> <heading id="h-0027">Cytotoxic T-Lymphocyte-Associated Protein 4 (Ipi4) Inhibitors</heading>
    <li> <para-num num="[0290]"> </para-num> <div id="p-0293" num="0290" class="description-line">Examples of Cytotoxic T-lymphocyte-associated protein 4 (ipi4) inhibitors include AGEN-2041, AGEN-1884, ipilumimab, belatacept, PSI-001, PRS-010, Probody mAbs, tremelimumab, and JHL-1155.</div>
    </li> <heading id="h-0028">Cyclophilin Inhibitors</heading>
    <li> <para-num num="[0291]"> </para-num> <div id="p-0294" num="0291" class="description-line">Examples of cyclophilin inhibitors include CPI-431-32, EDP-494, OCB-030, SCY-635, NVP-015, NVP-018, NVP-019, STG-175, and the compounds disclosed in U.S. Pat. No. 8,513,184 (Gilead Sciences), US20140030221 (Gilead Sciences), US20130344030 (Gilead Sciences), and US20130344029 (Gilead Sciences).</div>
    </li> <heading id="h-0029">HBV Viral Entry Inhibitors</heading>
    <li> <para-num num="[0292]"> </para-num> <div id="p-0295" num="0292" class="description-line">Examples of HBV viral entry inhibitors include Myrcludex B.</div>
    </li> <li> <div id="p-0296" num="0000" class="description-line">Antisense Oligonucleotide Targeting Viral mRNA</div>
    </li> <li> <para-num num="[0293]"> </para-num> <div id="p-0297" num="0293" class="description-line">Examples of antisense oligonucleotide targeting viral mRNA include ISIS-HBVRx, IONIS-HBVRx, IONIS-GSK6-LRx, IONIS-HBV-LRx, GSK-3389404, RG-6004.</div>
    </li> <li> <div id="p-0298" num="0000" class="description-line">Short Interfering RNAs (siRNA) and ddRNAi.</div>
    </li> <li> <para-num num="[0294]"> </para-num> <div id="p-0299" num="0294" class="description-line">Examples of siRNA include TKM-HBV (TKM-HepB), ALN-HBV, SR-008, HepB-nRNA, and ARC-520, ARC-521, ARB-1740, ARB-1467, DCR-HBVS, RG-6217, ALN-HBV-02, and ARO-HBV.</div>
    </li> <li> <para-num num="[0295]"> </para-num> <div id="p-0300" num="0295" class="description-line">Examples of DNA-directed RNA interference (ddRNAi) include BB-HB-331.</div>
    </li> <heading id="h-0030">Endonuclease Modulators</heading>
    <li> <para-num num="[0296]"> </para-num> <div id="p-0301" num="0296" class="description-line">Examples of endonuclease modulators include PGN-514.</div>
    </li> <heading id="h-0031">Ribonucelotide Reductase Inhibitors</heading>
    <li> <para-num num="[0297]"> </para-num> <div id="p-0302" num="0297" class="description-line">Examples of inhibitors of ribonucleotide reductase include Trimidox.</div>
    </li> <heading id="h-0032">HBV E Antigen Inhibitors</heading>
    <li> <para-num num="[0298]"> </para-num> <div id="p-0303" num="0298" class="description-line">Examples of HBV E antigen inhibitors include wogonin.</div>
    </li> <li> <div id="p-0304" num="0000" class="description-line">Covalently Closed Circular DNA (cccDNA) Inhibitors</div>
    </li> <li> <para-num num="[0299]"> </para-num> <div id="p-0305" num="0299" class="description-line">Examples of cccDNA inhibitors include BSBI-25, and CHR-101.</div>
    </li> <heading id="h-0033">Farnesoid X Receptor Agonist</heading>
    <li> <para-num num="[0300]"> </para-num> <div id="p-0306" num="0300" class="description-line">Example of farnesoid x receptor agonist such as EYP-001, GS-9674, EDP-305, MET-409, Tropifexor, AKN-083, RDX-023, BWD-100, LMB-763, INV-3, NTX-023-1, EP-024297 and GS-8670.</div>
    </li> <heading id="h-0034">HBV Antibodies</heading>
    <li> <para-num num="[0301]"> </para-num> <div id="p-0307" num="0301" class="description-line">Examples of HBV antibodies targeting the surface antigens of the hepatitis B virus include lenvervimab (GC-1102), XTL-17, XTL-19, KN-003, IV Hepabulin SN, and fully human monoclonal antibody therapy (hepatitis B virus infection, Humabs BioMed).</div>
    </li> <li> <para-num num="[0302]"> </para-num> <div id="p-0308" num="0302" class="description-line">Examples of HBV antibodies, including monoclonal antibodies and polyclonal antibodies, include Zutectra, Shang Sheng Gan Di, Uman Big (Hepatitis B Hyperimmune), Omri-Hep-B, Nabi-HB, Hepatect CP, HepaGam B, igantibe, Niuliva, CT-P24, hepatitis B immunoglobulin (intravenous, pH4, HBV infection, Shanghai RAAS Blood Products), and Fovepta (BT-088).</div>
    </li> <li> <para-num num="[0303]"> </para-num> <div id="p-0309" num="0303" class="description-line">Examples of fully human monoclonal antibodies include HBC-34.</div>
    </li> <li> <para-num num="[0304]"> </para-num> <div id="p-0310" num="0304" class="description-line">Examples of pMHC-HBV antigens and TCR-like antibodies against pMHC-HBV antigens include those disclosed in Zhu et al. (2017), Mol. Med. Rep. 16(6): 8605-8612; Shen et al. (2017) Sci. Rep. 7(1): 16400; Sastry et al. (2011), J. Virol. 85(5): 1935-1942; Low et al. (2012) PLoS One 7(12): e51397; Cheng et al. (2019) Sci. Immunol. 4(32); and Zhao (2018) Nat. Commun. 9(1): 2716.</div>
    </li> <heading id="h-0035">CCR2 Chemokine Antagonists</heading>
    <li> <para-num num="[0305]"> </para-num> <div id="p-0311" num="0305" class="description-line">Examples of CCR2 chemokine antagonists include propagermanium.</div>
    </li> <heading id="h-0036">Thymosin Agonists</heading>
    <li> <para-num num="[0306]"> </para-num> <div id="p-0312" num="0306" class="description-line">Examples of thymosin agonists include Thymalfasin, recombinant thymosin alpha 1 (GeneScience).</div>
    </li> <heading id="h-0037">Cytokines</heading>
    <li> <para-num num="[0307]"> </para-num> <div id="p-0313" num="0307" class="description-line">Examples of cytokines include recombinant IL-7, CYT-107, interleukin-2 (IL-2, Immunex), recombinant human interleukin-2 (Shenzhen Neptunus), IL-15, IL-21, IL-24, and celmoleukin.</div>
    </li> <heading id="h-0038">Nucleoprotein Modulators</heading>
    <li> <para-num num="[0308]"> </para-num> <div id="p-0314" num="0308" class="description-line">Nucleoprotein modulators may be either HBV core or capsid protein inhibitors. Examples of nucleoprotein modulators include GS-4882, AB-423, AT-130, GLS4, NVR-1221, NVR-3778, AL-3778, BAY 41-4109, morphothiadine mesilate, ARB-168786, ARB-880, JNJ-379, RG-7907, HEC-72702, AB-506, ABI-H0731, JNJ-440, ABI-H2158 and DVR-23.</div>
    </li> <li> <para-num num="[0309]"> </para-num> <div id="p-0315" num="0309" class="description-line">Examples of capsid inhibitors include the compounds disclosed in US20140275167 (Novira Therapeutics), US20130251673 (Novira Therapeutics), US20140343032 (Roche), WO2014037480 (Roche), US20130267517 (Roche), WO2014131847 (Janssen), WO2014033176 (Janssen), WO2014033170 (Janssen), WO2014033167 (Janssen), WO2015/059212 (Janssen), WO2015118057 (Janssen), WO2015011281 (Janssen), WO2014184365 (Janssen), WO2014184350 (Janssen), WO2014161888 (Janssen), WO2013096744 (Novira), US20150225355 (Novira), US20140178337 (Novira), US20150315159 (Novira), US20150197533 (Novira), US20150274652 (Novira), US20150259324, (Novira), US20150132258 (Novira), U.S. Pat. No. 9,181,288 (Novira), WO2014184350 (Janssen), WO2013144129 (Roche), WO2017198744 (Roche), US 20170334882 (Novira), US 20170334898 (Roche), WO2017202798 (Roche), WO2017214395 (Enanta), WO2018001944 (Roche), WO2018001952 (Roche), WO2018005881 (Novira), WO2018005883 (Novira), WO2018011100 (Roche), WO2018011160 (Roche), WO2018011162 (Roche), WO2018011163 (Roche), WO2018036941 (Roche), WO2018043747 (Kyoto Univ), US20180065929 (Janssen), WO2016168619 (Indiana University), WO2016195982 (The Penn State Foundation), WO2017001655 (Janssen), WO2017048950 (Assembly Biosciences), WO2017048954 (Assembly Biosciences), WO2017048962 (Assembly Biosciences), US20170121328 (Novira), US20170121329 (Novira).</div>
    </li> <li> <para-num num="[0310]"> </para-num> <div id="p-0316" num="0310" class="description-line">Examples of transcript inhibitors include the compounds disclosed in WO2017013046 (Roche), WO2017016960 (Roche), WO2017017042 (Roche), WO2017017043 (Roche), WO2017061466 (Toyoma chemicals), WO2016177655 (Roche), WO2016161268 (Enanta). WO2017001853 (Redex Pharma), WO2017211791 (Roche), WO2017216685 (Novartis), WO2017216686 (Novartis), WO2018019297 (Ginkgo Pharma), WO2018022282 (Newave Pharma), US20180030053 (Novartis), WO2018045911 (Zhejiang Pharma).</div>
    </li> <heading id="h-0039">Retinoic Acid-<figure-callout id="1" label="Inducible Gene" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">Inducible Gene</figure-callout> 1 Stimulators</heading>
    <li> <para-num num="[0311]"> </para-num> <div id="p-0317" num="0311" class="description-line">Examples of stimulators of retinoic acid-<figure-callout id="1" label="inducible gene" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">inducible gene</figure-callout> 1 include SB-9200, SB-40, SB-44, ORI-7246, ORI-9350, ORI-7537, ORI-9020, ORI-9198, and ORI-7170, RGT-100.</div>
    </li> <heading id="h-0040">NOD2 Stimulators</heading>
    <li> <para-num num="[0312]"> </para-num> <div id="p-0318" num="0312" class="description-line">Examples of stimulators of NOD2 include inarigivir soproxil (SB-9200).</div>
    </li> <heading id="h-0041">Phosphatidylinositol 3-Kinase (PI3K) Inhibitors</heading>
    <li> <para-num num="[0313]"> </para-num> <div id="p-0319" num="0313" class="description-line">Examples of PI3K inhibitors include idelalisib, ACP-319, AZD-8186, AZD-8835, buparlisib, CDZ-173, CLR-457, pictilisib, neratinib, rigosertib, rigosertib sodium, EN-3342, TGR-1202, alpelisib, duvelisib, IPI-549, UCB-5857, taselisib, XL-765, gedatolisib, ME-401, VS-5584, copanlisib, CAI orotate, perifosine, RG-7666, GSK-2636771, DS-7423, panulisib, GSK-2269557, GSK-2126458, CUDC-907, PQR-309, INCB-40093, pilaralisib, BAY-1082439, puquitinib mesylate, SAR-245409, AMG-319, RP-6530, ZSTK-474, MLN-1117, SF-1126, RV-1729, sonolisib, LY-3023414, SAR-260301, TAK-117, HMPL-689, tenalisib, voxtalisib, and CLR-1401.</div>
    </li> <heading id="h-0042">Indoleamine-2,3-Dioxygenase (IDO) Pathway Inhibitors</heading>
    <li> <para-num num="[0314]"> </para-num> <div id="p-0320" num="0314" class="description-line">Examples of IDO inhibitors include epacadostat (INCB24360), resminostat (4SC-201), indoximod, F-001287, SN-35837, NLG-919, GDC-0919, GBV-1028, GBV-1012, NKTR-218, and the compounds disclosed in US20100015178 (Incyte), US2016137652 (Flexus Biosciences, Inc.), WO2014073738 (Flexus Biosciences, Inc.), and WO2015188085 (Flexus Biosciences, Inc.).</div>
    </li> <heading id="h-0043">PD-1 Inhibitors</heading>
    <li> <para-num num="[0315]"> </para-num> <div id="p-0321" num="0315" class="description-line">Examples of PD-1 inhibitors include cemiplimab, nivolumab, pembrolizumab, pidilizumab, BGB-108, STI-A1014, SHR-1210, PDR-001, PF-06801591, IBI-308, GB-226, STI-1110, JNJ-63723283, CA-170, durvalumab, atezolizumab and mDX-400, JS-001, Camrelizumab, Sintilimab, Sintilimab, tislelizumab, BCD-100, BGB-A333 JNJ-63723283, GLS-010 (WBP-3055), CX-072, AGEN-2034, GNS-1480 (Epidermal growth factor receptor antagonist; Programmed <figure-callout id="1" label="cell death ligand" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">cell death ligand</figure-callout> 1 inhibitor), CS-1001 M-7824 (PD-L1/TGF- bifunctional fusion protein), Genolimzumab, BMS-936559.</div>
    </li> <heading id="h-0044">PD-L1 Inhibitors</heading>
    <li> <para-num num="[0316]"> </para-num> <div id="p-0322" num="0316" class="description-line">Examples of PD-L1 inhibitors include atezolizumab, avelumab, AMP-224, MEDI-0680, RG-7446, GX-P2, durvalumab, KY-1003, KD-033, KN-035, MSB-0010718C, TSR-042, ALN-PDL, STI-A1014, GS-4224, CX-072, and BMS-936559.</div>
    </li> <li> <para-num num="[0317]"> </para-num> <div id="p-0323" num="0317" class="description-line">Examples of PD-1 inhibitors include the compounds disclosed in WO2017112730 (Incyte Corp), WO2017087777 (Incyte Corp), WO2017017624, WO2014151634 (BristolMyers Squibb Co), WO201317322 (BristolMyers Squibb Co), WO2018119286 (Incyte Corp), WO2018119266 (Incyte Corp), WO2018119263 (Incyte Corp), WO2018119236 (Incyte Corp), WO2018119221 (Incyte Corp), WO2018118848 (BristolMyers Squibb Co), WO20161266460 (BristolMyers Squibb Co), WO2017087678 (BristolMyers Squibb Co), WO2016149351 (BristolMyers Squibb Co), WO2015033299 (Aurigene Discovery Technologies Ltd), WO2015179615 (Eisai Co Ltd; Eisai Research Institute), WO2017066227 (BristolMyers Squibb Co), WO2016142886 (Aurigene Discovery Technologies Ltd), WO2016142852 (Aurigene Discovery Technologies Ltd), WO2016142835 (Aurigene Discovery Technologies Ltd; Individual), WO2016142833 (Aurigene Discovery Technologies Ltd), WO2018085750 (BristolMyers Squibb Co), WO2015033303 (Aurigene Discovery Technologies Ltd), WO2017205464 (Incyte Corp), WO2016019232 (3M Co; Individual; Texas A&amp;M University System), WO2015160641 (BristolMyers Squibb Co), WO2017079669 (Incyte Corp), WO2015033301 (Aurigene Discovery Technologies Ltd), WO2015034820 (BristolMyers Squibb Co), WO2018073754 (Aurigene Discovery Technologies Ltd), WO2016077518 (BristolMyers Squibb Co), WO2016057624 (BristolMyers Squibb Co), WO2018044783 (Incyte Corp), WO2016100608 (BristolMyers Squibb Co), WO2016100285 (BristolMyers Squibb Co), WO2016039749 (BristolMyers Squibb Co), WO2015019284 (Cambridge Enterprise Ltd), WO2016142894 (Aurigene Discovery Technologies Ltd), WO2015134605 (BristolMyers Squibb Co), WO2018051255 (Aurigene Discovery Technologies Ltd), WO2018051254 (Aurigene Discovery Technologies Ltd), WO2017222976 (Incyte Corp), WO2017070089 (Incyte Corp), WO2018044963 (BristolMyers Squibb Co), WO2013144704 (Aurigene Discovery Technologies Ltd), WO2018013789 (Incyte Corp), WO2017176608 (BristolMyers Squibb Co), WO2018009505 (BristolMyers Squibb Co), WO2011161699 (Aurigene Discovery Technologies Ltd), WO2015119944 (Incyte Corp; Merck Sharp &amp; Dohme Corp), WO2017192961 (Incyte Corp), WO2017106634 (Incyte Corp), WO2013132317 (Aurigene Discovery Technologies Ltd), WO2012168944 (Aurigene Discovery Technologies Ltd), WO2015036927 (Aurigene Discovery Technologies Ltd), WO2015044900 (Aurigene Discovery Technologies Ltd), WO2018026971 (Arising International).</div>
    </li> <heading id="h-0045">OX-40 Receptor Agonists</heading>
    <li> <para-num num="[0318]"> </para-num> <div id="p-0324" num="0318" class="description-line">Examples of OX-40 receptor agonists include IBI-101</div>
    </li> <heading id="h-0046">IAP Inhibitors</heading>
    <li> <para-num num="[0319]"> </para-num> <div id="p-0325" num="0319" class="description-line">Examples of IAP inhibitors include APG-1387</div>
    </li> <heading id="h-0047">Recombinant Thymosin Alpha-1</heading>
    <li> <para-num num="[0320]"> </para-num> <div id="p-0326" num="0320" class="description-line">Examples of recombinant thymosin alpha-1 include NL-004 and PEGylated thymosin alpha-1.</div>
    </li> <heading id="h-0048">Bruton&#39;s Tyrosine Kinase (BTK) Inhibitors</heading>
    <li> <para-num num="[0321]"> </para-num> <div id="p-0327" num="0321" class="description-line">Examples of BTK inhibitors include ABBV-105, acalabrutinib (ACP-196), ARQ-531, BMS-986142, dasatinib, ibrutinib, GDC-0853, PRN-1008, SNS-062, ONO-4059, BGB-3111, ML-319, MSC-2364447, RDX-022, X-022, AC-058, RG-7845, spebrutinib, TAS-5315, TP-0158, TP-4207, HM-71224, KBP-7536, M-2951, TAK-020, AC-0025, and the compounds disclosed in US20140330015 (Ono Pharmaceutical), US20130079327 (Ono Pharmaceutical), and US20130217880 (Ono Pharmaceutical).</div>
    </li> <heading id="h-0049">KDM Inhibitors</heading>
    <li> <para-num num="[0322]"> </para-num> <div id="p-0328" num="0322" class="description-line">Examples of KDM5 inhibitors include the compounds disclosed in WO2016057924 (Genentech/Constellation Pharmaceuticals), US20140275092 (Genentech/Constellation Pharmaceuticals), US20140371195 (Epitherapeutics) and US20140371214 (Epitherapeutics), US20160102096 (Epitherapeutics), US20140194469 (Quanticel), US20140171432, US20140213591 (Quanticel), US20160039808 (Quanticel), US20140275084 (Quanticel), WO2014164708 (Quanticel).</div>
    </li> <li> <para-num num="[0323]"> </para-num> <div id="p-0329" num="0323" class="description-line">Examples of KDM1 inhibitors include the compounds disclosed in U.S. Pat. No. 9,186,337B2 (Oryzon Genomics), GSK-2879552, and RG-6016.</div>
    </li> <heading id="h-0050">STING Agonists</heading>
    <li> <para-num num="[0324]"> </para-num> <div id="p-0330" num="0324" class="description-line">Examples of STING agonists include SB-11285, AdVCA0848, STINGVAX, and compounds disclosed in WO 2018065360 (Biolog Life Science Institute Forschungslabor and Biochemica-Vertrieb GmbH, Germany), WO 2018009466 (Aduro Biotech), WO 2017186711 (InvivoGen), WO 2017161349 (Immune Sensor), WO 2017106740 (Aduro Biotech), US 20170158724 (Glaxo Smithkiline), WO 2017075477 (Aduro Biotech), US 20170044206 (Merck), WO 2014179760 (University of California), WO2018098203 (Janssn), WO2018118665 (Merck), WO2018118664 (Merck), WO2018100558 (Takeda), WO2018067423 (Merck), WO2018060323 (Boehringer).</div>
    </li> <li> <para-num num="[0325]"> </para-num> <div id="p-0331" num="0325" class="description-line">Examples of NNRTI include the compounds disclosed in WO2018118826 (Merck), WO2018080903 (Merck), WO2018119013 (Merck), WO2017100108 (Idenix), WO2017027434 (Merck), WO2017007701 (Merck), WO2008005555 (Gilead).</div>
    </li> <heading id="h-0051">HBV Replication Inhibitors</heading>
    <li> <para-num num="[0326]"> </para-num> <div id="p-0332" num="0326" class="description-line">Examples of hepatitis B virus replication inhibitors include isothiafludine, IQP-HBV, RM-5038, and Xingantie.</div>
    </li> <heading id="h-0052">Arginase Inhibitors</heading>
    <li> <para-num num="[0327]"> </para-num> <div id="p-0333" num="0327" class="description-line">Examples of Arginase inhibitors include CB-1158, C-201, and resminostat.</div>
    </li> <heading id="h-0053">Gene Therapy and Cell Therapy</heading>
    <li> <para-num num="[0328]"> </para-num> <div id="p-0334" num="0328" class="description-line">Gene therapy and cell therapy include the genetic modification to silence a gene, genetic approaches to directly kill the infected cells, the infusion of immune cells designed to replace most of the patient&#39;s own immune system to enhance the immune response to infected cells, or activate the patient&#39;s own immune system to kill infected cells, or find and kill the infected cells, and/or genetic approaches to modify cellular activity to further alter endogenous immune responsiveness against the infection.</div>
    </li> <heading id="h-0054">CAR-T Cell Therapy</heading>
    <li> <para-num num="[0329]"> </para-num> <div id="p-0335" num="0329" class="description-line">A population of immune effector cells engineered to express a chimeric antigen receptor (CAR) can be administered, wherein the CAR comprises an HBV antigen-binding domain. The immune effector cell is a T cell or an NK cell. In some embodiments, the T cell is a CD4+ T cell, a CD8+ T cell, or a combination thereof. Cells can be autologous or allogeneic.</div>
    </li> <heading id="h-0055">TCR-T Cell Therapy</heading>
    <li> <para-num num="[0330]"> </para-num> <div id="p-0336" num="0330" class="description-line">T cells expressing HBV-specific T cell receptors can be administered. TCR-T cells are engineered to target HBV derived peptides presented on the surface of virus-infected cells.</div>
    </li> <li> <para-num num="[0331]"> </para-num> <div id="p-0337" num="0331" class="description-line">T-Cells expressing HBV surface antigen (HBsAg)-specific TCR can be administered.</div>
    </li> <li> <para-num num="[0332]"> </para-num> <div id="p-0338" num="0332" class="description-line">TCR-T therapy directed to treatment of HBV, such as LTCR-H2-1, can be administered.</div>
    </li> <li> <para-num num="[0333]"> </para-num> <div id="p-0339" num="0333" class="description-line">In another specific embodiment, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with an HBV DNA polymerase inhibitor, one or two additional therapeutic agents selected from the group consisting of immunomodulators, TLR modulators, HBsAg inhibitors, HBsAg secretion or assembly inhibitors, HBV therapeutic vaccines, HBV antibodies including HBV antibodies targeting the surface antigens of the hepatitis B virus and bispecific antibodies and antibody-like therapeutic proteins (such as DARTs, DUOBODIES, BITES, XmAbs, TandAbs, Fab derivatives, or TCR-like antibodies), cyclophilin inhibitors, stimulators of retinoic acid-<figure-callout id="1" label="inducible gene" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">inducible gene</figure-callout> 1, stimulators of RIG-I like receptors, PD-1 inhibitors, PD-L1 inhibitors, Arginase inhibitors, PI3K inhibitors, MO inhibitors, and stimulators of NOD2, and one or two additional therapeutic agents selected from the group consisting of HBV viral entry inhibitors, NTCP inhibitors, HBx inhibitors, cccDNA inhibitors, HBV antibodies targeting the surface antigens of the hepatitis B virus, siRNA, miRNA gene therapy agents, sshRNAs, KDM5 inhibitors, and nucleoprotein modulators (HBV core or capsid protein modulators).</div>
    </li> <li> <para-num num="[0334]"> </para-num> <div id="p-0340" num="0334" class="description-line">In another specific embodiment, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with an HBV DNA polymerase inhibitor and at least a second additional therapeutic agent selected from the group consisting of: immunomodulators, TLR modulators, HBsAg inhibitors, HBV therapeutic vaccines, HBV antibodies including HBV antibodies targeting the surface antigens of the hepatitis B virus and bispecific antibodies and antibody-like therapeutic proteins (such as DARTs, DUOBODIES, BITES, XmAbs, TandAbs, Fab derivatives, or TCR-like antibodies), cyclophilin inhibitors, stimulators of retinoic acid-<figure-callout id="1" label="inducible gene" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">inducible gene</figure-callout> 1, stimulators of RIG-I like receptors, PD-1 inhibitors, PD-L1 inhibitors, Arginase inhibitors, PI3K inhibitors, IDO inhibitors, and stimulators of NOD2.</div>
    </li> <li> <para-num num="[0335]"> </para-num> <div id="p-0341" num="0335" class="description-line">In another specific embodiment, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with an HBV DNA polymerase inhibitor and at least a second additional therapeutic agent selected from the group consisting of: HBV viral entry inhibitors, NTCP inhibitors, HBx inhibitors, cccDNA inhibitors, HBV antibodies targeting the surface antigens of the hepatitis B virus, siRNA, miRNA gene therapy agents, sshRNAs, KDM5 inhibitors, and nucleoprotein modulators (HBV core or capsid protein inhibitors).</div>
    </li> <li> <para-num num="[0336]"> </para-num> <div id="p-0342" num="0336" class="description-line">In a particular embodiment, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with compounds such as those disclosed in U.S. Publication No. 2010/0143301 (Gilead Sciences), U.S. Publication No. 2011/0098248 (Gilead Sciences), U.S. Publication No. 2009/0047249 (Gilead Sciences), U.S. Pat. No. 8,722,054 (Gilead Sciences), U.S. Publication No. 2014/0045849 (Janssen), U.S. Publication No. 2014/0073642 (Janssen), WO2014/056953 (Janssen), WO2014/076221 (Janssen), WO2014/128189 (Janssen), U.S. Publication No. 2014/0350031 (Janssen), WO2014/023813 (Janssen), U.S. Publication No. 2008/0234251 (Array Biopharma), U.S. Publication No. 2008/0306050 (Array Biopharma), U.S. Publication No. 2010/0029585 (Ventirx Pharma), U.S. Publication No. 2011/0092485 (Ventirx Pharma), US2011/0118235 (Ventirx Pharma), U.S. Publication No. 2012/0082658 (Ventirx Pharma), U.S. Publication No. 2012/0219615 (Ventirx Pharma), U.S. Publication No. 2014/0066432 (Ventirx Pharma), U.S. Publication No. 2014/0088085 (Ventirx Pharma), U.S. Publication No. 2014/0275167 (Novira Therapeutics), U.S. Publication No. 2013/0251673 (Novira Therapeutics), U.S. Pat. No. 8,513,184 (Gilead Sciences), U.S. Publication No. 2014/0030221 (Gilead Sciences), U.S. Publication No. 2013/0344030 (Gilead Sciences), U.S. Publication No. 2013/0344029 (Gilead Sciences), US20140275167 (Novira Therapeutics), US20130251673 (Novira Therapeutics), U.S. Publication No. 2014/0343032 (Roche), WO2014037480 (Roche), U.S. Publication No. 2013/0267517 (Roche), WO2014131847 (Janssen), WO2014033176 (Janssen), WO2014033170 (Janssen), WO2014033167 (Janssen), WO2015/059212 (Janssen), WO2015118057 (Janssen), WO2015011281 (Janssen), WO2014184365 (Janssen), WO2014184350 (Janssen), WO2014161888 (Janssen), WO2013096744 (Novira), US20150225355 (Novira), US20140178337 (Novira), US20150315159 (Novira), US20150197533 (Novira), US20150274652 (Novira), US20150259324, (Novira), US20150132258 (Novira), U.S. Pat. No. 9,181,288 (Novira), WO2014184350 (Janssen), WO2013144129 (Roche), US20100015178 (Incyte), US2016137652 (Flexus Biosciences, Inc.), WO2014073738 (Flexus Biosciences, Inc.), WO2015188085 (Flexus Biosciences, Inc.), U.S. Publication No. 2014/0330015 (Ono Pharmaceutical), U.S. Publication No. 2013/0079327 (Ono Pharmaceutical), U.S. Publication No. 2013/0217880 (Ono pharmaceutical), WO2016057924 (Genentech/Constellation Pharmaceuticals), US20140275092 (Genentech/Constellation Pharmaceuticals), US20140371195 (Epitherapeutics) and US20140371214 (Epitherapeutics), US20160102096 (Epitherapeutics), US20140194469 (Quanticel), US20140171432, US20140213591 (Quanticel), US20160039808 (Quanticel), US20140275084 (Quanticel), WO2014164708 (Quanticel), U.S. Pat. No. 9,186,337B2 (Oryzon Genomics), and other drugs for treating HBV, and combinations thereof.</div>
    </li> <li> <para-num num="[0337]"> </para-num> <div id="p-0343" num="0337" class="description-line">In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, may be combined with one or more (e.g., one, two, three, four, one or two, one to three, or one to four) additional therapeutic agents in any dosage amount of the engineered meganuclease or nucleic acid.</div>
    </li> <li> <para-num num="[0338]"> </para-num> <div id="p-0344" num="0338" class="description-line">In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with 5-30 mg tenofovir alafenamide fumarate, tenofovir alafenamide hemifumarate, or tenofovir alafenamide. In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with 5-10; 5-15; 5-20; 5-25; 25-30; 20-30; 15-30; or 10-30 mg tenofovir alafenamide fumarate, tenofovir alafenamide hemifumarate, or tenofovir alafenamide. In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with 10 mg tenofovir alafenamide fumarate, tenofovir alafenamide hemifumarate, or tenofovir alafenamide. In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with 25 mg tenofovir alafenamide fumarate, tenofovir alafenamide hemifumarate, or tenofovir alafenamide. An engineered meganuclease disclosed herein, or a nucleic acid encoding the same, may be combined with the agents provided herein in any dosage amount of the compound (e.g., from 50 mg to 500 mg of compound) the same as if each combination of dosages were specifically and individually listed.</div>
    </li> <li> <para-num num="[0339]"> </para-num> <div id="p-0345" num="0339" class="description-line">In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with 100-400 mg tenofovir disoproxil fumarate, tenofovir disoproxil hemifumarate, or tenofovir disoproxil. In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with 100-150; 100-200, 100-250; 100-300; 100-350; 150-200; 150-250; 150-300; 150-350; 150-400; 200-250; 200-300; 200-350; 200-400; 250-350; 250-400; 350-400 or 300-400 mg tenofovir disoproxil fumarate, tenofovir disoproxil hemifumarate, or tenofovir disoproxil. In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with 300 mg tenofovir disoproxil fumarate, tenofovir disoproxil hemifumarate, or tenofovir disoproxil. In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with 250 mg tenofovir disoproxil fumarate, tenofovir disoproxil hemifumarate, or tenofovir disoproxil. In certain embodiments, an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, is combined with 150 mg tenofovir disoproxil fumarate, tenofovir disoproxil hemifumarate, or tenofovir disoproxil. An engineered meganuclease disclosed herein, or a nucleic acid encoding the same, may be combined with the agents provided herein in any dosage amount of the compound (e.g., from 50 mg to 500 mg of compound) the same as if each combination of dosages were specifically and individually listed.</div>
    </li> <li> <para-num num="[0340]"> </para-num> <div id="p-0346" num="0340" class="description-line">In one embodiment, kits comprising an engineered meganuclease disclosed herein, or a nucleic acid encoding the same, in combination with one or more (e.g., one, two, three, four, one or two, or one to three, or one to four) additional therapeutic agents are provided.</div>
    </li> <heading id="h-0056">EXAMPLES</heading>
    <li> <para-num num="[0341]"> </para-num> <div id="p-0347" num="0341" class="description-line">This invention is further illustrated by the following examples, which should not be construed as limiting. Those skilled in the art will recognize, or be able to ascertain, using no more than routine experimentation, numerous equivalents to the specific substances and procedures described herein. Such equivalents are intended to be encompassed in the scope of the claims that follow the examples below.</div>
    </li> <heading id="h-0057">Example 1</heading>
    <heading id="h-0058">Characterization of Meganucleases Having Specificity for the HBV 11-12 Recognition Sequence</heading>
    <li> <para-num num="[0342]"> </para-num> <div id="p-0348" num="0342" class="description-line">1. Meganucleases that Recognize and Cleave the HBV 11-12 Recognition Sequence</div>
    </li> <li> <para-num num="[0343]"> </para-num> <div id="p-0349" num="0343" class="description-line">The second-generation HBV 11-12 meganucleases, referred to as HBV 11-12L.363 (SEQ ID NO: 12) and HBV 11-12L.367 (SEQ ID NO: 13), were engineered to recognize and cleave the HBV 11-12 recognition sequence (SEQ ID NO: 10), which is present in multiple Hepatitis B virus genotypes, including genotypes A-G (SEQ ID NOs: 3-9, respectively). Each of these second-generation meganucleases comprises an N-terminal nuclease-localization signal derived from SV40, a first meganuclease subunit, a linker sequence, and a second meganuclease subunit. A first subunit in each HBV 11-12 meganuclease binds to the HBV11 recognition half-site of SEQ ID NO: 10, while a second subunit binds to the HBV12 recognition half-site (see, <figref idrefs="DRAWINGS">FIG. 2</figref>). HBV11-binding subunits and HBV12-binding subunits each comprise a 56 base pair hypervariable region, referred to as HVR1 and HVR2, respectively.</div>
    </li> <li> <para-num num="[0344]"> </para-num> <div id="p-0350" num="0344" class="description-line">The HVR1 region of each HBV11-binding subunit consists of residues 215-270 of SEQ ID NOs: 12 and 13. HBV11-binding subunits of HBV 11-12L.363 and HBV 11-12L.367 are identical to one another outside of the HVR1 region. The HVR1 region of each HBV 11-12 meganuclease comprises modifications relative to the wild-type I-CreI sequence (SEQ ID NO: 1) at positions 215, 217, 219, 221, 223, 224, 229, 231, 233, 235, 237, 239, 241, 259, 261, 263, 264, 266, and 268. The glycine at residue 262 is unmodified in HBV 11-12L.363 and modified to an arginine in HBV 11-12L.367. Although not modified relative to wild-type I-CreI in HBV 11-12L.363, this residue is believed to contribute, in combination with the modified HVR1 residues, to specificity of the nuclease. The HVR1 regions of HBV 11-12L.363 and HBV 11-12L.367 each share 85.71% sequence identity to the HVR1 region of the first-generation HBV 11-12x.26 meganuclease.</div>
    </li> <li> <para-num num="[0345]"> </para-num> <div id="p-0351" num="0345" class="description-line">The HVR2 region of each HBV12-binding subunit consists of residues 24-79 of SEQ ID NOs: 12 and 13. HBV12-binding subunits of HBV 11-12L.363 and HBV 11-12L.367 are identical to one another outside of the HVR2 region. The HVR2 region of each HBV 11-12 meganuclease comprises modifications relative to the wild-type I-CreI sequence (SEQ ID NO: 1) at <figure-callout id="24" label="positions" filenames="US20190338263A1-20191107-D00005.png" state="{{state}}"> <figure-callout id="30" label="positions" filenames="US20190338263A1-20191107-D00006.png,US20190338263A1-20191107-D00009.png" state="{{state}}"> <figure-callout id="40" label="positions" filenames="US20190338263A1-20191107-D00009.png,US20190338263A1-20191107-D00010.png" state="{{state}}"> <figure-callout id="70" label="positions" filenames="US20190338263A1-20191107-D00009.png" state="{{state}}"> <figure-callout id="75" label="positions" filenames="US20190338263A1-20191107-D00011.png" state="{{state}}">positions</figure-callout> </figure-callout> </figure-callout> </figure-callout> </figure-callout> 24, 26, 28, 30, 33, 38, 40, 42, 44, 46, 68, 70, 75, and 77. Although not modified relative to wild-type I-CreI, the serine residue at position 32 of SEQ ID NOs: 12 and 13 is believed to contribute, in combination with the modified HVR2 residues, to specificity of the nuclease. The HVR2 region of HBV 11-12L.363 and HBV 11-12L.367 each share 96.43% sequence identity to the HVR2 region of the first-generation HBV 11-12x.26 meganuclease.</div>
    </li> <heading id="h-0059">2. Optimization of First-Generation HBV 11-12 Nucleases</heading>
    <li> <para-num num="[0346]"> </para-num> <div id="p-0352" num="0346" class="description-line">The first-generation HBV 11-12x.26 meganuclease was evaluated for sequence specificity using a method very similar to GUIDE-seq (Tsai et al. (2015), Nat Biotechnology 33:187-197) but adjusted to find potential off-target sites for meganucleases. In general, potential off-target sites were identified by capturing a probe oligonucleotide in the double strand DNA break. The HBV nucleases generate a four <figure-callout id="3" label="base pair" filenames="US20190338263A1-20191107-D00003.png,US20190338263A1-20191107-D00007.png" state="{{state}}">base pair</figure-callout> 3 overhang so the probe oligo also contains randomized four base pair overhangs to improve ligation efficiency at sites more likely created by the nuclease cleavage. Specificity analysis of HBV 11-12x.26 in HEK 293 cells highlighted a number of positions within the protein-DNA interface that were not discriminating the correct sequence adequately. A library to address all of the problem interfaces would be too large to build and screen in our selection system so, instead, half sites were optimized sequentially. The HBV 11-12 single-chain meganuclease has the monomers fused in an orientation where the HBV12-binding subunit is in the N-terminus and the HBV11-binding subunit is in the C-terminus. Optimization of HBV11 began with re-randomizing amino acids in positions that dictate recognition site specificity. The library was sequentially positively and negatively selected against the intended site and the off-target, HBV11 Off: 5-TtCCtccCCATACTGCGGAACT-3 (SEQ ID NO: 23). Nucleases were evaluated using an integrated iGFFP assay (as described below) to determine on versus off target cleavage. Four promising nucleases, HBV 11-12L.188, L.190, L.206, and L.271, were re-evaluated in the oligo capture assay. Based on the reduction in read count and number of off-targets, L.188 and L.190 were chosen for subsequent library development. Positions in both the HBV11 and HBV12-binding subunits that contribute to recognition site specificity were randomized in this round of optimization. The libraries were simultaneously positively and negatively selected against the intended target site and either HBV11 Off or HBV12 Off: 5-TGCCGATCCATACTGatGAAaa-3 (SEQ ID NO: 24). The off-targets were alternated between successive rounds of selection. A 96-well plate of individual answers (i.e., nucleases) was evaluated for each library in the iGFFP assay (described below) against the intended site and both off-target sites. Two nucleases, HBV 11-12L.363 and L.367, were identified for further testing and were confirmed by full iGFFP testing (described below) that looks at toxicity of the nuclease over a 7 day period. These optimized nucleases were also evaluated for off-target specificity in the oligo capture assay. Finally, identified potential off-targets were verified using PCR amplification of the off-target and next generation sequencing to measure the frequency of indels at the potential off-target site.</div>
    </li> <heading id="h-0060">3. Evaluation of HBV 11-12 Recognition Sequence Cleavage and Off-Target Cutting</heading>
    <li> <para-num num="[0347]"> </para-num> <div id="p-0353" num="0347" class="description-line">To determine whether HBV 11-12 meganucleases could recognize and cleave the HBV 11-12 recognition sequence (SEQ ID NO: 10), each HBV 11-12 meganuclease was evaluated using the CHO cell reporter assay previously described (see WO 2012/167192, FIG. 5). To perform the assay, a pair of CHO cell reporter lines were produced which carried a non-functional Green Fluorescent Protein (GFP) gene expression cassette integrated into the genome of the cell. The GFP gene in each cell line was interrupted by a pair of recognition sequences such that intracellular cleavage of either recognition sequence by a meganuclease would stimulate a homologous recombination event resulting in a functional GFP gene. In both cell lines, one of the recognition sequences was derived from the HBV 11-12 target and the second recognition sequence was specifically recognized by a control meganuclease called <figure-callout id="23" label="CHO" filenames="US20190338263A1-20191107-D00005.png" state="{{state}}">CHO</figure-callout> 23/24. CHO reporter cells comprising the HBV 11-12 recognition sequence (SEQ ID NO: 10) and the <figure-callout id="23" label="CHO" filenames="US20190338263A1-20191107-D00005.png" state="{{state}}">CHO</figure-callout> 23/24 recognition sequence are referred to herein as HBV 11-12 cells.</div>
    </li> <li> <para-num num="[0348]"> </para-num> <div id="p-0354" num="0348" class="description-line">HBV 11-12 cells were transfected with plasmid DNA encoding HBV 11-12L.363 or HBV 11-12L.367, or encoding the <figure-callout id="23" label="CHO" filenames="US20190338263A1-20191107-D00005.png" state="{{state}}">CHO</figure-callout> 23/24 meganuclease. 410<sup>5 </sup>CHO cells were transfected with 50 ng of plasmid DNA in a 96-well plate using Lipofectamine 2000 (ThermoFisher) according to the manufacturer&#39;s instructions. At 48 hours post-transfection, cells were evaluated by flow cytometry to determine the percentage of GFP-positive cells compared to an untransfected negative control (1-2 bs). Both HBV 11-12 meganucleases were found to produce GFP-positive cells in cell lines comprising the HBV 11-12 recognition sequence at frequencies significantly exceeding the negative control and exceeding the <figure-callout id="23" label="CHO" filenames="US20190338263A1-20191107-D00005.png" state="{{state}}">CHO</figure-callout> 23/24 positive control, indicating that each HBV 11-12 meganuclease was able to efficiently recognize and cleave the intended HBV 11-12 recognition sequence in a cell (see, <figref idrefs="DRAWINGS">FIG. 6</figref>).</div>
    </li> <li> <para-num num="[0349]"> </para-num> <div id="p-0355" num="0349" class="description-line">Alternatively, the HBV 11-12 meganucleases were also transfected into HBV11 Off or HBV12 Off cells which contain one of the counter selected off-target sequences between the GFP direct repeats. Unlike the intended target site in HBV 11-12 CHO cells, a desirable nuclease in HBV11 Off or HBV12 Off CHO cells has only background level GFP positive cells because it is able to discriminate against cutting the off-target sequence. The CHO 23-24 target site acts as a positive control in these experiments, demonstrating that the GFP can still be produced if the target site is cut by the CHO 23-24 nuclease. The new nucleases demonstrated a significantly improved (i.e., increased) discrimination against the HBV11 Off (<figref idrefs="DRAWINGS">FIG. 7</figref>) and HBV12 Off (<figref idrefs="DRAWINGS">FIG. 8</figref>) recognition sequences compared to the first-generation HBV 11-12x.26 meganuclease.</div>
    </li> <li> <para-num num="[0350]"> </para-num> <div id="p-0356" num="0350" class="description-line">The efficacy of HBV 11-12L.363 and L.367 meganucleases was also determined in a time-<figure-callout id="2" label="dependent manner" filenames="US20190338263A1-20191107-D00001.png,US20190338263A1-20191107-D00007.png" state="{{state}}"> <figure-callout id="5" label="dependent manner" filenames="US20190338263A1-20191107-D00006.png,US20190338263A1-20191107-D00007.png" state="{{state}}"> <figure-callout id="7" label="dependent manner" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">dependent manner</figure-callout> </figure-callout> </figure-callout> 2, 5, and 7 days after introduction of the meganucleases into HBV 11-12 cells. In this study, HBV 11-12 cells (1.010<sup>6</sup>) were electroporated with 110<sup>6 </sup>copies of meganuclease mRNA per cell using a BioRad Gene Pulser Xcell according to the manufacturer&#39;s instructions. At 48 hours post-transfection, cells were evaluated by flow cytometry to determine the percentage of GFP-positive cells. A <figure-callout id="23" label="CHO" filenames="US20190338263A1-20191107-D00005.png" state="{{state}}">CHO</figure-callout> 23/24 meganuclease was also included at each time point as a positive control. Each of the meganucleases showed a superior GFP-positive percentage relative to CHO 23-24 and the percent GFP continued to increase over the course of the experiment, indicating no gross toxicity to the cells (<figref idrefs="DRAWINGS">FIG. 9</figref>).</div>
    </li> <li> <para-num num="[0351]"> </para-num> <div id="p-0357" num="0351" class="description-line">The extended iGFFP assay was also used to evaluate the same group of meganucleases for discrimination against the two off targets, HBV11 Off and HBV12 Off, over a 7 day period. In this case, cells containing either HBV11 Off or HBV12 Off, and CHO 23-24, were electroporated with 110<sup>6 </sup>copies of meganuclease mRNA per cell using a BioRad Gene Pulser Xcell according to the manufacturer&#39;s instructions. At 2, 5, and 7 days post-transfection, cells were evaluated by flow cytometry to determine the percentage of GFP-positive cells. A <figure-callout id="23" label="CHO" filenames="US20190338263A1-20191107-D00005.png" state="{{state}}">CHO</figure-callout> 23/24 meganuclease was also included at each time point as a positive control. Each of the nucleases showed excellent discrimination against both off-targets over the period observed (<figref idrefs="DRAWINGS">FIGS. 10A and 10B</figref>).</div>
    </li> <heading id="h-0061">4. Oligo Capture Assay and Analysis of Off-Target Cutting</heading>
    <li> <para-num num="[0352]"> </para-num> <div id="p-0358" num="0352" class="description-line">In these studies, an oligo capture assay was used to identify off target cutting induced by the first-generation HBV 11-12x.26 meganuclease and the optimized meganucleases HBV 11-12L.188, HBV 11-12L.363, and HBV 11-12L.367. Off target cutting was first assessed in HepG2 cells which lack the HBV 11-12 recognition sequence in their genome. Off target cutting was then assessed in a lentivirus-modified HepG2 cell line that comprises in its genome a partial HBV genome comprising the HBV 11-12 recognition sequence.</div>
    </li> <li> <para-num num="[0353]"> </para-num> <div id="p-0359" num="0353" class="description-line">Similar to GUIDE-seq, the oligo capture assay identifies potential off-target sites produced by the HBV 11-12 meganucleases by capturing an oligonucleotide at break sites within the cell&#39;s genomic DNA. GUIDE-seq was developed for CRISPR-Cas9 generated DNA breaks and there are a few key modifications to the chemistry and analysis in order to apply this technique to the present nucleases. Unlike CRISPR-cas9, the engineered meganucleases of the invention generate a four <figure-callout id="3" label="base pair" filenames="US20190338263A1-20191107-D00003.png,US20190338263A1-20191107-D00007.png" state="{{state}}">base pair</figure-callout> 3 overhang. To accommodate for this difference, the oligonucleotides used in oligo capture have randomized four base pair overhangs that could be compatible with the overhangs generated with the HBV 11-12 meganuclease. A higher frequency of insertion is observed due to the greater efficiency of ligating sticky ends rather than blunt ends. Cells were transfected with mRNA encoding the nuclease and the double stranded DNA oligonucleotides. After two days, the genomic DNA from these cells was isolated and sonicated to shear the DNA to smaller sizes. An oligonucleotide adapter was ligated to the sheared DNA and PCR was used to amplify any DNA pieces that contain an adapter at one end and the captured oligonucleotide at the other end. The amplified DNA was purified and sequencing libraries were prepared using standard commercial kits.</div>
    </li> <li> <para-num num="[0354]"> </para-num> <div id="p-0360" num="0354" class="description-line">Sequencing libraries were run on an Illumina MiSeq using V2 2x150 kits. The data was filtered and analyzed for valid sites that captured an oligonucleotide and a potential off-target site is predicted. Here again, the protocol needed to be adjusted from the PAM search used for CRISPR-cas9 to the HBV 11-12 meganuclease search. The software developed checks each sequence to make sure there is adapter and captured oligo flanking the sequence to verify that it is a valid read. The software also checks for PCR duplicates and removes reads that are identical to help reduce PCR bias. The sequence reads are aligned to a reference genome and grouped sequences within thousand base pair windows are scanned for a potential HBV 11-12 meganuclease site.</div>
    </li> <li> <para-num num="[0355]"> </para-num> <div id="p-0361" num="0355" class="description-line">Each HBV 11-12 meganuclease is a linked dimer. Each monomer recognizes a nine base pair half site with a four base pair spacer in the center between the two half sites. The software looks for the closest sequence match for each half site with no allowed gaps. The middle four base pairs are not considered in the off-target selection because the HBV 11-12 meganucleases can generally tolerate a higher amount of degeneracy at these positions in the target site. The software outputs a list of potential off-target sites with the number of base mismatches in the combined half sites but not counting the middle four base pair mismatches. The software does not eliminate any off-targets based on an arbitrary mismatch filter, unlike CRISPR-Cas9 which eliminates any off-target identified with more than six base pairs mismatched. Instead, background noise generated from random capture of the oligo at fragile spots or hot spots within the genome can be reduced in two ways. First, an untreated mock sample is also run though oligo capture and windows of integration sites without the nuclease present can be subtracted from the nuclease containing samples. We have also found that running the assay in triplicate and eliminating any sites that do not repeat in at least two of the three repeats is a good way to empirically remove random integration noise.</div>
    </li> <li> <para-num num="[0356]"> </para-num> <div id="p-0362" num="0356" class="description-line">Although read count does not directly correlate with cutting frequency at a particular site, it can generally highlight off-targets that are potentially more concerning or more valid because they occur more often. One way to graphically visualize the oligo capture data as a measure of number of potentially valid off-target sites is shown in <figref idrefs="DRAWINGS">FIG. 11</figref>. Each off-target generated by a particular nuclease is plotted based on the number of unique sequence reads aligned at that site. The number of base pair mismatches between the putative off-target site and the intended site are indicated by color scale with darker colors indicating sites that are more similar to the intended target site. For a nuclease with high-specificity, the intended site should have the highest read count. Better nucleases remove both the higher count sites (to the right of the graph) and the sites with high similarity (darker colored points).</div>
    </li> <li> <para-num num="[0357]"> </para-num> <div id="p-0363" num="0357" class="description-line">In <figref idrefs="DRAWINGS">FIG. 11</figref>, which was generated in the HepG2 cell line lacking the HBV 11-12 recognition sequence, each of the optimized meganucleases lacked the higher read count off-targets and reduced the number of high similarity off-targets observed for the first-generation HBV 11-12x.26 meganuclease. The HBV 11-12L.363 and HBV 11-12L.367 meganucleases, exhibited further improvements over the earlier generation HBV 11-12L.118 meganuclease. However, because oligo capture provides a relative activity of a nuclease to target sites within a sample, it is difficult to determine the extent to which these off-targets are cut without an on-target intended site for comparison.</div>
    </li> <li> <para-num num="[0358]"> </para-num> <div id="p-0364" num="0358" class="description-line">In <figref idrefs="DRAWINGS">FIG. 12</figref>, HBV 11-12x.26 and HBV 11-12L.363 were compared in the HepG2 HepB cell line, which comprises a partial HBV genome including the HBV 11-12 recognition sequence. While the number of reads aligned at the intended site cannot be compared between samples as a measure of total activity at the intended site, the distance between the points indicating the intended site (circled) and the points indicating off-target sites can be compared. The far larger distance between the intended site and the off-target sites for HBV 11-12L.363 than that of HBV 11-12x.26 indicates a large increase in the specificity of the enzyme and a large decrease in cleavage of off-target sites both in number of sites and percentage cleaved.</div>
    </li> <li> <para-num num="[0359]"> </para-num> <div id="p-0365" num="0359" class="description-line">In summary, the optimized meganucleases, and particularly HBV 11-12L.363 and HBV 11-12L.367, showed clear superiority in specificity over the parental HBV 11-12x.26 as determined by oligo capture. All three optimized enzymes showed a significant reduction in both highly similar, less frequently cleaved sites, and less similar, more frequently cut sites. Further analysis of HBV 11-12L.363 demonstrated a large increase in the ratio of cleavage activity at the intended site to cleavage activity at off-target sites compared to HBV 11-12x.26.</div>
    </li> <heading id="h-0062">Example 2</heading>
    <heading id="h-0063">Generation of Indels at Recognition Sequence In Vitro</heading>
    <li> <para-num num="[0360]"> </para-num> <div id="p-0366" num="0360" class="description-line">Studies were conducted to evaluate the efficacy of HBV 11-12 meganucleases for causing insertions and/or deletions (indels) at their intended recognition sequence (i.e., the HBV 11-12 recognition sequence). Indel formation was detected in these experiments by either a T7 endonuclease I (T7E) digest or digital PCR analysis.</div>
    </li> <li> <para-num num="[0361]"> </para-num> <div id="p-0367" num="0361" class="description-line">In these experiments, a HepG2 cell line (HepG2 HepB) was generated by Precision BioSciences to stably express one copy (as determined by digital PCR) of a 1500 bp region of the Hepatitis B genome including the HBV 11-12 meganuclease target site. HepG2 HepB (510<sup>5</sup>) cells were transfected with mRNA (1 g) encoding HBV 11-12L.26, HBV 11-12L.188, HBV 11-12L.363, HBV 11-12L.367, and HBV 11-12x.26, respectively, using the ThermoFisher Neon Transfection System according to the manufacturer&#39;s protocol. At two days post-transfection, genomic DNA was isolated from cells for analysis of indel formation by T7E and digital PCR. Genomic DNA from mock transfected HepG2 HepB cells was used as a control.</div>
    </li> <li> <para-num num="[0362]"> </para-num> <div id="p-0368" num="0362" class="description-line">For T7E analysis, genomic DNA was PCR amplified using P1 and P2 primers:</div>
    </li> <li> <div id="p-0369" num="0000" class="description-line">
      <tables id="TABLE-US-00003" num="00003">
        <patent-tables frame="none" colsep="0" rowsep="0" tabstyle="monospace">
          <table align="left" colsep="0" rowsep="0" cols="2" class="description-table" width="100%">
            <tbody><tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">P1:</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">(SEQIDNO:25)</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">[5-gccatttttcataagtgttaacttccgctcctc-3]</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">P2:</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">(SEQIDNO:26)</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">[5-cgtgcagtcactatggatcaactacttagatg-3]</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    </li> <li> <para-num num="[0363]"> </para-num> <div id="p-0370" num="0363" class="description-line">Amplification was confirmed by visualization of a 1650 bp band on an agarose gel. PCR-amplified DNA was denatured and slowly rehybridized to allow formation of heteroduplex DNA sequences and then digested with T7 endonuclease I. Digestion products were visualized on an agarose gel.</div>
    </li> <li> <para-num num="[0364]"> </para-num> <div id="p-0371" num="0364" class="description-line">While mock-transfected cells yielded a single band at 1650 bp, transfection with HBV 11-12L.26, HBV 11-12L.188, HBV 11-12L.363, HBV 11-12L.367 and HBV 11-12x.26, respectively, yielded two lower molecular weight bands at 600 bp and 1050 bp after T7E digestion, indicating successful gene editing (<figref idrefs="DRAWINGS">FIG. 13</figref>). Surprisingly, the increased intensity of the lower bands in HBV 11-12L.363 compared to the first-generation HBV 11-12x.26 indicates that a higher efficiency of gene editing at the target site was achieved.</div>
    </li> <li> <para-num num="[0365]"> </para-num> <div id="p-0372" num="0365" class="description-line">Digital PCR was performed using the QX200 droplet digital PCR system to quantify indel formation in HepG2 HepB cells after meganuclease transfection. A FAM-tagged TaqMan probe (T1) was designed to recognize the HBV 11-12 meganuclease target site, as well as a HEX-tagged TaqMan probe (T2) that binds genomic sequence 100 bp downstream of the target site, intended to serve as a reference probe. The probes were multiplexed for genomic DNA amplification using primers P3 and P4. Droplets were gated by fluorescence amplitude to indicate double-positive, double-negative, and single-positive populations. Indels were calculated as the number of HEX-positive droplets divided by the number of double-positive (FAM+/HEX+) droplets.</div>
    </li> <li> <div id="p-0373" num="0000" class="description-line">
      <tables id="TABLE-US-00004" num="00004">
        <patent-tables frame="none" colsep="0" rowsep="0" tabstyle="monospace">
          <table align="left" colsep="0" rowsep="0" cols="2" class="description-table" width="100%">
            <tbody><tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">P3:</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">(SEQIDNO:27)</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">[5-ggtctgtgccaagtgtttg-3]</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">P4:</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">(SEQIDNO:28)</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">[5-gtagacaaaggacgttccg-3]</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">T1:</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">(SEQIDNO:29)</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">[5-tgccgatccatactgcggaact-3]</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">T2:</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">(SEQIDNO:30)</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">[5-cacagcctagcagccatggaaac-3]</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    </li> <li> <para-num num="[0366]"> </para-num> <div id="p-0374" num="0366" class="description-line">Genomic DNA from cells treated with HBV 11-12 meganucleases showed 11-27% gene editing at the recognition site (<figref idrefs="DRAWINGS">FIG. 14</figref>). In agreement with the T7E data, genomic DNA from HBV 11-12L.363-treated cells advantageously yielded the highest efficiency of indel formation at 27%, while the first-generation HBV 11-12x.26 produced 13% indel formation, suggesting enhanced (i.e., increased) activity of the optimized HBV 11-12L.363 meganuclease.</div>
    </li> <li> <para-num num="[0367]"> </para-num> <div id="p-0375" num="0367" class="description-line">Together, these data indicate an ability of HBV 11-12 meganucleases to achieve 11-27% indel formation at their recognition site. Furthermore, HBV 11-12L.363 shows enhanced (i.e., increased) activity for indel formation compared to the first-generation HBV 11-12x.26 meganuclease.</div>
    </li> <heading id="h-0064">Example 3</heading>
    <heading id="h-0065">Indel Frequency in HepG2 HepB Cells after Electroporation with HBV 11-12 mRNA</heading>
    <li> <para-num num="[0368]"> </para-num> <div id="p-0376" num="0368" class="description-line">Further studies were conducted to evaluate the production of indels in HepG2 HepB cells following transfection with mRNA encoding the HBV 11-12x.26 or HBV 11-12L.363 meganucleases. HepG2 HepB cells described in Example 2 were electroporated with meganuclease-encoding mRNA according to the same protocols as above. In this experiment, two different mRNA batches encoding the HBV 11-12L.363 meganucleases were evaluated. Cells were electroporated with mRNA encoding either HBV 11-12x.26 (3605), a previously prepared batch of mRNA encoding HBV 11-12L.363 (3129), or a new batch of mRNA encoding HBV 11-12L.363 (3606). An mRNA encoding GFP was also electroporated into cells to serve as a transfection control. GFP-transfected cells were analyzed by flow cytometry, and transfection efficiency exceeded 90%. Cells were collected at 2 days and 6 days post-transfection, and subjected to gDNA isolation and ddPCR analysis as previously described in Example 2. Indel frequency was determined from ddPCR analysis.</div>
    </li> <li> <para-num num="[0369]"> </para-num> <div id="p-0377" num="0369" class="description-line">Data obtained from ddPCR demonstrated that HBV 11-12L.363, which was optimized from HBV 11-12x.26, shows 20<figure-callout id="2" label="% indels" filenames="US20190338263A1-20191107-D00001.png,US20190338263A1-20191107-D00007.png" state="{{state}}">% indels</figure-callout> 2 days post-transfection, and 33% indels at 6 days post-transfection (<figref idrefs="DRAWINGS">FIG. 15</figref>). Two batches of mRNA encoding HBV 11-12L.363 (3129 and 3606) were tested and showed consistent levels of indel formation. Each of these were superior to the level of indel formation observed using HBV 11-12x.26, which showed 10% and 15% indels at 2 days and 6 days post-transfection, respectively.</div>
    </li> <li> <para-num num="[0370]"> </para-num> <div id="p-0378" num="0370" class="description-line">Together these data suggest that the HBV 11-12L.363 nuclease is significantly more active in producing indels at the HBV 11-12 recognition sequence than the previous generation nuclease, HBV 11-12x.26. Furthermore, consistent levels of indels were observed between mRNA batches of HBV 11-12L.363.</div>
    </li> <heading id="h-0066">Example 4</heading>
    <heading id="h-0067">In Vitro Antiviral Evaluation of HBV 11-12L.363 in HBV-Integrated HepAD38 Cells by mRNA Expression</heading>
    <li> <para-num num="[0371]"> </para-num> <div id="p-0379" num="0371" class="description-line">Studies were conducted to evaluate the antiviral activities of HBV 11-12 meganuclease and efficacy for insertions and/or deletions (indels) at their intended recognition sequence in HBV-integrated HepAD38 cells. Antiviral activity, secreted HBs antigen was measured by Hepatitis B Surface Antigen Chemiluminescence Immunoassay (CLIA) kit. Indel formation was detected by GeneART Genomic Cleavage Detection kit.</div>
    </li> <li> <para-num num="[0372]"> </para-num> <div id="p-0380" num="0372" class="description-line">In this study, a HepAD38 cell line which expresses wild-type HBV, subtype ayw (Ladner, S K et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. <i>Antimicrobial agents and chemotherapyvol. </i>41, 8 (1997): 1715-20.) was maintained in Dulbecco&#39;s modified Eagle&#39;s/F12 medium (DMEM/F12; Thermo Fisher) supplemented with 2% fetal bovine serum, 500 g/ml of Penicillin-Streptomycin-Glutamine, 0.3 g/ml tetracycline, 10 mM HEPES, 1MEM Non-Essential Amino Acids and 1% Dimethyl sulfoxide at 37 C. and 5% carbon dioxide. HepAD38 (1.510{circumflex over ()}6) cells were transfected with mRNA (3 ug) encoding HBV 11-12L.363, HBV 11-12x.26 and mCherry (TriLink), respectively, by using the Lipofectamine MessengerMAX (Thermo Fisher), TranslT-mRNA (Mirus), and jetMESSENGER (Polyplus) according to the manufacturer&#39;s instructions.</div>
    </li> <li> <para-num num="[0373]"> </para-num> <div id="p-0381" num="0373" class="description-line">HepAD38 (1.510{circumflex over ()}6) cells were also transfected with mRNA (3 ug) formulated in lipid nanoparticles (LNPs). The lipid materials used for the formulation of LNPs consisted of Dlin-MC3-DMA, Cholesterol, DSPC, and DMG-PEG dissolved at a 50:38.5:10:1.5 molar ratio in ethanol at a total lipid concentration of 30 mM (N:P=8). The mix of lipids was stored at 80C and thawed by heating to 50 C. in heat block. Lipid mix was taken off heat and vortexed immediately before use in formulation. mRNA was stored at 80 C. and thawed at room temperature. Once thawed, the mRNA was diluted to 0.2 mg/mL in a 50 mM citrate buffer at pH=4.0. Microfluidic mixing of the mRNA and lipid solutions at a 3:1 ratio via Precision Nanosystems benchtop nanoassembler was performed. Crude solution was transferred to dialysis membrane and placed in 200 volume of PBS, pH=7.4, overnight. Final solution was collected from dialysis membrane and analyzed for physical characteristics such as size, PDI, and zeta potential, as well as for encapsulation efficiency. LNP transfection was performed with or without apolipoprotein E (1 g/mL).</div>
    </li> <li> <para-num num="[0374]"> </para-num> <div id="p-0382" num="0374" class="description-line">The mRNA materials encoding the HBV 11-12L.363, HBV 11-12x.26 nucleases comprised a clean cap structure (Trilink) with a uridine substitution to N1-methyl-pseudouridine.</div>
    </li> <li> <para-num num="[0375]"> </para-num> <div id="p-0383" num="0375" class="description-line">At <figure-callout id="4" label="day" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">day</figure-callout> 4 and <figure-callout id="6" label="day" filenames="US20190338263A1-20191107-D00007.png,US20190338263A1-20191107-D00008.png" state="{{state}}">day</figure-callout> 6 post-transfection, supernatant was collected for measuring secreted HBs antigen by CLIA assay (AutoBio). To determine the percentage of HBs antigen reduction, mCherry transfected in HepAD38 cells was used as 100% control.</div>
    </li> <li> <para-num num="[0376]"> </para-num> <div id="p-0384" num="0376" class="description-line">Through mRNA expression, both HBV 11-12L.363 and HBV 11-12x.26 showed similar antiviral activity, reducing 50% secreted HBs antigen. Four-day post-transfection had a higher effect than that of six-day post-transfection (<figref idrefs="DRAWINGS">FIG. 16</figref>).</div>
    </li> <li> <para-num num="[0377]"> </para-num> <div id="p-0385" num="0377" class="description-line">At six-day post-transfection, genomic DNA was isolated from cells for analysis of indel formation by GeneART Genomic Cleavage Detection Kit (Thermo Fisher). Genomic DNA from mCherry transfected in HepAD38 cells was used as a control.</div>
    </li> <li> <para-num num="[0378]"> </para-num> <div id="p-0386" num="0378" class="description-line">For Genomic Cleavage Detection assay, genomic DNA was PCR amplified using AD38-F1012 and AD38-R1479 primers:</div>
    </li> <li> <div id="p-0387" num="0000" class="description-line">
      <tables id="TABLE-US-00005" num="00005">
        <patent-tables frame="none" colsep="0" rowsep="0" tabstyle="monospace">
          <table align="left" colsep="0" rowsep="0" cols="2" class="description-table" width="100%">
            <tbody><tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">AD38-F1012:</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">(SEQIDNO:31)</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">[5-GGTTTTGCTGCCCCATTTACA-3]</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td"> </td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">AD38-R1479:</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">(SEQIDNO:32)</td>
              </tr>
              <tr class="description-tr">
                <td class="description-td"> </td>
                <td class="description-td">[5-TCCCAAGCGACCCCGAGAAG-3]</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    </li> <li> <para-num num="[0379]"> </para-num> <div id="p-0388" num="0379" class="description-line">Amplification was confirmed by the visualization of a 467 bp band on an agarose gel. PCR-amplified DNA was analyzed in the cleavage assay according to the manufacture&#39;s protocol. Digestion products were visualized on an agarose gel.</div>
    </li> <li> <para-num num="[0380]"> </para-num> <div id="p-0389" num="0380" class="description-line">While mCherry-transfected cells yielded a single band at 467 bp, transfected with HBV 11-12L.363 and HBV 11-12x.26, respectively, yielded two lower molecular weight bands at 267 bp and 200 bp after Detection Enzyme digestion, indicating successful gene editing (<figref idrefs="DRAWINGS">FIG. 17</figref>). Comparing HBV 11-12L.363 with the first-generation HBV 11-12x.26, the increased intensity of lower bands indicates the higher efficiency of gene editing at the target site was achieved.</div>
    </li> <li> <para-num num="[0381]"> </para-num> <div id="p-0390" num="0381" class="description-line">Overall, HBV 11-12L.363 showed similar antiviral activities as HBV 11-12x.26 in HBV-integrated HepAD38 cells by mRNA expression. Both HBV 11-12 meganuclease were capable of reducing 50% HBs antigen secretion and achieving significant indels. Although the antiviral activity observed in these studies is lower than reductions observed in previous lentiviral studies with HBV 11-12x.26, these differences could be attributed to lower delivery efficiency of mRNA transfection vs 100% lentiviral transduction, transient mRNA expression having shorter kinetics than persistent lentiviral expression, in addition to suboptimal timing and assay sensitivity for gene editing efficiency assessment.</div>
    
  </li> </ul>
  </div>
  </section>

  <section itemprop="claims" itemscope>
    <h2>Claims (<span itemprop="count">32</span>)</h2>
    
    <div itemprop="content" html><div mxw-id="PCLM215120561" lang="EN" load-source="patent-office" class="claims">
    <div class="claim"> <div id="CLM-00001" num="00001" class="claim">
      <div class="claim-text"> <b>1</b>. An engineered meganuclease that recognizes and cleaves a recognition sequence consisting of SEQ ID NO: 10 within a Hepatitis B virus genome, wherein said engineered meganuclease comprises a first subunit and a second subunit, wherein said first subunit binds to a first recognition half-site of said recognition sequence and comprises:
<div class="claim-text">(a) an amino acid sequence having at least 95% sequence identity to residues 198-344 of SEQ ID NO: 12 or 13; and</div> <div class="claim-text">(b) a first hypervariable (HVR1) region, wherein said HVR1 region has at least 95% sequence identity to an amino acid sequence corresponding to residues 215-270 of SEQ ID NO: 12 or 13;</div> <div class="claim-text">and wherein said second subunit binds to a second recognition half-site of said recognition sequence and comprises:</div> <div class="claim-text">(i) an amino acid sequence having at least 95% sequence identity to residues 7-153 of SEQ ID NO: 12 or 13; and</div> <div class="claim-text">(ii) a second hypervariable (HVR2) region, wherein said HVR2 region has at least 95% sequence identity to an amino acid sequence corresponding to residues 24-79 of SEQ ID NO: 12 or 13.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00002" num="00002" class="claim">
      <div class="claim-text"> <b>2</b>. The engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said HVR1 region comprises residues corresponding to residues 215, 217, 219, 221, 223, 224, 229, 231, 233, 235, 237, 259, 261, 266, and 268 of SEQ ID NO: 12 or 13.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00003" num="00003" class="claim">
      <div class="claim-text"> <b>3</b>. The engineered meganuclease of <claim-ref idref="CLM-00002">claim 2</claim-ref>, wherein said HVR1 region comprises residues corresponding to residues 239, 241, 263, and 264 of SEQ ID NO: 12.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00004" num="00004" class="claim">
      <div class="claim-text"> <b>4</b>. The engineered meganuclease of <claim-ref idref="CLM-00002">claim 2</claim-ref>, wherein said HVR1 region comprises residues corresponding to residues 241, 262, 263, and 264 of SEQ ID NO: 13.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-005-6" num="005-6" class="claim">
      <div class="claim-text"> <b>5</b>.-<b>6</b>. (canceled)</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00007" num="00007" class="claim">
      <div class="claim-text"> <b>7</b>. The engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said HVR1 region comprises residues 215-270 of SEQ ID NO: 12 or 13.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-08-11" num="08-11" class="claim">
      <div class="claim-text"> <b>8</b>.-<b>11</b>. (canceled)</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00012" num="00012" class="claim">
      <div class="claim-text"> <b>12</b>. The engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said first subunit comprises a residue corresponding to residue 271 of SEQ ID NO: 12 or 13.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00013" num="00013" class="claim">
      <div class="claim-text"> <b>13</b>. The engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said first subunit comprises residues 198-344 of SEQ ID NO: 12 or 13.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-00014" num="00014" class="claim">
      <div class="claim-text"> <b>14</b>. (canceled)</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00015" num="00015" class="claim">
      <div class="claim-text"> <b>15</b>. The engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said HVR2 region comprises residues corresponding to residues 24, 26, 28, 30, 32, 33, 38, 40, 42, 44, 46, 68, 70, 75, and 77 of SEQ ID NO: 12 or 13.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-00016" num="00016" class="claim">
      <div class="claim-text"> <b>16</b>. (canceled)</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00017" num="00017" class="claim">
      <div class="claim-text"> <b>17</b>. The engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said HVR2 region comprises residues 24-79 of SEQ ID NO: 12 or 13.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-18-20" num="18-20" class="claim">
      <div class="claim-text"> <b>18</b>.-<b>20</b>. (canceled)</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00021" num="00021" class="claim">
      <div class="claim-text"> <b>21</b>. The engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said second subunit comprises a residue corresponding to residue 80 of SEQ ID NO: 12 or 13.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00022" num="00022" class="claim">
      <div class="claim-text"> <b>22</b>. The engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said second subunit comprises residues 7-153 of SEQ ID NO: 12 or 13.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00023" num="00023" class="claim">
      <div class="claim-text"> <b>23</b>. The engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said engineered meganuclease comprises a linker, wherein said linker covalently joins said first subunit and said second subunit.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00024" num="00024" class="claim">
      <div class="claim-text"> <b>24</b>. The engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said engineered meganuclease comprises the amino acid sequence of SEQ ID NO: 12 or 13.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00025" num="00025" class="claim">
      <div class="claim-text"> <b>25</b>. The engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said engineered meganuclease exhibits at least one of the following optimized characteristics as compared to the HBV 11-12x.26 meganuclease set forth as SEQ ID NO: 14: improved specificity, enhanced efficiency of cleavage, and enhanced efficiency of indel formation.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00026" num="00026" class="claim">
      <div class="claim-text"> <b>26</b>. A polynucleotide comprising a nucleic acid sequence encoding said engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00027" num="00027" class="claim">
      <div class="claim-text"> <b>27</b>. The polynucleotide of <claim-ref idref="CLM-00026">claim 26</claim-ref>, wherein said polynucleotide is an mRNA.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-28-30" num="28-30" class="claim">
      <div class="claim-text"> <b>28</b>.-<b>30</b>. (canceled)</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00031" num="00031" class="claim">
      <div class="claim-text"> <b>31</b>. A recombinant DNA construct comprising said polynucleotide of <claim-ref idref="CLM-00026">claim 26</claim-ref>.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-32-37" num="32-37" class="claim">
      <div class="claim-text"> <b>32</b>.-<b>37</b>. (canceled)</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00038" num="00038" class="claim">
      <div class="claim-text"> <b>38</b>. A viral vector comprising a nucleic acid sequence encoding said engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-39-43" num="39-43" class="claim">
      <div class="claim-text"> <b>39</b>.-<b>43</b>. (canceled)</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00044" num="00044" class="claim">
      <div class="claim-text"> <b>44</b>. A pharmaceutical composition for treatment of a subject having Hepatitis B virus or hepatocellular carcinoma caused by Hepatitis B virus, said pharmaceutical composition comprising a pharmaceutically acceptable carrier and:
<div class="claim-text">(a) a nucleic acid encoding said engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>; or</div> <div class="claim-text">(b) said engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>.</div> </div>
    </div>
    </div> <div class="claim"> <div id="CLM-45-51" num="45-51" class="claim">
      <div class="claim-text"> <b>45</b>.-<b>51</b>. (canceled)</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00052" num="00052" class="claim">
      <div class="claim-text"> <b>52</b>. A lipid nanoparticle or lipid nanoparticle formulation comprising said mRNA of <claim-ref idref="CLM-00027">claim 27</claim-ref>.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00053" num="00053" class="claim">
      <div class="claim-text"> <b>53</b>. A method for treating a subject having Hepatitis B virus or hepatocellular carcinoma caused by Hepatitis B virus, said method comprising delivering to a target cell in said subject:
<div class="claim-text">(a) a therapeutically effective amount of a nucleic acid encoding said engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said engineered meganuclease is expressed in said target cell in vivo; or</div> <div class="claim-text">(b) a therapeutically effective amount of said engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>;</div> <div class="claim-text">wherein said engineered meganuclease recognizes and cleaves said recognition sequence consisting of SEQ ID NO: 10 within the Hepatitis B virus genome, and wherein the infection and/or proliferation of said Hepatitis B virus in said subject is reduced or eliminated.</div> </div>
    </div>
    </div> <div class="claim"> <div id="CLM-54-57" num="54-57" class="claim">
      <div class="claim-text"> <b>54</b>.-<b>57</b>. (canceled)</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00058" num="00058" class="claim">
      <div class="claim-text"> <b>58</b>. The engineered meganuclease of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said engineered meganuclease comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 12 or 13.</div>
    </div>
  </div> </div>
  </div>
  </section>

  <section itemprop="application" itemscope>

    <section itemprop="metadata" itemscope>
      <span itemprop="applicationNumber">US16/381,668</span>
      <span itemprop="priorityDate">2018-04-12</span>
      <span itemprop="filingDate">2019-04-11</span>
      <span itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </span>
      <span itemprop="ifiStatus">Active</span>
      <span itemprop="ifiExpiration">2039-07-31</span>
      <a href="/patent/US11142750B2/en">
        <span itemprop="representativePublication">US11142750B2</span>
        (<span itemprop="primaryLanguage">en</span>)
      </a>
    </section>

    <h2>Priority Applications (4)</h2>
    <table>
      <thead>
        <tr>
          <th>Application Number</th>
          <th>Priority Date</th>
          <th>Filing Date</th>
          <th>Title</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="priorityApps" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US16/381,668</span>
            
            <a href="/patent/US11142750B2/en">
              <span itemprop="representativePublication">US11142750B2</span>
                (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2019-04-11</td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
        </tr>
        <tr itemprop="priorityApps" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US17/479,173</span>
            
            <a href="/patent/US11788077B2/en">
              <span itemprop="representativePublication">US11788077B2</span>
                (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2021-09-20</td>
          <td itemprop="title">Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
        </tr>
        <tr itemprop="priorityApps" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US18/465,727</span>
            
            <a href="/patent/US20240035011A1/en">
              <span itemprop="representativePublication">US20240035011A1</span>
                (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2023-09-12</td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
     </td>
        </tr>
        <tr itemprop="priorityApps" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US19/029,554</span>
            
            <a href="/patent/US20250171757A1/en">
              <span itemprop="representativePublication">US20250171757A1</span>
                (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2025-01-17</td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
     </td>
        </tr>
      </tbody>
    </table>

    <h2>Applications Claiming Priority (2)</h2>
    <table>
      <thead>
        <tr>
          <th>Application Number</th>
          <th>Priority Date</th>
          <th>Filing Date</th>
          <th>Title</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="appsClaimingPriority" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US201862656831P</span>
            
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2018-04-12</td>
          <td itemprop="title"></td>
        </tr>
        <tr itemprop="appsClaimingPriority" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US16/381,668</span>
            <a href="/patent/US11142750B2/en">
              <span itemprop="representativePublication">US11142750B2</span>
                (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2019-04-11</td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
        </tr>
      </tbody>
    </table>

    

    <h2>Related Child Applications (1)</h2>
    <table>
      <thead>
        <tr>
          <th>Application Number</th>
          <th>Title</th>
          <th>Priority Date</th>
          <th>Filing Date</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="childApps" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US17/479,173</span>
            <span itemprop="relationType">Division</span>
            <a href="/patent/US11788077B2/en">
              <span itemprop="representativePublication">US11788077B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2021-09-20</td>
          <td itemprop="title">Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
        </tr>
      </tbody>
    </table>

    <h2>Publications (2)</h2>
    <table>
      <thead>
        <tr>
          <th>Publication Number</th>
          <th>Publication Date</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="pubs" itemscope repeat>
          <td>
            <span itemprop="publicationNumber">US20190338263A1</span>
            
            <span itemprop="thisPatent">true</span>
            <a href="/patent/US20190338263A1/en">
              US20190338263A1
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="publicationDate">2019-11-07</td>
        </tr>
        <tr itemprop="pubs" itemscope repeat>
          <td>
            <span itemprop="publicationNumber">US11142750B2</span>
            
            <a href="/patent/US11142750B2/en">
              US11142750B2
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="publicationDate">2021-10-12</td>
        </tr>
      </tbody>
    </table>

  </section>

  <section itemprop="family" itemscope>
    <h1>Family</h1>
    <h2>ID=66597642</h2>

    <h2>Family Applications (4)</h2>
    <table>
      <thead>
        <tr>
          <th>Application Number</th>
          <th>Title</th>
          <th>Priority Date</th>
          <th>Filing Date</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="applications" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US16/381,668</span>
            <span itemprop="ifiStatus">Active</span>
            <span itemprop="ifiExpiration">2039-07-31</span>
            <a href="/patent/US11142750B2/en">
              <span itemprop="representativePublication">US11142750B2</span>
                (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2019-04-11</td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
        </tr>
        <tr itemprop="applications" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US17/479,173</span>
            <span itemprop="ifiStatus">Active</span>
            
            <a href="/patent/US11788077B2/en">
              <span itemprop="representativePublication">US11788077B2</span>
                (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2021-09-20</td>
          <td itemprop="title">Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
        </tr>
        <tr itemprop="applications" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US18/465,727</span>
            <span itemprop="ifiStatus">Abandoned</span>
            
            <a href="/patent/US20240035011A1/en">
              <span itemprop="representativePublication">US20240035011A1</span>
                (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2023-09-12</td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
     </td>
        </tr>
        <tr itemprop="applications" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US19/029,554</span>
            <span itemprop="ifiStatus">Pending</span>
            
            <a href="/patent/US20250171757A1/en">
              <span itemprop="representativePublication">US20250171757A1</span>
                (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2025-01-17</td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
     </td>
        </tr>
      </tbody>
    </table>

    

    <h2>Family Applications After (3)</h2>
    <table>
      <thead>
        <tr>
          <th>Application Number</th>
          <th>Title</th>
          <th>Priority Date</th>
          <th>Filing Date</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="afterApplications" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US17/479,173</span>
            <span itemprop="ifiStatus">Active</span>
            
            <a href="/patent/US11788077B2/en">
                <span itemprop="representativePublication">US11788077B2</span>
                  (<span itemprop="primaryLanguage">en</span>)
              </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2021-09-20</td>
          <td itemprop="title">Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
        </tr>
        <tr itemprop="afterApplications" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US18/465,727</span>
            <span itemprop="ifiStatus">Abandoned</span>
            
            <a href="/patent/US20240035011A1/en">
                <span itemprop="representativePublication">US20240035011A1</span>
                  (<span itemprop="primaryLanguage">en</span>)
              </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2023-09-12</td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
     </td>
        </tr>
        <tr itemprop="afterApplications" itemscope repeat>
          <td>
            <span itemprop="applicationNumber">US19/029,554</span>
            <span itemprop="ifiStatus">Pending</span>
            
            <a href="/patent/US20250171757A1/en">
                <span itemprop="representativePublication">US20250171757A1</span>
                  (<span itemprop="primaryLanguage">en</span>)
              </a>
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="filingDate">2025-01-17</td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
     </td>
        </tr>
      </tbody>
    </table>

    <h2>Country Status (5)</h2>
    <table>
      <thead>
        <tr>
          <th>Country</th>
          <th>Link</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="countryStatus" itemscope repeat>
          <td>
            <span itemprop="countryCode">US</span>
            (<span itemprop="num">4</span>)
            <meta itemprop="thisCountry" content="true">
          </td>
          <td>
            <a href="/patent/US11142750B2/en">
              <span itemprop="representativePublication">US11142750B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
        </tr>
        <tr itemprop="countryStatus" itemscope repeat>
          <td>
            <span itemprop="countryCode">EP</span>
            (<span itemprop="num">1</span>)
            
          </td>
          <td>
            <a href="/patent/EP3775187A1/en">
              <span itemprop="representativePublication">EP3775187A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
        </tr>
        <tr itemprop="countryStatus" itemscope repeat>
          <td>
            <span itemprop="countryCode">AR</span>
            (<span itemprop="num">1</span>)
            
          </td>
          <td>
            <a href="/patent/AR115041A1/en">
              <span itemprop="representativePublication">AR115041A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
        </tr>
        <tr itemprop="countryStatus" itemscope repeat>
          <td>
            <span itemprop="countryCode">TW</span>
            (<span itemprop="num">1</span>)
            
          </td>
          <td>
            <a href="/patent/TW201945388A/en">
              <span itemprop="representativePublication">TW201945388A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
        </tr>
        <tr itemprop="countryStatus" itemscope repeat>
          <td>
            <span itemprop="countryCode">WO</span>
            (<span itemprop="num">1</span>)
            
          </td>
          <td>
            <a href="/patent/WO2019200247A1/en">
              <span itemprop="representativePublication">WO2019200247A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
        </tr>
      </tbody>
    </table>

    <h2>Cited By (12)</h2>
    <table>
      <caption>* Cited by examiner,  Cited by third party</caption>
      <thead>
        <tr>
          <th>Publication number</th>
          <th>Priority date</th>
          <th>Publication date</th>
          <th>Assignee</th>
          <th>Title</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="forwardReferencesOrig" itemscope repeat>
          <td>
            <a href="/patent/WO2021067181A1/en">
              <span itemprop="publicationNumber">WO2021067181A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2019-09-30</td>
          <td itemprop="publicationDate">2021-04-08</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
          <td itemprop="title">Hbv vaccines and methods treating hbv 
       </td>
        </tr>
        <tr itemprop="forwardReferencesOrig" itemscope repeat>
          <td>
            <a href="/patent/WO2021188959A1/en">
              <span itemprop="publicationNumber">WO2021188959A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2020-03-20</td>
          <td itemprop="publicationDate">2021-09-23</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
          <td itemprop="title">Prodrugs of 4&#39;-c-substituted-2-halo-2&#39;-deoxyadenosine nucleosides and methods of making and using the same 
       </td>
        </tr>
        <tr itemprop="forwardReferencesOrig" itemscope repeat>
          <td>
            <a href="/patent/US11142750B2/en">
              <span itemprop="publicationNumber">US11142750B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="publicationDate">2021-10-12</td>
          <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
        </tr>
        <tr itemprop="forwardReferencesOrig" itemscope repeat>
          <td>
            <a href="/patent/US11274285B2/en">
              <span itemprop="publicationNumber">US11274285B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-10-14</td>
          <td itemprop="publicationDate">2022-03-15</td>
          <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
          <td itemprop="title">Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome 
       </td>
        </tr>
        <tr itemprop="forwardReferencesOrig" itemscope repeat>
          <td>
            <a href="/patent/WO2022087149A2/en">
              <span itemprop="publicationNumber">WO2022087149A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2020-10-22</td>
          <td itemprop="publicationDate">2022-04-28</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
          <td itemprop="title">Interleukin-2-fc fusion proteins and methods of use 
       </td>
        </tr>
        <tr itemprop="forwardReferencesOrig" itemscope repeat>
          <td>
            <a href="/patent/WO2022241134A1/en">
              <span itemprop="publicationNumber">WO2022241134A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2021-05-13</td>
          <td itemprop="publicationDate">2022-11-17</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
          <td itemprop="title">COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS 
       </td>
        </tr>
        <tr itemprop="forwardReferencesOrig" itemscope repeat>
          <td>
            <a href="/patent/US20230031465A1/en">
              <span itemprop="publicationNumber">US20230031465A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            <span itemprop="examinerCited">*</span>
            
          </td>
          <td itemprop="priorityDate">2019-12-06</td>
          <td itemprop="publicationDate">2023-02-02</td>
          <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
       </td>
        </tr>
        <tr itemprop="forwardReferencesOrig" itemscope repeat>
          <td>
            <a href="/patent/US20250257340A1/en">
              <span itemprop="publicationNumber">US20250257340A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            <span itemprop="examinerCited">*</span>
            
          </td>
          <td itemprop="priorityDate">2022-02-23</td>
          <td itemprop="publicationDate">2025-08-14</td>
          <td><span itemprop="assigneeOriginal">Excision Biotherapeutics Inc</span></td>
          <td itemprop="title">Guide nucleic acid identification and methods of use 
       </td>
        </tr>
        <tr itemprop="forwardReferencesOrig" itemscope repeat>
          <td>
            <a href="/patent/WO2025240246A1/en">
              <span itemprop="publicationNumber">WO2025240246A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2024-05-13</td>
          <td itemprop="publicationDate">2025-11-20</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
          <td itemprop="title">Combination therapies with ribavirin 
       </td>
        </tr>
        <tr itemprop="forwardReferencesOrig" itemscope repeat>
          <td>
            <a href="/patent/WO2025240244A1/en">
              <span itemprop="publicationNumber">WO2025240244A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2024-05-13</td>
          <td itemprop="publicationDate">2025-11-20</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
          <td itemprop="title">Combination therapies comprising bulevirtide and lonafarnib for use in the treatment of hepatitis d virus infection 
       </td>
        </tr>
        <tr itemprop="forwardReferencesOrig" itemscope repeat>
          <td>
            <a href="/patent/WO2025240243A1/en">
              <span itemprop="publicationNumber">WO2025240243A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2024-05-13</td>
          <td itemprop="publicationDate">2025-11-20</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
          <td itemprop="title">Combination therapies with bulevirtide and an inhibitory nucleic acid targeting hepatitis b virus 
       </td>
        </tr>
        <tr itemprop="forwardReferencesOrig" itemscope repeat>
          <td>
            <a href="/patent/WO2025240242A1/en">
              <span itemprop="publicationNumber">WO2025240242A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2024-05-13</td>
          <td itemprop="publicationDate">2025-11-20</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
          <td itemprop="title">Combination therapies with ribavirin 
       </td>
        </tr>
      </tbody>
    </table>

    <h2>Families Citing this family (3)</h2>
    <table>
      <caption>* Cited by examiner,  Cited by third party</caption>
      <thead>
        <tr>
          <th>Publication number</th>
          <th>Priority date</th>
          <th>Publication date</th>
          <th>Assignee</th>
          <th>Title</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="forwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN120843482A/en">
              <span itemprop="publicationNumber">CN120843482A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2019-05-07</td>
          <td itemprop="publicationDate">2025-10-28</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">
        Optimization of engineered meganucleases for sequence recognition
       
       </td>
        </tr>
        <tr itemprop="forwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2021231259A1/en">
              <span itemprop="publicationNumber">WO2021231259A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2020-05-11</td>
          <td itemprop="publicationDate">2021-11-18</td>
          <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
          <td itemprop="title">Self-limiting viral vectors encoding nucleases 
       </td>
        </tr>
        <tr itemprop="forwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/AU2024270764A1/en">
              <span itemprop="publicationNumber">AU2024270764A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2023-05-15</td>
          <td itemprop="publicationDate">2025-12-04</td>
          <td><span itemprop="assigneeOriginal">Nchroma Bio, Inc.</span></td>
          <td itemprop="title">Compositions and methods for epigenetic regulation of hbv gene expression 
     </td>
        </tr>
      </tbody>
    </table>

    

    <h2>Family Cites Families (272)</h2>
    <table>
      <caption>* Cited by examiner,  Cited by third party</caption>
      <thead>
        <tr>
          <th>Publication number</th>
          <th>Priority date</th>
          <th>Publication date</th>
          <th>Assignee</th>
          <th>Title</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US4873192A/en">
              <span itemprop="publicationNumber">US4873192A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">1987-02-17</td>
          <td itemprop="publicationDate">1989-10-10</td>
          <td><span itemprop="assigneeOriginal">The United States Of America As Represented By The Department Of Health And Human Services</span></td>
          <td itemprop="title">Process for site specific mutagenesis without phenotypic selection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/DE69231693T2/en">
              <span itemprop="publicationNumber">DE69231693T2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">1991-12-23</td>
          <td itemprop="publicationDate">2001-05-31</td>
          <td><span itemprop="assigneeOriginal">Bayer Corp., East Walpole</span></td>
          <td itemprop="title">
        HBV AMPLIFICATION PROBE FOR USE IN HYBRIDIZATION SANDWICH ASSAY IN THE SOLUTION PHASE
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US6015832A/en">
              <span itemprop="publicationNumber">US6015832A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">1997-12-31</td>
          <td itemprop="publicationDate">2000-01-18</td>
          <td><span itemprop="assigneeOriginal">The Regents Of The University Of Michigan</span></td>
          <td itemprop="title">Methods of inactivating bacteria including bacterial spores 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US6506803B1/en">
              <span itemprop="publicationNumber">US6506803B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">1999-04-28</td>
          <td itemprop="publicationDate">2003-01-14</td>
          <td><span itemprop="assigneeOriginal">Regents Of The University Of Michigan</span></td>
          <td itemprop="title">Methods of preventing and treating microbial infections 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US6559189B2/en">
              <span itemprop="publicationNumber">US6559189B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">1999-04-28</td>
          <td itemprop="publicationDate">2003-05-06</td>
          <td><span itemprop="assigneeOriginal">Regents Of The University Of Michigan</span></td>
          <td itemprop="title">Non-toxic antimicrobial compositions and methods of use 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US6635676B2/en">
              <span itemprop="publicationNumber">US6635676B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">1999-04-28</td>
          <td itemprop="publicationDate">2003-10-21</td>
          <td><span itemprop="assigneeOriginal">Regents Of The University Of Michigan</span></td>
          <td itemprop="title">Non-toxic antimicrobial compositions and methods of use 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US7767216B2/en">
              <span itemprop="publicationNumber">US7767216B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">1999-04-28</td>
          <td itemprop="publicationDate">2010-08-03</td>
          <td><span itemprop="assigneeOriginal">The Regents Of The University Of Michigan</span></td>
          <td itemprop="title">Antimicrobial compositions and methods of use 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US6555674B2/en">
              <span itemprop="publicationNumber">US6555674B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2000-08-09</td>
          <td itemprop="publicationDate">2003-04-29</td>
          <td><span itemprop="assigneeOriginal">Nsgene A/S</span></td>
          <td itemprop="title">JeT promoter 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN1204248C/en">
              <span itemprop="publicationNumber">CN1204248C</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2002-02-05</td>
          <td itemprop="publicationDate">2005-06-01</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Process for preparing target ribonuclease for curing hepatitis B virus infection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US7074596B2/en">
              <span itemprop="publicationNumber">US7074596B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2002-03-25</td>
          <td itemprop="publicationDate">2006-07-11</td>
          <td><span itemprop="assigneeOriginal">Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College</span></td>
          <td itemprop="title">Synthesis and use of anti-reverse mRNA cap analogues 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US7404969B2/en">
              <span itemprop="publicationNumber">US7404969B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2005-02-14</td>
          <td itemprop="publicationDate">2008-07-29</td>
          <td><span itemprop="assigneeOriginal">Sirna Therapeutics, Inc.</span></td>
          <td itemprop="title">Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/TWI382019B/en">
              <span itemprop="publicationNumber">TWI382019B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2005-08-19</td>
          <td itemprop="publicationDate">2013-01-11</td>
          <td><span itemprop="assigneeOriginal">Array Biopharma Inc</span></td>
          <td itemprop="title">Aminodiazepines as toll-like receptor modulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/TW201402124A/en">
              <span itemprop="publicationNumber">TW201402124A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2005-08-19</td>
          <td itemprop="publicationDate">2014-01-16</td>
          <td><span itemprop="assigneeOriginal">Array Biopharma Inc</span></td>
          <td itemprop="title">8-substituted benzoazepines as toll-like receptor modulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/HUE043492T2/en">
              <span itemprop="publicationNumber">HUE043492T2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2005-08-23</td>
          <td itemprop="publicationDate">2019-08-28</td>
          <td><span itemprop="assigneeOriginal">Univ Pennsylvania</span></td>
          <td itemprop="title">
        RNAs and methods for their use containing modified nucleosides
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/ES2440801T3/en">
              <span itemprop="publicationNumber">ES2440801T3</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2005-10-18</td>
          <td itemprop="publicationDate">2014-01-30</td>
          <td><span itemprop="assigneeOriginal">Precision Biosciences</span></td>
          <td itemprop="title">
        Rationally designed meganucleases with sequence specificity and altered DNA binding affinity
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP4235837B2/en">
              <span itemprop="publicationNumber">JP4235837B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2006-04-04</td>
          <td itemprop="publicationDate">2009-03-11</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">
  Graininess prediction, profile creation and printing device
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2008005555A1/en">
              <span itemprop="publicationNumber">WO2008005555A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2006-07-07</td>
          <td itemprop="publicationDate">2008-01-10</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
          <td itemprop="title">Modulators of toll-like receptor 7 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2009001159A1/en">
              <span itemprop="publicationNumber">WO2009001159A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2007-06-25</td>
          <td itemprop="publicationDate">2008-12-31</td>
          <td><span itemprop="assigneeOriginal">Cellectis</span></td>
          <td itemprop="title">Method for enhancing the cleavage activity of i-crei derived meganucleases 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US8748373B2/en">
              <span itemprop="publicationNumber">US8748373B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2007-02-21</td>
          <td itemprop="publicationDate">2014-06-10</td>
          <td><span itemprop="assigneeOriginal">Fox Chase Cancer Center</span></td>
          <td itemprop="title">Hepatitis B virus compositions and methods of use 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EA021463B1/en">
              <span itemprop="publicationNumber">EA021463B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2007-06-29</td>
          <td itemprop="publicationDate">2015-06-30</td>
          <td><span itemprop="assigneeOriginal"> , .</span></td>
          <td itemprop="title">Purine derivatives and their use as modulators of toll-like receptor 7 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3098309B1/en">
              <span itemprop="publicationNumber">EP3098309B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2007-10-31</td>
          <td itemprop="publicationDate">2019-04-10</td>
          <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
          <td itemprop="title">Rationally-designed single-chain meganucleases with non-palindromic recognition sequences 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US20110117125A1/en">
              <span itemprop="publicationNumber">US20110117125A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2008-01-02</td>
          <td itemprop="publicationDate">2011-05-19</td>
          <td><span itemprop="assigneeOriginal">Tekmira Pharmaceuticals Corporation</span></td>
          <td itemprop="title">Compositions and methods for the delivery of nucleic acids 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/RS57132B1/en">
              <span itemprop="publicationNumber">RS57132B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2008-07-08</td>
          <td itemprop="publicationDate">2018-07-31</td>
          <td><span itemprop="assigneeOriginal">Incyte Holdings Corp</span></td>
          <td itemprop="title">1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP5600104B2/en">
              <span itemprop="publicationNumber">JP5600104B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2008-08-01</td>
          <td itemprop="publicationDate">2014-10-01</td>
          <td><span itemprop="assigneeOriginal">    </span></td>
          <td itemprop="title">
  Toll-like receptor agonist formulations and uses thereof
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/TWI534136B/en">
              <span itemprop="publicationNumber">TWI534136B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2008-12-09</td>
          <td itemprop="publicationDate">2016-05-21</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Intermediate compounds for preparation of compounds useful as modulators of toll-like receptors 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2010136841A2/en">
              <span itemprop="publicationNumber">WO2010136841A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2009-05-26</td>
          <td itemprop="publicationDate">2010-12-02</td>
          <td><span itemprop="assigneeOriginal">Cellectis</span></td>
          <td itemprop="title">Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2010136981A2/en">
              <span itemprop="publicationNumber">WO2010136981A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2009-05-26</td>
          <td itemprop="publicationDate">2010-12-02</td>
          <td><span itemprop="assigneeOriginal">Cellectis</span></td>
          <td itemprop="title">Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CA2771484C/en">
              <span itemprop="publicationNumber">CA2771484C</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2009-08-18</td>
          <td itemprop="publicationDate">2019-01-15</td>
          <td><span itemprop="assigneeOriginal">Ventirx Pharmaceuticals, Inc.</span></td>
          <td itemprop="title">Substituted benzoazepines as toll-like receptor modulators 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP5756804B2/en">
              <span itemprop="publicationNumber">JP5756804B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2009-08-18</td>
          <td itemprop="publicationDate">2015-07-29</td>
          <td><span itemprop="assigneeOriginal">   </span></td>
          <td itemprop="title">
  Substituted benzazepines as TOLL-like receptor modulators
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/AU2010310813B2/en">
              <span itemprop="publicationNumber">AU2010310813B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2009-10-22</td>
          <td itemprop="publicationDate">2015-06-18</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
          <td itemprop="title">Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2011106106A2/en">
              <span itemprop="publicationNumber">WO2011106106A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2010-02-24</td>
          <td itemprop="publicationDate">2011-09-01</td>
          <td><span itemprop="assigneeOriginal">Oryzon Genomics, S.A.</span></td>
          <td itemprop="title">Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3590938B1/en">
              <span itemprop="publicationNumber">EP3590938B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2010-05-31</td>
          <td itemprop="publicationDate">2023-05-24</td>
          <td><span itemprop="assigneeOriginal">ONO Pharmaceutical Co., Ltd.</span></td>
          <td itemprop="title">Purinone derivative as btk kinase inhibitor 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US8907053B2/en">
              <span itemprop="publicationNumber">US8907053B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2010-06-25</td>
          <td itemprop="publicationDate">2014-12-09</td>
          <td><span itemprop="assigneeOriginal">Aurigene Discovery Technologies Limited</span></td>
          <td itemprop="title">Immunosuppression modulating compounds 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/SG10201601089UA/en">
              <span itemprop="publicationNumber">SG10201601089UA</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2010-10-01</td>
          <td itemprop="publicationDate">2016-03-30</td>
          <td><span itemprop="assigneeOriginal">Ventirx Pharmaceuticals Inc</span></td>
          <td itemprop="title">Therapeutic Use Of A TLR Agonist And Combination Therapy 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/BR112013007678A2/en">
              <span itemprop="publicationNumber">BR112013007678A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2010-10-01</td>
          <td itemprop="publicationDate">2017-07-04</td>
          <td><span itemprop="assigneeOriginal">Ventirx Pharmaceuticals Inc</span></td>
          <td itemprop="title">
  method for treating allergic diseases
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/UY33775A/en">
              <span itemprop="publicationNumber">UY33775A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2010-12-10</td>
          <td itemprop="publicationDate">2012-07-31</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences Inc</span></td>
          <td itemprop="title">
  MACROCYCLIC INHIBITORS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND THEIR USES
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/PL2663550T3/en">
              <span itemprop="publicationNumber">PL2663550T3</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2011-01-12</td>
          <td itemprop="publicationDate">2017-07-31</td>
          <td><span itemprop="assigneeOriginal">Ventirx Pharmaceuticals, Inc.</span></td>
          <td itemprop="title">Substituted benzoazepines as toll-like receptor modulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/DK2663555T3/en">
              <span itemprop="publicationNumber">DK2663555T3</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2011-01-12</td>
          <td itemprop="publicationDate">2017-03-27</td>
          <td><span itemprop="assigneeOriginal">Ventirx Pharmaceuticals Inc</span></td>
          <td itemprop="title">
  SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/PH12013501683A1/en">
              <span itemprop="publicationNumber">PH12013501683A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2011-02-12</td>
          <td itemprop="publicationDate">2019-07-17</td>
          <td><span itemprop="assigneeOriginal">Globeimmune Inc</span></td>
          <td itemprop="title">Yeast-based therapeutic for chronic hepatitis b infection 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/PL3330257T3/en">
              <span itemprop="publicationNumber">PL3330257T3</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2011-04-08</td>
          <td itemprop="publicationDate">2020-06-15</td>
          <td><span itemprop="assigneeOriginal">Janssen Sciences Ireland Unlimited Company</span></td>
          <td itemprop="title">Pyrimidine derivatives for the treatment of viral infections 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/MX347966B/en">
              <span itemprop="publicationNumber">MX347966B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2011-05-18</td>
          <td itemprop="publicationDate">2017-05-18</td>
          <td><span itemprop="assigneeOriginal">Janssen Sciences Ireland Uc</span></td>
          <td itemprop="title">Quinazoline derivatives for the treatment of viral infections and further diseases. 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2012167192A2/en">
              <span itemprop="publicationNumber">WO2012167192A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2011-06-01</td>
          <td itemprop="publicationDate">2012-12-06</td>
          <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
          <td itemprop="title">Methods and products for producing engineered mammalian cell lines with amplified transgenes 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP2717895A1/en">
              <span itemprop="publicationNumber">EP2717895A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2011-06-08</td>
          <td itemprop="publicationDate">2014-04-16</td>
          <td><span itemprop="assigneeOriginal">Aurigene Discovery Technologies Limited</span></td>
          <td itemprop="title">Therapeutic compounds for immunomodulation 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/DE102011080362A1/en">
              <span itemprop="publicationNumber">DE102011080362A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2011-08-03</td>
          <td itemprop="publicationDate">2013-02-07</td>
          <td><span itemprop="assigneeOriginal">Robert Bosch Gmbh</span></td>
          <td itemprop="title">
  Electrical contact element with locking lance for a connector housing
 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/HRP20161377T1/en">
              <span itemprop="publicationNumber">HRP20161377T1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2011-11-29</td>
          <td itemprop="publicationDate">2017-02-10</td>
          <td><span itemprop="assigneeOriginal">Ono Pharmaceutical Co., Ltd.</span></td>
          <td itemprop="title">Purinone derivative hydrochloride 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/MX359634B/en">
              <span itemprop="publicationNumber">MX359634B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2011-12-21</td>
          <td itemprop="publicationDate">2018-10-03</td>
          <td><span itemprop="assigneeOriginal">Novira Therapeutics Inc</span></td>
          <td itemprop="title">Hepatitis b antiviral agents. 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/NZ627036A/en">
              <span itemprop="publicationNumber">NZ627036A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-02-08</td>
          <td itemprop="publicationDate">2016-03-31</td>
          <td><span itemprop="assigneeOriginal">Janssen Sciences Ireland Uc</span></td>
          <td itemprop="title">Piperidino-pyrimidine derivatives for the treatment of viral infections 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP2822957A1/en">
              <span itemprop="publicationNumber">EP2822957A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-03-07</td>
          <td itemprop="publicationDate">2015-01-14</td>
          <td><span itemprop="assigneeOriginal">Aurigene Discovery Technologies Limited</span></td>
          <td itemprop="title">Peptidomimetic compounds as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9422339B2/en">
              <span itemprop="publicationNumber">US9422339B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-03-29</td>
          <td itemprop="publicationDate">2016-08-23</td>
          <td><span itemprop="assigneeOriginal">Aurigene Discovery Technologies Limited</span></td>
          <td itemprop="title">Immunomodulating cyclic compounds 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US20130267517A1/en">
              <span itemprop="publicationNumber">US20130267517A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-03-31</td>
          <td itemprop="publicationDate">2013-10-10</td>
          <td><span itemprop="assigneeOriginal">Hoffmann-La Roche Inc.</span></td>
          <td itemprop="title">Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CA2865259A1/en">
              <span itemprop="publicationNumber">CA2865259A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-03-31</td>
          <td itemprop="publicationDate">2013-10-03</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2013159109A1/en">
              <span itemprop="publicationNumber">WO2013159109A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-04-20</td>
          <td itemprop="publicationDate">2013-10-24</td>
          <td><span itemprop="assigneeOriginal">Isis Pharmaceuticals, Inc.</span></td>
          <td itemprop="title">Modulation of hepatitis b virus (hbv) expression 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/KR20240135058A/en">
              <span itemprop="publicationNumber">KR20240135058A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-05-15</td>
          <td itemprop="publicationDate">2024-09-10</td>
          <td><span itemprop="assigneeOriginal">-  </span></td>
          <td itemprop="title">Cancer immunotherapy by disrupting pd-1/pd-l1 signaling 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/MX2014014766A/en">
              <span itemprop="publicationNumber">MX2014014766A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-06-08</td>
          <td itemprop="publicationDate">2015-05-11</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences Inc</span></td>
          <td itemprop="title">Macrocyclic inhibitors of flaviviridae viruses. 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/AR091279A1/en">
              <span itemprop="publicationNumber">AR091279A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-06-08</td>
          <td itemprop="publicationDate">2015-01-21</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences Inc</span></td>
          <td itemprop="title">
  MACROCICLIC INHIBITORS OF VIRUS FLAVIVIRIDAE
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9090653B2/en">
              <span itemprop="publicationNumber">US9090653B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-06-08</td>
          <td itemprop="publicationDate">2015-07-28</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
          <td itemprop="title">Macrocyclic inhibitors of flaviviridae viruses 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/IN2015MN00478A/en">
              <span itemprop="publicationNumber">IN2015MN00478A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-08-10</td>
          <td itemprop="publicationDate">2015-09-04</td>
          <td><span itemprop="assigneeOriginal">Janssen Sciences Ireland Uc</span></td>
          <td itemprop="title"></td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/UY34992A/en">
              <span itemprop="publicationNumber">UY34992A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-08-28</td>
          <td itemprop="publicationDate">2014-02-28</td>
          <td><span itemprop="assigneeOriginal">Janssen R &amp; D Ireland</span></td>
          <td itemprop="title">
  SULFAMOILARILAMIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2014033167A1/en">
              <span itemprop="publicationNumber">WO2014033167A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-08-28</td>
          <td itemprop="publicationDate">2014-03-06</td>
          <td><span itemprop="assigneeOriginal">Janssen R&amp;D Ireland</span></td>
          <td itemprop="title">Fused bicyclic sulfamoyl derivatives and the use thereof as medicaments for the treatment of hepatitis b 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EA201590384A1/en">
              <span itemprop="publicationNumber">EA201590384A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-09-10</td>
          <td itemprop="publicationDate">2015-10-30</td>
          <td><span itemprop="assigneeOriginal">. -  </span></td>
          <td itemprop="title">
  6-AMINO ACID-HETEROARYDYHYDROPYRIMIDINES FOR THE TREATMENT AND PREVENTION OF INFECTION OF THE HEPATITIS B VIRUS
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/DK2903968T3/en">
              <span itemprop="publicationNumber">DK2903968T3</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-10-02</td>
          <td itemprop="publicationDate">2017-01-30</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences Inc</span></td>
          <td itemprop="title">
  INHIBITORS OF HISTON DEMETHYLASES
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/HUE037064T2/en">
              <span itemprop="publicationNumber">HUE037064T2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-10-10</td>
          <td itemprop="publicationDate">2018-08-28</td>
          <td><span itemprop="assigneeOriginal">Janssen Sciences Ireland Uc</span></td>
          <td itemprop="title">
        Pyrrolo [3,2-d] pyrimidine derivatives for the treatment of viral infections and other diseases
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/KR101268466B1/en">
              <span itemprop="publicationNumber">KR101268466B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-11-12</td>
          <td itemprop="publicationDate">2013-06-04</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Slanted windmill 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9663474B2/en">
              <span itemprop="publicationNumber">US9663474B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-11-16</td>
          <td itemprop="publicationDate">2017-05-30</td>
          <td><span itemprop="assigneeOriginal">Janssen Sciences Ireland Uc</span></td>
          <td itemprop="title">Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP6256771B2/en">
              <span itemprop="publicationNumber">JP6256771B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-12-06</td>
          <td itemprop="publicationDate">2018-01-10</td>
          <td><span itemprop="assigneeOriginal">  </span></td>
          <td itemprop="title">
        Histone demethylase inhibitor
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US8969343B2/en">
              <span itemprop="publicationNumber">US8969343B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-12-19</td>
          <td itemprop="publicationDate">2015-03-03</td>
          <td><span itemprop="assigneeOriginal">Quanticel Pharmaceuticals, Inc.</span></td>
          <td itemprop="title">Histone demethylase inhibitors 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/SG11201504946VA/en">
              <span itemprop="publicationNumber">SG11201504946VA</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2012-12-21</td>
          <td itemprop="publicationDate">2015-07-30</td>
          <td><span itemprop="assigneeOriginal">Quanticel Pharmaceuticals Inc</span></td>
          <td itemprop="title">Histone demethylase inhibitors 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN105189468B/en">
              <span itemprop="publicationNumber">CN105189468B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-02-21</td>
          <td itemprop="publicationDate">2018-10-30</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">
        2-aminopyrimidine derivatives for the treatment of viral infections
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EA030451B1/en">
              <span itemprop="publicationNumber">EA030451B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-02-27</td>
          <td itemprop="publicationDate">2018-08-31</td>
          <td><span itemprop="assigneeOriginal"> </span></td>
          <td itemprop="title">Inhibitors of histone demethylases 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/PT2961732T/en">
              <span itemprop="publicationNumber">PT2961732T</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-02-28</td>
          <td itemprop="publicationDate">2017-06-26</td>
          <td><span itemprop="assigneeOriginal">Janssen Sciences Ireland Uc</span></td>
          <td itemprop="title">Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/AU2014249050B2/en">
              <span itemprop="publicationNumber">AU2014249050B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-03-12</td>
          <td itemprop="publicationDate">2017-10-05</td>
          <td><span itemprop="assigneeOriginal">Celgene Quanticel Research, Inc.</span></td>
          <td itemprop="title">Histone dementhylase inhibitors 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2014165128A2/en">
              <span itemprop="publicationNumber">WO2014165128A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-03-12</td>
          <td itemprop="publicationDate">2014-10-09</td>
          <td><span itemprop="assigneeOriginal">Novira Therapeutics, Inc.</span></td>
          <td itemprop="title">Hepatitis b antiviral agents 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN105980386B/en">
              <span itemprop="publicationNumber">CN105980386B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-03-13</td>
          <td itemprop="publicationDate">2021-08-13</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">
        Pyrazolo compounds and their uses
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CA2903081A1/en">
              <span itemprop="publicationNumber">CA2903081A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-03-14</td>
          <td itemprop="publicationDate">2014-09-25</td>
          <td><span itemprop="assigneeOriginal">Quanticel Pharmaceuticals, Inc.</span></td>
          <td itemprop="title">Histone demethylase inhibitors 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9308236B2/en">
              <span itemprop="publicationNumber">US9308236B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-03-15</td>
          <td itemprop="publicationDate">2016-04-12</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/HRP20171609T1/en">
              <span itemprop="publicationNumber">HRP20171609T1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-03-15</td>
          <td itemprop="publicationDate">2017-12-15</td>
          <td><span itemprop="assigneeOriginal">Quanticel Pharmaceuticals Inc</span></td>
          <td itemprop="title">
        HISTON DEMETHILASE INHIBITORS
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2014161888A1/en">
              <span itemprop="publicationNumber">WO2014161888A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-04-03</td>
          <td itemprop="publicationDate">2014-10-09</td>
          <td><span itemprop="assigneeOriginal">Janssen R&amp;D Ireland</span></td>
          <td itemprop="title">N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2014179760A1/en">
              <span itemprop="publicationNumber">WO2014179760A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-05-03</td>
          <td itemprop="publicationDate">2014-11-06</td>
          <td><span itemprop="assigneeOriginal">The Regents Of The University Of California</span></td>
          <td itemprop="title">Cyclic di-nucleotide induction of type i interferon 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/PT2997019T/en">
              <span itemprop="publicationNumber">PT2997019T</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-05-17</td>
          <td itemprop="publicationDate">2018-11-21</td>
          <td><span itemprop="assigneeOriginal">Janssen Sciences Ireland Uc</span></td>
          <td itemprop="title">Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JO3603B1/en">
              <span itemprop="publicationNumber">JO3603B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-05-17</td>
          <td itemprop="publicationDate">2020-07-05</td>
          <td><span itemprop="assigneeOriginal">Janssen Sciences Ireland Uc</span></td>
          <td itemprop="title">
        Sulfamoyl pyrolamide derivatives and their use as medicines to treat hepatitis B
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2014184328A1/en">
              <span itemprop="publicationNumber">WO2014184328A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-05-17</td>
          <td itemprop="publicationDate">2014-11-20</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/UA118680C2/en">
              <span itemprop="publicationNumber">UA118680C2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-07-25</td>
          <td itemprop="publicationDate">2019-02-25</td>
          <td><span itemprop="assigneeOriginal">   </span></td>
          <td itemprop="title">
        GLIOXAMID SUBSTITUTES OF PYROMAMIDE AND THEIR APPLICATION AS MEDICINES FOR THE TREATMENT OF HEPATITIS IN
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2015014815A1/en">
              <span itemprop="publicationNumber">WO2015014815A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-07-30</td>
          <td itemprop="publicationDate">2015-02-05</td>
          <td><span itemprop="assigneeOriginal">Janssen R&amp;D Ireland</span></td>
          <td itemprop="title">THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3030322A2/en">
              <span itemprop="publicationNumber">EP3030322A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-08-05</td>
          <td itemprop="publicationDate">2016-06-15</td>
          <td><span itemprop="assigneeOriginal">Cambridge Enterprise Limited</span></td>
          <td itemprop="title">Inhibition of cxcr4 signaling in cancer immunotherapy 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10471139B2/en">
              <span itemprop="publicationNumber">US10471139B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-08-15</td>
          <td itemprop="publicationDate">2019-11-12</td>
          <td><span itemprop="assigneeOriginal">The University Of Kansas</span></td>
          <td itemprop="title">Toll-like receptor agonists 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/SG11201601225RA/en">
              <span itemprop="publicationNumber">SG11201601225RA</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-09-04</td>
          <td itemprop="publicationDate">2016-03-30</td>
          <td><span itemprop="assigneeOriginal">Bristol Myers Squibb Co</span></td>
          <td itemprop="title">Compounds useful as immunomodulators 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/DK3363790T3/en">
              <span itemprop="publicationNumber">DK3363790T3</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-09-06</td>
          <td itemprop="publicationDate">2020-04-27</td>
          <td><span itemprop="assigneeOriginal">Aurigene Discovery Tech Ltd</span></td>
          <td itemprop="title">
        1,2,4-OXADIAZOLD DERIVATIVES AS IMMUNE MODULATORS
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN105813640A/en">
              <span itemprop="publicationNumber">CN105813640A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-09-06</td>
          <td itemprop="publicationDate">2016-07-27</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Cyclic peptidomimetic compounds as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN105849092A/en">
              <span itemprop="publicationNumber">CN105849092A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-09-06</td>
          <td itemprop="publicationDate">2016-08-10</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2015036927A1/en">
              <span itemprop="publicationNumber">WO2015036927A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-09-10</td>
          <td itemprop="publicationDate">2015-03-19</td>
          <td><span itemprop="assigneeOriginal">Aurigene Discovery Technologies Limited</span></td>
          <td itemprop="title">Immunomodulating peptidomimetic derivatives 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3711762A1/en">
              <span itemprop="publicationNumber">EP3711762A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-09-11</td>
          <td itemprop="publicationDate">2020-09-23</td>
          <td><span itemprop="assigneeOriginal">INSERM (Institut National de la Sant et de la Recherche Mdicale)</span></td>
          <td itemprop="title">A farnesoid x receptor agonsits foruse and pharmaceutical compositions for the treatment of chronic hepatitis b virus infection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2015044900A1/en">
              <span itemprop="publicationNumber">WO2015044900A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-09-27</td>
          <td itemprop="publicationDate">2015-04-02</td>
          <td><span itemprop="assigneeOriginal">Aurigene Discovery Technologies Limited</span></td>
          <td itemprop="title">Therapeutic immunomodulating compounds 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/ES2670550T3/en">
              <span itemprop="publicationNumber">ES2670550T3</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-10-14</td>
          <td itemprop="publicationDate">2018-05-30</td>
          <td><span itemprop="assigneeOriginal">Eisai R&amp;D Management Co., Ltd.</span></td>
          <td itemprop="title">
  Selectively substituted quinoline derivatives
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JO3554B1/en">
              <span itemprop="publicationNumber">JO3554B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-10-14</td>
          <td itemprop="publicationDate">2020-07-05</td>
          <td><span itemprop="assigneeOriginal">Eisai R&amp;D Man Co Ltd</span></td>
          <td itemprop="title">
        Selectively substituted quinolines
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3060547B1/en">
              <span itemprop="publicationNumber">EP3060547B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-10-23</td>
          <td itemprop="publicationDate">2017-10-11</td>
          <td><span itemprop="assigneeOriginal">Janssen Sciences Ireland UC</span></td>
          <td itemprop="title">Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CA2928003A1/en">
              <span itemprop="publicationNumber">CA2928003A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-11-14</td>
          <td itemprop="publicationDate">2015-05-21</td>
          <td><span itemprop="assigneeOriginal">Novira Therapeutics, Inc.</span></td>
          <td itemprop="title">Azepane derivatives and methods of treating hepatitis b infections 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2015088045A1/en">
              <span itemprop="publicationNumber">WO2015088045A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-12-13</td>
          <td itemprop="publicationDate">2015-06-18</td>
          <td><span itemprop="assigneeOriginal">Takeda Pharmaceutical Company Limited</span></td>
          <td itemprop="title">Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10654807B2/en">
              <span itemprop="publicationNumber">US10654807B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2013-12-20</td>
          <td itemprop="publicationDate">2020-05-19</td>
          <td><span itemprop="assigneeOriginal">The University Of Kansas</span></td>
          <td itemprop="title">Toll-like receptor 8 agonists 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9181288B2/en">
              <span itemprop="publicationNumber">US9181288B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-01-16</td>
          <td itemprop="publicationDate">2015-11-10</td>
          <td><span itemprop="assigneeOriginal">Novira Therapeutics, Inc.</span></td>
          <td itemprop="title">Azepane derivatives and methods of treating hepatitis B infections 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9169212B2/en">
              <span itemprop="publicationNumber">US9169212B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-01-16</td>
          <td itemprop="publicationDate">2015-10-27</td>
          <td><span itemprop="assigneeOriginal">Novira Therapeutics, Inc.</span></td>
          <td itemprop="title">Azepane derivatives and methods of treating hepatitis B infections 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/MX2016009828A/en">
              <span itemprop="publicationNumber">MX2016009828A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-01-30</td>
          <td itemprop="publicationDate">2016-10-31</td>
          <td><span itemprop="assigneeOriginal">Hoffmann La Roche</span></td>
          <td itemprop="title">Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection. 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3102237B1/en">
              <span itemprop="publicationNumber">EP3102237B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-02-04</td>
          <td itemprop="publicationDate">2020-12-02</td>
          <td><span itemprop="assigneeOriginal">Incyte Corporation</span></td>
          <td itemprop="title">Combination of a pd-1 antagonist and an ido1 inhibitor for treating cancer 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EA035848B1/en">
              <span itemprop="publicationNumber">EA035848B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-02-06</td>
          <td itemprop="publicationDate">2020-08-20</td>
          <td><span itemprop="assigneeOriginal">   </span></td>
          <td itemprop="title">Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3114144A1/en">
              <span itemprop="publicationNumber">EP3114144A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-03-05</td>
          <td itemprop="publicationDate">2017-01-11</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Treatment of renal cancer using a combination of an anti-pd-1 antibody and another anti-cancer agent 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/KR101933844B1/en">
              <span itemprop="publicationNumber">KR101933844B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-03-07</td>
          <td itemprop="publicationDate">2018-12-28</td>
          <td><span itemprop="assigneeOriginal">. -  </span></td>
          <td itemprop="title">Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9400280B2/en">
              <span itemprop="publicationNumber">US9400280B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-03-27</td>
          <td itemprop="publicationDate">2016-07-26</td>
          <td><span itemprop="assigneeOriginal">Novira Therapeutics, Inc.</span></td>
          <td itemprop="title">Piperidine derivatives and methods of treating hepatitis B infections 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9850225B2/en">
              <span itemprop="publicationNumber">US9850225B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-04-14</td>
          <td itemprop="publicationDate">2017-12-26</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Compounds useful as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/BR112016017261B1/en">
              <span itemprop="publicationNumber">BR112016017261B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-04-22</td>
          <td itemprop="publicationDate">2022-04-19</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">
  Compound, pharmaceutical composition, use of a compound and process for making a compound
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/MX380777B/en">
              <span itemprop="publicationNumber">MX380777B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-05-01</td>
          <td itemprop="publicationDate">2025-03-12</td>
          <td><span itemprop="assigneeOriginal">Novartis Ag</span></td>
          <td itemprop="title">
        COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS.
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CR20160512A/en">
              <span itemprop="publicationNumber">CR20160512A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-05-01</td>
          <td itemprop="publicationDate">2016-12-21</td>
          <td><span itemprop="assigneeOriginal">Novartis Ag</span></td>
          <td itemprop="title">
  COMPOUNDS AND COMPOSITIONS AS AGENTS OF THE TOLL TYPE 7 RECEIVER
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/RU2016146365A/en">
              <span itemprop="publicationNumber">RU2016146365A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-05-13</td>
          <td itemprop="publicationDate">2018-06-19</td>
          <td><span itemprop="assigneeOriginal">. -  </span></td>
          <td itemprop="title">
  NEW DIHYDROCHINOLYSINE FOR THE TREATMENT AND PREVENTION OF HEPATITIS B VIRUS INFECTION
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/AU2015264102C1/en">
              <span itemprop="publicationNumber">AU2015264102C1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-05-23</td>
          <td itemprop="publicationDate">2020-10-08</td>
          <td><span itemprop="assigneeOriginal">Eisai R&amp;D Management Co., Ltd.</span></td>
          <td itemprop="title">Combination therapies for the treatment of cancer 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3149169A1/en">
              <span itemprop="publicationNumber">EP3149169A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-05-30</td>
          <td itemprop="publicationDate">2017-04-05</td>
          <td><span itemprop="assigneeOriginal">The Board of Trustees of the Leland Stanford Junior University</span></td>
          <td itemprop="title">Compositions and methods of delivering treatments for latent viral infections 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/BR112016028255A2/en">
              <span itemprop="publicationNumber">BR112016028255A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-06-06</td>
          <td itemprop="publicationDate">2017-08-22</td>
          <td><span itemprop="assigneeOriginal">Flexus Biosciences Inc</span></td>
          <td itemprop="title">
  immunoregulatory agents
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2016012470A1/en">
              <span itemprop="publicationNumber">WO2016012470A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-07-25</td>
          <td itemprop="publicationDate">2016-01-28</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/AU2015296214B2/en">
              <span itemprop="publicationNumber">AU2015296214B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-08-01</td>
          <td itemprop="publicationDate">2019-11-07</td>
          <td><span itemprop="assigneeOriginal">Board Of Regents, The University Of Texas System</span></td>
          <td itemprop="title">Methods and therapeutic combinations for treating tumors 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CA2952541C/en">
              <span itemprop="publicationNumber">CA2952541C</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-08-14</td>
          <td itemprop="publicationDate">2019-10-01</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Pyridazones and triazinones for the treatment and prophylaxis of hepatitis b virus infection 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN112898308A/en">
              <span itemprop="publicationNumber">CN112898308A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-08-15</td>
          <td itemprop="publicationDate">2021-06-04</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Pyrrolopyrimidines as TLR7 agonists 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN107108629A/en">
              <span itemprop="publicationNumber">CN107108629A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-08-22</td>
          <td itemprop="publicationDate">2017-08-29</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Novel N2, N4, N7, the 6 quaternary triamines of pteridine 2,4,7 and 2,4,6,7 quaternary pteridine compounds and its synthesis and application method 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/BR112017003442A2/en">
              <span itemprop="publicationNumber">BR112017003442A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-08-27</td>
          <td itemprop="publicationDate">2017-11-28</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences Inc</span></td>
          <td itemprop="title">
  compounds and methods for inhibiting histone demethylases
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9884866B2/en">
              <span itemprop="publicationNumber">US9884866B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-09-08</td>
          <td itemprop="publicationDate">2018-02-06</td>
          <td><span itemprop="assigneeOriginal">Regents Of The University Of Minnesota</span></td>
          <td itemprop="title">Immunomodulators and immunomodulator conjugates 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/SG11201701896RA/en">
              <span itemprop="publicationNumber">SG11201701896RA</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-09-11</td>
          <td itemprop="publicationDate">2017-04-27</td>
          <td><span itemprop="assigneeOriginal">Bristol Myers Squibb Co</span></td>
          <td itemprop="title">Macrocyclic inhibitors of the pd-1/pd-l1 and cd80 (b7-1)/pd-li protein/protein interactions 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2016057924A1/en">
              <span itemprop="publicationNumber">WO2016057924A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-10-10</td>
          <td itemprop="publicationDate">2016-04-14</td>
          <td><span itemprop="assigneeOriginal">Genentech, Inc.</span></td>
          <td itemprop="title">Pyrrolidine amide compounds as histone demethylase inhibitors 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9732119B2/en">
              <span itemprop="publicationNumber">US9732119B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-10-10</td>
          <td itemprop="publicationDate">2017-08-15</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP2017531655A/en">
              <span itemprop="publicationNumber">JP2017531655A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-10-11</td>
          <td itemprop="publicationDate">2017-10-26</td>
          <td><span itemprop="assigneeOriginal">     </span></td>
          <td itemprop="title">
  Compounds for use in the treatment of infectious diseases
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9637485B2/en">
              <span itemprop="publicationNumber">US9637485B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-11-03</td>
          <td itemprop="publicationDate">2017-05-02</td>
          <td><span itemprop="assigneeOriginal">Hoffmann-La Roche Inc.</span></td>
          <td itemprop="title">6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/UY36390A/en">
              <span itemprop="publicationNumber">UY36390A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-11-05</td>
          <td itemprop="publicationDate">2016-06-01</td>
          <td><span itemprop="assigneeOriginal">Flexus Biosciences Inc</span></td>
          <td itemprop="title">
  MODULATING COMPOUNDS OF INDOLAMINE ENZYME 2,3-DIOXYGENASE (IDO), ITS SYNTHESIS METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP2017538678A/en">
              <span itemprop="publicationNumber">JP2017538678A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-11-05</td>
          <td itemprop="publicationDate">2017-12-28</td>
          <td><span itemprop="assigneeOriginal">  </span></td>
          <td itemprop="title">
        Immunomodulator
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/MX2017006302A/en">
              <span itemprop="publicationNumber">MX2017006302A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-11-13</td>
          <td itemprop="publicationDate">2018-02-16</td>
          <td><span itemprop="assigneeOriginal">Glaxosmithkline Biologicals Sa</span></td>
          <td itemprop="title">Adenine derivatives which are useful in the treatment of allergic diseases or other inflammatory conditions. 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9856292B2/en">
              <span itemprop="publicationNumber">US9856292B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-11-14</td>
          <td itemprop="publicationDate">2018-01-02</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CR20170237A/en">
              <span itemprop="publicationNumber">CR20170237A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-12-08</td>
          <td itemprop="publicationDate">2017-08-10</td>
          <td><span itemprop="assigneeOriginal">Hoffmann La Roche</span></td>
          <td itemprop="title">
  NEW COMPOUNDS OF 5-AMINO-6H-TIAZOLO [4,5-D] PIRIMIDIN-2,7-DIONA 3-SUBSTITUTED FOR THE TREATMENT AND PROFILAXIS OF VIRAL INFECTIONS.
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9861680B2/en">
              <span itemprop="publicationNumber">US9861680B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-12-18</td>
          <td itemprop="publicationDate">2018-01-09</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3233835B1/en">
              <span itemprop="publicationNumber">EP3233835B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-12-18</td>
          <td itemprop="publicationDate">2019-01-23</td>
          <td><span itemprop="assigneeOriginal">F.Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Benzazepine sulfonamide compounds 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9944678B2/en">
              <span itemprop="publicationNumber">US9944678B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-12-19</td>
          <td itemprop="publicationDate">2018-04-17</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2016102438A1/en">
              <span itemprop="publicationNumber">WO2016102438A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-12-23</td>
          <td itemprop="publicationDate">2016-06-30</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidine analogues 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9676793B2/en">
              <span itemprop="publicationNumber">US9676793B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-12-23</td>
          <td itemprop="publicationDate">2017-06-13</td>
          <td><span itemprop="assigneeOriginal">Hoffmann-Laroche Inc.</span></td>
          <td itemprop="title">Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN105732635A/en">
              <span itemprop="publicationNumber">CN105732635A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-12-29</td>
          <td itemprop="publicationDate">2016-07-06</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Toll-like receptor 7 agonist 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2016107832A1/en">
              <span itemprop="publicationNumber">WO2016107832A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-12-30</td>
          <td itemprop="publicationDate">2016-07-07</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Novel tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis b virus infection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9518057B2/en">
              <span itemprop="publicationNumber">US9518057B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-12-30</td>
          <td itemprop="publicationDate">2016-12-13</td>
          <td><span itemprop="assigneeOriginal">Novira Therapeutics, Inc.</span></td>
          <td itemprop="title">Derivatives and methods of treating hepatitis B infections 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2016107833A1/en">
              <span itemprop="publicationNumber">WO2016107833A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2014-12-31</td>
          <td itemprop="publicationDate">2016-07-07</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">A novel high-throughput method for quantification of hbv cccdna from cell lysate by real-time pcr 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/MA41338B1/en">
              <span itemprop="publicationNumber">MA41338B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-01-16</td>
          <td itemprop="publicationDate">2019-07-31</td>
          <td><span itemprop="assigneeOriginal">Hoffmann La Roche</span></td>
          <td itemprop="title">
  Pyrazine compounds for the treatment of infectious diseases
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP2018502604A/en">
              <span itemprop="publicationNumber">JP2018502604A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-01-27</td>
          <td itemprop="publicationDate">2018-02-01</td>
          <td><span itemprop="assigneeOriginal">     </span></td>
          <td itemprop="title">
  Recombinant HBV cccDNA, its production method and its use
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US20160222060A1/en">
              <span itemprop="publicationNumber">US20160222060A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-02-04</td>
          <td itemprop="publicationDate">2016-08-04</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Immunomodulators 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP6435054B2/en">
              <span itemprop="publicationNumber">JP6435054B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-02-11</td>
          <td itemprop="publicationDate">2018-12-05</td>
          <td><span itemprop="assigneeOriginal">     </span></td>
          <td itemprop="title">
        Novel 2-oxo-6,7-dihydrobenzo [a] quinolidine-3-carboxylic acid derivatives for the treatment and prevention of hepatitis B virus infection
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/MY199989A/en">
              <span itemprop="publicationNumber">MY199989A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-03-04</td>
          <td itemprop="publicationDate">2023-12-02</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences Inc</span></td>
          <td itemprop="title">Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/MY191185A/en">
              <span itemprop="publicationNumber">MY191185A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-03-06</td>
          <td itemprop="publicationDate">2022-06-04</td>
          <td><span itemprop="assigneeOriginal">Hoffmann La Roche</span></td>
          <td itemprop="title">Benzazepine dicarboxamide compounds 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EA201791629A1/en">
              <span itemprop="publicationNumber">EA201791629A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-03-10</td>
          <td itemprop="publicationDate">2018-02-28</td>
          <td><span itemprop="assigneeOriginal">   </span></td>
          <td itemprop="title">
  1,3,4-OXADIAZOL AND TIADIAZOLIC CONNECTIONS AS IMMUNOMODULATORS
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP2018507894A/en">
              <span itemprop="publicationNumber">JP2018507894A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-03-10</td>
          <td itemprop="publicationDate">2018-03-22</td>
          <td><span itemprop="assigneeOriginal">      </span></td>
          <td itemprop="title">
        3-Substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3267998A4/en">
              <span itemprop="publicationNumber">EP3267998A4</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-03-10</td>
          <td itemprop="publicationDate">2018-12-19</td>
          <td><span itemprop="assigneeOriginal">Aurigene Discovery Technologies Limited</span></td>
          <td itemprop="title">3-substituted 1,3,4-oxadiazole and thiadiazole compounds as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN114159430B/en">
              <span itemprop="publicationNumber">CN114159430B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-03-10</td>
          <td itemprop="publicationDate">2024-10-25</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">
        1,2,4-Oxadiazole and thiadiazole compounds as immunomodulators
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/AU2016230795A1/en">
              <span itemprop="publicationNumber">AU2016230795A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-03-10</td>
          <td itemprop="publicationDate">2017-09-07</td>
          <td><span itemprop="assigneeOriginal">Aurigene Discovery Technologies Limited</span></td>
          <td itemprop="title">Therapeutic cyclic compounds as immunomodulators 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US9809625B2/en">
              <span itemprop="publicationNumber">US9809625B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-03-18</td>
          <td itemprop="publicationDate">2017-11-07</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10442788B2/en">
              <span itemprop="publicationNumber">US10442788B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-04-01</td>
          <td itemprop="publicationDate">2019-10-15</td>
          <td><span itemprop="assigneeOriginal">Enanta Pharmaceuticals, Inc.</span></td>
          <td itemprop="title">Hepatitis B antiviral agents 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CA2982811A1/en">
              <span itemprop="publicationNumber">CA2982811A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-04-17</td>
          <td itemprop="publicationDate">2016-10-20</td>
          <td><span itemprop="assigneeOriginal">Indiana University Research And Technology Corporation</span></td>
          <td itemprop="title">Hepatitis b viral assembly effectors 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP6462155B2/en">
              <span itemprop="publicationNumber">JP6462155B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-05-04</td>
          <td itemprop="publicationDate">2019-01-30</td>
          <td><span itemprop="assigneeOriginal">     </span></td>
          <td itemprop="title">
        Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of HBsAg (HBV surface antigen) and HBV DNA production for the treatment of hepatitis B virus infection
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN107592864B/en">
              <span itemprop="publicationNumber">CN107592864B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-05-12</td>
          <td itemprop="publicationDate">2021-04-16</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">
        Novel substituted aminothiazolopyrimidinediones for the treatment and prevention of viral infections
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2016195982A2/en">
              <span itemprop="publicationNumber">WO2016195982A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-06-01</td>
          <td itemprop="publicationDate">2016-12-08</td>
          <td><span itemprop="assigneeOriginal">The Penn State Research Foundation</span></td>
          <td itemprop="title">Hepatitis b virus capsid assembly 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US20160376864A1/en">
              <span itemprop="publicationNumber">US20160376864A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-06-29</td>
          <td itemprop="publicationDate">2016-12-29</td>
          <td><span itemprop="assigneeOriginal">Cameron International Corporation</span></td>
          <td itemprop="title">Apparatus and method for distributing fluids to a wellbore 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN107820498B/en">
              <span itemprop="publicationNumber">CN107820498B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-06-30</td>
          <td itemprop="publicationDate">2020-06-19</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">
        Substituted aminothiazolopyrimidinediones for the treatment and prevention of viral infections
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/GB201511477D0/en">
              <span itemprop="publicationNumber">GB201511477D0</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-06-30</td>
          <td itemprop="publicationDate">2015-08-12</td>
          <td><span itemprop="assigneeOriginal">Redx Pharma Plc</span></td>
          <td itemprop="title">Antiviral compounds 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10875876B2/en">
              <span itemprop="publicationNumber">US10875876B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-07-02</td>
          <td itemprop="publicationDate">2020-12-29</td>
          <td><span itemprop="assigneeOriginal">Janssen Sciences Ireland Uc</span></td>
          <td itemprop="title">Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017007701A1/en">
              <span itemprop="publicationNumber">WO2017007701A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-07-07</td>
          <td itemprop="publicationDate">2017-01-12</td>
          <td><span itemprop="assigneeOriginal">Merck Sharp &amp; Dohme Corp.</span></td>
          <td itemprop="title">Antiviral phosphodiamide compounds 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN107849037B/en">
              <span itemprop="publicationNumber">CN107849037B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-07-21</td>
          <td itemprop="publicationDate">2020-04-17</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prevention of hepatitis B virus infection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017016960A1/en">
              <span itemprop="publicationNumber">WO2017016960A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-07-24</td>
          <td itemprop="publicationDate">2017-02-02</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Process for the preparation of (6s)-6-alkyl-10-alkoxy-9-(substituted alkoxy)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid analogues 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017017042A1/en">
              <span itemprop="publicationNumber">WO2017017042A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-07-27</td>
          <td itemprop="publicationDate">2017-02-02</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Novel tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP6559324B2/en">
              <span itemprop="publicationNumber">JP6559324B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-07-28</td>
          <td itemprop="publicationDate">2019-08-14</td>
          <td><span itemprop="assigneeOriginal">     </span></td>
          <td itemprop="title">
  Novel 6,7-dihydropyrido [2,1-a] phthalazin-2-ones for the treatment and prevention of hepatitis B virus infection
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US20180177872A1/en">
              <span itemprop="publicationNumber">US20180177872A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-07-29</td>
          <td itemprop="publicationDate">2018-06-28</td>
          <td><span itemprop="assigneeOriginal">Yong Jia</span></td>
          <td itemprop="title">Combination of PD-1 antagonist with an EGFR inhibitor 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/TWI639598B/en">
              <span itemprop="publicationNumber">TWI639598B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-08-10</td>
          <td itemprop="publicationDate">2018-11-01</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">
        Antiviral -amino acid phosphate diamine compound
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/BR112018002757A8/en">
              <span itemprop="publicationNumber">BR112018002757A8</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-08-13</td>
          <td itemprop="publicationDate">2023-04-11</td>
          <td><span itemprop="assigneeOriginal">Merck Sharp &amp; Dohme</span></td>
          <td itemprop="title">
  COMPOUND, PHARMACEUTICAL COMPOSITION, AND METHODS FOR INDUCING AN IMMUNE RESPONSE, FOR INDUCING TYPE I INTERFERON PRODUCTION, AND FOR TREATMENT OF A DISORDER
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US11130736B2/en">
              <span itemprop="publicationNumber">US11130736B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-08-21</td>
          <td itemprop="publicationDate">2021-09-28</td>
          <td><span itemprop="assigneeOriginal">University Of Kansas</span></td>
          <td itemprop="title">Human TLR8-selective agonists 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017038909A1/en">
              <span itemprop="publicationNumber">WO2017038909A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-08-28</td>
          <td itemprop="publicationDate">2017-03-09</td>
          <td><span itemprop="assigneeOriginal">Takeda Pharmaceutical Company Limited</span></td>
          <td itemprop="title">Heterocyclic compounds 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN108026092B/en">
              <span itemprop="publicationNumber">CN108026092B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-08-31</td>
          <td itemprop="publicationDate">2021-01-26</td>
          <td><span itemprop="assigneeOriginal">3M</span></td>
          <td itemprop="title">Guanidine-substituted imidazo [4,5-c ] ring compounds 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/TWI786639B/en">
              <span itemprop="publicationNumber">TWI786639B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-09-15</td>
          <td itemprop="publicationDate">2022-12-11</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Hepatitis b core protein modulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP6893501B2/en">
              <span itemprop="publicationNumber">JP6893501B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-09-17</td>
          <td itemprop="publicationDate">2021-06-23</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">
        Sulfinylphenyl or sulfonimideylphenyl benzazepine
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017047769A1/en">
              <span itemprop="publicationNumber">WO2017047769A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-09-17</td>
          <td itemprop="publicationDate">2017-03-23</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Activation inhibitor for toll-like receptor 7 or toll-like receptor 9 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3360554B1/en">
              <span itemprop="publicationNumber">EP3360554B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-10-05</td>
          <td itemprop="publicationDate">2021-07-28</td>
          <td><span itemprop="assigneeOriginal">FUJIFILM Toyama Chemical Co., Ltd.</span></td>
          <td itemprop="title">Anti-hepatitis b virus agent 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017061532A1/en">
              <span itemprop="publicationNumber">WO2017061532A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-10-07</td>
          <td itemprop="publicationDate">2017-04-13</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Pyrimidine compound 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10745382B2/en">
              <span itemprop="publicationNumber">US10745382B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-10-15</td>
          <td itemprop="publicationDate">2020-08-18</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Compounds useful as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017070089A1/en">
              <span itemprop="publicationNumber">WO2017070089A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-10-19</td>
          <td itemprop="publicationDate">2017-04-27</td>
          <td><span itemprop="assigneeOriginal">Incyte Corporation</span></td>
          <td itemprop="title">Heterocyclic compounds as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/BR112018008339A2/en">
              <span itemprop="publicationNumber">BR112018008339A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-10-28</td>
          <td itemprop="publicationDate">2018-10-30</td>
          <td><span itemprop="assigneeOriginal">Aduro Biotech Inc</span></td>
          <td itemprop="title">
  compositions and methods for activating interferon gene-dependent signaling enhancer
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/MA43172A/en">
              <span itemprop="publicationNumber">MA43172A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-11-04</td>
          <td itemprop="publicationDate">2018-09-12</td>
          <td><span itemprop="assigneeOriginal">Incyte Corp</span></td>
          <td itemprop="title">
  PHARMACEUTICAL COMPOSITIONS AND METHODS OF INHIBITION OF INDOLAMINE 2,3-DIOXYGENASE AND THEIR INDICATIONS
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/ES2934698T3/en">
              <span itemprop="publicationNumber">ES2934698T3</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-11-04</td>
          <td itemprop="publicationDate">2023-02-24</td>
          <td><span itemprop="assigneeOriginal">Hookipa Biotech Gmbh</span></td>
          <td itemprop="title">
        Hepatitis B virus vaccines
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP6524355B2/en">
              <span itemprop="publicationNumber">JP6524355B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-11-05</td>
          <td itemprop="publicationDate">2019-06-05</td>
          <td><span itemprop="assigneeOriginal">      Chia Tai Tianqing Pharmaceutical Group Co., Ltd.</span></td>
          <td itemprop="title">
        7- (thiazol-5-yl) pyrrolopyrimidine compounds as TLR7 agonists
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/RS63762B1/en">
              <span itemprop="publicationNumber">RS63762B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-11-19</td>
          <td itemprop="publicationDate">2022-12-30</td>
          <td><span itemprop="assigneeOriginal">Incyte Corp</span></td>
          <td itemprop="title">
        HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/KR20180082563A/en">
              <span itemprop="publicationNumber">KR20180082563A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-11-19</td>
          <td itemprop="publicationDate">2018-07-18</td>
          <td><span itemprop="assigneeOriginal">-  </span></td>
          <td itemprop="title">
        Antibodies to glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/PE20181297A1/en">
              <span itemprop="publicationNumber">PE20181297A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-12-03</td>
          <td itemprop="publicationDate">2018-08-07</td>
          <td><span itemprop="assigneeOriginal">Glaxosmithkline Ip Dev Ltd</span></td>
          <td itemprop="title">
  CYCLIC PURINE DINUCLEOTIDES AS STING MODULATORS
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3386512B1/en">
              <span itemprop="publicationNumber">EP3386512B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-12-10</td>
          <td itemprop="publicationDate">2023-11-22</td>
          <td><span itemprop="assigneeOriginal">Merck Sharp &amp; Dohme LLC</span></td>
          <td itemprop="title">Antiviral phosphodiamide prodrugs of tenofovir 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US20180369268A1/en">
              <span itemprop="publicationNumber">US20180369268A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-12-16</td>
          <td itemprop="publicationDate">2018-12-27</td>
          <td><span itemprop="assigneeOriginal">Aduro Biotech, Inc.</span></td>
          <td itemprop="title">Methods for identifying inhibitors of &#34;stimulator of interferon gene&#34;- dependent interferon production 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3390361B1/en">
              <span itemprop="publicationNumber">EP3390361B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-12-17</td>
          <td itemprop="publicationDate">2022-03-16</td>
          <td><span itemprop="assigneeOriginal">Incyte Corporation</span></td>
          <td itemprop="title">N-phenyl-pyridine-2-carboxamide derivatives and their use as pd-1/pd-l1 protein/protein interaction modulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/HUE066591T2/en">
              <span itemprop="publicationNumber">HUE066591T2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-12-17</td>
          <td itemprop="publicationDate">2024-08-28</td>
          <td><span itemprop="assigneeOriginal">Merck Patent Gmbh</span></td>
          <td itemprop="title">
        8-cyano-5-piperidinoquinolines as TLR7/8 antagonists and their use in the treatment of immune disorders
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/TWI767896B/en">
              <span itemprop="publicationNumber">TWI767896B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-12-22</td>
          <td itemprop="publicationDate">2022-06-21</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Heterocyclic compounds as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3394253B1/en">
              <span itemprop="publicationNumber">EP3394253B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2015-12-23</td>
          <td itemprop="publicationDate">2021-09-01</td>
          <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
          <td itemprop="title">Engineered meganucleases with recognition sequences found in the human beta-2 microglobulin gene 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/MX384799B/en">
              <span itemprop="publicationNumber">MX384799B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-02-19</td>
          <td itemprop="publicationDate">2025-03-14</td>
          <td><span itemprop="assigneeOriginal">Novartis Ag</span></td>
          <td itemprop="title">
        TETRACYCLIC PYRIDONE COMPOUNDS AS ANTIVIRALS.
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/KR102530488B1/en">
              <span itemprop="publicationNumber">KR102530488B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-03-18</td>
          <td itemprop="publicationDate">2023-05-08</td>
          <td><span itemprop="assigneeOriginal"> , </span></td>
          <td itemprop="title">
        Cyclic di-nucleotide compounds and methods of use
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/AU2017238758B2/en">
              <span itemprop="publicationNumber">AU2017238758B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-03-21</td>
          <td itemprop="publicationDate">2021-01-21</td>
          <td><span itemprop="assigneeOriginal">Council Of Scientific &amp; Industrial Research</span></td>
          <td itemprop="title">Blocking toll-like receptor 9 signaling with small molecule antagonist 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10358463B2/en">
              <span itemprop="publicationNumber">US10358463B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-04-05</td>
          <td itemprop="publicationDate">2019-07-23</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10533007B2/en">
              <span itemprop="publicationNumber">US10533007B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-04-19</td>
          <td itemprop="publicationDate">2020-01-14</td>
          <td><span itemprop="assigneeOriginal">Innate Tumor Immunity, Inc.</span></td>
          <td itemprop="title">NLRP3 modulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/BR112018071347A2/en">
              <span itemprop="publicationNumber">BR112018071347A2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-04-19</td>
          <td itemprop="publicationDate">2019-02-05</td>
          <td><span itemprop="assigneeOriginal">Innate Tumor Immunity Inc</span></td>
          <td itemprop="title">
  nlrp3 modulators
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3448393A1/en">
              <span itemprop="publicationNumber">EP3448393A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-04-25</td>
          <td itemprop="publicationDate">2019-03-06</td>
          <td><span itemprop="assigneeOriginal">Invivogen</span></td>
          <td itemprop="title">Novel complexes of immunostimulatory compounds, and uses thereof 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CA3022801A1/en">
              <span itemprop="publicationNumber">CA3022801A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-05-03</td>
          <td itemprop="publicationDate">2017-11-09</td>
          <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
          <td itemprop="title">Engineered nucleases useful for treatment of hemophilia a 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN107344931B/en">
              <span itemprop="publicationNumber">CN107344931B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-05-06</td>
          <td itemprop="publicationDate">2020-09-15</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Benzazepine derivative, preparation method thereof, pharmaceutical composition and application thereof 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/AR108396A1/en">
              <span itemprop="publicationNumber">AR108396A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-05-06</td>
          <td itemprop="publicationDate">2018-08-15</td>
          <td><span itemprop="assigneeOriginal">Incyte Corp</span></td>
          <td itemprop="title">
  HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017198744A1/en">
              <span itemprop="publicationNumber">WO2017198744A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-05-20</td>
          <td itemprop="publicationDate">2017-11-23</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Novel pyrazine compounds with oxygen, sulfur and nitrogen linker for the treatment of infectious diseases 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3464245B1/en">
              <span itemprop="publicationNumber">EP3464245B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-05-23</td>
          <td itemprop="publicationDate">2020-10-14</td>
          <td><span itemprop="assigneeOriginal">H. Hoffnabb-La Roche Ag</span></td>
          <td itemprop="title">Benzazepine dicarboxamide compounds with tertiary amide function 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017202703A1/en">
              <span itemprop="publicationNumber">WO2017202703A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-05-23</td>
          <td itemprop="publicationDate">2017-11-30</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Benzazepine dicarboxamide compounds with secondary amide function 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017202798A1/en">
              <span itemprop="publicationNumber">WO2017202798A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-05-26</td>
          <td itemprop="publicationDate">2017-11-30</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Xanthone derivatives for the treatment and prophylaxis of hepatitis b virus disease 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/ES2905980T3/en">
              <span itemprop="publicationNumber">ES2905980T3</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-05-26</td>
          <td itemprop="publicationDate">2022-04-12</td>
          <td><span itemprop="assigneeOriginal">Incyte Corp</span></td>
          <td itemprop="title">
  Heterocyclic compounds as immunomodulators
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017211791A1/en">
              <span itemprop="publicationNumber">WO2017211791A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-07</td>
          <td itemprop="publicationDate">2017-12-14</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Combination therapy of an hbsag inhibitor and a tlr7 agonist 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP2019521972A/en">
              <span itemprop="publicationNumber">JP2019521972A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-10</td>
          <td itemprop="publicationDate">2019-08-08</td>
          <td><span itemprop="assigneeOriginal">  </span></td>
          <td itemprop="title">
  Hepatitis B antiviral agent
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017216054A1/en">
              <span itemprop="publicationNumber">WO2017216054A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-12</td>
          <td itemprop="publicationDate">2017-12-21</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Dihydropyrimidinyl benzazepine carboxamide compounds 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017216686A1/en">
              <span itemprop="publicationNumber">WO2017216686A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-16</td>
          <td itemprop="publicationDate">2017-12-21</td>
          <td><span itemprop="assigneeOriginal">Novartis Ag</span></td>
          <td itemprop="title">8,9-fused 2-oxo-6,7-dihydropyrido-isoquinoline compounds as antivirals 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2017216685A1/en">
              <span itemprop="publicationNumber">WO2017216685A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-16</td>
          <td itemprop="publicationDate">2017-12-21</td>
          <td><span itemprop="assigneeOriginal">Novartis Ag</span></td>
          <td itemprop="title">Pentacyclic pyridone compounds as antivirals 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN109890819B/en">
              <span itemprop="publicationNumber">CN109890819B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-20</td>
          <td itemprop="publicationDate">2022-11-22</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Heterocyclic compounds as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN108290893B/en">
              <span itemprop="publicationNumber">CN108290893B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-22</td>
          <td itemprop="publicationDate">2021-01-05</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Dihydroperidinone derivatives, preparation method and application thereof 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3478680B1/en">
              <span itemprop="publicationNumber">EP3478680B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-29</td>
          <td itemprop="publicationDate">2020-04-22</td>
          <td><span itemprop="assigneeOriginal">H. Hoffnabb-La Roche Ag</span></td>
          <td itemprop="title">Novel tetrahydropyridopyrimidines for the treatment and prophylaxis of hbv infection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP6821716B2/en">
              <span itemprop="publicationNumber">JP6821716B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-29</td>
          <td itemprop="publicationDate">2021-01-27</td>
          <td><span itemprop="assigneeOriginal">     </span></td>
          <td itemprop="title">
        A novel dihydropyrrolopyrimidine for the treatment and prevention of hepatitis B virus infection
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10987359B2/en">
              <span itemprop="publicationNumber">US10987359B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-29</td>
          <td itemprop="publicationDate">2021-04-27</td>
          <td><span itemprop="assigneeOriginal">Novira Therapeutics, Inc.</span></td>
          <td itemprop="title">Oxadiazepinone derivatives and methods of treating hepatitis B infections 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN114057739A/en">
              <span itemprop="publicationNumber">CN114057739A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-29</td>
          <td itemprop="publicationDate">2022-02-18</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Diazepinone derivatives and their use in the treatment of hepatitis b infections 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10071079B2/en">
              <span itemprop="publicationNumber">US10071079B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-29</td>
          <td itemprop="publicationDate">2018-09-11</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/KR102468272B1/en">
              <span itemprop="publicationNumber">KR102468272B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-06-30</td>
          <td itemprop="publicationDate">2022-11-18</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Acoustic output device and control method thereof 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN109476675B/en">
              <span itemprop="publicationNumber">CN109476675B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-07-01</td>
          <td itemprop="publicationDate">2022-12-09</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">
        Dihydropyranopyrimidine derivatives for the treatment of viral infections
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP6301402B2/en">
              <span itemprop="publicationNumber">JP6301402B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-07-01</td>
          <td itemprop="publicationDate">2018-03-28</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">
        Ferritic stainless steel sheet and manufacturing method thereof
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US11098077B2/en">
              <span itemprop="publicationNumber">US11098077B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-07-05</td>
          <td itemprop="publicationDate">2021-08-24</td>
          <td><span itemprop="assigneeOriginal">Chinook Therapeutics, Inc.</span></td>
          <td itemprop="title">Locked nucleic acid cyclic dinucleotide compounds and uses thereof 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/MX2019000123A/en">
              <span itemprop="publicationNumber">MX2019000123A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-07-08</td>
          <td itemprop="publicationDate">2019-04-01</td>
          <td><span itemprop="assigneeOriginal">Squibb Bristol Myers Co</span></td>
          <td itemprop="title">1,3-dihydroxy-phenyl derivatives useful as immunomodulators. 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3484866B1/en">
              <span itemprop="publicationNumber">EP3484866B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-07-14</td>
          <td itemprop="publicationDate">2022-09-07</td>
          <td><span itemprop="assigneeOriginal">Incyte Corporation</span></td>
          <td itemprop="title">Heterocyclic compounds as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN109476668B/en">
              <span itemprop="publicationNumber">CN109476668B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-07-14</td>
          <td itemprop="publicationDate">2022-03-22</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">
        6,7-Dihydro-4H-pyrazolo[1,5-a]pyrazine and 6,7-dihydro-4H-triazolo[1,5-a]pyrazine for the treatment of infectious diseases compound
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018011160A1/en">
              <span itemprop="publicationNumber">WO2018011160A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-07-14</td>
          <td itemprop="publicationDate">2018-01-18</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018011100A1/en">
              <span itemprop="publicationNumber">WO2018011100A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-07-14</td>
          <td itemprop="publicationDate">2018-01-18</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Novel tetrahydropyrazolopyridine compounds for the treatment of infectious diseases 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN109415368B/en">
              <span itemprop="publicationNumber">CN109415368B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-07-14</td>
          <td itemprop="publicationDate">2021-04-30</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Carboxy 6, 7-dihydro-4H-pyrazolo [1,5-a ] pyrazine compounds for the treatment of infectious diseases 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018022282A1/en">
              <span itemprop="publicationNumber">WO2018022282A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-07-29</td>
          <td itemprop="publicationDate">2018-02-01</td>
          <td><span itemprop="assigneeOriginal">Newave Pharmaceutical Inc.</span></td>
          <td itemprop="title">Novel therapeutic agents for the treatment of hbv infection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018019297A1/en">
              <span itemprop="publicationNumber">WO2018019297A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-07-29</td>
          <td itemprop="publicationDate">2018-02-01</td>
          <td><span itemprop="assigneeOriginal">()</span></td>
          <td itemprop="title">Isoquinolinone compound and use thereof in preparation of antiviral drugs 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/AU2017307208B2/en">
              <span itemprop="publicationNumber">AU2017307208B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-07-30</td>
          <td itemprop="publicationDate">2021-01-21</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitors 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018026971A1/en">
              <span itemprop="publicationNumber">WO2018026971A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-08-03</td>
          <td itemprop="publicationDate">2018-02-08</td>
          <td><span itemprop="assigneeOriginal">Arising International, Llc</span></td>
          <td itemprop="title">Symmetric or semi-symmetric compounds useful as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP4198031A1/en">
              <span itemprop="publicationNumber">EP4198031A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-08-08</td>
          <td itemprop="publicationDate">2023-06-21</td>
          <td><span itemprop="assigneeOriginal">Merck Patent GmbH</span></td>
          <td itemprop="title">Tlr7/8 antagonists and uses thereof 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP2019526562A/en">
              <span itemprop="publicationNumber">JP2019526562A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-08-24</td>
          <td itemprop="publicationDate">2019-09-19</td>
          <td><span itemprop="assigneeOriginal">     </span></td>
          <td itemprop="title">
        Combination therapy of HBV capsid assembly inhibitor and nucleoside (Thi) analogue
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3889158B1/en">
              <span itemprop="publicationNumber">EP3889158B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-08-26</td>
          <td itemprop="publicationDate">2024-07-03</td>
          <td><span itemprop="assigneeOriginal">Solventum Intellectual Properties Company</span></td>
          <td itemprop="title">Fused [1,2]imidazo[4,5-c] ring compounds substituted with guanidino groups 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018044783A1/en">
              <span itemprop="publicationNumber">WO2018044783A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-08-29</td>
          <td itemprop="publicationDate">2018-03-08</td>
          <td><span itemprop="assigneeOriginal">Incyte Corporation</span></td>
          <td itemprop="title">Heterocyclic compounds as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10144706B2/en">
              <span itemprop="publicationNumber">US10144706B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-09-01</td>
          <td itemprop="publicationDate">2018-12-04</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Compounds useful as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/ES2826748T3/en">
              <span itemprop="publicationNumber">ES2826748T3</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-09-02</td>
          <td itemprop="publicationDate">2021-05-19</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences Inc</span></td>
          <td itemprop="title">
  Derivatives of 4,6-diamino-pyrido [3,2-d] pyrimidine as modulators of Toll-like receptors
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/ES2906581T3/en">
              <span itemprop="publicationNumber">ES2906581T3</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-09-02</td>
          <td itemprop="publicationDate">2022-04-19</td>
          <td><span itemprop="assigneeOriginal">Gilead Sciences Inc</span></td>
          <td itemprop="title">
  Toll-like receptor modulator compounds
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018043747A1/en">
              <span itemprop="publicationNumber">WO2018043747A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-09-05</td>
          <td itemprop="publicationDate">2018-03-08</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Anti-hepatitis b virus agent 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US11274115B2/en">
              <span itemprop="publicationNumber">US11274115B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-09-07</td>
          <td itemprop="publicationDate">2022-03-15</td>
          <td><span itemprop="assigneeOriginal">Glaxosmithkline Biological Sa</span></td>
          <td itemprop="title">Imidazoquinoline derivatives and their use in therapy 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018045911A1/en">
              <span itemprop="publicationNumber">WO2018045911A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-09-09</td>
          <td itemprop="publicationDate">2018-03-15</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Dihydropyrimidines, preparation method and use thereof 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN109641899B/en">
              <span itemprop="publicationNumber">CN109641899B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-09-09</td>
          <td itemprop="publicationDate">2022-07-22</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Compounds and compositions as endosomal Toll-like receptor inhibitors 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10660877B2/en">
              <span itemprop="publicationNumber">US10660877B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-09-09</td>
          <td itemprop="publicationDate">2020-05-26</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Pyridyl substituted indole compounds 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018051255A1/en">
              <span itemprop="publicationNumber">WO2018051255A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-09-14</td>
          <td itemprop="publicationDate">2018-03-22</td>
          <td><span itemprop="assigneeOriginal">Aurigene Discovery Technologies Limited</span></td>
          <td itemprop="title">Cyclic substituted-1,3,4-oxadiazole and thiadiazole compounds as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018051254A1/en">
              <span itemprop="publicationNumber">WO2018051254A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-09-14</td>
          <td itemprop="publicationDate">2018-03-22</td>
          <td><span itemprop="assigneeOriginal">Aurigene Discovery Technologies Limited</span></td>
          <td itemprop="title">Cyclic substituted-1,2,4-oxadiazole compounds as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10537590B2/en">
              <span itemprop="publicationNumber">US10537590B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-09-30</td>
          <td itemprop="publicationDate">2020-01-21</td>
          <td><span itemprop="assigneeOriginal">Boehringer Ingelheim International Gmbh</span></td>
          <td itemprop="title">Cyclic dinucleotide compounds 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/TN2020000159A1/en">
              <span itemprop="publicationNumber">TN2020000159A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-10-04</td>
          <td itemprop="publicationDate">2022-04-04</td>
          <td><span itemprop="assigneeOriginal">Merck Sharp &amp; Dohme</span></td>
          <td itemprop="title">BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US11001605B2/en">
              <span itemprop="publicationNumber">US11001605B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-10-07</td>
          <td itemprop="publicationDate">2021-05-11</td>
          <td><span itemprop="assigneeOriginal">Biolog Life Science Institute Gmbh &amp; Co. Kg</span></td>
          <td itemprop="title">Cyclic dinucleotides containing benzimidazole, method for the production of same, and use of same to activate stimulator of interferon genes (sting)-dependent signaling pathways 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/SG11201903042VA/en">
              <span itemprop="publicationNumber">SG11201903042VA</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-10-14</td>
          <td itemprop="publicationDate">2019-05-30</td>
          <td><span itemprop="assigneeOriginal">Precision Biosciences Inc</span></td>
          <td itemprop="title">Engineered meganucleases specific for recognition sequences in the hepatitis b virus genome 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/KR20190067235A/en">
              <span itemprop="publicationNumber">KR20190067235A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-10-20</td>
          <td itemprop="publicationDate">2019-06-14</td>
          <td><span itemprop="assigneeOriginal">   </span></td>
          <td itemprop="title">
        Double inhibitors of VISTA and PD-1 pathway
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3532069A4/en">
              <span itemprop="publicationNumber">EP3532069A4</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-10-26</td>
          <td itemprop="publicationDate">2020-05-13</td>
          <td><span itemprop="assigneeOriginal">Merck Sharp &amp; Dohme Corp.</span></td>
          <td itemprop="title">
        ARYL-AMIDE PHOSPHODIAMIDE COMPOUNDS ANTIVIRALS
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018078149A1/en">
              <span itemprop="publicationNumber">WO2018078149A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-10-31</td>
          <td itemprop="publicationDate">2018-05-03</td>
          <td><span itemprop="assigneeOriginal">F. Hoffmann-La Roche Ag</span></td>
          <td itemprop="title">Novel cyclicsulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US10988507B2/en">
              <span itemprop="publicationNumber">US10988507B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-11-07</td>
          <td itemprop="publicationDate">2021-04-27</td>
          <td><span itemprop="assigneeOriginal">Bristol-Myers Squibb Company</span></td>
          <td itemprop="title">Immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018089695A1/en">
              <span itemprop="publicationNumber">WO2018089695A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-11-11</td>
          <td itemprop="publicationDate">2018-05-17</td>
          <td><span itemprop="assigneeOriginal">Dynavax Technologies Corporation</span></td>
          <td itemprop="title">Toll-like receptor antagonist compounds and methods of use 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CN108069969B/en">
              <span itemprop="publicationNumber">CN108069969B</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-11-11</td>
          <td itemprop="publicationDate">2020-09-18</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Nitrogen-containing heterocyclic compound, preparation method, intermediate, pharmaceutical composition and application 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JOP20170188A1/en">
              <span itemprop="publicationNumber">JOP20170188A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-11-25</td>
          <td itemprop="publicationDate">2019-01-30</td>
          <td><span itemprop="assigneeOriginal">Janssen Biotech Inc</span></td>
          <td itemprop="title">Cyclic dinucleotides as sting agonists 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/AU2017366621B2/en">
              <span itemprop="publicationNumber">AU2017366621B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-11-28</td>
          <td itemprop="publicationDate">2021-07-29</td>
          <td><span itemprop="assigneeOriginal">Jiangsu Hengrui Medicine Co., Ltd.</span></td>
          <td itemprop="title">Pyrazolo-heteroaryl derivative, preparation method and medical use thereof 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JOP20170192A1/en">
              <span itemprop="publicationNumber">JOP20170192A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-12-01</td>
          <td itemprop="publicationDate">2019-01-30</td>
          <td><span itemprop="assigneeOriginal">Takeda Pharmaceuticals Co</span></td>
          <td itemprop="title">Cyclic dinucleotide 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/JP2020511420A/en">
              <span itemprop="publicationNumber">JP2020511420A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-12-20</td>
          <td itemprop="publicationDate">2020-04-16</td>
          <td><span itemprop="assigneeOriginal">    </span></td>
          <td itemprop="title">
        Combination of PD-1 antagonists with cyclic dinucleotide STING agonists for the treatment of cancer
       
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/ES2891528T3/en">
              <span itemprop="publicationNumber">ES2891528T3</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-12-20</td>
          <td itemprop="publicationDate">2022-01-28</td>
          <td><span itemprop="assigneeOriginal">Bristol Myers Squibb Co</span></td>
          <td itemprop="title">
  Compounds useful as immunomodulators
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3558324A4/en">
              <span itemprop="publicationNumber">EP3558324A4</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-12-20</td>
          <td itemprop="publicationDate">2020-08-05</td>
          <td><span itemprop="assigneeOriginal">Merck Sharp &amp; Dohme Corp.</span></td>
          <td itemprop="title">
        CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT
       
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3558963B1/en">
              <span itemprop="publicationNumber">EP3558963B1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-12-22</td>
          <td itemprop="publicationDate">2022-03-23</td>
          <td><span itemprop="assigneeOriginal">Incyte Corporation</span></td>
          <td itemprop="title">Bicyclic heteroaromatic compounds as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/GEAP202215134A/en">
              <span itemprop="publicationNumber">GEAP202215134A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-12-22</td>
          <td itemprop="publicationDate">2022-05-10</td>
          <td><span itemprop="assigneeOriginal">Incyte Corp</span></td>
          <td itemprop="title">Heterocyclic compounds as immunomodulators 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/RU2019122625A/en">
              <span itemprop="publicationNumber">RU2019122625A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-12-22</td>
          <td itemprop="publicationDate">2021-01-22</td>
          <td><span itemprop="assigneeOriginal">    .</span></td>
          <td itemprop="title">
  ANTIVIRAL BENZYLAMINE-PHOSPHODIAMIDE COMPOUNDS
 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018119221A1/en">
              <span itemprop="publicationNumber">WO2018119221A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-12-22</td>
          <td itemprop="publicationDate">2018-06-28</td>
          <td><span itemprop="assigneeOriginal">Incyte Corporation</span></td>
          <td itemprop="title">Pyridine derivatives as immunomodulators 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/CA3047573A1/en">
              <span itemprop="publicationNumber">CA3047573A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-12-22</td>
          <td itemprop="publicationDate">2018-06-28</td>
          <td><span itemprop="assigneeOriginal">Merck Sharp &amp; Dohme Corp.</span></td>
          <td itemprop="title">Antiviral aliphatic ester prodrugs of tenofovir 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018119263A1/en">
              <span itemprop="publicationNumber">WO2018119263A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-12-22</td>
          <td itemprop="publicationDate">2018-06-28</td>
          <td><span itemprop="assigneeOriginal">Incyte Corporation</span></td>
          <td itemprop="title">Heterocyclic compounds derivatives as pd-l1 internalization inducers 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US20180179201A1/en">
              <span itemprop="publicationNumber">US20180179201A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2016-12-22</td>
          <td itemprop="publicationDate">2018-06-28</td>
          <td><span itemprop="assigneeOriginal">Incyte Corporation</span></td>
          <td itemprop="title">Heterocyclic compounds as immunomodulators 
     </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2018199338A1/en">
              <span itemprop="publicationNumber">WO2018199338A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2017-04-27</td>
          <td itemprop="publicationDate">2018-11-01</td>
          <td><span itemprop="assigneeOriginal"></span></td>
          <td itemprop="title">Nucleic acid molecule for treatment of hepatitis b 
       </td>
        </tr>
        <tr itemprop="backwardReferencesFamily" itemscope repeat>
          <td>
            <a href="/patent/US11142750B2/en">
              <span itemprop="publicationNumber">US11142750B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
            
            
          </td>
          <td itemprop="priorityDate">2018-04-12</td>
          <td itemprop="publicationDate">2021-10-12</td>
          <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
        </tr>
      </tbody>
    </table>

    <ul>
      <li itemprop="applicationsByYear" itemscope repeat>
        <span itemprop="year">2019</span>
        <ul>
          <li itemprop="application" itemscope repeat>
            <span itemprop="filingDate">2019-04-11</span>
            <span itemprop="countryCode">US</span>
            <span itemprop="applicationNumber">US16/381,668</span>
            <a href="/patent/US11142750B2/en"><span itemprop="documentId">patent/US11142750B2/en</span></a>
            <span itemprop="legalStatusCat">active</span>
            <span itemprop="legalStatus">Active</span>
            <span itemprop="thisApp" content="true" bool></span>
          </li>
          <li itemprop="application" itemscope repeat>
            <span itemprop="filingDate">2019-04-11</span>
            <span itemprop="countryCode">TW</span>
            <span itemprop="applicationNumber">TW108112734A</span>
            <a href="/patent/TW201945388A/en"><span itemprop="documentId">patent/TW201945388A/en</span></a>
            <span itemprop="legalStatusCat">unknown</span>
            <span itemprop="legalStatus"></span>
            
          </li>
          <li itemprop="application" itemscope repeat>
            <span itemprop="filingDate">2019-04-12</span>
            <span itemprop="countryCode">WO</span>
            <span itemprop="applicationNumber">PCT/US2019/027203</span>
            <a href="/patent/WO2019200247A1/en"><span itemprop="documentId">patent/WO2019200247A1/en</span></a>
            <span itemprop="legalStatusCat">not_active</span>
            <span itemprop="legalStatus">Ceased</span>
            
          </li>
          <li itemprop="application" itemscope repeat>
            <span itemprop="filingDate">2019-04-12</span>
            <span itemprop="countryCode">AR</span>
            <span itemprop="applicationNumber">ARP190100963A</span>
            <a href="/patent/AR115041A1/en"><span itemprop="documentId">patent/AR115041A1/en</span></a>
            <span itemprop="legalStatusCat">unknown</span>
            <span itemprop="legalStatus"></span>
            
          </li>
          <li itemprop="application" itemscope repeat>
            <span itemprop="filingDate">2019-04-12</span>
            <span itemprop="countryCode">EP</span>
            <span itemprop="applicationNumber">EP19725244.8A</span>
            <a href="/patent/EP3775187A1/en"><span itemprop="documentId">patent/EP3775187A1/en</span></a>
            <span itemprop="legalStatusCat">active</span>
            <span itemprop="legalStatus">Pending</span>
            
          </li>
        </ul>
      </li>
      <li itemprop="applicationsByYear" itemscope repeat>
        <span itemprop="year">2021</span>
        <ul>
          <li itemprop="application" itemscope repeat>
            <span itemprop="filingDate">2021-09-20</span>
            <span itemprop="countryCode">US</span>
            <span itemprop="applicationNumber">US17/479,173</span>
            <a href="/patent/US11788077B2/en"><span itemprop="documentId">patent/US11788077B2/en</span></a>
            <span itemprop="legalStatusCat">active</span>
            <span itemprop="legalStatus">Active</span>
            
          </li>
        </ul>
      </li>
      <li itemprop="applicationsByYear" itemscope repeat>
        <span itemprop="year">2023</span>
        <ul>
          <li itemprop="application" itemscope repeat>
            <span itemprop="filingDate">2023-09-12</span>
            <span itemprop="countryCode">US</span>
            <span itemprop="applicationNumber">US18/465,727</span>
            <a href="/patent/US20240035011A1/en"><span itemprop="documentId">patent/US20240035011A1/en</span></a>
            <span itemprop="legalStatusCat">not_active</span>
            <span itemprop="legalStatus">Abandoned</span>
            
          </li>
        </ul>
      </li>
      <li itemprop="applicationsByYear" itemscope repeat>
        <span itemprop="year">2025</span>
        <ul>
          <li itemprop="application" itemscope repeat>
            <span itemprop="filingDate">2025-01-17</span>
            <span itemprop="countryCode">US</span>
            <span itemprop="applicationNumber">US19/029,554</span>
            <a href="/patent/US20250171757A1/en"><span itemprop="documentId">patent/US20250171757A1/en</span></a>
            <span itemprop="legalStatusCat">active</span>
            <span itemprop="legalStatus">Pending</span>
            
          </li>
        </ul>
      </li>
    </ul>

    </section>

  

  

  <h2>Cited By (16)</h2>
  <table>
    <caption>* Cited by examiner,  Cited by third party</caption>
    <thead>
      <tr>
        <th>Publication number</th>
        <th>Priority date</th>
        <th>Publication date</th>
        <th>Assignee</th>
        <th>Title</th>
      </tr>
    </thead>
    <tbody>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/US11274285B2/en">
            <span itemprop="publicationNumber">US11274285B2</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2016-10-14</td>
        <td itemprop="publicationDate">2022-03-15</td>
        <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
        <td itemprop="title">Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/US11142750B2/en">
            <span itemprop="publicationNumber">US11142750B2</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2018-04-12</td>
        <td itemprop="publicationDate">2021-10-12</td>
        <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
        <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/US11788077B2/en">
            <span itemprop="publicationNumber">US11788077B2</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2018-04-12</td>
        <td itemprop="publicationDate">2023-10-17</td>
        <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
        <td itemprop="title">Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/EP4458975A2/en">
            <span itemprop="publicationNumber">EP4458975A2</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2019-09-30</td>
        <td itemprop="publicationDate">2024-11-06</td>
        <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
        <td itemprop="title">Hbv vaccines and methods treating hbv 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/WO2021067181A1/en">
            <span itemprop="publicationNumber">WO2021067181A1</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2019-09-30</td>
        <td itemprop="publicationDate">2021-04-08</td>
        <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
        <td itemprop="title">Hbv vaccines and methods treating hbv 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/US12410418B2/en">
            <span itemprop="publicationNumber">US12410418B2</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          <span itemprop="examinerCited">*</span>
          
        </td>
        <td itemprop="priorityDate">2019-12-06</td>
        <td itemprop="publicationDate">2025-09-09</td>
        <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
        <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/US20230031465A1/en">
            <span itemprop="publicationNumber">US20230031465A1</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          <span itemprop="examinerCited">*</span>
          
        </td>
        <td itemprop="priorityDate">2019-12-06</td>
        <td itemprop="publicationDate">2023-02-02</td>
        <td><span itemprop="assigneeOriginal">Precision Biosciences, Inc.</span></td>
        <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/WO2021188959A1/en">
            <span itemprop="publicationNumber">WO2021188959A1</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2020-03-20</td>
        <td itemprop="publicationDate">2021-09-23</td>
        <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
        <td itemprop="title">Prodrugs of 4&#39;-c-substituted-2-halo-2&#39;-deoxyadenosine nucleosides and methods of making and using the same 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/WO2022087149A2/en">
            <span itemprop="publicationNumber">WO2022087149A2</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2020-10-22</td>
        <td itemprop="publicationDate">2022-04-28</td>
        <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
        <td itemprop="title">Interleukin-2-fc fusion proteins and methods of use 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/EP4667499A2/en">
            <span itemprop="publicationNumber">EP4667499A2</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2020-10-22</td>
        <td itemprop="publicationDate">2025-12-24</td>
        <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
        <td itemprop="title">Interleukin-2-fc fusion proteins and methods of use 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/WO2022241134A1/en">
            <span itemprop="publicationNumber">WO2022241134A1</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2021-05-13</td>
        <td itemprop="publicationDate">2022-11-17</td>
        <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
        <td itemprop="title">COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/US20250257340A1/en">
            <span itemprop="publicationNumber">US20250257340A1</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          <span itemprop="examinerCited">*</span>
          
        </td>
        <td itemprop="priorityDate">2022-02-23</td>
        <td itemprop="publicationDate">2025-08-14</td>
        <td><span itemprop="assigneeOriginal">Excision Biotherapeutics Inc</span></td>
        <td itemprop="title">Guide nucleic acid identification and methods of use 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/WO2025240246A1/en">
            <span itemprop="publicationNumber">WO2025240246A1</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2024-05-13</td>
        <td itemprop="publicationDate">2025-11-20</td>
        <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
        <td itemprop="title">Combination therapies with ribavirin 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/WO2025240244A1/en">
            <span itemprop="publicationNumber">WO2025240244A1</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2024-05-13</td>
        <td itemprop="publicationDate">2025-11-20</td>
        <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
        <td itemprop="title">Combination therapies comprising bulevirtide and lonafarnib for use in the treatment of hepatitis d virus infection 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/WO2025240243A1/en">
            <span itemprop="publicationNumber">WO2025240243A1</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2024-05-13</td>
        <td itemprop="publicationDate">2025-11-20</td>
        <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
        <td itemprop="title">Combination therapies with bulevirtide and an inhibitory nucleic acid targeting hepatitis b virus 
       </td>
      </tr>
      <tr itemprop="forwardReferences" itemscope repeat>
        <td>
          <a href="/patent/WO2025240242A1/en">
            <span itemprop="publicationNumber">WO2025240242A1</span>
            (<span itemprop="primaryLanguage">en</span>)
          </a>
          
          
        </td>
        <td itemprop="priorityDate">2024-05-13</td>
        <td itemprop="publicationDate">2025-11-20</td>
        <td><span itemprop="assigneeOriginal">Gilead Sciences, Inc.</span></td>
        <td itemprop="title">Combination therapies with ribavirin 
       </td>
      </tr>
    </tbody>
  </table>

  <section>
    <h2>Also Published As</h2>
    <table>
      <thead>
        <tr>
          <th>Publication number</th>
          <th>Publication date</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="docdbFamily" itemscope repeat>
          <td>
            <a href="/patent/US11142750B2/en">
              <span itemprop="publicationNumber">US11142750B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="publicationDate">2021-10-12</td>
        </tr>
        <tr itemprop="docdbFamily" itemscope repeat>
          <td>
            <a href="/patent/US11788077B2/en">
              <span itemprop="publicationNumber">US11788077B2</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="publicationDate">2023-10-17</td>
        </tr>
        <tr itemprop="docdbFamily" itemscope repeat>
          <td>
            <a href="/patent/US20240035011A1/en">
              <span itemprop="publicationNumber">US20240035011A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="publicationDate">2024-02-01</td>
        </tr>
        <tr itemprop="docdbFamily" itemscope repeat>
          <td>
            <a href="/patent/AR115041A1/en">
              <span itemprop="publicationNumber">AR115041A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="publicationDate">2020-11-18</td>
        </tr>
        <tr itemprop="docdbFamily" itemscope repeat>
          <td>
            <a href="/patent/EP3775187A1/en">
              <span itemprop="publicationNumber">EP3775187A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="publicationDate">2021-02-17</td>
        </tr>
        <tr itemprop="docdbFamily" itemscope repeat>
          <td>
            <a href="/patent/US20220056427A1/en">
              <span itemprop="publicationNumber">US20220056427A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="publicationDate">2022-02-24</td>
        </tr>
        <tr itemprop="docdbFamily" itemscope repeat>
          <td>
            <a href="/patent/TW201945388A/en">
              <span itemprop="publicationNumber">TW201945388A</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="publicationDate">2019-12-01</td>
        </tr>
        <tr itemprop="docdbFamily" itemscope repeat>
          <td>
            <a href="/patent/WO2019200247A1/en">
              <span itemprop="publicationNumber">WO2019200247A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="publicationDate">2019-10-17</td>
        </tr>
        <tr itemprop="docdbFamily" itemscope repeat>
          <td>
            <a href="/patent/US20250171757A1/en">
              <span itemprop="publicationNumber">US20250171757A1</span>
              (<span itemprop="primaryLanguage">en</span>)
            </a>
          </td>
          <td itemprop="publicationDate">2025-05-29</td>
        </tr>
      </tbody>
    </table>
  </section>

  <section>
    <h2>Similar Documents</h2>
    <table>
      <thead>
        <tr>
          <th>Publication</th>
          <th>Publication Date</th>
          <th>Title</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="similarDocuments" itemscope repeat>
          <td>
            <meta itemprop="isPatent" content="true">
              <a href="/patent/US11788077B2/en">
                <span itemprop="publicationNumber">US11788077B2</span>
                (<span itemprop="primaryLanguage">en</span>)
              </a>
            
            
          </td>
          <td>
            <time itemprop="publicationDate" datetime="2023-10-17">2023-10-17</time>
            
            
          </td>
          <td itemprop="title">Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
        </tr>
        <tr itemprop="similarDocuments" itemscope repeat>
          <td>
            <meta itemprop="isPatent" content="true">
              <a href="/patent/US20240271111A1/en">
                <span itemprop="publicationNumber">US20240271111A1</span>
                (<span itemprop="primaryLanguage">en</span>)
              </a>
            
            
          </td>
          <td>
            <time itemprop="publicationDate" datetime="2024-08-15">2024-08-15</time>
            
            
          </td>
          <td itemprop="title">Engineered meganucleases specific for recognition sequences in the hepatitis b virus genome 
     </td>
        </tr>
        <tr itemprop="similarDocuments" itemscope repeat>
          <td>
            <meta itemprop="isPatent" content="true">
              <a href="/patent/US12410418B2/en">
                <span itemprop="publicationNumber">US12410418B2</span>
                (<span itemprop="primaryLanguage">en</span>)
              </a>
            
            
          </td>
          <td>
            <time itemprop="publicationDate" datetime="2025-09-09">2025-09-09</time>
            
            
          </td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome 
       </td>
        </tr>
        <tr itemprop="similarDocuments" itemscope repeat>
          <td>
            <meta itemprop="isPatent" content="true">
              <a href="/patent/EP3704238A1/en">
                <span itemprop="publicationNumber">EP3704238A1</span>
                (<span itemprop="primaryLanguage">en</span>)
              </a>
            
            
          </td>
          <td>
            <time itemprop="publicationDate" datetime="2020-09-09">2020-09-09</time>
            
            
          </td>
          <td itemprop="title">Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a 
     </td>
        </tr>
        <tr itemprop="similarDocuments" itemscope repeat>
          <td>
            <meta itemprop="isPatent" content="true">
              <a href="/patent/US20250346877A1/en">
                <span itemprop="publicationNumber">US20250346877A1</span>
                (<span itemprop="primaryLanguage">en</span>)
              </a>
            
            
          </td>
          <td>
            <time itemprop="publicationDate" datetime="2025-11-13">2025-11-13</time>
            
            
          </td>
          <td itemprop="title">Engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
       </td>
        </tr>
        <tr itemprop="similarDocuments" itemscope repeat>
          <td>
            <meta itemprop="isPatent" content="true">
              <a href="/patent/US20240408235A1/en">
                <span itemprop="publicationNumber">US20240408235A1</span>
                (<span itemprop="primaryLanguage">en</span>)
              </a>
            
            
          </td>
          <td>
            <time itemprop="publicationDate" datetime="2024-12-12">2024-12-12</time>
            
            
          </td>
          <td itemprop="title">Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency 
     </td>
        </tr>
        <tr itemprop="similarDocuments" itemscope repeat>
          <td>
            <meta itemprop="isPatent" content="true">
              <a href="/patent/HK40082808A/en">
                <span itemprop="publicationNumber">HK40082808A</span>
                (<span itemprop="primaryLanguage">en</span>)
              </a>
            
            
          </td>
          <td>
            <time itemprop="publicationDate" datetime="2023-06-16">2023-06-16</time>
            
            
          </td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
       </td>
        </tr>
        <tr itemprop="similarDocuments" itemscope repeat>
          <td>
            <meta itemprop="isPatent" content="true">
              <a href="/patent/HK40082808B/en">
                <span itemprop="publicationNumber">HK40082808B</span>
                (<span itemprop="primaryLanguage">en</span>)
              </a>
            
            
          </td>
          <td>
            <time itemprop="publicationDate" datetime="2025-08-22">2025-08-22</time>
            
            
          </td>
          <td itemprop="title">Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome 
       </td>
        </tr>
        <tr itemprop="similarDocuments" itemscope repeat>
          <td>
            <meta itemprop="isPatent" content="true">
              <a href="/patent/HK40006308A/en">
                <span itemprop="publicationNumber">HK40006308A</span>
                (<span itemprop="primaryLanguage">en</span>)
              </a>
            
            
          </td>
          <td>
            <time itemprop="publicationDate" datetime="2020-05-22">2020-05-22</time>
            
            
          </td>
          <td itemprop="title">Engineered meganucleases specific for recognition sequences in the hepatitis b virus genome 
       </td>
        </tr>
        <tr itemprop="similarDocuments" itemscope repeat>
          <td>
            <meta itemprop="isPatent" content="true">
              <a href="/patent/HK40006308B/en">
                <span itemprop="publicationNumber">HK40006308B</span>
                (<span itemprop="primaryLanguage">en</span>)
              </a>
            
            
          </td>
          <td>
            <time itemprop="publicationDate" datetime="2023-05-19">2023-05-19</time>
            
            
          </td>
          <td itemprop="title">Engineered meganucleases specific for recognition sequences in the hepatitis b virus genome 
       </td>
        </tr>
        <tr itemprop="similarDocuments" itemscope repeat>
          <td>
            <meta itemprop="isPatent" content="true">
              <a href="/patent/EA042452B1/en">
                <span itemprop="publicationNumber">EA042452B1</span>
                (<span itemprop="primaryLanguage">en</span>)
              </a>
            
            
          </td>
          <td>
            <time itemprop="publicationDate" datetime="2023-02-15">2023-02-15</time>
            
            
          </td>
          <td itemprop="title">
        ENGINEERED MEGANUCLASES SPECIFIC TO THE RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME
       
     </td>
        </tr>
      </tbody>
    </table>
  </section>

  <section>
    <h2>Legal Events</h2>
    <table>
      <thead>
        <tr>
          <th>Date</th>
          <th>Code</th>
          <th>Title</th>
          <th>Description</th>
        </tr>
      </thead>
      <tbody>
        <tr itemprop="legalEvents" itemscope repeat>
          <td><time itemprop="date" datetime="2019-04-11">2019-04-11</time></td>
          <td itemprop="code">FEPP</td>
          <td itemprop="title">Fee payment procedure</td>
          <td>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Free format text</strong>:
              <span itemprop="value">ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY</span>
            </p>
          </td>
        </tr>
        <tr itemprop="legalEvents" itemscope repeat>
          <td><time itemprop="date" datetime="2019-06-13">2019-06-13</time></td>
          <td itemprop="code">AS</td>
          <td itemprop="title">Assignment</td>
          <td>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Owner name</strong>:
              <span itemprop="value">PRECISION BIOSCIENCES, INC., NORTH CAROLINA</span>
            </p>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Free format text</strong>:
              <span itemprop="value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SMITH, JAMES JEFFERSON;LAPE, JANEL;BARTSEVICH, VICTOR;AND OTHERS;REEL/FRAME:049456/0083</span>
            </p>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Effective date</strong>:
              <span itemprop="value">20190515</span>
            </p>
          </td>
        </tr>
        <tr itemprop="legalEvents" itemscope repeat>
          <td><time itemprop="date" datetime="2019-08-26">2019-08-26</time></td>
          <td itemprop="code">STPP</td>
          <td itemprop="title">Information on status: patent application and granting procedure in general</td>
          <td>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Free format text</strong>:
              <span itemprop="value">APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED</span>
            </p>
          </td>
        </tr>
        <tr itemprop="legalEvents" itemscope repeat>
          <td><time itemprop="date" datetime="2020-08-17">2020-08-17</time></td>
          <td itemprop="code">STPP</td>
          <td itemprop="title">Information on status: patent application and granting procedure in general</td>
          <td>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Free format text</strong>:
              <span itemprop="value">DOCKETED NEW CASE - READY FOR EXAMINATION</span>
            </p>
          </td>
        </tr>
        <tr itemprop="legalEvents" itemscope repeat>
          <td><time itemprop="date" datetime="2021-02-16">2021-02-16</time></td>
          <td itemprop="code">STPP</td>
          <td itemprop="title">Information on status: patent application and granting procedure in general</td>
          <td>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Free format text</strong>:
              <span itemprop="value">NON FINAL ACTION MAILED</span>
            </p>
          </td>
        </tr>
        <tr itemprop="legalEvents" itemscope repeat>
          <td><time itemprop="date" datetime="2021-05-21">2021-05-21</time></td>
          <td itemprop="code">STPP</td>
          <td itemprop="title">Information on status: patent application and granting procedure in general</td>
          <td>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Free format text</strong>:
              <span itemprop="value">RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER</span>
            </p>
          </td>
        </tr>
        <tr itemprop="legalEvents" itemscope repeat>
          <td><time itemprop="date" datetime="2021-06-07">2021-06-07</time></td>
          <td itemprop="code">STPP</td>
          <td itemprop="title">Information on status: patent application and granting procedure in general</td>
          <td>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Free format text</strong>:
              <span itemprop="value">NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS</span>
            </p>
          </td>
        </tr>
        <tr itemprop="legalEvents" itemscope repeat>
          <td><time itemprop="date" datetime="2021-09-09">2021-09-09</time></td>
          <td itemprop="code">STPP</td>
          <td itemprop="title">Information on status: patent application and granting procedure in general</td>
          <td>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Free format text</strong>:
              <span itemprop="value">PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED</span>
            </p>
          </td>
        </tr>
        <tr itemprop="legalEvents" itemscope repeat>
          <td><time itemprop="date" datetime="2021-09-22">2021-09-22</time></td>
          <td itemprop="code">STCF</td>
          <td itemprop="title">Information on status: patent grant</td>
          <td>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Free format text</strong>:
              <span itemprop="value">PATENTED CASE</span>
            </p>
          </td>
        </tr>
        <tr itemprop="legalEvents" itemscope repeat>
          <td><time itemprop="date" datetime="2025-04-10">2025-04-10</time></td>
          <td itemprop="code">FEPP</td>
          <td itemprop="title">Fee payment procedure</td>
          <td>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Free format text</strong>:
              <span itemprop="value">ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY</span>
            </p>
          </td>
        </tr>
        <tr itemprop="legalEvents" itemscope repeat>
          <td><time itemprop="date" datetime="2025-04-11">2025-04-11</time></td>
          <td itemprop="code">MAFP</td>
          <td itemprop="title">Maintenance fee payment</td>
          <td>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Free format text</strong>:
              <span itemprop="value">PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY</span>
            </p>
            <p itemprop="attributes" itemscope repeat>
              <strong itemprop="label">Year of fee payment</strong>:
              <span itemprop="value">4</span>
            </p>
          </td>
        </tr>
      </tbody>
    </table>
  </section>

</article>

    </search-app>
    
    <script></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  </body>
</html>
